0000704415-14-000015.txt : 20140314 0000704415-14-000015.hdr.sgml : 20140314 20140314162205 ACCESSION NUMBER: 0000704415-14-000015 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140314 DATE AS OF CHANGE: 20140314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHWAYS, INC CENTRAL INDEX KEY: 0000704415 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 621117144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19364 FILM NUMBER: 14694733 BUSINESS ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 6156144929 MAIL ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HEALTHWAYS INC DATE OF NAME CHANGE: 20000322 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HEALTHCORP INC /DE DATE OF NAME CHANGE: 19940211 10-K 1 form10-k_123113.htm HEALTHWAYS, INC. FORM 10-K  
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 10-K
 
[X]   Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Fiscal Year Ended December 31, 2013

or

[  ]   Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission file number 000-19364
 
 
HEALTHWAYS, INC.
(Exact name of registrant as specified in its charter)


Delaware
 
62-1117144
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)

701 Cool Springs Boulevard, Franklin, TN  37067
(Address of principal executive offices) (Zip code)

(615) 614-4929
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Name of each exchange on which registered
Common Stock - $.001 par value, and
 
The NASDAQ Stock Market LLC
 
related Preferred Stock Purchase Rights
 
 

Securities registered pursuant to Section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes  ¨ 
  No  x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.

Yes  ¨ 
  No  x
1
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes  x 
  No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes   x 
   No   ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.                  
x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non- accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer", "accelerated filer", and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ¨
Accelerated filer  x
Non-accelerated filer  ¨
Smaller reporting company  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes  ¨ 
  No  x

As of June 30, 2013, the last business day of the registrant's most recently completed second fiscal quarter, the aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $534.7 million based on the price at which the shares were last sold for such date on The NASDAQ Stock Market.

As of March 7, 2014, 35,208,572 shares of Common Stock were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant's Proxy Statement for the 2014 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K.

2
Healthways, Inc.
Form 10-K
Table of Contents

 
 
 
Page
Part I
 
 
 
 
Item 1.
Business
4
 
Item 1A.
Risk Factors
11
 
Item 1B.
Unresolved Staff Comments
19
 
Item 2.
Properties
19
 
Item 3.
Legal Proceedings
19
 
Item 4.
Mine Safety Disclosures
20
Part II
 
 
 
 
Item 5.
Market for Registrant's Common Equity, Related Stockholder
 
 
 
Matters and Issuer Purchases of Equity Securities
22
 
Item 6.
Selected Financial Data
24
 
Item 7.
Management's Discussion and Analysis of Financial Condition and
 
 
 
Results of Operations
25
 
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
38
 
Item 8.
Financial Statements and Supplementary Data
40
 
Item 9.
Changes in and Disagreements with Accountants on Accounting and
 
 
 
Financial Disclosure
72
 
Item 9A.
Controls and Procedures
72
 
Item 9B.
Other Information
72
Part III
 
 
 
 
Item 10.
Directors, Executive Officers and Corporate Governance
73
 
Item 11.
Executive Compensation
73
 
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
73
 
Item 13.
Certain Relationships and Related Transactions, and Director Independence
73
 
Item 14.
Principal Accounting Fees and Services
73
Part IV
 
 
 
 
Item 15.
Exhibits, Financial Statement Schedules
74

3
PART I
 
Item 1.
Business

Overview

Founded and incorporated in Delaware in 1981, Healthways, Inc. ("Healthways") provides specialized, comprehensive solutions to help people improve their well-being, thereby improving their health and productivity and reducing their health-related costs.

We believe well-being consists of five essential elements:

·
  Purpose: Liking what you do each day and being motivated to achieve your goals

·
  Social: Having supportive relationships and love in your life

·
  Financial: Managing your economic life to reduce stress and increase security

·
  Community: Liking where you live, feeling safe and having pride in your community

·
  Physical: Having good health and enough energy to get things done daily

Our solutions provide highly specific and personalized interventions for each individual in a population, irrespective of health status, age or payor.  Through a simple, but powerful, data-driven process we identify the needs of each individual and determine the right level of support. This allows us to deploy successful strategies to sustain engagement, to use the best science to drive behavior change and ultimately deliver meaningful, measurable outcomes. Our services are delivered using a range of methods desired by an individual including venue-based face-to-face interactions; print; phone; mobile and remote devices with unique applications; on-line including social networks; and any combination thereof to motivate and sustain healthy behaviors.

In North America, our customers include health plans, both commercial and Medicare Advantage, large self-insured employers, including state and municipal government entities, and providers of healthcare, including integrated healthcare systems, hospitals, and physician groups, in all 50 states and the District of Columbia. We also provide services to commercial healthcare businesses and/or government entities in Brazil, Australia, and France.  All of our interventions were developed with over 30 years of experience based in science and ongoing innovation. Our technology-driven infrastructure is compatible with, and integrated into, our customer and other vendor systems. We operate domestic and international well-being improvement call centers staffed with a wide range of licensed health professionals.  Our fitness center network encompasses approximately 15,000 U.S. locations.  We also maintain an extensive network of over 88,000 complementary, alternative and physical medicine practitioners, which offers convenient access to the significant number of individuals who seek health services outside of the traditional healthcare system.

Our guiding philosophy and approach to market are predicated on the fundamental belief that healthier people cost less and are more productive.  As described more fully below, our programs are designed to improve individual and organizational well-being by helping people adopt or maintain healthy behaviors, reduce health-related risk factors, and optimize their care for identified health conditions.

First, our programs are designed to help people adopt or maintain healthy behaviors by:

 
· 
fostering wellness and disease prevention through total population screening, well-being assessments and supportive interventions; and
 
 
· 
engaging people in our well-being improvement programs and networks, such as fitness, weight management, stress management, financial and lifestyle management skills, chiropractic, and complementary and alternative medicine.

Our prevention programs focus on education, physical fitness, nutrition, health coaching, and tools that support behavior change. These programs improve the well-being status of member populations and reduce the short- and long-term health-related costs for participants, including associated costs from the loss of employee productivity. Many of our programs for lifestyle support, management and education are delivered through web-based portals and mobile applications and may also offer a social networking enhancement opportunity. Our web-based tools include the Well-Being Connect® portal, and our educational capabilities include the Dave Ramsey Core™ Financial Wellness program. We also utilize mobile applications such as wellbeingGO®, and our MeYou Health subsidiary unique mobile applications include Well-Being Tracker™, Daily Challenge®, and Walkadoo™.
4
Second, our programs are designed to help people reduce health-related risk factors by:

 
· 
promoting personal change and improvement in the lifestyle behaviors that lead to poor health or chronic conditions; and
 
 
· 
providing educational materials and personal interactions with highly trained healthcare professionals to create and sustain healthier behaviors for those individuals at risk or in the early stages of chronic conditions.
 
We engage our customers' covered populations through specific interactions that are sensitive to each individual's health risks and needs. In many situations, we utilize predictive modeling capabilities to allow us to identify and stratify those participants who are most at risk for an adverse health event. Our programs are designed to motivate people to make positive lifestyle changes and accomplish individual goals, such as increasing physical activity for seniors through the Healthways SilverSneakers® fitness solution, overcoming nicotine addiction through the QuitNet® on-line smoking cessation community, or generating sustainable weight-loss through our Innergy® solution.

Finally, our programs are designed to help people optimize care for identified health conditions by:

 
· 
incorporating the latest, evidence-based clinical guidelines into interventions to optimize patient health outcomes;
 
 
· 
developing care support plans and motivating members to set attainable goals for themselves;
 
 
· 
providing local market resources to address acute episodic interventions;
 
 
· 
coordinating members' care as an extension of their healthcare providers;
 
 
· 
providing software technology solutions and management consulting in support of well-being improvement services; and
 
 
· 
providing high-risk care management for members at risk for hospitalization due to complex conditions.
 
Our approach is to use proprietary, analytic models to identify individuals who are likely to incur future high costs, including those who have specific gaps in care, and through evidence-based interventions drive adherence to proven standards of care, medication regimens and physicians' plans of care to reduce disease progression and related medical spending. Specific examples of interventions include our Care Transitions hospital readmissions avoidance program and the Dr. Dean Ornish Program for Reversing Heart Disease™.

We recognize that each individual in a given population plays a variety of roles in his or her pursuit of improved well-being, often simultaneously.  By providing the full spectrum of services to meet each individual's needs, we believe our interventions can be delivered at scale and in a manner that reflects those unique needs over time.  We believe that real and sustainable behavior change generates measurable, long-term cost savings and improved individual and business performance for our customers.
 
Customer Contracts

Our fees are generally billed on a per member per month ("PMPM") basis or upon member participation.  For PMPM fees, we generally determine our contract fees by multiplying the contractually negotiated PMPM rate by the number of members covered by our services during the month.  We typically set PMPM rates during contract negotiations with customers based on the value we expect our programs to create and a sharing of that value between the customer and the Company.  In addition, some of our services, such as the Healthways SilverSneakers fitness solution, include fees that are based upon member participation.

Our contracts with health plans and integrated healthcare systems generally range from three to five years with several comprehensive strategic agreements extending up to ten years in length.  Contracts with self-insured employers typically have two to four-year terms.  Some of our contracts allow the customer to terminate early.

Some of our contracts place a portion of our fees at risk based on achieving certain performance metrics, cost savings, and/or clinical outcomes improvements ("performance-based").  Approximately 4% of revenues recorded during the year ended December 31, 2013 were performance-based of which 3% were subject to final reconciliation as of December 31, 2013.
5
Technology

Our solutions require sophisticated analytical, data management, Internet, and computer-telephony capabilities based on state-of-the-art technology. These solutions help us deliver our services to large populations within our customer base. Our predictive modeling capabilities, including insights gained from well-being assessments such as the Gallup-Healthways Well-Being 5™ diagnostic tool, allow us to identify and stratify those participants who are most at risk for an adverse health event. We incorporate behavior-change science with consumer-friendly interactions to facilitate consumer preferences for engagement and convenience supporting improvement across all five elements of well-being: physical, financial, social, purpose and community. We use sophisticated data analytical and reporting solutions to validate the impact of our programs on clinical and financial outcomes. Our application offerings support integrating the primary care physician into the team of well-being experts working on behalf of participants. We continue to invest heavily in technology, as evidenced by our long-term applications and technology services outsourcing agreement with HP Enterprise Services, LLC, and are continually expanding and improving our proprietary clinical, data management, and reporting systems to continue to meet the information management requirements of our services.  The behavior change techniques and predictive modeling incorporated in our technology identify an individual's readiness to change and provide personalized support through appropriate interactions using a range of methods desired by an individual, including venue-based face-to-face; print; phone; mobile and remote devices; on-line; and any combination thereof to motivate and sustain healthy behaviors.
 
Backlog

Backlog represents the estimated average annualized revenue at target performance over the term of the contract for business awarded but not yet started.  Annualized revenue in backlog as of December 31, 2013 and 2012 was as follows:
 
 
December 31,
  
December 31,
  
(In thousands)
2013
  
2012
  
Annualized revenue in backlog
  
$
39,800
    
$
39,000
  

Business Strategy

The World Health Organization defines health as "…not only the absence of infirmity and disease, but also a state of physical, mental, and social well-being."

Our business strategy reflects our passion to enhance well-being and, as a result, reduce overall health-related costs and improve workforce engagement, yielding better performance for individuals, families, health plans, governments, employers, integrated healthcare systems, and communities. Our solutions are designed to improve well-being by helping people to:
 
 
· 
adopt or maintain healthy behaviors;
 
 
· 
reduce health-related risk factors; and
 
 
· 
optimize care for identified health conditions.
 
We believe it is critical to impact an entire population's well-being and underlying health status in a long-term, cost-effective way.  Believing that what gets measured gets acted upon, in 2008, we entered into an exclusive, 25-year relationship with Gallup to create a definitive measure and empiric database of changes in the well-being of the U.S. population, known as the Gallup-Healthways Well-Being Index® ("WBI"), as well as processes to establish benchmarking for purposes of comparing the well-being of any subset of the national population.  The responses to the over 1.9 million completed WBI surveys to date have provided Gallup and us with an unmatched database to support our mutual goal of understanding the causes and effects of well-being for a population.  In October 2012, we created a global joint venture with Gallup that has developed the next generation of Gallup-Healthways individual well-being assessment tools, the Gallup-Healthways Well-Being 5, to provide employers, health providers, insurers and other interested parties with a validated capability to assess, measure and report on changes in the well-being of their employees, patients, members and customers.
6
To enhance well-being within their respective populations, our current and prospective customers require solutions that focus on the underlying drivers of healthcare demand, address worsening health status, reverse or slow unsustainable cost trends, foster healthy behaviors, mitigate health risk factors, and manage chronic conditions.  Our strategy is to deliver programs that engage individuals and help them enhance their well-being and underlying health status regardless of their starting point.  Published, peer-reviewed studies prove we can achieve well-being improvements in a population that generate significant cost savings and increases in productivity by providing effective programs that support the individual throughout his or her well-being journey.
 
Our strategy includes, as a priority, the ongoing expansion of our value proposition through our total population management capabilities.  We continue to enhance our well-being improvement solutions to extend our reach and effectiveness and to meet increasing demand for integrated solutions.  The flexibility of our programs allows customers to provide a range of services they deem appropriate for their organizations.  Customers may select from certain single program options up to a total-population approach, in which all members of a customer's population are eligible to receive our services.  Our strategy also includes the ongoing enhancement and deployment of our proprietary technology platform known as Embrace®.  This platform, which is essential to our total population management solution, enables us to integrate data from the healthcare organizations and other entities interacting with an individual.  Embrace provides for the delivery of our integrated solutions and ongoing communications between the individual and his or her medical and health experts, using a range of methods, including venue-based face-to-face interactions; print; phone; mobile and remote devices with unique applications; on-line including social networks; and any combination thereof to motivate and sustain healthy behaviors.
 
A number of contracts signed since 2011 have expanded both the level of integration and breadth of services provided to major regional commercial health plans, in some cases as they develop and implement a number of patient-centered medical home models.  Our services extend beyond chronic care and wellness programs to include a full range of care management functions, as well as a variety of health promotion, prevention and quality improvement solutions. Examples include our collaboration with Blue Zones, LLC in delivering a scaled well-being improvement solution to support health plan initiatives in a number of states; our wholly-owned subsidiary MeYou Health, LLC in bringing to market well-being improvement tools in the social media space through internet and personal device delivery methods; and our exclusive partnership with Dr. Ornish that is creating access to the Dr. Dean Ornish Program for Reversing Heart Disease for a growing number of health plans.
 
We continue to provide a variety of services to most of the major Medicare Advantage health plans and expect this market to grow as Medicare Advantage offerings gain an increasing share of the growing Medicare-eligible population. Our Silver Sneakers program is the largest single program within our current services but some of our health plan customers are adding additional services including web-based and mobile applications for personal support and social networking as more of the senior population becomes interested in these modalities of interaction.

Self-insured employers, including state and municipal government entities acting as employers, continue to demand services that focus across the entire population of employees and their dependent family members. Our well-being improvement solution, in addition to improving individuals' health and reducing direct healthcare costs, targets a much larger improvement in employer performance and profitability by reducing the impact of productivity lost for health-related reasons.  With the success of our work aimed at total population management, we expect to gain an even greater competitive advantage in responding to employers' needs for a healthier, higher-performing, and less costly workforce.

Significant ongoing changes in government regulation of healthcare continue to afford us expanding opportunities to provide services to integrated healthcare systems, hospitals, and physicians, in addition to health plans and employers. In 2011, we acquired Navvis & Company, a well-established provider of strategic counsel and change management services enabling its healthcare system clients to become future-ready clinical enterprises within healthcare's rapidly emerging value-based reimbursement system.  Our strategy includes providing integrated healthcare systems, hospitals, and physician enterprises with both consultative strategic planning services and a range of capabilities that enable and support the delivery of Physician-Directed Population Health solutions. Beginning in 2012, we signed and began the implementation of the initial set of contracts with integrated healthcare systems to provide these services. Although we initially anticipated a rapid aggregation of risk lives within health systems as creating a fast-developing market for our total population management services, we have since observed a slowing in the pace of adoption of value-based models as well as operational and data integration challenges between payors and our health system customers, which have led to a delay in the timing of achieving the originally expected volume of risk lives associated collectively with our health system customers. We expect to continue to grow the number and size of our health systems relationships through the ongoing deployment of services including, for example, consulting, hospital readmission avoidance and the Dr. Dean Ornish Program for Reversing Heart Disease.
7
We expect to continue to expand our international business beyond our current contracts in Australia, Brazil, and France. Our strategy is to help countries with single-payor models that to a large extent have a relatively fixed infrastructure that can be leveraged through our effective care coordination models. This approach allows us to partner either directly with government entities or with the private side of healthcare insurers and service providers that operate in those countries. Though most international business development has a relatively long sales cycle, the pipeline of opportunities continues to grow.
 
We plan to increase our competitive advantage in delivering our services by leveraging the scope of our well-being improvement capabilities, including our medical information content, behavior change processes and techniques, strategic relationships, health provider networks, and fitness center relationships.  We also plan to continue to scale the delivery of our solutions employing a blend of our scalable, state-of-the-art well-being improvement call centers and proprietary technologies, modalities, and techniques.  We may add new capabilities and technologies through internal development, strategic alliances with other entities, and/or selective acquisitions or investments.  A recent example is our exclusive agreement with The Lampo Group, Inc. — headed by Dave Ramsey, a leading voice on money and business — for Healthways to deliver the CORE™ Financial Wellness program as part of our well-being improvement solution.

We will continue to enhance, expand and integrate additional capabilities with health plans, integrated healthcare systems, employers, domestic government entities, and communities, as well as the public and private sectors of healthcare in international markets.
 
Segment and Major Customer Information

We have aggregated our operating segments into one reportable segment, well-being improvement services.  During 2013, Humana, Inc. ("Humana") comprised approximately 10.5% of our revenues. Our primary contract with Humana continues through 2016. No other customer accounted for 10% or more of our revenues in 2013.
 
Competition

The healthcare industry is highly competitive and subject to continual change in the manner in which services are provided.  Other entities, whose financial, research, staff, and marketing resources may exceed our resources, are marketing a variety of population health improvement services and other services or have announced an intention to offer such services to health plans, both commercial and Medicare Advantage; large self-insured employers, including state and municipal government entities; and providers of healthcare, including integrated healthcare systems, hospitals, and physician groups.  These entities include health and wellness companies, retail drug stores, major pharmaceutical companies, health plans, healthcare web-based and/or print content companies,  home healthcare organizations, providers, pharmacy benefit management companies, medical device and diagnostic companies, healthcare information technology companies, Internet-based medical content companies, revenue cycle management companies, consulting firms and other entities.
 
We believe we have advantages over our competitors because of the breadth and depth of our well-being improvement capabilities, including the scope of our strategic relationships; state-of-the-art proprietary information technology; predictive modeling and data integration capabilities; behavior-change techniques; the comprehensive recruitment and training of our clinical colleagues; our experienced management team; the comprehensive clinical nature and evidence-based scientific foundation of our product offerings; our established reputation for providing well-being improvement services to members wishing to maintain health, who possess  health risk factors or are diagnosed with chronic diseases; and the proven financial and clinical results delivered by our programs as evidenced through a library of published peer-reviewed outcomes studies.  However, we cannot assure you that we can compete effectively with other entities such as those noted above.
 
Industry Integration and Consolidation

Consolidation has been an important factor in all aspects of the healthcare industry, including the well-being and health management sector.  While we believe the size of our membership base provides us with the economies of scale to compete even in a consolidating market, we cannot assure you that we can effectively compete with companies formed as a result of industry consolidation or that we can retain existing health plan, integrated healthcare system, or employer customers if they are acquired by other entities which already have or contract for programs similar to ours or are not interested in our programs.
8

The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, "PPACA") required the U.S. Department of Health & Human Services ("HHS") to establish a Medicare Shared Savings Program that promotes accountability and coordination of care among providers through the creation of Accountable Care Organizations ("ACOs").  The program allows providers, including hospitals, physicians, and other designated professionals, to form ACOs and voluntarily work together to invest in infrastructure and redesign delivery processes to achieve high quality and efficient delivery of services.  We provide support and services for multiple ACOs that serve Medicare Fee-for-Service beneficiaries through our partnerships with integrated health systems.  Further, PPACA required HHS to establish voluntary national bundled payment programs under which participating groups of providers receive a single payment for certain medical conditions or episodes of care.  While ACOs and bundled payments are Medicare programs under PPACA, commercial insurers and private managed care health plans may increasingly shift to ACO and bundled payment models as well.  We expect these and other changes resulting from PPACA to further encourage integration and increase consolidation in the healthcare industry.
 
Governmental Regulation

Governmental regulation impacts us in a number of ways in addition to those regulatory risks presented under Item 1A. "Risk Factors" below.
 
Patient Protection and Affordable Care Act

PPACA changes how healthcare services are covered, delivered, and reimbursed through, among other things, significant reductions in the growth of Medicare program payments.  In addition, PPACA reforms certain aspects of health insurance, expands existing efforts to tie Medicare and Medicaid payments to performance and quality, and contains provisions intended to strengthen fraud and abuse enforcement.  PPACA contains provisions that have, and will continue to have, an impact on our customers, including commercial health plans and Medicare Advantage programs. 
 
Among other things, PPACA decreases the number of uninsured individuals and expands coverage through the expansion of public programs and private sector health insurance as well as a number of health insurance market reforms.  In addition, PPACA encourages the utilization of preventive services and wellness programs, such as those we provide.  However, PPACA also directly affects the customers or prospective customers that contract for our services and may increase their costs and/or reduce their revenues.  For example, PPACA prohibits commercial health plans from using gender, health status, family history, or occupation to set premium rates, eliminates pre-existing condition exclusions, and bans annual benefit limits.  In addition, PPACA mandates minimum medical loss ratios ("MLRs") for health plans such that the percentage of health coverage premium revenue spent on healthcare medical costs and quality improvement expenses be at least 80% for individual and small group health plans and 85% for large group coverage and Medicare Advantage plans, with policyholders receiving rebates, and the Centers for Medicare and Medicaid Services ("CMS") receiving refunds in the case of Medicare Advantage plans, if the actual loss ratios fall below these minimums. 
 
Changes in laws governing reimbursement to health plans providing services under governmental programs such as Medicare and Medicaid may affect us.  PPACA will impact Medicare Advantage programs in a variety of ways.  PPACA reduces premium payments to Medicare Advantage plans such that the managed care per capita payments paid by CMS to Medicare Advantage plans are, on average, equal to those for traditional Medicare.  While PPACA will award bonuses to Medicare Advantage plans that achieve service benchmarks and quality ratings, overall payments to Medicare Advantage plans are expected to be significantly reduced under PPACA.  The impact of these reductions on our business is not yet clear.

It is difficult to predict with any reasonable certainty the full impact of PPACA on the Company due to the law's complexity, lack of implementing regulations or interpretive guidance, gradual and potentially delayed implementation, remaining or new court challenges, and possible amendment or repeal.

Other Laws

While many of the governmental and regulatory requirements affecting healthcare delivery generally do not directly apply to us, our customers must comply with a variety of regulations including Medicare Advantage marketing and other restrictions, the licensing and reimbursement requirements of federal, state and local agencies and the requirements of municipal building codes and health codes.  Certain of our services, including health service utilization management and certain claims payment functions, require licensure by government agencies.  We are subject to a variety of legal requirements in order to obtain and maintain such licenses.
9

Certain of our professional healthcare employees, such as nurses, must comply with individual licensing requirements.  All of our healthcare professionals who are subject to licensing requirements are licensed in the state in which they are physically present, such as the professionals located at a well-being improvement call center.  Multiple state licensing requirements for healthcare professionals who provide services telephonically over state lines may require some of our healthcare professionals to be licensed in more than one state.  We continually monitor legislative, regulatory and judicial developments in telemedicine in order to stay in compliance with state and federal laws; however, new agency interpretations, federal or state legislation or regulations, or judicial decisions could increase the requirement for multi-state licensing of all well-being improvement call center health professionals, which would increase our costs of services.
 
Federal privacy regulations issued pursuant to the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") extensively restrict the use and disclosure of individually-identifiable health information by health plans, most healthcare providers, and certain other entities (collectively, "covered entities").  Federal security regulations issued pursuant to HIPAA require covered entities to implement and maintain administrative, physical and technical safeguards to protect the confidentiality, integrity and availability of electronic individually-identifiable health information. Because we handle individually-identifiable health information on behalf of covered entities, we are considered a "business associate" and are required to comply with most aspects of the HIPAA privacy and security regulations. On January 17, 2013, HHS released a final rule that, among other things, changed the requirements for agreements between covered entities and business associates as well as agreements between business associates and their subcontractors. Covered entities and business associates were required to comply with the final rule beginning September 23, 2013, except that existing agreements may qualify for an extended compliance date of September 22, 2014.
 
We may be subject to civil and criminal penalties for violations of HIPAA and its implementing regulations.  The American Recovery and Reinvestment Act of 2009 ("ARRA") significantly increased the civil penalties for violations, with penalties of up to $50,000 per violation for a maximum civil penalty of $1.5 million in a calendar year for violations of the same requirement.  In addition, we may be contractually or directly obligated to comply with any applicable state laws or regulations related to the confidentiality and security of confidential personal information.  In the event of a data breach involving individually-identifiable health information, we are subject to contractual obligations and state and federal requirements that require us to notify our customers.  These requirements may also require us or our customers to notify affected individuals, regulatory agencies, and the media of the data breach. In addition, the 2013 regulations create a presumption that non-permitted uses and disclosures of unsecured individually identifiable health information constitute breaches for which notice is required, unless it can be demonstrated that there is a low probability the information has been compromised.

Federal law contains various prohibitions related to false statements and false claims, some of which apply to private payors as well as federal programs.  Actions may be brought under the federal False Claims Act by the government as well as by private individuals, known as "whistleblowers," who are permitted to share in any settlement or judgment.

There are many potential bases for liability under the False Claims Act, including knowingly and improperly avoiding repayment of an overpayment received from the government and the knowing failure to report and return an overpayment within 60 days of identifying the overpayment. Liability under the False Claims Act also arises when an entity knowingly submits a false claim for reimbursement to the federal government, and the False Claims Act defines the term "knowingly" broadly. The Health Reform Law provides that submission of claims for services or items generated in violation of certain "fraud and abuse" provisions of the Social Security Act, including the anti-kickback provisions, constitutes a false or fraudulent claim under the False Claims Act. In some cases, whistleblowers, the federal government, and some courts have taken the position that entities that allegedly have violated other statutes, such as the federal self-referral prohibition commonly known as the Stark Law, have thereby submitted false claims under the False Claims Act.  From time to time, participants in the healthcare industry, including our company and our customers, may be subject to actions under the False Claims Act, and it is not possible to predict the impact of such actions.

Employees

As of March 1, 2014, we had approximately 2,500 employees.  Our employees are not subject to any collective bargaining agreements.  We believe we have good relationships with our employees.
10
Available Information

Our Internet address is www.healthways.com.  We make available free of charge, on or through our Internet website, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission ( the "SEC").  The public may read and copy any materials that we file with the SEC at the SEC's Public Reference Room at 100 F Street NE, Washington DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov.
 
Item 1A. Risk Factors

In the execution of our business strategy, our operations and financial condition are subject to certain risks.  A summary of certain material risks is provided below, and you should take such risks into account in evaluating any investment decision involving the Company.  This section does not describe all risks applicable to us and is intended only as a summary of certain material factors that could impact our operations in the industry in which we operate.  Other sections of this Annual Report on Form 10-K (this "Report") contain additional information concerning these and other risks.

We depend on payments from customers, and cost reduction pressure on our customers may adversely affect our business and results of operations.

The healthcare industry in which we operate currently faces significant cost reduction pressures as a result of increased competition, constrained revenues from governmental and private revenue sources, increasing underlying medical care costs, and general economic conditions.  We believe that these pressures will continue and possibly intensify.

We believe that our solutions, which are geared to foster well-being improvement by engaging people in health improvement programs, specifically assist our customers in controlling the high costs of healthcare; however, the pressures to reduce costs in the short term may negatively affect our ability to sign and/or retain contracts under existing terms or to restructure these contracts on terms that would not have a material negative impact on our results of operations.  These financial pressures could have a negative impact on our results of operations.

A significant percentage of our revenues is derived from health plan customers.

A significant percentage of our revenues is derived from health plan customers.  The health plan industry continues to undergo a period of consolidation, and we cannot assure you that we will be able to retain health plan customers if they are acquired by other health plans that already participate in competing programs or are not interested in our programs.  In addition, a reduction in the number of covered lives enrolled with our health plan customers or a decision by our health plan customers to take programs in-house could adversely affect our results of operations.  Our health plan customers are subject to increased obligations under PPACA, including new benefit mandates, limitations on exclusions and factors used for rate setting, requirements for MLRs, and increased taxes.  In determining how to meet these requirements, health plan customers or prospective customers may seek reduced fees or choose to reduce or delay the purchase of our services.

In addition, PPACA established American Health Benefit Exchanges ("Exchanges") and required that each state establish or participate in an Exchange as of January 1, 2014 where individuals may compare and purchase health insurance. Health plans participating in an Exchange must offer a set of minimum benefits and may elect to offer additional benefits. Chronic disease management is classified as a minimum essential health benefit. The parameters of the chronic disease management benefit may vary based upon each state's specific benchmark plan which sets the standard for each market.  It is possible that our services will not qualify under these standards. We cannot predict whether individuals who are currently receiving our services will switch to health plans offered through the Exchanges that do not include our services.  If we are unable to provide services to health plans participating in Exchanges, if health plans in the Exchanges that engage our services are not successful, or if the Exchanges otherwise reduce the number of members receiving our services or the payments we receive, our results of operations could be negatively impacted.
11
We currently derive a significant percentage of our revenues from one customer.
 
Because of the size of its membership, Humana comprised approximately 10.5% of our revenues in 2013.  Our primary contract with Humana continues through 2016. No other customer accounted for 10% or more of our revenues in 2013. The loss of, or the restructuring of a contract with, Humana or other large customers could have a material adverse effect on our business and results of operations.
 
Our business strategy is dependent in part on developing new and additional products to complement our existing services, as well as establishing additional distribution channels through which we may offer our products and services.
 
Our strategy focuses on helping people adopt or maintain healthy behaviors, reducing health-related risk factors, and optimizing care for identified health conditions.  While we have considerable experience in solutions for a broad range of health conditions, any new or modified programs will involve inherent risks of execution, such as our ability to implement our programs within expected timelines or cost estimates; our ability to obtain adequate financing to provide the capital that may be necessary to support our operations and to support or guarantee our performance under new contracts; and our ability to deliver outcomes on any new products or services.  In addition, as part of our business strategy, we may enter into relationships to establish additional distribution channels through which we may offer our products and services.  As we offer products through new or alternative distribution channels, we may face difficulties, such as potential customer overlap that may lead to pricing conflicts, which may adversely affect our business.
 
Our strategy relating to the development and introduction of new products and services exposes us to risks such as limited customer acceptance and additional expenditures that may not result in additional net revenue.

An important component of our strategy is to focus on new products and services that enable us to provide immediate value to our customers, such as Dr. Dean Ornish's Lifestyle Management Programs.  Customer acceptance of these new products and services cannot be predicted with certainty, and if we fail to execute properly on this strategy or to adapt this strategy as market conditions evolve, our ability to grow revenue and results of operations may be adversely affected.

 If we fail to successfully implement our business strategy, our financial performance and our growth could be materially and adversely affected.

Our future financial performance and success are dependent in large part upon our ability to implement our business strategy successfully.  Implementation of our strategy will require effective management of our operational, financial and human resources and will place significant demands on those resources.  See Item 1. "Business – Business Strategy" for more information regarding our business strategy.   There are risks involved in pursuing our strategy, including the following:

•
We may not be able to hire or retain the personnel necessary to manage our strategy effectively.
 
•
We may be unsuccessful in implementing improvements to operational efficiency and such efforts may not yield the intended result.
 
•
Execution of our strategy may cause us to incur substantial implementation costs, make substantial investments in technology and/or incur additional indebtedness, which may divert capital away from our traditional business operations.
 
In addition to the risks set forth above, implementation of our business strategy could also be affected by a number of factors beyond our control, such as increased competition, legal developments, government regulation, general economic conditions, increased operating costs or expenses, and changes in industry trends. We may decide to alter or discontinue certain aspects of our business strategy at any time. If we are not able to implement our business strategy successfully, our long-term growth and profitability may be adversely affected. Even if we are able to implement some or all of the initiatives of our business strategy successfully, our operating results may not improve to the extent we anticipate, or at all.
12
Our inability to renew and/or maintain contracts with our customers could adversely affect our business and results of operations.
 
We have several contracts subject to renewal in 2014 that individually represented more than 2% of our 2013 revenues and collectively represented 20% of our 2013 revenues. If our customers choose not to renew their contracts with us, our business and results of operations could be materially adversely affected.
 
Failure to successfully execute on the terms of our contracts could result in significant harm to our business. 

Our ability to grow and expand our business is contingent upon our ability to achieve desired performance metrics, cost savings, and/or clinical outcomes improvements under our existing contracts and to favorably resolve contract billing and interpretation issues with our customers.  Some of our contracts place a portion of our fees at risk based on achieving such metrics, savings, and/or improvements.  We cannot guarantee that we will achieve and reach mutual agreement with customers with respect to contractually required performance metrics, cost savings and/or clinical outcomes improvements under our contracts within the expected time frames.  Unusual and unforeseen patterns of healthcare utilization by individuals with diseases or conditions for which we provide services could adversely affect our ability to achieve desired performance metrics, cost savings, and clinical outcomes.  Our inability to meet or exceed the targets under our customer contracts could have a material adverse effect on our business and results of operations.  Also, our ability to provide financial guidance with respect to performance-based contracts is contingent upon our ability to accurately forecast variables that affect performance and the timing of revenue recognition under the terms of our contracts ahead of data collection and reconciliation.

In addition, certain of our contracts are increasing in complexity, requiring integration of data, systems, people, programs and services, the execution of sophisticated business activities, and the delivery of a broad array of services to large numbers of people who may be geographically dispersed.  The failure to successfully manage and execute the terms of these agreements could result in the loss of fees and/or contracts and could adversely affect our business and results of operations.

We depend on the timely receipt of accurate data from our customers and our accurate analysis of such data.

Identifying which members may benefit from receiving our services and measuring our performance under our contracts are highly dependent upon the timely receipt of accurate data from our customers and our accurate analysis of such data.  Data acquisition, data quality control and data analysis are complex processes that carry a risk of untimely, incomplete or inaccurate data from our customers or flawed analysis of such data, which could have a material adverse effect on our ability to recognize revenues.

Our ability to achieve estimated annualized revenue in backlog is based on certain estimates.

Our ability to achieve estimated annualized revenue in backlog in the manner and within the timeframe we expect is based on certain estimates regarding the implementation of our services.  We cannot assure you that the amounts in backlog will ultimately result in revenues in the manner and within the timeframe we expect.

Changes in macroeconomic conditions may adversely affect our business.

Economic difficulties and other macroeconomic conditions could reduce the demand and/or the timing of purchases for certain of our services from customers and potential customers.  A loss of a significant customer or a reduction in a customer's enrolled lives could have a material adverse effect on our business and results of operations.  In addition, changes in economic conditions could create liquidity and credit constraints.  We cannot assure you that we would be able to secure additional financing if needed and, if such funds were available, whether the terms or conditions would be acceptable to us.
13
The continued expansion of our services into international markets subjects us to additional business, regulatory and financial risks.
 
We provide health improvement programs and services in Brazil, Australia, and France, and we intend to continue expanding our international operations as part of our business strategy.  We have incurred and expect to continue to incur costs in connection with pursuing business opportunities in international markets.  Our success in the international markets will depend in part on our ability to anticipate the rate of market acceptance of our solutions and the individual market dynamics and regulatory requirements in potential international markets.  Because the international market for our services is still developing and also involves many new solutions, there is no guarantee that we will be able to achieve the necessary cost savings and clinical outcomes improvements under our contracts with international customers within the expected time frames and reach mutual agreement with customers with respect to those outcomes.  The failure to accurately forecast the costs necessary to implement our strategy of establishing a presence in these markets could have a material adverse effect on our business.

In addition, as a result of doing business in foreign markets, we are subject to a variety of risks which are different from or additional to the risks we face within the United States. Our future operating results in these countries or in other countries or regions throughout the world could be negatively affected by a variety of factors that are beyond our control.  These factors include political conditions, economic conditions, legal and regulatory constraints, currency regulations, and other matters in any of the countries or regions in which we operate, now or in the future.  In addition, foreign currency exchange rates and fluctuations may have an impact on our future costs or on future cash flows from our international operations, and could adversely affect our financial performance.  Other factors that may impact our international operations include foreign trade, monetary and fiscal policies both of the United States and of other countries, laws, regulations, and other activities of foreign governments, agencies, and similar organizations. Additional risks inherent in our international operations generally include, among others, the costs and difficulties of managing international operations, adverse tax consequences and greater difficulty in enforcing intellectual property rights in countries other than the United States.

We may experience difficulties associated with the implementation and/or integration of new businesses, services (including outsourced services), technologies, solutions, or products.

We may face substantial difficulties, costs, and delays in effectively implementing and/or integrating acquired businesses, services (including outsourced services), or technologies into our platform.  Implementing internally-developed solutions and/or integrating newly acquired businesses, services (including outsourced services), and technologies could be costly and time-consuming and may strain our resources.  Consequently, we may not be successful in implementing and/or integrating these new businesses, services, or technologies and may not achieve anticipated revenue and cost benefits.

The performance of our business and the level of our indebtedness could prevent us from meeting the obligations under our debt agreement or the cash convertible notes or have an adverse effect on our future financial condition, our ability to raise additional capital, or our ability to react to changes in the economy or our industry.

On June 8, 2012, we entered into the Fifth Amended and Restated Revolving Credit and Term Loan Agreement (the "Fifth Amended Credit Agreement"), which was amended on February 5, 2013 and July 1, 2013. On July 16, 2013, we completed a private placement of $150.0 million aggregate principal amount of cash convertible senior notes due 2018 (the "Cash Convertible Notes"), and on October 1, 2013, we entered into an Investment Agreement (the "Investment Agreement") with CareFirst Holdings, LLC ("CareFirst"). Pursuant to the Investment Agreement, we issued to CareFirst a convertible subordinated promissory note in an aggregate original principal amount of $20 million (the "CareFirst Convertible Note"). As of December 31, 2013, our long-term debt, including the current portion but excluding the debt discount, was $283.6 million.
 
Our ability to service our indebtedness (including the Cash Convertible Notes and the CareFirst Convertible Note) will depend on our ability to generate cash in the future.  We cannot assure you that our business will generate sufficient cash flow from operations or that future borrowings will be available in an amount sufficient to enable us to service our indebtedness or to fund other liquidity needs.
14

The Fifth Amended Credit Agreement contains various financial covenants, restricts the payment of dividends, and limits the amount of repurchases of our common stock.  A breach of any of these covenants could result in a default under the Fifth Amended Credit Agreement, in which all amounts outstanding under the Fifth Amended Credit Agreement may become immediately due and payable, and all commitments under the Fifth Amended Credit Agreement to extend further credit may be terminated. In addition, a payment default, including an acceleration following an event of default, under the Fifth Amended Credit Agreement or under our indenture for the Cash Convertible Notes, could each trigger an event of default under the other debt instrument, which could result in the principal of and the accrued and unpaid interest on such debt becoming due and payable.

Our indebtedness could have a material adverse effect on our future financial condition or our ability to react to changes in the economy or industry by, among other things:

•
increasing our vulnerability to a downturn in general economic conditions, loss of revenue and/or profit margins in our business, or to increases in interest rates, particularly with respect to the portion of our outstanding debt that is subject to variable interest rates;
 
•
potentially limiting our ability to obtain additional financing or to obtain such financing on favorable terms;
 
•
causing us to dedicate a portion of future cash flow from operations to service or pay down our debt, which reduces the cash available for other purposes, such as operations, capital expenditures, and future business opportunities; and
 
•
possibly limiting our ability to adjust to changing market conditions and placing us at a competitive disadvantage compared to our competitors who may be less leveraged.
 
The conditional conversion feature of the Cash Convertible Notes, if triggered, may adversely affect our financial condition and operating results.

The cash conversion feature of the Cash Convertible Notes (the "Cash Conversion Derivative") requires bifurcation from the Cash Convertible Notes in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 815, Derivatives and Hedging. In the event the conditional conversion feature of the Cash Convertible Notes is triggered, holders of Cash Convertible Notes will be entitled to convert the Cash Convertible Notes at any time during specified periods at their option.  If one or more holders elect to convert their Cash Convertible Notes, we would be required to pay cash to settle any such conversion, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their Cash Convertible Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Cash Convertible Notes as a current rather than long-term liability, which could result in a material reduction of our net working capital.
 
The accounting for the Cash Convertible Notes and related cash convertible notes hedge transactions may result in volatility to our consolidated statements of comprehensive income (loss).

The Cash Conversion Derivative that is part of the Cash Convertible Notes is accounted for as a derivative liability pursuant to ASC Topic 470, Debt, relating to derivative instruments and hedging activities. In general, the initial valuation of the conversion option was bifurcated from the debt component of the Cash Convertible Notes and is measured at fair value each reporting period. For each financial statement period after issuance of the Cash Convertible Notes, a hedge gain (or loss) will be reported in our consolidated statements of comprehensive income (loss) to the extent the valuation of the Cash Conversion Derivative changes from the previous period. In connection with the issuance of the Cash Convertible Notes, we entered into privately negotiated convertible note hedge transactions (the "Cash Convertible Notes Hedges"), which are cash-settled and are recorded and carried at fair value as a derivative asset and are intended to offset the gain (or loss) associated with changes to the valuation of the Cash Conversion Derivative. Although we do not expect there to be a material net impact to our consolidated statements of comprehensive income (loss) as a result of our issuing the Cash Convertible Notes and entering into the Cash Convertible Notes Hedges, we cannot assure you these transactions will be completely offset, which may result in volatility to our consolidated statements of comprehensive income (loss).
15

We are subject to counterparty risk with respect to the Cash Convertible Note Hedges.

The counterparties to the Cash Convertible Notes Hedges (the "Counterparties") are financial institutions or affiliates of financial institutions, and we will be subject to the risk that these Counterparties may default or otherwise fail to perform, or may exercise certain rights to terminate their obligations, under the Cash Convertible Notes Hedges. Our exposure to the credit risk of the Counterparties will not be secured by any collateral. If one or more of the Counterparties to one or more of the Cash Convertible Notes Hedges becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at the time under those transactions. Our exposure will depend on many factors but, generally, the increase in our exposure will be correlated to the increase in the market price of our common stock and in volatility of our common stock. In addition, upon a default or other failure to perform, or a termination of obligations, by one of the Counterparties, we may suffer adverse tax consequences and dilution with respect to our common stock.  We can provide no assurances as to the financial stability or viability of any of the Counterparties.

We have a significant amount of goodwill and intangible assets, the value of which could become impaired.

We have recorded significant portions of the purchase price of certain acquisitions as goodwill and/or intangible assets.  At December 31, 2013, we had approximately $338.8 million and $79.2 million of goodwill and intangible assets, respectively.  We review goodwill and intangible assets not subject to amortization for impairment on an annual basis (during the fourth quarter) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable.  If we determine that the carrying values of our goodwill and/or intangible assets are impaired, we may incur a non-cash charge to earnings, which could have a material adverse effect on our results of operations for the period in which the impairment occurs.

A failure of our information systems could adversely affect our business.

Our ability to deliver our services depends on effectively using information technology.  We expect to continually invest in updating and expanding our information technology capabilities.  In some cases, we may have to make systems investments before we generate revenues from contracts with new customers.  In addition, these system requirements expose us to technology obsolescence risks.

The nature of our business involves the receipt and storage of a significant amount of health information about the participants of our programs.  If we experience a data security breach, we could be exposed to government enforcement actions and private litigation.  In addition, our customers could lose confidence in our ability to protect the health information of their members, which could cause them to discontinue usage of our services.

We rely upon our information systems for operating and monitoring all major aspects of our business. These systems and our operations could be damaged or interrupted by natural disasters, power loss, network failure, improper operation by our employees, data privacy or security breaches, computer viruses, computer hacking, network penetration or other illegal intrusions or other unexpected events. Any disruption in the operation of our information systems, regardless of the cause, could adversely impact our operations, which may adversely affect our financial condition, results of operations and cash flows.
 
If we lose the services of our Chief Executive Officer or other members of our senior management team, we may not be able to execute our business strategy.

We believe that our success depends in signficant part upon the continued service of our senior management team. In particular, we believe that our Chief Executive Officer, Ben R. Leedle, Jr., is critical to our strategic direction and is uniquely positioned to lead the Company through the current transformational period in the healthcare industry that is largely due to the changes resulting from healthcare reform. The loss of our Chief Executive Officer, even temporarily, or any other member of our senior management team could have a material adverse effect on our business.
16
We face competition for staffing, which may increase our labor costs and reduce profitability.

We compete with other healthcare and services providers in recruiting qualified management, including executives with the required skills and experience to operate and grow our business, and staff personnel for the day-to-day operations of our business and well-being improvement call centers, including nurses, health coaches, and other healthcare professionals.  In some markets, the scarcity of nurses, experienced health coaches, and other medical support personnel has become a significant operating issue to healthcare businesses.  All of these challenges may require us to enhance wages and benefits to recruit and retain qualified management and other professionals.  A failure to attract and retain qualified management, nurses, health coaches, and other healthcare professionals, or to control labor costs, could have a material adverse effect on our profitability.
 
Our industry is a rapidly evolving and highly competitive segment of the healthcare industry.

The rapidly growing industry in which we operate is a continually evolving segment of the overall healthcare industry with many entities, whose financial, research, staff, and marketing resources may exceed our resources, marketing or announcing an intention to offer a variety of population health improvement services and other services to health plans, integrated healthcare systems, self-insured employers, and government entities.

We believe we have advantages over our competitors because of the breadth and depth of our well-being improvement capabilities, including our scope of strategic relationships, state-of-the-art proprietary information technology, predictive modeling capabilities, behavior-change techniques, the comprehensive recruitment and training of our clinical colleagues, our experienced management team, the comprehensive clinical nature of our product offerings, our established reputation for providing well-being improvement services to members with health risk factors or chronic diseases, and the proven financial and clinical outcomes of our programs.  However, we cannot assure you that we can compete effectively with other companies such as those noted above.
 
We are party to litigation that could force us to pay significant damages and/or harm our reputation.

We are subject to certain legal proceedings, which potentially involve large claims and significant defense costs (see Item 3. "Legal Proceedings").  These legal proceedings and any other claims that we may face, whether with or without merit, could result in costly litigation, and divert the time, attention, and resources of our management.  Although we currently maintain various types of liability insurance, there can be no assurance that the coverage limits of such insurance policies will be adequate or that all such claims will be covered by insurance.  Although we believe that we have conducted our operations in full compliance with applicable statutory and contractual requirements and that we have meritorious defenses to outstanding claims, it is possible that resolution of these legal matters could have a material adverse effect on our results of operations.  In addition, legal expenses associated with the defense of these matters may be material to our results of operations in a particular financial reporting period.
 
Our business could be negatively affected as a result of a proxy contest and the actions of activist stockholders.

We recently received a notice from North Tide Capital, LLC ("North Tide"), one of our stockholders, that indicates its intention to nominate four directors for election to our Board at our 2014 Annual Meeting of Stockholders. If a proxy contest involving North Tide or its affiliates ensues, or if we become engaged in a proxy contest with another activist stockholder in the future, our business could be adversely affected because:

 
•
responding to proxy contests and other actions by activist stockholders can disrupt our operations, be costly and time-consuming, and divert the attention of our management and employees;
 
 
•
perceived uncertainties as to our future direction may result in the loss of potential business opportunities, and may make it more difficult to attract and retain qualified personnel and business partners; and
 
 
•
if individuals are elected to our Board to pursue an activist stockholder's particular agenda, it may adversely affect our ability to effectively implement our business strategy.
 
17
Compliance with new federal and state legislative and regulatory initiatives could adversely affect our results of operations or may require us to spend substantial amounts acquiring and implementing new information systems or modifying existing systems.
 
Our customers are subject to considerable state and federal government regulation.  Many of these regulations are vaguely written and subject to differing interpretations that may, in certain cases, result in unintended consequences that could impact our ability to effectively deliver services.
 
We believe that federal requirements governing the confidentiality of individually-identifiable health information permit us to obtain individually-identifiable health information for well-being improvement purposes from a covered entity; however, state laws or regulations could impose additional and more restrictive privacy and security restrictions.  We are required to comply with most requirements of the HIPAA privacy and security regulations and may be subject to criminal or civil penalties for violations of these regulations. The regulations that implemented many of these ARRA requirements revised the standards for agreements with business associates and required, in most instances, amendments to existing agreements with our customers and subcontractors.  Compliance with the final rule was required beginning September 23, 2013, except that existing business associate agreements may qualify for an extended compliance date of September 23, 2014. In addition, the regulations create a presumption that non-permitted uses and disclosures of unsecured individually identifiable health information constitute breaches for which notice must be made by us or our customers to affected individuals and, in some cases, the media, unless it can be demonstrated that there is a low probability that the information has been compromised. This presumption and revised standard for determining whether a non-permitted use or disclosure constitutes a breach may result in a greater number of incidents being classified as breaches and, thus, a greater number of required notifications.
 
Although we continually monitor the extent to which federal and state legislation or regulations may govern our operations, new federal or state legislation or regulations in this area that restrict our ability to obtain and handle individually-identifiable health information or that otherwise restrict our operations could have a material adverse effect on our results of operations.
 
Government regulators may interpret current regulations or adopt new legislation governing our operations in a manner that subjects us to penalties or negatively impacts our ability to provide services.

Broadly written Medicare fraud and abuse laws and regulations that are subject to varying interpretations may expose us to potential civil and criminal litigation regarding the structure of current and past contracts entered into with our customers.

Expanding the well-being and health management industry to Medicare beneficiaries enrolled in Medicare Advantage plans could lead to increased direct regulation of well-being and health management services.  Further, providing services to Medicare Advantage beneficiaries may result in our being subject directly to various federal laws and regulations, including provisions related to fraud and abuse, false claims and billing and reimbursement for services, and the federal False Claims Act.

In addition, certain of our services, including health utilization management and certain claims payment functions, require licensure by government agencies.  We are subject to a variety of legal requirements in order to obtain and maintain such licenses, but little guidance is available to determine the scope of some of these requirements.  Failure to obtain and maintain any required licenses or failure to comply with other laws and regulations applicable to our business could have a material negative impact on our operations.

Certain of our professional healthcare employees, such as nurses, must comply with individual licensing requirements.

All of our healthcare professionals who are subject to licensing requirements, such as the professionals located at a well-being improvement call center, are licensed in the state in which they are physically present.  Multiple state licensing requirements for healthcare professionals who provide services telephonically over state lines may require us to license some of our healthcare professionals in more than one state.  We continually monitor legislative, regulatory and judicial developments in telemedicine; however, new agency interpretations, federal or state  legislation or regulations, or judicial decisions could increase the requirement for multi-state licensing of all well-being improvement call center health professionals, which would increase our costs of services and could have a material adverse effect on our results of operations.

18
Healthcare reform legislation may result in a reduction to our revenues from government health plans and private insurance companies.
 
Among other things, PPACA decreases the number of uninsured individuals and expands coverage through the expansion of public programs and private sector health insurance and a number of health insurance market reforms.  PPACA also encourages utilization of preventive services and wellness programs, such as those provided by the Company.  However, PPACA also directly affects the customers or prospective customers that contract for our services and may increase their costs and/or reduce their revenues.  For example, PPACA prohibits commercial health plans from using gender, health status, family history, or occupation to set premium rates, eliminates pre-existing condition exclusions, and bans annual benefit limits.  In addition, PPACA mandates minimum MLRs for health plans such that the percentage of health coverage premium revenue spent on healthcare medical costs and quality improvement expenses must be at least 80% for individual and small group health plans and 85% for large group coverage and Medicare Advantage plans, with policyholders receiving rebates, and CMS receiving refunds in the case of Medicare Advantage plans, if the actual loss ratios fall below these minimums.  PPACA provides for reductions in funding to Medicare Advantage programs, which may cause some Medicare Advantage plans to raise beneficiary premiums or limit benefits.  
 
While we believe that our programs and services specifically assist our customers in controlling their costs and improving their competitiveness, it is possible that the reforms imposed by PPACA will adversely affect the profitability of our customers and cause our customers or prospective customers to reduce or delay the purchase of our services or to demand reduced fees.  Further, demand for our programs could be reduced if Medicare Advantage plans respond to PPACA funding reductions or other changes by eliminating our programs or by limiting or changing benefits in a manner that causes some Medicare Advantage beneficiaries to terminate their Medicare Advantage coverage.  
 
Because of PPACA's complexity, lack of implementing regulations or interpretive guidance, gradual and potentially delayed implementation, remaining or new court challenges, and possible amendment or repeal, we are unable to predict all of the ways in which PPACA could impact the Company.  We could also be impacted by future healthcare reform legislative initiatives and/or government regulation.
 
Item 1B. Unresolved Staff Comments

Not applicable.

Item 2.
Properties

We lease approximately 264,000 square feet of office space in Franklin, Tennessee, which contains our corporate headquarters and one of our well-being improvement call centers, pursuant to an agreement that expires in February 2023.  We also lease approximately 92,000 square feet of office space in Chandler, Arizona which contains additional corporate employees and one of our well-being improvement call centers.

In addition, we lease office space for our seven other well-being improvement call center locations for an aggregate of approximately 160,000 square feet of space with lease terms expiring on various dates from 2014 to 2020.  Our operations support and training offices contain approximately 66,000 square feet in aggregate and have lease terms expiring from 2014 to 2020.
 
Item 3.
  Legal Proceedings

Contract Disputes

We currently are involved in a contractual dispute with Blue Cross Blue Shield of Minnesota regarding fees paid to us as part of a former contractual relationship.  On January 25, 2010, Blue Cross Blue Shield of Minnesota issued notice of arbitration with the American Arbitration Association in Minneapolis in accordance with the terms of the contract alleging violations of certain contract provisions and seeking recoupment of an unspecified amount of payments made to us under the contract. We believe we performed our services in compliance with the terms of our agreement and that the assertions made in the arbitration notice are without merit.  On August 3, 2011, we asserted numerous counterclaims against Blue Cross Blue Shield of Minnesota. The arbitration hearing concluded on October 23, 2013.  During and after the conclusion of the arbitration hearing in October, the parties entered into settlement negotiations to resolve all claims in dispute. The parties have jointly requested that the arbitrator not issue any award or decision while the parties are engaged in settlement discussions. We cannot predict whether these discussions will result in a settlement. 
19

We are involved in a contractual dispute with Plastipak Packaging, Inc. ("Plastipak"). On September 10, 2012, Plastipak filed suit in the Circuit Court for Wayne County, Michigan seeking damages relating to an alleged breach of a services agreement with us.  The case is currently in the discovery phase of litigation.  We deny Plastipak's claims and intend to vigorously defend the action. 
 
Performance Award Lawsuit

On September 4, 2012, Milton Pfeiffer ("Plaintiff"), claiming to be a stockholder of the Company, filed a putative derivative action against the Company and the Board of Directors (the "Board") in Delaware Chancery Court (the "Court") alleging that the Compensation Committee of the Board and the Board breached their fiduciary duties and violated the Company's 2007 Stock Incentive Plan (the "Plan") by granting Ben R. Leedle, Jr., Chief Executive Officer and President of the Company, discretionary performance awards under the Plan in the form of options to purchase an aggregate of 500,000 shares of the Company's common stock, which consisted of a performance award in November 2011 granting Mr. Leedle the right to purchase 365,000 shares and a performance award in February 2012 granting Mr. Leedle the right to purchase 135,000 shares (the "Performance Awards").  Plaintiff alleges that the Performance Awards exceeded what is authorized by the Plan and that the Company's 2012 proxy statement, in which the Performance Awards are disclosed, is false and misleading.  Plaintiff also alleges that Mr. Leedle breached his fiduciary duties and was unjustly enriched by receiving the Performance Awards.  Plaintiff is seeking, among other things, the rescission or disgorgement of all alleged "excess" awards granted to Mr. Leedle under the Performance Awards, to recover any incidental damages to the Company, and an award of attorneys' fees and expenses.  On November 2, 2012, the Company and the Board filed a Motion to Dismiss because Plaintiff failed to make a demand upon the Board as required by Delaware law.  On November 8, 2013, the Court denied the Company's Motion to Dismiss. On February 21, 2014, the Company filed its answer and intends to vigorously defend the allegations.
Outlook

We are also subject to other contractual disputes, claims and legal proceedings that arise from time to time in the ordinary course of our business.  While we are unable to estimate a range of potential losses, we do not believe that any of the legal proceedings pending against us as of the date of this report will have a material adverse effect on our liquidity or financial condition.  As these matters are subject to inherent uncertainties, our view of these matters may change in the future.
 
Item 4. Mine Safety Disclosures

Not applicable.
20
Executive Officers of the Registrant
 
The following table sets forth certain information regarding our executive officers as of March 14, 2014.  Executive officers of the Company serve at the pleasure of the Board.

Officer
Age
Position
 
 
 
Ben R. Leedle, Jr.
53
Chief Executive Officer and director of the Company since September 2003.  President of the Company from May 2002 through October 2008 and April 2011 to present.  Executive Vice President and Chief Operating Officer of the Health Plan Group from 2000 until May 2002.  Senior Vice President of the Company from 1996 until 2000.
 
 
 
Michael Farris
54
Chief Commercial Officer of the Company since October 2012.  Navvis & Company Chief Executive Officer from 2004 to September 2012.
 
 
 
Alfred Lumsdaine
48
Chief Financial Officer of the Company since January 2011.  Chief Accounting Officer of the Company from February 2002 until January 2011.
 
 
 
Peter Choueiri
48
President, Healthways International, since January 2012 and Chief Operating Officer, Healthways International, from June 2011 through January 2012.  Head of Global Markets for North America, Middle East/Africa, and Southern Europe/Latin America for Munich Reinsurance Company in Germany from May 2009 to May 2011 and Head of Divisional Unit Healthcare from October 2005 to May 2009.
 
 
 
Glenn Hargreaves
47
Chief Accounting Officer of the Company since July 2012 and Controller since January 2011.  Director of Tax of the Company from April 2005 until January 2011.
 
 
 
Mary Flipse
47
General Counsel of the Company since July 2012.  Director, Corporate Counsel of the Company from February 2012 to July 2012.  Operations Counsel of the Company from August 2011 until February 2012.  Assistant General Counsel of King Pharmaceuticals from May 2005 to July 2011.

21
PART II
Item 5.  Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock is traded on The NASDAQ Stock Market ("NASDAQ") under the symbol "HWAY".

The following table sets forth the high and low sales prices per share of our common stock as reported by NASDAQ for the relevant periods.

 
  
High
    
Low
  
Year ended December 31, 2013
  
   
 
First quarter
  
$
13.24
    
$
9.82
  
Second quarter
    
17.62
      
10.97
  
Third quarter
    
22.20
      
15.36
  
Fourth quarter
    
18.72
      
9.59
  
 
                
Year ended December 31, 2012
                
First quarter
  
$
8.49
    
$
6.66
  
Second quarter
    
8.00
      
6.21
  
Third quarter
    
11.96
      
7.73
  
Fourth quarter
    
11.94
      
8.58
  

Unregistered Sales of Equity Securities

On November 7, 2013, Ben R. Leedle, Jr., our Chief Executive Officer, and Alfred Lumsdaine, our Chief Financial Officer, purchased 20,000 and 4,000 unregistered shares of common stock, respectively, from the Company for consideration of $235,000 and $47,000, respectively. The issuance of the shares was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, because it was a transaction not involving a public offering.
 
On July 15, 2013, we entered into an exclusive partnership with Dean Ornish, M.D., to operate and license his Lifestyle Management Programs. In partial consideration for this exclusive partnership, we issued 45,362 unregistered shares of our common stock to Dean Ornish, M.D., and Ed McCall. The number of shares of our common stock issued in this transaction was calculated based on the average closing trading price per share of our common stock on NASDAQ over the 30 trading days immediately prior to the effective date of this transaction. The issuance of the shares was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, because it was a transaction not involving a public offering.
 
Holders

At March 1, 2014, there were approximately 10,600 holders of our common stock, including 217 stockholders of record.
22

Dividends

We have never declared or paid a cash dividend on our common stock.  We intend to retain any earnings to finance the growth and development of our business and do not expect to declare or pay any cash dividends in the foreseeable future.  Our Board will review our dividend policy from time to time and may declare dividends at its discretion; however, our Fifth Amended Credit Agreement places restrictions on the payment of dividends.  For further discussion of the Fifth Amended Credit Agreement, see Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operation - Liquidity and Capital Resources."
 
Securities Authorized for Issuance Under Equity Compensation Plans

See Part III, Item 12, "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters", for information regarding securities authorized for issuance under our equity compensation plans, which is incorporated by reference herein.
23
Item 6.  Selected Financial Data

The following table represents selected financial data.  The table should be read in conjunction with Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Item 8, "Financial Statements and Supplementary Data" of this Report.

(In thousands, except per share data)
  
Year Ended December 31,
    
Year Ended December 31,
    
Year Ended December 31,
    
Year Ended December 31,
    
Year Ended December 31,
  
 
  
2013
    
2012
    
2011
    
2010
    
2009
  
Operating Results:
  
   
   
   
   
 
Revenues
  
$
663,285
    
$
677,170
    
$
688,765
    
$
720,333
    
$
717,426
  
Cost of services (exclusive of depreciation and amortization included below)
    
547,387
      
533,880
      
510,724
      
493,713
      
522,999
  
Selling, general and administrative expenses
    
61,205
      
60,888
      
64,843
      
72,830
      
71,535
  
Depreciation and amortization
    
52,791
      
51,734
      
49,988
      
52,756
      
49,289
  
Impairment loss
    
—
      
—
      
183,288
      
—
      
—
  
Restructuring and related charges
    
—
      
1,773
      
9,036
      
10,258
      
—
  
Operating income (loss)
  
$
1,902
    
$
28,895
    
$
(129,114
)
  
$
90,776
    
$
73,603
  
Gain on sale of investment
    
—
      
—
      
—
      
(1,163
)
    
(2,581
)
Interest expense
    
16,079
      
14,149
      
13,193
      
14,164
      
15,717
  
Legal settlement and related costs
    
—
      
—
      
—
      
—
      
39,956
  
 
                                        
Income (loss) before income taxes
  
$
(14,177
)
  
$
14,746
    
$
(142,307
)
  
$
77,775
    
$
20,511
  
Income tax expense (benefit)
    
(5,636
)
    
6,722
      
15,386
      
30,445
      
10,137
  
Net income (loss)
  
$
(8,541
)
  
$
8,024
    
$
(157,693
)
  
$
47,330
    
$
10,374
  
 
                                        
Basic income (loss) per share:
  
$
(0.25
)
  
$
0.24
    
$
(4.68
)
  
$
1.39
    
$
0.31
  
 
                                        
Diluted income (loss) per share: (1)
  
$
(0.25
)
  
$
0.24
    
$
(4.68
)
  
$
1.36
    
$
0.30
  
 
                                        
Weighted average common shares and
                                        
equivalents:
                                        
Basic
    
34,489
      
33,597
      
33,677
      
34,129
      
33,730
  
Diluted (1)
    
34,489
      
33,836
      
33,677
      
34,902
      
34,359
  
 
                                        
Balance Sheet Data:
                                        
Cash and cash equivalents
  
$
2,584
    
$
1,759
    
$
864
    
$
1,064
    
$
2,356
  
Working capital (deficit)
    
(5,194
)
    
13,551
      
8,774
      
547
      
(44,296
)
Total assets
    
749,011
      
748,268
      
708,905
      
861,689
      
882,366
  
Long-term debt
    
237,582
      
278,534
      
266,117
      
243,425
      
254,345
  
Other long-term liabilities
    
51,003
      
26,602
      
31,351
      
39,140
      
42,615
  
Stockholders' equity
    
302,690
      
278,821
      
265,716
      
430,841
      
377,277
  
 
                                        
Other Operating Data:
                                        
Annualized revenue in backlog
  
$
39,800
    
$
39,000
    
$
29,400
    
$
37,100
    
$
32,400
  

(1)
The assumed exercise of stock-based compensation awards for the year ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive.

24
Item 7.  Management's Discussion and Analysis of Financial Condition and Results of Operations
 
Overview

Founded and incorporated in Delaware in 1981, Healthways, Inc. ("Healthways") provides specialized, comprehensive solutions to help people improve their well-being, thereby improving their health and productivity and reducing their health-related costs.

We believe well-being consists of five essential elements:

·
  Purpose: Liking what you do each day and being motivated to achieve your goals

·
  Social: Having supportive relationships and love in your life

·
  Financial: Managing your economic life to reduce stress and increase security

·
  Community: Liking where you live, feeling safe and having pride in your community

·
  Physical: Having good health and enough energy to get things done daily
 
Our solutions provide highly specific and personalized interventions for each individual in a population, irrespective of health status, age or payor.  Through a simple, but powerful, data-driven process we identify the needs of each individual and determine the right level of support. This allows us to deploy successful strategies to sustain engagement, to use the best science to drive behavior change and ultimately deliver meaningful, measurable outcomes. Our services are delivered using a range of methods desired by an individual including venue-based face-to-face interactions; print; phone; mobile and remote devices with unique applications; on-line including social networks; and any combination thereof to motivate and sustain healthy behaviors.

In North America, our customers include health plans, both commercial and Medicare Advantage, large self-insured employers, including state and municipal government entities, and providers of healthcare, including integrated healthcare systems, hospitals, and physician groups, in all 50 states and the District of Columbia. We also provide services to commercial healthcare businesses and/or government entities in Brazil, Australia and France.  All of our interventions are developed with over 30 years of experience based in science and ongoing innovation. Our technology-driven infrastructure is compatible with, and integrated into, our customer and other vendor systems. We operate domestic and international well-being improvement call centers staffed with a wide range of licensed health professionals.  Our fitness center network encompasses approximately 15,000 U.S. locations.  We also maintain an extensive network of over 88,000 complementary, alternative and physical medicine practitioners, which offers convenient access to the significant number of individuals who seek health services outside of the traditional healthcare system.

Our guiding philosophy and approach to market is predicated on the fundamental belief that healthier people cost less and are more productive.  As described more fully below, our programs are designed to improve individual and organizational well-being by helping people adopt or maintain healthy behaviors, reduce health-related risk factors, and optimize their care for identified health conditions.

First, our programs are designed to help people adopt or maintain healthy behaviors by:

 
·
fostering wellness and disease prevention through total population screening, well-being assessments and supportive interventions; and
 
 
·
engaging people in our well-being improvement programs and networks, such as fitness, weight management, stress management, financial and lifestyle management skills, chiropractic, and complementary and alternative medicine.

Our prevention programs focus on education, physical fitness, nutrition, health coaching, and tools that support behavior change. These programs improve the well-being status of member populations and reduce the short- and long-term health-related costs for participants, including associated costs from the loss of employee productivity. Many of our programs for lifestyle support, management and education are delivered through web-based portals and mobile applications and may also offer a social networking enhancement opportunity. Our web-based tools include the Well-Being Connect® portal and our educational capabilities include the Dave Ramsey Core™ Financial Wellness program. We also utilize mobile applications such as wellbeingGO®, and our MeYou Health subsidiary unique mobile applications include Well-Being Tracker™, Daily Challenge® and Walkadoo™.
25
Second, our programs are designed to help people reduce health-related risk factors by:

 
· 
promoting personal change and improvement in the lifestyle behaviors that lead to poor health or chronic conditions; and
 
 
· 
providing educational materials and personal interactions with highly trained healthcare professionals to create and sustain healthier behaviors for those individuals at risk or in the early stages of chronic conditions.
 
We engage our customers' covered populations through specific interactions that are sensitive to each individual's health risks and needs. In many situations, we utilize predictive modeling capabilities to allow us to identify and stratify those participants who are most at risk for an adverse health event. Our programs are designed to motivate people to make positive lifestyle changes and accomplish individual goals, such as increasing physical activity for seniors through the Healthways SilverSneakers fitness solution, overcoming nicotine addiction through the QuitNet on-line smoking cessation community, or generating sustainable weight-loss through our Innergy solution.

Finally, our programs are designed to help people optimize care for identified health conditions by:

 
·
incorporating the latest, evidence-based clinical guidelines into interventions to optimize patient health outcomes;
 
 
·
developing care support plans and motivating members to set attainable goals for themselves;
 
 
·
providing local market resources to address acute episodic interventions;
 
 
·
coordinating members' care as an extension of their healthcare providers;
 
 
·
providing software technology solutions and management consulting in support of well-being improvement services; and
 
 
·
providing high-risk care management for members at risk for hospitalization due to complex conditions.

Our approach is to use proprietary, analytic models to identify individuals who are likely to incur future high costs, including those who have specific gaps in care, and through evidence-based interventions drive adherence to proven standards of care, medication regimens and physicians' plans of care to reduce disease progression and related medical spending. Specific examples of interventions include our Care Transitions hospital readmissions avoidance program and the Dr. Dean Ornish Program for Reversing Heart Disease.

We recognize that each individual in a given population plays a variety of roles in his or her pursuit of improved well-being, often simultaneously.  By providing the full spectrum of services to meet each individual's needs, we believe our interventions can be delivered at scale and in a manner that reflects those unique needs over time.  We believe that real and sustainable behavior change generates measurable, long-term cost savings and improved individual and business performance for our customers.

Forward-Looking Statements

Management's Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements, which are based upon current knowledge, assumptions, beliefs, estimates and expectations, involve a number of risks and uncertainties, and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief, or expectations of the Company, including, without limitation, all statements regarding the Company's future earnings and results of operations, and can be identified by the use of words like "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan," or "continue" and similar expressions.  Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary from those in the forward-looking statements as a result of various factors, including, but not limited to:

 
·
the effectiveness of management's strategies and decisions;
 
 
·
our ability to sign and implement new customer contracts for our solutions;
 
26
 
·
our ability to accurately forecast the costs required to successfully implement new contracts;
 
 
·
our ability to renew and/or maintain contracts with our customers under existing terms or restructure these contracts on terms that would not have a material negative impact on our results of operations;
 
 
·
our ability to effectively compete against other entities, whose financial, research, staff, and marketing resources may exceed our resources;
 
 
·
our ability to accurately forecast our revenues, margins, earnings and net income, as well as any potential charges that we may incur as a result of changes in our business;
 
 
·
our ability to accurately forecast performance and the timing of revenue recognition under the terms of our customer contracts ahead of data collection and reconciliation;
 
 
·
the costs and management distraction related to a proxy contest;
 
 
·
the impact of PPACA on our operations and/or the demand for our services;
 
 
·
our ability to anticipate change and respond to emerging trends in the domestic and international markets for healthcare and the impact of the same on demand for our services;
 
 
·
the risks associated with deriving a significant concentration of our revenues from a limited number of customers;  
 
 
·
the risks associated with foreign currency exchange rate fluctuations and our ability to hedge against such fluctuations;
 
 
·
our ability to achieve and reach mutual agreement with customers with respect to the contractually required performance metrics, cost savings and clinical outcomes improvements, or to achieve such metrics, savings and improvements within the timeframes contemplated by us;
 
 
·
our ability to achieve estimated annualized revenue in backlog in the manner and within the timeframe we expect, which is based on certain estimates regarding the implementation of our services;
 
 
·
our ability and/or the ability of our customers to enroll participants and to accurately forecast their level of enrollment and participation in our programs in a manner and within the timeframe anticipated by us;
 
 
·
the ability of our customers to provide timely and accurate data that is essential to the operation and measurement of our performance under the terms of our contracts;
 
 
·
our ability to favorably resolve contract billing and interpretation issues with our customers;
 
 
·
our ability to service our debt (including the Cash Convertible Notes and CareFirst Convertible Note), make principal and interest payments as those payments become due, and remain in compliance with our debt covenants;
 
 
·
the risks associated with changes in macroeconomic conditions, which may reduce the demand and/or the timing of purchases for our services from customers or potential customers, reduce the number of covered lives of our existing customers, or restrict our ability to obtain additional financing;
 
 
·
counterparty risk associated with the Cash Convertible Notes Hedges, interest rate swap agreements, and foreign currency exchange contracts;
 
 
27
 
·
the risks associated with valuation of the Cash Convertible Notes Hedges and the Cash Conversion Derivative, which may result in volatility to our consolidated statements of comprehensive income (loss) if these transactions do not completely offset;
 
 
 
·
our ability to integrate new or acquired businesses, services (including outsourced services), or technologies into our business and to accurately forecast the related costs;
 
 
·
our ability to anticipate and respond to strategic changes, opportunities, and emerging trends in our industry and/or business and to accurately forecast the related impact on our revenues and earnings;
 
 
·
the impact of any impairment of our goodwill or other intangible assets;
 
 
·
our ability to develop new products and deliver and report outcomes on those products;
 
 
·
our ability to implement our integrated data and technology solutions platform within the required timeframe and expected cost estimates and to develop and enhance this platform and/or other technologies to meet evolving customer and market needs;
 
 
·
our ability to obtain adequate financing to provide the capital that may be necessary to support our operations and to support or guarantee our performance under new contracts;
 
 
·
unusual and unforeseen patterns of healthcare utilization by individuals with diseases or conditions for which we provide services;
 
 
·
the ability of our customers to maintain the number of covered lives enrolled in the plans during the terms of our agreements;
 
 ·
the risks associated with data privacy or security breaches, computer hacking, network penetration and other illegal intrusions;
 
 
·
the impact of PPACA on our operations and/or the demand for our services;
 
 
·
the impact of any new or proposed legislation, regulations and interpretations relating to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and any legislative or regulatory changes with respect to Medicare Advantage;
         
 
  · 
the impact of future state, federal, and international legislation and regulations applicable to our business, including PPACA, on our ability to deliver our services and on the financial health of our customers and their willingness to purchase our services;
 
 
·
current geopolitical turmoil, the continuing threat of domestic or international terrorism, and the potential emergence of a health pandemic;
 
 
·
the impact of legal proceedings involving us and/or our subsidiaries; and
         
 
 
·
other risks detailed in this Report, including those set forth in Item 1A. "Risk Factors."

We undertake no obligation to update or revise any such forward-looking statements.

Critical Accounting Policies

We describe our accounting policies in Note 1 to the consolidated financial statements.  We prepare the consolidated financial statements in conformity with generally accepted accounting principles in the United States ("U.S. GAAP"), which requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and related disclosures at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results may differ from those estimates.

We believe the following accounting policies are the most critical in understanding the estimates and judgments that are involved in preparing our financial statements and the uncertainties that could impact our results of operations, financial condition and cash flows.
28
Revenue Recognition

Our fees are generally billed on a PMPM basis or upon member participation.  For PMPM fees, we generally determine our contract fees by multiplying the contractually negotiated PMPM rate by the number of members covered by our services during the month.  We typically set PMPM rates during contract negotiations with customers based on the value we expect our programs to create and a sharing of that value between the customer and the Company.  In addition, some of our services, such as the Healthways SilverSneakers fitness solution, include fees that are based upon member participation.
 
Our contracts with health plans and integrated healthcare systems generally range from three to five years with a number of comprehensive strategic agreements extending up to ten years in length.  Contracts with self-insured employers typically have two to four-year terms. Some of our contracts allow the customer to terminate early. 
 
Our performance-based contracts place a portion of our fees at risk based on achieving certain performance metrics, cost savings, and/or clinical outcomes improvements. Approximately 4% of revenues recorded during the year ended December 31, 2013 were performance-based of which 3% were subject to final reconciliation as of December 31, 2013.

We recognize revenue as follows: (1) we recognize the fixed portion of PMPM fees and fees for service as revenue during the period in which we perform our services; and (2) we recognize performance-based revenue based on the most recent assessment of our performance, which represents the amount that the customer would legally be obligated to pay if the contract were terminated as of the latest balance sheet date.
 
We generally bill our customers each month for the entire amount of the fees contractually due for the prior month's enrollment, which typically includes the amount, if any, that is performance-based and may be subject to refund should we not meet performance targets.  Fees for service are typically billed in the month after the services are provided.  Deferred revenues arise from contracts that permit upfront billing and collection of fees covering the entire contractual service period, generally 12 months.  A limited number of our contracts provide for certain performance-based fees that we cannot bill until we reconcile them with the customer.

We generally assess our level of performance for our contracts based on medical claims and other data that the customer is contractually required to supply, interim assessments of achievement against performance targets, or metrics available from our operating platforms.  A minimum of four to nine months' data is typically required for us to measure performance.  In assessing our performance, we may include estimates such as medical claims incurred but not reported. In addition, we may also provide contractual allowances for billing adjustments (such as data reconciliation differences) as appropriate.

If data is insufficient or incomplete to measure performance, or interim performance measures indicate that we are not meeting performance targets, we do not recognize performance-based fees subject to refund as revenues but instead record them in a current liability account entitled "contract billings in excess of earned revenue."  Only in the event we do not meet performance levels by the end of the measurement period, typically one year, are we contractually obligated to refund some or all of the performance-based fees.  We would only reverse revenues that we had already recognized if performance to date in the measurement period, previously above targeted levels, subsequently dropped below targeted levels.  Historically, any such adjustments have been immaterial to our financial condition and results of operations.
 
During the settlement process under a contract, which generally occurs six to eight months after the end of a contract year, we settle any performance-based fees and reconcile healthcare claims and clinical data.  As of December 31, 2013, cumulative performance-based revenues that have not yet been settled with our customers but that have been recognized in the current and prior years totaled approximately $24.2 million, all of which were based on actual data. Data reconciliation differences, for which we provide contractual allowances until we reach agreement with respect to identified issues, can arise between the customer and us due to customer data deficiencies, omissions, and/or data discrepancies.

Performance-related adjustments (including any amounts recorded as revenue that were ultimately refunded), changes in estimates, or data reconciliation differences may cause us to recognize or reverse revenue in a current fiscal year that pertains to services provided during a prior fiscal year.  During 2013, 2012 and 2011, we recognized a net increase in revenue of $8.2 million, $9.2 million, and $2.9 million, respectively, that related to services provided prior to each respective year.
29

Impairment of Intangible Assets and Goodwill

We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable.  We may elect to perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.  If we conclude during the qualitative assessment that this is the case or if we elect not to perform a qualitative assessment, we perform a quantitative review as described below. 
 
During a quantitative review of goodwill, we estimate the fair value of each reporting unit using a combination of a discounted cash flow model and a market-based approach, and we reconcile the aggregate fair value of our reporting units to our consolidated market capitalization.  Estimating fair value requires significant judgments, including management's estimate of future cash flows, which is dependent on internal forecasts, estimation of the long-term growth rate for our business, the useful life over which cash flows will occur, and determination of our weighted average cost of capital, as well as relevant comparable company earnings multiples for the market-based approach.  Changes in these estimates and assumptions could materially affect the estimate of fair value and potential goodwill impairment for each reporting unit.

If we determine that the carrying value of goodwill is impaired based upon an impairment review, we calculate any impairment using a fair-value-based goodwill impairment test as required by U.S. GAAP.  The fair value of a reporting unit is the price that would be received upon a sale of the unit as a whole in an orderly transaction between market participants at the measurement date.

Except for a trade name that has an indefinite life and is not subject to amortization, we amortize identifiable intangible assets, such as acquired technologies and customer contracts, over their estimated useful lives using the straight-line method.  We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable.  If we determine that the carrying value of other identifiable intangible assets may not be recoverable, we calculate any impairment using an estimate of the asset's fair value based on the estimated price that would be received to sell the asset in an orderly transaction between market participants.
 
We review intangible assets not subject to amortization, which consist of a trade name, on an annual basis or more frequently whenever events or circumstances indicate that the assets might be impaired.  We estimate the fair value of the trade name using a present value technique, which requires management's estimate of future revenues attributable to this trade name, estimation of the long-term growth rate for these revenues, and determination of our weighted average cost of capital.  Changes in these estimates and assumptions could materially affect the estimate of fair value for the trade name.

Future events could cause us to conclude that impairment indicators exist and that goodwill and/or other intangible assets are impaired. Any resulting impairment loss could have a material adverse impact on our financial condition and results of operations.

Income Taxes

The objectives of accounting for income taxes are to recognize the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in an entity's financial statements or tax returns.  Accounting for income taxes requires significant judgment in determining income tax provisions, including determination of deferred tax assets, deferred tax liabilities, and any valuation allowances that might be required against deferred tax assets, and in evaluating tax positions.
30
We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.  U.S. GAAP also provides guidance on derecognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and income tax disclosures.  Judgment is required in assessing the future tax consequences of events that have been recognized in our financial statements or tax returns. Variations in the actual outcome of these future tax consequences could materially impact our consolidated financial position, results of operations, and cash flows.
 
Share-Based Compensation

We measure and recognize compensation expense for all share-based payment awards over the required vesting period based on estimated fair values at the date of grant.  Determining the fair value of stock options at the grant date requires judgment in developing assumptions, which involve a number of variables.  These variables include, but are not limited to, the expected stock price volatility over the term of the awards and expected stock option exercise behavior.  In addition, we also use judgment in estimating the number of share-based awards that are expected to be forfeited. These assumptions and judgment are further described in Note 13 to the consolidated financial statements.
 
Results of Operations

The following table sets forth the components of the statements of operations for the fiscal years ended December 31, 2013, 2012 and 2011 expressed as a percentage of revenues.

 
  
Year Ended
December 31,
  
 
  
2013
    
2012
    
2011
  
 
  
   
   
 
Revenues
    
100.0
%
    
100.0
%
    
100.0
%
Cost of services (exclusive of depreciation and amortization included below)
    
82.5
%
    
78.8
%
    
74.2
%
Selling, general and administrative expenses
    
9.2
%
    
9.0
%
    
9.4
%
Depreciation and amortization
    
8.0
%
    
7.6
%
    
7.3
%
Impairment loss
    
—
      
—
      
26.6
%
Restructuring and related charges
    
—
      
0.3
%
    
1.3
%
Operating income (loss) (1)
    
0.3
%
    
4.3
%
    
(18.7
)%
 
                        
Interest expense
    
2.4
%
    
2.1
%
    
1.9
%
 
                        
Income (loss) before income taxes (1)
    
(2.1
)%
    
2.2
%
    
(20.7
)%
Income tax expense (benefit)
    
(0.8
)%
    
1.0
%
    
2.2
%
 
                        
Net income (loss)
    
(1.3
)%
    
1.2
%
    
(22.9
)%

(1)
Figures may not add due to rounding.
 
Revenues

Revenues for fiscal 2013 decreased $13.9 million, or 2.1%, over fiscal 2012, primarily due to contract terminations, including our contract with CIGNA in February 2013 as well as one other health plan contract (the "two terminated contracts").  These decreases were somewhat offset by the following:

•
the commencement of contracts with new customers; and
 
•
increased participation and/or increased membership in customers' existing programs.

31
Revenues for fiscal 2012 decreased $11.6 million, or 1.7%, over fiscal 2011, primarily due to decreases in revenue from the wind-down of our contract with CIGNA in advance of the contract's expiration in February 2013, as well as certain other contract or program terminations with three smaller health plan customers.  These decreases were somewhat offset by the following:

•
the commencement of contracts with new customers;
 
•
an increase in participation in our fitness solutions, as well as in the number of members eligible to participate in such solutions; and
 
•
an increase in performance-based revenues due to our ability to measure and achieve performance targets on certain contracts during the year ended December 31, 2012.

Cost of Services

Cost of services (excluding depreciation and amortization) as a percentage of revenues for fiscal 2013 increased to 82.5% compared to 78.8% for fiscal 2012, primarily due to the following:

•
the impact of the two terminated contracts, which carried a lower than average cost of services as a percentage of revenues, as well as the impact of certain costs that could not be reduced in the same proportion and/or timeframe as the overall decrease in revenues; and
 
 
•
an increase in support costs primarily related to both our Embrace platform and program enrollment partially offset by recoupment of fees related to certain supplier service level agreements.
 
These increases in cost of services for fiscal 2013 were slightly offset by the following decreases:

•
continued economies of scale gained in our fitness solutions; and
 
 
•
a reduction in healthcare benefit costs related to a decrease in claims for fiscal 2013 compared to fiscal 2012.
 
Cost of services (excluding depreciation and amortization) as a percentage of revenues for fiscal 2012 increased to 78.8% compared to 74.2% for fiscal 2011, primarily due to the following:

•
the wind-down of our contract with CIGNA and certain other contract or program terminations with three smaller health plan customers to whom we provided traditional disease management services, all of which carried a lower than average cost of services as a percentage of revenues;
 
•
increased costs related to the implementation of a significant number of new contracts and the launch of new business in the evolving health systems market; and
 
•
an expanded and extended contract during the year ended December 31, 2012 which moved from a cost-plus model to a volume-based model in which revenues are expected to ramp over time, while the underlying cost structure remained consistent with the year ended December 31, 2011.

These increases in cost of services for fiscal 2012 were partially offset by decreases in cost of services (excluding depreciation and amortization) as a percentage of revenues due to the following:

•
an increase in performance-based revenues wherein a significant portion of the related costs were incurred and recognized in a prior period;
 
•
costs associated with implementing a new and innovative contract in 2011 for which we weren't able to recognize revenue until 2012; and
 
•
efficiencies gained in our fitness solutions through certain cost management initiatives.

32
Selling, General and Administrative Expenses

Selling, general and administrative expenses as a percentage of revenues remained relatively consistent at 9.2% for fiscal 2013 compared to 9.0% for fiscal 2012.

Selling, general and administrative expenses as a percentage of revenues decreased to 9.0% for fiscal 2012 compared to 9.4% for fiscal 2011, primarily due to certain cost reductions from a restructuring of the Company in 2011 that was largely completed during the fourth quarter of 2011.

Depreciation and Amortization

Depreciation and amortization expense increased 2.0% for fiscal 2013 compared to fiscal 2012, primarily due to increased depreciation expense related to our Embrace platform.

Depreciation and amortization expense increased 3.5% for fiscal 2012 compared to fiscal 2011, primarily due to increased depreciation expense related to our Embrace platform, partially offset by decreased amortization expense due to certain intangible assets becoming fully amortized during 2011.

Restructuring and Related Charges and Impairment Loss
 
During fiscal 2012, we incurred net charges of $1.8 million related to a restructuring of the Company in the fourth quarter of 2012, which primarily consisted of termination benefits related to capacity realignment.
 
During fiscal 2011, we incurred net charges of $9.0 million related to a restructuring of the Company in the fourth quarter of 2011, which primarily consisted of termination benefits and costs associated with capacity reductions following CIGNA's decision to wind down its contract beginning in 2012.  Also during fiscal 2011, we incurred charges of $183.3 million primarily related to an impairment of goodwill during the fourth quarter of 2011.

Interest Expense

Interest expense for fiscal 2013 increased $1.9 million compared to fiscal 2012, primarily due to amortization of the debt discount related to the Cash Convertible Notes. This increase was somewhat offset by a decrease in interest expense related to the write-off in 2012 of previously deferred loan costs as a result of entering into the Fifth Amended Credit Agreement.

Interest expense for fiscal 2012 increased $1.0 million compared to fiscal 2011, primarily due to the write-off of previously deferred loan costs as a result of entering into the Fifth Amended Credit Agreement in June 2012.

Income Tax Expense

Our effective tax benefit rate for 2013 was 39.8%, which included a favorable $1.1 million reduction to an unrecognized tax position due to the expiration of the applicable statutes of limitations for the 2009 tax year. 
 
Our effective tax rate increased to 45.6% for fiscal 2012 compared to fiscal 2011, primarily due to routine reconciliations of estimated amounts and the relatively small base of pretax income for 2012 in relation to certain unrecognized tax benefits and non-deductible expenses.

In 2011 we had positive income tax expense of $15.4 million despite a pre-tax loss of $142.3 million primarily due to an impairment loss of $183.3 million, the majority of which was not deductible for tax purposes.
33

Liquidity and Capital Resources

Operating activities for fiscal 2013 provided cash of $71.5 million compared to $40.7 million for fiscal 2012.  The increase in operating cash flow resulted primarily from the following:
 
•
a decrease in days sales outstanding in accounts receivable from 57 days at December 31, 2012 to 49 days at December 31, 2013;
 
•
the timing of several significant vendor payments; and
 
•
severance payments made in 2012, which did not recur in 2013, as a result of a restructuring of the Company that was completed during the fourth quarter of 2011.
 
Investing activities during fiscal 2013 used $49.9 million in cash, which primarily consisted of capital expenditures associated with our Embrace platform.

Financing activities during fiscal 2013 used $19.9 million in cash primarily related to net payments under the Fifth Amended Credit Agreement and payments for the Cash Convertible Notes Hedges, mostly offset by proceeds from the Cash Convertible Notes, the CareFirst Convertible Note, the sale of warrants, and exercises of stock options.
 
Credit Facility

On June 8, 2012, we entered into the Fifth Amended Credit Agreement.  The Fifth Amended Credit Agreement provides us with a $200.0 million revolving credit facility that expires on June 8, 2017 and includes a swingline sub facility of $20.0 million and a $75.0 million sub facility for letters of credit.  The Fifth Amended Credit Agreement also provides a $200.0 million term loan facility that matures on June 8, 2017, $110.0 million of which remained outstanding at December 31, 2013, and an uncommitted incremental accordion facility of $200.0 million.

Borrowings under the Fifth Amended Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month rate (or with the approval of affected lenders, nine-month or twelve-month rate) for Eurodollar deposits ( "LIBOR") or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.  The LIBOR margin varies between 1.75% and 3.00%, and the Base Rate margin varies between 0.75% and 2.00%, depending on our leverage ratio.  The Fifth Amended Credit Agreement also provides for an annual fee ranging between 0.30% and 0.50% of the unused commitments under the revolving credit facility.  Extensions of credit under the Fifth Amended Credit Agreement are secured by guarantees from all of the Company's active domestic subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.
34

On February 5, 2013, we entered into an amendment to the Fifth Amended Credit Agreement, which included, among other things, a temporary increase in the LIBOR and Base Rate margins of 0.25%.  The increased margins were effective through December 31, 2013 and applied only when our total funded debt to EBITDA ratio was greater than or equal to 3.50 to 1.00.  On July 1, 2013, we entered into an additional amendment to the Fifth Amended Credit Agreement, which provided for, among other things, the amendment of certain negative covenants to permit the issuance of and payments related to the Cash Convertible Notes, Cash Convertible Notes Hedges and warrants described below as well as increases in the maximum required levels of total funded debt to EBITDA beginning with the quarter ended September 30, 2013.  As of December 31, 2013, availability under the revolving credit facility totaled $38.7 million as calculated under the most restrictive covenant.

We are required to repay outstanding revolving loans under the revolving credit facility in full on June 8, 2017. We are required to repay term loans in quarterly principal installments aggregating (1) 1.250% of the original aggregate principal amount of the term loans during each of the eight quarters beginning with the quarter ended September 30, 2012, (2) 1.875% of the original aggregate principal amount of the term loans during each of the next four quarters beginning with the quarter ending September 30, 2014, and (3) 2.500% of the original aggregate principal amount of the term loans during each of the remaining quarters prior to maturity on June 8, 2017, at which time the entire unpaid principal balance of the term loans is due and payable.   

The Fifth Amended Credit Agreement contains financial covenants that require us to maintain specified ratios or levels at December 31, 2013 of (1) a maximum total funded debt to EBITDA of 4.75 and (2) a minimum total fixed charge coverage of 1.50.  As of December 31, 2013, our total funded debt to EBITDA ratio was 4.13, and our total fixed charge coverage ratio was 1.82, each as defined in the Fifth Amended Credit Agreement. We were in compliance with all of the financial covenant requirements of the Fifth Amended Credit Agreement as of December 31, 2013. 
 
The Fifth Amended Credit Agreement contains various other affirmative and negative covenants that are typical for financings of this type.  Among other things, the Fifth Amended Credit Agreement limits repurchases of our common stock and the amount of dividends that we can pay to holders of our common stock. A breach of any of these covenants could result in a default under the Fifth Amended Credit Agreement, in which all amounts outstanding under the Fifth Amended Credit Agreement may become immediately due and payable, and all commitments under the Fifth Amended Credit Agreement to extend further credit may be terminated. In addition, a payment default, including an acceleration following an event of default, under the Fifth Amended Credit Agreement or under our indenture for the Cash Convertible Notes, could each trigger an event of default under the other debt instrument, which could result in the principal of and the accrued and unpaid interest on such debt becoming due and payable.

In order to reduce our exposure to interest rate fluctuations on our floating rate debt commitments, we maintain interest rate swap agreements that effectively modify our exposure to interest rate risk by converting a portion of our floating rate debt to fixed obligations, thus reducing the impact of interest rate changes on future interest expense.  Under these agreements, we receive a variable rate of interest based on LIBOR, and we pay a fixed rate of interest with interest rates ranging from 0.690% to 1.480% plus a spread (see Note 7 to the consolidated financial statements).  We maintain interest rate swap agreements with current notional amounts of $145.0 million and termination dates ranging from November 2015 to December 2016.  Of this amount, $95.0 million was effective at December 31, 2013, and $50.0 million will become effective in December 2015, as older interest rate swap agreements expire.  We have designated these interest rate swap agreements as qualifying cash flow hedges.  We currently meet the hedge accounting criteria under U.S. GAAP in accounting for these interest rate swap agreements.
 
Cash Convertible Senior Notes
 
On July 16, 2013, we completed a private placement of $150.0 million aggregate principal amount of Cash Convertible Notes due 2018, which bear interest at a rate of 1.50% per year, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2014. The Cash Convertible Notes will mature on July 1, 2018, unless earlier repurchased or converted into cash in accordance with their terms prior to such date. The Cash Convertible Notes are convertible into cash based on the conversion rate set forth below and are not convertible into our common stock or any other securities under any circumstances. The initial cash conversion rate is approximately 51.38 shares of our common stock per $1,000 principal amount of Cash Convertible Notes (equivalent to an initial conversion price of approximately $19.46 per share of common stock). The Cash Convertible Notes are our senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Cash Convertible Notes.
35

In connection with the issuance of the Cash Convertible Notes, we entered into Cash Convertible Notes Hedges, which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elect to convert the Cash Convertible Notes at a time when our stock price exceeds the conversion price. The Cash Convertible Notes Hedges, which are recorded and carried at fair value as a derivative asset, are intended to offset the gain (or loss) associated with changes to the valuation of the Cash Conversion Derivative. We also entered into separate privately negotiated warrant transactions (the "Warrants") initially relating, in the aggregate, to a notional number of shares of our common stock underlying the Cash Convertible Notes Hedges. The warrant transactions could have a dilutive effect to the extent that the market price per share of our common stock (as measured under the terms of the warrant transactions) exceeds the applicable strike price of the Warrants. The initial strike price of the Warrants is approximately $25.95 per share, which effectively increases the conversion price of the Cash Convertible Notes to a 60% premium to our stock price on July 1, 2013.
 
The net proceeds from the sale of the Cash Convertible Notes were approximately $145.3 million, after deducting the initial purchasers' discounts and commissions and the placement expenses. We used $21.6 million of the net proceeds from the sale of the Cash Convertible Notes to pay the cost of the Cash Convertible Notes Hedges (after such cost was partially offset by the proceeds to the Company from the sale of the Warrants), and we used the remainder of the net proceeds from the sale of the Cash Convertible Notes to reduce the outstanding indebtedness under the Fifth Amended Credit Agreement.

Aside from the initial premium paid, we will not be required to make any cash payments under the Cash Convertible Notes Hedges and could be entitled to receive an amount of cash from the option counterparties generally equal to the amount by which the market price per share of common stock exceeds the strike price of the Cash Convertible Note Hedges during the relevant valuation period. The strike price under the Cash Convertible Notes Hedges is initially equal to the conversion price of the Cash Convertible Notes. Additionally, if the market price per share of our common stock exceeds the strike price of the Warrants on any warrant exercise date  we will be obligated to issue to the option counterparties a number of shares based on the amount by which the then-current market price per share of our common stock exceeds the then-effective strike price of each Warrant. We will not receive any additional proceeds if the Warrants are exercised.
 
CareFirst Convertible Note
 
On October 1, 2013, we entered into an Investment Agreement with CareFirst, which is in addition to certain existing commercial agreements between us and CareFirst relating to, among other things, disease management and care coordination services (the "Commercial Agreements"). Pursuant to the Investment Agreement, we issued the CareFirst Convertible Note in the aggregate original principal amount of $20 million to CareFirst for a purchase price of $20 million. The CareFirst Convertible Note bears interest at a rate of 4.75% per year, payable quarterly in arrears on March 31, June 30, September 30 and December 31 of each calendar year, beginning on December 31, 2013. The CareFirst Convertible Note may be prepaid only under limited circumstances and upon the terms and conditions specified therein. If the CareFirst Convertible Note has not been fully converted or redeemed in accordance with its terms, it will mature on October 1, 2019. The CareFirst Convertible Note is subordinate in right of payment to the prior payment in full of (a) all indebtedness of the Company under the Fifth Amended Credit Agreement, and (b) any other senior debt of the Company, which currently includes only the Cash Convertible Notes.

We believe that cash flows from operating activities, our available cash, and our anticipated available credit under the Fifth Amended Credit Agreement will continue to enable us to meet our contractual obligations and fund our current operations for the foreseeable future.  We cannot assure you that we would always be able to secure additional financing if needed and, if such funds were available, whether the terms or conditions would be acceptable to us.

If contract development accelerates or acquisition opportunities arise, we may need to issue additional debt or equity securities to provide the funding for these increased growth opportunities. We may also issue debt or equity securities in connection with future acquisitions or strategic alliances.  We cannot assure you that we would be able to issue additional debt or equity securities on terms that would be acceptable to us.
 
Any material commitments for capital expenditures are included in the "Contractual Obligations" table below.
36

Contractual Obligations

The following schedule summarizes our contractual cash obligations as of December 31, 2013:

 
  
Payments Due By Year Ended December 31,
  
(In thousands)
  
     
2015 -
      
2017 -
    
2019 and
    
 
 
  
2014
      
2016
      
2018
    
After
    
Total
  
Deferred compensation plan payments (1)
  
$
1,615
    
$
1,142
    
$
523
    
$
5,538
    
$
8,818
  
Long-term debt and related interest (2)
    
20,938
      
51,667
      
219,861
      
20,736
      
313,202
  
Operating lease obligations
    
13,198
      
22,545
      
20,905
      
33,262
      
89,910
  
Capital lease obligations (3)
    
1,199
      
66
      
—
      
—
      
1,265
  
Purchase obligations
    
3,152
      
—
      
—
      
—
      
3,152
  
Outsourcing obligations (4)
    
23,017
      
40,020
      
36,154
      
43,025
      
142,216
  
Other contractual cash obligations (5)
    
15,960
      
42,710
      
19,949
      
25,500
      
104,119
  
Total contractual cash obligations
  
$
79,079
    
$
158,150
    
$
297,392
    
$
128,061
    
$
662,682
  

(1) Consists of payments under a non-qualified deferred compensation plan and performance cash awards.

(2) Consists of scheduled principal payments, repayment of outstanding revolving loans, and estimated interest payments on outstanding borrowings under the Fifth Amended Credit Agreement. Also includes payments in respect of the Cash Convertible Notes and CareFirst Convertible Note and payments of cash interest thereon. Total estimated interest payments are $8.4 million for 2014, $14.2 million for 2015 and 2016 combined, $6.2 million for 2017 and 2018 combined, and $0.7 million for 2019 and after.

(3) Consists of scheduled principal payments and estimated interest payments on capital lease obligations.  Estimated interest payments are immaterial.
 
(4) Outsourcing obligations primarily include a ten-year applications and technology services outsourcing agreement with HP Enterprise Services, LLC entered into in May 2011 that contains minimum fee requirements.  Total payments over the remaining term, including an estimate for future contractual cost of living adjustments, must equal or exceed a minimum level of approximately $142.2 million; however, based on initial required service and equipment level assumptions, we estimate that the remaining payments will be approximately $297.6 million.  The agreement allows us to terminate all or a portion of the services after the first two years provided we pay certain termination fees, which could be material to the Company.

(5) Other contractual cash obligations include a 25-year strategic relationship agreement with Gallup that we entered into in January 2008 and a 5-year global joint venture agreement with Gallup that we entered into in October 2012.  We have minimum remaining contractual cash obligations of $42.0 million related to these agreements, $7.5 million of which will occur during each of 2014 and 2015, $6.0 million which will occur in each of 2016 and 2017 and the remaining $15.0 million of which will occur ratably over the following 15 years. The majority of the remaining other contractual cash obligations consists of royalty and license fees related to certain programs or product offerings.
 
Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements as of December 31, 2013.
37

Recently Issued Accounting Standards

In July 2012, the FASB issued Accounting Standards Update ("ASU") No. 2012-02, "Intangibles—Goodwill and Other (Topic 350)—Testing Indefinite-Lived Intangible Assets for Impairment."  ASU No. 2012-02 permits an entity to perform a qualitative assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value.  If the entity concludes that this is the case, it must perform the currently prescribed quantitative impairment test by comparing the fair value of the indefinite-lived intangible asset with its carrying value.  Otherwise, the quantitative impairment test is not required. ASU No. 2012-02 is effective for fiscal years beginning after September 15, 2012, with earlier adoption permitted.  We adopted this standard for the fiscal year beginning January 1, 2013.  The adoption of this standard did not have a material impact on our consolidated results of operations, financial position, cash flows, or notes to the consolidated financial statements.
 
In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220)—Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income,"  which requires companies to provide information about the amounts reclassified out of accumulated other comprehensive income ("AOCI") by component. In addition, entities are required to present, either on the face of the statement where net income is presented or in the accompanying notes, significant amounts reclassified out of AOCI by the respective line items of net income, but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period. For amounts that are not required to be reclassified in their entirety to net income, entities are required to cross-reference to other disclosures that provide additional detail on those amounts. ASU No. 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012.  We adopted this standard for the interim period beginning January 1, 2013.  The adoption of this standard did not have a material impact on our consolidated results of operations, financial position, cash flows, or notes to the consolidated financial statements.
 
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk
 
We are subject to market risk related to interest rate changes, primarily as a result of the Fifth Amended Credit Agreement.  Borrowings under the Fifth Amended Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) one-month, two-month, three-month or six-month (or with the approval of affected lenders, nine-month or twelve-month) LIBOR or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) the Base Rate (as previously defined), as selected by the Company.  The LIBOR margin varies between 1.75% and 3.00%, and the Base Rate margin varies between 0.75% and 2.00%, depending on our leverage ratio.  On February 5, 2013, we entered into an amendment to the Fifth Amended Credit Agreement, which provided for, among other things, a temporary increase in the LIBOR and Base Rate margins of 0.25%. The increased margins were effective through December 31, 2013 and applied only when our total funded debt to EBITDA ratio was greater than or equal to 3.50 to 1.00.

In order to reduce our interest rate exposure under the Fifth Amended Credit Agreement, we have entered into interest rate swap agreements effectively converting a portion of our floating rate debt to fixed obligations with interest rates ranging from 0.690% to 1.480% plus a spread.

We estimate that a one-point interest rate change would have resulted in a change in interest expense of approximately $0.7 million for the twelve months ended December 31, 2013.
 
Foreign Currency Exchange Rate Risk
 
 As a result of our investment in international initiatives, we are also exposed to foreign currency exchange rate risks. Because a significant portion of these risks is economically hedged with currency options and forwards contracts and because our international initiatives are not yet material to our consolidated results of operations, a 10% change in foreign currency exchange rates would not have had a material impact on our consolidated results of operations, financial position, or cash flows for the twelve months ended December 31, 2013.  We do not execute transactions or hold derivative financial instruments for trading purposes.

38
Report of Independent Registered Public Accounting Firm


The Board of Directors and Stockholders of Healthways, Inc.

We have audited the accompanying consolidated balance sheets of Healthways, Inc. as of December 31, 2013 and 2012, and the related consolidated statements of operations, comprehensive income (loss), changes in stockholders' equity and cash flows for each of the three years in the period ended December 31, 2013. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Healthways, Inc. at December 31, 2013 and 2012, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2013, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Healthways Inc.'s internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992 framework) and our report dated March 14, 2014 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Nashville, Tennessee
March 14, 2014
 
39
Item 8. Financial Statements and Supplementary Data

HEALTHWAYS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands)

ASSETS

 
  
December 31, 2013
    
December 31, 2012
  
Current assets:
  
   
 
Cash and cash equivalents
  
$
2,584
    
$
1,759
  
Accounts receivable, net
    
89,484
      
108,337
  
Prepaid expenses
    
9,228
      
9,727
  
Other current assets
    
6,857
      
7,227
  
Income taxes receivable
    
1,402
      
5,920
  
Deferred tax asset
    
9,667
      
8,839
  
Total current assets
    
119,222
      
141,809
  
 
                
Property and equipment:
                
Leasehold improvements
    
37,463
      
40,679
  
Computer equipment and related software
    
290,392
      
267,902
  
Furniture and office equipment
    
22,881
      
23,552
  
Capital projects in process
    
25,228
      
11,799
  
 
    
375,964
      
343,932
  
Less accumulated depreciation
    
(217,766
)
    
(187,438
)
 
    
158,198
      
156,494
  
 
                
Other assets
    
53,629
      
21,042
  
Intangible assets, net
    
79,162
      
90,228
  
Goodwill, net
    
338,800
      
338,695
  
 
                
Total assets
  
$
749,011
    
$
748,268
  
 
See accompanying notes to the consolidated financial statements.
40
HEALTHWAYS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)

LIABILITIES AND STOCKHOLDERS' EQUITY

 
  
December 31, 2013
    
December 31, 2012
  
Current liabilities:
  
   
 
Accounts payable
  
$
33,125
    
$
26,343
  
Accrued salaries and benefits
    
20,157
      
24,909
  
Accrued liabilities
    
32,065
      
39,234
  
Deferred revenue
    
4,496
      
5,643
  
Contract billings in excess of earned revenue
    
17,411
      
14,793
  
Current portion of long-term debt
    
14,340
      
11,801
  
Current portion of long-term liabilities
    
2,822
      
5,535
  
Total current liabilities
    
124,416
      
128,258
  
 
                
Long-term debt
    
237,582
      
278,534
  
Long-term deferred tax liability
    
33,320
      
36,053
  
Other long-term liabilities
    
51,003
      
26,602
  
 
                
Stockholders' equity:
                
 
                
Preferred stock $.001 par value, 5,000,000 shares authorized, none outstanding
    
—
      
—
  
Common stock $.001 par value, 120,000,000 shares authorized, 35,107,303 and 33,924,464 shares outstanding
    
35
      
34
  
Additional paid-in capital
    
283,244
      
251,357
  
Retained earnings
    
48,000
      
56,541
  
Treasury stock, at cost, 2,254,953 shares in treasury
    
(28,182
)
    
(28,182
)
Accumulated other comprehensive loss
    
(407
)
    
(929
)
Total stockholders' equity
    
302,690
      
278,821
  
 
                
Total liabilities and stockholders' equity
  
$
749,011
    
$
748,268
  
 
See accompanying notes to the consolidated financial statements.

41
HEALTHWAYS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except earnings per share data)

 
  
Year Ended December 31,
  
 
  
2013
    
2012
    
2011
  
Revenues
  
$
663,285
    
$
677,170
    
$
688,765
  
Cost of services (exclusive of depreciation and amortization of $36,183, $36,094, and $36,248, respectively, included below)
    
547,387
      
533,880
      
510,724
  
Selling, general and administrative expenses
    
61,205
      
60,888
      
64,843
  
Depreciation and amortization
    
52,791
      
51,734
      
49,988
  
Impairment loss
    
—
      
—
      
183,288
  
Restructuring and related charges
    
—
      
1,773
      
9,036
  
 
                        
Operating income (loss)
    
1,902
      
28,895
      
(129,114
)
Interest expense
    
16,079
      
14,149
      
13,193
  
 
                        
Income (loss) before income taxes
    
(14,177
)
    
14,746
      
(142,307
)
Income tax expense (benefit)
    
(5,636
)
    
6,722
      
15,386
  
 
                        
Net income (loss)
  
$
(8,541
)
  
$
8,024
    
$
(157,693
)
 
                        
Earnings (loss) per share:
                        
Basic
  
$
(0.25
)
  
$
0.24
    
$
(4.68
)
 
                        
Diluted(1)
  
$
(0.25
)
  
$
0.24
    
$
(4.68
)
 
                        
Comprehensive income (loss)
  
$
(8,019
)
  
$
8,884
    
$
(156,049
)
 
                        
Weighted average common shares and equivalents
                        
Basic
    
34,489
      
33,597
      
33,677
  
Diluted (1)
    
34,489
      
33,836
      
33,677
  
 
See accompanying notes to the consolidated financial statements.
 
(1) The assumed exercise of stock-based compensation awards for the years ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive.
42

HEALTHWAYS, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)

 
  
Year Ended December 31,
  
 
  
2013
    
2012
    
2011
  
 
  
   
   
 
Net income (loss)
  
$
(8,541
)
  
$
8,024
    
$
(157,693
)
Other comprehensive income (loss), net of tax
                        
Net change in fair value of interest rate swaps, net of income taxes of $972,  $493, and $1,109, respectively
    
1,277
      
780
      
1,714
  
Foreign currency translation adjustment
    
(755
)
    
80
      
(70
)
Total other comprehensive income, net of tax
    
522
      
860
      
1,644
  
Comprehensive income (loss)
  
$
(8,019
)
  
$
8,884
    
$
(156,049
)
 
See accompanying notes to the consolidated financial statements.
43

HEALTHWAYS, INC.
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
(In thousands)

 
  
Preferred
Stock
    
Common
Stock
    
Additional
Paid-in
Capital
    
Retained
Earnings
    
Treasury
Stock
    
Other
Comprehensive Income (Loss)
    
Total
  
Balance, December 31, 2010
  
$
—
    
$
34
    
$
232,524
    
$
206,210
      
(4,494
)
  
$
(3,433
)
  
$
430,841
  
Comprehensive loss
    
—
      
—
      
—
      
(157,693
)
    
—
      
1,644
      
(156,049
)
Repurchases of common stock
    
—
      
(2
)
    
—
      
—
      
(23,688
)
    
—
      
(23,690
)
Exercise of stock options
    
—
      
1
      
4,824
      
—
      
—
      
—
      
4,825
  
Tax effect of stock options and restricted stock units
    
—
      
—
      
(2,719
)
    
—
      
—
      
—
      
(2,719
)
Share-based employee compensation expense
    
—
      
—
      
9,246
      
—
      
—
      
—
      
9,246
  
Issuance of stock in conjunction with Navvis acquisition
    
—
      
—
      
3,262
      
—
      
—
      
—
      
3,262
  
Balance, December 31, 2011
  
$
—
    
$
33
    
$
247,137
    
$
48,517
    
$
(28,182
)
  
$
(1,789
)
  
$
265,716
  
Comprehensive income
    
—
      
—
      
—
      
8,024
      
—
      
860
      
8,884
  
Exercise of stock options
    
—
      
1
      
2,834
      
—
      
—
      
—
      
2,835
  
Tax effect of stock options and restricted stock units
    
—
      
—
      
(5,043
)
    
—
      
—
      
—
      
(5,043
)
Share-based employee compensation expense
    
—
      
—
      
6,371
      
—
      
—
      
—
      
6,371
  
Issuance of stock in conjunction with Ascentia acquisition
    
—
      
—
      
58
      
—
      
—
      
—
      
58
  
Balance, December 31, 2012
  
$
—
    
$
34
    
$
251,357
    
$
56,541
    
$
(28,182
)
  
$
(929
)
  
$
278,821
  
Comprehensive loss
    
—
      
—
      
—
      
(8,541
)
    
—
      
522
      
(8,019
)
Exercise of stock options
    
—
      
1
      
12,747
      
—
      
—
      
—
      
12,748
  
Tax effect of stock options and restricted stock units
    
—
      
—
      
(3,225
)
    
—
      
—
      
—
      
(3,225
)
Share-based employee compensation expense
    
—
      
—
      
7,116
      
—
      
—
      
—
      
7,116
  
Issuance of warrants
    
—
      
—
      
15,150
      
—
      
—
      
—
      
15,150
  
Issuance of stock in conjunction with Ornish partnership
    
—
      
—
      
467
      
—
      
—
      
—
      
467
  
Other
    
—
      
—
      
(368
)
    
—
      
—
      
—
      
(368
)
Balance, December 31, 2013
  
$
—
    
$
35
    
$
283,244
    
$
48,000
    
$
(28,182
)
  
$
(407
)
  
$
302,690
  

See accompanying notes to the consolidated financial statements.

44
HEALTHWAYS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 
  
Year Ended December 31,
  
 
  
2013
    
2012
    
2011
  
 
  
   
   
 
Cash flows from operating activities:
  
   
   
 
Net income (loss)
  
$
(8,541
)
  
$
8,024
    
$
(157,693
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities, net of business acquisitions:
                        
Depreciation and amortization
    
52,791
      
51,734
      
49,988
  
Impairment loss
    
—
      
—
      
183,288
  
Amortization and write-off of deferred loan costs
    
1,685
      
2,284
      
1,894
  
Amortization of debt discount
    
3,140
      
—
      
—
  
Share-based employee compensation expense
    
7,116
      
6,371
      
9,246
  
Deferred income taxes
    
(5,077
)
    
(1,334
)
    
(3,572
)
Excess tax benefits from share-based payment arrangements
    
(718
)
    
(492
)
    
(433
)
Decrease (increase) in accounts receivable, net
    
19,099
      
(23,439
)
    
(7,452
)
(Increase) decrease in other current assets
    
(598
)
    
2,984
      
6,960
  
Increase (decrease) in accounts payable
    
9,224
      
(995
)
    
1,466
  
Decrease in accrued salaries and benefits
    
(5,780
)
    
(12,980
)
    
(8,932
)
(Decrease) increase in other current liabilities
    
(1,196
)
    
13,637
      
2,676
  
Other
    
383
      
(5,096
)
    
(1,144
)
Net cash flows provided by operating activities
    
71,528
      
40,698
      
76,292
  
 
                        
Cash flows from investing activities:
                        
Acquisition of property and equipment
    
(41,346
)
    
(48,912
)
    
(49,290
)
Business acquisitions, net of cash acquired, and equity investments
    
(830
)
    
(4,693
)
    
(23,523
)
Other
    
(7,717
)
    
(6,872
)
    
(6,889
)
Net cash flows used in investing activities
    
(49,893
)
    
(60,477
)
    
(79,702
)
 
                        
Cash flows from financing activities:
                        
Proceeds from issuance of long-term debt
    
352,850
      
755,550
      
439,621
  
Payments of long-term debt
    
(529,874
)
    
(736,355
)
    
(417,490
)
Repurchases of common stock
    
—
      
—
      
(23,690
)
Excess tax benefits from share-based payment arrangements
    
718
      
492
      
433
  
Exercise of stock options
    
12,748
      
2,835
      
4,825
  
Deferred loan costs
    
(5,264
)
    
(2,547
)
    
—
  
Proceeds from cash convertible senior notes
    
150,000
      
—
      
—
  
Proceeds from convertible note
    
20,000
      
—
      
—
  
Proceeds from sale of warrants
    
15,150
      
—
      
—
  
Payments for cash convertible note hedge transactions
    
(36,750
)
    
—
      
—
  
Change in outstanding checks and other
    
526
      
582
      
(709
)
Net cash flows (used in) provided by financing activities
    
(19,896
)
    
20,557
      
2,990
  
 
                        
Effect of exchange rate changes on cash
    
(914
)
    
117
      
220
  
 
                        
Net increase (decrease) in cash and cash equivalents
    
825
      
895
      
(200
)
 
                        
Cash and cash equivalents, beginning of period
    
1,759
      
864
      
1,064
  
 
                        
Cash and cash equivalents, end of period
    
2,584
      
1,759
      
864
  
 
                        
Supplemental disclosure of cash flow information:
                        
Cash paid during the period for interest
  
$
10,080
    
$
12,001
    
$
11,106
  
Cash paid during the period for income taxes
  
$
650
    
$
2,282
    
$
7,874
  
 
                        
45

Noncash Activities:
  
   
   
 
Issuance of unregistered common stock associated with Navvis acquisition
  
$
—
    
$
—
    
$
3,262
  
Issuance of unregistered common stock associated with Ascentia acquisition
  
$
—
    
$
58
    
$
—
  
Issuance of unregistered common stock associated with Ornish partnership
  
$
467
    
$
—
    
$
—
  

See accompanying notes to the consolidated financial statements.

46
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended December 31, 2013, 2012, and 2011

1. Summary of Significant Accounting Policies

Healthways, Inc. and its wholly-owned subsidiaries provide specialized, comprehensive solutions to help people improve physical, emotional and social well-being, thereby reducing both direct healthcare costs and associated costs from the loss of health-related employee productivity.  In North America, our customers include health plans, employers, integrated healthcare systems, hospitals, physicians, and government entities in all 50 states and the District of Columbia. We also provide health improvement programs and services in Brazil, Australia, and France.

As used throughout these notes to the consolidated financial statements, unless the context otherwise indicates, the terms "we," "us," "our," or the "Company" refer collectively to Healthways, Inc. and its wholly-owned subsidiaries.
 
a.  Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned by the Company.  We have eliminated all intercompany profits, transactions and balances.

b.  Cash and Cash Equivalents - Cash and cash equivalents primarily include cash, tax-exempt debt instruments, commercial paper, and other short-term investments with original maturities of less than three months.

c.  Accounts Receivable, net - Billed receivables primarily represent fees that are contractually due in the ordinary course of providing our services, net of contractual adjustments and allowances for doubtful accounts.  Unbilled receivables primarily represent fees for services based on the estimated utilization of fitness facilities, which are generally billed in the following month, and certain performance-based fees that are billed when performance metrics are met and reconciled with the customer.  Historically, we have experienced minimal instances of customer non-payment and therefore consider our accounts receivable to be collectible, but we provide reserves, when appropriate, for doubtful accounts and for billing adjustments (such as data reconciliation differences) on a specific identification basis.

d.  Property and Equipment - Property and equipment is carried at cost and includes expenditures that increase value or extend useful lives.  We recognize depreciation using the straight-line method over useful lives of three to seven years for computer software and hardware and four to seven years for furniture and other office equipment.  Leasehold improvements are depreciated over the shorter of the estimated life of the asset or the life of the lease, which ranges from two to fifteen years.  Depreciation expense for the years ended December 31, 2013, 2012, and 2011 was $40.1 million, $39.1 million, and $36.6 million, respectively, including amortization of assets recorded under capital leases.

Net computer software at December 31, 2013 and 2012 was $99.1 million and $103.7 million, respectively.  Depreciation expense related to computer software for the years ended December 31, 2013, 2012, and 2011 was $26.5 million, $24.9 million, and $21.4 million, respectively.

e.  Other Assets - Other assets consist primarily of cash convertible notes hedges, long-term investments, long-term customer incentives, and deferred loan costs net of accumulated amortization.

f.  Intangible Assets - Intangible assets subject to amortization include customer contracts, acquired technology, patents, distributor and provider networks, a perpetual license, and other intangible assets which we amortize on a straight-line basis over estimated useful lives ranging from two to 25 years.  We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable.

Intangible assets not subject to amortization at December 31, 2013 and 2012 consist of a trade name of $29.0 million.  We review intangible assets not subject to amortization on an annual basis or more frequently whenever events or circumstances indicate that the assets might be impaired.  See Note 4 for further information on intangible assets.

g.  Goodwill - We recognize goodwill for the excess of the purchase price over the fair value of tangible and identifiable intangible net assets of businesses that we acquire.

We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable.  We allocate goodwill to reporting units based on the reporting unit expected to benefit from the combination.
47

We estimate the fair value of each reporting unit using a combination of a discounted cash flow model and a market-based approach, and we reconcile the aggregate fair value of our reporting units to our consolidated market capitalization.

h. Contract Billings in Excess of Earned Revenue - Contract billings in excess of earned revenue primarily represent performance-based fees subject to refund that we have not recognized as revenues because either (1) data from the customer is insufficient or incomplete to measure performance; or (2) interim performance measures indicate that we are not currently meeting performance targets.

i. Income Taxes - We file a consolidated federal income tax return that includes all of our domestic wholly owned subsidiaries.  Generally accepted accounting principles in the United States ("U.S. GAAP") generally require that we record deferred income taxes for the tax effect of differences between the book and tax bases of our assets and liabilities.  We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

j. Revenue Recognition - Our fees are generally billed on a per member per month ("PMPM") basis or upon member participation.  For PMPM fees, we generally determine our contract fees by multiplying the contractually negotiated PMPM rate by the number of members covered by our services during the month.  We typically set PMPM rates during contract negotiations with customers based on the value we expect our programs to create and a sharing of that value between the customer and the Company.  In addition, some of our services, such as the Healthways SilverSneakers® fitness solution, include fees that are based upon member participation.

Our contracts with health plans and integrated healthcare systems generally range from three to five years with a number of comprehensive strategic agreements extending to ten years in length.  Contracts with self-insured employers typically have two to four-year terms. Some of our contracts allow the customer to terminate early.

Some of our contracts place a portion of our fees at risk based on achieving certain performance metrics, cost savings, and/or clinical outcomes improvements ("performance-based").  Approximately 4% of revenues recorded during the year ended December 31, 2013 were performance-based of which 3% were subject to final reconciliation as of December 31, 2013.

We recognize revenue as follows: (1) we recognize the fixed portion of PMPM fees and fees for service as revenue during the period we perform our services; and (2) we recognize performance-based revenue based on the most recent assessment of our performance, which represents the amount that the customer would legally be obligated to pay if the contract were terminated as of the latest balance sheet date.

We generally bill our customers each month for the entire amount of the fees contractually due for the prior month's enrollment, which typically includes the amount, if any, that is performance-based and may be subject to refund should we not meet performance targets.  Fees for participation are typically billed in the month after the services are provided.  Deferred revenues arise from contracts that permit upfront billing and collection of fees covering the entire contractual service period, generally 12 months.  A limited number of our contracts provide for certain performance-based fees that cannot be billed until after they are reconciled with the customer.

We generally assess our level of performance for our contracts based on medical claims and other data that the customer is contractually required to supply, interim assessments of achievement against performance targets, or metrics available from our operating platforms.  A minimum of four to nine months' data is typically required for us to measure performance.  In assessing our performance, we may include estimates such as medical claims incurred but not reported.  In addition, we may also provide contractual allowances for billing adjustments (such as data reconciliation differences) as appropriate.

If data is insufficient or incomplete to measure performance, or interim performance measures indicate that we are not meeting performance targets, we do not recognize performance-based fees subject to refund as revenues but instead record them in a current liability account entitled "contract billings in excess of earned revenue."  Only in the event we do not meet performance levels by the end of the measurement period, typically one year, are we contractually obligated to refund some or all of the performance-based fees.  We would only reverse revenues that we had already recognized if performance to date in the measurement period, previously above targeted levels, subsequently dropped below targeted levels.  Historically, any such adjustments have been immaterial to our financial condition and results of operations.
48

During the settlement process under a contract, which generally occurs six to eight months after the end of a contract year, we settle any performance-based fees and reconcile healthcare claims and clinical data.  As of December 31, 2013, cumulative performance-based revenues that have not yet been settled with our customers but that have been recognized in the current and prior years totaled approximately $24.2 million, all of which were based on actual data.  Data reconciliation differences, for which we provide contractual allowances until we reach agreement with respect to identified issues, can arise between the customer and us due to customer data deficiencies, omissions, and/or data discrepancies.

Performance-related adjustments (including any amounts recorded as revenue that were ultimately refunded), changes in estimates, or data reconciliation differences may cause us to recognize or reverse revenue in a current fiscal year that pertains to services provided during a prior fiscal year.  During 2013, 2012 and 2011, we recognized a net increase in revenue of $8.2 million, $9.2 million, and $2.9 million, respectively, that related to services provided prior to each respective year.

k.  Earnings (Loss) Per Share – We calculate basic earnings (loss) per share using weighted average common shares outstanding during the period.  We calculate diluted earnings (loss) per share using weighted average common shares outstanding during the period plus the effect of all dilutive potential common shares outstanding during the period unless the impact would be anti-dilutive.  See Note 14 for a reconciliation of basic and diluted earnings (loss) per share.

l.  Share-Based Compensation – We recognize all share-based payments to employees, including grants of employee stock options, in the consolidated statements of operations over the required vesting period based on estimated fair values at the date of grant.  See Note 13 for further information on share-based compensation.
 
m. Derivative Instruments and Hedging Activities – We use derivative instruments to manage risks related to interest rate swap agreements, foreign currencies, and the cash convertible senior notes (as discussed in Note 6). We account for derivatives in accordance with Financial Accounting Standards Board Standards Board ("FASB")  Accounting Standards Codification ("ASC") Topic 815, which establishes accounting and reporting standards requiring that certain derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value will be recognized currently in earnings unless specific hedge accounting criteria are met. As permitted under our master netting arrangements, the fair value amounts of our interest rate swaps and foreign currency options and/or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets. See Note 7 for further information on derivative instruments and hedging activities.
 
n. Management Estimates – In preparing our consolidated financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect: (1) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements; and (2) the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

2.
Recent Accounting Standards

In July 2012, the FASB issued Accounting Standards Update ("ASU") No. 2012-02, "Intangibles—Goodwill and Other (Topic 350)—Testing Indefinite-Lived Intangible Assets for Impairment."  ASU No. 2012-02 permits an entity to perform a qualitative assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value.  If the entity concludes that this is the case, it must perform the currently prescribed quantitative impairment test by comparing the fair value of the indefinite-lived intangible asset with its carrying value.  Otherwise, the quantitative impairment test is not required. ASU No. 2012-02 is effective for fiscal years beginning after September 15, 2012, with earlier adoption permitted.  We adopted this standard for the fiscal year beginning January 1, 2013.  The adoption of this standard did not have a material impact on our consolidated results of operations, financial position, cash flows, or notes to the consolidated financial statements.
49

In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220)—Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income," which requires companies to provide information about the amounts reclassified out of accumulated other comprehensive income ("AOCI") by component. In addition, entities are required to present, either on the face of the statement where net income is presented or in the accompanying notes, significant amounts reclassified out of AOCI by the respective line items of net income, but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period. For amounts that are not required to be reclassified in their entirety to net income, entities are required to cross-reference to other disclosures that provide additional detail on those amounts. ASU No. 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012.  We adopted this standard for the interim period beginning January 1, 2013. The adoption of this standard did not have a material impact on our consolidated results of operations, financial position, cash flows, or notes to the consolidated financial statements.
 
3. Goodwill

The change in carrying amount of goodwill during the years ended December 31, 2011, 2012, and 2013 is shown below:

(In thousands)
  
 
Balance, December 31, 2010
  
$
496,265
  
Navvis purchase
    
21,527
  
Impairment loss
    
(182,400
)
Balance, December 31, 2011
    
335,392
  
Ascentia purchase
    
3,303
  
Balance, December 31, 2012
    
338,695
  
Other adjustments
    
105
  
Balance, December 31, 2013
  
$
338,800
  

In August 2011, we acquired Navvis & Company ("Navvis"), a firm that provides strategic counsel and change management services to healthcare systems, for $23.7 million in cash.  In addition, we issued 432,902 unregistered shares of our common stock which were valued in the aggregate at $3.3 million.

We performed a quantitative goodwill impairment review during the fourth quarter of 2011, and as a result of changes in our long-term projections related to the wind-down of our contract with CIGNA, we recorded a $182.4 million goodwill impairment loss.

In April 2012, we acquired Ascentia Health Care Solutions ("Ascentia"), a firm that supports and promotes population health management, patient centered programs, payer strategies and physician practice enhancement programs, for $5.5 million in cash.  In addition, we issued 14,409 unregistered shares of our common stock which were valued in the aggregate at $0.1 million.

As of January 1, 2013, the gross amount of goodwill totaled $521.1 million, and we had accumulated impairment losses of $182.4 million.
 
4. Intangible Assets

Intangible assets subject to amortization at December 31, 2013 consisted of the following:

(In thousands)
  
Gross Carrying
Amount
    
Accumulated
Amortization
    
Net
  
 
  
   
   
 
Customer contracts
  
$
59,574
    
$
51,512
    
$
8,062
  
Acquired technology
    
29,431
      
25,589
      
3,842
  
Patents
    
24,547
      
15,081
      
9,466
  
Distributor and provider networks
    
8,709
      
7,190
      
1,519
  
Perpetual license to survey-based data
    
30,000
      
3,986
      
26,014
  
Other
    
5,077
      
3,867
      
1,210
  
Total
  
$
157,338
    
$
107,225
    
$
50,113
  

50
Intangible assets subject to amortization at December 31, 2012 consisted of the following:

(In thousands)
  
Gross Carrying
Amount
    
Accumulated
Amortization
    
Net
  
 
  
   
   
 
Customer contracts
  
$
59,305
    
$
44,571
    
$
14,734
  
Acquired technology
    
29,287
      
24,299
      
4,988
  
Patents
    
24,337
      
12,723
      
11,614
  
Distributor and provider networks
    
8,709
      
6,669
      
2,040
  
Perpetual license to survey-based data
    
29,000
      
2,708
      
26,292
  
Other
    
5,097
      
3,586
      
1,511
  
Total
  
$
155,735
    
$
94,556
    
$
61,179
  

Intangible assets subject to amortization are being amortized over estimated useful lives ranging from two to 25 years.  Total amortization expense for the years ended December 31, 2013, 2012, and 2011, was $12.7 million, $12.6 million, and $13.4 million, respectively.  The following table summarizes the estimated amortization expense for each of the next five years and thereafter:

(In thousands)
  
 
Year ending December 31,
  
 
2014
  
$
11,170
  
2015
    
6,783
  
2016
    
5,003
  
2017
    
3,343
  
2018
    
3,307
  
2019 and thereafter
    
20,507
  
Total
  
$
50,113
  

Intangible assets not subject to amortization at December 31, 2013 and 2012 consist of a trade name of $29.0 million.
 
5.            Income Taxes

Income tax expense is comprised of the following:

(In thousands)
  
Year Ended December 31,
  
 
  
2013
    
2012
    
2011
  
Current taxes
  
   
   
 
Federal
  
$
(1,311
)
  
$
(1,271
)
  
$
9,388
  
State
    
741
      
774
      
2,109
  
Foreign
    
1,693
      
1,754
      
1,707
  
Deferred taxes
                        
Federal
    
(5,842
)
    
4,803
      
2,169
  
State
    
(1,018
)
    
413
      
438
  
Foreign
    
101
      
249
      
(425
)
Total
  
$
(5,636
)
  
$
6,722
    
$
15,386
  

51
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.  The following table sets forth the significant components of our net deferred tax liability as of December 31, 2013 and 2012:
 
(In thousands)
  
December 31, 2013
    
December 31, 2012
  
 
  
   
 
Deferred tax asset:
  
   
 
Accruals and reserves
  
$
14,159
    
$
10,910
  
Deferred compensation
    
3,933
      
6,597
  
Share-based payments
    
10,703
      
12,213
  
Net operating loss carryforwards
    
8,303
      
7,914
  
Cash conversion derivative
    
3,553
      
—
  
Other assets and liabilities
    
1,486
      
1,533
  
 
    
42,137
      
39,167
  
Valuation allowance
    
(3,630
)
    
(3,242
)
 
  
$
38,507
    
$
35,925
  
Deferred tax liability:
                
Property and equipment
  
$
(44,740
)
  
$
(47,317
)
Intangible assets
    
(13,418
)
    
(15,700
)
Cash convertible notes hedges
    
(3,553
)
    
—
  
Other assets and liabilities
    
(449
)
    
(122
)
 
    
(62,160
)
    
(63,139
)
Net deferred tax liability
  
$
(23,653
)
  
$
(27,214
)
 
                
Net current deferred tax asset
  
$
9,667
    
$
8,839
  
Net long-term deferred tax liability
    
(33,320
)
    
(36,053
)
 
  
$
(23,653
)
  
$
(27,214
)

Based on the Company's historical and expected future taxable earnings, we believe it is more likely than not that the Company will realize the benefit of the existing deferred tax assets, net of the valuation allowance, at December 31, 2013.

For 2013, 2012 and 2011, the tax benefit of share-based compensation, excluding the tax benefit related to the deferred tax asset for share-based payments, was recorded as additional paid-in capital.  We recorded a tax effect of $1.0 million, $0.5 million, and $1.1 million in 2013, 2012, and 2011, respectively, related to our interest rate swap agreements (see Note 7) to stockholders' equity as a component of accumulated other comprehensive income (loss).

At December 31, 2013, we had international net operating loss carryforwards totaling approximately $13.9 million with an indefinite carryforward period, approximately $11.0 million of federal loss carryforwards originating from acquired entities, and approximately $17.7 million of state loss carryforwards.  We have provided a valuation allowance on certain deferred tax assets associated with our international net operating loss carryforwards.  The federal loss carryforwards are subject to an annual limitation under Internal Revenue Code Section 382, and expire in 2021 if not utilized.  The state loss carryforwards are expected to be fully utilized during future periods.

Undistributed earnings of the Company's foreign subsidiaries amounted to approximately $10.7 million as of December 31, 2013. Those earnings are considered to be indefinitely reinvested and, accordingly, no U.S. federal or state income taxes have been recorded thereon. Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to both U.S. income taxes (subject to an adjustment for foreign tax credits) and potential withholding taxes payable to the various foreign countries. Determination of the amount of unrecognized deferred U.S. income tax liability is not practical because of the complexities associated with its hypothetical calculation; however, unrecognized foreign tax credits would be available to reduce a portion of the U.S. tax liability.
52
The difference between income tax expense computed using the statutory federal income tax rate and the effective rate is as follows:
 
 
Year Ended December 31,
  
(In thousands)
  
2013
    
2012
    
2011
  
 
  
   
   
 
Statutory federal income tax
  
$
(4,962
)
  
$
5,161
    
$
(49,808
)
Non-deductible goodwill impairment expense
    
—
      
—
      
61,785
  
State income taxes, less federal income tax benefit
    
(669
)
    
453
      
1,520
  
Permanent items
    
634
      
389
      
434
  
Change in valuation allowance
    
388
      
285
      
972
  
Prior year tax adjustments
    
140
      
263
      
150
  
Uncertain tax position reversal
    
(1,137
)
    
—
      
—
  
Other
    
(30
)
    
171
      
333
  
Income tax expense (benefit)
  
$
(5,636
)
  
$
6,722
    
$
15,386
  

Uncertain Tax Positions

During 2013, we recorded a $1.1 million reduction to an unrecognized tax benefit due to the expiration of the applicable statutes of limitations for the 2009 tax year. As of December 31, 2013 and 2012, we had $0.3 and $1.3 million, respectively, of unrecognized tax benefits that, if recognized, would affect our effective tax rate. Our policy is to include interest and penalties related to unrecognized tax benefits in income tax expense.  During 2012, and 2011, we included an immaterial amount of net interest related to uncertain tax positions as a component of income tax expense.

The aggregate changes in the balance of unrecognized tax benefits, exclusive of interest, were as follows:

(In thousands)
  
 
Unrecognized tax benefits at December 31, 2011
  
$
1,392
  
Decreases based upon tax positions related to prior years
    
(44
)
Unrecognized tax benefits at December 31, 2012
  
$
1,348
  
Decreases based upon a lapse of the applicable statute of limitations
    
(1,060
)
Unrecognized tax benefits at December 31, 2013
  
$
288
  

We file income tax returns in the U.S. Federal jurisdiction and in various state and foreign jurisdictions.  Tax years remaining subject to examination in these jurisdictions include 2010 to present.
53

6. Long-Term Debt

1.50% Cash Convertible Senior Notes Due 2018

On July 16, 2013, the Company completed a private placement of $150.0 million aggregate principal amount of cash convertible senior notes due 2018 (the "Cash Convertible Notes"),  which bear interest at a rate of 1.50 % per year, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2014. The Cash Convertible Notes will mature on July 1, 2018, unless earlier repurchased or converted into cash in accordance with their terms prior to such date. The Cash Convertible Notes are convertible into cash based on the conversion rate set forth below and are not convertible into our common stock or any other securities under any circumstances. The initial cash conversion rate is 51.38 shares of our common stock per $1,000 principal amount of Cash Convertible Notes (equivalent to an initial conversion price of approximately $19.46 per share of common stock). The Cash Convertible Notes are our senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Cash Convertible Notes. As a result of this transaction, we recognized deferred loan costs of approximately $3.9 million, which are being amortized over the term of the Cash Convertible Notes using the effective interest method.

The cash conversion feature of the Cash Convertible Notes (the "Cash Conversion Derivative") requires bifurcation from the Cash Convertible Notes in accordance with ASC Topic 815, Derivatives and Hedging, and is recorded in other long-term liabilities as a derivative liability and carried at fair value. The fair value of the Cash Conversion Derivative at the time of issuance of the Cash Convertible Notes was $36.8 million, which was recorded as a debt discount for purposes of accounting for the debt component of the Cash Convertible Notes. The debt discount is being amortized over the term of the Cash Convertible Notes using the effective interest method. For the twelve months ended December 31, 2013, we recorded $3.1  million of interest expense related to the amortization of the debt discount based upon an effective interest rate of 5.7%. The net carrying amount of the Cash Convertible Notes at  December 31, 2013 was $116.4 million, net of the unamortized discount of $33.6 million.

In connection with the issuance of the Cash Convertible Notes, we entered into privately negotiated convertible note hedge transactions (the "Cash Convertible Notes Hedges"), which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elected to convert the Cash Convertible Notes at a time when our stock price exceeded the conversion price. The initial cost of the Cash Convertible Notes Hedges was $36.8 million. The Cash Convertible Notes Hedges are recorded in other assets as a derivative asset under FASB ASC Topic 815 and are carried at fair value.  See Note 8 for additional information regarding the Cash Convertible Notes Hedges and the Cash Conversion Derivative and their fair values as of December 31, 2013.

In July 2013, we also sold separate privately negotiated warrants (the "Warrants") initially relating, in the aggregate, to approximately 7.7 million shares of our common stock underlying the Cash Convertible Notes Hedges. The Warrants have an initial strike price of approximately $25.95 per share, which effectively increases the conversion price of the Cash Convertible Notes to a 60% premium to our stock price on July 1, 2013. The Warrants will be net share settled by issuing a number of shares of our common stock per Warrant corresponding to the excess of the market price per share of our common stock (as measured on each warrant exercise date under the terms of the Warrants) over the applicable strike price of the Warrants. The Warrants meet the definition of derivatives under the guidance in ASC Topic 815; however, because these instruments have been determined to be indexed to our own stock and meet the criteria for equity classification under ASC Topic 815-40, the Warrants have been accounted for as an adjustment to our additional paid-in-capital.

If the market value per share of our common stock exceeds the strike price of the warrants, the warrants will have a dilutive effect on net income per share, and the "treasury stock" method will be used in calculating the dilutive effect on earnings per share.
54

CareFirst Convertible Note

On October 1, 2013, we entered into an Investment Agreement (the "Investment Agreement") with CareFirst Holdings, LLC ("CareFirst"), which is in addition to certain existing commercial agreements between us and CareFirst relating to, among other things, disease management and care coordination services (the "Commercial Agreements"). Pursuant to the Investment Agreement, we issued to CareFirst a convertible subordinated promissory note in the aggregate original principal amount of $20 million (the "CareFirst Convertible Note") for a purchase price of $20 million. The CareFirst Convertible Note bears interest at a rate of 4.75% per year, payable quarterly in arrears on March 31, June 30, September 30 and December 31 of each calendar year, beginning on December 31, 2013. The CareFirst Convertible Note may be prepaid only under limited circumstances and upon the terms and conditions specified therein. If the CareFirst Convertible Note has not been fully converted or redeemed in accordance with its terms, it will mature on October 1, 2019.  The CareFirst Convertible Note is subordinate in right of payment to the prior payment in full of (a) all indebtedness of the Company under the Fifth Amended Credit Agreement, and (b) any other senior debt of the Company, which currently includes only the Cash Convertible Notes.
 
The CareFirst Convertible Note is convertible into shares of our common stock at the conversion rate determined by dividing (a) the sum of the portion of the principal to be converted and accrued and unpaid interest with respect to such principal by (b) the conversion price equal to $22.41 per share of our common stock.  The conversion price is subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications and similar events.
 
CareFirst has an opportunity to earn warrants to purchase shares of our common stock ("CareFirst Warrants") based on achievement of certain quarterly thresholds (the "Revenue Thresholds") for revenue derived from both the Commercial Agreements and from new business to us from third parties as a result of an introduction or referral to us by CareFirst (collectively, the "Quarterly Revenue").  If the Quarterly Revenue is greater than or equal to the applicable Revenue Threshold for any quarter ending on or prior to September 30, 2017, then we will issue to CareFirst a certain number of warrants exercisable for the number of shares of our common stock ("CareFirst Warrant Shares") determined in accordance with the terms of the Investment Agreement unless (i) CareFirst elects to receive a cash payment in accordance with the terms of the Investment Agreement or (ii) there is a change of control. The aggregate number of CareFirst Warrant Shares in any single 12-month period beginning on October 1, 2013 cannot exceed 400,000, and the aggregate number of CareFirst Warrant Shares issuable pursuant to the Investment Agreement cannot exceed 1,600,000. If issued, the CareFirst Warrants will have a dilutive effect on net income per share, and the "treasury stock" method will be used in calculating the dilutive effect on earnings per share. 
 
Also on October 1, 2013, in connection with the execution of the Investment Agreement, we entered into a Registration Rights Agreement with CareFirst, pursuant to which we agreed to use commercially reasonable efforts to cause any registration statement covering an underwritten offering of our common stock for our own account or for the account of any holder of our common stock (other than a registration statement on Form S-4 or Form S-8 or any successor thereto) to include those registrable common shares that any holder of such registrable common shares has requested to be registered. 

The term of the Investment Agreement expires on the earlier of (a) December 31, 2017 and (b) the first date on which no Commercial Agreement is in effect. 

Credit Facility

On June 8, 2012, we entered into the Fifth Amended Credit Agreement.  The Fifth Amended Credit Agreement provides us with a $200.0 million revolving credit facility that expires on June 8, 2017 and includes a swingline sub facility of $20.0 million and a $75.0 million sub facility for letters of credit.  The Fifth Amended Credit Agreement also provides a $200.0 million term loan facility that matures on June 8, 2017, $110.0 million of which remained outstanding at December 31, 2013, and an uncommitted incremental accordion facility of $200.0 million.

Borrowings under the Fifth Amended Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month rate (or with the approval of affected lenders, nine-month or twelve-month rate) for Eurodollar deposits ("LIBOR") or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.  The LIBOR margin varies between 1.75% and 3.00%, and the Base Rate margin varies between 0.75% and 2.00%, depending on our leverage ratio.  The Fifth Amended Credit Agreement also provides for an annual fee ranging between 0.30% and 0.50% of the unused commitments under the revolving credit facility.  Extensions of credit under the Fifth Amended Credit Agreement are secured by guarantees from all of the Company's active domestic subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.
55

On February 5, 2013, we entered into an amendment to the Fifth Amended Credit Agreement, which included, among other things, a temporary increase in the LIBOR and Base Rate margins of 0.25%.  The increased margins were effective through December 31, 2013 and applied only when our total funded debt to EBITDA ratio was greater than or equal to 3.50 to 1.00.  On July 1, 2013, we entered into an additional amendment to the Fifth Amended Credit Agreement, which provided for, among other things, the amendment of certain negative covenants to permit the issuance of and payments related to the Cash Convertible Notes described above as well as increases in the maximum required levels of total funded debt to EBITDA beginning with the quarter ended June 30, 2013.  As of December 31, 2013, availability under the revolving credit facility totaled $38.7 million as calculated under the most restrictive covenant.

              We are required to repay outstanding revolving loans under the revolving credit facility on June 8, 2017. We are required to repay term loans in quarterly principal installments aggregating (1) 1.250% of the original aggregate principal amount of the term loans during each of the eight quarters beginning with the quarter ended September 30, 2012, (2) 1.875% of the original aggregate principal amount of the term loans during each of the next four quarters beginning with the quarter ending September 30, 2014, and (3) 2.500% of the original aggregate principal amount of the term loans during each of the remaining quarters prior to maturity on June 8, 2017, at which time the entire unpaid principal balance of the term loans is due and payable.

             The following table summarizes the minimum annual principal payments and repayments of the revolving advances under the Fifth Amended Credit Agreement, the Cash Convertible Notes, and the CareFirst Convertible Note for each of the next five years and thereafter:

(In thousands)
  
 
Year ending December 31,
  
 
2014
  
$
12,500
  
2015
    
17,500
  
2016
    
20,000
  
2017
    
63,625
  
2018
    
150,000
  
2019 and thereafter
    
20,000
  
Total
  
$
283,625
  

The Fifth Amended Credit Agreement contains financial covenants that require us to maintain specified ratios or levels of (1) total funded debt to EBITDA and (2) fixed charge coverage.  As of December 31, 2013, we were in compliance with all of the financial covenant requirements of the Fifth Amended Credit Agreement.

The Fifth Amended Credit Agreement contains various other affirmative and negative covenants that are typical for financings of this type.  Among other things, the Fifth Amended Credit Agreement limits repurchases of the Company's common stock and the amount of dividends that the Company can pay to holders of its common stock.
 
7. Derivative Instruments and Hedging Activities

We use derivative instruments to manage risks related to interest rate swap agreements, foreign currencies, and the Cash Convertible Notes. We account for derivatives in accordance with FASB ASC Topic 815 which establishes accounting and reporting standards requiring that derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value shall be recognized currently in earnings unless specific hedge accounting criteria are met. As permitted under our master netting arrangements, the fair value amounts of our interest rate swaps and foreign currency options and/ or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets.

56
Derivative Instruments Designated as Hedging Instruments

Cash Flow Hedges
 
Derivative instruments that are designated and qualify as cash flow hedges are recorded at estimated fair value in the consolidated balance sheets, with the effective portion of the gains and losses being reported in accumulated other comprehensive income or loss ("accumulated OCI").  Cash flow hedges for all periods presented consist solely of interest rate swap agreements, which effectively modify our exposure to interest rate risk by converting a portion of our floating rate debt to fixed obligations, thus reducing the impact of interest rate changes on future interest expense. Under these agreements, we receive a variable rate of interest based on LIBOR (as defined in Note 6), and we pay a fixed rate of interest with interest rates ranging from 0.690% to 1.480% plus a spread (see Note 6).  We maintain interest rate swap agreements with current notional amounts of $145.0 million and termination dates ranging from November 2015 to December 2016.  Of this amount, $95.0 million was effective at December 31, 2013, and $50.0 million will become effective in December 2015, as older interest rate swap agreements expire. Gains and losses on these interest rate swap agreements are reclassified to interest expense in the same period during which the hedged transaction affects earnings or the period in which all or a portion of the hedge becomes ineffective.  As of December 31, 2013, we expect to reclassify $0.4 million of net losses on interest rate swap agreements from accumulated OCI to interest expense within the next 12 months due to the scheduled payment of interest associated with our debt.
 
The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the twelve months ended December 31, 2013 and 2012:

(In thousands)
For the Twelve Months Ended
  
Derivatives in Cash Flow Hedging Relationships
December 31, 2013
  
December 31, 2012
  
(Gain) loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect
  
$
(332
)
  
$
2,029
  
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect
  
$
(1,916
)
  
$
(3,302
)

Gains and losses representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.  During the twelve months ended December 31, 2013 and 2012, there were no gains or losses on cash flow hedges recognized in our consolidated statements of comprehensive income (loss) resulting from hedge ineffectiveness.

Derivative Instruments Not Designated as Hedging Instruments

Our Cash Conversion Derivative, Cash Convertible Notes Hedges, and foreign currency options and/or forward contracts do not qualify for hedge accounting treatment under U.S. GAAP and are measured at fair value with gains and losses recognized immediately in the consolidated statements of comprehensive income (loss). These derivative instruments not designated as hedging instruments did not have a material impact on our consolidated statements of comprehensive income (loss) during the twelve months ended December 31, 2013 and 2012.

The Cash Conversion Derivative is accounted for as a derivative liability and carried at fair value. In order to offset the risk associated with the Cash Conversion Derivative, we entered into Cash Convertible Notes Hedges which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elected to convert the Cash Convertible Notes at a time when our stock price exceeded the conversion price. The Cash Convertible Notes Hedges are accounted for as a derivative asset and carried at fair value.

The gains and losses resulting from changes in the fair values of the Cash Conversion Derivative and the Cash Convertible Notes Hedges are reported in the consolidated statements of comprehensive income (loss) as follows:
57
 
Twelve Months Ended
  
 
(In thousands)
December 31, 2013
  
December 31, 2012
  
Statements of Comprehensive Income (Loss) Classification
Cash Convertible Notes Hedges:
 
 
    
Net unrealized loss
  
$
(8,984
)
  
$
—
  
Selling, general and administrative expense
Cash Conversion Derivative:
                
     
Net unrealized gain
  
$
8,984
    
$
—
  
Selling, general and administrative expense

We also enter into foreign currency options and/or forward contracts in order to minimize our earnings exposure to fluctuations in foreign currency exchange rates.  Our foreign currency exchange contracts require current period mark-to-market accounting, with any change in fair value being recorded each period in the consolidated statements of comprehensive income (loss) in selling, general and administrative expenses. At December 31, 2013, we had forward contracts with notional amounts of $16.3 million to exchange foreign currencies, primarily the Australian dollar and Euro, that were entered into in order to hedge forecasted foreign net income (loss) and intercompany debt. We routinely monitor our foreign currency exposures to maximize the overall effectiveness of our foreign currency hedge positions.  We do not execute transactions or hold derivative financial instruments for trading or other purposes.

The estimated gross fair values of derivative instruments at December 31, 2013 and December 31, 2012, excluding the impact of netting derivative assets and liabilities when a legally enforceable master netting agreement exists, were as follows:

 
  
December 31, 2013
    
December 31, 2012
  
(In thousands)
  
Foreign currency exchange contracts
    
Interest rate swap agreements
    
Cash Convertible Notes Hedges and Cash Conversion Derivative
    
Foreign currency exchange contracts
    
Interest rate swap agreements
  
Assets:
  
   
   
   
   
 
Derivatives not designated as hedging instruments:
  
   
   
   
   
 
Other current assets
  
$
178
    
$
—
    
$
—
    
$
73
    
$
—
  
Other assets
    
—
      
—
      
27,766
      
—
      
—
  
Total assets
  
$
178
    
$
—
    
$
27,766
    
$
73
    
$
—
  
 
                                        
Liabilities:
                                        
Derivatives not designated as hedging instruments:
                                        
Accrued liabilities
  
$
67
    
$
—
    
$
—
    
$
255
    
$
—
  
Other long-term liabilities
    
—
      
—
      
27,766
      
—
      
—
  
 
                                        
Derivatives designated as hedging instruments:
                                        
Accrued liabilities
    
—
      
—
      
—
      
—
      
1,742
  
Other long-term liabilities
    
—
      
505
      
—
      
—
      
1,221
  
Total liabilities
  
$
67
    
$
505
    
$
27,766
    
$
255
    
$
2,963
  

8.
Fair Value Measurements

We account for certain assets and liabilities at fair value.  Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.
Fair Value Hierarchy

The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are:
58

Level 1:  Quoted prices in active markets for identical assets or liabilities;
Level 2:  Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-based valuation techniques in which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3:  Unobservable inputs that are supported by little or no market activity and typically reflect management's estimates of assumptions that market participants would use in pricing the asset or liability.

Assets and Liabilities Measured at Fair Value on a Recurring Basis
 
The following tables present our assets and liabilities measured at fair value on a recurring basis at December 31, 2013 and December 31, 2012:

 
(In thousands)
December 31, 2013
  
Level 2
    
Level 3
    
Gross Fair
Value
    
Netting (1)
    
Net Fair
Value
  
Assets:
  
   
   
   
   
 
Foreign currency exchange contracts
  
$
178
    
$
—
    
$
178
    
$
(57
)
  
$
121
  
Cash Convertible Notes Hedges
    
—
      
27,766
      
27,766
      
—
      
27,766
  
Liabilities:
                                        
Foreign currency exchange contracts
  
$
67
    
$
—
    
$
67
    
$
(57
)
  
$
10
  
Interest rate swap agreements
    
505
      
—
      
505
      
—
      
505
  
Cash Conversion Derivative
    
—
      
27,766
      
27,766
      
—
      
27,766
  

 
(In thousands)
December 31, 2012
  
Level 2
    
Level 3
    
Gross Fair
Value
    
Netting (1)
    
Net Fair
Value
  
Assets:
  
   
   
   
   
 
Foreign currency exchange contracts
  
$
73
    
$
—
    
$
73
    
$
(73
)
  
$
—
  
Liabilities:
                                        
Foreign currency exchange contracts
  
$
255
    
$
—
    
$
255
    
$
(73
)
  
$
182
  
Interest rate swap agreements
    
2,963
      
—
      
2,963
      
—
      
2,963
  

(1) This column reflects the impact of netting derivative assets and liabilities by counterparty when a legally enforceable master netting agreement exists.

The fair values of forward foreign currency exchange contracts are valued using broker quotations of similar assets or liabilities in active markets.  The fair values of interest rate swap agreements are primarily determined based on the present value of future cash flows using internal models and third-party pricing services with observable inputs, including interest rates, yield curves and applicable credit spreads. The fair values of the Cash Convertible Notes Hedges and the Cash Conversion Derivative are measured using Level 3 inputs. These instruments are not actively traded and are valued using an option pricing model that uses observable and unobservable market data for inputs, such as expected time to maturity of the derivative instruments, the risk-free interest rate, the expected volatility of our common stock and other factors. The Cash Convertible Notes Hedges and the Cash Conversion Derivative were designed such that changes in their fair values would offset, with minimal impact to the consolidated statements of comprehensive income (loss). Therefore, the sensitivity of changes in the unobservable inputs to the option pricing model for such instruments is mitigated.
 
The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):

(In thousands)
  
Balance at December 31, 2012
    
Purchases of Level 3 Instruments
    
Issuances of Level 3 Instruments
    
Gains/(Losses) included in Earnings
    
Balance at December 31, 2013
  
Cash Convertible Notes Hedges
  
$
—
    
$
36,750
    
$
—
    
$
(8,984
)
  
$
27,766
  
Cash Conversion Derivative
    
—
      
—
      
(36,750
)
    
8,984
      
(27,766
)

59
The gains and losses included in earnings noted above represent the change in the fair value of these financial instruments and are recorded each period in the consolidated statements of comprehensive income (loss) in selling, general and administrative expenses.

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

We measure certain assets at fair value on a nonrecurring basis in the fourth quarter of our fiscal year, including the following:

·    
reporting units measured at fair value in the first step of a goodwill impairment test; and
 
·    
indefinite-lived intangible assets measured at fair value for impairment assessment.

Each of the assets above is classified as Level 3 within the fair value hierarchy.

During the fourth quarter of 2013, we reviewed goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment).  The fair value of a reporting unit is the price that would be received to sell the unit as a whole in an orderly transaction between market participants at the measurement date.  We may elect to perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.  However, we elected not to perform a qualitative assessment, instead proceeding to the quantitative review described below.

We estimated the fair value of each reporting unit using a combination of a discounted cash flow model and a market-based approach, and we reconciled the aggregate fair value of our reporting units to our consolidated market capitalization.  Estimating fair value requires significant judgments, including management's estimate of future cash flows, which is dependent on internal forecasts, estimation of the long-term growth rate for our business, the useful life over which cash flows will occur, and determination of our weighted average cost of capital, as well as relevant comparable company earnings multiples for the market-based approach.  Changes in these estimates and assumptions could materially affect the estimate of fair value and goodwill impairment for each reporting unit.  We determined that the carrying value of goodwill was not impaired based upon the impairment review.

Also during the fourth quarter of 2013, we estimated the fair value of our indefinite-lived intangible asset, which consisted of a trade name, using a present value technique, which required management's estimate of future revenues attributable to this trade name, estimation of the long-term growth rate and royalty rate for this revenue, and determination of our weighted average cost of capital.  Changes in these estimates and assumptions could materially affect the estimate of fair value for the trade name.  We determined that the carrying value of the trade name was not impaired based upon the impairment review.

Fair Value of Other Financial Instruments

In addition to foreign currency exchange contracts, interest rate swap agreements, the Cash Convertible Notes Hedges, and the Cash Conversion Derivative, the estimated fair values of which are disclosed above, the estimated fair value of each class of financial instruments at December 31, 2013 was as follows:

Cash and cash equivalents – The carrying amount of $2.6 million approximates fair value because of the short maturity of those instruments (less than three months).

Long-term debt – The estimated fair value of outstanding borrowings under the Fifth Amended Credit Agreement, which includes a revolving credit facility and a term loan facility, the Cash Convertible Notes and the CareFirst Convertible Note (see Note 6) are determined based on the fair value hierarchy as discussed above.  The revolving credit facility and the term loan facility are not actively traded and therefore are classified as Level 2 valuations based on the market for similar instruments.  The estimated fair value is based on the average of the prices set by the issuing bank given current market conditions and is not necessarily indicative of the amount we could realize in a current market exchange. The estimated fair value and carrying amount of outstanding borrowings under the Fifth Amended Credit Agreement at December 31, 2013 are $113.1 million and $113.6 million, respectively.
60
The Cash Convertible Notes are actively traded and therefore are classified as Level 1 valuations. The estimated fair value at December 31, 2013 was $148.1 million, which is based on the last quoted price of the Cash Convertible Notes on December 31, 2013, and the par value was $150.0 million. The carrying amount of the Cash Convertible Notes at December 31, 2013 was $116.4 million, which is net of the debt discount discussed in Note 6.

The CareFirst Convertible Note was issued at its fair value of $20.0 million on October 1, 2013. It is not actively traded and is not based upon either an observable market, other than the market for our common stock, or on an observable index and is therefore classified as a Level 3 valuation. At December 31, 2013, the carrying amount of the CareFirst Convertible Note of $20.0 million approximates fair value because there were no factors present that would result in a change in the fair value since its issuance on October 1, 2013.

9. Other Long-Term Liabilities

Other long-term liabilities consist primarily of the Cash Conversion Derivative (see Notes 6 and 7), deferred rent (see Note 12), a deferred compensation plan, and accrued performance cash (if pre-established performance metrics are met).

We have a non-qualified deferred compensation plan under which certain employees may defer a portion of their salaries and receive a Company matching contribution plus a discretionary contribution based on the Company's performance against targets.  Company contributions vest equally over four years.  We do not fund the plan and carry it as an unsecured obligation.  Participants in the plan elect payout dates for their account balances, which can be no earlier than four years from the period of the deferral.

As of December 31, 2013 and 2012, other long-term liabilities included vested amounts under the non-qualified deferred compensation plan of $6.8 and $6.6 million, respectively, net of the current portions of $1.0 and $4.1 million, respectively.  For the next five years ending December 31, 2018 we must make estimated plan payments of $1.0 million, $0.3 million, $0.4 million, $0.3 million, and $0.2 million, respectively.

In addition, under our stock incentive plan, we issue performance-based cash awards to certain employees based on pre-established performance metrics. Based on achievement of the performance metrics, the awards vest on the third anniversary of the grant date and are paid shortly thereafter.

As of December 31, 2013 and 2012, no accrued performance cash amounts were included in other long-term liabilities.
 
10. Restructuring and Related Charges and Impairment Loss

In December 2012, we began a restructuring of the Company (the "2012 Restructuring"), which was largely completed by the end of 2012, primarily focused on capacity realignment. The majority of these charges were presented as a separate line item in the consolidated statement of operations. We do not expect to incur significant additional costs or adjustments related to this restructuring.

In November 2011, we began a restructuring of the Company (the "2011 Restructuring"), which was largely completed by the end of 2011, primarily focused on aligning our capacity requirements and organizational structure following CIGNA's decision to wind-down its contract beginning in 2012.  The majority of these charges were presented as a separate line item in the consolidated statement of operations.  We do not expect to incur significant additional costs or adjustments related to this restructuring.
 
In November 2010, we began a restructuring of the Company (the "2010 Restructuring"), which was largely completed by the end of 2010, primarily focused on aligning resources with current and emerging markets and consolidating operating capacity.  The majority of these charges were presented as a separate line item in the consolidated statement of operations.  We do not expect to incur significant additional costs or adjustments related to this restructuring.
61
The change in accrued restructuring and related charges related to the 2012 Restructuring, 2011 Restructuring, and 2010 Restructuring activities described above during the year ended December 31, 2013 were as follows:

(In thousands)
  
2012
Restructuring
    
2011
Restructuring(1)
      
2010
Restructuring(2)
      
Total
  
Accrued restructuring and related charges at December 31, 2010
  
$
—
    
$
—
      
$
7,607
      
$
7,607
  
Additions
    
—
      
8,430
        
—
        
8,430
  
Payments
    
—
      
(4
)
      
(5,124
)
      
(5,128
)
Adjustments
    
—
      
—
        
(900
)
(3) 
    
(900
)
Accrued restructuring and related charges at December 31, 2011
  
$
—
    
$
8,426
      
$
1,583
        
10,009
  
Additions
    
1,773
      
—
        
—
        
1,773
  
Payments
    
—
      
(7,368
)
      
(822
)
      
(8,190
)
Adjustments
    
—
      
(504
)
(4) 
    
(132
)
(3) 
    
(636
)
Accrued restructuring and related charges at December 31, 2012
  
$
1,773
    
$
554
      
$
629
        
2,956
  
Additions
    
—
      
—
        
—
        
—
  
Payments
    
(1,700
)
    
(366
)
      
(629
)
      
(2,695
)
Adjustments
    
(73
)
    
(29
)
        
— 
      
(102
)
Accrued restructuring and related charges at December 31, 2013
  
$
—
    
$
159
      
$
—
        
159
  

(1) Excludes non-cash charges of approximately $0.6 million, which primarily consisted of share-based compensation costs.

(2) Excludes non-cash charges of approximately $1.8 million, which primarily consisted of share-based compensation costs.

(3) Adjustments resulted primarily from a favorable adjustment to lease termination costs due to a sublease of certain unused office space.

(4)  Adjustments resulted primarily from actual employee tax and benefit amounts differing from previous estimates.
 
In December 2011, we recorded an impairment loss of $183.3 million which consisted of a goodwill impairment loss of $182.4 million (see Note 3) and an intangible asset write-off of $0.9 million.
62
11. Commitments and Contingencies

Contract Disputes

We currently are involved in a contractual dispute with Blue Cross Blue Shield of Minnesota regarding fees paid to us as part of a former contractual relationship.  On January 25, 2010, Blue Cross Blue Shield of Minnesota issued notice of arbitration with the American Arbitration Association in Minneapolis in accordance with the terms of the contract alleging violations of certain contract provisions and seeking recoupment of an unspecified amount of payments made to us under the contract. We believe we performed our services in compliance with the terms of our agreement and that the assertions made in the arbitration notice are without merit.  On August 3, 2011, we asserted numerous counterclaims against Blue Cross Blue Shield of Minnesota. The arbitration hearing concluded on October 23, 2013.  During and after the conclusion of the arbitration hearing in October, the parties entered into settlement negotiations to resolve all claims in dispute. The parties have jointly requested that the arbitrator not issue any award or decision while the parties are engaged in settlement discussions. We cannot predict whether these discussions will result in a settlement. 
 
We are involved in a contractual dispute with Plastipak Packaging, Inc. ("Plastipak"). On September 10, 2012, Plastipak filed suit in the Circuit Court for Wayne County, Michigan seeking damages relating to an alleged breach of a services agreement with us.  The case is currently in the discovery phase of litigation.  We deny Plastipak's claims and intend to vigorously defend the action. 
 
Performance Award Lawsuit

On September 4, 2012, Milton Pfeiffer ("Plaintiff"), claiming to be a stockholder of the Company, filed a putative derivative action against the Company and the Board of Directors (the "Board") in Delaware Chancery Court (the "Court") alleging that the Compensation Committee of the Board and the Board breached their fiduciary duties and violated the Company's 2007 Stock Incentive Plan (the "Plan") by granting Ben R. Leedle, Jr., Chief Executive Officer and President of the Company, discretionary performance awards under the Plan in the form of options to purchase an aggregate of 500,000 shares of the Company's common stock, which consisted of a performance award in November 2011 granting Mr. Leedle the right to purchase 365,000 shares and a performance award in February 2012 granting Mr. Leedle the right to purchase 135,000 shares (the "Performance Awards").  Plaintiff alleges that the Performance Awards exceeded what is authorized by the Plan and that the Company's 2012 proxy statement, in which the Performance Awards are disclosed, is false and misleading.  Plaintiff also alleges that Mr. Leedle breached his fiduciary duties and was unjustly enriched by receiving the Performance Awards.  Plaintiff is seeking, among other things, the rescission or disgorgement of all alleged "excess" awards granted to Mr. Leedle under the Performance Awards, to recover any incidental damages to the Company, and an award of attorneys' fees and expenses.  On November 2, 2012, the Company and the Board filed a Motion to Dismiss because Plaintiff failed to make a demand upon the Board as required by Delaware law.  On November 8, 2013, the Court denied the Company's Motion to Dismiss. On February 21, 2014, the Company filed its answer and intends to vigorously defend the allegations.

Outlook

We are also subject to other contractual disputes, claims and legal proceedings that arise from time to time in the ordinary course of our business.  While we are unable to estimate a range of potential losses, we do not believe that any of such legal proceedings pending against us as of the date of this report will have a material adverse effect on our liquidity or financial condition.  As these matters are subject to inherent uncertainties, our view of these matters may change in the future.

Contractual Commitments

We entered into a 25-year strategic relationship agreement with Gallup in January 2008 and a 5-year global joint venture agreement with Gallup in October 2012.  We have minimum remaining contractual cash obligations of $42.0 million related to these agreements.
63

In May 2011, we entered into a ten-year applications and technology services outsourcing agreement with HP Enterprise Services, LLC that contains minimum fee requirements.  Total payments over the remaining term, including an estimate for future contractual cost of living adjustments, must equal or exceed a minimum level of approximately $142.2 million; however, based on initial required service and equipment level assumptions, we estimate that the remaining payments will be approximately $297.6 million.  The agreement allows us to terminate all or a portion of the services after the first two years provided we pay certain termination fees, which could be material to the Company.

12. Leases

We maintain operating lease agreements principally for our corporate office space, our well-being improvement call centers, and our operations support and training offices.  We lease approximately 264,000 square feet of office space in Franklin, Tennessee, which contains our corporate headquarters and one of our well-being improvement call centers.  This lease commenced in March 2008 and expires in February 2023.  We also lease approximately 92,000 square feet of office space in Chandler, Arizona which contains additional corporate colleagues and one of our well-being improvement call centers.  In addition, we lease office space for our seven other well-being improvement call center locations for an aggregate of approximately 160,000 square feet of space with lease terms expiring on various dates from 2014 to 2020.  Our operations support and training offices contain approximately 66,000 square feet in aggregate and have lease terms expiring from 2014 to 2020.

Our corporate office lease agreement contains escalation clauses and provides for two renewal options of five years each at then prevailing market rates.  The base rent for the initial 15-year term ranges from $4.2 million to $6.3 million per year over the term of the lease.  The landlord provided a tenant improvement allowance equal to approximately $10.3 million.  We record leasehold improvement incentives as deferred rent and amortize them as reductions to rent expense over the lease term.

Most of our operating leases include escalation clauses, some of which are fixed amounts, and some of which reflect changes in price indices.  We recognize rent expense on a straight-line basis over the lease term.  Certain operating leases contain renewal options to extend the lease for additional periods.  For the years ended December 31, 2013, 2012, and 2011, rent expense under lease agreements was approximately $12.9 million, $12.9 million, and $12.7 million, respectively.  Our capital lease obligations, which primarily include computer equipment leases, are included in long-term debt and the current portion of long-term debt.
 
The following table summarizes our future minimum lease payments under all capital leases and non-cancelable operating leases for each of the next five years and thereafter:

 
(In thousands)
  
Capital
    
Operating
  
Year ending December 31,
  
Leases
    
Leases
  
2014
  
$
1,199
    
$
13,198
  
2015
    
66
      
11,781
  
2016
    
—
      
10,764
  
2017
    
—
      
10,198
  
2018
    
—
      
10,707
  
2019 and thereafter
    
—
      
33,262
  
Total minimum lease payments
  
$
1,265
    
$
89,910
  
Less amount representing interest
    
(34
)
        
Present value of minimum lease payments
    
1,231
          
Less current portion
    
(1,166
)
        
 
  
$
65
          

64
13.        Share-Based Compensation

We have several stockholder-approved stock incentive plans for our employees and directors.  We currently have three types of share-based awards outstanding under these plans: stock options, restricted stock units, and restricted stock.  We believe that such awards align the interests of our employees and directors with those of our stockholders.

We grant options under these plans at market value on the date of grant, except in the case of certain performance awards which may be granted at a price above market value.  The options generally vest over four years based on service conditions and expire ten years from the date of grant.  Restricted stock units and restricted stock awards generally vest over four years.  We recognize share-based compensation expense on a straight-line basis over the vesting period.  Options, restricted stock units, and restricted stock awards generally provide for accelerated vesting upon a change in control or normal or early retirement (as defined in the applicable stock incentive plan).  At December 31, 2013, we had reserved approximately 0.2 million shares for future equity grants under our stock incentive plans.
 
Following are certain amounts recognized in the consolidated statements of operations for share-based compensation arrangements for the years ended December 31, 2013, 2012, and 2011.  We did not capitalize any share-based compensation costs during these periods.

 
  
Year Ended
  
 
  
December 31,
    
December 31,
  
December 31,
  
(In millions)
  
2013
    
2012
  
2011
  
Total share-based compensation
  
$
7.1
    
$
6.4
    
$
9.2
  
Share-based compensation included in cost of services
    
2.9
      
3.0
      
4.1
  
Share-based compensation included in selling, general and administrative expenses
    
4.2
      
3.4
      
4.5
  
Share-based compensation included in restructuring and related charges
    
—
      
—
      
0.6
  
Total income tax benefit recognized
    
2.8
      
2.5
      
3.6
  

As of December 31, 2013, there was $16.5 million of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the stock incentive plans.  That cost is expected to be recognized over a weighted average period of 2.0 years.
 
Stock Options

We use a lattice-based binomial option valuation model ("lattice binomial model") to estimate the fair values of stock options.  We base expected volatility on historical volatility due to the low volume of traded options on our stock.  The expected term of options granted is derived from the output of the lattice binomial model and represents the period of time that options granted are expected to be outstanding.  We used historical data to estimate expected option exercise and post-vesting employment termination behavior within the lattice binomial model.
65

The following table sets forth the weighted average grant-date fair values of options and the weighted average assumptions we used to develop the fair value estimates under each of the option valuation models for the years ended December 31, 2013, 2012 and 2011:

 
  
Year Ended December 31,
  
 
  
2013
    
2012
    
2011
  
Weighted average grant-date fair value of options per share
  
$
7.29
    
$
4.01
    
$
5.94
  
 
                        
Assumptions:
                        
Expected volatility
    
53.8
%
    
54.4
%
    
53.0
%
Expected dividends
    
—
      
—
      
—
  
Expected term (in years)
    
5.1
      
5.1
      
5.6
  
Risk-free rate
    
1.9
%
    
2.0
%
    
2.4
%

A summary of option activity as of December 31, 2013 and the changes during the year then ended is presented below:

Options
  
Shares (thousands)
    
Weighted
Average Exercise
Price Per Share
    
Weighted Average
Remaining Contractual Term
    
Aggregate  Intrinsic Value (thousands)
  
Outstanding at January 1, 2013
    
4,689
    
$
15.65
    
   
 
Granted
    
1,085
      
13.26
    
   
 
Exercised
    
(1,077
)
    
14.25
    
   
 
Forfeited
    
(163
)
    
11.34
    
   
 
Expired
    
(209
)
    
25.50
    
   
 
Outstanding at December 31, 2013
    
4,325
    
$
15.09
      
6.4
    
$
13,182
  
Exercisable at December 31, 2013
    
2,032
    
$
19.21
      
4.3
    
$
3,992
  

The total intrinsic value, which represents the difference between the market price of the underlying common stock and the option's exercise price, of options exercised during the years ended December 31, 2013, 2012 and 2011 was $3.2 million, $1.3 million, and $1.9 million, respectively.

Cash received from option exercises under all share-based payment arrangements during 2013 was $12.7 million.  The actual tax benefit realized during 2013 for the tax deductions from option exercises totaled $1.3 million.  We issue new shares of common stock upon exercise of stock options.

Restricted Stock and Restricted Stock Units

The fair value of restricted stock and restricted stock units ("nonvested shares") is determined based on the closing bid price of the Company's common stock on the grant date. The weighted average grant-date fair value of nonvested shares granted during the years ended December 31, 2013, 2012 and 2011, was $13.12, $8.29, and $13.26, respectively.
66
The following table sets forth a summary of our nonvested shares as of December 31, 2013 as well as activity during the year then ended.  The total grant-date fair value of shares vested during the years ended December 31, 2013, 2012 and 2011 was $3.1 million, $3.6 million, and $7.4 million, respectively.

Nonvested Shares
  
Shares (thousands)
    
Weighted Average Grant Date Fair Value Per Share
  
Nonvested at January 1, 2013
    
1,013
    
$
9.93
  
Granted
    
186
      
13.12
  
Vested
    
(293
)
    
10.43
  
Forfeited
    
(65
)
    
10.15
  
Nonvested at December 31, 2013
    
841
    
$
10.44
  

14. Earnings (Loss) Per Share
 
The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the years ended December 31, 2013, 2012, and 2011:

 
(In thousands except per share data)
  
Year Ended December 31,
  
Numerator:
  
2013
    
2012
    
2011
  
Net income (loss)
  
$
(8,541
)
  
$
8,024
    
$
(157,693
)
 
                        
Denominator:
                        
Shares used for basic earnings (loss) per share
    
34,489
      
33,597
      
33,677
  
Effect of dilutive stock options and restricted stock units outstanding:
                        
Non-qualified stock options (1)
    
—
      
37
      
—
  
Restricted stock units (1)
    
—
      
202
      
—
  
Shares used for diluted earnings (loss) per share (1)
    
34,489
      
33,836
      
33,677
  
 
                        
Earnings per share:
                        
Basic
  
$
(0.25
)
  
$
0.24
    
$
(4.68
)
Diluted (1)
  
$
(0.25
)
  
$
0.24
    
$
(4.68
)
 
                        
Dilutive securities outstanding not included in the computation of earnings per share because their effect is anti-dilutive:
                        
Non-qualified stock options
    
3,234
      
4,926
      
4,845
  
Restricted stock units
    
334
      
193
      
469
  
Warrants related to Cash Convertible Notes
    
7,707
      
—
      
—
  
CareFirst Convertible Note
    
892
      
—
      
—
  
 
(1) The assumed exercise of stock-based compensation awards for the years ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive.
67
15.            Accumulated OCI

The following tables summarize the changes in accumulated OCI, net of tax, for the twelve months ended December 31, 2013 and 2012:

 (In thousands)
  
Net Change in Fair Value of Interest Rate Swaps
    
Foreign Currency Translation Adjustments
    
Total
  
Accumulated OCI, net of tax, as of January 1, 2013
  
$
(1,790
)
  
$
861
    
$
(929
)
Other comprehensive income (loss) before reclassifications, net of tax
    
189
      
(755
)
    
(566
)
Amounts reclassified from accumulated OCI, net of tax
    
1,088
      
—
      
1,088
  
Net increase (decrease) in other comprehensive income (loss), net of tax
    
1,277
      
(755
)
    
522
  
Accumulated OCI, net of tax, as of December 31, 2013
  
$
(513
)
  
$
106
    
$
(407
)


 (In thousands)
  
Net Change in Fair Value of Interest Rate Swaps
    
Foreign Currency Translation Adjustments
    
Total
  
Accumulated OCI, net of tax, as of January 1, 2012
  
$
(2,570
)
  
$
781
    
$
(1,789
)
Other comprehensive income (loss) before reclassifications, net of tax
    
(1,244
)
    
80
      
(1,164
)
Amounts reclassified from accumulated OCI, net of tax
    
2,024
      
—
      
2,024
  
Net increase in other comprehensive income (loss), net of tax
    
780
      
80
      
860
  
Accumulated OCI, net of tax, as of December 31, 2012
  
$
(1,790
)
  
$
861
    
$
(929
)
 
                        
     

The following table provides details about reclassifications out of accumulated OCI for the twelve months ended December 31, 2013:

 
Twelve Months Ended December 31,
 
Statement of Comprehensive Income
 (In thousands)
2013
 
2012
 
(Loss) Classification
Interest rate swaps
 
$
1,916
 
 
$
3,302
 
Interest expense
 
 
 
(828
)
 
 
(1,278
)
Income tax benefit
 
 
$
1,088
 
 
$
2,024
 
Net of tax

See Note 7 for further discussion of our interest rate swaps.
68

16.
Stockholder Rights Plan

On June 19, 2000, our Board adopted a stockholder rights plan under which holders of common stock as of June 30, 2000 received preferred stock purchase rights as a dividend at the rate of one right per share.  As amended in June 2004 and July 2006, each right initially entitles its holder to purchase one one-hundredth of a Series A preferred share at $175.00, subject to adjustment.  Upon becoming exercisable, each right will allow the holder (other than the person or group whose actions have triggered the exercisability of the rights), under alternative circumstances, to buy either securities of the Company or securities of the acquiring company (depending on the form of the transaction) having a value of twice the then current exercise price of the rights.

With certain exceptions, each right will become exercisable only when a person or group acquires, or commences a tender or exchange offer for, 15% or more of our outstanding common stock.  Rights will also become exercisable in the event of certain mergers or asset sales involving more than 50% of our assets or earning power.  The rights will expire on June 15, 2014, unless redeemed or exchanged.  Our Board reviews the plan periodically to determine if the maintenance and continuance of the plan is still in the best interests of the Company and its stockholders.
 
17. Employee Benefits

We have a 401(k) Retirement Savings Plan (the "401(k) Plan") available to substantially all of our employees.  Employees can contribute up to a certain percentage of their base compensation as defined in the 401(k) Plan.  The Company matching contributions are subject to vesting requirements.  Company contributions under the 401(k) Plan totaled $3.1 million, $2.9 million, and $3.5 million for the years ended December 31, 2013, 2012, and 2011, respectively.

18. Segment Disclosures

We have aggregated our operating segments into one reportable segment, well-being improvement services.  Our integrated well-being improvement services include disease management, health coaching, and wellness and prevention programs. Further, we report revenues from our external customers on a consolidated basis since well-being improvement is the only service that we provide.

During 2013 and 2012, we derived approximately 10.5% and 11.5%, respectively, of our revenues from one customer and during 2011, we derived approximately 17% of our revenues from a separate customer, with no other customer comprising 10% or more of our revenues.
69

19. Quarterly Financial Information (unaudited)


(In thousands, except per share data)
  
   
   
   
 
 
  
   
   
   
 
Year Ended
December 31, 2013
  
First
    
Second
    
Third
    
Fourth
  
 
    
(1)
 
    
(1)
 
    
(2)
 
    
(1)  (2)
 
Revenues
  
$
165,165
    
$
162,270
    
$
166,615
    
$
169,235
  
Gross margin
  
$
15,083
    
$
19,916
    
$
26,391
    
$
18,326
  
Income (loss) before income taxes
  
$
(6,044
)
  
$
(1,650
)
  
$
1,108
    
$
(7,591
)
Net income (loss)
  
$
(3,949
)
  
$
(1,101
)
  
$
1,799
    
$
(5,290
)
 
                                
Basic earnings (loss) per share (3)
  
$
(0.12
)
  
$
(0.03
)
  
$
0.05
    
$
(0.15
)
Diluted earnings (loss) per share (3)
  
$
(0.12
)
  
$
(0.03
)
  
$
0.05
    
$
(0.15
)

Year Ended
December 31, 2012
  
First
    
Second
    
Third
    
Fourth
  
 
    
(1)
 
  
   
     
(4)
 
Revenues
  
$
165,218
    
$
170,214
    
$
166,559
    
$
175,180
  
Gross margin
  
$
16,300
    
$
32,061
    
$
30,619
    
$
28,217
  
Income (loss) before income taxes
  
$
(4,116
)
  
$
8,732
    
$
8,542
    
$
1,587
  
Net income (loss)
  
$
(2,665
)
  
$
5,057
    
$
5,028
    
$
604
  
 
                                
Basic earnings (loss) per share (3)
  
$
(0.08
)
  
$
0.15
    
$
0.15
    
$
0.02
  
Diluted earnings (loss) per share (3)
  
$
(0.08
)
  
$
0.15
    
$
0.15
    
$
0.02
  

(1) The assumed exercise of stock-based compensation awards for this period was not considered in the calculation of diluted earnings (loss) per share because the impact would have been anti-dilutive.

(2) Includes charges related to non-cash interest associated with amortization of a debt discount of $1.5 million and $1.6 million for the third and fourth quarter, respectively.

(3) We calculated earnings per share for each of the quarters based on the weighted average number of shares and dilutive securities outstanding for each period.  Accordingly, the sum of the quarters may not necessarily be equal to the full year income per share.

(4) Includes charges related to one-time termination benefits associated with capacity realignment of $1.8 million.
70

Report of Independent Registered Public Accounting Firm


The Board of Directors and Stockholders of Healthways, Inc.

We have audited Healthways, Inc.'s internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992 framework) (the COSO criteria). Healthways, Inc.'s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management's Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the company's internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, Healthways, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2013, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Healthways, Inc. as of December 31, 2013 and 2012, and the related consolidated statements of operations, comprehensive income (loss), changes in stockholders' equity, and cash flows for each of the three years in the period ended December 31, 2013 of Healthways, Inc. and our report dated March 14, 2014 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Nashville, Tennessee
March 14, 2014
71

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Not applicable.

Item 9A.
Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company's principal executive officer and principal financial officer have reviewed and evaluated the effectiveness of the Company's disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) as of December 31, 2013.  Based on that evaluation, the principal executive officer and principal financial officer have concluded that the Company's disclosure controls and procedures are effective.  They are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms and to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company's management, including the principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

Management's Annual Report on Internal Control over Financial Reporting

Management, including the principal executive officer and principal financial officer, is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) promulgated under the Exchange Act.  Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

Management has performed an assessment of the effectiveness of the Company's internal control over financial reporting as of December 31, 2013 based on criteria established in Internal Control — Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the "COSO framework"), and believes that the COSO framework is a suitable framework for such an evaluation.  Based on this assessment, management has concluded that the Company's internal control over financial reporting was effective as of December 31, 2013.

Ernst & Young LLP, the independent registered public accounting firm that audited the Company's consolidated financial statements for the year ended December 31, 2013, has issued an attestation report on the Company's internal control over financial reporting which is included in this Report.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company's internal controls over financial reporting during the quarter ended December 31, 2013 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
 
Item 9B. Other Information

Not applicable.
72

PART III

Item 10.
Directors, Executive Officers and Corporate Governance

Information concerning our directors, director nomination procedures, audit committee, audit committee financial experts, code of ethics, and compliance with Section 16(a) of the Exchange Act will be included under the headings "Election of Directors," "Corporate Governance," and "Director Compensation" in our Proxy Statement for the 2014 Annual Meeting of Stockholders and is incorporated herein by reference.

Pursuant to General Instruction G(3) of Form 10-K, information concerning our executive officers is included in Part I of this Report, under the caption "Executive Officers of the Registrant."
 
Code of Business Conduct
 
We have adopted a code of business conduct ("code of conduct") applicable to our principal executive, financial, and accounting officers. Copies of both the code of conduct, as well as any waiver of a provision of the code of conduct granted to any principal executive, financial, and accounting officers or material amendment to the code of conduct, if any, are available, without charge, on our website at www.healthways.com.
 
Item 11.
Executive Compensation

Information required by this item will be included under the heading "Executive Compensation" in our Proxy Statement for the 2014 Annual Meeting of Stockholders and is incorporated herein by reference.
 
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
 
Information required by this item will be included under the headings "Security Ownership of Certain Beneficial Owners and Management" and "Adoption of the Company's 2014 Stock Incentive Plan" in our Proxy Statement for the 2014 Annual Meeting of Stockholders and is incorporated herein by reference.
 
Item 13.
Certain Relationships and Related Transactions, and Director Independence

Information required by this item will be included under the heading "Corporate Governance" in our Proxy Statement for the 2014 Annual Meeting of Stockholders and is incorporated herein by reference.
 
Item 14.
Principal Accounting Fees and Services

Information required by this item will be included under the heading "Ratification of Independent Registered Public Accounting Firm" in our Proxy Statement for the 2014 Annual Meeting of Stockholders and is incorporated herein by reference.
73

PART IV

Item 15.
Exhibits, Financial Statement Schedules

 (a)
The following documents are filed as part of this Report:

1.            The financial statements filed as part of this Report are included in Part II, Item 8 of this Report.

2.            We have omitted all Financial Statement Schedules because they are not required under the instructions to the applicable accounting regulations of the SEC or the information to be set forth therein is included in the financial statements or in the notes thereto.

3.            Exhibits

2.1
 
Stock Purchase Agreement dated October 11, 2006 among Healthways, Inc., Axia Health Management, Inc., and Axia Health Management LLC [incorporated herein by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K dated December 1, 2006, File No. 000-19364]
 
 
 
3.1
 
Restated Certificate of Incorporation, as amended [incorporated by reference to Exhibit 3.1 to Form 10-Q of the Company's fiscal quarter ended February 29, 2008, File No. 000-19364]
 
 
 
3.2
 
Certificate of Amendment to Restated Certificate of Incorporation, as amended, dated as of October 10, 2013 [incorporated by reference to Exhibit 3.2 to Form 10-Q of the Company's fiscal quarter ended September 30, 2013, File No. 000-19364]
 
 
 
3.3
 
Amended and Restated Bylaws [incorporated by reference to Exhibit 3.2 to Form 10-Q of the Company's fiscal quarter ended February 29, 2004, File No. 000-19364]
 
 
 
3.4
 
Amendment to Amended and Restated Bylaws [incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated November 15, 2007, File No. 000-19364]
 
 
 
3.5
 
Amendment No. 2 to Amended and Restated Bylaws [incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated September 3, 2008, File No. 000-19364]
 
 
 
4.1
 
Article IV of the Company's Restated Certificate of Incorporation (included in Exhibit 3.1)
 
 
 
4.2
 
Rights Agreement dated June 19, 2000 between the Company and SunTrust Bank, including the Form of Rights Certificate (Exhibit A), the Form of Summary of Rights (Exhibit B) and the Form of Certificate of Amendment to the Restated Certificate of Incorporation of the Company (Exhibit C) [incorporated herein by reference to Exhibit 4 to the Company's Current Report on Form 8-K dated June 21, 2000, File No. 000-19364]
 
 
 
4.3
 
Amendment No. 1 to Rights Agreement dated June 15, 2004 between the Company and SunTrust Bank [incorporated herein by reference to Exhibit 4 to the Company's Current Report on Form 8-K dated June 17, 2004, File No. 000-19364]
 
4.4
 
 
Amendment No. 2 to Rights Agreement dated July 19, 2006 between the Company and SunTrust Bank [incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K dated July 19, 2006, File No. 000-19364]
 
 
4.5
 
Indenture dated as of July 8, 2013 between the Company and U.S. Bank National Association [incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]
 
 
 
4.6
 
Form of 1.50% Cash Convertible Senior Note due 2018 (included in Exhibit 4.5)
 
 
74
10.1
 
Office Lease dated as of May 4, 2006 between the Company and Highwoods/Tennessee Holdings, L.P. [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated May 5, 2006, File No. 000-19364]
 
 
 
10.2
 
Master Services Agreement dated May 25, 2011 between the Company and HP Enterprise Services, LLC [incorporated by reference to Exhibit 10.1 to Form 10-Q of the Company's fiscal quarter ended June 30, 2011, File No. 000-19364] *
 
 
 
10.3
 
Fifth Amended and Restated Revolving Credit and Term Loan Agreement dated June 8, 2012 between the Company and SunTrust Bank as Administrative Agent, JPMorgan Chase Bank, N.A.as Documentation Agent, and U.S. Bank National Association and Fifth Third Bank as Co-Syndication Agents [incorporated by reference to Exhibit 10.1 to Company's Current Report on Form 8-K dated June 11, 2012, File No. 000-19364]
 
 
 
10.4
 
First Amendment to Fifth Amended and Restated Revolving Credit and Term Loan Agreement dated February 5, 2013 between the Company and SunTrust Bank as Administrative Agent [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated February 7, 2013, File No. 000-19364]
 
 
 
10.5
 
Second Amendment to Fifth Amended and Restated Revolving Credit and Term Loan Agreement dated March 15, 2013 between the Company and SunTrust Bank as Administrative Agent [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended March 31, 2013, File No. 000-19364]
 
 
 
10.6
 
Third Amendment to Fifth Amended and Restated Revolving Credit and Term Loan Agreement and First Amendment to Second Amended and Restated Subsidiary Guarantee Agreement [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated July 1, 2013, File No. 000-19364]
 
 
 
10.7
 
Call Option Transaction Confirmation dated as of July 1, 2013 between the Company and JPMorgan Chase Bank, National Association, London Branch [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]
 
 
 
10.8
 
Amendment to Call Option Transaction Confirmation dated as of July 11, 2013 between the Company and JPMorgan Chase Bank, National Association, London Branch [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated July 16, 2013, File No. 000-19364]
 
 
 
10.9
 
Call Option Transaction Confirmation dated as of July 1, 2013 between the Company and Morgan Stanley & Co. International plc [incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]
 
 
 
10.10
 
Amendment to Call Option Transaction Confirmation dated as of July 11, 2013 between the Company and Morgan Stanley & Co. Internal plc [incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated July 16, 2013, File No. 000-19364]
 
 
 
10.11
 
Base Warrants Confirmation dated as of July 1, 2013 between the Company and JPMorgan Chase Bank, National Association, London Branch [incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]
 
 
 
10.12
 
Additional Warrants Confirmation dated as of July 11, 2013 between the Company and JPMorgan Chase Bank, National Association, London Branch [incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated July 16, 2013, File No. 000-19364]
 
 
 
10.13
 
Base Warrants Confirmation dated as of July 1, 2013 between the Company and Morgan Stanley & Co. International plc [incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K dated July 8, 2013, File No. 000-19364]
 
 
 
10.14
 
Additional Warrants Confirmation dated as of July 11, 2013 between the Company and Morgan Stanley & Co. International plc [incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K dated July 16, 2013, File No. 000-19364]

75
10.15
 
Investment Agreement dated October 1, 2013 between the Company and CareFirst Holdings, LLC [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated October 2, 2013, File No. 000-19364]*
 
 
 
10.16
 
Convertible Senior Subordinated Note dated October 1, 2013 issued by the Company to CareFirst Holdings, LLC [incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated October 2, 2013, File No. 000-19364]
 
10.17
 
Form of Common Stock Purchase Warrant [incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated October 2, 2013, File No. 000-19364]
 
 
 
10.18
 
Registration Rights Agreement dated October 1, 2013 between the Company and CareFirst Holdings, LLC [incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K dated October 2, 2013, File No. 000-19364]
 
Management Contracts and Compensatory Plans
 
 
 
10.19
 
Amended and Restated Employment Agreement dated December 21, 2012 between the Company and Ben R. Leedle, Jr. [incorporated by reference to Exhibit 10.5 to Form 10-K of the Company's fiscal year ended December 31, 2012, File No. 000-19364]
 
 
 
10.20
 
Amended and Restated Employment Agreement dated November 30, 2012 between the Company and Alfred Lumsdaine [incorporated by reference to Exhibit 10.6 to Form 10-K of the Company's fiscal year ended December 31, 2012, File No. 000-19364]
 
 
 
10.21
 
Employment Agreement dated August 31, 2011 between the Company and Michael R. Farris [incorporated by reference to Exhibit 10.12 to Form 10-K of the Company's fiscal year ended December 31, 2011, File No. 000-19364]
 
 
 
10.22
 
Amendment to Employment Agreement dated December 1, 2012 between the Company and Michael R. Farris [incorporated by reference to Exhibit 10.10 to Form 10-K of the Company's fiscal year ended December 31, 2012, File No. 000-19364]
 
 
 
10.23
 
Employment Agreement dated January 1, 2012 between the Company and Peter Choueiri [incorporated by reference to Exhibit 10.1 to Form 10-Q of the Company's fiscal quarter ended March 31, 2012, File No. 000-19364]
 
10.24
 
Employment Agreement dated July 29, 2012 between the Company and Glenn Hargreaves [incorporated by reference to Exhibit 10.1 to Form 10-Q of the Company's fiscal quarter ended June 30, 2012, File No. 000-19364]
 
 
 
10.25
 
Employment Agreement dated July 29, 2012 between the Company and Mary Flipse [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended June 30, 2012, File No. 000-19364]
 
 
 
10.26
 
Amended and Restated Corporate and Subsidiary Capital Accumulation Plan [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended June 30, 2011, File No. 000-19364]
 
 
 
10.27
 
Form of Indemnification Agreement by and among the Company and the Company's directors [incorporated by reference to Exhibit 10.15 to Registration Statement on Form S-1 (Registration No. 33-41119)]
 
76
10.28
 
2007 Stock Incentive Plan, as amended [incorporated by reference to Exhibit 10.16 to Form 10-K of the Company's fiscal year ended December 31, 2012, File No. 000-19364]
 
 
 
10.29
 
1996 Stock Incentive Plan, as amended  [incorporated by reference to Exhibit 10.20 to Form 10-K of the Company's fiscal year ended August 31, 2006, File No. 000-19364]
 
 
 
10.30
 
Amended and Restated 2001 Stock Option Plan  [incorporated by reference to Exhibit 10.21 to Form 10-K of the Company's fiscal year ended August 31, 2006, File No. 000-19364]
 
 
 
10.31
 
Form of Non-Qualified Stock Option Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.24 to Form 10-K of the Company's fiscal year ended August 31, 2007, File No. 000-19364]
 
 
 
10.32
 
Form of Restricted Stock Unit Award Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.25 to Form 10-K of the Company's fiscal year ended August 31, 2007, File No. 000-19364]
 
 
 
10.33
 
Form of Non-Qualified Stock Option Agreement (for Directors) under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended June 30, 2010, File No. 000-19364]
 
 
 
10.34
 
Form of Restricted Stock Unit Award Agreement (for Directors) under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.3 to Form 10-Q of the Company's fiscal quarter ended June 30, 2010, File No. 000-19364]
 
10.35
 
2007 Stock Incentive Plan Performance Cash Award Agreement dated March 3, 2009 [incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated March 4, 2009, File No. 000-19364]
 
 
 
10.36
 
2007 Stock Incentive Plan Performance Cash Award Agreement dated May 25, 2011 [incorporated by reference to Exhibit 10.3 to Form 10-Q of the Company's fiscal quarter ended June 30, 2011, File No. 000-19364]
 
10.37
 
Form of Non-Qualified Stock Option Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.2 to Form 10-Q of the Company's fiscal quarter ended March 31, 2012, File No. 000-19364]
 
 
 
10.38
 
Form of Restricted Stock Unit Award Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.3 to Form 10-Q of the Company's fiscal quarter ended March 31, 2012, File No. 000-19364]
 
 
 
10.39
 
2007 Stock Incentive Plan Performance Cash Award Agreement dated January 18, 2012 [incorporated by reference to Exhibit 10.4 to Form 10-Q of the Company's fiscal quarter ended March 31, 2012, File No. 000-19364]
 
 
 
10.40
 
Form of Non-Qualified Stock Option Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.28 to Form 10-K of the Company's fiscal year ended December 31, 2012, File No. 000-19364]
 
 
 
10.41
 
Form of Restricted Stock Unit Award Agreement under the Company's 2007 Stock Incentive Plan [incorporated by reference to Exhibit 10.29 to Form 10-K of the Company's fiscal year ended December 31, 2012, File No. 000-19364]
 
 
 
10.42
 
2007 Stock Incentive Plan Performance Cash Award Agreement dated February 28, 2013 [incorporated by reference to Exhibit 10.30 to Form 10-K of the Company's fiscal year ended December 31, 2012, File No. 000-19364]

77
10.43
 
2007 Stock Incentive Plan Performance Cash Award Agreement for Peter Choueiri dated February 28, 2013 [incorporated by reference to Exhibit 10.31 to Form 10-K of the Company's fiscal year ended December 31, 2012, File No. 000-19364]
 
 
 
14.1
 
Code of Business Conduct of Healthways, Inc.
 
21
 
Subsidiary List
 
 
 
23
 
Consent of Ernst & Young LLP
 
 
 
31.1
 
Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Ben R. Leedle, Jr., Chief Executive Officer
 
 
 
31.2
 
Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002 made by Alfred Lumsdaine, Chief Financial Officer
 
 
 
32
 
Certification Pursuant to 18 U.S.C section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 made by Ben R. Leedle, Jr., Chief Executive Officer, and Alfred Lumsdaine, Chief Financial Officer
 
 
 
 
 
*Portions of this Exhibit have been omitted and filed separately with the U.S. Securities and Exchange Commission as part of an application for confidential treatment pursuant to the Securities Exchange Act of 1934.

(b)
Exhibits

Refer to Item 15(a)(3) above.

(c)
Not applicable

78
SIGNATURES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 
HEALTHWAYS, INC
 
 
 
 
March 14, 2014
 
By:
/s/ Ben R. Leedle, Jr.
 
 
 
Ben R. Leedle, Jr.
 
 
 
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature
 
Title
 
Date
 
 
 
 
 
/s/ Ben R. Leedle, Jr.
 
Chief Executive Officer and Director (Principal
 
March 14, 2014
Ben R. Leedle, Jr.
 
Executive Officer)
 
 
 
 
 
 
 
/s/ Alfred Lumsdaine
 
Chief Financial Officer (Principal Financial Officer)
 
March 14, 2014
Alfred Lumsdaine
 
 
 
 
 
 
 
 
 
/s/ Glenn Hargreaves
 
Controller and Chief Accounting Officer (Principal Accounting Officer)
 
March 14, 2014
Glenn Hargreaves
 
 
 
 
 
 
 
 
 
/s/ John W. Ballantine
 
Chairman of the Board and Director
 
March 14, 2014
John W. Ballantine
 
 
 
 
 
 
 
 
 
/s/ William D. Novelli
 
Director
 
March 14, 2014
William D. Novelli
 
 
 
 
 
 
 
 
 
/s/ Donato J. Tramuto
 
Director
 
March 14, 2014
Donato Tramuto
 
 
 
 
 
 
 
 
 
/s/    John A. Wickens
 
Director
 
March 14, 2014
John A. Wickens
 
 
 
 
 
 
 
 
 
/s/ Mary Jane England, M.D.
 
Director
 
March 14, 2014
Mary Jane England, M.D.
 
 
 
 
 
 
 
 
 
/s/ Alison Taunton-Rigby
 
Director
 
March 14, 2014
Alison Taunton-Rigby
 
 
 
 
 
 
 
 
 
/s/ Jay C. Bisgard, M.D.
 
Director
 
March 14, 2014
Jay C. Bisgard, M.D.
 
 
 
 
 
 
 
 
 
/s/ C. Warren Neel
 
Director
 
March 14, 2014
C. Warren Neel
 
 
 
 
 
 
 
 
 
/s/ Kevin G. Wills
 
Director
 
March 14, 2014
Kevin Wills
 
 
 
 
 
 
79
 EX-32 2 ex32.htm EX-32, SECTION 906 CEO AND CFO CERTIFICATION
Exhibit 32



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Healthways, Inc. (the "Company") on Form 10-K for the period ending December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Ben R. Leedle, Jr., Chief Executive Officer of the Company, and Alfred Lumsdaine, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Ben R. Leedle, Jr.___________
Ben R. Leedle, Jr.
Chief Executive Officer
March 14, 2014



/s/ Alfred Lumsdaine___________
Alfred Lumsdaine
Chief Financial Officer
March 14, 2014

 EX-14.1 3 ex14-1.htm EX-14.1, CODE OF BUSINESS CONDUCT OF HEALTHWAYS, INC.
Exhibit 14.1
 



 

 
CODE OF BUSINESS CONDUCT





 
HEALTHWAYS SHARED VALUES

Trust and be trustworthy Respect those with whom we interact
Be responsible for our individual commitments Support each other to maximize our collective success Collaborate for best solutions
Pursue excellence in all of our endeavors Strive for health in mind, body and spirit

Introductory Letter from our CEO







Dear Fellow Colleagues:

At Healthways we are, as our Shared Values state, in pursuit of excellence in all our endeavors. One of those endeavors is our commitment to legal compliance and ethical conduct. We have an Enterprise Risk Management Committee ("ERMC") staffed by senior management to assist me in the oversight of enterprise risk and compliance. We have eliminated the concept of a Code of Conduct officer and established our CFO and General Counsel as co-chairs of the ERMC and asked them to serve as the Company's compliance officers. Together they will work to address the ever-changing compliance requirements of our business and update the Audit Committee of our Board of Directors on risk-related matters. We have also revised the Employee Handbook, and we have revised our Code of Business Conduct.

The new Code of Business Conduct is more concise. Some of its former content that addressed individual colleague behavior has found a new home in the Healthways Colleague Handbook. We have streamlined the mechanisms for reporting potential incidents and clarified responsibilities consistent with our new ERMC structure. The new Code is relevant, up to date and addresses the increasing breadth of our business. The Code will help ensure we retain our position as the leader in well-being without sacrificing our standards of quality, business service and ethical behavior.

Since our inception, we have built our business reputation on our character, and our Shared Values, each of which is reflected in how well we live them as individuals and as a Company. Our continued success depends on each of us doing our part to uphold these values in our day-to- day work and in all decisions we make.

Healthways competes vigorously with our competitors to achieve business success, but it is critical for each of us to understand that we must be concerned with more than just results. It matters how those results are achieved. By living our Shared Values, we have created an atmosphere of trust and cooperation, whether at our world headquarters in Franklin, Tennessee, or our operations in Sydney, Australia. We will not tolerate conduct designed to achieve results through illegal or unethical means anywhere in the world.

I cannot emphasize enough that each of us is responsible for our own conduct, for learning and understanding the policies and standards that apply to us and our actions.

If you have questions about any Healthways policy or if you have questions about the propriety of your own or a fellow colleague's conduct, you must report your concerns to your manager, the Healthways Legal Department, or the ERMC. If you wish, you may report your concerns anonymously, where local law allows, via the Code of Conduct Hotline at 866.225.0836. In addition, if your concerns relate to financial or accounting issues, you may report these matters
 
ii
Healthways Code of Business Conduct August 2013
 

directly to our Audit Committee via the Accounting Concerns Hotline at 888.253.5759. I am committed to creating an environment that supports open communication, and provides each of you the means to report known or suspected violations without fear of reprisal. All Healthways managers are responsible for creating such an environment and setting the standards of integrity and trust.

Please review the Code of Business Conduct carefully, and use it as a reference tool. As we continue to grow, this Code will be a source of support in maintaining Healthways' integrity and character.

Thanks to all of you for making Healthways a company of great results and great character.

Sincerely,

 
/s/ Ben R. Leedle, Jr.
 
 
Ben R. Leedle, Jr.
 
 
President & Chief Executive Officer
 
 
iii
Healthways Code of Business Conduct August 2013
 

Table of Contents

HEALTHWAYS SHARED HEALTHWAYS SHARED VALUES
i
 
 
Introductory Letter from our CEO
 
ii
Table of Contents
 
iv
General Standards of Conduct and the Code
 
1
What is the "Code of Business Conduct"?
 
1
Reporting Concerns
 
2
How do I report a violation of the Code?
2
What can I expect if I make a report?
2
Are there penalties if I violate the Code?
2
Are there waivers to the Code?
 
3
Business and Financial Records and Transactions
 
3
Accuracy of Healthways' Books and Records
3
Deficiencies in Internal Controls for Financial Reporting
 
4
Trading in Healthways Securities
 
4
Inquiries from Third Parties
4
Insider Trading
4
Trading Window for Officers and Directors
5
Anti-Hedging Policy
 
6
Fair Dealing with Healthways
 
6
Appropriate Use of Healthways Proprietary Information and Assets
6
Privacy
 
7
Fair Dealing with Customers, Participants and Competitors
 
7
Fair Competition
7
Payments for Referrals
8
Kickback and Patient Referral Activities
8
Payments or Gifts from Other Health Care Providers
8
Medical Director Agreements
9
Fraud Waste and Abuse
 
9
 
 
4
Healthways Code of Business Conduct August 2013
Conflicts of Interest
 
10
Improper Personal Benefits from Healthways
10
Corporate Opportunities
10
Financial Interests
11
Business Courtesies
11
Outside Employment and Associations
 
11
Working with Governments and Dealings with Foreign Countries
 
11
Political Contributions
12
Anti-Bribery
12
Foreign Corrupt Practices Act
13
Anti-Boycott Laws
14
U.S. Trade Sanction and Export Control Laws
 
14
Acknowledgement
16
 
 
  
5
Healthways Code of Business Conduct August 2013


General Standards of Conduct and the Code

Our ethical conduct is essential and contributes significantly to the ultimate success of Healthways, Inc. (the "Company"). Ethical conduct can be described in numerous ways, but includes all of the following:

•
Doing the right thing, not necessarily the expedient thing
•
Acting in the best interests of the Company's shareholders
•
Telling the truth
•
Keeping our word

What is the "Code of Business Conduct"?

The Code of Business Conduct (the "Code") describes the Company's worldwide business conduct standards. These standards flow from applicable laws, best business practices and our Shared Values. They are applicable to colleagues at all levels, in all of our domestic and international locations, as well as the Company's Board of Directors. Accordingly, any reference to "colleague" in this Code includes employees, as well as non-employee members of the Company's Board of Directors.

It is important to our customers that colleagues conduct business in a legal and ethical manner. An important component of the Company's success has been a commitment to the highest standards of ethical behavior and compliance with applicable laws and regulations. Therefore, each colleague must review and understand the principles contained in this Code and its application to their duties and responsibilities. The Code does not describe all laws, regulations or internal policies. Rather, it provides guideposts for day-to-day conduct upon which colleagues, customers, shareholders, health care and business communities and regulatory authorities will judge our integrity. Each colleague is responsible for assuring compliance with this Code. It is important that colleagues respect and commit to follow the standards set forth in it.

 
Questions to Ask Yourself When Considering a Course of Conduct
 
Am I dealing with this problem in a truthful and honest manner?
 
Would my actions be consistent with the Code?
 
Would my actions be legal? Ethical?
 
Would my actions protect Healthways' reputation as an ethical company?

If the answer to any of these questions is less than an unqualified "yes" then reconsider the contemplated course of action, and seek guidance since the Code cannot capture every situation that might be encountered while working at Healthways. When in doubt, ask for assistance from any one of the following: your manager, the Legal Department, or the ERMC.

In addition to the information contained in this Code, it is important to note that Healthways has additional policies and procedures such as those contained in the Healthways Colleague Handbook. Each of us is responsible for knowing and complying with all such policies and procedures.

Reporting Concerns

How do I report a violation of the Code?

•
You must report potential violations of the Code. You can do so anonymously, where local law allows, by contacting the Code Hotline at 866.225.0836 or by reporting online at https://secure.ethicspoint.com. The Code Hotline is maintained by an independent third-party and is available 24 hours every day. International dialing instructions are available on the website and translators are available if needed.

•
You may report potential violations of the Code in connection with the Company's business activities to the ERMC by directing communications to the General Counsel or another member of the Legal Department.

•
You may report violations regarding accounting activities and/or the financial records of the Company by contacting the Accounting Concerns Hotline at 888.253.5759. This line is maintained by the Audit Committee of the Company's Board of Directors.

What can I expect if I make a report?

The Company takes all reports of potential Code violations seriously, and colleagues should feel free to make reports without fear of retaliation. Any retaliation against a colleague who sincerely raises an issue is a violation of the Code. Raising a concern in good faith, or participating in an investigation, cannot be the basis for any adverse employment action, including separation, demotion, suspension, loss of benefits, threats, harassment or discrimination.

Colleagues who raise a concern or provide information related to an investigation, must be treated with courtesy and respect. Attacks of retaliation must be reported as a violation of the Code.

The Company is committed to the confidential treatment and investigation of each incident that is reported. Confidentiality will be maintained to the fullest extent possible, consistent with the Company's need to conduct an adequate review, and the requirements of applicable law.

Are there penalties if I violate the Code?

Yes. Violations of the standards contained in this Code or in other Company policies and procedures, whether resulting from carelessness or intentional actions, put the Company and its reputation at risk. The ERMC and/or the Company's Audit Committee may determine appropriate actions in the event of a Code violation, which may include disciplinary action and reporting to senior management of the Company and the Board of Directors. 
 
2
Healthways Code of Business Conduct August 2013
Doing any of the following may subject colleagues to disciplinary action, up to and including termination from employment:

(a)
Violating the law, the Code, or acting against legal advice from the Company's Legal Department or a directive from the ERMC;

(b)
Intentionally concealing information about your own or another colleague's acts or omissions with respect to any of the matters listed in Item (a) above; or

(c)
Threatening or engaging in retaliation against a colleague who reports a suspected violation of law or the Code.

In addition, violations of the law may expose you (and Healthways) to civil and/or criminal penalties, including prison terms and fines, against which the Company may not be able to or willing to protect you.

Are there waivers to the Code?

Waivers of the Code are rarely, if ever, granted. They are only granted by the ERMC and/or the Audit Committee of the Company's Board of Directors or, in the case of officers and directors, the full Board of Directors. Therefore, you should give serious consideration before submitting any such request. If a waiver of the Code is granted, the Company may be required to make public disclosures if mandated by law.
 
 
Business and Financial Records and Transactions

Accuracy of Healthways' Books and Records

Federal law requires that the Company maintain adequate controls to assure that the information set forth in books and records (including financial records, expense reports, time-worked reports, customer and vendor contracts, and personnel-related documents completed by colleagues) is accurate, timely and complete. The deliberate falsification of Company contracts, reports or records is a serious and direct violation of the Code and, perhaps, the law. Falsification of records consists of altering, fabricating, falsifying, forging or deliberately omitting any part of a document, contract or record for the purpose of gaining an advantage, or misrepresenting the value of the document, contract or record.

Colleagues must ensure that all disclosures in our periodic reports and submissions filed with the Securities and Exchange Commission ("SEC") and other public communications are full, fair, accurate, timely and understandable. Accordingly, it is our duty to promptly bring to the attention of the ERMC any information that could materially affect the disclosures made by Healthways in its public communications.

Colleagues who are responsible for recording transactions or events into the Company's records may not intentionally delay them, or intentionally record incorrect, incomplete or misleading information  about  any transaction  or event.  Other colleagues who are not  responsible for
 
 
3
Healthways Code of Business Conduct August 2013
recording transactions or events must ensure that all information submitted for recording is timely, accurate and complete.

 
Do
 
Don't
 
Report in PeopleSoft only the time worked by yourself or a colleague.
 
Falsify data or create false data, including customer- related data and outcomes.
 
Make truthful and honest entries in the Company's records and any public record.
 
Falsify work hours, expenses or other work-related reports.
 
Report vendor payments on the date on which they were made.
 
Falsify payments from a vendor to meet budgeting requirements.

Deficiencies in Internal Controls for Financial Reporting

Creating and complying with the Company's internal controls for financial reporting is every colleague's responsibility. Any concerns or information about significant deficiencies in the design or operation of internal controls that could adversely affect the Company's ability to record, process, summarize or report financial data should be promptly reported to the Audit Committee. In addition, any fraud, whether or not material, involving Company assets, contracts or colleagues must be immediately reported to the Audit Committee.

 
Trading in Healthways Securities

Healthways' colleagues may not use or assist others in using non-public information about the Company or its business partners to profit in the stock market.

Inquiries from Third Parties

It is our policy that all requests for information regarding the Company from investors, investment analysts, stockholders and others, must be referred to the Director of Investor Relations. Except as specifically authorized, colleagues may not respond to any questions posed by these third parties, but rather should politely refer them to our Vice President of Investor Relations. These rules do not apply to inquiries from customers or potential customers relating to relevant business operations that we receive in the ordinary course of business.

Insider Trading

Colleagues may come to know information about Healthways or its business partners before it is disclosed to the public. This information is often called "inside" or "material, non-public" information. According to securities laws, information is considered "material" if it would influence an investor to buy, sell or hold the securities of the company about which the information relates. The information is "non-public" until it has been fully disclosed to the public, and three business days have passed to permit the securities market to absorb the information.  Common examples of information that would be regarded as material include
 
 
4
Healthways Code of Business Conduct August 2013

unreported earnings information, news of the pending or actual signing of a significant contract, news of a pending or actual loss of a significant contract for business, the instigation of new litigation, news of changes in senior management, or news of a pending acquisition or merger.

Because the Company is a publicly traded company, we are obligated to understand and comply with the laws that relate to the use of inside information. In general, these laws prohibit colleagues buying or selling the Company's stock if they possess material, non-public information regarding the Company, a practice known as "insider trading." Insider trading is a violation of Healthways' Code and the law.

Securities laws dictate that colleagues also refrain from "tipping." Tipping occurs when a person who has material inside information discloses it to another person, such as a family member or friend, who then buys or sells securities based upon that information. In such a situation, the person disclosing the information may be liable for violating securities laws, even if he or she did not personally make a trade or profit from the activity.

If you have any questions or concerns about insider trading or a suspicious trade, you should immediately report the information to the CFO or General Counsel.

Trading Window for Officers and Directors

The Company limits the time period during which officers and directors may trade in Company stock. These "trading windows" are designed to allow for adequate dissemination of material inside information to the public before officers and directors may buy or sell Healthways stock or initiate trading plans to buy or sell such stock. The trading window begins on the third business day following the day that Healthways has made a public announcement of material information (including an earnings release) and continues for fifteen business days. Thus, if a material announcement is made on a Monday, Thursday would be the first day on which a trade could be made. It is important to note that anyone in possession of material, non-public information that has not been publicly disclosed for three business days, must not trade in Company securities even if a "trading window" is open.

For Company officers and directors, Healthways allows for future trades pursuant to a binding contract, trading instruction or written plan for trading adopted when the officer or director is not aware of material non-public information. All such plans must be described in writing, must satisfy applicable legal requirements and must be approved in advance by the CFO or the General Counsel. In addition, the officer or director wishing to trade under such a plan must have:

•
Entered into a binding contract to trade; or
•
Instructed a third-party to trade the stock; and in either case
•
Adopted a written plan for trading at a time when not possessing material inside information.
 
 
5
Healthways Code of Business Conduct August 2013

In addition, the plan must:

•
Specify the price and amount of stock to be traded and the date or period during which the trading should occur; or
•
Contain a formula or algorithm for trading; and in either case
•
Restrict subsequent influence over trading by the officer or director.
 
In certain limited circumstances, the officer or director may be required to suspend a trading plan, if requested by the Company to avoid conflicts with the timing of certain business activities.

In addition, directors and certain officers must also comply with the provisions of federal securities laws regulating sales, short-swing (six months) liability provisions. They may also be subject to the Section 16 reporting requirements of the SEC. If you have any questions, please contact the CFO or the General Counsel.
Anti-Hedging Policy

Healthways considers it inappropriate for any employee or director to hedge or monetize transactions to lock in the value of his/her Company stock holdings. Such transactions, because they allow the holder to own Company securities without the full risks and rewards of ownership, potentially separate the holder's interests from those of other Company stockholders. Healthways employees and directors may not engage in any derivative transactions of Company securities, including put options, call options, prepaid variable contracts, equity swaps, collars, or exchange funds. Healthways employees and directors may not sell short any Company securities.

 
Fair Dealing with Healthways

Appropriate Use of Healthways Proprietary Information and Assets

Our continued success depends on our ability to safeguard Healthways' proprietary information. "Proprietary Information and Assets" refers to all trade secrets, confidential information and all other knowledge, information, documents or materials that are owned, developed or possessed by Healthways and are not generally known to the public. This information may include identities of customers and prospective customers, identities of individual contacts who work for customers, models and strategies, contract formats, business plans and related operation methodologies, financial information or measures, databases, computer programs, treatment protocols, operating procedures and organizational structures.

Each colleague must carefully consider any action that could inappropriately divulge Proprietary Information and Assets, including actions that have the potential to interfere with the ownership rights of the Company, including transferring, licensing or assigning proprietary information, patents, copyrights or trademarks. In addition, we may not permit Proprietary Information and Assets to be used by an outside party in a manner that is not in the ordinary course of the
 
 
6
Healthways Code of Business Conduct August 2013
 
Company's business unless this use is pursuant to the terms of a contract which has been approved in writing by our CEO or CFO.

All proprietary information created or possessed by colleagues while employed by Healthways is the property of Healthways. It must be returned to the Company when employment ends.

Privacy

All colleagues must respect others' privacy, as well as that of our customers and their members. To do so, colleagues must handle personal data responsibly and in compliance with all applicable privacy laws. Those who handle the personal data of others must:

•
Act in accordance with applicable law;
•
Act in accordance with any relevant contractual obligations;
•
Collect, use and process such information only for legitimate business purposes;
•
Limit access to the information to those who have a legitimate business need to know; and
•
Take precautions to prevent the unauthorized disclosure of the information.

Refer to the HIPAA Privacy Policy located on @healthways or contact the Privacy Office if you have additional questions or concerns regarding privacy matters.

Fair Dealing with Customers, Participants and Competitors

Healthways places great value on partnerships with its customers, suppliers, participants and their families, and requires that each of these constituencies be treated with fairness and integrity. This means not providing any customers or suppliers an unfair advantage over another, or making false or misleading statements about Healthways' products or services to secure a business relationship.  This same level of integrity applies to all dealings with competitors.

Fair Competition

Healthways competes fairly and complies with all related laws in all locations where it does business. These laws are often complex, and vary from country to country. Remember, conduct that is permissible in one country may not be lawful in another. When in doubt, colleagues should contact the Legal Department for guidance.

Healthways competes ethically and legally in the global marketplace. At no time may colleagues engage in activities that unfairly limit free trade or competition. In order to compete fairly, colleagues must follow the antitrust and competition laws in the countries where Healthways does business. These laws are designed to preserve a fair and level playing field for all businesses by prohibiting formal and informal agreements and practices that improperly restrain trade. To comply with these laws, colleagues may never discuss with competitors activities that may restrain trade, such as price fixing, bid rigging, or improperly dividing or allocating markets, territories or customers, or enter into formal or informal agreements with suppliers, distributors or customers that may improperly restrict competition.
 
7
Healthways Code of Business Conduct August 2013


Colleagues are cautioned to exercise particular caution when discussing any of these topics, especially when attending industry association meetings. If a discussion ensues regarding a prohibited topic, you should stop the conversation immediately and report it to the Legal Department. Questions regarding antitrust and competition laws should be directed to the Legal Department.

Payments for Referrals

Colleagues may not pay anyone for referrals to participate in Healthways' programs that violate applicable law. Any payments made by Healthways to physicians or to other potential referral sources must be made solely in exchange for the fair value of services provided by the referral source. Similarly, in circumstances where the Company is in a position to make referrals to physicians, health professionals or other health care facilities, these referrals must be made on the basis of what is best for the program participant, as limited by utilization review criteria and case management standards in customer contracts. All such referrals must be made without regard to the value or volume of referrals any such physician, health professional or other health care facility has made or may make to Healthways.

Kickback and Patient Referral Activities

In the United States, federal and state laws prohibit "kickback" activities within the health care field. Healthways requires compliance with these laws. This prohibition is broad and includes any circumstance in which someone attempts in any manner to buy or sell any Medicare, Medicaid, TriCare or government-sponsored program. Any violation of this law can expose Healthways and the colleague and customer involved to significant penalties including substantial fines and exclusion from participation in Medicare or Medicaid health care programs. In addition, any person participating in these "kickback" activities is subject to potential criminal prosecution. Healthways prohibits kickbacks and other types of referral fees described herein, and any such fees, where specifically permitted under local written law, may not be agreed to or paid without obtaining the prior written consent of the Legal Department.

Because many of the provisions of the laws regarding kickbacks and payment for referrals are very broad and technical, it is important that all contracts with customers (including any contract amendments affecting changes in payment terms or services to be provided), be reviewed and approved in writing by the Legal Department prior to execution to assure compliance with these laws.  For additional guidance and answers to specific questions, contact the Legal Department.

Payments or Gifts from Other Health Care Providers

Colleagues may not accept or solicit payments or gifts, including personal entertainment from health care providers, such as physicians, pharmaceutical companies, medical supply companies, hospitals or home health care companies in exchange for referrals to the entity providing the payment of its affiliates. There may be circumstances when health care providers to whom we may refer program participants make payments to Healthways in return for services provided by Healthways or in sponsorship of Healthways events. In these circumstances it is important that these payments are:
 
8
Healthways Code of Business Conduct August 2013
•
Of fair value in exchange for services provided by Healthways;
•
Made to Healthways or to the customer and not to a Healthways colleague; and
•
Approved in writing by the ERMC.

Medical Director Agreements

Medical Director or Physician Advisory Agreements must be for administrative or clinical services reasonably needed by Healthways, such as those to increase the quality or efficiency of delivery of services or to comply with licensure, certification or accreditation standards. Medical Director and Physician Advisory Agreements, as well as amendments to these agreements must:

•
Be in writing;
•
Clearly define the physician's duties and obligations;
•
Reflect consideration for services based upon a reasonable, fixed, fair market rate of compensation based on time spent in the performance of the duties without regard to the value or volume of any referrals by the physician to the Healthways operation; and
•
Be in a form approved by the Legal Department.

It is also mandatory that physician time records be appropriately maintained to document the actual services provided by physicians under these agreements.

Colleagues must ensure that any other payment to, or for the benefit of, a Medical Director or other actual or potential referral source for services other than the services provided under an approved Medical Director or Physician Advisory Agreement is approved in advance by the Legal Department.

Fraud, Waste and Abuse

As a supplier of services that supports Medicare and Medicaid benefits, Healthways has zero tolerance for any activity that constitutes fraud, waste or abuse. The detection, correction and prevention of fraud, waste and abuse are critical to maintaining legal compliance, as well as positive relationships with our customers.

The following are definitions of fraud, waste and abuse:

Fraud means an intentional deception or misrepresentation made by a person with the knowledge that the deception could result in some unauthorized benefit to himself or herself or some other person. It includes any act that constitutes fraud under applicable federal or state law. The most common type of fraud involves a false statement, misrepresentation or deliberate omission that is necessary to the determination of payment for Medicare or Medicaid benefits. For example, charging, intentionally, a health plan customer for member visits to a SilverSneakers® participating location when the member did not in fact visit the location could be considered fraud depending on the circumstances.

Waste means to use up health care benefits or spend health care dollars with no real need.
 
9
Healthways Code of Business Conduct August 2013
Abuse means practices that are inconsistent with sound fiscal, business or treatment practices and result in unnecessary cost to the health care system, or in reimbursement for services that are not medically necessary or that fail to meet professionally recognized standards for care.

Healthways is committed to ensuring compliance with all federal and state laws and regulations governing fraud, waste and abuse, and suspected violations should be reported immediately. If you have questions or need additional guidance, please contact the Legal Department.

 
Conflicts of Interest

Colleagues must always act in the best interests of Healthways' stockholders when performing our jobs. A conflict of interest occurs when your private interests interfere, or appear to interfere, in any way, with the interests of Healthways. Conflicts of interest can also arise when you, a friend or a member of your family take action or have interests that may impair your ability to perform your duties at Healthways.

There are laws that specifically apply to conflicts of interest where an officer or director is involved. These situations require special consideration and the Legal Department should be consulted. Although we cannot list every conceivable conflict, set forth below are some common examples that illustrate actual or apparent conflicts of interest that should be avoided.

Improper Personal Benefits from Healthways

Conflicts of interest arise when colleagues, friends or family members receive improper personal benefits as a result of their relationship or ties to Healthways. Colleagues may not accept any benefits from Healthways that have not been duly authorized and approved pursuant to our policies and procedures.

In all dealings with friends or family who are employed by, or have ownership interests in, customers or suppliers of Healthways, colleagues must not let their personal relationships affect, or appear to affect, their ability to act in the best interests of Healthways.

Corporate Opportunities

Colleagues who learn of a business or investment opportunity through the use of corporate property or information or their position at Healthways, these opportunities must be brought to the attention of the CEO or the ERMC. This includes opportunities from a competitor or actual or potential supplier or business associate of Healthways, as well as a principal, officer, director or colleague of any of these parties. Regardless of whether Healthways is interested in the opportunity, colleagues may not participate in the opportunity or invest in it without the prior written consent of the ERMC. Additionally, colleagues may not participate in a joint venture, partnership or other business arrangement with the Company while employed by it.
 
 
10
Healthways Code of Business Conduct August 2013

Financial Interests

Neither colleagues nor their immediate family may have any financial interest in an outside business which competes with or provides products or services to Healthways which could conflict or appear to conflict with their ability to carry out the responsibilities of their duties in the best interests of the Company. An investment of $25,000 or less in a company that provides products or services to or is a competitor of Healthways will not be considered a conflict of interest.  Prior written approval of the ERMC must be obtained prior to investing more than
$25,000 in a company that provides services to or is a competitor of Healthways (excluding investments in mutual funds or exchange-traded securities).

Business Courtesies

Colleagues may not accept business courtesies, including gifts, payments, special consideration or discounts, of more than a nominal value (defined as greater than $50.00), nor may they accept extravagant entertainment from any customers, suppliers or business partners without prior written approval from the ERMC. This rule also applies to matters of value offered or provided to the immediate family of colleagues.

Outside Employment and Associations

No colleague whether full-time, part-time or PRN (as needed), may be employed by or receive compensation from Healthways' competitors or potential competitors, vendors, suppliers, physicians, or other health care entities. Each colleague must provide a list of all anticipated or existing employment or associations with a supplier, vendor, competitor or potential competitor, customer, physician or other health care provider for approval by the Senior Vice President of Human Resources.

Colleagues may hold jobs outside the scope of their employment with Healthways provided that it does not interfere with their responsibilities and obligations to Healthways. Employment, consulting or membership on boards of directors (or similar governing bodies) may not be accepted if their involvement could impair or conflict (or appear to impair or conflict) with their ability to carry out their job duties in the best interests of Healthways.

In addition, colleagues may devote reasonable periods of time to charitable and community activities and industry or professional activities, so long as such activities do not interfere with their responsibilities with Healthways. However, in no event may an officer be employed by or provide consulting services for any person or entity other than Healthways or serve on the board of directors of any public or private company without the prior written consent of the CEO (or the Nominating and Corporate Governance Committee in the case of the CEO).


Working with Governments and Dealings with Foreign Countries

Each country or market outside the United States has unique legal requirements that control the manner in which Healthways operates its business in those jurisdictions. Colleagues who work in a market outside the United States are responsible for learning about and abiding by such laws
 
 
11
Healthways Code of Business Conduct August 2013
and the Healthways Foreign Anti-Corruption Program. Colleagues are required to contact the Legal Department in advance of initiating contacts in new foreign markets so that local counsel may be consulted, if appropriate. Colleagues may not participate in any transaction that could potentially violate any international laws or regulations. The Legal Department should be consulted for guidance on appropriate actions.

Following is a summary of certain laws that may affect Healthways' business. You are encouraged to contact the Legal Department with any questions about these or any other laws affecting Healthways' international business operations and operations with governments.

Political Contributions

Healthways encourages colleagues to participate in the political process and respects their right to participate or not participate as they wish. However, the laws that govern business activity frequently prohibit corporations from making political contributions. Thus, colleague contributions to a candidate for elected office or a political party must not be, or appear to be, made with or reimbursed by Healthways' funds or assets. Similarly, colleagues may not devote work time to any campaign for a candidate or political party, nor permit any campaign or candidate to use any Company facility or property. No employee should make another colleague feel compelled or pressured to work for or on behalf of, or make contributions to, any legislation, candidate, political party or action committee, or to cast his or her vote in a particular manner.

Anti-Bribery

Bribery is prohibited. Many countries, including the United States, have laws prohibiting the bribery of government officials that carry significant individual and corporate penalties, including imprisonment. Examples of bribes include payments to government officials to encourage a decision to award or continue business relations, to influence the outcome of a government audit or inspection, or to influence tax or other legislation. Other payments to government officials also may constitute bribes in some jurisdictions.
 
 
12
Healthways Code of Business Conduct August 2013

 
Type of Government Official
 
Example
 
Official or employee of any national, regional, local or other government entity
 
A customs inspector, police officer or government minister; also, foreign licensing and regulatory authorities are almost always foreign officials
 
Elected official
 
A mayor, legislator or council member
 
Officer or employee of a government-owned or controlled company
 
Health care providers, hospital employees and health insurance employees
 
Private person acting temporarily in an official capacity for or on behalf of any government entity
 
A government consultant acting under government authority
 
Candidate for political or elected government office
 
A candidate for the local legislature
 
Political party or party official
 
The head of the local party
 
Officer, employee or representative of a public international organization
 
An employee of the World Bank, the Inter-American Development Bank or the United Nations

Foreign Corrupt Practices Act

The United States Foreign Corrupt Practices Act ("FCPA") is a criminal law that prohibits direct and indirect payments and other transactions with foreign officials to influence the performance of official duties or to obtain or retain business.

The FCPA prohibits providing anything of value to foreign officials for the purpose of obtaining or retaining business. Additionally, the FCPA requires Healthways to keep accurate and complete records of its transactions, and to design and maintain internal controls over the use of Healthways' funds and assets.

The phrases "anything of value" and "obtain or retain business" are defined very broadly. For example, "anything of value" may include meals, gifts, entertainment, travel and charitable donations to a foreign official. "Obtain or retain business" may include any activity that could benefit Healthways. Colleagues should keep in mind that Healthways can be held responsible for the FCPA violations of its agents, consultants, shareholders and third-party representatives acting on behalf of Healthways.

The penalties for FCPA violations can be severe and can include felony criminal convictions. Healthways can be fined heavily for violations, and the individuals involved can suffer heavy fines and imprisonment.

It is the policy of Healthways to comply with both the letter and the spirit of the FCPA, as well as the anti-corruption laws of other countries. In countries where common customs and practices might indicate acceptance of standards of conduct different from those to which Healthways subscribes, we must continue to follow the Company's more stringent Code and policies. Healthways expects all colleagues and third-party agents who are involved in or support
 
 
13
Healthways Code of Business Conduct August 2013
international business activities, including those who are employed by or support Healthways' international operations, to read, understand and comply with the Healthways' Foreign Anti- Corruption Program.

If you have questions or would like more information about the FCPA or Healthways' Foreign Anti-Corruption Program, please contact the Legal Department.

Anti-Boycott Laws

Anti-boycott laws restrict or prohibit U.S. companies and non-U.S. business concerns controlled by U.S. companies from participating in certain aspects of one country's boycott of another country, company or individual. Certain activities that advance or involve participation in boycott-type activities may be restricted or prohibited by law, and may be accompanied by heavy civil penalties and jail sentences.  Some examples include:

•
Furnishing information about activities in or with boycotted countries;

•
Refusing to do business, or agreeing to refuse to do business, with or in a boycotted country, with any business concern organized under the laws of a boycotted country, with any foreign national or resident of a boycotted country or with any person who has dealt with a boycotted person or country when such refusal is pursuant to an unsanctioned foreign boycott.

It is imperative that colleagues understand and follow these laws when pursuing international business opportunities. We must comply at all times with both the literal requirements and the spirit of these laws.

Colleagues may not take any action responsive to any request or requirement of compliance with a foreign boycott that is not sanctioned by the U.S. government. Further, it is Healthways' policy that all requests for compliance of such a boycott be reported to the Legal Department for further reporting to the U.S. Department of Treasury. Colleagues must also report any matter which involves or might involve, directly or indirectly, an illegal boycott.

U.S. Trade Sanction and Export Control Laws

The U.S. government has established a comprehensive system of trade sanctions and export control laws that regulate the worldwide transfer of U.S.-origin goods, technology and services to non-U.S. persons. In essence, these laws restrict U.S. companies and persons from being involved in international trade with prohibited countries and parties. U.S. trade sanctions also strictly prohibit or limit commercial trade and most other dealings (even non-commercial) with specific sanctioned countries, primarily those that support terrorism.

In certain limited circumstances, a company may provide goods or services to a sanctioned country if it obtains a proper license. Most consumer services do not require a license to export to any countries other than specifically sanctioned destinations. However, new business activities must undergo legal review for compliance with U.S. government licensing requirements. For more information about license exports and/or sanctioned countries, you should contact the Legal Department.
 
14
Healthways Code of Business Conduct August 2013

Because U.S. trade controls protect national security and other vital U.S. interests, penalties for even unintentional violations may be severe, and include millions of dollars in fines and imprisonment and seizure of goods and assets. Other consequences may include harm to the Company's business reputation, and exposure to government audits. In addition, violations may lead to disciplinary action by Healthways, up to and including termination of employment. Before proceeding with any transaction involving a sanctioned country or prohibited party, contact the Legal Department for guidance.
 
 
15
Healthways Code of Business Conduct August 2013

Acknowledgement


All colleagues must electronically sign (via iLearn) an acknowledgement form confirming that they have read the Code of Business Conduct and agree to abide by its provisions, and are required to make similar acknowledgements on an annual basis. Failure to read the Code or sign the acknowledgement form does not excuse a colleague from compliance with the Code.
 
 
16
Healthways Code of Business Conduct August 2013

EX-21 4 ex21.htm EX-21, SUBSIDIARY LIST
Exhibit 21


SUBSIDIARY LIST
AS OF MARCH 14, 2014


 
 
 
NAME OF SUBSIDIARY
 
STATE OR
JURISDICTION OF ORGANIZATION
 
 
 
OWNED BY
 
 
OWNERSHIP PERCENTAGE
 
 
 
 
 
American Healthways Services, LLC
 
DE
Healthways, Inc.
100%
 
 
 
 
 
American Healthways Government Services, Inc.
 
DE
Healthways, Inc.
100%
 
 
 
 
 
Healthways International, Inc.
 
DE
Healthways, Inc.
100%
 
 
 
 
 
CareSteps.com, Inc.
 
DE
Healthways, Inc.
100%
 
 
 
 
 
Axonal Information Solutions, Inc
 
DE
CareSteps.com, Inc.
100%
 
 
 
 
 
Clinical Decision Support, LLC
 
DE
American Healthways Services, LLC
100%
 
 
 
 
 
DIGOP, LLC
 
DE
American Healthways Services, LLC
100%
 
 
 
 
 
StatusOne Health Systems, LLC
 
DE
American Healthways Services, LLC
100%
 
 
 
 
 
Population Health Support, LLC
 
DE
American Healthways Services, LLC
100%
 
 
 
 
 
Healthways Health Support, LLC
 
DE
American Healthways Services, LLC
100%
 
 
 
 
 
MeYou Health, LLC
 
DE
American Healthways Services, LLC
100%
 
 
 
 
 
Health Honors, LLC
 
DE
American Healthways Services, LLC
100%
 
 
 
 
 
Healthways Hawaii, LLC
 
DE
American Healthways Services, LLC
100%
 
 
 
 
 
Navvis Healthcare, LLC
 
MO
American Healthways Services, LLC
100%
 
 
 
 
 
Healthways Ornish, LLC
 
DE
American Healthways Services, LLC
100%
 
 
 
 
 
Healthways Wholehealth Networks, Inc.
 
DE
Healthways Health Support, LLC
100%
 
 
 
 
 
Healthways HealthTrends, LLC
 
DE
Healthways Health Support, LLC
100%
 
 
 
 
 
Healthways QuitNet, LLC
 
DE
Healthways Health Support, LLC
100%
 
 
 
 
 
Healthcare Dimensions PR, Inc.
 
DE
Healthways Health Support, LLC
100%
 
 
 
 
 
WholeHealthMD.com, LLC
 
DE
Healthways Health Support, LLC
100%
 
 
 
 
 
American WholeHealth Networks IPA of New York, Inc.
 
DE
Healthways WholeHealth Networks, Inc.
100%
 
 
 
 
 
Healthways WholeHealth Networks - Northeast, Inc.
 
DE
Healthways WholeHealth Networks, Inc.
100%
 
 
 
 
 
Alignis of New York, Inc.
 
NY
Healthways WholeHealth Networks - Northeast, Inc.
100%
 
 
 
 
 
AlignisOne of New York IPA, Inc.
 
NY
Healthways WholeHealth Networks - Northeast, Inc.
100%
 
 
 
 
 
AlignisOne of New Jersey, Inc.
 
NJ
Healthways WholeHealth Networks - Northeast, Inc.
100%
 
 
 
 
 
Healthways International, S.a.ŕ.l.
 
Luxembourg
Healthways International, Inc.
100%
 
 
 
 
 
Healthways International, LTD
 
United Kingdom
Healthways International, S.a.ŕ.l
100%
 
 
 
 
 
Healthways International, GmbH
 
Germany
Healthways International, S.a.ŕ.l.
100%
 
 
 
 
 
Healthways Australia PTY LTD
 
Australia
Healthways International, S.a.ŕ.l.
100%
 
 
 
 
 
Healthways SAS
 
France
Healthways International, S.a.ŕ.l.
100%
 
 
 
 
 
Healthways Brasil Servicos de Consultoria Ltda.
 
Brazil
Healthways International, S.a.ŕ.l.
100%
 
 
 
 
 
Healthways Wellness Services Private Limited
 
India
Healthways International, S.a.ŕ.l.
100%
 
 
 
 
 
Navvis Consulting, LLC
 
MO
Navvis Healthcare, LLC
100%
 
 
 
 
 
 
 
 
 
 
The Strategy Group, LLC
 
VA
Navvis Healthcare, LLC
100%
 
Ascentia Health Care Solutions, L.L.C.
 
DE
Navvis Healthcare, LLC
100%
 
 
 
 
 
 

EX-23 5 ex23.htm EX-23, CONSENT OF ERNST & YOUNG LLP
Exhibit 23

Consent of Independent Registered Public Accounting Firm


We consent to the incorporation by reference in the following Registration Statements:

1.
Registration Statement (Form S-8 No. 333-167818) pertaining to the Healthways, Inc. 2007 Stock Incentive Plan,

2.
Registration Statement (Form S-8 No. 333-140950) pertaining to the Healthways, Inc. 2007 Stock Incentive Plan,

3.
Registration Statement (Form S-8 No. 333-122881) pertaining to the American Healthways, Inc. 1996 Stock Incentive Plan,

4.
Registration Statement (Form S-8 No. 333-113149) pertaining to the American Healthways, Inc. 1996 Stock Incentive Plan,

5.
Registration Statement (Form S-8 No. 333-103510) pertaining to the American Healthways, Inc. 1996 Stock Incentive Plan,

6.
Registration Statement (Form S-8 No. 333-70948) pertaining to the American Healthways, Inc. 2001 Stock Option Plan for New Employees,

7.
Registration Statement (Form S-8 No. 333-33336) pertaining to the American Healthways, Inc. 1996 Stock Incentive Plan, and

8.
Registration Statement (Form S-8 No. 333-04615) pertaining to the American Healthcorp, Inc. 1996 Stock Incentive Plan;

of our reports dated March 14, 2014, with respect to the consolidated financial statements of Healthways, Inc. and the effectiveness of internal control over financial reporting of Healthways, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2013.
 
/s/ Ernst & Young LLP

Nashville, Tennessee
March 14, 2014

 EX-31.1 6 ex31-1.htm EX-31.1, SECTION 302 CEO CERTIFICATION
Exhibit 31.1
CERTIFICATION

I, Ben R. Leedle, Jr., certify that:

1.            I have reviewed this annual report on Form 10-K of Healthways, Inc.;

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.            The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.            The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:    March 14, 2014

 
/s/ Ben R. Leedle, Jr.
 
 
Ben R. Leedle, Jr.
 
 
Chief Executive Officer
 

EX-31.2 7 ex31-2.htm EX-31.2, SECTION 302 CFO CERTIFICATION
Exhibit 31.2
CERTIFICATION

I, Alfred Lumsdaine, certify that:

1.            I have reviewed this annual report on Form 10-K of Healthways, Inc.;

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.            The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.            The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: March 14, 2014

 
/s/ Alfred Lumsdaine
 
 
Alfred Lumsdaine
 
 
Chief Financial Officer
 

EX-101.INS 8 hway-20131231.xml XBRL INSTANCE DOCUMENT 0000704415 2013-01-01 2013-12-31 0000704415 2014-03-07 0000704415 2013-06-30 0000704415 2012-12-31 0000704415 2013-12-31 0000704415 2012-01-01 2012-12-31 0000704415 2011-01-01 2011-12-31 0000704415 2010-12-31 0000704415 us-gaap:TreasuryStockMember 2010-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-12-31 0000704415 us-gaap:RetainedEarningsMember 2010-12-31 0000704415 us-gaap:CommonStockMember 2010-12-31 0000704415 us-gaap:PreferredStockMember 2010-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0000704415 us-gaap:TreasuryStockMember 2011-01-01 2011-12-31 0000704415 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000704415 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0000704415 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0000704415 us-gaap:TreasuryStockMember 2013-01-01 2013-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0000704415 us-gaap:PreferredStockMember 2011-01-01 2011-12-31 0000704415 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0000704415 us-gaap:PreferredStockMember 2013-01-01 2013-12-31 0000704415 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0000704415 us-gaap:PreferredStockMember 2012-01-01 2012-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-01-01 2012-12-31 0000704415 us-gaap:TreasuryStockMember 2012-01-01 2012-12-31 0000704415 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000704415 us-gaap:PreferredStockMember 2013-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000704415 us-gaap:TreasuryStockMember 2012-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0000704415 us-gaap:RetainedEarningsMember 2012-12-31 0000704415 us-gaap:PreferredStockMember 2012-12-31 0000704415 us-gaap:CommonStockMember 2013-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000704415 us-gaap:TreasuryStockMember 2013-12-31 0000704415 us-gaap:CommonStockMember 2012-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000704415 us-gaap:RetainedEarningsMember 2013-12-31 0000704415 us-gaap:TreasuryStockMember 2011-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-12-31 0000704415 us-gaap:CommonStockMember 2011-12-31 0000704415 2011-12-31 0000704415 us-gaap:PreferredStockMember 2011-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0000704415 us-gaap:RetainedEarningsMember 2011-12-31 0000704415 us-gaap:MinimumMember us-gaap:LeaseholdImprovementsMember 2013-01-01 2013-12-31 0000704415 us-gaap:MaximumMember us-gaap:LeaseholdImprovementsMember 2013-01-01 2013-12-31 0000704415 us-gaap:FurnitureAndFixturesMember 2013-01-01 2013-12-31 0000704415 us-gaap:MaximumMember hway:ComputerSoftwareAndHardwareMember 2013-01-01 2013-12-31 0000704415 hway:ComputerSoftwareAndHardwareMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000704415 us-gaap:MaximumMember us-gaap:FurnitureAndFixturesMember 2013-01-01 2013-12-31 0000704415 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2013-12-31 0000704415 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2012-12-31 0000704415 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2012-01-01 2012-12-31 0000704415 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2013-01-01 2013-12-31 0000704415 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2011-01-01 2011-12-31 0000704415 us-gaap:MaximumMember 2013-01-01 2013-12-31 0000704415 us-gaap:MinimumMember 2013-01-01 2013-12-31 0000704415 hway:AscentiaHealthCareSolutionsMember 2012-01-01 2012-12-31 0000704415 hway:NavvisCompanyMember 2011-01-01 2011-12-31 0000704415 hway:AscentiaHealthCareSolutionsMember 2012-12-31 0000704415 hway:NavvisCompanyMember 2011-12-31 0000704415 hway:AcquiredTechnologyMember 2013-12-31 0000704415 us-gaap:PatentsMember 2013-12-31 0000704415 us-gaap:DistributionRightsMember 2013-12-31 0000704415 us-gaap:OtherIntangibleAssetsMember 2013-12-31 0000704415 us-gaap:OtherIntangibleAssetsMember 2012-12-31 0000704415 us-gaap:PatentsMember 2012-12-31 0000704415 us-gaap:CustomerContractsMember 2013-12-31 0000704415 us-gaap:LicensingAgreementsMember 2012-12-31 0000704415 us-gaap:LicensingAgreementsMember 2013-12-31 0000704415 hway:AcquiredTechnologyMember 2012-12-31 0000704415 us-gaap:DistributionRightsMember 2012-12-31 0000704415 us-gaap:CustomerContractsMember 2012-12-31 0000704415 us-gaap:ForeignCountryMember 2013-12-31 0000704415 us-gaap:StateAndLocalJurisdictionMember 2013-12-31 0000704415 us-gaap:InternalRevenueServiceIRSMember 2013-12-31 0000704415 us-gaap:ForeignCountryMember 2013-01-01 2013-12-31 0000704415 us-gaap:StateAndLocalJurisdictionMember 2013-01-01 2013-12-31 0000704415 us-gaap:InternalRevenueServiceIRSMember 2013-01-01 2013-12-31 0000704415 us-gaap:ConvertibleDebtMember 2013-07-01 2013-07-16 0000704415 hway:CarefirstConvertibleNoteMember 2013-09-29 2013-10-01 0000704415 hway:CarefirstConvertibleNoteMember 2013-10-01 0000704415 us-gaap:ConvertibleDebtMember 2018-06-30 2018-07-01 0000704415 hway:CarefirstConvertibleNoteMember 2019-09-30 2019-10-01 0000704415 us-gaap:ConvertibleDebtMember 2013-01-01 2013-12-31 0000704415 us-gaap:ConvertibleDebtMember 2013-07-16 0000704415 2013-07-16 0000704415 hway:CarefirstConvertibleNoteMember 2013-12-31 0000704415 us-gaap:ConvertibleDebtMember 2013-12-31 0000704415 us-gaap:RevolvingCreditFacilityMember 2013-01-01 2013-12-31 0000704415 hway:UncommittedIncrementalAccordionFacilityMember 2013-12-31 0000704415 hway:SwinglineSubFacilityMember 2013-12-31 0000704415 us-gaap:RevolvingCreditFacilityMember 2013-12-31 0000704415 us-gaap:LetterOfCreditMember 2013-12-31 0000704415 us-gaap:LondonInterbankOfferedRateLIBORMember 2013-01-01 2013-12-31 0000704415 hway:TermLoanFacilityMember 2013-12-31 0000704415 hway:TermLoanFacilityMember 2013-01-01 2013-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ForwardContractsMember 2013-12-31 0000704415 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2013-01-01 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2013-12-31 0000704415 hway:EffectiveIn2015Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember hway:EffectiveInNovember2013Member 2013-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2012-12-31 0000704415 us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember 2013-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember 2013-12-31 0000704415 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2012-12-31 0000704415 us-gaap:NondesignatedMember us-gaap:InterestRateSwapMember 2013-12-31 0000704415 us-gaap:NondesignatedMember hway:CashConvertibleNotesHedgeMember 2013-12-31 0000704415 us-gaap:NondesignatedMember us-gaap:InterestRateSwapMember 2012-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2012-12-31 0000704415 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2013-12-31 0000704415 us-gaap:NondesignatedMember us-gaap:OtherNoncurrentAssetsMember hway:CashConvertibleNotesHedgeMember us-gaap:SwapMember 2013-12-31 0000704415 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember us-gaap:InterestRateSwapMember 2012-12-31 0000704415 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2013-12-31 0000704415 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2013-12-31 0000704415 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2012-12-31 0000704415 hway:CashConvertibleNotesHedgeMember us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember 2013-12-31 0000704415 hway:CashConvertibleNotesHedgeMember 2013-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000704415 us-gaap:InterestRateSwapMember hway:OtherLongTermLiabilitiesMember us-gaap:NondesignatedMember 2012-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:AccruedLiabilitiesMember 2012-12-31 0000704415 hway:CashConvertibleNotesHedgeMember us-gaap:NondesignatedMember us-gaap:AccruedLiabilitiesMember 2013-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:AccruedLiabilitiesMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember hway:OtherLongTermLiabilitiesMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember hway:OtherLongTermLiabilitiesMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2012-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:AccruedLiabilitiesMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccruedLiabilitiesMember hway:CashConvertibleNotesHedgeMember 2013-12-31 0000704415 hway:CashConvertibleNotesHedgeMember hway:OtherLongTermLiabilitiesMember us-gaap:NondesignatedMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember hway:CashConvertibleNotesHedgeMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember us-gaap:AccruedLiabilitiesMember 2013-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccruedLiabilitiesMember 2012-12-31 0000704415 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember us-gaap:AccruedLiabilitiesMember 2012-12-31 0000704415 us-gaap:InterestRateSwapMember hway:OtherLongTermLiabilitiesMember us-gaap:NondesignatedMember 2013-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccruedLiabilitiesMember 2012-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember hway:OtherLongTermLiabilitiesMember 2012-12-31 0000704415 us-gaap:ForeignExchangeContractMember hway:OtherLongTermLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000704415 hway:OtherLongTermLiabilitiesMember hway:CashConvertibleNotesHedgeMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000704415 us-gaap:NondesignatedMember hway:OtherLongTermLiabilitiesMember us-gaap:ForeignExchangeContractMember 2013-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember hway:OtherLongTermLiabilitiesMember us-gaap:InterestRateSwapMember 2012-12-31 0000704415 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember 2013-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2013-01-01 2013-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2012-01-01 2012-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NettingAndCollateralMember hway:CashConvertibleNotesHedgeMember 2013-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember us-gaap:NettingAndCollateralMember 2012-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember 2013-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2012-12-31 0000704415 hway:CashConvertibleNotesHedgeMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2013-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2012-12-31 0000704415 us-gaap:EstimateOfFairValueFairValueDisclosureMember hway:CashConvertibleNotesHedgeMember us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000704415 us-gaap:FairValueInputsLevel2Member hway:CashConvertibleNotesHedgeMember us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000704415 us-gaap:NettingAndCollateralMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2013-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PortionAtFairValueFairValueDisclosureMember 2013-12-31 0000704415 hway:CashConvertibleNotesHedgeMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PortionAtFairValueFairValueDisclosureMember 2013-12-31 0000704415 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2013-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember us-gaap:PortionAtFairValueFairValueDisclosureMember 2012-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignExchangeContractMember 2012-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2013-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NettingAndCollateralMember 2012-12-31 0000704415 hway:CashConversionDerivativeMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000704415 us-gaap:NettingAndCollateralMember us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2013-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:PortionAtFairValueFairValueDisclosureMember 2012-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember hway:CashConversionDerivativeMember 2013-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember hway:CashConversionDerivativeMember us-gaap:PortionAtFairValueFairValueDisclosureMember 2013-12-31 0000704415 hway:CashConversionDerivativeMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000704415 us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember 2012-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember hway:CashConversionDerivativeMember us-gaap:NettingAndCollateralMember 2013-12-31 0000704415 us-gaap:PortionAtFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember 2013-12-31 0000704415 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2012-12-31 0000704415 hway:CashConvertibleNotesHedgeMember 2012-12-31 0000704415 hway:CashConversionDerivativeMember 2012-12-31 0000704415 hway:CashConvertibleNotesHedgeMember 2013-01-01 2013-12-31 0000704415 hway:CashConversionDerivativeMember 2013-01-01 2013-12-31 0000704415 hway:CashConversionDerivativeMember 2013-12-31 0000704415 hway:CashConvertibleNotesHedgeMember 2013-12-31 0000704415 hway:FifthAmendedCreditFacilityMember 2013-12-31 0000704415 hway:CashConvertibleNotesMember 2013-12-31 0000704415 hway:CarefirstConvertibleNoteMember 2013-12-31 0000704415 hway:RestructuringPlan2012Member 2010-12-31 0000704415 hway:RestructuringPlan2010Member 2010-12-31 0000704415 hway:RestructuringPlan2011Member 2010-12-31 0000704415 hway:RestructuringPlan2010Member 2013-01-01 2013-12-31 0000704415 hway:RestructuringPlan2011Member 2011-01-01 2011-12-31 0000704415 hway:RestructuringPlan2011Member 2013-01-01 2013-12-31 0000704415 hway:RestructuringPlan2012Member 2012-01-01 2012-12-31 0000704415 hway:RestructuringPlan2012Member 2011-01-01 2011-12-31 0000704415 hway:RestructuringPlan2011Member 2012-01-01 2012-12-31 0000704415 hway:RestructuringPlan2010Member 2011-01-01 2011-12-31 0000704415 hway:RestructuringPlan2012Member 2013-01-01 2013-12-31 0000704415 hway:RestructuringPlan2010Member 2012-01-01 2012-12-31 0000704415 hway:RestructuringPlan2012Member 2012-12-31 0000704415 hway:RestructuringPlan2010Member 2013-12-31 0000704415 hway:RestructuringPlan2011Member 2012-12-31 0000704415 hway:RestructuringPlan2010Member 2011-12-31 0000704415 hway:RestructuringPlan2012Member 2011-12-31 0000704415 hway:RestructuringPlan2011Member 2013-12-31 0000704415 hway:RestructuringPlan2010Member 2012-12-31 0000704415 hway:RestructuringPlan2011Member 2011-12-31 0000704415 hway:RestructuringPlan2012Member 2013-12-31 0000704415 hway:OfficeSpaceInChandlerMember 2013-12-31 0000704415 hway:CallCentersMember 2013-12-31 0000704415 hway:CorporateOfficeSpaceMember 2013-12-31 0000704415 hway:OperationsSupportAndTrainingOfficesMember 2013-12-31 0000704415 us-gaap:MinimumMember hway:CorporateOfficeSpaceMember 2013-01-01 2013-12-31 0000704415 hway:CorporateOfficeSpaceMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2013-01-01 2013-12-31 0000704415 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2011-01-01 2011-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2012-01-01 2012-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2012-01-01 2012-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2011-01-01 2011-12-31 0000704415 us-gaap:RestrictedStockMember 2012-12-31 0000704415 us-gaap:RestrictedStockMember 2013-01-01 2013-12-31 0000704415 us-gaap:RestrictedStockMember 2013-12-31 0000704415 us-gaap:CostOfSalesMember 2013-01-01 2013-12-31 0000704415 us-gaap:CostOfSalesMember 2011-01-01 2011-12-31 0000704415 us-gaap:CostOfSalesMember 2012-01-01 2012-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2011-01-01 2011-12-31 0000704415 us-gaap:RestructuringChargesMember 2011-01-01 2011-12-31 0000704415 us-gaap:RestructuringChargesMember 2012-01-01 2012-12-31 0000704415 us-gaap:RestructuringChargesMember 2013-01-01 2013-12-31 0000704415 us-gaap:StockCompensationPlanMember 2012-01-01 2012-12-31 0000704415 us-gaap:StockCompensationPlanMember 2013-01-01 2013-12-31 0000704415 us-gaap:StockCompensationPlanMember 2011-01-01 2011-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2013-01-01 2013-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2011-01-01 2011-12-31 0000704415 hway:HwayWarrantsRelatedToCashConvertibleNotesMember 2011-01-01 2011-12-31 0000704415 us-gaap:StockCompensationPlanMember 2012-01-01 2012-12-31 0000704415 us-gaap:StockCompensationPlanMember 2013-01-01 2013-12-31 0000704415 us-gaap:StockCompensationPlanMember 2011-01-01 2011-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2012-01-01 2012-12-31 0000704415 hway:HwayWarrantsRelatedToCashConvertibleNotesMember 2012-01-01 2012-12-31 0000704415 hway:HwayWarrantsRelatedToCashConvertibleNotesMember 2013-01-01 2013-12-31 0000704415 hway:CarefirstConvertibleNoteMember 2012-01-01 2012-12-31 0000704415 hway:CarefirstConvertibleNoteMember 2011-01-01 2011-12-31 0000704415 hway:CarefirstConvertibleNoteMember 2013-01-01 2013-12-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2011-12-31 0000704415 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-12-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2012-12-31 0000704415 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2011-12-31 0000704415 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-01-01 2012-12-31 0000704415 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-01-01 2013-12-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2012-01-01 2012-12-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2013-01-01 2013-12-31 0000704415 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-12-31 0000704415 us-gaap:AccumulatedTranslationAdjustmentMember 2013-12-31 0000704415 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-01-01 2012-12-31 0000704415 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-01-01 2013-12-31 0000704415 2013-07-01 2013-09-30 0000704415 2012-01-01 2012-03-31 0000704415 2013-01-01 2013-03-31 0000704415 2013-04-01 2013-06-30 0000704415 2012-07-01 2012-09-30 0000704415 2013-10-02 2013-12-31 0000704415 2012-10-01 2012-12-31 0000704415 2012-04-01 2012-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:sqft hway:Segment false --12-31 2013-12-31 No No Yes Accelerated Filer 534700000 Healthways, Inc. 0000704415 35208572 2013 FY 10-K 92000 160000 264000 66000 89484000 108337000 26343000 33125000 32065000 39234000 217766000 187438000 -407000 -929000 781000 -1790000 -1789000 861000 -2570000 -513000 106000 283244000 251357000 3600000 2800000 2500000 0 0 6371000 0 0 0 9246000 0 7116000 9246000 0 0 0 7116000 0 0 0 0 0 6371000 0 0 0 2719000 0 0 0 0 0 5043000 3225000 0 0 0 0 0 5043000 0 2719000 0 3225000 0 7100000 2900000 4100000 3000000 9200000 3400000 4200000 4500000 600000 0 0 6400000 1894000 2284000 1685000 12600000 12700000 13400000 3140000 0 0 334000 469000 0 4926000 3234000 4845000 193000 0 7707000 0 0 892000 183288000 0 0 749011000 748268000 119222000 141809000 0 -73000 178000 73000 27766000 73000 27766000 0 0 -57000 121000 27766000 178000 0 0 100000 3300000 5500000 23700000 432902 14409 66000 1265000 0 34000 0 0 1231000 0 1199000 267902000 290392000 825000 895000 -200000 1759000 2584000 1064000 864000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">b.&#160; Cash and Cash Equivalents - Cash and cash equivalents primarily include cash, tax-exempt debt instruments, commercial paper, and other short-term investments with original maturities of less than three months.</div><div><br /></div></div> 7700000 25.95 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">11.</td><td style="text-align: left; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Commitments and Contingencies</td></tr></table></div><div><br /></div><div style="text-align: left; font-style: italic; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><u>Contract Disputes</u></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We currently are involved in a contractual dispute with Blue Cross Blue Shield of Minnesota regarding fees paid to us as part of a former contractual relationship. &#160;On January 25, 2010, Blue Cross Blue Shield of Minnesota issued notice of arbitration with the American Arbitration Association in Minneapolis in accordance with the terms of the contract alleging violations of certain contract provisions and seeking recoupment of an unspecified amount of payments made to us under the contract. We believe we performed our services in compliance with the terms of our agreement and that the assertions made in the arbitration notice are without merit. &#160;On August 3, 2011, we asserted numerous counterclaims against Blue Cross Blue Shield of Minnesota. The arbitration hearing concluded on October&#160;23, 2013.&#160; During and after the conclusion of the arbitration hearing in October, the parties entered into&#160;settlement negotiations to resolve all claims&#160;in dispute.&#160;The parties have jointly requested that the arbitrator not issue any award&#160;or decision while the parties are engaged in settlement discussions. We cannot predict whether these discussions will result in a settlement.&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We are involved in a contractual dispute with Plastipak Packaging, Inc. ("Plastipak"). On September 10, 2012, Plastipak filed suit in the Circuit Court for Wayne County, Michigan seeking damages relating to an alleged breach of a services agreement with us.&#160; The case is currently in the discovery phase of litigation.&#160; We deny Plastipak's claims and intend to vigorously defend the action.&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; font-style: italic; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><u>Performance Award Lawsuit</u></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">On September 4, 2012, Milton Pfeiffer ("Plaintiff"), claiming to be a stockholder of the Company, filed a putative derivative action against the Company and the Board of Directors (the "Board") in Delaware Chancery Court (the "Court") alleging that the Compensation Committee of the Board and the Board breached their fiduciary duties and violated the Company's 2007 Stock Incentive Plan (the "Plan") by granting Ben R. Leedle, Jr., Chief Executive Officer and President of the Company, discretionary performance awards under the Plan in the form of options to purchase an aggregate of 500,000 shares of the Company's common stock, which consisted of a performance award in November 2011 granting Mr. Leedle the right to purchase 365,000 shares and a performance award in February 2012 granting Mr. Leedle the right to purchase 135,000 shares (the "Performance Awards"). &#160;Plaintiff alleges that the Performance Awards exceeded what is authorized by the Plan and that the Company's 2012 proxy statement, in which the Performance Awards are disclosed, is false and misleading. &#160;Plaintiff also alleges that Mr.&#160;Leedle breached his fiduciary duties and was unjustly enriched by receiving the Performance Awards. &#160;Plaintiff is seeking, among other things, the rescission or disgorgement of all alleged "excess" awards granted to Mr.&#160;Leedle under the Performance Awards, to recover any incidental damages to the Company, and an award of attorneys' fees and expenses. &#160;On November 2, 2012, the Company and the Board filed a Motion to Dismiss because Plaintiff failed to make a demand upon the Board as required by Delaware law.&#160; On November 8, 2013, the Court denied the Company's Motion to Dismiss. On February 21, 2014, the Company filed its answer and intends to vigorously defend the allegations.</div><div><br /></div><div style="text-align: left; font-style: italic; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><u>Outlook</u></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We are also subject to other contractual disputes, claims and legal proceedings that arise from time to time in the ordinary course of our business.&#160; While we are unable to estimate a range of potential losses, we do not believe that any of such legal proceedings pending against us as of the date of this report will have a material adverse effect on our liquidity or financial condition.&#160; As these matters are subject to inherent uncertainties, our view of these matters may change in the future.</div><div><br /></div><div style="text-align: left; font-style: italic; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><u>Contractual Commitments</u></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We entered into a 25-year strategic relationship agreement with Gallup in January 2008 and a 5-year global joint venture agreement with Gallup in October 2012.&#160; We have minimum remaining contractual cash obligations of $42.0 million related to these agreements.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In May 2011, we entered into a ten-year applications and technology services outsourcing agreement with HP Enterprise Services, LLC that contains minimum fee requirements.&#160; Total payments over the remaining term, including an estimate for future contractual cost of living adjustments, must equal or exceed a minimum level of approximately $142.2 million; however, based on initial required service and equipment level assumptions, we estimate that the remaining payments will be approximately $297.6 million.&#160; The agreement allows us to terminate all or a portion of the services after the first two years provided we pay certain termination fees, which could be material to the Company.</div><div><br /></div></div> 0.001 0.001 34000 35000 120000000 120000000 33924464 35107303 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">17.</td><td style="text-align: justify; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Employee Benefits</td></tr></table></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We have a 401(k) Retirement Savings Plan (the "401(k) Plan") available to substantially all of our employees.&#160; Employees can contribute up to a certain percentage of their base compensation as defined in the 401(k) Plan.&#160; The Company matching contributions are subject to vesting requirements.&#160; Company contributions under the 401(k) Plan totaled $3.1 million, $2.9 million, and $3.5 million for the years ended December 31, 2013, 2012, and 2011, respectively.</div><div><br /></div></div> -156049000 -8019000 8884000 0 522000 0 0 -157693000 0 1644000 0 0 0 -8541000 0 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt; font-weight: bold;">15.</font>&#160;&#160;<font style="font-family: Arial; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Arial; font-size: 10pt; font-weight: bold;">Accumulated OCI</font></div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following tables summarize the changes in accumulated OCI, net of tax, for the twelve months ended December 31, 2013 and 2012:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;<font style="font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands)</font></div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net Change in Fair Value of Interest Rate Swaps</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Foreign Currency Translation Adjustments</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accumulated OCI, net of tax, as of January 1, 2013</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,790</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">861</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(929</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Other comprehensive income (loss) before reclassifications, net of tax</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">189</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(755</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(566</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Amounts reclassified from accumulated OCI, net of tax</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,088</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,088</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Net increase (decrease) in other comprehensive income (loss), net of tax</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,277</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(755</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">522</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accumulated OCI, net of tax, as of December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(513</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">106</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(407</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;<font style="font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands)</font></div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net Change in Fair Value of Interest Rate Swaps</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Foreign Currency Translation Adjustments</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 17px;"><td valign="bottom" style="background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accumulated OCI, net of tax, as of January 1, 2012</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(2,570</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">781</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,789</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Other comprehensive income (loss) before reclassifications, net of tax</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,244</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">80</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,164</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Amounts reclassified from accumulated OCI, net of tax</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,024</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,024</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Net increase&#160;in other comprehensive income (loss), net of tax</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">780</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">80</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">860</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accumulated OCI, net of tax, as of December 31, 2012</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,790</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">861</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(929</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="text-align: justify; font-family: Arial; clear: both; font-size: 1pt;">&#160;&#160;&#160;&#160;&#160;</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table provides details about reclassifications out of accumulated OCI for the twelve months ended December 31, 2013:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td colspan="7" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Twelve Months Ended December 31,</div></td><td style="width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Statement of Comprehensive Income</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;<font style="font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands)</font></div></td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td style="width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td style="width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">(Loss) Classification</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Interest rate swaps</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">$</div></td><td style="background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">1,916</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">$</div></td><td style="background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">3,302</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Interest expense</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">(828</div></td><td style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">)</div></td><td style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">(1,278</div></td><td style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Income tax benefit</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 4px double; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">$</div></td><td style="border-bottom: #000000 4px double; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">1,088</div></td><td style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 4px double; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">$</div></td><td style="border-bottom: #000000 4px double; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">2,024</div></td><td style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Net of tax</div></td></tr></table><div style="clear: both;"><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">See Note&#160;7 for further discussion of our interest rate swaps.</div></div> 0.115 0.105 0.17 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">a.&#160; Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned by the Company.&#160; We have eliminated all intercompany profits, transactions and balances.</div><div><br /></div></div> 25228000 11799000 300000 200000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table summarizes our future minimum lease payments under all capital leases and non-cancelable operating leases for each of the next five years and thereafter:</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><br /> &#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Capital</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Operating</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Year ending December 31,</div></td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Leases</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Leases</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2014</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,199</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">13,198</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2015</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">66</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">11,781</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2016</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,764</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2017</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,198</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2018</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,707</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2019 and thereafter</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">33,262</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Total minimum lease payments</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,265</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">89,910</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Less amount representing interest</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(34</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; background-color: #ffffff; width: 13%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Present value of minimum lease payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,231</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Less current portion</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(1,166</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; background-color: #ffffff; width: 13%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">65</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; background-color: #eaf9e8; width: 13%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> 300000 1000000 400000 36248000 36094000 36183000 510724000 533880000 547387000 774000 741000 2109000 1707000 1693000 1754000 9388000 -1311000 -1271000 0.0025 2013-07-16 2013-10-01 20000000 150000000 20000000 150000000 116400000 113600000 116400000 20000000 51.38 19.46 22.41 0.0566 36750000 33600000 36750000 0.015 0.0475 Borrowings under the Fifth Amended Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month rate (or with the approval of affected lenders, nine-month or twelve-month rate) for Eurodollar deposits ("LIBOR") or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company. The LIBOR margin varies between 1.75% and 3.00%, and the Base Rate margin varies between 0.75% and 2.00%, depending on our leverage ratio. On February 5, 2013, we entered into a First Amendment to the Fifth Amended Credit Agreement, which included, among other things, a temporary increase in the LIBOR and Base Rate margins of 0.25%. The increased margins are effective through December 31, 2013 and apply only in the event that our total funded debt to EBITDA ratio is greater than or equal to 3.50 to 1.00. 2018-07-01 2019-10-01 2017-06-08 33320000 36053000 4100000 1000000 63139000 62160000 2169000 -5842000 4803000 3939543 -425000 101000 249000 -5077000 -1334000 -3572000 438000 -1018000 413000 8839000 9667000 4496000 5643000 42137000 39167000 12213000 10703000 1533000 1486000 14159000 10910000 9667000 8839000 38507000 35925000 3933000 6597000 8303000 7914000 3630000 3242000 122000 449000 33320000 36053000 44740000 47317000 15700000 13418000 27214000 23653000 6800000 6600000 3500000 3100000 2900000 36600000 39100000 24900000 26500000 40100000 21400000 49988000 51734000 52791000 16300000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">7.</td><td style="text-align: left; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Derivative Instruments and Hedging Activities</td></tr></table></div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We use derivative instruments to manage risks related to interest rate swap agreements, foreign currencies, and the Cash Convertible Notes. We account for derivatives in accordance with FASB ASC Topic 815 which establishes accounting and reporting standards requiring that derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value shall be recognized currently in earnings unless specific hedge accounting criteria are met. As permitted under our master netting arrangements, the fair value amounts of our interest rate swaps and foreign currency options and/ or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets.</div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: Arial; font-size: 10pt;"><u>Derivative Instruments Designated as Hedging Instruments</u></div><div><br /></div><div style="text-align: justify; font-style: italic; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Cash Flow Hedges</div><div style="text-align: justify; font-style: italic; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Derivative instruments that are designated and qualify as cash flow hedges are recorded at estimated fair value in the consolidated balance sheets, with the effective portion of the gains and losses being reported in accumulated other comprehensive income or loss ("accumulated OCI").&#160; Cash flow hedges for all periods presented consist solely of interest rate swap agreements, which effectively modify our exposure to interest rate risk by converting a portion of our floating rate debt to fixed obligations, thus reducing the impact of interest rate changes on future interest expense. Under these agreements, we receive a variable rate of interest based on LIBOR (as defined in Note 6), and we pay a fixed rate of interest with interest rates ranging from 0.690% to 1.480% plus a spread (see Note 6).&#160; We maintain interest rate swap agreements with current notional amounts of $145.0 million and termination dates ranging from November 2015 to December 2016.&#160; Of this amount, $95.0 million was effective at December 31, 2013, and $50.0 million will become effective in December 2015, as older interest rate swap agreements expire. Gains and losses on these interest rate swap agreements are reclassified to interest expense in the same period during which the hedged transaction affects earnings or the period in which all or a portion of the hedge becomes ineffective.&#160; As of December 31, 2013, we expect to reclassify $0.4 million of net losses on interest rate swap agreements from accumulated OCI to interest expense within the next 12 months due to the scheduled payment of interest associated with our debt.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the twelve months ended&#160;December 31, 2013 and 2012:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr style="height: 21px;"><td valign="bottom" style="padding-bottom: 2px; width: 63%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td colspan="7" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">For the Twelve Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 63%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">Derivatives in Cash Flow Hedging Relationships</div></td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 63%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">(Gain) loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(332</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,029</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 63%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,916</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,302</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Gains and losses representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.&#160; During the twelve months ended December 31, 2013 and 2012, there were no gains or losses on cash flow hedges recognized in our consolidated statements of comprehensive income (loss) resulting from hedge ineffectiveness.</div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: Arial; font-size: 10pt;"><u>Derivative Instruments Not Designated as Hedging Instruments</u></div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Our Cash Conversion Derivative, Cash Convertible Notes Hedges, and foreign currency options and/or forward contracts do not qualify for hedge accounting treatment under U.S. GAAP and are measured at fair value with gains and losses recognized immediately in the consolidated statements of comprehensive income (loss). These derivative instruments not designated as hedging instruments did not have a material impact on our consolidated statements of comprehensive income (loss) during the twelve months ended&#160;December 31, 2013 and 2012.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The Cash Conversion Derivative is accounted for as a derivative liability and carried at fair value. In order to offset the risk associated with the Cash Conversion Derivative, we entered into Cash Convertible Notes Hedges which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elected to convert the Cash Convertible Notes at a time when our stock price exceeded the conversion price. The Cash Convertible Notes Hedges are accounted for as a derivative asset<font style="font-style: italic; font-family: Arial; font-size: 10pt;">&#160;</font>and carried at fair value.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The gains and losses resulting from changes in the fair values of the Cash Conversion Derivative and the Cash Convertible Notes Hedges are reported in the consolidated statements of comprehensive income (loss) as follows:</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 33%; vertical-align: bottom;"><div>&#160;</div></td><td colspan="7" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Twelve Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div>&#160;</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Statements of Comprehensive Income (Loss) Classification</div></td></tr><tr><td valign="bottom" style="width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Cash Convertible Notes Hedges:</div></td><td colspan="3" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 39%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;&#160;&#160;&#160;</div></td></tr><tr style="height: 13px;"><td valign="bottom" style="background-color: #eaf9e8; width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Net unrealized loss</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(8,984</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Selling, general and administrative expense</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Cash Conversion Derivative:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div>&#160;&#160;&#160;&#160;&#160;</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Net unrealized gain</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,984</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Selling, general and administrative expense</div></td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We also enter into foreign currency options and/or forward contracts in order to minimize our earnings exposure to fluctuations in foreign currency exchange rates.&#160; Our foreign currency exchange contracts require current period mark-to-market accounting, with any change in fair value being recorded each period in the consolidated statements of comprehensive income (loss) in selling, general and administrative expenses. At December 31, 2013, we had forward contracts with notional amounts of $16.3 million to exchange foreign currencies, primarily the Australian dollar and Euro, that were entered into in order to hedge forecasted foreign net income (loss) and intercompany debt. We routinely monitor our foreign currency exposures to maximize the overall effectiveness of our foreign currency hedge positions.&#160; We do not execute transactions or hold derivative financial instruments for trading or other purposes.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The estimated gross fair values of derivative instruments at December 31, 2013 and December 31, 2012, excluding the impact of netting derivative assets and liabilities when a legally enforceable master netting agreement exists, were as follows:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Foreign currency exchange contracts</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Interest rate swap agreements</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Cash Convertible Notes Hedges and Cash Conversion Derivative</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Foreign currency exchange contracts</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Interest rate swap agreements</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">Assets:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 29%; vertical-align: bottom;"><div style="text-align: left; font-style: italic; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Derivatives not designated as hedging instruments:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Other current assets</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">178</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Other assets</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">178</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">Liabilities:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-style: italic; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Derivatives not designated as hedging instruments:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Accrued liabilities</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">67</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">255</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Other long-term liabilities</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-style: italic; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Derivatives designated as hedging instruments:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Accrued liabilities</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,742</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Other long-term liabilities</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,221</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Total liabilities</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">67</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">255</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,963</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> LIBOR (as defined in Note 6) 0 0 0 73000 0 27766000 0 73000 0 27766000 0 178000 178000 0 0 27766000 255000 0 0 0 0 0 505000 2963000 67000 67000 505000 0 27766000 27766000 0 1742000 255000 0 0 0 0 0 0 1221000 0 27766000 8984000 0 0 -8984000 0.01480 2029000 -332000 -3302000 -1916000 0.00690 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">m. Derivative Instruments and Hedging Activities &#8211; We use derivative instruments to manage risks related to interest rate swap agreements, foreign currencies, and the cash convertible senior notes (as discussed in Note 6).&#160;We account for derivatives in accordance with&#160;Financial Accounting Standards Board&#160;Standards Board ("FASB")&#160;&#160;Accounting Standards Codification</font><font style="font-family: Arial; font-size: 10pt;"> ("</font><font style="font-family: Arial; font-size: 10pt;">ASC") Topic 815, which establishes accounting and reporting standards requiring that certain derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value will be recognized currently in earnings unless specific hedge accounting criteria are met.&#160;As permitted under our master netting arrangements, the fair value amounts of our interest rate swaps and foreign currency options and/or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets. See Note 7 for further information on derivative instruments and hedging activities.</font></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify; text-indent: -36pt; font-family: Arial; margin-left: 36pt; font-size: 10pt; font-weight: bold;">13.&#160; &#160; &#160; &#160; Share-Based Compensation</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We have several stockholder-approved stock incentive plans for our employees and directors.&#160; We currently have three types of share-based awards outstanding under these plans: stock options, restricted stock units, and restricted stock.&#160; We believe that such awards align the interests of our employees and directors with those of our stockholders.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We grant options under these plans at market value on the date of grant, except in the case of certain performance awards which may be granted at a price above market value.&#160; The options generally vest over four years based on service conditions and expire ten years from the date of grant.&#160; Restricted stock units and restricted stock awards generally vest over four years.&#160; We recognize share-based compensation expense on a straight-line basis over the vesting period.&#160; Options, restricted stock units, and restricted stock awards generally provide for accelerated vesting upon a change in control or normal or early retirement (as defined in the applicable stock incentive plan).&#160; At December 31, 2013, we had reserved approximately 0.2 million shares for future equity grants under our stock incentive plans.<br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Following are certain amounts recognized in the consolidated statements of operations for share-based compensation arrangements for the years ended December 31, 2013, 2012, and 2011.&#160; We did not capitalize any share-based compensation costs during these periods.</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In millions)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Total share-based compensation</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7.1</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">9.2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Share-based compensation included in cost of services</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.9</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3.0</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.1</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Share-based compensation included in selling, general and administrative expenses</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.5</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Share-based compensation included in restructuring and related charges</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.6</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Total income tax benefit recognized</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.8</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.5</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3.6</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">As of December 31, 2013, there was $16.5 million of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the stock incentive plans.&#160; That cost is expected to be recognized over a weighted average period of 2.0 years.<br /></div><div style="text-align: left; font-style: italic; font-family: Arial; font-size: 10pt;">Stock Options</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We use a lattice-based binomial option valuation model ("lattice binomial model") to estimate the fair values of stock options.&#160; We base expected volatility on historical volatility due to the low volume of traded options on our stock.&#160; The expected term of options granted is derived from the output of the lattice binomial model and represents the period of time that options granted are expected to be outstanding.&#160; We used historical data to estimate expected option exercise and post-vesting employment termination behavior within the lattice binomial model.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table sets forth the weighted average grant-date fair values of options and the weighted average assumptions we used to develop the fair value estimates under each of the option valuation models for the years ended December 31, 2013, 2012 and 2011:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Weighted average grant-date fair value of options per share</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7.29</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.01</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5.94</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Assumptions:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Expected volatility</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">53.8</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">54.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">53.0</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Expected dividends</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Expected term (in years)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5.1</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5.1</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5.6</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Risk-free rate</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1.9</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.0</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;">A summary of option activity as of December 31, 2013 and the changes during the year then ended is presented below:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 35%; vertical-align: bottom;"><div style="text-align: center; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Options</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Shares (thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Weighted</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Average Exercise</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Price Per Share</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Weighted Average</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Remaining Contractual Term</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Aggregate&#160; Intrinsic Value (thousands)</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Outstanding at January 1, 2013</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4,689</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15.65</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Granted</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,085</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">13.26</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #ffffff; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #ffffff; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Exercised</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,077</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">14.25</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Forfeited</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(163</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">11.34</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #ffffff; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #ffffff; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Expired</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(209</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">25.50</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Outstanding at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4,325</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15.09</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">13,182</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Exercisable at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,032</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">19.21</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.3</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,992</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The total intrinsic value, which represents the difference between the market price of the underlying common stock and the option's exercise price, of options exercised during the years ended December 31, 2013, 2012 and 2011 was $3.2 million, $1.3 million, and $1.9 million, respectively.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Cash received from option exercises under all share-based payment arrangements during 2013 was $12.7 million.&#160; The actual tax benefit realized during 2013 for the tax deductions from option exercises totaled $1.3 million.&#160; We issue new shares of common stock upon exercise of stock options.</div><div><br /></div><div style="text-align: left; font-style: italic; font-family: Arial; font-size: 10pt;">Restricted Stock and Restricted Stock Units</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The fair value of restricted stock and restricted stock units ("nonvested shares") is determined based on the closing bid price of the Company's common stock on the grant date.&#160;The weighted average grant-date fair value of nonvested shares granted during the years ended December 31, 2013, 2012 and 2011, was $13.12, $8.29, and $13.26, respectively.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table sets forth a summary of our nonvested shares as of December 31, 2013 as well as activity during the year then ended.&#160; The total grant-date fair value of shares vested during the years ended December 31, 2013, 2012 and 2011 was $3.1 million, $3.6 million, and $7.4 million, respectively.</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 45%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Nonvested Shares</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Shares (thousands)</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Weighted Average Grant Date Fair Value Per Share</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Nonvested at January 1, 2013</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">9.93</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Granted</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">186</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">13.12</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Vested</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(293</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10.43</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Forfeited</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(65</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Nonvested at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">841</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10.44</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">14.</td><td style="text-align: justify; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Earnings (Loss) Per Share</td></tr></table></div><div style="text-align: justify;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt; margin-right: 1.9pt;">The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the years ended December 31, 2013, 2012, and 2011:</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt; margin-right: 1.9pt;"><br /> &#160;</div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: center; text-indent: -18pt; font-family: Arial; margin-left: 18pt; font-size: 10pt; font-weight: bold;">(In thousands except per share data)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Numerator:</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; text-indent: -18pt; font-family: Arial; margin-left: 18pt; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net income (loss)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(8,541</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">8,024</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(157,693</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div>&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Denominator:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Shares used for basic earnings (loss) per share</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">34,489</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">33,597</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">33,677</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Effect of dilutive stock options and restricted stock units outstanding:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Non-qualified stock options <sup>(1)</sup></div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">37</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;"><!--Anchor-->Restricted stock units <sup>(1)</sup></div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">202</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Shares used for diluted earnings (loss) per share<sup> (1)</sup></div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">34,489</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">33,836</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">33,677</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Earnings per share:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Basic</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(0.25</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">0.24</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(4.68</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Diluted <sup>(1)</sup></div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(0.25</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">0.24</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(4.68</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Dilutive securities outstanding not included in the computation of earnings per share because their effect is anti-dilutive:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Non-qualified stock options</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">3,234</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">4,926</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">4,845</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Restricted stock units</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">334</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">193</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">469</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Warrants related to Cash Convertible Notes</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">7,707</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">CareFirst Convertible Note</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">892</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr></table><div style="clear: both;">&#160;</div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(1)</sup> The assumed exercise of stock-based compensation awards for the years ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive.</div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">k.&#160; Earnings (Loss) Per Share &#8211; We calculate</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">basic earnings (loss) per share using weighted average common shares outstanding during the period.&#160; We calculate diluted earnings (loss) per share using</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">weighted average common shares outstanding during the period plus the effect of all dilutive potential common shares outstanding during the period unless the impact would be anti-dilutive.&#160; See Note 14 for a reconciliation of basic and diluted earnings (loss) per share.</font></div><div><br /></div></div> 0.24 -0.25 -4.68 -4.68 0.24 -0.25 -914000 117000 220000 20157000 24909000 1267000 16500000 P2Y 492000 718000 433000 718000 433000 492000 -36750000 36750000 <div style="font-family: Arial; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 10%; vertical-align: top;"><div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">8.</div></td><td style="width: 90%; vertical-align: top;"><div style="text-align: justify; font-family: Arial; font-size: 10pt; font-weight: bold;">Fair Value Measurements</div></td></tr></table><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We account for certain assets and liabilities at fair value.&#160; Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.</div><div style="text-align: left; font-style: italic; margin-top: 9pt; font-family: Arial; font-size: 10pt;">Fair Value Hierarchy</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; font-family: Arial; margin-left: 36pt; font-size: 10pt;">Level 1:&#160; Quoted prices in active markets for identical assets or liabilities;</div><div style="text-align: left; margin-top: 9pt; font-family: Arial; margin-left: 36pt; font-size: 10pt;">Level 2:&#160; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-based valuation techniques in which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and</div><div style="text-align: left; margin-top: 9pt; font-family: Arial; margin-left: 36pt; font-size: 10pt;">Level 3:&#160; Unobservable inputs that are supported by little or no market activity and typically reflect management's estimates of assumptions that market participants would use in pricing the asset or liability.</div><div><br /></div><div style="text-align: left; font-style: italic; font-family: Arial; font-size: 10pt;">Assets and Liabilities Measured at Fair Value on a Recurring Basis</div><div style="text-align: left; font-style: italic; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following tables present our assets and liabilities measured at fair value on a recurring basis at December 31, 2013 and December 31, 2012:</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><br />&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gross Fair</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Netting<sup> (1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net Fair</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Assets:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Foreign currency exchange contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">178</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">178</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(57</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">121</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Cash Convertible Notes Hedges</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Liabilities:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Foreign currency exchange contracts</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">67</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">67</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(57</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Interest rate swap agreements</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Cash Conversion Derivative</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br />&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -10pt; font-family: Arial; margin-left: 10pt; font-size: 10pt; font-weight: bold;">(In thousands)</div><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gross Fair</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Netting<sup> (1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net Fair</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Assets:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Foreign currency exchange contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Liabilities:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Foreign currency exchange contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">255</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">255</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">182</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Interest rate swap agreements</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">2,963</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">2,963</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">2,963</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: justify; font-family: Arial; font-size: 10pt;"><sup>(1)</sup> This column reflects the impact of netting derivative assets and liabilities by counterparty when a legally enforceable master netting agreement exists.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The fair values of forward foreign currency exchange contracts are valued using broker quotations of similar assets or liabilities in active markets.&#160; The fair values of interest rate swap agreements are primarily determined based on the present value of future cash flows using internal models and third-party pricing services with observable inputs, including interest rates, yield curves and applicable credit spreads. The fair values of the Cash Convertible Notes Hedges and the Cash Conversion Derivative are measured using Level 3 inputs. These instruments are not actively traded and are valued using an option pricing model that uses observable and unobservable market data for inputs, such as expected time to maturity of the derivative instruments, the risk-free interest rate, the expected volatility of our common stock and other factors. The Cash Convertible Notes Hedges and the Cash Conversion Derivative were designed such that changes in their fair values would offset, with minimal impact to the consolidated statements of comprehensive income (loss). Therefore, the sensitivity of changes in the unobservable inputs to the option pricing model for such instruments is mitigated.</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Balance at </div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Purchases of Level 3 Instruments</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Issuances of Level 3 Instruments</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gains/(Losses) included in Earnings</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Balance at </div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Cash Convertible Notes Hedges</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">36,750</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(8,984</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Cash Conversion Derivative</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(36,750</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">8,984</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The gains and losses included in earnings noted above represent the change in the fair value of these financial instruments and are recorded each period in the consolidated statements of comprehensive income (loss) in selling, general and administrative expenses.</div><div><br /></div><div style="text-align: left; font-style: italic; font-family: Arial; font-size: 10pt;">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We measure certain assets at fair value on a nonrecurring basis in the fourth quarter of our fiscal year, including the following:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 15%; vertical-align: top;"><div style="text-align: right; font-family: Symbol; font-size: 10pt;">&#183;&#160;&#160;&#160;&#160; </div></td><td style="width: 85%; vertical-align: top;"><div style="text-align: justify; font-family: Arial; font-size: 10pt;">reporting units measured at fair value in the first step of a goodwill impairment test; and</div><div style="text-align: justify; font-family: Arial; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 15%; vertical-align: top;"><div style="text-align: right; font-family: Symbol; font-size: 10pt;">&#183;&#160;&#160;&#160;&#160; </div></td><td style="width: 85%; vertical-align: top;"><div style="text-align: justify; font-family: Arial; font-size: 10pt;">indefinite-lived intangible assets measured at fair value for impairment assessment.</div></td></tr></table><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;">Each of the assets above is classified as Level 3 within the fair value hierarchy.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">During the fourth quarter of 2013, we reviewed goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment).&#160;&#160;The fair value of a reporting unit is the price that would be received to sell the unit as a whole in an orderly transaction between market participants at the measurement date.&#160;&#160;We may elect to perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.&#160;&#160;However, we elected not to perform a qualitative assessment, instead proceeding to the quantitative review described below.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We estimated the fair value of each reporting unit using a combination of a discounted cash flow model and a market-based approach, and we reconciled the aggregate fair value of our reporting units to our consolidated market capitalization.&#160;&#160;Estimating fair value requires significant judgments, including management's estimate of future cash flows, which is dependent on internal forecasts, estimation of the long-term growth rate for our business, the useful life over which cash flows will occur, and determination of our weighted average cost of capital, as well as relevant comparable company earnings multiples for the market-based approach.&#160;&#160;Changes in these estimates and assumptions could materially affect the estimate of fair value and goodwill impairment for each reporting unit.&#160;&#160;We determined that the carrying value of goodwill was not impaired based upon the impairment review.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Also during the fourth quarter of 2013, we estimated the fair value of our indefinite-lived intangible asset, which consisted of a trade name, using a present value technique, which required management's estimate of future revenues attributable to this trade name, estimation of the long-term growth rate and royalty rate for this revenue, and determination of our weighted average cost of capital.&#160;&#160;Changes in these estimates and assumptions could materially affect the estimate of fair value for the trade name.&#160;&#160;We determined that the carrying value of the trade name was not impaired based upon the impairment review.</div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: Arial; font-size: 10pt;">Fair Value of Other Financial Instruments</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In addition to foreign currency exchange contracts, interest rate swap agreements, the Cash Convertible Notes Hedges, and the Cash Conversion Derivative, the estimated fair values of which are disclosed above, the estimated fair value of each class of financial instruments at December 31, 2013 was as follows:</div><div><br /></div><div style="text-align: left; text-indent: 0pt; font-family: Arial; margin-left: 36pt; font-size: 10pt;">Cash and cash equivalents &#8211; The carrying amount of $2.6 million approximates fair value because of the short maturity of those instruments (less than three months).</div><div><br /></div><div style="text-align: left; text-indent: 0pt; font-family: Arial; margin-left: 36pt; font-size: 10pt;">Long-term debt &#8211; The estimated fair value of outstanding borrowings under the Fifth Amended Credit Agreement, which includes a revolving credit facility and a term loan facility, the Cash Convertible Notes and the CareFirst Convertible Note (see Note 6) are determined based on the fair value hierarchy as discussed above.&#160; The revolving credit facility and the term loan facility are not actively traded and therefore are classified as Level 2 valuations based on the market for similar instruments.&#160; The estimated fair value is based on the average of the prices set by the issuing bank given current market conditions and is not necessarily indicative of the amount we could realize in a current market exchange. The estimated fair value and carrying amount of outstanding borrowings under the Fifth Amended Credit Agreement at December 31, 2013 are $113.1 million and $113.6 million, respectively.</div><div style="text-align: left; text-indent: 0pt; font-family: Arial; margin-left: 36pt; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 0pt; font-family: Arial; margin-left: 36pt; font-size: 10pt;">The Cash Convertible Notes are actively traded and therefore are classified as Level 1 valuations. The estimated fair value at December 31, 2013 was $148.1 million, which is based on the last quoted price of the Cash Convertible Notes on December 31, 2013, and the par value was $150.0 million. The carrying amount of the Cash Convertible Notes at December 31, 2013 was $116.4 million, which is net of the debt discount discussed in Note 6.</div><div><br /></div><div style="text-align: left; text-indent: 0pt; font-family: Arial; margin-left: 36pt; font-size: 10pt;">The CareFirst Convertible Note was issued at its fair value of $20.0 million on October 1, 2013. It is not actively traded and is not based upon either an observable market, other than the market for our common stock, or on an observable index and is therefore classified as a Level 3 valuation.&#160;At December 31, 2013, the carrying amount of the CareFirst Convertible Note of $20.0 million approximates fair value because there were no factors present that would result in a change in the fair value since its issuance on October 1, 2013.</div><div><br /></div></div> -8984000 8984000 0 0 -27766000 27766000 P25Y P2Y 29431000 24547000 8709000 5077000 5097000 24337000 155735000 59574000 29000000 30000000 29287000 157338000 8709000 59305000 3307000 5003000 3867000 94556000 7190000 2708000 3986000 25589000 51512000 12723000 15081000 3586000 44571000 107225000 24299000 6669000 8062000 9466000 3842000 1519000 11614000 1210000 4988000 26292000 2040000 1511000 61179000 26014000 50113000 14734000 20507000 11170000 3343000 6783000 22881000 23552000 105000 182400000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">f.&#160; Intangible Assets - Intangible assets subject to amortization include customer contracts, acquired technology, patents, distributor and provider networks, a perpetual license, and other intangible assets which we amortize on a straight-line basis over estimated useful lives ranging from two to 25 years.&#160; We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Intangible assets not subject to amortization at December 31, 2013 and 2012 consist of a trade name of $29.0 million.&#160; We review intangible assets not subject to amortization on an annual basis or more frequently whenever events or circumstances indicate that the assets might be impaired.&#160; See Note 4 for further information on intangible assets.</div><div><br /></div></div> 338695000 338800000 496265000 335392000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">3.</td><td style="text-align: left; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Goodwill</td></tr></table></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The change in carrying amount of goodwill during the years ended December 31, 2011, 2012, and 2013 is shown below:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 85%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Balance, December 31, 2010</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">496,265</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Navvis purchase</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">21,527</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Impairment loss</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(182,400</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Balance, December 31, 2011</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">335,392</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Ascentia purchase</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,303</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Balance, December 31, 2012</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">338,695</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Other adjustments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">105</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Balance, December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">338,800</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><!--Anchor--><!--Anchor--><!--Anchor-->In August 2011, we acquired Navvis &amp; Company ("Navvis"), a firm that provides strategic counsel and change management services to healthcare systems, for $23.7 million in cash.&#160; In addition, we issued 432,902 unregistered shares of our common stock which were valued in the aggregate at $3.3 million.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We performed a quantitative goodwill impairment review during the fourth quarter of 2011, and as a result of changes in our long-term projections related to the wind-down of our contract with CIGNA, we recorded a $182.4 million goodwill impairment loss.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><!--Anchor--><!--Anchor-->In April 2012, we acquired Ascentia Health Care Solutions ("Ascentia"), a firm that supports and promotes population health management, patient centered programs, payer strategies and physician practice enhancement programs, for $5.5 million in cash.&#160; In addition, we issued 14,409 unregistered shares of our common stock which were valued in the aggregate at $0.1 million.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">As of January 1, 2013, the gross amount of goodwill totaled $521.1 million, and we had&#160;accumulated impairment losses of $182.4 million.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div></div> 182400000 521100000 3303000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">g.&#160; Goodwill - We recognize goodwill for the excess of the purchase price over the fair value of tangible and identifiable intangible net assets of businesses that we acquire.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable.&#160; We allocate goodwill to reporting units based on the reporting unit expected to benefit from the combination.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We estimate the fair value of each reporting unit using a combination of a discounted cash flow model and a market-based approach, and we reconcile the aggregate fair value of our reporting units to our consolidated market capitalization.</div><div><br /></div></div> 15083000 28217000 26391000 30619000 18326000 32061000 19916000 16300000 900000 0.05 -0.12 -0.08 0.15 -0.03 0.15 0.02 -0.15 -14177000 14746000 -142307000 -4116000 1587000 -7591000 -6044000 8542000 1108000 -1650000 8732000 0.15 -0.15 -0.12 -0.08 0.15 0.02 -0.03 0.05 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify;"><font style="font-family: Arial; font-size: 10pt; font-weight: bold;">5.</font><font style="font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Arial; font-size: 10pt; font-weight: bold;">Income Taxes</font></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Income tax expense is comprised of the following:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="10" valign="bottom" style="vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Current taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Federal</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(1,311</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(1,271</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">9,388</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">State</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">741</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">774</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">2,109</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Foreign</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,693</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,754</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,707</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Deferred taxes</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Federal</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(5,842</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">4,803</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">2,169</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">State</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(1,018</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">413</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">438</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Foreign</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">101</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">249</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(425</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(5,636</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">6,722</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">15,386</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.&#160; The following table sets forth the significant components of our net deferred tax liability as of December 31, 2013 and 2012:</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1.51%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1.51%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Deferred tax asset:</div></td><td valign="bottom" style="width: 1.51%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Accruals and reserves</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">14,159</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,910</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Deferred compensation</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,933</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6,597</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Share-based payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,703</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">12,213</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Net operating loss carryforwards</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,303</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7,914</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Cash conversion derivative</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,553</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Other assets and liabilities</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,486</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,533</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">42,137</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">39,167</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Valuation allowance</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,630</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,242</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">38,507</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">35,925</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Deferred tax liability:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Property and equipment</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(44,740</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(47,317</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Intangible assets</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(13,418</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(15,700</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Cash convertible notes hedges</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,553</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Other assets and liabilities</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(449</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(122</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(62,160</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(63,139</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net deferred tax liability</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(23,653</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(27,214</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net current deferred tax asset</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">9,667</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,839</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net long-term deferred tax liability</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(33,320</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(36,053</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(23,653</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(27,214</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Based on the Company's historical and expected future taxable earnings, we believe it is more likely than not that the Company will realize the benefit of the existing deferred tax assets, net of the valuation allowance, at December 31, 2013.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">For 2013, 2012 and 2011, the tax benefit of share-based compensation, excluding the tax benefit related to the deferred tax asset for share-based payments, was recorded as additional paid-in capital.&#160; We recorded a tax effect of $1.0 million, $0.5 million, and $1.1 million in 2013, 2012, and 2011, respectively, related to our interest rate swap agreements (see Note 7) to stockholders' equity as a component of accumulated other comprehensive income (loss).</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">At December 31, 2013, we had international net operating loss carryforwards totaling approximately $13.9 million with an indefinite carryforward period, approximately $11.0 million of federal loss carryforwards originating from acquired entities, and approximately $17.7 million of state loss carryforwards.&#160; We have provided a valuation allowance on certain deferred tax assets associated with our international net operating loss carryforwards.&#160; The federal loss carryforwards are subject to an annual limitation under Internal Revenue Code Section 382, and expire in 2021 if not utilized.&#160; The state loss carryforwards are expected to be fully utilized during future periods.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Undistributed earnings of the Company's foreign subsidiaries amounted to approximately $10.7 million as of December 31, 2013. Those earnings are considered to be indefinitely reinvested and, accordingly, no U.S. federal or state income taxes have been recorded thereon. Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to both U.S. income taxes (subject to an adjustment for foreign tax credits) and potential&#160;withholding taxes payable to the various foreign countries. Determination of the amount of unrecognized deferred U.S. income tax liability is not practical because of the complexities associated with its hypothetical calculation; however, unrecognized foreign tax credits would be available to reduce a portion of the U.S. tax liability.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The difference between income tax expense computed using the statutory federal income tax rate and the effective rate is as follows:</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"></td><td valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Statutory federal income tax</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(4,962</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,161</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(49,808</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Non-deductible goodwill impairment expense</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">61,785</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">State income taxes, less federal income tax benefit</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(669</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">453</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,520</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Permanent items</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">634</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">389</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">434</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Change in valuation allowance</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">388</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">285</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">972</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Prior year tax adjustments</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">140</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">263</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">150</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Uncertain tax position reversal</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,137</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Other</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(30</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">171</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">333</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Income tax expense (benefit)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(5,636</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6,722</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15,386</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; font-style: italic; font-family: Arial; font-size: 10pt;">Uncertain Tax Positions</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">During 2013, we recorded a $1.1 million reduction to an unrecognized tax benefit due to the&#160;expiration of the applicable statutes of limitations for the 2009 tax year. As of December 31, 2013 and 2012, we had $0.3 and $1.3 million, respectively, of unrecognized tax benefits that, if recognized, would affect our effective tax rate. Our policy is to include interest and penalties related to unrecognized tax benefits in income tax expense.&#160; During 2012, and 2011, we included an immaterial amount of net interest related to uncertain tax positions as a component of income tax expense.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The aggregate changes in the balance of unrecognized tax benefits, exclusive of interest, were as follows:</div><div><br /></div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Unrecognized tax benefits at December 31, 2011</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,392</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Decreases based upon tax positions related to prior years</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(44</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Unrecognized tax benefits at December 31, 2012</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,348</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Decreases based upon a lapse of the applicable statute of limitations</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,060</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Unrecognized tax benefits at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">288</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We file income tax returns in the U.S. Federal jurisdiction and in various state and foreign jurisdictions.&#160; Tax years remaining subject to examination in these jurisdictions include 2010 to present.</div></div> -5636000 15386000 6722000 972000 388000 285000 634000 389000 434000 2282000 650000 7874000 263000 140000 150000 333000 171000 -30000 61785000 0 0 1402000 5920000 -4962000 5161000 -49808000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">i. Income Taxes - We file a consolidated federal income tax return that includes all of our domestic wholly owned subsidiaries.&#160; Generally accepted accounting principles in the United States ("U.S. GAAP") generally require that we record deferred income taxes for the tax effect of differences between the</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">book and tax bases of our</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">assets and liabilities.&#160; We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.&#160; The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.</font></div><div><br /></div></div> 453000 -669000 1520000 23439000 7452000 -19099000 -995000 9224000 1466000 -2984000 598000 -6960000 -1196000 13637000 2676000 -12980000 -5780000 -8932000 0 37000 0 202000 0 0 29000000 29000000 29000000 90228000 79162000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">4.</td><td style="text-align: left; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Intangible Assets</td></tr></table></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Intangible assets subject to amortization at December 31, 2013 consisted of the following:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 58%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;"><!--Anchor--><!--Anchor-->(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gross Carrying</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Amount</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Accumulated</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Customer contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">59,574</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">51,512</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,062</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Acquired technology</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">29,431</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">25,589</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,842</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Patents</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">24,547</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15,081</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">9,466</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Distributor and provider networks</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,709</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7,190</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,519</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Perpetual license to survey-based data</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">30,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,986</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">26,014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Other</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,077</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,867</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,210</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">157,338</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">107,225</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">50,113</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Intangible assets subject to amortization at December 31, 2012 consisted of the following:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr style="height: 31px;"><td valign="bottom" style="width: 58%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gross Carrying</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Amount</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Accumulated</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;"><!--Anchor-->Customer contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">59,305</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">44,571</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">14,734</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Acquired technology</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">29,287</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">24,299</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4,988</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Patents</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">24,337</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">12,723</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">11,614</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Distributor and provider networks</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,709</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6,669</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,040</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Perpetual license to survey-based data</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">29,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,708</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">26,292</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Other</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,097</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,586</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,511</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">155,735</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">94,556</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">61,179</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Intangible assets subject to amortization are being amortized over estimated useful lives ranging from two to 25 years.&#160; Total amortization expense for the years ended December 31, 2013, 2012, and 2011, was $12.7 million, $12.6 million, and $13.4 million, respectively.&#160; The following table summarizes the estimated amortization expense for each of the next five years and thereafter:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 70%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Year ending December 31,</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2014</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">11,170</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2015</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6,783</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2016</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,003</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2017</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,343</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2018</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,307</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2019 and thereafter</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">20,507</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">50,113</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Intangible assets not subject to amortization at December 31, 2013 and 2012 consist of a trade name of $29.0 million.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div></div> 16079000 14149000 13193000 -3302000 -1916000 400000 12001000 10080000 11106000 2014-02-14 2020-10-31 2020-08-31 37463000 40679000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">12.</td><td style="text-align: left; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Leases</td></tr></table></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">We maintain operating lease agreements principally for our corporate office space, our well-being improvement call centers, and our operations support and training offices.&#160; We lease approximately 264,000 square feet of office space in Franklin, Tennessee, which contains our corporate headquarters</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">and one of our well-being improvement call centers.&#160; This lease commenced in March 2008 and expires in February 2023.&#160; We also lease approximately 92,000 square feet of office space in Chandler, Arizona which contains additional corporate colleagues and one of our well-being improvement call centers.&#160; In addition, we lease office space for our seven other well-being improvement call center locations for an aggregate of approximately 160,000 square feet of space with lease terms expiring on various dates from 2014 to 2020.&#160; Our operations support and training offices contain approximately 66,000 square feet in aggregate and have lease terms expiring from 2014 to 2020.</font></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Our corporate office lease agreement contains escalation clauses and provides for two renewal options of five years each at then prevailing market rates.&#160; The base rent for the initial 15-year term ranges from $4.2 million to $6.3 million per year over the term of the lease.&#160; The landlord provided a tenant improvement allowance equal to approximately $10.3 million.&#160; We record leasehold improvement incentives as deferred rent and amortize them as reductions to rent expense over the lease term.</div><div style="text-align: left; text-indent: 36pt;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Most of our operating leases include escalation clauses, some of which are fixed amounts, and some of which reflect changes in price indices.&#160; We recognize rent expense on a straight-line basis over the lease term.&#160; Certain operating leases contain renewal options to extend the lease for additional periods.&#160; For the years ended December 31, 2013, 2012, and 2011, rent expense under lease agreements was approximately $12.9 million, $12.9 million, and $12.7 million, respectively.&#160; Our capital lease obligations, which primarily include computer equipment leases, are included in long-term debt and the current portion of long-term debt.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table summarizes our future minimum lease payments under all capital leases and non-cancelable operating leases for each of the next five years and thereafter:</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><br /> &#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Capital</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Operating</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Year ending December 31,</div></td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Leases</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Leases</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2014</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,199</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">13,198</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2015</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">66</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">11,781</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2016</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,764</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2017</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,198</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2018</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,707</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">2019 and thereafter</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">33,262</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Total minimum lease payments</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,265</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">89,910</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Less amount representing interest</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(34</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; background-color: #ffffff; width: 13%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Present value of minimum lease payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,231</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Less current portion</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(1,166</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; background-color: #ffffff; width: 13%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">65</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 4px; background-color: #eaf9e8; width: 13%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> 124416000 128258000 10000 505000 0 0 2963000 0 255000 0 505000 -57000 255000 2963000 27766000 27766000 27766000 -73000 0 2963000 182000 67000 0 67000 505000 0 0 748268000 749011000 200000000 20000000 200000000 75000000 2017-06-08 2012-06-08 110000000 The Fifth Amended Credit Agreement also provides for an annual fee ranging between 0.30% and 0.50% of the unused commitments under the revolving credit facility. 38700000 113100000 148100000 20000000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">6.</td><td style="text-align: left; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Long-Term Debt</td></tr></table></div><div><br /></div><div style="text-align: left; font-style: italic; font-family: Arial; font-size: 10pt;">1.50% Cash Convertible Senior Notes Due 2018</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">On July 16, 2013, the Company completed a private placement of $150.0 million aggregate principal amount of cash convertible senior notes due 2018 (the "Cash Convertible Notes"),&#160; which bear interest at a rate of 1.50 % per year, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2014. The Cash Convertible Notes will mature on July 1, 2018, unless earlier repurchased or converted into cash in accordance with their terms prior to such date. The Cash Convertible Notes are convertible into cash based on the conversion rate set forth below and are not convertible into our common stock or any other securities under any circumstances. The initial cash conversion rate is 51.38 shares of our common stock per $1,000 principal amount of Cash Convertible Notes (equivalent to an initial conversion price of approximately $19.46 per share of common stock). The Cash Convertible Notes are our senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Cash Convertible Notes. As a result of this transaction, we recognized deferred loan costs of approximately $3.9 million, which are being amortized over the term of the Cash Convertible Notes using the effective interest method.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The cash conversion feature of the Cash Convertible Notes (the "Cash Conversion Derivative")&#160;requires bifurcation from the Cash Convertible Notes in accordance with ASC Topic 815, <font style="font-style: italic; font-family: Arial; font-size: 10pt;">Derivatives and Hedging,</font> and is recorded in other long-term liabilities as a derivative liability and carried at fair value. The fair value of the Cash Conversion Derivative at the time of issuance of the Cash Convertible Notes was $36.8 million, which was recorded as a debt discount for purposes of accounting for the debt component of the Cash Convertible Notes. The debt discount is being amortized over the term of the Cash Convertible Notes using the effective interest method. For the twelve months ended December 31, 2013, we recorded $3.1&#160; million of interest expense related to the amortization of the debt discount based upon an effective interest rate of 5.7%. The net carrying amount of the Cash Convertible Notes at&#160; December 31, 2013&#160;was $116.4 million, net of the unamortized discount of $33.6 million.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In connection with the issuance of the Cash Convertible Notes, we entered into privately negotiated convertible note hedge transactions&#160;(the "Cash Convertible Notes Hedges"), which are cash-settled and are intended to reduce our exposure to potential cash payments that we&#160;would be required to make if holders elected to convert the Cash Convertible Notes at a time when our stock price exceeded the conversion price. The initial cost of the Cash Convertible Notes Hedges was $36.8 million. The Cash Convertible Notes Hedges are recorded in other assets as a derivative asset under FASB ASC Topic 815 and are carried at fair value.&#160; See Note 8 for additional information regarding the Cash Convertible Notes Hedges and the Cash Conversion Derivative and their fair values as of December 31, 2013.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In July 2013, we also sold separate privately negotiated warrants (the "Warrants") initially relating, in the aggregate, to approximately 7.7 million shares of our common stock underlying the Cash Convertible Notes Hedges. The Warrants have an initial strike price of approximately $25.95 per share, which effectively increases the conversion price of the Cash Convertible Notes to a 60% premium to our stock price on July 1, 2013. The Warrants will be net share settled by issuing a number of shares of our common stock per Warrant corresponding to the excess of the market price per share of our common stock (as measured on each warrant exercise date under the terms of the Warrants) over the applicable strike price of the Warrants. The Warrants meet the definition of derivatives under the guidance in ASC Topic 815; however, because these instruments have been determined to be indexed to our own stock and meet the criteria for equity classification under ASC Topic 815-40, the Warrants have been accounted for as an adjustment to our additional paid-in-capital.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">If the market value per share of our common stock exceeds the strike price of the warrants, the warrants will have a dilutive effect on net income per share, and the "treasury stock" method will be used in calculating the dilutive effect on earnings per share.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; font-style: italic; font-family: Arial; font-size: 10pt;">CareFirst Convertible Note</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">On October 1, 2013, we entered into an Investment Agreement (the "Investment Agreement")&#160;with CareFirst Holdings, LLC ("CareFirst"), which is in addition to certain existing commercial agreements between us and CareFirst relating to, among other things, disease management and care coordination services (the "Commercial Agreements").&#160;Pursuant to the Investment Agreement, we issued to CareFirst a convertible subordinated promissory note in the aggregate original principal amount of $20 million (the "CareFirst Convertible Note") for a purchase price of $20 million.&#160;The CareFirst Convertible Note bears interest at a rate of 4.75% per year, payable quarterly in arrears on March 31, June 30, September 30 and December 31 of each calendar year, beginning on December 31, 2013. The CareFirst Convertible Note may be prepaid only under limited circumstances and upon the terms and conditions specified therein.&#160;If the CareFirst Convertible Note has not been fully converted or redeemed in accordance with its terms, it will mature on October 1, 2019.&#160; The CareFirst Convertible Note is subordinate in right of payment to the prior payment in full of (a) all indebtedness of the Company under&#160;the Fifth Amended Credit Agreement, and (b) any other senior debt of the Company, which currently includes&#160;only the Cash Convertible Notes.</div><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The CareFirst Convertible Note is convertible into shares of our common stock at the conversion rate determined by dividing (a) the sum of the portion of the principal to be converted and accrued and unpaid interest with respect to such principal by (b) the conversion price equal to $22.41 per share of our common stock. &#160;The conversion price is subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications and similar events.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">CareFirst has an opportunity to earn warrants to purchase shares of our common stock ("CareFirst Warrants") based on achievement of certain quarterly thresholds (the "Revenue Thresholds") for revenue derived from both the Commercial Agreements and from new business to us from third parties as a result of an introduction or referral to us by CareFirst (collectively, the "Quarterly Revenue"). &#160;If the Quarterly Revenue is greater than or equal to the applicable Revenue Threshold for any quarter ending on or prior to September 30, 2017, then we will issue to CareFirst a certain number of&#160;warrants exercisable for the number of shares of our common stock ("CareFirst Warrant Shares") determined in accordance with the terms of the Investment Agreement unless (i) CareFirst&#160;elects to receive a cash payment in accordance with the terms of the Investment Agreement or (ii) there is a change of control. The aggregate number of CareFirst Warrant Shares in any single 12-month period beginning on October 1, 2013 cannot exceed 400,000, and the aggregate number of CareFirst Warrant Shares issuable pursuant to the Investment Agreement cannot exceed 1,600,000. If issued, the CareFirst Warrants will have a dilutive effect on net income per share, and the "treasury stock" method will be used in calculating the dilutive effect on earnings per share.&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Also on October 1, 2013, in connection with the execution of the Investment Agreement,&#160;we entered into a Registration Rights Agreement with CareFirst, pursuant to which we agreed to use commercially reasonable efforts to cause any registration statement covering an underwritten offering of our common stock for our own account or for the account of any holder of our common stock (other than a registration statement on Form S-4 or Form S-8 or any successor thereto) to include those registrable common shares that any holder of such registrable common shares has requested to be registered.&#160;</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The term of the Investment Agreement&#160;expires on the earlier of (a) December 31, 2017 and (b) the first date on which no Commercial Agreement is in effect.<font style="font-style: italic; font-family: Arial; font-size: 10pt;">&#160;</font></div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: Arial; font-size: 10pt;">Credit Facility</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">On June 8, 2012, we entered into the Fifth Amended Credit Agreement.&#160; The Fifth Amended Credit Agreement provides us with a $200.0 million revolving credit facility that expires on June 8, 2017 and includes a swingline sub facility of $20.0 million and a $75.0 million sub facility for letters of credit.&#160; The Fifth Amended Credit Agreement also provides a $200.0 million term loan facility that matures on June 8, 2017, $110.0 million of which remained outstanding at December 31, 2013, and an uncommitted incremental accordion facility of $200.0 million.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Borrowings under the Fifth Amended Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month rate (or with the approval of affected lenders, nine-month or twelve-month rate) for Eurodollar deposits ("LIBOR") or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.&#160; The LIBOR margin varies between 1.75% and 3.00%, and the Base Rate margin varies between 0.75% and 2.00%, depending on our leverage ratio.&#160; The Fifth Amended Credit Agreement also provides for an annual fee ranging between 0.30% and 0.50% of the unused commitments under the revolving credit facility.&#160; Extensions of credit under the Fifth Amended Credit Agreement are secured by guarantees from all of the Company's active domestic subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">On February 5, 2013, we entered into an amendment to the Fifth Amended Credit Agreement, which included, among other things, a temporary increase in the LIBOR and Base Rate margins of 0.25%.&#160; The increased margins were effective through December 31, 2013 and applied only when our total funded debt to EBITDA ratio was greater than or equal to 3.50 to 1.00.&#160; On July 1, 2013, we entered into an additional amendment to the Fifth Amended Credit Agreement, which provided for, among other things, the amendment of certain negative covenants to permit the issuance of and payments related to the Cash Convertible Notes described above as well as increases in the maximum required levels of total funded debt to EBITDA beginning with the quarter ended June 30, 2013.&#160; As of December 31, 2013, availability under the revolving credit facility totaled $38.7 million as calculated under the most restrictive covenant.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;We are required to repay outstanding revolving loans under the revolving credit facility on June 8, 2017. We are required to repay term loans in quarterly principal installments aggregating (1) 1.250% of the original aggregate principal amount of the term loans during each of the eight quarters beginning with the quarter ended September 30, 2012, (2) 1.875% of the original aggregate principal amount of the term loans during each of the next four quarters beginning with the quarter ending September 30, 2014, and (3) 2.500% of the original aggregate principal amount of the term loans during each of the remaining quarters prior to maturity on June 8, 2017, at which time the entire unpaid principal balance of the term loans is due and payable.</div><div><br /></div><div><font style="font-family: Arial; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font>The following table summarizes the minimum annual principal payments and repayments of the revolving advances under the Fifth Amended Credit Agreement, the Cash Convertible Notes, and the CareFirst Convertible Note&#160;for each of the next five years and thereafter:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 80%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">Year ending December 31,</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2014</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">12,500</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2015</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">17,500</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2016</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">20,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2017</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">63,625</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2018</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">150,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2019 and thereafter</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">20,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 36pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 3px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 3px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">283,625</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The Fifth Amended Credit Agreement contains financial covenants that require us to maintain specified ratios or levels of (1) total funded debt to EBITDA and (2) fixed charge coverage.&#160; As of December 31, 2013, we were in compliance with all of the financial covenant requirements of the Fifth Amended Credit Agreement.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The Fifth Amended Credit Agreement contains various other affirmative and negative covenants that are typical for financings of this type.&#160; Among other things, the Fifth Amended Credit Agreement limits repurchases of the Company's common stock and the amount of dividends that the Company can pay to holders of its common stock.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div></div> 17500000 63625000 150000000 20000000 20000000 11801000 14340000 278534000 237582000 12500000 -79702000 -60477000 -49893000 2990000 -19896000 20557000 71528000 76292000 40698000 -157693000 -8541000 8024000 5028000 5057000 -2665000 -1101000 604000 1799000 -3949000 -5290000 50 1 2010 2010 2010 33262000 10198000 10707000 0 10764000 4200000 12700000 12900000 12900000 6300000 13198000 -129114000 1902000 28895000 2021-12-31 11781000 89910000 13900000 17700000 11000000 0 1644000 522000 860000 -755000 780000 1277000 80000 -1278000 -828000 80000 -70000 -755000 -2024000 -1088000 53629000 21042000 6857000 7227000 383000 -1144000 -5096000 780000 1714000 1277000 1109000 972000 493000 2000000 0 26602000 51003000 2822000 5535000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">9.</td><td style="text-align: left; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Other Long-Term Liabilities</td></tr></table></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Other long-term liabilities consist primarily of the Cash Conversion Derivative (see Notes 6 and 7), deferred rent (see Note 12), a deferred compensation plan, and accrued performance cash (if pre-established performance metrics are met).</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We have a non-qualified deferred compensation plan under which certain employees may defer a portion of their salaries and receive a Company matching contribution plus a discretionary contribution based on the Company's performance against targets.&#160; Company contributions vest equally over four years.&#160; We do not fund the plan and carry it as an unsecured obligation.&#160; Participants in the plan elect payout dates for their account balances, which can be no earlier than four years from the period of the deferral.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><!--Anchor--><!--Anchor-->As of December 31, 2013 and 2012, other long-term liabilities included vested amounts under the non-qualified deferred compensation plan of $6.8 and $6.6 million, respectively, net of the current portions of $1.0 and $4.1 million, respectively.&#160; For the next five years ending December 31, 2018 we must make estimated plan payments of $1.0 million, $0.3 million, $0.4 million, $0.3 million, and $0.2 million, respectively.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In addition, under our stock incentive plan, we issue performance-based cash awards to certain employees based on pre-established performance metrics. Based on achievement of the performance metrics, the awards vest on the third anniversary of the grant date and are paid shortly thereafter.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">As of December 31, 2013 and 2012, no&#160;accrued performance cash amounts were included in other long-term liabilities.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div></div> 1800000 600000 0 0 0 36750000 0 36750000 10300000 0 23690000 0 7717000 6872000 6889000 2547000 0 5264000 4693000 830000 23523000 366000 0 2695000 0 5128000 629000 1700000 4000 7368000 8190000 5124000 822000 41346000 49290000 48912000 0.001 0.001 0 0 5000000 5000000 0 0 9228000 9727000 526000 -709000 582000 0 15150000 0 0 0 0 15150000 0 0 0 150000000 0 352850000 755550000 439621000 2835000 12748000 4825000 P2Y P15Y P4Y P7Y P3Y P7Y 343932000 375964000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">d.&#160; Property and Equipment - Property and equipment is carried at cost and includes expenditures that increase value or extend useful lives.&#160; <!--Anchor--><!--Anchor--><!--Anchor-->We recognize depreciation using the straight-line method over useful lives of three to seven years for computer software and hardware and four to seven years for furniture and other office equipment.&#160; Leasehold improvements are depreciated over the shorter of the estimated life of the asset or the life of the lease, which ranges from two to fifteen years.&#160; Depreciation expense for the years ended December 31, 2013, 2012, and 2011 was $40.1 million, $39.1 million, and $36.6 million, respectively, including amortization of assets recorded under capital leases.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Net computer software at December 31, 2013 and 2012 was $99.1 million and $103.7 million, respectively.&#160; Depreciation expense related to computer software for the years ended December 31, 2013, 2012, and 2011 was $26.5 million, $24.9 million, and $21.4 million, respectively.</div><div><br /></div></div> 158198000 156494000 99100000 103700000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">19.</td><td style="text-align: justify; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Quarterly Financial Information (unaudited)</td></tr></table></div><div><br /></div><div><br /></div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands, except per share data)</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">First</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Second</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Third</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Fourth</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td style="text-align: center; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td style="text-align: center; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td style="text-align: center; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(2)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td style="text-align: center; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(1)&#160; (2)</sup></div></td><td nowrap="nowrap" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#160;</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Revenues</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">165,165</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">162,270</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">166,615</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">169,235</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Gross margin</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15,083</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">19,916</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">26,391</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">18,326</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Income (loss) before income taxes</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(6,044</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,650</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,108</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(7,591</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net income (loss)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,949</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,101</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,799</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(5,290</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Basic earnings (loss) per share <sup>(3)</sup></div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.12</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.03</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.05</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Diluted earnings (loss) per share <sup>(3)</sup></div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.12</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.03</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.05</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr style="height: 39px;"><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; width: 103px; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">First</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 7px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Second</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Third</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Fourth</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td style="text-align: center; background-color: #eaf9e8; width: 93px; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 7px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td style="text-align: center; background-color: #eaf9e8; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(4)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#160;</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Revenues</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">165,218</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">170,214</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">166,559</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">175,180</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Gross margin</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">16,300</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">32,061</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">30,619</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">28,217</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Income (loss) before income taxes</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(4,116</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,732</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,542</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,587</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net income (loss)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(2,665</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,057</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,028</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">604</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Basic earnings (loss) per share <!--Anchor--><!--Anchor--><sup>(3)</sup></div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.08</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.02</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Diluted earnings (loss) per share <sup>(3)</sup></div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.08</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.02</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(1)</sup> The assumed exercise of stock-based compensation awards for this period was not considered in the calculation of diluted earnings (loss) per share because the impact would have been anti-dilutive.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(2)</sup> Includes charges related to non-cash interest associated with amortization of a debt discount of $1.5 million and $1.6 million for the third and fourth quarter, respectively.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(3)</sup> We calculated earnings per share for each of the quarters based on the weighted average number of shares and dilutive securities outstanding for each period.&#160;&#160;Accordingly, the sum of the quarters may not necessarily be equal to the full year income per share.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(4)</sup> Includes charges related to one-time termination benefits associated with capacity realignment of $1.8 million.</div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">c.&#160; Accounts Receivable, net - Billed receivables primarily represent fees that are contractually due in the ordinary course of providing our services, net of contractual adjustments and allowances for doubtful accounts.&#160; Unbilled receivables primarily represent fees for services based on the estimated utilization of fitness facilities, which are generally billed in the following month, and certain performance-based fees that are billed when performance metrics are met and reconciled with the customer.&#160; Historically, we have experienced minimal instances of customer non-payment and therefore consider our accounts receivable to be collectible, but we</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">provide reserves, when appropriate, for doubtful accounts and for billing adjustments (such as data reconciliation differences) on a specific identification basis.</font></div><div><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table provides details about reclassifications out of accumulated OCI for the twelve months ended December 31, 2013:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td colspan="7" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Twelve Months Ended December 31,</div></td><td style="width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Statement of Comprehensive Income</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;<font style="font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands)</font></div></td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td style="width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td style="width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">(Loss) Classification</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Interest rate swaps</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">$</div></td><td style="background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">1,916</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">$</div></td><td style="background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">3,302</div></td><td style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Interest expense</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">(828</div></td><td style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">)</div></td><td style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">(1,278</div></td><td style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Income tax benefit</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 4px double; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">$</div></td><td style="border-bottom: #000000 4px double; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">1,088</div></td><td style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">&#160;</div></td><td style="border-bottom: #000000 4px double; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">$</div></td><td style="border-bottom: #000000 4px double; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: Arial; font-size: 10pt;">2,024</div></td><td style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Net of tax</div></td></tr></table><div style="clear: both;"><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">See Note&#160;7 for further discussion of our interest rate swaps.</div></div> 736355000 417490000 529874000 1800000 0 9036000 1773000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><!--Anchor--><!--Anchor--><font style="font-family: Arial; font-size: 10pt; font-weight: bold;">10.</font></td><td style="text-align: justify; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Restructuring and Related Charges and Impairment Loss</td></tr></table></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><!--Anchor--><!--Anchor-->In December 2012, we began a restructuring of the Company (the "2012 Restructuring"), which was largely completed by the end of 2012, primarily focused on capacity realignment. The majority of these charges were presented as a separate line item in the consolidated statement of operations. We do not expect to incur significant additional costs or adjustments related to this restructuring.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In November 2011, we began a restructuring of the Company (the "2011 Restructuring"), which was largely completed by the end of 2011, primarily focused on aligning our capacity requirements and organizational structure following CIGNA's decision to wind-down its contract beginning in 2012.&#160; <!--Anchor--><!--Anchor-->The majority of these charges were presented as a separate line item in the consolidated statement of operations.&#160; We do not expect to incur significant additional costs or adjustments related to this restructuring.</div><div>&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In November 2010, we began a restructuring of the Company (the "2010 Restructuring"), which was largely completed by the end of 2010, primarily focused on aligning resources with current and emerging markets and consolidating operating capacity.&#160;&#160;The majority of these charges were presented as a separate line item in the consolidated statement of operations.&#160;&#160;We do not expect to incur significant additional costs or adjustments related to this restructuring.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The change in accrued restructuring and related charges related to the 2012 Restructuring, 2011 Restructuring, and 2010 Restructuring activities described above during the year ended December 31, 2013 were as follows:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 32%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1.09%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Restructuring</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1.09%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div><div style="text-align: center; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt; font-weight: bold;">Restructuring</font><sup>(1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1.09%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2010</div><div style="text-align: center; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt; font-weight: bold;">Restructuring</font><sup>(2)</sup></div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accrued restructuring and related charges at December 31, 2010</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7,607</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7,607</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Additions</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,430</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,430</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(5,124</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(5,128</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Adjustments</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(900</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;"><sup>(3)</sup>&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(900</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accrued restructuring and related charges at&#160;December 31, 2011</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,426</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,583</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,009</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Additions</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">1,773</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.49%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,773</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(7,368</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(822</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(8,190</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Adjustments</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(504</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.49%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;"><sup>(4)</sup>&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(132</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;"><sup>(3)</sup>&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(636</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accrued restructuring and related charges at December 31, 2012</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,773</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">554</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">629</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,956</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Additions</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,700</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(366</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(629</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(2,695</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Adjustments</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(29</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;"><sup>&#8212;</sup>&#160;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(102</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accrued restructuring and related charges at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">159</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">159</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(1) </sup>Excludes non-cash charges of approximately $0.6 million, which primarily consisted of share-based compensation costs.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(2) </sup>Excludes non-cash charges of approximately $1.8 million, which primarily consisted of share-based compensation costs.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(3)</sup><sup>&#160;</sup><font style="font-family: Arial; font-size: 10pt;">Adjustments resulted primarily from a favorable adjustment to lease termination costs due to a sublease of certain unused office space.</font></div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(4)</sup><sup>&#160; </sup><font style="font-family: Arial; font-size: 10pt;">Adjustments resulted primarily from actual employee tax and benefit amounts differing from previous estimates.</font></div><div>&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In December 2011, we recorded an impairment loss of $183.3 million which consisted of a goodwill impairment loss of $182.4 million (see Note 3) and an intangible asset write-off of $0.9 million.</div></div> 0 900000 29000 73000 504000 900000 102000 0 0 132000 0 636000 0 7607000 7607000 0 10009000 1773000 0 554000 1583000 0 159000 2956000 629000 8426000 159000 0 0 8430000 0 1773000 1773000 0 0 0 0 0 0 8430000 56541000 48000000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">j. Revenue Recognition - Our fees are generally billed on a per member per month ("PMPM") basis or upon member participation.&#160; For PMPM fees, we generally determine our contract fees by multiplying the contractually negotiated PMPM rate by the number of members covered by our services during the month.&#160; We typically set PMPM rates during contract negotiations with customers based on the value we expect our programs to create and a sharing of that value between the customer and the Company.&#160; In addition, some of our services, such as the Healthways SilverSneakers&#174; fitness solution, include fees that are based upon member participation.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Our contracts with health plans and integrated healthcare systems generally range from three to five years with a number of comprehensive strategic agreements extending to ten years in length.&#160; Contracts with self-insured employers typically have two to four-year terms. Some of our contracts allow the customer to terminate early.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Some of our contracts place a portion of our fees at risk based on achieving certain performance metrics, cost savings, and/or clinical outcomes improvements ("performance-based").&#160; Approximately 4% of revenues recorded during the year ended December 31, 2013 were performance-based of which 3% were subject to final reconciliation as of December 31, 2013.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We recognize revenue as follows: (1) we recognize the fixed portion of PMPM fees and fees for service as revenue during the period we perform our services; and (2) we recognize&#160;performance-based revenue&#160;based on the most recent assessment of our performance, which represents the amount that the customer would legally be obligated to pay if the contract were terminated as of the latest balance sheet date.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We generally bill our customers each month for the entire amount of the fees contractually due for the prior month's enrollment, which typically includes the amount, if any, that is performance-based and may be subject to refund should we not meet performance targets.&#160; Fees for participation are typically billed in the month after the services are provided.&#160; Deferred revenues arise from contracts that permit upfront billing and collection of fees covering the entire contractual service period, generally 12 months.&#160; A limited number of our contracts provide for certain performance-based fees that cannot be billed until after they are reconciled with the customer.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We generally assess our level of performance for our contracts based on medical claims and other data that the customer is contractually required to supply, interim assessments of achievement against performance targets, or metrics available from our operating platforms.&#160; A minimum of four to nine months' data is typically required for us to measure performance.&#160; In assessing our performance, we may include estimates such as medical claims incurred but not reported.&#160; In addition, we may also provide contractual allowances for billing adjustments (such as data reconciliation differences) as appropriate.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">If&#160;data is insufficient or incomplete to measure performance, or interim performance measures indicate that we are not meeting&#160;performance targets, we do not recognize performance-based fees subject to refund as revenues but instead record them in a current liability account entitled "contract billings in excess of earned revenue."&#160; Only in the event we do not meet performance levels by the end of the measurement period, typically one year, are we contractually obligated to refund some or all of the performance-based fees.&#160; We would only reverse revenues that we had already recognized if performance to date in the measurement period, previously above targeted levels, subsequently dropped below targeted levels.&#160; Historically, any such adjustments have been immaterial to our financial condition and results of operations.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">During the settlement process under a contract, which generally occurs six to eight months after the end of a contract year, we settle any performance-based fees and reconcile healthcare claims and clinical data.&#160; As of December 31, 2013, cumulative performance-based revenues that have not yet been settled with our customers but that have been recognized in the current and prior years totaled approximately $24.2 million, all of which were based on actual data.&#160; Data reconciliation differences, for which we provide contractual allowances until we reach agreement with respect to identified issues, can arise between the customer and us due to customer data deficiencies, omissions, and/or data discrepancies.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Performance-related adjustments (including any amounts recorded as revenue that were ultimately refunded), changes in estimates, or data reconciliation differences may cause us to recognize or reverse revenue in a current fiscal year that pertains to services provided during a prior fiscal year.&#160; During 2013, 2012 and 2011, we recognized a net increase in revenue of $8.2 million, $9.2 million, and $2.9 million, respectively, that related to services provided prior to each respective year.</div><div><br /></div></div> 3992000 P5Y1M6D P5Y7M6D P5Y1M6D P4Y3M18D P6Y4M24D <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Intangible assets subject to amortization are being amortized over estimated useful lives ranging from two to 25 years.&#160; Total amortization expense for the years ended December 31, 2013, 2012, and 2011, was $12.7 million, $12.6 million, and $13.4 million, respectively.&#160; The following table summarizes the estimated amortization expense for each of the next five years and thereafter:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 70%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Year ending December 31,</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2014</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">11,170</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2015</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6,783</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2016</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,003</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2017</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,343</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2018</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,307</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">2019 and thereafter</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">20,507</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 65%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">50,113</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> 677170000 663285000 688765000 166615000 165218000 165165000 162270000 166559000 169235000 175180000 170214000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following tables present our assets and liabilities measured at fair value on a recurring basis at December 31, 2013 and December 31, 2012:</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><br /> &#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gross Fair</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Netting<sup> (1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net Fair</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Assets:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Foreign currency exchange contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">178</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">178</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(57</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">121</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Cash Convertible Notes Hedges</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Liabilities:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Foreign currency exchange contracts</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">67</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">67</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(57</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Interest rate swap agreements</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Cash Conversion Derivative</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /> &#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -10pt; font-family: Arial; margin-left: 10pt; font-size: 10pt; font-weight: bold;">(In thousands)</div><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gross Fair</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Netting<sup> (1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net Fair</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Assets:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Foreign currency exchange contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Liabilities:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Foreign currency exchange contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">255</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">255</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">182</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Interest rate swap agreements</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">2,963</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">2,963</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">2,963</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: justify; font-family: Arial; font-size: 10pt;"><sup>(1)</sup> This column reflects the impact of netting derivative assets and liabilities by counterparty when a legally enforceable master netting agreement exists.</div><div><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table sets forth a summary of our nonvested shares as of December 31, 2013 as well as activity during the year then ended.&#160; The total grant-date fair value of shares vested during the years ended December 31, 2013, 2012 and 2011 was $3.1 million, $3.6 million, and $7.4 million, respectively.</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 45%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Nonvested Shares</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Shares (thousands)</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Weighted Average Grant Date Fair Value Per Share</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Nonvested at January 1, 2013</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">9.93</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Granted</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">186</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">13.12</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Vested</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(293</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10.43</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Forfeited</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(65</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 45%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Nonvested at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">841</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 17%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10.44</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">A summary of option activity as of December 31, 2013 and the changes during the year then ended is presented below:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 35%; vertical-align: bottom;"><div style="text-align: center; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Options</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Shares (thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Weighted</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Average Exercise</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Price Per Share</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Weighted Average</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Remaining Contractual Term</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Aggregate&#160; Intrinsic Value (thousands)</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Outstanding at January 1, 2013</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4,689</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15.65</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Granted</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,085</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">13.26</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #ffffff; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #ffffff; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Exercised</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,077</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">14.25</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Forfeited</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(163</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">11.34</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #ffffff; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #ffffff; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Expired</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(209</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">25.50</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Outstanding at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4,325</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15.09</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">13,182</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 35%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Exercisable at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,032</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 140px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">19.21</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.3</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,992</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table sets forth the weighted average grant-date fair values of options and the weighted average assumptions we used to develop the fair value estimates under each of the option valuation models for the years ended December 31, 2013, 2012 and 2011:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Weighted average grant-date fair value of options per share</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7.29</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.01</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5.94</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Assumptions:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Expected volatility</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">53.8</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">54.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">53.0</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Expected dividends</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Expected term (in years)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5.1</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5.1</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5.6</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Risk-free rate</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1.9</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.0</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">%</div></td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Income tax expense is comprised of the following:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="10" valign="bottom" style="vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Current taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Federal</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(1,311</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(1,271</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">9,388</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">State</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">741</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">774</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">2,109</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Foreign</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,693</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,754</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,707</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Deferred taxes</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Federal</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(5,842</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">4,803</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">2,169</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">State</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(1,018</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">413</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">438</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Foreign</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">101</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">249</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(425</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(5,636</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">6,722</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 12%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">15,386</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-indent: 36pt;">&#160;The following table summarizes the minimum annual principal payments and repayments of the revolving advances under the Fifth Amended Credit Agreement, the Cash Convertible Notes, and the CareFirst Convertible Note&#160;for each of the next five years and thereafter:<br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 80%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">Year ending December 31,</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2014</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">12,500</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2015</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">17,500</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2016</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">20,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2017</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">63,625</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2018</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">150,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">2019 and thereafter</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">20,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 80%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 36pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 3px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 3px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">283,625</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The difference between income tax expense computed using the statutory federal income tax rate and the effective rate is as follows:</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"></td><td valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Statutory federal income tax</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(4,962</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,161</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(49,808</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Non-deductible goodwill impairment expense</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">61,785</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">State income taxes, less federal income tax benefit</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(669</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">453</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,520</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Permanent items</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">634</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">389</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">434</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Change in valuation allowance</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">388</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">285</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">972</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Prior year tax adjustments</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">140</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">263</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">150</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Uncertain tax position reversal</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,137</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Other</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(30</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">171</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">333</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 64%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Income tax expense (benefit)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(5,636</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6,722</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15,386</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.&#160; The following table sets forth the significant components of our net deferred tax liability as of December 31, 2013 and 2012:</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1.51%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1.51%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Deferred tax asset:</div></td><td valign="bottom" style="width: 1.51%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Accruals and reserves</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">14,159</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,910</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Deferred compensation</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,933</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6,597</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Share-based payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,703</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">12,213</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Net operating loss carryforwards</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,303</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7,914</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Cash conversion derivative</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,553</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Other assets and liabilities</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,486</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,533</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">42,137</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">39,167</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Valuation allowance</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,630</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,242</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">38,507</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">35,925</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Deferred tax liability:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Property and equipment</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(44,740</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(47,317</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Intangible assets</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(13,418</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(15,700</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Cash convertible notes hedges</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,553</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Other assets and liabilities</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(449</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(122</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(62,160</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(63,139</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net deferred tax liability</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(23,653</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(27,214</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net current deferred tax asset</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">9,667</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,839</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 55%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net long-term deferred tax liability</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 2%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(33,320</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(36,053</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 55%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1.51%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 2%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(23,653</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 20%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(27,214</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The aggregate changes in the balance of unrecognized tax benefits, exclusive of interest, were as follows:</div><div><br /></div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Unrecognized tax benefits at December 31, 2011</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,392</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Decreases based upon tax positions related to prior years</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(44</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Unrecognized tax benefits at December 31, 2012</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,348</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Decreases based upon a lapse of the applicable statute of limitations</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,060</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Unrecognized tax benefits at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">288</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The gains and losses resulting from changes in the fair values of the Cash Conversion Derivative and the Cash Convertible Notes Hedges are reported in the consolidated statements of comprehensive income (loss) as follows:</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 33%; vertical-align: bottom;"><div>&#160;</div></td><td colspan="7" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Twelve Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div>&#160;</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Statements of Comprehensive Income (Loss) Classification</div></td></tr><tr><td valign="bottom" style="width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Cash Convertible Notes Hedges:</div></td><td colspan="3" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 39%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;&#160;&#160;&#160;</div></td></tr><tr style="height: 13px;"><td valign="bottom" style="background-color: #eaf9e8; width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Net unrealized loss</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(8,984</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Selling, general and administrative expense</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Cash Conversion Derivative:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 39%; vertical-align: bottom;"><div>&#160;&#160;&#160;&#160;&#160;</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 33%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Net unrealized gain</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,984</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 39%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">Selling, general and administrative expense</div></td></tr></table><div style="clear: both;"><br /></div></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div></div> <div style="font-family: Arial; font-size: 10pt;"><div><br /></div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands, except per share data)</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">First</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Second</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Third</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Fourth</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td style="text-align: center; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td style="text-align: center; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td style="text-align: center; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(2)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td valign="bottom" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><sup>&#160;</sup></td><td style="text-align: center; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(1)&#160; (2)</sup></div></td><td nowrap="nowrap" style="text-align: center; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#160;</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Revenues</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">165,165</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">162,270</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">166,615</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">169,235</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Gross margin</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15,083</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">19,916</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">26,391</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">18,326</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Income (loss) before income taxes</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(6,044</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,650</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,108</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(7,591</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net income (loss)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,949</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,101</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,799</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(5,290</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Basic earnings (loss) per share <sup>(3)</sup></div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.12</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.03</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.05</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Diluted earnings (loss) per share <sup>(3)</sup></div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.12</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.03</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.05</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr style="height: 39px;"><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; width: 103px; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">First</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 7px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Second</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Third</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Fourth</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td style="text-align: center; background-color: #eaf9e8; width: 93px; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 7px; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;">&#160;</td><td style="text-align: center; background-color: #eaf9e8; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;"><sup>(4)</sup></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#160;</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Revenues</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">165,218</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">170,214</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">166,559</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">175,180</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Gross margin</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">16,300</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">32,061</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">30,619</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">28,217</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Income (loss) before income taxes</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(4,116</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,732</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,542</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,587</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net income (loss)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(2,665</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,057</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,028</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">604</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Basic earnings (loss) per share <!--Anchor--><!--Anchor--><sup>(3)</sup></div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.08</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.02</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Diluted earnings (loss) per share <sup>(3)</sup></div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(0.08</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.02</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(1)</sup> The assumed exercise of stock-based compensation awards for this period was not considered in the calculation of diluted earnings (loss) per share because the impact would have been anti-dilutive.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(2)</sup> Includes charges related to non-cash interest associated with amortization of a debt discount of $1.5 million and $1.6 million for the third and fourth quarter, respectively.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(3)</sup> We calculated earnings per share for each of the quarters based on the weighted average number of shares and dilutive securities outstanding for each period.&#160;&#160;Accordingly, the sum of the quarters may not necessarily be equal to the full year income per share.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(4)</sup> Includes charges related to one-time termination benefits associated with capacity realignment of $1.8 million.</div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt; margin-right: 1.9pt;">The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the years ended December 31, 2013, 2012, and 2011:</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt; margin-right: 1.9pt;"><br /> &#160;</div><table align="center" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: center; text-indent: -18pt; font-family: Arial; margin-left: 18pt; font-size: 10pt; font-weight: bold;">(In thousands except per share data)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Numerator:</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; text-indent: -18pt; font-family: Arial; margin-left: 18pt; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Net income (loss)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(8,541</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">8,024</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(157,693</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div>&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Denominator:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Shares used for basic earnings (loss) per share</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">34,489</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">33,597</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">33,677</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Effect of dilutive stock options and restricted stock units outstanding:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Non-qualified stock options <sup>(1)</sup></div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">37</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;"><!--Anchor-->Restricted stock units <sup>(1)</sup></div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">202</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Shares used for diluted earnings (loss) per share<sup> (1)</sup></div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">34,489</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">33,836</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">33,677</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Earnings per share:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Basic</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(0.25</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">0.24</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(4.68</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Diluted <sup>(1)</sup></div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(0.25</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">0.24</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">(4.68</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div>&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Dilutive securities outstanding not included in the computation of earnings per share because their effect is anti-dilutive:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Non-qualified stock options</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">3,234</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">4,926</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">4,845</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Restricted stock units</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">334</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">193</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">469</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">Warrants related to Cash Convertible Notes</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">7,707</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 64%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 25.2pt; font-size: 10pt;">CareFirst Convertible Note</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">892</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr></table><div style="clear: both;">&#160;</div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(1)</sup> The assumed exercise of stock-based compensation awards for the years ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive.</div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Intangible assets subject to amortization at December 31, 2013 consisted of the following:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 58%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;"><!--Anchor--><!--Anchor-->(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gross Carrying</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Amount</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Accumulated</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Customer contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">59,574</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">51,512</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,062</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Acquired technology</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">29,431</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">25,589</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,842</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Patents</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">24,547</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">15,081</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">9,466</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Distributor and provider networks</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,709</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7,190</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,519</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Perpetual license to survey-based data</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">30,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,986</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">26,014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Other</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,077</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,867</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,210</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">157,338</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">107,225</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">50,113</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Intangible assets subject to amortization at December 31, 2012 consisted of the following:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 95%; font-family: Arial; font-size: 10pt;"><tr style="height: 31px;"><td valign="bottom" style="width: 58%; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gross Carrying</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Amount</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Accumulated</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Amortization</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 58%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;"><!--Anchor-->Customer contracts</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">59,305</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">44,571</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">14,734</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Acquired technology</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">29,287</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">24,299</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4,988</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Patents</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">24,337</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">12,723</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">11,614</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Distributor and provider networks</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,709</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6,669</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,040</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Perpetual license to survey-based data</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">29,000</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,708</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">26,292</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Other</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">5,097</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,586</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,511</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 58%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 14.4pt; font-size: 10pt;">Total</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">155,735</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 12%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">94,556</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">61,179</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following tables summarize the changes in accumulated OCI, net of tax, for the twelve months ended December 31, 2013 and 2012:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;<font style="font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands)</font></div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net Change in Fair Value of Interest Rate Swaps</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Foreign Currency Translation Adjustments</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accumulated OCI, net of tax, as of January 1, 2013</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,790</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">861</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(929</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Other comprehensive income (loss) before reclassifications, net of tax</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">189</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(755</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(566</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Amounts reclassified from accumulated OCI, net of tax</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,088</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,088</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Net increase (decrease) in other comprehensive income (loss), net of tax</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,277</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(755</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">522</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accumulated OCI, net of tax, as of December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(513</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">106</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(407</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;<font style="font-family: Arial; font-size: 10pt; font-weight: bold;">(In thousands)</font></div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Net Change in Fair Value of Interest Rate Swaps</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Foreign Currency Translation Adjustments</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 17px;"><td valign="bottom" style="background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accumulated OCI, net of tax, as of January 1, 2012</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(2,570</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">781</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,789</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Other comprehensive income (loss) before reclassifications, net of tax</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,244</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">80</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,164</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Amounts reclassified from accumulated OCI, net of tax</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,024</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,024</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">Net increase&#160;in other comprehensive income (loss), net of tax</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">780</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">80</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">860</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 50%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accumulated OCI, net of tax, as of December 31, 2012</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,790</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">861</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(929</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 50%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 14%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="text-align: justify; font-family: Arial; clear: both; font-size: 1pt;">&#160;&#160;&#160;&#160;&#160;</div><div><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Following are certain amounts recognized in the consolidated statements of operations for share-based compensation arrangements for the years ended December 31, 2013, 2012, and 2011.&#160; We did not capitalize any share-based compensation costs during these periods.</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Year Ended</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div>&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In millions)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Total share-based compensation</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7.1</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">6.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">9.2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Share-based compensation included in cost of services</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.9</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3.0</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.1</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Share-based compensation included in selling, general and administrative expenses</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3.4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">4.5</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Share-based compensation included in restructuring and related charges</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">0.6</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Total income tax benefit recognized</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.8</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2.5</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3.6</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The change in carrying amount of goodwill during the years ended December 31, 2011, 2012, and 2013 is shown below:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 85%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Balance, December 31, 2010</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">496,265</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Navvis purchase</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">21,527</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Impairment loss</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(182,400</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Balance, December 31, 2011</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">335,392</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Ascentia purchase</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">3,303</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Balance, December 31, 2012</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">338,695</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Other adjustments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">105</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 70%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Balance, December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">338,800</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The change in accrued restructuring and related charges related to the 2012 Restructuring, 2011 Restructuring, and 2010 Restructuring activities described above during the year ended December 31, 2013 were as follows:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 32%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1.09%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2012</div><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Restructuring</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1.09%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2011</div><div style="text-align: center; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt; font-weight: bold;">Restructuring</font><sup>(1)</sup></div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1.09%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">2010</div><div style="text-align: center; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt; font-weight: bold;">Restructuring</font><sup>(2)</sup></div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accrued restructuring and related charges at December 31, 2010</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7,607</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">7,607</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Additions</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,430</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,430</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(4</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(5,124</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(5,128</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Adjustments</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(900</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;"><sup>(3)</sup>&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(900</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accrued restructuring and related charges at&#160;December 31, 2011</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">8,426</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,583</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">10,009</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Additions</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">1,773</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.49%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,773</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(7,368</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(822</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(8,190</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Adjustments</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: middle;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(504</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.49%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;"><sup>(4)</sup>&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(132</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;"><sup>(3)</sup>&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(636</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accrued restructuring and related charges at December 31, 2012</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,773</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">554</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">629</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,956</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Additions</div></td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Payments</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,700</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(366</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.49%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(629</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(2,695</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Adjustments</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(29</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;"><sup>&#8212;</sup>&#160;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(102</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1.09%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 32%; vertical-align: middle;"><div style="text-align: left; text-indent: -7.2pt; font-family: Arial; margin-left: 7.2pt; font-size: 10pt;">Accrued restructuring and related charges at December 31, 2013</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">159</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1.49%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11.14%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">159</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1.09%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(1) </sup>Excludes non-cash charges of approximately $0.6 million, which primarily consisted of share-based compensation costs.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(2) </sup>Excludes non-cash charges of approximately $1.8 million, which primarily consisted of share-based compensation costs.</div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(3)</sup><sup>&#160;</sup><font style="font-family: Arial; font-size: 10pt;">Adjustments resulted primarily from a favorable adjustment to lease termination costs due to a sublease of certain unused office space.</font></div><div><br /></div><div style="text-align: left; font-family: Arial; font-size: 10pt;"><sup>(4)</sup><sup>&#160; </sup><font style="font-family: Arial; font-size: 10pt;">Adjustments resulted primarily from actual employee tax and benefit amounts differing from previous estimates.</font></div><div>&#160;</div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The estimated gross fair values of derivative instruments at December 31, 2013 and December 31, 2012, excluding the impact of netting derivative assets and liabilities when a legally enforceable master netting agreement exists, were as follows:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="10" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Foreign currency exchange contracts</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Interest rate swap agreements</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Cash Convertible Notes Hedges and Cash Conversion Derivative</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Foreign currency exchange contracts</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Interest rate swap agreements</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">Assets:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 29%; vertical-align: bottom;"><div style="text-align: left; font-style: italic; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Derivatives not designated as hedging instruments:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;"></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Other current assets</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">178</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Other assets</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">178</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">73</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">Liabilities:</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-style: italic; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Derivatives not designated as hedging instruments:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: middle;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Accrued liabilities</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">67</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">255</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Other long-term liabilities</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-family: Arial; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; font-style: italic; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Derivatives designated as hedging instruments:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 15%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 11%; vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Accrued liabilities</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">1,742</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: top;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Other long-term liabilities</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">1,221</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 29%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Total liabilities</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">67</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 9%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">505</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 15%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">255</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #eaf9e8; width: 11%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,963</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="clear: both;"><br /></div></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the twelve months ended&#160;December 31, 2013 and 2012:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr style="height: 21px;"><td valign="bottom" style="padding-bottom: 2px; width: 63%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td colspan="7" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">For the Twelve Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 63%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">Derivatives in Cash Flow Hedging Relationships</div></td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="3" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 63%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">(Gain) loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(332</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">2,029</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 63%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(1,916</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">(3,302</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">18.</td><td style="text-align: justify; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Segment Disclosures</td></tr></table></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We have aggregated our operating segments into one reportable segment, well-being improvement services.&#160; Our integrated well-being improvement services include disease management, health coaching, and wellness and prevention programs. Further, we report revenues from our external customers on a consolidated basis since well-being improvement is the only service that we provide.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">During 2013 and 2012, we derived approximately 10.5% and 11.5%, respectively, of our revenues from one customer and during 2011, we derived approximately 17% of our revenues from a separate customer, with no other customer comprising 10% or more of our revenues.</div></div> 61205000 64843000 60888000 186000 8.29 13.26 13.12 13.12 13.26 11.34 1013000 841000 293000 7116000 9246000 6371000 P4Y P4Y 1085000 9.93 10.44 10.15 65000 25.50 14.25 19.21 0 0 0 3600000 3100000 7400000 209000 163000 10.43 2032000 200000 1900000 1300000 3200000 0.538 0.53 0.544 0.024 0.019 0.02 7.29 4.01 5.94 15.65 15.09 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">l.&#160; Share-Based Compensation &#8211; We recognize all share-based payments to employees, including grants of employee stock options, in the consolidated statements of operations over the required vesting period based on estimated fair values at the date of grant.&#160; See Note 13 for further information on share-based compensation.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div></div> 4689000 4325000 13182000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 36pt; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold; align: right;">1.</td><td style="text-align: justify; width: auto; font-family: Arial; font-size: 10pt; vertical-align: top; font-weight: bold;">Summary of Significant Accounting Policies</td></tr></table></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Healthways, Inc. and its wholly-owned subsidiaries provide specialized, comprehensive solutions to help people improve physical, emotional and social well-being, thereby reducing both direct healthcare costs and associated costs from the loss of health-related employee productivity.&#160; In North America, our customers include health plans, employers, integrated healthcare systems, hospitals, physicians, and government entities in all 50 states and the District of Columbia. We also provide health improvement programs and services in Brazil, Australia, and France.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">As used throughout these notes to the consolidated financial statements, unless the context otherwise indicates, the terms "we," "us," "our," or the "Company" refer collectively to Healthways, Inc. and its wholly-owned subsidiaries.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">a.&#160; Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned by the Company.&#160; We have eliminated all intercompany profits, transactions and balances.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">b.&#160; Cash and Cash Equivalents - Cash and cash equivalents primarily include cash, tax-exempt debt instruments, commercial paper, and other short-term investments with original maturities of less than three months.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">c.&#160; Accounts Receivable, net - Billed receivables primarily represent fees that are contractually due in the ordinary course of providing our services, net of contractual adjustments and allowances for doubtful accounts.&#160; Unbilled receivables primarily represent fees for services based on the estimated utilization of fitness facilities, which are generally billed in the following month, and certain performance-based fees that are billed when performance metrics are met and reconciled with the customer.&#160; Historically, we have experienced minimal instances of customer non-payment and therefore consider our accounts receivable to be collectible, but we</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">provide reserves, when appropriate, for doubtful accounts and for billing adjustments (such as data reconciliation differences) on a specific identification basis.</font></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">d.&#160; Property and Equipment - Property and equipment is carried at cost and includes expenditures that increase value or extend useful lives.&#160; <!--Anchor--><!--Anchor--><!--Anchor-->We recognize depreciation using the straight-line method over useful lives of three to seven years for computer software and hardware and four to seven years for furniture and other office equipment.&#160; Leasehold improvements are depreciated over the shorter of the estimated life of the asset or the life of the lease, which ranges from two to fifteen years.&#160; Depreciation expense for the years ended December 31, 2013, 2012, and 2011 was $40.1 million, $39.1 million, and $36.6 million, respectively, including amortization of assets recorded under capital leases.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Net computer software at December 31, 2013 and 2012 was $99.1 million and $103.7 million, respectively.&#160; Depreciation expense related to computer software for the years ended December 31, 2013, 2012, and 2011 was $26.5 million, $24.9 million, and $21.4 million, respectively.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">e.&#160; Other Assets - Other assets consist primarily of cash convertible notes hedges, long-term investments, long-term customer incentives, and deferred loan costs net of accumulated amortization.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">f.&#160; Intangible Assets - Intangible assets subject to amortization include customer contracts, acquired technology, patents, distributor and provider networks, a perpetual license, and other intangible assets which we amortize on a straight-line basis over estimated useful lives ranging from two to 25 years.&#160; We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Intangible assets not subject to amortization at December 31, 2013 and 2012 consist of a trade name of $29.0 million.&#160; We review intangible assets not subject to amortization on an annual basis or more frequently whenever events or circumstances indicate that the assets might be impaired.&#160; See Note 4 for further information on intangible assets.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">g.&#160; Goodwill - We recognize goodwill for the excess of the purchase price over the fair value of tangible and identifiable intangible net assets of businesses that we acquire.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable.&#160; We allocate goodwill to reporting units based on the reporting unit expected to benefit from the combination.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We estimate the fair value of each reporting unit using a combination of a discounted cash flow model and a market-based approach, and we reconcile the aggregate fair value of our reporting units to our consolidated market capitalization.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">h. Contract Billings in Excess of Earned Revenue - Contract billings in excess of earned revenue primarily represent performance-based fees subject to refund that we have</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">not recognized as revenues because either (1)</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">data from the customer is insufficient or incomplete to measure performance; or (2)</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">interim performance measures indicate that we are not currently meeting</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">performance targets.</font></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">i. Income Taxes - We file a consolidated federal income tax return that includes all of our domestic wholly owned subsidiaries.&#160; Generally accepted accounting principles in the United States ("U.S. GAAP") generally require that we record deferred income taxes for the tax effect of differences between the</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">book and tax bases of our</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">assets and liabilities.&#160; We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.&#160; The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.</font></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">j. Revenue Recognition - Our fees are generally billed on a per member per month ("PMPM") basis or upon member participation.&#160; For PMPM fees, we generally determine our contract fees by multiplying the contractually negotiated PMPM rate by the number of members covered by our services during the month.&#160; We typically set PMPM rates during contract negotiations with customers based on the value we expect our programs to create and a sharing of that value between the customer and the Company.&#160; In addition, some of our services, such as the Healthways SilverSneakers&#174; fitness solution, include fees that are based upon member participation.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Our contracts with health plans and integrated healthcare systems generally range from three to five years with a number of comprehensive strategic agreements extending to ten years in length.&#160; Contracts with self-insured employers typically have two to four-year terms. Some of our contracts allow the customer to terminate early.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Some of our contracts place a portion of our fees at risk based on achieving certain performance metrics, cost savings, and/or clinical outcomes improvements ("performance-based").&#160; Approximately 4% of revenues recorded during the year ended December 31, 2013 were performance-based of which 3% were subject to final reconciliation as of December 31, 2013.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We recognize revenue as follows: (1) we recognize the fixed portion of PMPM fees and fees for service as revenue during the period we perform our services; and (2) we recognize&#160;performance-based revenue&#160;based on the most recent assessment of our performance, which represents the amount that the customer would legally be obligated to pay if the contract were terminated as of the latest balance sheet date.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We generally bill our customers each month for the entire amount of the fees contractually due for the prior month's enrollment, which typically includes the amount, if any, that is performance-based and may be subject to refund should we not meet performance targets.&#160; Fees for participation are typically billed in the month after the services are provided.&#160; Deferred revenues arise from contracts that permit upfront billing and collection of fees covering the entire contractual service period, generally 12 months.&#160; A limited number of our contracts provide for certain performance-based fees that cannot be billed until after they are reconciled with the customer.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">We generally assess our level of performance for our contracts based on medical claims and other data that the customer is contractually required to supply, interim assessments of achievement against performance targets, or metrics available from our operating platforms.&#160; A minimum of four to nine months' data is typically required for us to measure performance.&#160; In assessing our performance, we may include estimates such as medical claims incurred but not reported.&#160; In addition, we may also provide contractual allowances for billing adjustments (such as data reconciliation differences) as appropriate.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">If&#160;data is insufficient or incomplete to measure performance, or interim performance measures indicate that we are not meeting&#160;performance targets, we do not recognize performance-based fees subject to refund as revenues but instead record them in a current liability account entitled "contract billings in excess of earned revenue."&#160; Only in the event we do not meet performance levels by the end of the measurement period, typically one year, are we contractually obligated to refund some or all of the performance-based fees.&#160; We would only reverse revenues that we had already recognized if performance to date in the measurement period, previously above targeted levels, subsequently dropped below targeted levels.&#160; Historically, any such adjustments have been immaterial to our financial condition and results of operations.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">During the settlement process under a contract, which generally occurs six to eight months after the end of a contract year, we settle any performance-based fees and reconcile healthcare claims and clinical data.&#160; As of December 31, 2013, cumulative performance-based revenues that have not yet been settled with our customers but that have been recognized in the current and prior years totaled approximately $24.2 million, all of which were based on actual data.&#160; Data reconciliation differences, for which we provide contractual allowances until we reach agreement with respect to identified issues, can arise between the customer and us due to customer data deficiencies, omissions, and/or data discrepancies.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">Performance-related adjustments (including any amounts recorded as revenue that were ultimately refunded), changes in estimates, or data reconciliation differences may cause us to recognize or reverse revenue in a current fiscal year that pertains to services provided during a prior fiscal year.&#160; During 2013, 2012 and 2011, we recognized a net increase in revenue of $8.2 million, $9.2 million, and $2.9 million, respectively,&#160;that related to services provided prior to each respective year.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">k.&#160; Earnings (Loss) Per Share &#8211; We calculate</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">basic earnings (loss) per share using weighted average common shares outstanding during the period.&#160; We calculate diluted earnings (loss) per share using</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">weighted average common shares outstanding during the period plus the effect of all dilutive potential common shares outstanding during the period unless the impact would be anti-dilutive.&#160; See Note 14 for a reconciliation of basic and diluted earnings (loss) per share.</font></div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">l.&#160; Share-Based Compensation &#8211; We recognize all share-based payments to employees, including grants of employee stock options, in the consolidated statements of operations over the required vesting period based on estimated fair values at the date of grant.&#160; See Note 13 for further information on share-based compensation.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">m. Derivative Instruments and Hedging Activities &#8211; We use derivative instruments to manage risks related to interest rate swap agreements, foreign currencies, and the cash convertible senior notes (as discussed in Note 6).&#160;We account for derivatives in accordance with&#160;Financial Accounting Standards Board&#160;Standards Board ("FASB")&#160;&#160;Accounting Standards Codification</font><font style="font-family: Arial; font-size: 10pt;"> ("</font><font style="font-family: Arial; font-size: 10pt;">ASC") Topic 815, which establishes accounting and reporting standards requiring that certain derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value will be recognized currently in earnings unless specific hedge accounting criteria are met.&#160;As permitted under our master netting arrangements, the fair value amounts of our interest rate swaps and foreign currency options and/or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets. See Note 7 for further information on derivative instruments and hedging activities.</font></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">n. Management Estimates &#8211; In preparing our consolidated financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect: (1) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements; and (2)</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">the reported amounts of revenues and expenses during the reporting period.&#160; Actual results could differ from those estimates.</font></div><div><br /></div></div> 12748000 1000 1000 0 0 4824000 0 0 2835000 12747000 1000 0 0 0 0 0 2834000 0 0 4825000 0 467000 0 58000 3262000 0 0 0 58000 0 0 0 0 3262000 0 0 0 0 467000 0 0 0 3262000 0 0 1077000 -368000 0 0 -368000 0 0 0 278821000 302690000 430841000 -4494000 -3433000 206210000 34000 0 232524000 0 283244000 -28182000 -929000 56541000 0 35000 251357000 -28182000 34000 -407000 48000000 -28182000 -1789000 33000 265716000 0 247137000 48517000 23688000 -8024000 0 23690000 2000 0 0 -860000 0 0 0 0 0 -8884000 2254953 2254953 28182000 28182000 10700000 -44000 300000 1300000 1100000 1392000 1348000 288000 0 -1137000 0 297600000 142200000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">n. Management Estimates &#8211; In preparing our consolidated financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect: (1) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements; and (2)</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">the reported amounts of revenues and expenses during the reporting period.&#160; Actual results could differ from those estimates.</font></div><div><br /></div></div> 33597000 34489000 33677000 33677000 33836000 34489000 400000 1600000 283625000 0.6 2013-10-01 145000000 95000000 50000000 0 -566000 -1164000 -1244000 189000 80000 -755000 2024000 1088000 1088000 2024000 0 0 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: justify; text-indent: 36pt; font-family: Arial; font-size: 10pt;">The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt; font-weight: bold;">(In thousands)</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Balance at December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Purchases of Level 3 Instruments</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Issuances of Level 3 Instruments</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Gains/(Losses) included in Earnings</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Balance at December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #eaf9e8; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Cash Convertible Notes Hedges</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">36,750</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1px; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1px; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 10%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(8,984</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #eaf9e8; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #eaf9e8; width: 1%; vertical-align: middle;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: Arial; margin-left: 9pt; font-size: 10pt;">Cash Conversion Derivative</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: top;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: top;"><div style="font-family: Arial; font-size: 10pt;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1px; vertical-align: top;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1px; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 10%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(36,750</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">8,984</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 13%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">(27,766</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: middle;"><div style="font-family: Arial; font-size: 10pt;">)</div></td></tr></table><div style="clear: both;"><br /></div></div> P15Y -1166000 65000 42000000 P10Y <div style="font-family: Arial; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 5.35%; vertical-align: top;"><div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">16.</div></td><td style="width: 94.65%; vertical-align: top;"><div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">Stockholder Rights Plan</div></td></tr></table><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">On June 19, 2000, our Board adopted a stockholder rights plan under which holders of common stock as of June 30, 2000 received preferred stock purchase rights as a dividend at the rate of one right per share.&#160; As amended in June 2004 and July 2006, each right initially entitles its holder to purchase one one-hundredth of a Series A preferred share at $175.00, subject to adjustment.&#160; Upon becoming exercisable, each right will allow the holder (other than the person or group whose actions have triggered the exercisability of the rights), under alternative circumstances, to buy either securities of the Company or securities of the acquiring company (depending on the form of the transaction) having a value of twice the then current exercise price of the rights.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">With certain exceptions, each right will become exercisable only when a person or group acquires, or commences a tender or exchange offer for, 15% or more of our outstanding common stock.&#160; Rights will also become exercisable in the event of certain mergers or asset sales involving more than 50% of our assets or earning power.&#160; The rights will expire on June 15, 2014, unless redeemed or exchanged.&#160; Our Board reviews the plan periodically to determine if the maintenance and continuance of the plan is still in the best interests of the Company and its stockholders.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div></div> We are required to repay outstanding revolving loans under the revolving credit facility on June 8, 2017. We are required to repay term loans in quarterly principal installments aggregating (1) 1.250% of the original aggregate principal amount of the term loans during each of the eight quarters beginning with the quarter ended September 30, 2012, (2) 1.875% of the original aggregate principal amount of the term loans during each of the next four quarters beginning with the quarter ending September 30, 2014, and (3) 2.500% of the original aggregate principal amount of the term loans during each of the remaining quarters prior to maturity on June 8, 2017, at which time the entire unpaid principal balance of the term loans is due and payable. <div style="font-family: Arial; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Arial; font-size: 10pt;"><tr><td style="width: 10%; vertical-align: top;"><div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">2.</div></td><td style="width: 90%; vertical-align: top;"><div style="text-align: justify; font-family: Arial; font-size: 10pt; font-weight: bold;">Recent Accounting Standards</div></td></tr></table><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In July 2012, the FASB issued Accounting Standards Update ("ASU") No. 2012-02, "Intangibles&#8212;Goodwill and Other (Topic 350)&#8212;Testing Indefinite-Lived Intangible Assets for Impairment."&#160; ASU No. 2012-02 permits an entity to perform a qualitative assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value.&#160; If the entity concludes that this is the case, it must perform the currently prescribed quantitative impairment test by comparing the fair value of the indefinite-lived intangible asset with its carrying value.&#160; Otherwise, the quantitative impairment test is not required. ASU No. 2012-02 is effective for fiscal years beginning after September 15, 2012, with earlier adoption permitted.&#160; We adopted this standard for the fiscal year beginning January 1, 2013. &#160;The adoption of this standard did not have a material impact on our consolidated results of operations, financial position, cash flows, or notes to the consolidated financial statements.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220)&#8212;Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income," which requires companies to provide information about the amounts reclassified out of accumulated other comprehensive income ("AOCI") by component. In addition, entities are required to present, either on the face of the statement where net income is presented or in the accompanying notes, significant amounts reclassified out of AOCI by the respective line items of net income, but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period. For amounts that are not required to be reclassified in their entirety to net income, entities are required to cross-reference to other disclosures that provide additional detail on those amounts. ASU No. 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012. &#160;We adopted this standard for the interim period beginning January 1, 2013. The adoption of this standard did not have a material impact on our consolidated results of operations, financial position, cash flows, or notes to the consolidated financial statements.</div><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">&#160;</div></div> 21527000 0.04 24200000 2900000 9200000 8200000 0.03 0 3553000 3553000 0 -1060000 20000000 0 0 0 467000 0 0 0 58000 <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Arial; font-size: 10pt;">h. Contract Billings in Excess of Earned Revenue - Contract billings in excess of earned revenue primarily represent performance-based fees subject to refund that we have</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">not recognized as revenues because either (1)</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">data from the customer is insufficient or incomplete to measure performance; or (2)</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">interim performance measures indicate that we are not currently meeting</font><font style="font-family: Arial; font-size: 10pt;">&#160;</font><font style="font-family: Arial; font-size: 10pt;">performance targets.</font></div><div><br /></div></div> <div style="font-family: Arial; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: Arial; font-size: 10pt;">e.&#160; Other Assets - Other assets consist primarily of cash convertible notes hedges, long-term investments, long-term customer incentives, and deferred loan costs net of accumulated amortization.</div><div><br /></div></div> 14793000 17411000 The assumed exercise of stock-based compensation awards for the years ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive. The assumed exercise of stock-based compensation awards for this period was not considered in the calculation of diluted earnings (loss) per share because the impact would have been anti-dilutive. Includes charges related to one-time termination benefits associated with capacity realignment of $1.8 million. Includes charges related to non-cash interest associated with amortization of a debt discount of $1.5 million and $1.6 million for the third and fourth quarter, respectively. We calculated earnings per share for each of the quarters based on the weighted average number of shares and dilutive securities outstanding for each period.  Accordingly, the sum of the quarters may not necessarily be equal to the full year income per share. Excludes non-cash charges of approximately $0.6 million, which primarily consisted of share-based compensation costs Excludes non-cash charges of approximately $1.8 million, which primarily consisted of share-based compensation costs. Adjustments resulted primarily from actual employee tax and benefit amounts differing from previous estimates. Adjustments resulted primarily from a favorable adjustment to lease termination costs due to a sublease of certain unused office space. EX-101.SCH 9 hway-20131231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 020100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 030100 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - Recent Accounting Standards link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - Derivative Investments and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - Other Long-Term Liabilities link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - Restructuring and Related Charges and Impairment Loss link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 061200 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 061300 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 061400 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 061500 - Disclosure - Accumulated OCI link:presentationLink link:calculationLink link:definitionLink 061600 - Disclosure - Stockholder Rights Plan link:presentationLink link:calculationLink link:definitionLink 061700 - Disclosure - Employee Benefits link:presentationLink link:calculationLink link:definitionLink 061800 - Disclosure - Segment Disclosures link:presentationLink link:calculationLink link:definitionLink 061900 - Disclosure - Quarterly Financial Information (unaudited) link:presentationLink link:calculationLink link:definitionLink 070100 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 080300 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 080400 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 080500 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 080601 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 080700 - Disclosure - Derivative Investments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 081000 - Disclosure - Restructuring and Related Charges and Impairment Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 081200 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 081300 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 081400 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 081500 - Disclosure - Accumulated OCI (Tables) link:presentationLink link:calculationLink link:definitionLink 081900 - Disclosure - Quarterly Financial Information (unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 090502 - Disclosure - Income Taxes (Details) CALC 01 link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 090602 - Disclosure - Long-Term Debt, Line of Credit and Term Loan (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - Derivative Investments and Hedging Activities (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - Other Long-Term Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - Restructuring and Related Charges and Impairment Loss (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 091200 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 091300 - Disclosure - Share-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 091400 - Disclosure - Earnings (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 091500 - Disclosure - Accumulated OCI (Details) link:presentationLink link:calculationLink link:definitionLink 091700 - Disclosure - Employee Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 091800 - Disclosure - Segment Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 091900 - Disclosure - Quarterly Financial Information (unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 hway-20131231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 hway-20131231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 hway-20131231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Amendment Flag Current Fiscal Year End Date Document Period End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type Area of leased property (in square feet) Award Type [Axis] Summary of Significant Accounting Policies [Abstract] Accounts receivable, net Accounts payable Accrued Liabilities [Member] Accrued Liabilities [Member] Accrued liabilities Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated other comprehensive loss Accumulated OCI, net of tax Beginning Balance Accumulated OCI, net of tax Ending Balance Accumulated Other Comprehensive Income (Loss) [Member] Net Change in Fair Value of Interest Rate Swaps [Member] Accumulated OCI [Abstract] Accumulated Other Comprehensive Income Loss [Line Items] Accumulated Other Comprehensive Income Loss [Table] Foreign Currency Translation Adjustments [Member] Additional paid-in capital Additional Paid-in Capital [Member] Total income tax benefit recognized Adjustments to reconcile net income to net cash provided by operating activities, net of business acquisitions: Share-based employee compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Tax effect of stock options and restricted stock units Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Allocated share-based compensation Amortization of deferred loan costs Amortization expense Amortization of debt discount Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive (in shares) Impairment loss Total assets Assets Current assets: ASSETS [Abstract] Total current assets Assets, Current Assets, Fair Value Base Rate [Member] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Business Acquisition [Axis] Value of common stock issued Business Acquisition [Line Items] Business Acquisition, Acquiree [Domain] Cash payment for the acquisition Unregistered shares of common stock issued (in shares) 2015 Capital Leases, Future Minimum Payments Due in Two Years Total minimum lease payments Capital Leases, Future Minimum Payments Due 2018 Capital Leases, Future Minimum Payments Due in Five Years Less amount representing interest Capital Leases, Future Minimum Payments, Interest Included in Payments 2016 Capital Leases, Future Minimum Payments Due in Three Years 2017 Capital Leases, Future Minimum Payments Due in Four Years Future minimum lease payments under capital leases [Abstract] Present value of minimum lease payments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments 2019 and thereafter Capital Leases, Future Minimum Payments Due Thereafter 2014 Capital Leases, Future Minimum Payments Due, Next Twelve Months Computer equipment and related software Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Noncash Activities: Cash Flow Hedging [Member] Warrant Shares Initially Sold underlying Cash Convertible Notes Hedges Warrants Strike Price Commitments and Contingencies [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Common stock, par value (in dollars per share) Common Stock [Member] Common stock $.001 par value, 120,000,000 shares authorized, 35,107,303 and 33,924,464 shares outstanding Common Stock, Value, Issued Common stock, shares authorized (in shares) Common stock, shares outstanding (in shares) Employee Benefits Compensation and Employee Benefit Plans [Text Block] Employee Benefits [Abstract] Components of income tax expense [Abstract] Significant components of net deferred tax liability [Abstract] Comprehensive income (loss) Total comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Accumulated OCI Comprehensive Income (Loss) Note [Text Block] Percentage of revenues from one customer (in hundredths) Principles of Consolidation Capital projects in process 2015 Contractual Obligation, Due in Second Year 2018 Contractual Obligation, Due in Fifth Year Summary of future minimum lease payments under all capital leases and non-cancelable operating leases Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block] 2017 Contractual Obligation, Due in Fourth Year 2014 Contractual Obligation, Due in Next Twelve Months 2016 Contractual Obligation, Due in Third Year Cash Convertible Notes [Member] Convertible Debt [Member] Cost of services, depreciation and amortization Cost of Services, Depreciation and Amortization Cost of services (exclusive of depreciation and amortization of $36,183, $36,094, and $36,248, respectively, included below) Cost of Services Share-Based Compensation Included in Cost of Services [Member] Cost of Sales [Member] Credit Facility [Axis] Credit Facility [Domain] State Current taxes [Abstract] Foreign Current Foreign Tax Expense (Benefit) Federal Customer Contracts [Member] Derivatives Designated as Hedging Instruments [Member] Designated as Hedging Instrument [Member] Basis spread on variable rate increased (in hundredths) Debt Instrument, Description of Variable Rate Basis Debt Instrument [Line Items] Schedule of Long-term Debt Instruments [Table] Notes, Issuance Date Debt Instrument, Convertible, Number of Equity Instruments Aggregate Principal of convertible notes Debt Instrument, Carrying Amount Debt Instrument, Carrying Amount Debt Instrument, Convertible, Conversion Ratio Initial Conversion rate Debt Instrument, Convertible, Conversion Price Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Unamortized Discount Debt Instrument, Unamortized Discount Interest Rate for Notes Interest rate description Maturity date Debt Instrument, Maturity Date Net long-term deferred tax liability Deferred Tax Liabilities, Gross, Noncurrent Current portions of the non-qualified deferred compensation plan Deferred tax asset [Abstract] Total Deferred Tax Liabilities, Gross Federal Deferred Federal Income Tax Expense (Benefit) Deferred Finance Costs, Gross Deferred taxes [Abstract] Foreign Deferred income taxes State Deferred State and Local Income Tax Expense (Benefit) Net current deferred tax asset Deferred revenue Deferred tax assets, Gross Deferred Tax Assets, Gross Share-based payments Other assets and liabilities Accruals and reserves Deferred tax asset Total Deferred Tax Assets, Net of Valuation Allowance Deferred compensation Net operating loss carryforwards Valuation allowance Deferred Tax Assets, Valuation Allowance Other assets and liabilities Deferred Tax Liabilities, Other Long-term deferred tax liability Property and equipment Deferred Tax Liabilities, Property, Plant and Equipment Intangible assets Deferred Tax Liabilities, Intangible Assets Net deferred tax liability Deferred Tax Liabilities, Net Deferred tax liability [Abstract] Vested amounts under the non-qualified deferred compensation plan Company contributions under the 401(k) Plan Defined Contribution Plan, Cost Recognized Depreciation Depreciation and amortization Depreciation, Depletion and Amortization Fair Values of Derivative Instruments [Abstract] Derivative Instruments in Hedges, at Fair Value, Net [Abstract] Derivative Asset, Notional Amount Assets [Abstract] Derivative Asset, Fair Value, Amount Not Offset Against Collateral [Abstract] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Liabilities [Abstract] Derivative Liability, Fair Value, Amount Not Offset Against Collateral [Abstract] Derivative Investments and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Investments and Hedging Activities [Abstract] Derivative Liability, Notional Amount Description of variable rate basis Assets Derivative Asset, Fair Value, Gross Asset Derivative Liability, Fair Value, Gross Liability Liabilities Derivative, by Nature [Axis] Derivative, Gain (Loss) on Derivative, Net, Total Derivative, Gain on Derivative Derivative, Loss on Derivative Derivative, Name [Domain] Higher variable interest rate range (in hundredths) Derivative Contract Type [Domain] Derivative Contract [Domain] Hedging Relationship [Axis] (Gain) loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect Lower variable interest rate range (in hundredths) Derivative Instruments and Hedging Activities Derivatives, Fair Value [Line Items] Share-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Share-Based Compensation [Abstract] Distributor and Provider Networks [Member] Distribution Rights [Member] Earnings per share [Abstract] Earnings Per Share, Basic and Diluted [Abstract] Earnings (Loss) Per Share Earnings Per Share [Text Block] Earnings (Loss) Per Share Basic (in dollars per share) Diluted (in dollars per share) Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Earnings (loss) per share: Earnings (Loss) Per Share [Abstract] Effect of exchange rate changes on cash Embedded Derivative Financial Instruments [Member] Accrued salaries and benefits Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Stock Options [Member] Employee Stock Option [Member] Tax benefit realized from option exercised Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted Weighted average period for recognition of unrecognized compensation cost Equity Component [Domain] Gross Fair Value [Member] Estimate of Fair Value Measurement [Member] Excess tax benefits from share-based payment arrangements Excess Tax Benefit from Share-based Compensation, Operating Activities Excess tax benefits from share-based payment arrangements Excess Tax Benefit from Share-based Compensation, Financing Activities Measurement Frequency [Axis] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Issuances into Level 3 Recurring [Member] Fair Value, Measurement Frequency [Domain] Purchases into Level 3 Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements [Abstract] Fair Value, Measurements, Fair Value Hierarchy [Domain] Assets and liabilities measured at fair value on a recurring basis [Abstract] Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Level 3 [Member] Gains/ (Losses) included in Earnings Balance at end of period Balance at beginning of period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Level 2 [Member] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Financial Instrument [Axis] Estimated useful life Estimated useful life Gross Carrying Amount 2018 Finite-Lived Intangible Assets [Line Items] 2016 Estimated future amortization expense [Abstract] Accumulated Amortization Total Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] 2019 and thereafter 2014 2017 2015 International [Member] Foreign Exchange Contract [Member] Foreign Currency Exchange Contracts [Member] Forward Contracts [Member] Furniture and Other Office Equipment [Member] Furniture and Fixtures [Member] Furniture and office equipment Gains or losses on cash flow hedges recognized in our consolidated statements of comprehensive income (loss) resulting from hedge ineffectiveness Goodwill, Other Changes Impairment loss Goodwill impairment Loss Goodwill, Impairment Loss Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Goodwill, net Balance, beginning of period Balance, end of period Goodwill Goodwill Disclosure [Text Block] Goodwill, Impaired, Accumulated Impairment Loss Goodwill [Roll Forward] Goodwill, Gross Ascentia purchase Goodwill, Acquired During Period Goodwill Gross margin Hedging Designation [Axis] Hedging Designation [Domain] Hedging Relationship [Domain] Indefinite-lived intangible asset impairment loss Intangible asset write-off Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Basic earnings (loss) per share (in dollars per share) CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Income (loss) before income taxes Income (loss) before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Income Statement Location [Axis] Income Taxes [Abstract] Income Tax Authority [Domain] Income Tax Contingency [Line Items] Diluted earnings (loss) per share (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Income Tax Authority [Axis] Income Taxes Income Tax Disclosure [Text Block] Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain] Income Statement Location [Domain] Income Tax Contingency [Table] Income tax expense (benefit) Income tax expense Income Tax Expense (Benefit) Change in valuation allowance Difference between income tax expense computed using statutory federal income tax rate and effective rate [Abstract] Effective Income Tax Rate Reconciliation, Amount [Abstract] Permanent items Cash paid during the period for income taxes Prior year tax adjustments Other Non-deductible goodwill impairment expense Uncertain Tax Positions [Abstract] Income taxes receivable Statutory federal income tax Income Taxes State income taxes, less federal income tax benefit Decrease (increase) in accounts receivable, net Increase (Decrease) in Accounts Receivable Increase (decrease) in accounts payable Increase (decrease) in other current assets Increase (Decrease) in Other Current Assets (Decrease) increase in other current liabilities Increase (Decrease) in Other Current Liabilities Decrease in accrued salaries and benefits Increase (Decrease) in Stockholders' Equity [Roll Forward] Effect of dilutive stock options and restricted stock units outstanding (in shares) Intangible assets not subject to amortization Intangible Assets [Abstract] Intangible assets, net Intangible Assets Intangible Assets Disclosure [Text Block] Interest expense Reclassification to interest expense Reclassification of net losses on interest rate swap agreements from accumulated OCI to interest expense within the next 12 months Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Cash paid during the period for interest Interest Rate Swap [Member] Interest Rate Swap Agreements [Member] Federal [Member] LIBOR [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Lease expiration date Leasehold improvements Leasehold Improvements [Member] Leases [Abstract] Leases Leases of Lessee Disclosure [Text Block] Letters of Credit Sub Facility [Member] Total current liabilities Liabilities, Current Liabilities, Fair Value Liabilities, Fair Value Disclosure, Recurring Total liabilities and stockholders' equity Liabilities and Equity Current liabilities: LIABILITIES AND STOCKHOLDERS' EQUITY [Abstract] Perpetual License to Survey-Based Data [Member] Licensing Agreements [Member] Maximum borrowing capacity Expiration date Initiation date Amount outstanding Line of Credit Facility [Line Items] Commitment fee description Line of Credit Facility [Table] Availability under the revolving credit facility under most restrictive covenant Outstanding borrowings under the Fifth Amended Credit Agreement Loans Payable, Fair Value Disclosure Long-Term Debt [Abstract] Outstanding borrowings under the Fifth Amended Credit Agreement Long-term Debt Debt Instrument, Fair Value Long-Term Debt Long-term Debt [Text Block] 2015 Long-term Debt, Maturities, Repayments of Principal in Year Two 2017 Long-term Debt, Maturities, Repayments of Principal in Year Four 2018 Long-term Debt, Maturities, Repayments of Principal in Year Five 2019 and thereafter Long-term Debt, Maturities, Repayments of Principal after Year Five 2016 Long-term Debt, Maturities, Repayments of Principal in Year Three Minimum annual principal payments and repayments of the revolving advances [Abstract] Current portion of long-term debt Long-term debt Long-term Debt, Excluding Current Maturities 2014 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months Amount of treble damages sought under the Sherman Antitrust Act and injunctive relief Maximum [Member] Minimum [Member] Netting [Member] Cash flows from financing activities: Cash flows from investing activities: Net cash flows used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from operating activities: Net cash flows (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Net cash flows provided by operating activities Net Cash Provided by (Used in) Operating Activities Net income (loss) Net income (loss) Net income (loss) Net income (loss)- numerator for basic earnings per share Recent Accounting Standards [Abstract] Number of states in which customers are located Number of reportable segments Derivatives Not Designated as Hedging Instruments [Member] Not Designated as Hedging Instrument [Member] Open tax year Open Tax Year 2019 and thereafter Operating Leases, Future Minimum Payments, Due Thereafter Future minimum lease payments under operating leases [Abstract] 2017 Operating Leases, Future Minimum Payments, Due in Four Years 2018 Operating Leases, Future Minimum Payments, Due in Five Years Total sublease income 2016 Operating Leases, Future Minimum Payments, Due in Three Years Rent expense 2014 Operating Leases, Future Minimum Payments Due, Next Twelve Months Operating income (loss) Operating Income (Loss) Operating Loss Carryforwards [Table] Operating loss carryforwards, expiration dates Operating Loss Carryforwards [Line Items] 2015 Operating Leases, Future Minimum Payments, Due in Two Years Operating Leased Assets [Line Items] Total minimum lease payments Operating Leases, Future Minimum Payments Due Operating loss carryforwards 2014 Other Commitment, Due in Next Twelve Months Total other comprehensive income, net of tax Net increase (decrease) in other comprehensive income (loss), net of tax Other Noncurrent Assets [Member] Other Current Assets [Member] Other Current Assets [Member] Tax effect of reclassification Foreign currency translation adjustment Reclassification Adjustment on Derivatives Included in Net Income Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Other assets Other Long-Term Liabilities [Abstract] Other current assets Other [Member] Other comprehensive income (loss) Other Other Operating Activities, Cash Flow Statement Net change in fair value of interest rate swaps, net of income taxes of $972, $493, and $1,109, respectively Tax effect on interest rate swap agreements Net change in fair value of interest rate swaps, income taxes Accrued performance cash amount, current portion Other long-term liabilities Current portion of long-term liabilities Other Long-Term Liabilities Other Liabilities Disclosure [Text Block] Non-cash charges primarily consisting of share-based compensation costs Accrued performance cash amount Sun Trust Bank Prime Rate [Member] Prime Rate [Member] Patents [Member] Payments for Hedge, Financing Activities Payments for cash convertible note hedge transactions Sale of investment Payments for (Proceeds from) Investments Tenant improvement allowance Payments for (Proceeds from) Tenant Allowance Repurchases of common stock Payments for Repurchase of Common Stock Other Payments for (Proceeds from) Other Investing Activities Deferred loan costs Payments of Loan Costs Business acquisitions, net of cash acquired, and equity investments Payments to Acquire Businesses, Net of Cash Acquired Payments Payments for Restructuring Acquisition of property and equipment Payments to Acquire Property, Plant, and Equipment Net Fair Value [Member] Preferred stock, par value (in dollars per share) Preferred stock $.001 par value, 5,000,000 shares authorized, none outstanding Preferred stock, shares authorized (in shares) Preferred stock, shares outstanding (in shares) Preferred Stock [Member] Prepaid expenses Change in outstanding checks and other Proceeds from sale of warrants Issuance of Warrants Proceeds from cash convertible senior notes Proceeds from issuance of long-term debt Exercise of stock options Cash received from option exercises Proceeds from Stock Options Exercised Useful life Property and equipment: Property and equipment, gross Property, Plant and Equipment, Gross Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment [Line Items] Quarterly Financial Information (unaudited) Quarterly Financial Information [Text Block] Quarterly Financial Information (unaudited) [Abstract] Range [Axis] Range [Domain] Accounts Receivable, net Receivables, Policy [Policy Text Block] Amounts reclassified from accumulated other comprehensive income to: [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification Out Of Accumulated Other Comprehensive Income [Domain] Reclassification Out Of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Changes in unrecognized tax benefits [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Payments of long-term debt Repayments of Long-term Debt Restricted Stock and Restricted Stock Units (RSUs) [Member] Restricted Stock Units [Member] Restricted Stock Units [Member] Nonvested Shares [Member] Cumulative net cash and non-cash charges Restructuring and Related Cost, Cost Incurred to Date Restructuring and related charges Restructuring and Related Charges and Impairment Loss Restructuring, Impairment, and Other Activities Disclosure [Text Block] Restructuring Plan [Domain] Adjustments Restructuring Reserve, Accrual Adjustment Accrued restructuring and related charges, beginning of period Accrued restructuring and related charges, end of period Restructuring Reserve Restructuring and Related Charges and Impairment Loss [Abstract] Restructuring Plan [Axis] Additions Restructuring Costs Restructuring Reserve [Roll Forward] Restructuring Cost and Reserve [Line Items] Share-Based Compensation Included in Restructuring and Related Charges [Member] Restructuring Charges [Member] Retained Earnings [Member] Retained earnings Revenue Recognition [Abstract] Revenue Recognition Fifth Amended Credit Agreement [Member] Revolving Credit Facility [Member] Exercisable Expected term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Estimated future amortization expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Revenues Sales Revenue, Services, Net Assets and liabilities measured at fair value on a recurring basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Summary of nonvested shares Schedule of Nonvested Share Activity [Table Text Block] Summary of option activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Weighted average grant-date fair values of options and the weighted average assumptions used Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Components of income tax expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Minimum annual principal payments and repayments of the revolving advances Difference between income tax expense computed using statutory federal income tax rate and effective rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Significant components of net deferred tax liability Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Changes in unrecognized tax benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table] Gains and Losses on Cash Convertible Notes Hedges and Cash Conversion Derivative Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Schedule of quarterly financial information Reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share Intangible assets subject to amortization Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of changes in accumulated other comprehensive income (AOCI) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of Operating Leased Assets [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Allocated share-based compensation costs Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Change in carrying amount of goodwill Schedule of Goodwill [Table Text Block] Schedule of Restructuring and Related Costs [Table] Schedule of Property, Plant and Equipment [Table] Change in accrued restructuring and related charges Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Fair values of derivative instruments Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Effect of cash flow hedges on consolidated balance sheets Derivative Instruments, Gain (Loss) [Table Text Block] Segment Disclosures [Abstract] Segment Disclosures Segment Reporting Disclosure [Text Block] Share-Based Compensation Included in Selling, General and Administrative Expenses [Member] Selling, General and Administrative Expenses [Member] Selling, general and administrative expenses Summary of stock options [Abstract] Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Weighted-Average Exercise Price [Roll Forward] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Weighted average grant-date fair value of nonvested shares granted (in dollars per share) Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted (in dollars per share) Forfeited (in dollars per share) Nonvested, beginning of period (in shares) Nonvested, end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based employee compensation expense Share-based Compensation Award vesting period Weighted-Average Grant Date Fair Value [Roll Forward] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Nonvested, end of period (in dollars per share) Nonvested, beginning of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Expired (in dollars per share) Exercised (in dollars per share) Exercisable, end of period (in dollars per share) Expected dividends (in hundredths) Total grant-date fair value of shares vested Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Vested (in dollars per share) Exercisable, end of period (in shares) Weighted-Average Remaining Contractual Term [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Number of shares reserved for future equity grants (in shares) Total intrinsic value of options exercised during period Expected volatility (in hundredths) Risk-free rate (in hundredths) Weighted average grant-date fair values of options and weighted average assumptions used [Abstract] Weighted average grant-date fair value of options per share (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding Shares [Roll Forward] Award Type [Domain] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Computer Software [Member] State [Member] Statement [Table] Statement [Line Items] CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY [Abstract] CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] Statement, Equity Components [Axis] Equity Components [Axis] CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) CONSOLIDATED BALANCE SHEETS [Abstract] Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Issuance of stock in conjunction with acquisition Stock Issued During Period, Value, Acquisitions Issuance of unregistered common stock associated with Navvis acquisition Non-Qualified Stock Options [Member] Non-Qualified Stock Options [Member] Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Other Stockholders' Equity, Other Stockholders' equity: Stockholders' equity: Total stockholders' equity Balance Balance Stockholders' Equity Attributable to Parent Supplemental disclosure of cash flow information: Note Hedges and Conversions [Member] Types of Financial Instruments [Domain] Repurchases of common stock Treasury Stock, Value, Acquired, Cost Method Treasury stock (in shares) Treasury Stock [Member] Treasury stock, at cost, 2,254,953 shares in treasury Treasury Stock, Value Undistributed Earnings of Foreign Subsidiaries Decreases based upon tax positions related to prior years Unrecognized tax benefits that affect our effective tax rate Reduction resulting from lapse of applicable statute of Limitations Balance, beginning of period Balance, end of period Unrecognized Tax Benefits Uncertain tax position reversal Estimate of remaining payments pursuant to outsourcing agreement Unrecorded Unconditional Purchase Obligation, Change of Amount as Result of Variable Components Total minimum payments required under outsourcing agreement over remaining term Unrecorded Unconditional Purchase Obligation Management Estimates Reference Rate [Domain] Reference Rate [Axis] Weighted average common shares and equivalents Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (in shares) Shares used for basic earnings (loss) per share (in shares) Diluted (in shares) Shares used for diluted earnings (loss) per share (in shares) Maximum aggregate number of CareFirst Warrant Shares in any single 12-month period beginning on October 1, 2013 CareFirst Warrant Shares for one year period Maximum aggregate number of CareFirst Warrant Shares issuable pursuant to the Investment Agreement CareFirst Warrant Shares Maximum Carrying amount of long-term debt, including unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. Long-term Debt, including unamortized discount Total The initial strike price of the warrants effectively increase the conversion price of the notes to this percentage above the stock price. Conversion price premium percentage Date entered into a Registration Rights Agreement with CareFirst Date of Registration Rights Agreement Document and Entity Information [Abstract] Aggregate notional amount effective as of the latest balance sheet date. Notional Amount Effective As Of Latest Balance Sheet Date Current notional amount Represents noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Other long term liabilities [Member] Other Long-Term Liabilities [Member] Derivatives in Cash Flow Hedging Relationships [Abstract] Derivatives in Cash Flow Hedging Relationships [Abstract] Aggregate notional amount of interest rate derivatives that will become effective after the latest balance sheet date, which relates to the currency amount specified in the interest rate derivative instruments. Notional amount effective in future Represents the portion of the derivative that will become in effective in 2013. Effective in June 2013 [Member] Represents the portion of the derivative that will become in effective in 2015. Effective in 2015 [Member] Represents the portion of the derivative that will become in effective in 2013. Effective in November 2013 [Member] Reclassification Adjustments Out Of Aoci [Abstract] Reclassification adjustments out of AOCI [Abstract] Net of tax amount, before reclassification adjustments, of the change in accumulated other comprehensive income (loss) related to translation gain (loss), unrealized gain (loss) on derivatives, pension liability adjustment and unrealized gain (loss) on equity investment. Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax Other comprehensive loss before reclassifications, net of tax Net of tax amount of the income statement impact of the reclassification adjustment for translation gain (loss), unrealized gain (loss) on derivatives, pension liability adjustment and unrealized gain (loss) on equity investment. Other Comprehensive Income Loss Reclassification Adjustments Net Of Tax Amounts reclassified from accumulated OCI, net of tax Tabular Disclosure of Level 3 Rollforward Level 3 Financial Instruments [Table Text Block] Warrants related to the issuance of the Cash Convertible Notes Warrants Related to Cash Convertible Notes [Member] Denominator [Abstract] Denominator [Abstract] Numerator [Abstract] Numerator [Abstract] Facility (Corporate office space) held for productive use including, but not limited to, office, production, storage and distribution facilities. Corporate office space [Member] Corporate Headquarters and Call Center [Member] Facility (Chandler office space) held for productive use including, but not limited to, office, production, storage and distribution facilities. Office Space in Chandler [Member] Facility (Operations support and training offices) held for productive use including, but not limited to, office, production, storage and distribution facilities. Operations support and training offices [Member] Operations Support and Training Offices [Member] Term of the operating lease. Operating lease, term Operating lease term Facility (Call centers) held for productive use including, but not limited to, office, production, storage and distribution facilities. Call centers [Member] Other Call Center Locations [Member] Represents the current portion of present value of minimum lease payments for capital leases net of executory costs, including amounts paid by the lessee to the lessor for insurance, maintenance and taxes. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments, Current Less current portion Represents the noncurrent portion of the present value of minimum lease payments for capital leases net of executory costs, including amounts paid by the lessee to the lessor for insurance, maintenance and taxes. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments, Noncurrent Future minimum lease payments, net of current portion Future minimum lease payments, under all capital leases and non cancelable operating leases [Abstract] Minimum remaining contractual cash obligations related to the global joint venture agreement and strategic relationship agreement with Gallup. Minimum remaining contractual cash obligations Contractual Commitment [Abstract] Anti Trust Lawsuit [Abstract] Anti-Trust Lawsuit [Abstract] Share based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions [Abstract] Assumptions [Abstract] Period after which the share based compensation option awards expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D'. Share based payment award, expiration period Expiration period Aggregate Intrinsic Value [Abstract] Restricted Stock and Restricted Stock Units [Abstract] Estimated future plan payments [Abstract] Estimated future plan payments under non-qualified deferred compensation plan [Abstract] Estimated future plan payments, performance cash awards [Abstract] Estimated future plan payments for performance cash awards [Abstract] Cash convertible senior notes due 2018 Cash Convertible Notes [Member] Cash Convertible Notes [Member] Revolving Credit Facility which includes a swingline sub facility and a sub facility for letters of credit Fifth Amended Credit Facility [Member] Convertible subordinated promissory note issued to CareFirst on October 1, 2013 in the aggregate original principal amount of $20 million CareFirst Convertible Note [Member] Cash Conversion Derivative Cash Conversion Derivative [Member] Cash-settled hedge entered into in connection with the issuance of the Cash Convertible Notes, intended to reduce our exposure to potential cash payments that we would be required to make if holders elect to convert the Cash Convertible Notes at a time when our stock price exceeds the conversion price Cash Convertible Notes Hedge [Member] Cash Convertible Notes Hedges and Cash Conversion Derivative [Member] Represents the 2010 Restructuring which primarily focused on aligning resources with current and emerging markets and consolidating operating capacity. Restructuring Plan 2010 [Member] 2010 Restructuring Plan [Member] 2011 restructuring of the company- primarily focused on aligning our capacity requirements and organizational structure following CIGNA's decision to wind down its contract. Restructuring Plan 2011 [Member] 2011 Restructuring Plan [Member] Represents the 2012 Restructuring which primarily focused on aligning resources with current and emerging markets and consolidating operating capacity. Restructuring Plan 2012 [Member] 2012 Restructuring Plan [Member] The entire disclosure related to an entity's stockholder rights plan. Stockholder Rights Plan [Text Block] Stockholder Rights Plan Stockholder Rights Plan [Abstract] This element represents terms of periodic payment. Periodic payment Terms of periodic payments The federal funds rate is the interest rate at which depository institutions actively trade balances held at the Federal Reserve, called federal funds, with each other, usually overnight, on an uncollateralized basis. Federal Funds Rate [Member] A type of option that a borrower can have inserted into a syndicated credit agreement at the outset of the transaction which allows it to increase the principal under the credit agreement, subject to there being no event of default. The interest, maturity and other terms applicable to the increased commitment will be identical to those applicable to the existing credit facility to which the increase relates. Companies typically purchase an accordion feature in anticipation of the need for more capital for possible expansion opportunities. Uncommitted Incremental Accordion Facility [Member] A large loan that a company may take out in order to repay other debts. A swingline loan is much like a line of credit or a demand loan, but differs in that it must be used to repay outstanding debt. Swingline Sub Facility [Member] A loan from a bank for a specified amount that has a specified repayment schedule and a floating interest rate. Term Loan Facility [Member] Acquired technology in a business combination, which can include the right to use, market, sell, or offer for sale products, compounds, or intellectual property. Acquired technology [Member] Acquired Technology [Member] Description of the impact of recently issued or adopted accounting standards on the company's financial statements. Recent Accounting Standards [Text Block] Recent Accounting Standards A firm that supports diabetes education program management for diabetes educators Chiron Data Systems, Inc. [Member] Chiron Data Systems, Inc. Firm that provides strategic counsel and change management services to healthcare systems. Navvis & Company [Member] Firm that supports and promotes population health management, patient centered programs, payer strategies and physician practice enhancement programs. Ascentia Health Care Solutions [Member] Ascentia [Member] The aggregate amount of additional goodwill acquired in the period and allocated to the reportable segment. The value is stated at fair value based on the purchase price allocation. Goodwill, Additional Acquisition During Period Navvis purchase Goodwill [Abstract] The percentage of the revenues that were performance-based Percentage of performance based revenues (in hundredths) Purchased software applications and the corresponding computer equipment (examples computers, printers, and servers). Computer software and hardware [Member] Computer Software and Hardware [Member] Cumulative performance-based revenues that have not yet been settled with our customers but that have been recognized in the current and prior years. Cumulative performance based revenues not settled yet but recognized Cumulative performance-based revenues not settled yet but recognized The increase (decrease) in net revenue recognized during the reporting period, relating to services provided in prior periods. Net increase in revenue relating to services provided in prior periods Net increase in revenue relating to services provided in prior periods The percentage of the revenues that were performance-based and were subject to final reconciliation. Percentage of performance based revenues subject to final reconciliation (in hundredths) Intangible Assets (Excluding Goodwill) [Abstract] Intangible Assets [Abstract] Deferred Tax Liability attributable to Cash Convertible Notes Hedges Deferred Tax Liability on Cash Convertible Notes Hedges HWAY Deferred Tax Liability on Cash Convertible Notes Hedges Deferred Tax Asset attributable to Cash Conversion Derivative Deferred Tax Asset on Cash Conversion Derivative Amount of net decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations Decreases based upon a lapse of the applicable statute of limitations The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. Proceeds from convertible note The fair value of stock issued in noncash financing activities related to the Ornish partnership. Stock Issued 3 Issuance of unregistered common stock associated with Ornish partnership The fair value of stock issued in noncash financing activities. Stock Issued 2 Issuance of unregistered common stock associated with Ascentia acquisition Disclosure of accounting policy for contract billings in excess of earned revenue. Contract Billings in Excess of Earned Revenue [Policy Text Block] Contract Billings in Excess of Earned Revenue Disclosure of accounting policy for other assets. Other Assets [Policy Text Block] Other Assets Liabilities representing performance-based fees billed on contracts that exceed the performance-based revenues earned to date by the entity based on the entity's inability to measure its performance or its performance results to date not achieving contractual targets. Billings In Excess Of Earned Revenue Contract billings in excess of earned revenue EX-101.PRE 13 hway-20131231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 14 hwaylogo.jpg begin 644 hwaylogo.jpg M_]C_X``02D9)1@`!`0$`>`!X``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#,#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**X+QY\5]!\#J MUL[?;M5QE;.%N5]W;HH_7VKSJSL_B;\6\7%Y?'0/#\GW5C#()%]ESN?ZL0/2 M@#U[6O'_`(4\/DKJ>O644@ZQ*_F./^`KD_I7)3_'WP:KLEJNIWC#H(+7K_WT M15OP]\$O!FAHK3V+:G<`/QK0KQ_ M7?@+IOFF_P#"6IW6B7Z$E`)&:/Z`YW+]&`X:,_W67J#]:UZ`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`KQ?XM_%\Z$\OAWPY*&U3[MS=+R+?/\*^K^_;Z].D^+WC_P#X M0GPUY=G(/[6OLQVP[QC^*3\,@#W/L:\P^!GP_&NZF_BS6(S-:6\I^RK+SYTW M4N<]0OZM]*`.@^%GP="^7XE\7PM/>R'S8+.?YMN>=\N?O,>N#T[\]/P\"^'WU&['FSN=EM;@X,S^GL!U)_KBLOX8Z?JT MVE2^*/$%Q))JNLA9?*)(2W@&?+15Z#@Y]>>>IR?%OXU6=F&9])6X\J M%!T%NGS.WU8*3^(':OJ=5"J%4``<`#M0`M>3_$'4=4^'/B6#QAIYFN=&OG6# M5;)G)4,!A9$S]TD#'ID#/6O6*QO%>AQ>)?"NIZ/*H874#(F>SXRA_!@#^%`% MS2-6LM=TFVU/3YQ-:7*!XW'<>X[$="/6FZQHVG:_IDNG:I:1W5K*,-'(,_B/ M0CL1R*^??@'XQFTKQ!-X1OY"L%TS-;JQ_P!7.OWE]MP!_$#UKZ1H`^7O%'AC MQ#\%O$L>N>'[J2329GVI(W(/?RI@.OL>_;!KW7P#X\T[QYH8O;7$5W%A;JU) MRT3?U4]C_4&M[6-(LM=TFYTS481-:7*%)$/IZCT(Z@]C7RE)_;'P6^)S+$[2 M11$$9X6[MF]??C\&6@#Z[HJCHVK6FNZ/::I82>9:W48DC;V/8^X.0?<5>H`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`I"0`23@"EKEOB/K+:!\/=;OT?9*ML8XF]'?Y%_5J`/F/QOK-U\1OB?(MF3 M)'-<+96*CD!`VT$?4Y;\:^M-!T:U\/:#9:19+BWM(A&OJWJQ]R_:-F>/P'81`_+)J*;OPC?_LZV*7'CZ[NGZVMB[+]6 M95_D37U#7S)^SC)94/J&&1_.OC'XE3KYKWROC+X?7\GA;XIZ6TK$&*]^R38]&)C;^>?PK[-H`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KR[X_RF/X82 MJ.DEW"I_,G^E>HUYA\?83+\+KAP.(KJ%S^>W_P!FH`X?]FB$'4/$4V.5B@0' MZES_`$%?0]?.W[-,ZKJGB"W+?,\,+@?1F!_]"%?1-`!7E7[0.GF\^&IN%'_' MG>12GZ'*?S<5ZK63XHT5/$?A?4]'D(`N[=HU9AD*V/E/X'!_"@#Y'^%FO)X= M^(VD7DK!8'E^SRD]`L@VY_`D'\*]D_:*U^_T[0-,TNTEDB@U"20W!0XWJ@7" M$^A+9(]J^<;NUN-/O9K2X1HKB"0QR(>"K*<$?F*^D](AT[XX?"^WM;^Y,.M: M>0CS*,M'*!@.1W5QR??/I0!\SQR/#*DD3LDB,&5U."I'0@]C7V+X-\633_"& MT\3:L^Z6&SDDF=N/,\LL,_4[1^)KR>P_9NUEM15=0UJQ2R##<\"NTC#V!``/ MX_G6E\;?$-CX:\*Z?X`T0A%\M#<*IR4B7E5/NQ^8_3WH`\$N[F2]O9[J4YDF MD:1C[DY/\Z^W?!M@^E^"=#L9!B2"QA1QZ,$&?UKY%^'?AM_%7CK3--$>^#S1 M+<\<")#EL_7I]2*^U@,#`Z4`%%%%`'Q7XX4:7\4-;,''DZG)(OUW[J^T87\V M".3^\H;\Q7Q;XQ<:S\4-7$.<7&J/&G_?S:*^TXD\N)$_NJ!0`ZBBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*YWQYHI\ M0>!=9TQ`#)-;,8P1_&OS+^H%=%10!\E?`O6$TGXFVL4K%4OHGM?^!'#+^J@? MC7UK7R#\3O#UQX$^)4D]DIBMY)A?6+CH/FR0/]ULC'IBOJ;PKX@M_%/ABPUF MV(V7,09E'\#CAE_`@B@#8HHHSB@#YX^/7P\DBNF\7Z7"6ADPNH(@^XW02?0\ M`^^#WKS#P!XLU;PCXHM[S2HWN&E(BEM%!/VA2?NX'?T/8U]?:[XB\/Z-:2C6 M]3LK>)E*O'/(N7!'(V]3D=L5\ZW_`,1?"7A&:Z'PZT)%O)BV=3O%+&,'M$K< M@?7'N#0![+X]^)NG^"M!CFDC+:O=1!K>PI(ZR8Z`'KZD8'J/DG4M1O=XO+F3?(YY+,?\X`J9FU?Q1K19OM6I:E=/S@&220_Y_*O9?!'A'PM\ M.M1L]0\>:I9Q:Y)AK6Q8^8+;T=]H(W>A/`]SR`#N/@O\/6\(:`VI:C%MU?4% M!=6ZPQ=0GU[G\!VKU"JECJFGZI`)M/O;:[B(R'@E5Q^AJW0`5GZYJD6B:#?Z MI.P$=I`\QS_LC.*T*\9_:$\6+IWANW\.6\@^TZBWF3`'E85/?_>8#_ODT`>. M_#'3)?$WQ3TH3*9`+DWDY[83+Y/U8`?C7V17A_[._A)K+2KSQ/=1;9+W]Q:Y M'/E*?F;Z%@!_P"O<*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`.*^)W@6+QUX6>UC"IJ-L3+9R-Q\^.4)]&Z M?7![5XI\'_'4W@CQ'/X9U[?;6-S-L82\?9;CID^@.,'\#ZU]05Y9\5?A+!XR MB?5M)"0:Y&O.>%N@!PK>C=`&_`^H`.Z\1>'K?Q/IJV<][?V@5Q(LMC<&%P<$ M=1U'/0Y%>7:O\%/$EPQ^P_$'4I(S_P`L[QY#Q]0_/Y5B?#GXM7?A>Y'A/QND MT"VY\J*YF4[X.P20=2OHW;Z=/H&">*Y@2:"5)8G&Y)$8,K#U!'44`?.9_9OU MZ24M+X@L"2RW=KXJEFEE8LQOX2 M[L?=P>3^%>\T4`?.5M^SMXDM)A);^);.!A_'$)%;]*[#1O@UJ\&W^UO'^N31 M_P`4-I.\8/\`P(L?Y5Z[6+XF\5Z/X1TI]0UB[6&,<(@Y>5O[JKW/^3B@"/5M M5TOP-X2:[O;B3[)90A%,LA>24@85*OCOXJ$=K$;71K9\+N_U5LI_B8_Q2$=A^@R:^A?! M_A#3/!>@Q:7ID?`^:69@-\S]V8_T["@#7L+&VTVPM[&SA6&VMXQ''&HX50,` M58HHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`.5\9?#W0/'%J$U2VVW*#$5W#A94]L]Q['(KRJ'PK\ M3/A5,S>')UUW102S6N"<#.3^[SE3[H37O]%`'DNB_'S09I/LOB*QO-$O%P'$ MD9D0'\!N'XK7=:?XZ\*:I'OL_$6FR#T-PJM^3$&M'4]#TG68Q'JFFVEZ@Z"X MA5\?3(XKD[SX->`KTY;0(XCZP32)^@;%`'4MXAT5%W-K&GJOJ;E!_6L'5?BG MX)TR?F*]Q@@AMH5AMXHXHE&%2-0JCZ`5)0! M3TO2K#1;"*PTVTBM;6(82*)<`>_N?[XJ:)'CIJT? MZ2"OM.@`KQ;X@?&C5_!7C2\T6+2K.ZMXTC>)W9E;YE!.<'!YSZ5[37RE^T`H M'Q/D([V<)/ZT`?2/@W6;GQ#X0TO6+N...>\@$K)$#M7)/`R2:W*YGX>1>1\. M?#J?]0^$_FH/]:Z:@#Y\UOX_:]HOB;5-*.CZ?.EI=RP1L"ZL0K$#/)YXI7^/ M?BM%RW@Q5]R)-?#[XO:YXQ\;1:->Z7 M9V-N8))3@/YA*C@`DX_3M7LM1M!$\BR-$AD3[KE1E?H>U24`%9/B?7(?#?AG M4=8GQMM(&D"DXW-CY5_$X'XUK5XC^T+K\IL=+\)V8+W%_*)I$7J5!PB_BW_H M-`&I\'_BGJ'CB]U'3]92T2[AC6:#R%*;TSAL@D\@E?SKUJOC#P+K%QX&^)%G M/>*T)M[DVMY&>JJ3L<'Z=?PK[/!R,T`%NKKS[XVIO\`A-K'^R83_P"14H`POAG\7M3\>^*GTNXTRUM(([5Y MRT;,S$AE`'/`'S&O7J^8?V/-0?\`NZ<__HQ*^GJ`.?\`&^MW/AOP7JFL M6:Q-<6D7F(LP)4GJN,@_A3@`HP``/04`?.DO[1VNV[F.?PU:1OC.UY'4_D:5OVA?%#1!XO"]J% M89#$2L"/7M7-_'X8^*$WO:0_R-?17P\`'PY\.`?]`Z#_`-`%`'%?"CXGZWX[ MUW4++5+6RMH[:V$JK`CAB2P'.YCQ7JEW*T-G/*F"Z1LPSTR!FG""%9C,(HQ* M1MWA1NQZ9]*2Y7?:S)_>1A^E`'@?A[X_:[KGB#2=).C:?&;NZB@DE5G.%9@& M(&>#CW-?0-?%WPSC!^*'A]#VOD/Y'/\`2OM&@`KQ/Q[\:]7\&>--0T2+2K*Y MAA$;12.S*V&16YQP>2?2O;*^2OCNNWXK7Y_O00'_`,A@?TH`^GO"NJSZYX4T MK5;F-(Y[RUCG=(P0JEAG`SVYK"^)GBG5_!OAN/6]+M;>ZBAF"744P;[C,-@=^M:O@90G@'P\H[:=;_^BUJUXFT:/Q#X9U+2)!Q=V[Q@^C$?*?P.#0!Y MM\,/B_?>.O%5QI5]86MI&+4S1>46+%E8`@DGT/IVKUZOC/X:ZB_AOXI:1)XBVK"D@)5G9@!G!'')/X M5R'PG^*M]X]U;4;'4K2TMI((4EA$&[YAG#9R3W*UA?M':PPTW1=`A+&2YF:X M=5[A1M4?B6/Y5Y?\(M5?0/BEI8E!C$\K6'_M(ZOY.@Z/I"GFYN&N''LBX M'ZO^E`'6?"SQYK/C^&_O[RPMK*QMV6&(1;F,DAY8Y/8#;QC^*O1*Y+X:>'1X M8\`:58,H$[1>?/[R/\Q_+('X5UM`&-XLU^+POX5U'69=I%K"612?O/T5?Q8@ M5P/P?^*%_P".9]2L=82U2\MU66'R%*ATZ-P2>0$+$,]Q? M2B:2->K#.V-?Q;)_`5Y)\/M9F\$?$NSEO`8A%<-9WB'^%2=C9^AY_"@#[,KA M_B9XHU[P9HL6N:5:6MY9Q/LO(9E; MQ"6VN8VBE0]U(P:`/(_AU\:[KQCXQ31M0T^ULXYX6,!B9BQD7G!)/3:&[=17 MLU?$^M:9J7PZ\?/`K%;K3KE9K>4CB10=R-]".OXBOL7P[K=KXD\/V.KV9S!= M1"0#/W3W4^X.1^%`%;QCXBB\*>$]1UJ0*QMHB8T8X#R'A5_$D5P_PR^(WB/X MA:C,TNEV=EIEHO[^9-[-)(?NHN3@=R>O&/6N8^/NO7&J:KI/@C3`99Y76::- M#DL[';&A_,G\17K/@?PI;>#/"EGH\&UG1=]Q*/\`EK*?O-_0>P%`%KQ+XFTS MPGHLNJZM/Y5NF%``RSL>BJ.Y->/1_%_Q[XKGE;P=X21[.,[?,F1I#^+950?; MFL3]H_5KB7Q1IFD;R+:WM//"YX+NS`D_@@_,U[IX'LK'3_`^BP:<$^S?8XW5 ME_C+*"6/N22:`/'8_COXI\.ZG]B\7^&$1NI$:O!(!Z@-D,/R^M>ZZ1J<.M:/ M9ZG;I*D-U$LT:RKM8*PR,BN>^(/@.T\?:''8SRK;W$,JR0W/E[BG]X8R."/? MT/:NKBB2&%(HU"HBA5`[`=*`'T444`%%%%`!1110`4444`%%%%`!1110!\1Z M;JL?A[XAQ:K+$\L=CJ)F9$(!8*^<"O"ACP+X?'_4.M_\`T6M;M8O@ M]=G@G05SG&G6_P#Z+6MJ@#XP\=R+;_%G6YGSLCU1W;`YP'R:]Z/[0?@D#A=3 M/TMA_P#%5X1XVC6?XP:O$X!1]696!Z$%\&OJ!_ACX(<8/AC3?PA`_E0!7\%? M$S1_'E_>6VDVUZBVD:O))<(J@[B0``&/H:[2N?T#P3X=\+7EQ=:)IJ67IBDV7=]_HD&#S\P^8CZ+NY]<5XCX'L?BIH6D&Y\*Z9(E MGJ`6;S?*A;S``0I^?G')_.@"7X^>&1HWCD:I#'MMM5C\TD#`$J\./Q^5O^!& MO:?/(^ZZM1]DN,]=R``$_5=I^I->(>,K#XM>(M&)\2Z5++9V M6ZXWB&%3&`#D_)SC'4>U7/V>?$W]G>*;K09I,0:C'OB#'@2ISQ]5S^0H`^FZ MX+XT#/PFUS_=B_\`1J5WM<%\9_\`DDVN?[L7_HU*`/(_V;A_Q6FJG_J''_T8 ME?3-?,_[-W_(YZK_`-@\_P#HQ*^F*`"BBB@#Y1^/_P#R4^7_`*](?Y&OHKX? M`CX=>'`?^@=!_P"@"OG7X_?\E0E_Z](?Y&OHSP#_`,D\\._]@Z#_`-`%`'14 MU_\`5M]#3J:_^K;Z&@#XA\,:U%X;\;V.L30O+%9W7F-&A`+`9X&:]W'[27A[ M'S:+J@/L8S_[-7BG@.SM=3^)FD6EY!'<6L][MDBD&5=>>"*^JQ\-O!0''A?2 M_P`;=30!P!_:2\.]M%U7_P`A_P#Q5>*?$?Q7;>-/&,^M6EO+;PR1QH(Y2-WR MK@].*^JF^&O@INOA?2_PMU%?,OQBTC3]#^(UY8:7:16EJD416*(84$H"?UH` M^J?""[?!6@J!C&G6_'_;-:VJR/"O_(GZ)_UX0?\`HM:UZ`/C_P",&COX>^*. MHM"/*2Y9;V$KQC=R3_WV&KZJ\,:NFO>%],U5#Q=6R2'V8CD?GFO&_P!I/12U MIHNN(G^K=[25O8_,G\G_`#K0^#?C&.T^$.J27+;FT'S7VL>J$%U'XMN%`&)J M&[QS^TK!;#+6>CNH;/(`A^9OSD./QKA/BUI$OACXIZA+#E%GE%_`V,/?VB;'1OF MDLM/9(I,=_&C MQ1_PC?P]NXXI-EWJ)^R0XZ@,/G/_`'SD?4B@#SKP/N^(WQVU#Q+(/,T_3F,D M&>@"_)"/KQN^H-/#0T3Q\U_"FVVU6/[0,#@2#AQ^>&_X%3_!%C\5M!T; MS_"VF2I97^V?S/*A;S!CY3\_.,?SI?&NG_%CQ!H_F^)]*EDL[#=/O$4*F,8^ M8_)SC'\J`/=OA5XE'BCX>Z;=.VZYMT^RW'^^@`S^*[3^-=I7S1^SQXH^P>); MOP]/)B'44\R$$\"5!D@?5<_]\BOI>@#QSX^^"AJ_AU/$EI%F]TT8FVCEX">? M^^2<_0M7&?!/XD6OAK3]6TG6+C99Q1/>VV3_`!*/FC7W;@@>N?6OI.:&.X@D MAF19(I%*.C#(92,$'VKXC\<:#%X9\;:MHUNY>&VG(C)Z[2`R@^X!`_"@#V/X M,:)=>+/%NJ?$+6EWN9F2V!&1YA')&>RJ0H^OM7OE9'A;1K7P_P"%]-TNS7;# M;P*HR,%CC+,?!_M$>$+RY:R\46<+RQ01?9KO8,F-02RN1Z MW'K7">`OC'K?@JVCTZ6)-1TI3E8)&*O$#UV/V'L01]*^MG19$9'4,K#!4C(( M]*\M\7?`GPUX@,ESIF='O6YS`NZ%C[Q]O^`D4`;G@_XK>%_&3I;VEV;:_8?\ M>ET-CD^BGHWX'/M7;U\2^+O!VM>`M;6TU%=CY\RVN86.R0`_>4]01QQU%?4O MPI\3W/BSX?V-_>MOO(RUO._]]D.-Q]R,$^Y-`':T444`%%%%`!1110`4444` M%%%%`!2$A5)/0"]%M+^%H+N"RBBEC8@E650"...U;E M`'QEXND!^,&JR=0-9?\`26OLVOE+Q#\+?'FI>,=5U.TT&79-?RS12&:-<@N2 MIY;Z5T1T3X\E-WVVZ^GVR'/\Z`/HOI17@GA/2OB]%XTTI_$,VI-I2S@W'^EH MR%<'J%;D9QVKV_5;BZM-)N[BRM6NKN.)FA@4@&1\?*,D@#G%`'SI\7=1F\HKXMUZQNOA[\2;B&V++)IMX);=L]4R&3\U(S^-?:E>&_&KX::YXI\3: M=J>@6`N6>W,-Q^\5`A4Y4DL1U#$?\!H`]DT?5+?6]&L]4M&W07<*S)SG`(SC MZCI^%<=\:B!\)M:SW$(_\BI4'P=TSQ)X?\,SZ#XBL)+321;8E8`D!P3R2!T%`'D'[-O\`R-^K M_P#7A_[46OI:OE?P[\-?BQX?GEN-&M'T^:5-CL+J$$KG..6/<5MSZ'\>%4YO M+QN/^6=[#G^=`'T;FBO-?A'9>,+.UU4>,A?&[:6,PO=3B4%,'(7#$#GK]17I M5`'R9\>GW?%.[']VWA'_`([G^M?1_P`/FW_#KPX?^H=!_P"@"O%OB=\,_&7B MOX@ZKJFFZ3YEF1&L4C3QIO"QJ#@%L]--%\;Z%J=_HQCM8;I'E83QL8U!ZD!LU]04`%?) M'QV8'XKZB/2&`?\`D-:^MZ^;_B=\,_&/BCXA:MJFFZ.9;-O+6*1IXUWA8U!P M"P/4&@#WGPH0?!VAD=#I\'_HM:UZQ_"EM<67@_1;2\B:*Y@L88I8V()5E0`C MCW%;%`'$_%O1O[;^&6LP+'OE@B%S'Z@QG<:U8K'YDWV@#X7T MOQ#>Z1I6KZ=;$"'5(5AGSU`5PP(_(CZ$U];?"G01X>^'&D6S*%GFB^U3>[2? M-S[@%1^%>%O\$O$[^,W1=*VZ(=1*"8S)Q!O^]MW9QM]J^I418T5$4*J@``=` M*`'5\S_%2_D\??%[3_"]F^8+65;/*\X=B#*WX`8_X#7T5K-S>6FC7EQI]JUW M>I$Q@@4@;WQ\HY(&,XS[5XA\*OAEXGT;XBMK?B2R\H1P22I+YJ2;Y7X/W2>< M,QH`]XM;:&RM(;6W01PPHL<:#HJ@8`_(4Z:*.>%X94#QNI5E/0@C!%/HH`^* MM7MKOX>?$F>.WW++I=Z)(#G[R9W+GZJ1GZU]DZ5J4&L:3::C:L&@NH5F0@YX M89KQ;XS_``RUWQ1XML=3T"P%QYMMY5R?,1`K*>"=Q'4''_`:[+X/Z=XCT'PK M)H7B*PDMY+*8_9I#(KJ\3-=?\=:YJUCHS26LMP3$QGC4NH``(!;/:@#Z4L#NTZU;KF)#^@JQ M532ED32+)9HS'*((PZ'JK;1D5;H`YFX\;Z;:>/K?PC XML 15 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings (Loss) Per Share (Tables)
 12 Months Ended
Dec. 31, 2013
Earnings (Loss) Per Share [Abstract]  
Reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share
The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the years ended December 31, 2013, 2012, and 2011:

 
(In thousands except per share data)
 
Year Ended December 31,
 
Numerator:
 
2013
  
2012
  
2011
 
Net income (loss)
 
$
(8,541
)
 
$
8,024
  
$
(157,693
)
 
            
Denominator:
            
Shares used for basic earnings (loss) per share
  
34,489
   
33,597
   
33,677
 
Effect of dilutive stock options and restricted stock units outstanding:
            
Non-qualified stock options (1)
  
—
   
37
   
—
 
Restricted stock units (1)
  
—
   
202
   
—
 
Shares used for diluted earnings (loss) per share (1)
  
34,489
   
33,836
   
33,677
 
 
            
Earnings per share:
            
Basic
 
$
(0.25
)
 
$
0.24
  
$
(4.68
)
Diluted (1)
 
$
(0.25
)
 
$
0.24
  
$
(4.68
)
 
            
Dilutive securities outstanding not included in the computation of earnings per share because their effect is anti-dilutive:
            
Non-qualified stock options
  
3,234
   
4,926
   
4,845
 
Restricted stock units
  
334
   
193
   
469
 
Warrants related to Cash Convertible Notes
  
7,707
   
—
   
—
 
CareFirst Convertible Note
  
892
   
—
   
—
 
 
(1) The assumed exercise of stock-based compensation awards for the years ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive.
XML 16 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares reserved for future equity grants (in shares) 200,000    
Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted $ 16,500,000    
Weighted average period for recognition of unrecognized compensation cost 2 years    
Weighted average grant-date fair values of options and weighted average assumptions used [Abstract]      
Weighted average grant-date fair value of options per share (in dollars per share) $ 7.29 $ 4.01 $ 5.94
Assumptions [Abstract]      
Expected volatility (in hundredths) 53.80% 54.40% 53.00%
Expected dividends (in hundredths) 0.00% 0.00% 0.00%
Expected term 5 years 1 month 6 days 5 years 1 month 6 days 5 years 7 months 6 days
Risk-free rate (in hundredths) 1.90% 2.00% 2.40%
Shares [Roll Forward]      
Outstanding, beginning of period (in shares)   4,689,000  
Granted (in shares) 1,085,000    
Exercised (in shares) (1,077,000)    
Forfeited (in shares) (163,000)    
Expired (in shares) (209,000)    
Outstanding, end of period (in shares) 4,325,000   4,689,000
Exercisable, end of period (in shares) 2,032,000    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding, beginning of period (in dollars per share)   $ 15.65  
Granted (in dollars per share) $ 13.26    
Exercised (in dollars per share) $ 14.25    
Forfeited (in dollars per share) $ 11.34    
Expired (in dollars per share) $ 25.50    
Outstanding, end of period (in dollars per share) $ 15.09   $ 15.65
Exercisable, end of period (in dollars per share) $ 19.21    
Weighted-Average Remaining Contractual Term [Abstract]      
Outstanding 6 years 4 months 24 days    
Exercisable 4 years 3 months 18 days    
Aggregate Intrinsic Value [Abstract]      
Outstanding 13,182,000    
Exercisable 3,992,000    
Cash received from option exercises 12,748,000 2,835,000 4,825,000
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Allocated share-based compensation 7,100,000 6,400,000 9,200,000
Total income tax benefit recognized 2,800,000 2,500,000 3,600,000
Share-Based Compensation Included in Cost of Services [Member]
      
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Allocated share-based compensation 2,900,000 3,000,000 4,100,000
Share-Based Compensation Included in Selling, General and Administrative Expenses [Member]
      
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Allocated share-based compensation 4,200,000 3,400,000 4,500,000
Share-Based Compensation Included in Restructuring and Related Charges [Member]
      
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Allocated share-based compensation 0 0 600,000
Stock Options [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Aggregate Intrinsic Value [Abstract]      
Total intrinsic value of options exercised during period 3,200,000 1,300,000 1,900,000
Tax benefit realized from option exercised 1,267,000    
Stock Options [Member] | Maximum [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration period 10 years    
Nonvested Shares [Member]
      
Restricted Stock and Restricted Stock Units [Abstract]      
Weighted average grant-date fair value of nonvested shares granted (in dollars per share) $ 13.12    
Shares [Roll Forward]      
Nonvested, beginning of period (in shares) 1,013,000    
Granted (in shares) 186,000    
Vested (in shares) (293,000)    
Forfeited (in shares) (65,000)    
Nonvested, end of period (in shares) 841,000    
Weighted-Average Grant Date Fair Value [Roll Forward]      
Nonvested, beginning of period (in dollars per share) $ 9.93    
Granted (in dollars per share) $ 13.12    
Vested (in dollars per share) $ 10.43    
Forfeited (in dollars per share) $ 10.15    
Nonvested, end of period (in dollars per share) $ 10.44    
Restricted Stock and Restricted Stock Units (RSUs) [Member]
      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Restricted Stock and Restricted Stock Units [Abstract]      
Weighted average grant-date fair value of nonvested shares granted (in dollars per share) $ 13.12 $ 8.29 $ 13.26
Total grant-date fair value of shares vested $ 3,100,000 $ 3,600,000 $ 7,400,000
Weighted-Average Grant Date Fair Value [Roll Forward]      
Granted (in dollars per share) $ 13.12 $ 8.29 $ 13.26
XML 17 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Investments and Hedging Activities (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Derivatives, Fair Value [Line Items]    
Debt Instrument, Unamortized Discount $ 33,600,000  
Lower variable interest rate range (in hundredths) 0.69%  
Higher variable interest rate range (in hundredths) 1.48%  
Current notional amount 145,000,000  
Fair Values of Derivative Instruments [Abstract]    
Liabilities 27,766,000  
Reclassification of net losses on interest rate swap agreements from accumulated OCI to interest expense within the next 12 months 400,000  
Derivatives in Cash Flow Hedging Relationships [Abstract]    
(Gain) loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect (332,000) 2,029,000
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect (1,916,000) (3,302,000)
Selling, General and Administrative Expenses [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Derivative, Gain on Derivative 8,984,000 0
Derivative, Loss on Derivative (8,984,000) 0
Interest Rate Swap Agreements [Member] | Derivatives Designated as Hedging Instruments [Member]
    
Derivatives, Fair Value [Line Items]    
Description of variable rate basis LIBOR (as defined in Note 6)  
Notional amount effective in future 95,000,000  
Fair Values of Derivative Instruments [Abstract]    
Liabilities 505,000 2,963,000
Interest Rate Swap Agreements [Member] | Derivatives Designated as Hedging Instruments [Member] | Accrued Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 0 1,742,000
Interest Rate Swap Agreements [Member] | Derivatives Designated as Hedging Instruments [Member] | Other Long-Term Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 505,000 1,221,000
Interest Rate Swap Agreements [Member] | Derivatives Designated as Hedging Instruments [Member] | Effective in November 2013 [Member]
    
Derivatives, Fair Value [Line Items]    
Notional amount effective in future 0  
Interest Rate Swap Agreements [Member] | Derivatives Designated as Hedging Instruments [Member] | Effective in 2015 [Member]
    
Derivatives, Fair Value [Line Items]    
Notional amount effective in future 50,000,000  
Interest Rate Swap Agreements [Member] | Derivatives Not Designated as Hedging Instruments [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 0 0
Interest Rate Swap Agreements [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Other Current Assets [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 0 0
Interest Rate Swap Agreements [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Accrued Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 0 0
Interest Rate Swap Agreements [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Other Long-Term Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 0 0
Interest Rate Swap Agreements [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Other Noncurrent Assets [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 0 0
Foreign Currency Exchange Contracts [Member] | Derivatives Designated as Hedging Instruments [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 67,000 255,000
Foreign Currency Exchange Contracts [Member] | Derivatives Designated as Hedging Instruments [Member] | Accrued Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 0 0
Foreign Currency Exchange Contracts [Member] | Derivatives Designated as Hedging Instruments [Member] | Other Long-Term Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 0 0
Foreign Currency Exchange Contracts [Member] | Derivatives Not Designated as Hedging Instruments [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 178,000 73,000
Foreign Currency Exchange Contracts [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Other Current Assets [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 178,000 73,000
Foreign Currency Exchange Contracts [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Accrued Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 67,000 255,000
Foreign Currency Exchange Contracts [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Other Long-Term Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 0 0
Foreign Currency Exchange Contracts [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Other Noncurrent Assets [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 0 0
Foreign Currency Exchange Contracts [Member] | Forward Contracts [Member] | Derivatives Not Designated as Hedging Instruments [Member]
    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Notional Amount 16,300,000  
Cash Convertible Notes Hedges and Cash Conversion Derivative [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 27,766,000  
Cash Convertible Notes Hedges and Cash Conversion Derivative [Member] | Derivatives Designated as Hedging Instruments [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 27,766,000  
Cash Convertible Notes Hedges and Cash Conversion Derivative [Member] | Derivatives Designated as Hedging Instruments [Member] | Accrued Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 0  
Cash Convertible Notes Hedges and Cash Conversion Derivative [Member] | Derivatives Designated as Hedging Instruments [Member] | Other Long-Term Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 0  
Cash Convertible Notes Hedges and Cash Conversion Derivative [Member] | Derivatives Not Designated as Hedging Instruments [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 27,766,000  
Cash Convertible Notes Hedges and Cash Conversion Derivative [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Other Current Assets [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 0  
Cash Convertible Notes Hedges and Cash Conversion Derivative [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Accrued Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 0  
Cash Convertible Notes Hedges and Cash Conversion Derivative [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Other Long-Term Liabilities [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Liabilities 27,766,000  
Cash Convertible Notes Hedges and Cash Conversion Derivative [Member] | Note Hedges and Conversions [Member] | Derivatives Not Designated as Hedging Instruments [Member] | Other Noncurrent Assets [Member]
    
Fair Values of Derivative Instruments [Abstract]    
Assets 27,766,000  
Embedded Derivative Financial Instruments [Member] | Derivatives Designated as Hedging Instruments [Member]
    
Derivatives, Fair Value [Line Items]    
Debt Instrument, Unamortized Discount $ 36,750,000  
EXCEL 18 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0"2(,<$+0(``)(C```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,VLMNVS`0!=!]@?Z#P&UA MT7RE26`[BSZ6;8"F'\!*8UNP1`HDD]I_7TI.@B!P'1@UT+N1((N;B;#2S MFVW7%@\48N/=G(ERR@IRE:\;MYJSGW=?)Y>LB,FZVK;>T9SM*+*;Q?MWL[M= M3['(NUVW+YS=*'SJ;\&%:\M]7&KHC+Z?2"5]XE4^TG]<'/EX$V<.,OR_L?") M.21(#@620X/D,"`Y+D!R?`3)<0F2XPHDAYBB!$$15:"0*E!,%2BH"A15!0JK M`L55@0*K0)%5HL@J4625*+)*%%DEBJP215:)(JM$D56BR"I19%4HLBH4616* MK`I%5H4BJT*15:'(JE!D52BR*A19-8JL&D56C2*K1I%5H\BJ4635*+)J%%DU MBJP:15:#(JM!D=6@R&I09#4HLAH460V*K`9%5H,BJ_E?LJ8\\4!\O/X[96.9 M-SZYQ[1K*9[Y,]F^Z%N=US90_2.%/!MR]@`O:Q_+D2&K>0\:)EQJJ@_TYN-$S>(/````__\# M`%!+`P04``8`"````"$`M54P(_4```!,`@``"P`(`E]R96QS+RYR96QS(*($ M`BB@``(````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````(R2ST[#,`S&[TB\0^3[ZFY("*&ENTQ( MNR%4'L`D[A^UC:,D0/?VA`."2F/;T?;GSS];WN[F:50?'&(O3L.Z*$&Q,V)[ MUVIXK9]6#Z!B(F=I%,<:CAQA5]W>;%]XI)2;8M?[J+*+BQJZE/PC8C0=3Q0+ M\>QRI9$P4P>J/OH\^;*W-$UO>"_F M?6*73HQ`GA,[RW;E0V8+J<_;J)I"RTF#%?.&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;',@H@0!**```0`````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``"\FLUNVS`0A.\%^@X"[[7,75))BLBY%`5R;=,'$"S:,F)+@LC^^.U+N(7B M`.WD(LS%@"28'HB[W\S*NG_X=3H6/\(4#T-?&[M:FR+TVZ$]]/O:?'OZ_.'6 M%#$U?=L=B\?W?_)1R;E+\4N\,8B[Q*'VO3I31^+,NX[<*IB:MA M#'V^LANF4Y/RX;0OQV;[W.Q#*>MU54[7:YC-JS6+Q[8VTV-KU11/YS'_]-N+ M#[O=81L^#=OOI]"G?_Q&^7.8GF,70LJ+-M,^I-K,IV)YN6)UE36;\C]R\OW@ MRKE%6H0W*R>9[Y MC92=##)"CL<"$P7#@VDQUDLF?G9`]SC<*?830Y[W++]P4)_$+8_"/0'8?N#0']0 M=NDHK!W']@<'_<&SDY>'RUJWF:`@,6'"*J M16LGY?E8JO6-\V-Y_\^ET\DL5S%/M!(W MSEYDSO?;O_^ZWFGS_J;U>P<$5';C;*S=7G6[6;01*<^^Z:U0\&2E3YMM)7<+VCNJ0+R_PO(OBET4J7J789;\G%Q!RO;''+T&^B_3+#,(ZY6='E=L[9H1!I=A4 M66GW;*8.V9<:2EAD?08[:CY[& M4Q8^3*?+$$E\/--@S1S(^4BF3?3*2<`D!/4Z?EB%;W+/%\Q2I!$@E M.!L+48%45&F!S%=;ZO^!S'CQB%0ND$I)Q1>W!"HXF`&2&7PMF"(QXX?1$PX& ME_KR:S)E@LDY)LZP"$;&)?3^JW6\DPDT>E76"XR'2UB=*5AE+=\2P499 M)FQM,8R$2P"=@4FF@BWY)Q@B6A`CX!(@YUJME\*D;"+>:NG!)7<)@!-AY`=X MW(>`IOX`TRK,+RM[_4'$>'EPZXICER!XSZ5AKSS)!7L4/,L->!D(80%<;I?` MM[`;85BUB[GD;S*15M9R,,#^X!+R7B!^DTOB8,H]0%D*0X@[F0+PZA5,N M*P\?'#>&SB/03;E1$&<&:)08)ZTGVZ7&#V/H'?>KK`% M7V+V/,+>T6J@_\$\\$XN,6T^H8TX3HL"YL\G_&'C:9F,V?,)>U7G%O[3,AN# MYQ/PSMM0+7T81)^`>,*'6@+"/,*5J=&[YZVD%A"FTR?&>#"!EO4QES[A\H07 M4)TAYM(G7)ZPA!8=C*5/L&PX0\M\3&=`Z#S?9SB?0PQI0"`]WV@01.4X02TB M`FS5:!-AN4QPIP6U$`BLM--:)'"W!`336JNUS,;=$A`XZ[U&IP]KBU,D\56! MS:42Q2UK;`2\P#".,XA[)"",GF_:6BEPCP0$TE-->]@9"FA8RPN!]/0=`FY% M%NM@$^D36,\W/]Y8'W<-#!HNDPJ"Q_BD7(8GM M8V)@T-`YY2)4!Q>H3\!MNDC+AFJ5(>B2:T)1V$;W]FNY)-2V7!=:1(:8V#XA M]KR=U0C!/M\OD>V6%@6OV1%/(GC_+SZ*%^B2P^[QOQ^WOP```/__`P!02P,$ M%``&``@````A`!ELT_V8!@``#1L``!@```!X;"]W;W)KP+FFZCI52'`7FE76JWVXYD2DJ`;0@3T]MY_ MOV-L4\_0)NE+TPSGC'UF//;$/'SYT9R,[U77U^UYLV`K:V%4Y[+=U>?#9O'/ MW]DR7!C]4)QWQ:D]5YO%SZI??'G\]9>'U[;[UA^K:C#`P[G?+([#<%F;9E\> MJZ;H5^VE.L.3?=LUQ0!?NX/97[JJV(VDYF3:EN6;35&?%\+#NKO'1[O?UV6U M;Z:HOOVO=[?:X@VI`GGH'GMOW&H5]W MW`1D<\;.Q@S\V1F[:E^\G(:_VM??JOIP'"#='BCBPM:[G]NJ+R&BX&9E>]Q3 MV9Y@`O#7:&J^-"`BQ8_Q\[7>#'KGTUH)`@#?VEX&7)UN!-)5O$:4K_1]F' MM',G3]S+Z`L2V\.2_?X8.@_F=UAEI83$`@*;Q`1A&)$H!%]2W.N6&E)JR*@A MUPPF*)QDPCJB,AVHC/?7M%+%2425B^<<"XBNRL:(1"$F5*-HSPT<&I5$ M`#31B.$X84A%4T:&&,P*;%)CN<9`HF'7I*)OUS0G$=$1$2T@0K3/;(LD(1'/ M-=T1LD09]RL6C0I23#(2,X$1TU\REP7D-$XD0I>L MQ'8N,D^LD+)KW'?>+%ET*$DWF%S.!D:(]GQ99(@&Z9IWB M!S8IAG3&R-`@S'-H6Y?K%"R8]Q[W"Q:="A),8ALS@9&"0\\EFW8B`;I@G1): MM%5(9XP,#\*\P)\O;.%T'`9+YIW'_9)%GP(IF9K(B)P%,?\=#?LX##AAR#)( M)LBT5T^6#TGI!%&D;+)\2,HG")"P;MY_W*];="LHU62[B9G`1./YN^07![CG M2B1`3[5.`0;9%=,9(\.#N"N?1#_7*5@P;T,TP>.OX(!?;]SXA>.%'RK0LF$6J88O0>[QDR,ORO2#=<(,#QYL;$KC;/3@3+9%> M*8P>Y+$$72T5K;62-P;*\A9(4E_IY/>M5&Z2.8X7D:TVG5$R/(KCTQ,VURE(LDUZNKN+923B M]HY9I*QC"?I8O03<*!;LQ@GI89K>Y28C;N91NN4&1XZTACQRMZO%GK>(C/XF MC25(7$\L0XO112,!VJ)!%/C12C*1SA@98BR9YUNTK\QU$M8.B_[^0K$Y&J[> MQ*4POTV)YZ9D;MK.3>G#(A;XJ;J#E52G4Z]4;8O M_-;?AS-\LHHW$C&\D1@S1>WV&JX_88[$OK77<,4YMV.%5[F+:UXM?_G7B=(;X,[66\W7UN!W@-,?Y[ MA-=.%:PV:P7@?=L.Z@M,UIQ>9#W^#P``__\#`%!+`P04``8`"````"$`.BK3 M*UL)``"P-0``&0```'AL+W=O\'V'.K21&VU9@*9WNMY^BJJRP2(:B MTA?IV/Y4JL,BZU"*=??;C]-Q]KV^M(?FO)Z+FV0^J\^[9G\X/ZWG__W/UU^7 M\UG;;<_[[;$YU^OYS[J=_W;_CU_NWIK+M_:YKKL91#BWZ_ESU[W<+A;M[KD^ M;=N;YJ4^PR>/S>6T[>#EY6G1OESJ[;X_Z'1(,3#X7CH?O9! MY[/3[O:/IW-SV3X<0?+58+B'1_ MMS^``CWLLTO]N)Y_$;>JD//%_5T_0/\[U&^M\?NL?6[>_GDY[/\\G&L8;:B3 MKL!#TWS3Z!][_18NW\W;[_7AZ?G#LHM09$6=KO_ MJ>IV!R,*86[2/HU=)%U*(8OQ5!8HJQ\E MM>VV]W>7YFT&4P\2;U^V>B*+6XA\'1X4,PS81^,%&G60+SK*>@YK!H:BA2)_ MOR_S_&[Q'0JS(V;C,H(3U9700Z?#*N.-!>0[)`WC:2;MK^4U-PWKW*Y1-_@& MQ!Z23:U$7"++.*)<9"D'A"4+13>3U2.(^+"I"1J"`IT]3-KC*952YEX0I`)$)`,46` MAKD`:%A\>#?(H`"9")$YR54F4@A1KAQ$(1*1?SDE?PWS_,O<7@#(4`'2$E)S M9A!'].C;B&)(EG.$S2"])[!ZY?A*U@=9*SE?6H5`QC^$_5RK1@D5(IB*%5<1 M7LD:UF70+3U-A-W3\6.J`$P/=W@K1`+:5(A@F0MHFV8!PJGWM)&[/?OI>V4](*/D@PK/7;F9,GY'LT?N&D;>;C\#/KXLW\66/2##[$,*SUX87GSW: MXY"]O7(%?H[99UGNRQZ18/8AA&>O?2X^>W3%(7M[N0K\_)I]HJ<]7]$5(<'L MH[U70)@)V6N:M\[4<=\^Y'J.$M)$>C5@H*"&$,(KH&TNO@)HBE#?P=5=^]+; M>!!Z70)>_V+,!P9&C%\G%Z&]SA`1MY<3Z)"FF#)QYI3IM*FV6<^D&F<4G8P* M:\?A:K3S35>#?LG4Y"L^_3<"(?^0HJ.-(XH0U()2AO-P)=K\#"4CK16MDBEP MG$V$_)04C"(J&(5+T"YH2(B<6NB=T$F&=>)>)XB0P9*4440%HS`IZ22;[FG> MKDIA>S5!YGPJA66)E0>R$!5$N`CMC$8]PE,J11_E4\HV/8),$59^U3BB@@B7 M`.F8$N*F5*J/LC:LSJ4G04$I&">`J&`4+D5[97PUT%EY-9PIY=IO*:RN7*4N M9)5,!1$N`L9B@@A-6^M"6MN,38I08)"K<40%$2[!?G(`O=XN+.I2DU_EBM9ZHO)P;&PTUI,!ELOFU'$^(>"B[`L M?$2$S[JM^;Q)$:)=E9`";E@[(DPFSV4I'$91G!@1D]P[==W;W1H2A"*62>'3 M@'$0$7G97_GS8BD*$Z/A4_:=>NS;N3E`D#\)FE3C]AV,PN:4OJ41WZ9ZFKZ=>=Q;6C>G-P3Y3XYE&$=4$.$2/N7>68Q[$Q24 M,N[>P2ASNMEB"<4>DJS]P.5%E,NG2OTQ4Q_J'@(H"9($+3 M?%F4N=UJ,X1(A)1+]^YJQ9D\7;F,(B9&A.7?8;_(T&_-2GC6-D(H(EOFGE9+ M<1#)5TOW3K\B)$:"Y=MQ6Y`,K9EM09Q.2Y`_"5KB&">`J&`4/J4FN7?FNK>G M&J8S?U`-$_F@&HCX57()D[P[<[V[E-8?WS8$^4].5<`X`40%HW`)G[+NS&/= MSF4208$\JW%$!1$F)9]DW3UM]RC[,HD@ZE&YS-TF6EE,EKF,(L8_%%S$)._. M/=[M-%J"4(20R=+C%IQ)R]2])ZV(B1&A_3/:\G)TVW"C)0A%K/+"_5-BQ1`A M"N%>@"AB8C18MAW7:7.T[W"G)48150P"I?R*0_//1[N MM%R"@E+&/3P8A4O15AF_T-%8S87N^6:$:="P:75W?%4^BBA"_`/!)4SR\-SC MX6[#10@71RGZ>_?\VKJB.(@41>&J5(3$2+`\/+ROS=&[S2IXUC="F!__^*.MNK;.O)#$/]`<`G:D8UE'5D-?1274DK[.Q,2(7\25(U11`6C<"F?LG'I ML7&GV1(4E()Q`H@*1N%2((Q9E?`REYJVJN'<2"`()Y;>\NE_?!%7C/'_;581 MX]?)15@^/B+"X]].NY4(D8C5TK,U9`A\5\IS#4Y(C`3+OT.G`F7;GW&A3%B1%A.7?D$D?G#6]O)4+^)&B)CR(J&(5/J4D. M+ET']]3#=/#T@WIPQE\/9/Q#P45,\G#I>G@I[8M7@OPGISI@G`"B@E&8A.)3 M'MX?97FXTVH)"N19C2,JB'`IDSR\\%V%V]4@")[E(%>J[9I=P[M@11HUT6;GX51Z2G%RM"8B18WCTB`;W6E.`N[`(A ME"!2?2?$]CN.2.'>+5&$Q$@`QJQ"7)LM]%'6FG#VM03YD\#E/8ZH(,(GU"3G MAJ=:[.V'IQH(T=?@_=5@B+\:B/@'`B7@`S+XZ,>IOCS557T\MK-=\ZH??M%? M=1S>'1[,^9+JAR:L]S?PP$[_=,MB^`">EWG9/M5_;2]/AW,[.]:/$#*Y*2&K M"SYQ@R^ZYJ5_X.2AZ>!)F?[79W@RJH9'/9(;@!^;IKN^@!,OAF>M[O\&``#_ M_P,`4$L#!!0`!@`(````(0!IN'F"$0H``-&PO=V]R:W-H965T M7H[KWOLM]WA M?JINLNFD/6RZQ^WA^7[ZO_]^GBVFD_ZT/CRN=]VAO9_^;/OI;P]__]O=6W?\ MVK^T[6D"$0[]_?3E='J]G<_[S4N[7_>NN-^?8)?C\_S_O78KA^' M#^UW\SS+JOE^O3U,,<+M,25&]_2TW;2FVWS;MX<3!CFVN_4)\N]?MJ_].=I^ MDQ)NOSY^_?8ZVW3[5PCQ9;O;GGX.0:>3_>;V]^=#=UQ_V8'N'ZI8;\ZQAU^\ M\/OMYMCUW=/I!L+-,5%?\W*^G$.DA[O'+2BPPSXYMD_WTT_JUE3U=/YP-PS0 MG]OVK7?^/^E?NK=_'+>/_]H>6AAMF"<[`U^Z[JM%?W^T+\&'Y]ZG/P\S\._C MY+%]6G_;G?[3O?VSW3Z_G&"Z2U!DA=T^_C1MOX$1A3`W>6DC;;H=)``_)_NM M+0T8D?6/X=^W[>/IY7ZJJYNRSK0"?/*E[4^?MS;D=++YUI^Z_5\(*0J%07(* M4D#V]'Y^DR]*55;C4>:8T2#0K$_KA[MC]S:!JH%K]J]K6X/J%B*?E6$>%ZT? M206--L@G&^5^"N4.*GJ8G^\/=5G=S;_#F&Z(6?F,XD1S)NP`VK#&>6$.^5Z2 MAJ%PDPY/PSDW"]O$):NO2=;"4!U.;G59 M7^(.H[)"!B;KDK\8ZF:4,#&"90^721]J"]]/86@NF>6E&+@5,O50)#.EE%FAE7M`KG* MEB[!PK+N%[PL M5LC`S%^J2\Q-,TJ8&,&RM];MK(OQ)<;"4WZ%I;IBZ%=(4/IJTRQCL/:<9%"!;)G@&816/(*##I]\`=: MIB\KGR`J_2S0MHS("S:TV+>,F!5Y^>'H*VMRI6T93P3&@9^!)9F+L*:7+@(MDHN0*Y+= M@,.R13.PU*$9<)&J7#*SHJ9&)$6"=;YT">B37(*W*C$S!2\-:6!,GH<65H5, MB@AK@.DBT"ZY"&G+"B&JD"VPJ*DB+!FF"Z!+1,)J'VFMGU557P M19'65H:4@6HS"I$4"=8)TR6@;[H2ZDH<65:*F2M4B5_K#6/T4E4^8XA)$)%? MY=(#S4TNKZ4(@K"49KJR[2#6G$8P>6`C98A)$7&54^=X('5G`D[PPJD)HG5I M4?(M,E839\HEWTO@RD1,B@A(*+V<OT9JK4*]`1%"BOE,H"Y8B8L+67(C5^.$&6H M=!':>@L(;BWYG6,(2I%A3=%9G]+V3?8NE)!35X7L#M>29^&-$P4*;YPN;X[N M.7+KBHZ*D9I"#W5[&^X\R.Q=,YX5@5-",USUO"V9J=`FG)"4B;C*KG/?K@/+ MD^O%LPI.D7ZI-!2)BJ[22OL[1$-0B@SKC.DS@3[*9F(A=QVYZ\>S7%>A';B` MZCRT\R`H1<95MIW[MITOO8)R;7M9!1RYH3@X%XM%<"8P2H($>_I)GXF!%@O4 M4IHV050K6FM[[)3KK("J+#!=AJ`4&<*VTQ8H[=MW[9V-"$(YR]H_0S>,*`)W MT0PCX`XG:QYF&-J:J-,9B4+0>L&[+N>NNI+^-X2^GX9'$RU\'#%1A$L1%IXH M!0W8;?:ZDNQ'&H5`T;?6>L^"P(%T_,WW=SG76=N]+^+8V&PJ`RO6`F@$<\1A0\!LN_N,JV!YK;ML[DFDK0 M.3O6?5@XC(`OFMWZQOP9(;R2YR_\.KX.%;Y/ZTPNI01A_L.^3G1HPXA\N)G` MN]\P0EF![S%X_L*F1_)'>W8]#!T) M/TYS@L+WY;I^K]2A%U<$43_;4A9$PXCA-K)$#"'A_0E7\DN>7/B>7'N';(*H MLX?O'3PI9]M^WP"+]=E0E!0IUOZNWH,7:)K0!>][<.^&)D'A)&B5Q3@1Q$2C M\%FYRI\+WY]K^88D."S^=+I>'"(*H M18;[_5Z/$!.=#;Q6&.%:KK+S,F#GM3Q($!2^.$T'QHD@)AJ%2X`POS`=]E/R MD"W;O$0HDFC<"G"SD>F`^V7-[A74;Y'U[78T#>E#XDX)HIP$5<9 M>1DP\EH>F`B*S@/&B2`F&H5+^"4C+]&`64EYMS8)BN39C",FBC`I]NZ?NUC% M2VJ@N8/7M>QP@JC#<9,K=[G$1&2:*,(U"`=/VXU4Z.1L.KQ=+D&1/)MQQ$01 M+L4:I6/E(].!MAKO\`HA5X+?X0%(=G@4X2*LFZ:+L+2L*;DKK!!R18C\FG'$ M1!$N`:[D2D@L*?NI,0^O$(I*&45,-`J73A#^I;N"`WO`PXF)R#11 MA&OX)0^O4CRS3ABH@B7!S M1/B8S;X]/K=-N]OUDTWWS3XCE,/7"9=7+\\O?(&OA ML9KL!N"GKCN=?X$+SR^/I#W\'P``__\#`%!+`P04``8`"````"$`6>#='PT) M```S.P``&0```'AL+W=O8BB:E/ MBX=?B^1:%A_^^+7?#7X6I[JL#H]#9S09#HK#IMJ6A]?'X;__8M^6PT'=Y(=M MOJL.Q>/P=U$/_WCZ^]\>/JK3C_JM*)H!63C4C\.WICFNQ^-Z\U;L\WI4'8L# M77FI3ON\H8^GUW%]/!7YMKUIOQN[D\E\O,_+PU!:6)]NL5&]O)2;(JPV[_OB MT$@CIV*7-]3^^JT\UIVU_>86<_O\]./]^&U3[8]DXKGNA M.N7/.^KW+V>:;SK;[8>>^7VY.55U]=*,R-Q8-K3?Y]5X-29+3P_;DGH@AGUP M*EX>A]^==>:YP_'30SM`_RF+C_KB_T']5GW$IW+[C_)0T&B33D*!YZKZ(5"^ M%45T\[AW-VL5^-=IL"U>\O==\V?UD13EZUM#%@\UXW MU?Z_$G*4*6G$54:FU'IUW1VYRYDSF]]AA>IKFT)_.RO.:.K.%LM[VC)75N@! M[SI$S;NQ(ZMN-*B_W=UP&,9R2%N%PKS)GQY.U<>`'GLR4A]SX43.VJ$/G39R M),]J?246J22L?!=F'H?4']*AIB?LY]-B.7D8_Z2G8J,8O\\X.A%TA'@$A-G0 M+(AD@516$*PC+BLVS,8=TYE-.BN?-QFW\.Z63X(4UEN;=DQG-NO,4L&8AO<\ MQJ2M-L;7G_MN*`4MAK(SZW<%GVUQ]98$?<+S="3L(\N9CD1]9+$T:F*2H8Y> MZ&Q4%5]C##M)GS$(WB<69HO3:\Q"[U769SYKTE3R[E))T)I*9D%@%H1F0606 M,%F@C^Y4[T]\`Y/

R,-L(T]=[A!X*FF5Y[U)9Z`WW)T._S MXVAT(8!$"(D($@P2,2022'!(I)#(;(0F%BTI=X@EZ,[AT+SYA?4F@ALQ&:4"+R-'?%'L4]]IV; MN,L4['.ST>YH?-::+D6R6L6D1DD M8D@DD."02"&1V0A-((<\2E-(!)_8S=K;=*D6*U,J!5E&-,!(B)$((PPC,4:2 M,R*BZYDS\HP=`S\#7VZP4HQD5D273\2[]\^2(LM@>-IB940YOH)F[2SI>7/A M:H8_!8JQ2!QB),((PTBL$-7>^6+6;V^"S7",I!C)K(@NH8B.+R6TSY&.#*:U M;?[*2"/X"K+($F`DQ$BD$#7F*V\U,R=LAJW$&$DPPC&28B2S(KIP(NR^0S@9 MI>O"&=&7[TC(*AQ$0FPE4DBW":($ZN46B/[O;8(8MAIC),$(QTBJD*[YTY'T M]G:*$K^<7O,SJU5=6!I^3=@;UT1QF[DF&JDPWY&056"(A-A*I!#IF4X[%]*X MZ%LEANW$&$ENJ8IC.ZEFA[X?:G_T%F=V1I=1A.^7_GFCC#+JU_W46.=]\=4) M:6V5$2(AMA)AA&$D5LBJ70!?/"%)]1T*VC4*@F&D[8H;;A+:+T?GBEUM`AI%8(;8V)M@,QTB*D1$%N),,(P M$F,DP0C'2(J1S(IH`KIF[L4N7(N+_:5(/K@3QXS7U76UXW/EED_?/@6*L7D= M1B*,,(S$&$DPPC&28B2S(KIH9L8%B-9E6I1H9J3NRNM*-!7%F*))QBH:1")5 MD\4*PTB,D00C'",I1C(KHHM&BY4V50+1!'[A:<9NV7?E=2G:]4`E4(QEN$., M1!AA&(DQDF"$8R3%2&9%=-%$HN-R?0.BR;S(>7HT(V]77I>BS3UZXZP7#P>* ML8HFS5B0"%MA&(DQDF"$8R3%2&9%=-%H8.X13>`7GF;&V:Z\KJ;'ZUF,0$$6 M24*,1!AA&(DQDF"$8R3%2&9%=-5$KN(.5Y.IC3\?RETRTGYE>NKH2ZO/AD9&Q= M`@58!CS$2(01AI$8(PE&.$92C&161)?-S);<%G:[U[(FO1!.0A9U`F7'@H08 MB10B)^?%XDJFG6$K,482C'",I!C)K(@NH)DW`5.FS'/H?M>;,F$R)'`A$F(D MP@C#2(R11"%JY^7,VS=MC$0XQW92C&161)-.O)BB39FW?:73WF9^,V?ZGH+4 MFT777W=0C,WY,!)AA&$D5HAJ[_77';`9CI$4(YD5T244F8K;5SU/)C9T[S,6 M-5]!%ED"C(08B3#",!)C),$(QTBJ$.7#UU[@R:Q6=.%(`TVX&WU/W*;[WG)B MQN9T\@WLX`.,A!B),,(P$F,DP0C'2*H0*>"U&5B<&?QZY*1^\DR@/'&V+TZO M15#L=O5@4[V+\WY+2B>?2\]G$;][XNR34>X[:SH-UB]GSIK.=_7+N;.F`UK] M\ M4!&PO M=V]R:W-H965T3C$E^'.[)`[-+=?W_/,>^.5 M3$6Q\\DL]#U>Q"))B]/.__>?YR^1[TG%BH1EHN`[_X-+_^O^UU^V%U&]R#/G MRH,*A=SY9Z7*31#(^,QS)F>BY`7\Y2BJG"GX6)T"65:<)691G@4T#)=!SM+" MQPJ;:DP-<3RF,7\2\6O."X5%*IXQ!?KE.2WEM5H>CRF7L^KEM?P2B[R$$HI[>;SY?BI$Q0X9]/U.%BR^UC8?>N7S-*Z$%$Q4_[OQO9/-(5WZPWQJ#?J3\(EN_>_(L+K]5:?)'6G!P&_9)[\!! MB!<-_9[H_X+%06_UL]F!ORHOX4?VFJF_Q>5WGI[."K;[`3K2C6V2CRGNJC`8ZP]YU/@3A-U'GGSY>SAU4X)P#W#ERJYU27]+WX M52J1_T00,:*PEI'VQ!3;;RMQ\6"_`2U+ID\/V4!AK6D.G=W6!&+TFF]ZD5D* M:`E&ONVC,-H&;]!\7&,>^QC2(`(@;Q0`:UO!?68-=IG735VC[K&/H0VBPSR? MPJS!QGO;,PF;NLB,F(7O-9AE@^@P`V1\SQH,N]*J&A'K)3(C9@0SG)0V\[C] MUHOEG7D1M.G6=@?EHGP:M9#4L0Z]R3@5UTX<@J#V`$?W,$!U5HV=0W]`]>GOF M:A<0U*:W\]+UP`F_@2W`1+N?_61T[)%)N6?0CO'$ME5W?DT^_2U@9<.IV_2D MU",W8H_:RC4O@L8X/BGZ".;:@./7\+-I87WI=$XG!:!!#SE>@Z[)V\1CEW=2 M^M$;Z4=M1^AX#1KA.'42\/X9-^BA^[4&C2'7@=2:;A._GW_-OGZEI9ACG?RE M[MU3@]HJ(FIOB>X.`*JM8\`$C79VGKKQ3Q$T>/7IYT";>MP-9%8Y$N9NW->@ MM@/VG'3[GQ1T=$S0U:`QY)."#AY]/?-[05>#KF-GC<&N\=6'3ZN2G?B?K#JE MA?0R?H1;+ISI>Z["-Q]^4*(T#YF#4/!6,[^>X6W.X7T5ZKOY*(2Z?M"ORN:U MO_\/``#__P,`4$L#!!0`!@`(````(0`J5YDG?PL``"1(```9````>&PO=V]R M:W-H965T+Z?_N??7V[*Z:0]K0^/ZUUSJ.^G/^MV^MO#7_]R M]]X:EWJ_;6?-:']R5I^:X7Y_?MZ MK->/W:#];AXO%OE\O]X>IACA]A@2HWEZVF[JS\WF;5\?3ACD6._6)\>_?=F^ MMGVT_28DW'Y]_/;V>K-I]J\NQ-?M;GOZV06=3O:;VS^>#\UQ_77GYOTC2M>; M/G;WRRC\?KLY-FWS=)JY<',D.IYS-:_F+M+#W>/6S0#2/CG63_?33]'M*EH4 MT_G#79>A_V[K]W;P\Z1]:=[_=MP^_KD]U"[=3BB0X&O3?`/H'X_P)S=X/AK] MI9/@G\?)8_VT?MN=_M6\_[W>/K^ZW;B4NC"S.(-(FV;G M"+BOD_T6UH9+R?I']_U]^WAZN9\F^2PK%DGDX).O=7OZLH60T\GFK3TU^_\A M**)0&"2F(.X[!8GS61$MJJ0(#Y)0$/>=@D3Q+"ZS*,O]5.8XK2Y+G]>G]O:UC)T:V+W*<')W-.V*5\N41!D$\0Y7[JBL:EHG4J?W\HD^AN M_MT)LR',.$R$2^]1$PZP.3G5^[HKRP$X^:"#+F!DHDK%SM;,.A^ MZA)P3DY1I9S!$C%%)VN2Y`OXQR$KA+BOYS`?TV`DW7*_GB0,XB3+@4"H,F*B M#&GFL[+B_WZ_^9`4$XLC`CCGO\(9!DG.,K&(Z3E'L[3L>P)!#R3#N=.<+Y=3?;$)K0T:\6.D(?X(VSXB26!-))H-0FA*<3'$#P3%U_ ML$6/T#>&S3/)9-T0"--YDR1N_R=59Y!X$5=#".<)9B!X!LB.%L)YRM49(8AX M1E6D+$^.29(%FPQGZH213/TE'L$HL4!3D:XE@4SE,8X.X3S!!41&`WBB=_`5 M*GL1[#+=9'02M$(M".H]68#F\U+U!2?"2AKM(AAN92IV#PL(\M'2%P+PE-X ME==$Z!)\\8U2:%D)\;,@C%\LW,9>?!U:%K'<^A!H6!QE*GKG2@%]%!EG*(S& MPQ`-ABO\$;E+SS)&$"["2M_P$&8XBX\PG*![L>O[3`RC?'L>`NDD4&H3PGF" M#0SZH2>1:!HLD8ETEAA!F,AL`9D4;88AXBI/AA!.S\UR2`]NX]]`Q.@-O(=_M`[J0):!4#XM".=YE MPD:05=A#1!3'T<7"AI1=7]C=*%G8\DZ!0%9AFQ"6QN0JH^G0LG]+JR:0R0^] M2(=P?L)G[/Z=H+\PF5.Y#`FD%_3YHO?D)Q'.$E;0W2BA<";\8TD@/3U8*":$ M9]"%&:Y$3P8![548028_"\+Y"6OQ\$,K\"B,H+Z079$.ZY02&.PIB?"40*$5 M;\GD+4L7VN[<)H0G4G$8:`2>A*+#V)T[09`IN`7A/(7#>/BA(S#!LU'+Z6V# MWSR1TOI%SDFX"6@,;V5XN"FNDLD[JP1!9NXL"..9*K;BU[@;)8M:MD4"63Q- M".=YE:VD:`>VQ@32V_:%BYR3BS]LA&$:IS!*-FQY]T<@,W<81X=PGHJQ!&@, MH[P:(T@G@=626A#.TX49YM.NE130(H^CO3:!+FB,$>1%S@FZ^N!V+U!C]`*^ M_L3-^Q(.6MP$S-Q9$,Y3\90`C=%3G$+GMZ7*9%3'"#)Y6A#.4WB*1V/T`);' ML<:]46B].M4O*CX2+""KU()PGHJG!&B,7N#1V#(,JF,+ MPGAFPE-LC3NTJ..1'Q-(EBHRNW"14)7'_#T:`QHH?&HCC,$X28[+\8[;`:(,W9.QLFY M"0S)@=C^0[`,1@F2F3P:(9">(5J.&$>'<)Z*N02(C:;@$=MR#N)I03A/82X> ML=$,[*:=]8ZA->T+%SDG822!&BN&DLGS$/<1"9\QFQ#.4S&7`(W1%#P:6\Y! M&EL0SE.8BT=C-`./QKUCJ!KK%QDGJ-GKZ[@;)>HXERP]NVCF:`=-X9,P$PJ8=%?#Y'/'>!4,4E]^YR*'] M#\B%[<*Z45)L>2I"(#U#)#:\^J7-.$^B"R-Y!H@-HWQW4SF"3)X6A/,4YF(7 M=(YFX!$;09;80X0EMG"40+$59\GET4W>.\OE+;<)X4E47"9`;#003V7[72:W M()RG$\A=W88A=H#[;8!-+OKRY>=!8R2 MW5N>A1'(S!W&T2&C0$M\CBRZ@)! M%S36+W).PE'"ZAA6@>26R[,P`CD2YX,H>4YB0CA/82Z>W*%?<&VEJ11^4S$A MG)\P%0\_-`%6O[E(SK)`$#ES]_F0T4:,,'J..4'A)B!T0)$HKI++PY("03H) M*A(+PGDJQA+`$PV!"SY*J.4:Q-.",)ZE,!9;\`[M*V8"H>`7/BQ-&#W7G*!P M%!`<;G\\1!5GR>6!28D@G00FTH1PGHK+^`4OT1ULP0ED\@QVF1*L8'`OX\DC MH(7@H^U8%_)^:@N.@?0Y\$0ZS)!@6"LO890@FLO3$P+I)$APC*-#.$_%<@($ M1\OQ"(X@G03QM""H5':T^N(E7:`Y,Z=$6 MG$!F$R>,/@=.$-K]@&!8:50JSL4N[0G/P"-X[B%;:%$$GSYD)>PE46K&90IZ@5+W-:/V%E+8@G*=B M-@%*HTEX2MMR$N)I03A/838>I=$;,A+T$*JW83"'/ M42K+22B#%H3Q=!]4_I6BQF&^JNY1>F4@51LCN`K'L>6.%F@1MMX]RNSE/4B? MB"#I7D]VR6CA^H>/+8R3_5R>KT0+1.E$^HQ:&$%6L1Y_H4<+]!Z[TGN4S14C MZ1C!U8&&B?7E$^`BGR,CCQ:(\JB/(/=5.=42)(7WA&W>NO4AR1;R+*-'Z3QZ M\7NG"N`JW,B74+0/+KK<<$0+RV1ZCA9&Y/.7G`@>M"+%'S_NH4?1`Q_RHON_ M;^)MSQZD)QW)XC-9\&DC^_KX7*_JW:Z=;)HW>-Y*[/Y3Z?FOYX?!?(KAP1WB M[TMX2`S\?7Z^X![1\KI^KO^Q/CYO#^UD5S^YD(L9G*(>\2$O^,NI>>V>X/Q\GX?_`P``__\#`%!+`P04``8` M"````"$`&3ZBX[($```=%```&0```'AL+W=OZ75:C^>0S`0-8E1G);VW^]Q M3DACA^N$E[:$89CQ\?&X9_WMH\BM=U:)C)<;F\Q=K8__S]\K2P M+5$GY2')>D4NB*I7M\N3RDO+D"QS_*L_FQ(;:M(5]]/):^2?0Z^/TB0 MI#?NYL6`OLC2B@M^K&=`YZ#0H>>ELW2`:;L^9.!`+KM5L>/&?B8KZGFVLUTW M"_1OQJZB][5!(' M!37^:%(GVW7%KQ9L&OA*<4GD%B0K(+X90QF=U9\Y!8N2Y%FR;&S8[6!"0'G> MMY%/ULX[+&G:8N(A1D/L;@BY?I*6]AXXH+<3#2O1%WV_"C=M$BRUW5AC?`#< MG5A/E;H;(GQ?A=`A9!%V$$6L_XA8"8;-T=,6^9JZ&#%0K$[_O/OF9MUVHPAJ M0BCJX6NF+[4$;VQ8FDY9I"]7H$&K9^@6G?&++%7J$W"D6-?*H)F3D]4S(JX(/M3%W!,&@ M5,TLM)9H048SR-.VS>#`P:8V\JAF9`#VS(R8P+A432QU$Z9,QL"#1HWV!(&,=1B&4F""J!1F"TZN`D:E4(="N!;&\E8-/HX51"&U9<+=Y MOLSFGZ4;D5'8\S"Q+3!`52]ZSC74(U[&H[IE02^![RW=KPNE6@V9B3TG(SV! M":HZ^&+&N""FF&U[8A1"6Q9T`'%N*(9,QND6,$=5"]I%/R:FL&TMC$*HD46M M@HS&Z18P2.%V(40HD)HECP'DKL!JW=.P9MW8),%EH([I)0 MWJMZ+=L4BAI95`M:8D_K:N].<@=Z5[<@HY5^2ZLE+_)28L'_SEU3[LI MT',S!-*>QS`=:D8I3O<&#&@=&<11$.%XQU\4?-+,R/9 M\QK&,LV?9QC#,9A.N#,`'SFO;R_D`*D;[&W_!P``__\#`%!+`P04``8`"``` M`"$`.%JPC[@&``!0)```&0```'AL+W=O/W^N3\ZULNZHY;]U@X;M.>2Z:774^;-V___K\ M8>TZ79^?=_FI.9=;]T?9N1^??O[I\;5IOW;'LNP=B'#NMNZQ[R\/GM<5Q[+. MNT5S*<_PS+YIZ[R'/]N#UUW:,M\-%]4G+_3]E5?GU=G%"`_M+3&:_;XJ2M$4 M+W5Y[C%(6Y[R'O+OCM6ENT:KBUO"U7G[]>7RH6CJ"X1XKDY5_V,(ZCIU\?#E M<&[:_/D$NK\'<5Y<8P]_3,+75=$V7;/O%Q#.PT2GFC?>QH-(3X^["A3(LCMM MN=^ZGX('$8>N]_0X%.B?JGSMM-^=[MB\_M)6N]^J)?MG) MA^!B;W+UYZ$#?[3.KMSG+Z?^S^;UU[(Z''MH]Q(426$/NQ^B[`JH*(19A$L9 MJ6A.D`#\[]25'`VH2/Y]^/E:[?KCUHU6BV7B1P'@SG/9]9\K&=)UBI>N;^I_ M$0I4*`P2JB`19*^>#^\.$JL@\/,M2+A>!LN5/14/90U5$GF?/SVVS:L#HP>) M=Y=<#G+P`)&OY4$Q8\'^KUY0*!GDDXRR=>&>@5)TT.1O3U"A1^\;-*903#IE M`DID5T)V0885V@,>Y#LF#?74DY[OY34W"(@G3\L<;6N`4D62H?K!Q.#KXH(8/M"#=#'?D\V1%A1(B0 M`)92O1_F.V*@>2/X/:$@4R?LB#`B5(*TN;M'*D!S)(MKP$J=*BA8XAWN+_CR MFRG"(%88$:I$NB)3$L/:9FD*>BE5PO8&:8"0IH0Y" M=DJ5L,U%&B"D;I$8W@_`/[H69(J93U3MC6ZV[@#"<"WV)6NXBMWM`:MYJB#4 MLIZ7(E]]ZR*RF4,$B:(6C;$@M"W2*+6V6`8+;96V@^\_Y)L!R,]0ZLR.""-" M)4BKU"39><#S=69V1!@1*@4F_?[1"N55?)LUZ0M"1BE61*B7FH]"I4C#U.X2\VH5 MHKU"`F\+;LAL.E60_N))R'8NV0S$6B:,"!4!KZ6+N.U6#^55[#X)^;Y$0;H8 MEF=F1X01H5*8E]\H!>V:KEJ3T;)[NOS(S&S[PHA0*;MEM-"++:,U->PD9+=0%DXAUC)A1(@(^6[C_E5KN(JO6BR)5$&F M5,8$&&,0J5(=[W9$"-)\VYP0U20GM]TU9J! M6%>%$:$BI$]K(FZ[U2-Y%1?#M_$*TL6P/#,[(HP(E0*O]`XI\BK;7BM"R"C% MB@AC%"J%>;MYU8K0B\VKEH)T"=-WAC,0:YDP(E0$<_4;1VO.W=G;C32R&G=F M1X01H5+>Y>T1VK9EU;)[NXJCMV[2%5,4*H5YNV6TT(LMHS4U["1D[[RR:`I- M1)@0*N(N5X]F7#V:++U6P\Y4'&,?3%&(A/A=GCY<95NM%&3(,[,CPHA0*&PO=V]R M:W-H965T%J_/JR?]Z_;S]=_;X_7 MOW_YYS\^_=H??AR?MMO3%2F\'C]?/YU.;\[M[7'SM'U9'V_V;]M7.O*X/[RL M3_3/P_?;X]MANWZHG5Z>;T>#P>SV9;U[O6X4G,,Y&OO'Q]UFZ^XW/U^VKZ=& MY+!]7I^H_<>GW=N1U5XVY\B]K`\_?K[]MMF_O)'$M]WS[O1W+7I]];)QPN^O M^\/ZVS.=]U_#R7K#VO4_0/YEMSGLC_O'TPW)W38-Q7.^N[V[):4OGQYV=`:B MVZ\.V\?/UU^'3C6>7=]^^51WT+]WVU_'SM]7QZ?]K]5A]Y#L7K?4VY0GD8%O M^_T/81H^"$3.M^#MUQDH#E M3_Y.2%Y?;7X>3_N7_S1&0RG5B(RD"'U:1'H_KD0.>=&4W,NH7TR8'.:N"= M]*-/#GC>F0UIS#5#0`P^.09ZSVW8#AKZ@X.==W9#'BKB#PYVUOD->:R(/SCH MF6?(HT5,#'8]L[V<]V$G\>>UET?`L#,$SFPOCX%A9Q#8,G+;3.9Z;7#7I_67 M3X?]KRM:<"DOQ[>U6+Z'CA#A5:&94>TZ\=XR0>N#4/DJ9#Y?DS^M`$=:V_[\ M,A\,/]W^2>O11MK-DLJ6;,$NK@D\$_@F6)D@ M,$%H@L@$L0D2$Z0FR$R0FZ`P06F"J@.TA-"Z`@D9TYIHOY3R'!%>=-'LS)'9 MZ$[O\/O&1BR;[42:Z2;+UJ1-"A`/B`]D!20`$@*)@,1`$B`ID`Q(#J0`4@*I MND3+$:WDD".QJE^XL`D96AMI)+0)F0^,:7(OC?JRUIJT60/B`?&!K(`$0$(@ M$9`82`(D!9(!R8$40$H@59=H6:,$:5GKGU'"NDX.=^I]0YIM='T)60)Q@7A` M?"`K(`&0$$@$)`:2`$F!9$!R(`60$DC5)5K'TZ;E@HX7UGK'-V1,.YAVGLS& M`V/IDF[J$N1*M_JVI\Z7!\1OR*B^NZEM5J`3@%<()`*=&'02\$J!9*"3@TX! M7B60JJNCY8(Z\8)<"&L]%PVA7/"T6$J;3L=+FT['`_$;TNUXT`DDF2JA$%$$ M2C$H)>B6(LI`*0>E`MU*1%572>M^VL5>T/W"6N_^AFA383HP+O1+::2ZS6W( MA);&S@PR=LA>:\2I]2510BN0#EJOKK1Q$0M;(Y:.0#H&Z:3UZDJ/]7F?MD8L MG8%T#M)%Z]65GNC296O$TE576LLKW>]J>6UN=6Y$_>#TM-O\N-]3Q],UW'+- M&=,M3;WT?!4B>KH;0BKBKF$+\APY&:Q2L0 M"L`M!!*A4`Q"";BE0#(4RD&H`+<22*4):2D2%8;>'/VQ?WLO1U2%XB35,GJ6 M)!J-U**(R&4T;JT\UIJ.Z@3_9LQ(OSVN?%8MF[0Z@86%+;-K1^UQI1VW3&DG M%I:V3&H;TSUKCROMO&5*N["PLF7=;?%L/-7G9M6:U0-=3[2XU^W6'2R3KIM0 M86XDM$$CNHJVZ^5BKK=@*6ZDR*\SB5Q&M$RT?J.A<9/EL=5=G?3A;$K_Z=J^ M-*'[/EYZ5NREYFS`J#=%FLZ%Q=AF& MR]E+A2L8]88KV8K#W8UPJ#2):CI3'RGB)OR"D=+K]BI*(%C'JCA6PEH]W= MF4,W8@L5+6:DHB6,>J.E;-5$&]&US5C^,K90T7)&*EK!J#=:R5;RW!;CD9&D MBBTL"PI)7S),A+FQH#1(6U#NC&FQ%"5E-)Q3M>^=BS-QL9ZY4LK M44MJK49#8T.QPD8$C'H;$=H;L=`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`D0AH@A1C"A!E"+*$.6("D0EHDI#>BY$6>R":<]5M,X5ID$?5)Z'TDI5 MC%V)/J@]*RL>RSXCI;5"^8"M:&NEEJ.QL34*E17+1XR4?(SR"5OI\L:%-556 M+)\Q4O(YRA=LIA:19^-$K7%Z-'<:.=2 M6G0GIT3=\5I=E$[G14CM5T(6&6L=ONAA47L MJM1B1DHML7BF%I:QJU++&2FU@I$ZZ9+%^*2-(5ZQ2RVL9_"R6B+E`S(EBWW= MG154G:5?YZ[+9427QG8)Q%(B6W&A=#H:&L417YIT[\+82VTH`D:]X4*VDN'H MN9:AT9<1AHO92X5+&/6&2]F*SVXVG9HWY!@N9R\5KF#4&ZYD*SZ[Z7!A%$$J M+9P^4FC7K\WU_N\G1L+<6(H;)`9CFW&L.DM':@A?-EQ&O?<='EO)V@8]:V&< MG,\6:GZM&*EH`:/>:"%;-='&H\',+.6PA8H6,U+1$D:]T5*VDM$H&(P3V;DJ M6LY.*EK!J#=:R59-M-%B-#1NE"JVL"PHHEK4O21\,$R$N3%,&J3=JD'5>22- MU!QP&?7.`4]:&7=JL*8T\OTW22N.J!H1,.IM1,A6S41>BS/$FVBUSW9K-Y7(NMU-0,&/4V M(F2K9FI.!U-C9D9LH-:!F)$*EC#J#9:R%0<;&=,D8P,5+&>D@A6,>H.5THJZ M5Q0.9@/CNENQBF7)$96J"P9.4]CJ%B+%6B/&A!KN2T0N(U4P]23J%H4EZDS= M%3LJ^8"1T@I1*T*MF!V55L)(::6HE:%6SHY*JV"DM$K4JC0M?1*+6LL%N6A* M,UHN&J1-XAD4A2E5,(LEZAUFGG349_$4=@I2ZX-9#(T(N%V]C0A5(YHBF?FL M0<0R:F+%C-3$2ACU!DL_"I:QC`J6,U+!"D:]P4HSF/E@>,4REFE,5Y9+AHXP M-];_!HG1V:Z]6.0=22LUZEU&=*1UM-R+-([ZU@&'3F/UT=8!&A&/\>LK,XX843&[Y]Q^E&P3!IT%KNV;ZJG-9 MH7"$A4)&S;N9X@'$)2(7D8?(1[1"%"`*$46(8D0)HA11ABA'5"`J$54:TG(A M!OX%T[@VUZ=QB[KCA9XWTQ_*6';,>*2[%N99F&]A*PL++"RTL,C"8@M++"RU ML,S"<@LK+*RTL$IG>K[,&E[_#=L8:W6,.G,'D8O(0^0C6B$*$(6((D0QH@11 MBBA#E",J$)6(*@WIN;BL&C?&:ER+]+ECW/(M.V9J[K":VOMY%CO?PE86%EA8 M:&&1A<46EEA8:F&9A>465EA8:6&5SO1\T6;HDK5.F!MKG43=N0/('0/R$/F( M5H@"1"&B"%&,*$&4(LH0Y8@*1"6B2D-Z+D3)IGOG(;Z+$+O-"U]O'#>EG^XM M28OT265\G[;LF*E)Q6K=287,M_BN+"RPL-#"(@N++2RQL-3",@O++:RPL-+" M*IWIB135F&XB/[@@-<4;+5\2=2<5('<,R$/D(UHA"A"%B")$,:($48HH0Y0C M*A"5B"H-Z;FXK+1"WZ'"`L=(GSM&=6?9>JIYXEJ89V&^A:TL++"PT,(B"XLM M++&PU,(R"\LMK+"PTL+$3^(TO5SW59.OYC=NFM^Q>-D>OF^7V^?GX]5F_U/\ M?LUT0'>++6Y^7.=^/*5?UZEOP^'(C']WQSPRNG/$UI^6-_/(>$`^]8L?<$3\ MBD\]%>'(B([4)08X,J8C]1><<&1"1^J7<8PC])VM([ZCQ;;1]Z^.^+X5C]`/ M#'VUQJ]%$8`?>AI#T<\*8!'Z*$/1SP=@$?HJ0[J%=N1)1T1 MCU>@#SU?XWC6(_0`C2.>K$`?>H[&65F/T.,TE'J;#STOXXA'*U`M7CCTTA_R M9.'0BW[(LX5#K_LASQ<.O?.'O%@XI8U7E$@;7RZA41]?^'0"Y'( M5PMG9>/!PJ$W(=$^6CCT/B1R=^;0B^?(@YE#+Y(C3V8.O1B.O)@YI8V[<\>K M2T3&>`[F#KTNC3K)W*&7GY$7L^6TK1#_1];;^ODW7A^^[U^/5\_:1EL!! M_5;KH?F1K^8?)_GFY+?]B7Z=N__WPLMD<;T##^^&A]W(\?DSZ_'? M_;?^X6._63W5@]Y>^_9@,.J_K;;OO4;#9'^)CMWS\W:]F>W6/]XV[\=&R7[S MNCJ"_X>7[<>!M+VM+U'WMMI___'QVWKW]@$JOFY?M\>_:J6]F[?UQ/_VOMNO MOK["O/^TG-6:=-?_,/5OV_5^=]@]'V]!7;]QE,_YOG_?!TV?/SUM80;BM-_L M-\\/O2_6I+H;]/J?/]4GZ+_;S<]#Y_W-X67WT]MOGZ+M^P;.-L1)1.#K;O== MB/I/`L'@/AN]J".0[6^>-L^K'Z_'8O=SN=E^>SE"N(]OQ\.A,QJ[YPV-<""\XD#[UK&'[KB>YQD/71P(KU?.#998[2N\TMPN M,WF/`^&53)X__Q:D36U*O+EN>A8E@'B#0YW+3JD%.=-8E%'Z+$D>\:8=>E'(6I8YX0XY>N"XL2A[Q!L?"F3J3 MIQ9EC7A#UF#17[(*;_::,U%5IMCJN/G_:[W[>0*F'+#I\K,2% MPYH(;52/&L_;"G6J0$%E$EJ^"#4//9@[U)X#5-4_/L,*_]3_`RKA&F4>N8RE M2DQ)0I0]H7:F@[D.%CKP=+#4@:^#0`>A#B(=Q#I(=)#J(--!KH-"!Z4.J@[H M0P#;*,*"_G]$4:@14:3S_TA`AM760D82-&2F@[D.%CKP=+#4@:^#0`>A#B(= MQ#I(=)#J(--!KH-"!Z4.J@Y00@;5@84,&H\3C0"M,S$*+OF==>;(PL&?$9"1@) M&8D8B1E)&$D9R1C)&2D8*1FIND2)+`211=8>WEX?6Z&HCBW%Y!$)M"AMM!U' M+ZVM$`V;,3)G9,&(Q\B2$9^1@)&0D8B1F)&$D921C)&#7D;M1>&:>,S!B9,[)@Q&-DR8C/2,!(R$C$2,Q(PDC*2,9( MSDC!2,E(U25*<*#;OB(X0EH-#I)!M_NT+4>[Y#52G1#.&N(X=;MJ#RQM_4,Z=HI6CRQ5<`NN&BM;(3)6=54KT88H*=%N;CANQ7;`\66[_OZX@Y(( M5SC#$KV#2#6W&T*)F@1((`G(A2FA^Q;-&N0(6W2?XCAWZF3FK1!I6J`FVVTU M>5SYLAW75:ZEH=\*D?*`*P]12.99A$(#.9>XU=0UIP4F:87(7(J:.G/)4$B: MRU&H8ZY@FDI&*AS6Z%:B#O>X+.H@UH2\VGV<"CEL1U',A0HUY@VQN^V0XXS4 M:$Y1R&Y#-T,"'5V;!+:E#9LW0JYPD3+%=K4UMD!-S3Z=N&'UF+7E)=;\2ZP% MS%K(2(1$SC9&]HH.XXV^2F*W3LRA0C)R,\)P66NU<4SAJ0ZE011 M9T$N"I&A5->+G$9*+PI"THL2D>:% MUG-5-/"4%VH^B1T;OB5Z98T8,=FB)S5OV MBSPC1^2)]-JA\DPND=U)JSXBM[LL6"('K3)9'T-2)MV-6C%I,R8Q:3-!I-AT MAEJ+EK;*X.9=KC$]N[-6K!MX9ZCU9'DK)ETKD'5.1XGHO&M5J^R4:VJRB7TE M/=GLD?CL[YK>2'PJHV<;(K6H#;4&<8HCE:*&(Z&H=4^NWB&1S<$O\H^T=?.O M84J=0P0OG8!J-GVT:3?=PMBQ-8&`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`NP%,4Z_0U,T(RM^>(U+YFI"WF!0T\=3&OMZ@\DI*^+@E)B[[9HG8#&=#` MLQ9#E.HV,1&-E%[$A*07"2)MWMK"3FG@62\RE.IZD=-(Z45!2'I1(M*\T!JZ MB@:>\D+)+_%M.R6__E$K56M1KUZ$U$+$6BD4ZQ8B1)U.9XY(O6X/]+2C@:>N MVTW:<8M+&B@[!=]H<:0MFH`&GK482BE:E!&BSK1CDI).)(A@VC0P1:2U0R/M M>I:1,MF-YH@Z)@N2DB9+1.J9UC]RJFC@J7FK*0;M+TLQ<$/=6KK\8U?Q49O6 M*A$2=536.%?K.*GF115]: M%/V2-=0"')!B:2OD*"(DS<>(SD\X0:GS$TY)O70BXR@G))TH$($3E-@E(K!H MG'!%6GC3!.'D^64-Y5;Y99_LUFJT&H:[ULUS"^*CU2E)233C:,[1@B./HR5' M/D0:V-##? MP`(#"PTL,K#8P!(#2PTL,[#5@M2(7;<59_.MN!9!3-J[3^IMWBYI<4'NWA1#1$ ML)#8D1$UV='QG"D;E79D7LX4F^DZ4?N!O1C#OH19P+/?1D\ M`Y>-'H/#9G]ML%WOI>@6[#LX4N\@LR-@'/I_;CUU)_#U?,XS=P+?T><\=R>Y MB1?N!+ZN1-XOFV=8?H-ZQVW?_)I(\\\1GZGXNCO"KX!`T81'^^%77S:PDS80CS`^ M[W9'^@<,]]O?D?G\-P```/__`P!02P,$%``&``@````A`/$HS]]G!P``3QT` M`!D```!X;"]W;W)K&ULK%E=U M^<8PL7?B#PQ,.]/I;-MG@G',Q#8>(,GNO^\5ND)?K).T>5G6)T=7TM'1U07= M??U^/DU>RJ:MZLO"L*:F,2DO1;VO+H\+XZ]O\9>Y,6F[_++/3_6E7!@_RM;X MNOSUE[O7NGEJCV7932#"I5T8QZZ[1K-96QS+<]Y.ZVMY@;\9RU MUZ;,]WVC\VEFFZ8_.^?5Q:`1HN8],>K#H2K*35T\G\M+1X,TY2GO8/SML;JV M+-JY>$^X<]X\/5^_%/7Y"B$>JE/5_>B#&I-S$:6/E[K)'TXP[^^6FQ5@8]U:4V:8Q6][U`OU= ME:^M\/])>ZQ?=TVU_ZVZE*`VK!-9@8>Z?B+4=$\@:#S36L?]"OS13/;E(7\^ M=7_6KTE9/1X[6&X/9D0F%NU_;,JV`$4AS-3V2*2B/L$`X-_)N2+6`$7R[PO# MAHZK?7=<&(X_]0+3L8`^>2C;+JY(2&-2/+==??Z'DBP,18,X&`2>&,3RIZ[M M!?,^RHV6+K:$)^N>]WZC'8RM'S8\68^WA^AC`WAB`WL:6&;H!!#B1D-?7K!+8LJ-E>G/ MP[O9"SBZ0,Y*YU@R8\T8Q+XD[$8%MBH0J\!.!1(52%4@$X`9R#)H`WOE,[0A M88@V;%8K!G"Q;$4(QF!--BJP58%8!78JD*A`J@*9`$A"P'[_#"%(&,@[@DG< MT)1GOJ(<"Y:$.TFFK`?*H(Z&;#4DUI"=AB0:DFI()B*22)#:/D,D$@8V(RP% M%T!3"4FW5!HH@TH:LM606$-V&I)H2*HAF8A(*D$6UE2RO>F0G-^=<4B@7BWMI"5N>*")0)@RVMBW5UI3D\D-F0Y$`CO2A MF1MZ\F[8#B2V&V(,%`ZR[BAB\=`)BG`.U!JU`2!!9.(J$H@*VJPI'2:)P%`G$W.JJMMOOY,.2C[F71] M&%D[A%RKK^5L4S,<$CQG,,J&0:(O;$OQQ9:Q@CZR985*F1@S`M_9.X1L>^@L M81`\A%E23Y""'UDCFPRRACS$2D4/Z`1UI5\ MC"N+0MQ'R@Y?(T'R$6TC^0BA-WR$+-%'%))\A)#H(X0&'YG*4F8X3,@HL$7D M1`1CDC3Z3^\-EE.;S%=SAR"27 M49;#^TR1Y9I]MG(FC-DC+F,E*&BRWH%X?L73)P4&.R8?'^U86%ARZ>Q M0L@6Y^^&RC*OD26YD<8"-PK+H)^;R,)ST_:5=8I99-&;M(WD30JYD.IX+E`[ M2S&62\JKE^4\#"TEHV9LMB-V)97PYXJ-M;4H-H5LF,TP#5<]W-<694GI$6-) MUF68O'1:84)I8%W>IVTIK!WV*;F9-I1R)H4";O`,&X[9EU3.JJ+0@6S>-\H3 M6GW#:<5/8"S(Q5E[IK+0:ZA?^QJ%)[,-@\1C&%G,G8Y22L2LC>A.[)\/*4&6 MS3M+$0IX+9,QUHCW2*FL*F5Y'WR5L&C!+6E%(\AN.C.N38$/);Y0E^8U"(WZ#5[01%?]/NNPCRL4Q0D)N6B,DYD;6 MT)$WG5(K;@<:35A:;F21!?3?`]+IHY47P,0BVHHK[$7PS&<&#"+XPZ/AF'L%+O(XG\PC> MP'5\$T;;/N.A^NM>[[_:GP5W#=U=\-J;@-UV`C<59.!%].1^*[ M$+]_O5`#N1%\1(0&L^$/<)UUS1_+W_/FL;JTDU-Y`''-?F\W]$*,_NCPI?>A M[N`B"_2'6PVXN"SA0L$D1_ZAKCOV@W0P7(4N_P4``/__`P!02P,$%``&``@` M```A`*E*`;YR$@``XUD``!D```!X;"]W;W)K&UL MK)Q=<]NXDH;OMVK_@\OW1Q;U85NJ)*_L]_XG_=7EX?KUZO#]]?M_6/M M]/QT->CWKZ^>[WOARMR.OVZ?Y(]W_XMOM^ M8+7GAW/DGN]??_OQ_5\/^^?O)/%Y][0[_EF+7EX\/TS3KR_[U_O/3_3)U^^7CY5TP MW8QN+Z\^?:@[Z']WVY^'UK\O#M_V/Q>ON\=B][*EWJ8XF0A\WN]_,Z;IHT'D M?`7><1V!U>O%X_;+_8^GXV;_,]GNOGX[4KC']$3FP::/?X;;PP/U*,GT!F.C M]+!_HAN@_[]XWIFA03UR_\?'RP$UO'L\?OMX.;SNC6_ZPX#,+SYO#\=X9R0O M+QY^'([[Y_^S1H&3LB)#)T)_GWMU[V;H#\9OM'BC?.CO^]\2,JU^E[I+]]K M<%:3$^=(?YUC.S@G>B>@<50W:?[QKJ<,>$"8?[SS.0,:1+95&4TW9SUHP"/( M_(/[:'*>*P^A0,;0>0$U:6)O5P;1N>,VX%%D_N%N^+87C/K7)FU.18:'4=`: M1S?GC?F`!Y+YQWFQN;+I7L\>X?WQ_M.'U_W/"YJ2*;J'[_=F@@^F1H[G#7OK MS4SR5Q,)S2!&Y<[(?+PD?YHC#C3[_?[I>A)\N/J=9JP'9S-#&V4Q9PLS/1G9 M4(-(@UB#A0:)!JD&F0:Y!H4&I0:5!DL-5AJL-=BTP!6%IXD19=$_$2,C8V+$ MO3MC($$;^"&;LP6[A!I$&L0:+#1(-$@UR#3(-2@T*#6H-%AJL-)@K<&F!;R` MT.3T3P3$R-`ZVTJ:<7_D1V!F;^ M(Q;&VH^%);M)XI5([?=@^_S?8TN&FRZ4B.(6W&[!;-B/CQ<$1V!',@H24CTQ+O M[,;]B9\_46/$^1,#60!)@*1`,B`YD`)(":2RY*8>>E[7TI;U9-?^9__]K[J6 M=OC=*U9-[UHTJ$\$ZN`N0#P1MU;DM'@J5BR> M@7@N1B>D"K%BJ1)1U5;W`D&U[V[!FK2%LY(VFK8'2RK=)O:](+)M[_ MU+"L6+1NVDLO4T%`9`?7YC"P:]EHS6VUIPJF$:.S0EJPFIB,=8[,G>/@IA5, MYRB9%CFKFXE-M9Y:6V)W?=B:[%`X823"J2^L>BI#V9PUY'X+1B);^K*C7M\+ MR$0-S,IKQX^(J2[UT>6&I9SMA+'D-&P MT8H<"D0@GC$0X]87I6-C/X(Q=1#AG),(%(Q$N?>%1;^P+ M5^S2D1.F5M01."\GC*?*"8M43JB;F9MS31,J&6,A(QECD4.4$Y)?@QNU,8B= ME9<9()^@?'J6?(;R.6O)W1>,Y.Y+D3=+5+\'*6%OTMZWGQ*F#&P'Y(U4<%6C MC(^9.?S%5%!W,&=[W3D0JT#'@]_ZOGP$:G3@P9N=<3-?G.S(F[L6I/6!"C MQH;GN5#<&$6(8D0+1`FB%%&&*$=4("H158B6B%:(UH@V'O)3R!21[T@A6W/2 M',E=.C.?9)C@>(O[0$T^<[%BQQ!1A"A&M$"4($H198AR1`6B$E&%:(EHA6B- M:.,A/SRF$'U'>&S=ZH7'HO8IBOD(B2+60B&B"%&,:($H090BRA#EB`I$):(* MT1+1"M$:T<9#?BQ,+=J.Q2\=JY@/S>R,QXDP8R1KXMRAFU&39Z%#WM'*8*P* METBL6#Y&M$"4($H198AR1`6B$E'E4%=9:0I.Z&EZOX#V-^;\BJO*\P^S`EO" M>HGA4+O7+1I+[1`ZQUMS+M99V8N!=+B3L2\[V.+1(OM&1WT$DXCC7U3W8L#* MF4-C4>=4:_O[7(;\( M&:@[G;.5K#1%5&%H0=I6!(&(E6BEH9:N7L*%H%(]$J4:ORM+P58*!+\#?Z#TOO M6D&7W@-5-,_92L9&R$AV[Y%#-,2E2UUE+^-LP8ZBE3`2K12U,K82K9R1:!6, M1*M$K8JM.H:D*>[:4_T;76K,U41BT9C6U68^&`]4"3$?6*MV(W<6='@X0$>,I+A%CE$:2`AP<,/=I31O&`D\@DC MD4_/DL_84>1S1B)?,!+Y\BSYBAT[\L>4O>_('U.RLO M?ZSC0$99Y*PX?]XX[(R=N;<".%$9S0DW+>VD[VLGPW9R%I5V"D;23JG;4;U2 M><)^CKROKC;'@'I>LTCER(U_6CEWCEZ.6$=*:4Z;R%FYW5``A^:L0IW?FD-A M6G/",G@2=I2V4K\MM;1E['"RI9RMI*6"D;14JI;T_%FQRU^UY0?,%,7M1/K% M$RVS,[:1E*Z\UGNT&5NU)T`UN.9BPW$,$46(8D0+1`FB%%&&*$=4("H158B6 MB%:(UH@V'O(#JY\L-C*N%VGKT1'ELX>S6(1:WCJ_D`4(@H0A0C M6B!*$*6(,D0YH@)1B:A"M$2T0K1&M/&0%PNSC7U'+&IS?_/MT(BV>*U44;7V MW%FU(A9V.@[5J7$D5IQ0,2-Y*VR!\@E;>?,1'Z)\BNV\N75^K`6*Y;?,,+WEH;O*_UKQI`H>;FYL[*BRM8 M1]:(-@X%M`^AN_5G57VD MH0/'Q]>G5[XA'G4X9`ZH9+8=ZI*`K63S'#*2S7/$R!X2TQ?GU*0=LX'TPX*1 M*">,Z&:;6X+3V-19`A(ZE6(T;VU:B@ M?ZLZ.78&M$IP[RW81Y031J*<.N3J^F#8&ZC%*$/IG'5$NG"(ON_6W$'9P2I4 M6Z+:JL-SW<$VGIH?/YJ1WA,_8Z[B9Y%*295+<_/*+CFVJW1&[92T5MY)UGBD M]D0Q.Y)Q,V(&@6IQP58RW!-&TF+J$.CM0&]-,6N.I(&<=D2X< M\O/5=58KARM46Z+:JD-MW<$VGIJ?K]V'-._\9@/M$R#<%OEI/%([E+ES]-+8 M.M(VCOLQS:3F.XT56'Y[J#;3PU/]SZ**?>2?V=]P!H@H+06Z0R M7HW3(2<,KZQ6[B/`2A5=L=?(QUFQE^RP8!K=J M9MRP1=V:/T#,N4][GO_[`\2>)+7/F\P[UF;Q]G;=([4!FK.5I%/HT$A0Q(A? M)QFJ9XU91E)KP4AD$I9I3S$=`\3>^*V=%H))3[]>D;&TM)8SDM8*:8T'>NF0 MDQ[UU$Q9L8H(+QF)\$J$3XSS-5O9/AM.]+=G-ZQ<-^:-#UJC.L;'6-:+\TJQ M6J;>]\E]7D_4%#%CJ_8XT:-$;+@K0T01HAC1`E&"*$64(GRZ=S6=F:I_.B#8OS90ZUF_/S<5*PN.T9.6,T"I&M$"4 M($H198AR1`6B$E&%:(EHA6B-:.,A/SSFK.@=X;%'2^TYEN9($['6_F2.*$04 M(8H1+1`EB%)$&:(<48&H1%0A6B):(5HCVGC(C\5;IT]G?3%RA(=/#IG=6BN# MU/HU=U;M%U<=\EY<'<-1OUAQZL6L):FW<*CUMF,BCNW[4@M2*E8LGWGR?A^: MXY;V>/ZU$SSSJ8B>ABSR]Q)C51O,G6.[SF`DQ7O$R)[@!?"ETY@-9!%>,))% M.&%T^@3/6;F3@DE/?T+.#1?X6'0[)S``S^S2I M7T-&4L]$#O%1UJU:H6-WO7U&QBHBG#`2X50)#WOZVZJ9)^T/.%-3OZ.+7`DN M49R-+%(#2VU1YFPECB&C]L"R6OXYU!@ZRK5(O=[,!W@.Q?+28L)(6DP=XG.H M?D^7WAD[=0PO4WFV^TXGZWD3GJU?O5'G2EIZSN8!QW`$-')6,CA"AVA;RG-- MY-`-E6RB-58G]S$[GCX"PA83=I064VFQ/@+J]P(U&#)VPK**7E/OZ-*_4W?7 MBO[)J4-JQ.J3;[:2\1,Z1$N@=*\KA6VER:T+JTY-A%A"1)65X!6_"\;3.YKQ.UJG*^8;;5U72(R^ M3-5UA?J,OMJ#5^C0:VH.N?`*'6!-S8$57@E'PVE$VP>\0KN1J=EKX!7Z0<^[ MSGZAKNSL2>K(3OOA=-.I/YK>T?'9B"+2P>G#&'KPKBOTP0H]>-<5.N@G MGZZNIT-[\NFZ0H?(Y-,5%#H0)I^N*_2>Q-1\7(M/0Z]+3,VGMGB%WIH@M:XK M]%H$]5G7%?I`D>ZMJSOIPT%2Z[I"KR5,S4L'>`?T.3==Z6J'7BN9F@^ST8?> M+IF:S[3Q"KUD0O?6E7[TY@)=Z;H#^BBH:\8D5J7SXSN>M9Y!_06T-2\:(#MT,M`4_-R`5ZAMWVFYAT#O$(O M_4S-JP9XA=[]H2AT]5M(F=Z9SK?3J*MGDMLI_>`-MI!35W;QD#JRJT\2ZL8N MGE,GUORJF?OH)W:_WW_=EO>O7W=6K_9%>^Q]']S-#G_=' M^G%=6ECIESCIQY2W]$,E??,UN2_[_9'_@Q[@JOEYYD__+P````#__P,`4$L# M!!0`!@`(````(0"UA'#J%@L``+PQ```9````>&PO=V]R:W-H965T<#%HO9W6NWHR1&QU9@ MNT]O/T61I2)9:B?9Z9MV\KGXDRH6BRR%??O[]\/+Z&MS.N_;X]W8N9F.1\UQ MUS[LCT]WX__\&?^V&(_.E^WQ8?O2'IN[\8_F//[]_I__N/W6GCZ?GYOF,@*% MX_EN_'RYO*XFD_/NN3ELSS?M:W.$;Q[;TV%[@5]/3Y/SZZG9/G2-#B\3=SH- M)H?M_CB6"JO3>S3:Q\?]KMFTNR^'YGB1(J?F97N!\9^?]Z]G5#OLWB-WV)X^ M?WG];=<>7D'BT_YE?_G1B8Y'A]TJ>SJVI^VG%WCN[XZWW:%V]PN3/^QWI_;< M/EYN0&XB!\J?>3E93D#I_O9A#T\@W#XZ-8]WXS^<5>TNQY/[V\Y!_]TWW\[: MSZ/S<_LM.>T?ROVQ`6_#/(D9^-2VGX5I]B`0-)ZPUG$W`_\ZC1Z:Q^V7E\N_ MVV]ILW]ZOL!T^_!$XL%6#S\VS7D''@69&]<72KOV!08`_XX.>Q$:X)'M][NQ M"QWO'R[/=^-9<.//IS,'S$>?FO,EW@O)\6CWY7QI#_^31HZ2DB(S)0*?2L0) MKC;P5`/XQ%YOW(7O^('H]4I/\&TW7/C$GIP;S_7GBVZ\5UK"@+J6\*E:NO2< M5]K-53OXQ!ZO/QNLK*XC^/S8LRU50_C$GM[Y;`Z$3=>G`_.$;:^/TH$)ETVT MF7_?'#@XW>('[,V[<;SI6[/GX+R+'U3+J[,PD=':!?]F>]G>WY[:;R/(*/"< MY]>MR$_.2HAAV,N)[!?"S]8!+`"A\H>0N1O#3$&(GV'Q?KT/EL'MY"LLN)VR M67,;Q[0(T4*L+B&[L4%D@]@&B0U2&V0VR&U0V*"T066#6@,3<&WO7PB*7^%? M(2/\BYY9(R"'NY8ST0*;;&P0V2"V06*#U`:9#7(;%#8H;5#9H-:`X4Q8)K_" MF4(&TK,6K'XP-;VWEC8B#5!$FR9A;])[F)&(D9B1A)&4D8R1G)&"D9*1BI%: M)X:S(1G\"F<+&4@N,*7DR.7<=.5:&5WS=F_2>YN1B)&8D821E)&,D9R1@I&2 MD8J16B>&MV$?-KP]?.S`="NL.Z>B,]:*P%[5N]D/[/S:&V&S#2,1(S$C"2,I M(QDC.2,%(R4C%2.U3@P?PL-_P(?"VO2A(C.O3[,A1QN.(HYBCA*.4HXRCG*. M"HY*CBJ.:@,9WH-SV0>\)ZQ-[RD2D/,8V3`2,1(SDC"2,I(QDC-2,%(R4C%2 MZ\1PF*C\^-'I9@[Q>7G>[SZO6UB*D-(&EO(,CDCRX"1$3#]*,H-NM95L;^[2 MR.]*&GE4DF2NIU#7MQ)`U!MA`H@921A)&APE+._K-][9S]?L\+0=/SBGBZ#_U@9NY5H;3272_)0DSJUWMWZE@MHO[[ MWNM*0Q9_XJ2;2.+0"2]5K3Q4M4(@Z[]'U5R2.:W`@JF6?2LU5BM"JOY[5*UU M56-&1+'T:Z>D4S3G!)&G'R#L\T.HK/Q9GWPVV'"F-W0=JRB)>C,X!VGKS3,G M/<8.('WV5JZS-*T2M*)AI+W^U6%D:.;)(%I,76L$.6IKLXN(NBM1Y_I35[V9 M^=2^^3PU=O"SIS;#`98-#P>?\B$NT8%\""\K,"&*([>U+A7RN[<_7;8+.=HH M%%!.C!#1.HL1N7VD)%PK12O2RA"15HZ(M`JN5:(5:56(2*M&U&F9?H7(,?SZ MAO^$N;6&%#+6D!]82R$49W1H:2PBA>A$%*&5?`,B$(S042AF2(BK0P1 M:>6(2*M`1%HE(M*J$)%6C:C3,GTJJAY[[W9]L9N\X5U5+M&4K\7+&^%P#\[V M?6[P`ZO$"969%L0;A8R(E6*!3`,SSUM8.2;&1C2"A$NG:$5!ER%2TC/?SJ(Y M6I!TP:5+M"+I"A%*!W/KZ6NT&`AO41+]7U.A:BD:[5J\P.JF0IP*\$64'RS, MM!8J,R/094N?`BI"*PJH&!$%9X*(@C-%1%H9(M+*$9%6@8BT2D2D52$BK1K1 M0*"#)PSOOA'>PMQ*'@IY^B;@!U98AN)5N4@>E*,W"AGA+:T"_83ESJUW+S$V MI)E-N'R*5A2'&2*G.S/-K"#,\6O2+;ANB5:D6R&Z.NP:K09B7%1==HP[VM;X MKE)!_"G`GAR%/*-:L!T:JI9&P,N6`056I*P"F*-^\0Q,CFSH4]PF7#Y%+9+/ M$(FM7AR3K?-LCBHD7"#2%P0;=T7"5\9=H];`&A$5GCT[[N)OE!:.JADIT-:( MS%UB;AV_0V5F+",E-J.`C'JUA8STH7U"-@MH#`D73U%($\^0>4I\MIA91X5< MF6CB!1N<14Q:9<#S`(F<-A5>7OBC2 M0HXVB"BJ(T24C6-$%,@)(I)/$9%6AHBT_MQ:XZ$CS8SPELC8)12BXW&L&FH!EW"M%*UHI62( M2"M'1--?<*T2K4BK0D1:-:).RXA5=[`Z_FC.[U3,#1F1I^=I?VZ]=`B5F9[S ML>7UXC#JS>`LJLVE59#&V`$DY-Z*E\1H1=&:]OI07&@MK1R3]6;R5`E_=K=& MD*.VMC@047=EKW.UNZHW,Y_:+HFQ@Y\]M1D#@R7QWWEIY?+J&)&ULUCN#)69 MOO04"B#?_GP>(K2"#-E;^7-K+F*T,IULG1(3/H@4&UX=1(96OR;D2`*:3W#RK^S?_3EB"MDK'0@D;;.0V6E MH0TBVB$B1+1#Q(AH026(:$&EB$@K0T1:.2+2*A"15HF(M"I$I%4CXCN7*^IE MVZ_P]OB-,KYK9OE15MZ.M8-9-42H6AK+2+;4=S!E!74.GC!B1+3K)%PK12O: M=3)$I)4C(JV":Y5H15H5(M*J$0WL8'9E?OU4X/)Z')%5GMCUN#(SXI77XV@U MET=>=\92D&I#$9=@&XJX%!%%7(9(*GM+U\J=.1J0Z_+K'`;'[PMB7<@V;QC0B\V8>.OV#Q369X,MGT:O3' MYVB`Q0,L&6#I`,L&6#[`B@%6#K!J@(G;X=(KW7-(Q\OKWO+&ZZ$Y/35A\_)R M'NW:+^(J-[RQO;_ML;QGOO97<,,(G&/S8`679P;X?`571`:XNX`+Z]U0;"5W MB5?9K6\VBQ5!:F^4JZEZL6_;I<@77`+A]N5S!'_(YASOT?W2KVM)9P]WZ M[DAH3M>_G+15WL^-1>X-8\S!G<48;_)='`'QZGXA7M8]M>\!?10?__ M+N[_`@``__\#`%!+`P04``8`"````"$`3TWBNN0+``!4.```&0```'AL+W=O M9$">A)N`4,+=OORU+[9;4#H$Y\S+)_&C]6^[6K>5P^^>/W5OO6W4X M;NO]7=^Y&?9[U7Y3/VWW+W?]__P5_C'K]XZG]?YI_5;OJ[O^S^K8__/^G_^X M_5X?OAQ?J^K4`X7]\:[_>CJ]+P:#X^:UVJV/-_5[M8=/GNO#;GV"_QY>!L?W M0[5^:AKMW@;N<.@-=NOMOB\5%H=+-.KGY^VF\NO-UUVU/TF10_6V/D'_CZ_; M]R.J[3:7R.W6AR]?W__8U+MWD'C>#^8#4+J_?=K"$XBP]P[5\UW_P5F4([<_ MN+]M`O3?;?7]J/W>.[[6WZ/#]BG?[BN(-N1)9."QKK\(T^1)(&@\8*W#)@/_ M.O2>JN?UU[?3O^OO<;5]>3U!NB?P1.+!%D\__>JX@8B"S(T[$4J;^@TZ`/_V M=ELQ-"`BZQ]W?1<<;Y].KW?]D7W6N8 M`HUW^*DTYC=39S@?3<_W>J[:P4_L-:3M3&<=^+CQ)'[YY>XZF"KQ"SJ>:.&Z M,%D.I%KVAG(.OUW:>H2MX1?5"Z_-]:4B.&`<;<13X:&[`I!`J#T+FK@^#`H;]$2;TMWMO/KL= M?(-)N%$V2V[CF!8KM!`S3LCZ-@AL$-H@LD%L@\0&J0TR&^0V*&Q0:F``H6WC M"X/D=\17R(CX8F26""C@KA5,M,`FO@T"&X0VB&P0VR"Q06J#S`:Y#0H;E!HP M@@FSYW<$4\C`DJT-ULEL9$9O*6W$JD$CVC19M29MA!D)&`D9B1B)&4D821G) M&,D9*1@I=6($&Q:#WQ%L(0.+"Z24`CF?FZ%<*J-ST6Y-VF@S$C`2,A(Q$C.2 M,)(RDC&2,U(P4NK$B#;LGD:TNX\BN-P*ZR:H&(RE)+.I%N;);&*&>=4:83.? MD8"1D)&(D9B1A)&4D8R1G)&"D5(G1@SA7'-%#(6U&4-)1EZ[RJX8\1D)&`D9 MB1B)&4D821G)&,D9*1@I=6($#$:+$3"Y^=^(H]SI=;OYLJSE*;9C,(Y@DY=; MOQ`QXZB(4,'3P&3F66-1&DW';;!]2<9FLZG9+&B-<`B'2HBR%DGBT&X9MZWT M'EGGDZ0U0NF426=,.F];D32%ZT12I>ZM)$346/:!S(7K)N$_%6_0Z@_ M.XP)"3,CDKCZ^CJ968OP2ADU=9<\?BD"6T2;2->Q$AE(HZGH8IOM^=`,0*B4 M]-RZCM6!B'4@OJ0#2=L!<>R<>=:A,FU=8^PSYB>_Q$_1^M$?U/)6MM[(2']0 M(]50"_%4>Z+D_*`2Q2DG&IH)EL0%[UH2[!.A,IK2E&N;86P"2:;SY@SOV&,D ME!^/FO*Z&2,1$XV9:-**ZKVS3EQI*TU&>N0:;QGSEC-O1:>WL3D@RT^\&7D2 M%2A/%,[)BQ;)1L),F4*N/KLFBCCIG'E&*U(.5%H:LY_>X9A0QC.[2K!IQCWF&-#\EB01S'B)JZUUI381%[$Z16Q M*`5^=]YDP0C*N(XM&R]P0V=L>7,KX"NTHH:^0F-CP+--3UG-=*N)?>,1HOSY M;0^MJ!/Q19U(J!-RUENC,D5A?5;*2+GD*[_(5T&^:.Q,[#JN)(]DI8\PH MX*@TD!E7463J,GD1$_AGQQ70BKI685X2-&559(CRV)8 MLM#A4B%CT_"&UF%GA5;4T$>DG^5XI:2LC%+)&UH51(A:^BC1UU!Y[$8KZD2, MZ&PG$NJ$V#3@I9%Y,$Y11=\T9*2,34.AL[X*\D69]X;LJ*"T/GI@,_.B<&:9 MOZ1H.%`\1'1%4.@$%1.^K-:1[!064$!158=R57] M(H\Q]YB01Y')F35,4W*%WE2'[VA74"1/%GI3V)F393%+&OP ME%>1V7SK\G>0TDN8*J)"UXUF%Q`JM:*#["GU2)BDK MJTRR@A"B_$<;@-SQT(HZ$5_4B80ZT:R3[((0A;6IAXA\Y1?Y*L@7K8J3N;7' MEBC_T0,;LU3DALW2Z\ND1L9*OKSN@)F)2]I*66FCVD=$5H%"L-=APU`A_680 M&]*4CA&15L*U4JZ584/2RA&15L&U2D/+C*LHA?75[WR9!*G5J!E#41BR&,+?GJI*ZOI7'N+2Q!ZF"@E1[!&_ MIE(-9^/F*.X.'6O;\\D`GS7@*$3_%)&(K,1Y#92M@CPF`U1..$JY4[UM9D%4 M7N>R<-'K5U?6;\:JH>I".CZNE)5VK/45TFM0M#('D35&0V4E'E5+%4UK5=/( M3F@>8^XQZ?9HS;?T(H^9LG(F^@V4YWP0?7%/Q:/_=]:;1M'<%A6"48T#?:60 M/O85^J3@1*N/WB>'W%G$G<4HHX]0-M$2M/KHZB7ESC*%C+'O.70;8@Q^>,7? M$?ZKEZ!&QHJY+/W@+2W%G"$?&Y)5P%'(4<11S%'"45 M?O!5%'L)5\@\'=L+[8JL,,H^1P%'(4<11S%'"4J^#/J(;B[/UM-\'O/\_```` M__\#`%!+`P04``8`"````"$`33=L,N-1Y4L^<[;;+]^?EJ^;]]5#YI_5+O/'M___[^NOS?;/ MWWQ9O2UWYYN/U;L\\KS9OBWW\L_MCXO=QW:U M?#K\T-OKQ=7EY>W%VW+]G@DJW&]=:FR>G]>/J]+F\>?;ZGT?%-FN7I=[6?_= MR_IC=ZSV]NA2[FVY_?/GQY?'S=N'E/B^?EWO_SD4S9R]/=[7?[QOMLOOK[+= M?WO7R\=C[<,_$N7?UH_;S6[SO#^7[B[D(J??OZM)8M\'?[V7;U M_)!1WKWJ>G>9BV]?#WMHLE[]VD7^?K9[V?RJ;M=/K?7[2G:W/%'^4_!]L_G3 MI_4G?TA^^"+QTY7#4]#;GCVMGI<_7_>#S:_::OWC92_/]XULDK]E]T__E%:[ M1]FE4N;\ZL:O]+AYE160_Y^]K?UC0W;)\N_#G[_63_N7ATSV]OPF=YGUA)]] M7^WVE;5?,G/V^'.WW[Q-`^3I4D&1*UU$_M1%O*OSJ_R-=W-[0I6LKB)_?E8Y M=56N=9';:)&35R6GJTA,_OM>N=-%Y,]C$=E!CKO4DR,A>&+\0T(_,S M^/S*7\(R[FL1/K.1'[\^SWF7=]G<"W?"[W]>(OB?JC-H6DN8J+8E+D\H8I)4TV&R]33I+\39Q44D@N M'S?5P,C_PVTRUJ6&HHZB@:*)HH6BG13F7NLDB;&YW:0PB_22Q"C23PJSR"!) MC"+#I#"+C)+$*#)."K/()$F,(M.D,(O,DL0H,D\*L\@B28PB2F=08'B\FE64 MSF#4F&5T"*,D44:',&K,,CJ$49(HHU,8-689#J'B%"J.H>(<*@ZBXB2JE"B: M&\U1E$G8H>&F[[H+:>%A'Y<7F5@?]V=467D1MO=S_Z?\?N[/L/P&7S`'BN9` MR1PHFP,5NX:21-/N_%33-I:L2*5FUI@ZJ=30FB@UM29*C>TGBK5/.3T6:Y_V2:VO M8VW3'"B:`R5SH&P.5,R!:C`0:9OF0-T<:)@#37.@=1R(/D_&#+?M8#IIQC@W MTG4PO31CS)3[#F:09HSS1D,',THSQOFO, M_13F+EK)W+HPBU%D;EV8SR@R5SPUL^:*IX;67/'4U)HKGAK;SQ6/M4TYU7U" MV_2UG#.(G%?*WQF_@1<"(\]">.[)V(@BBA**,HH*BBJ*&HHZB@:*)HH6BC:* M#HHNBAZ*/HH!BB&*$8HQB@F**8H9BCF*!0JEF'#J%,=.<>X4!T]Q\A1'3W'V M%(=/T+=]_9"14U)A3\[??KG\Y:7Q8MF.@EPV\7@G^KCQLUW+ M8[WH8VD+[D=!RH('T<>_R*4*YIH/8R"EPB@*O"LO46$XNPI#I_B]"F.G^+\*0Z@X@0J:P1C?=N_9-C] M^C9?FW-IXVVK0F!L?1M%"449105%%44-11U%`T4312L0-X>Y]&UR0MJ./GYU M6P1K9RV:*6B(G79*@Q4 MRG.GBI:E*QVCX+!)7;R.42#2%\\Y4APDQ4E2'"7%65)AF-+V5BQ'OYGCQ[.4 M_GN`+4Y*YTGO4[-`K/G*->2QYNMV49K_4V83-LZZ%P+SFW4(9L\!L?3I$HHR MB@J**HH:BCJ*!HHFBA:*-HH.BBZ*'HH^B@&*(8H1BC&*"8HIBAF*.8H%"J68 MZ-A9,J6*7(5SISAXBI.G.'J*LZ.K6OC@Y]NLQN;6F31"DK*(9OC@;Q?1 M8M)FTF'29=)CTFIJ$ M%A_<5R7E(Y<+?EX_'EPNZ`7(\NP4F928E)E4F%29U)C4F30T"5Y+OJ2_F#2Y M3HM)FTF'29=)CTF?R8#)D,F(R9C)A,F4R8S)G,F"B?1X3)OT>#8.D90>SW4< M0BD]GNLXQ%*F\5S'(9@RC>WO^A29E)B4F5285#6Q7=13XS)U)HW8DKZD7RC5Y#HM)FTF'29=)CTF M?28#)D,F(R9C)A,F4R8S)G,F"R;2Y#%NTN39.&12YO%)/W[P0[H]C)>;>AQ=Y]-0 M@Q?6C-7Q;Y[Q_S,^ZY7+M)ETF'29])CTF0R8#)F,F(R93)A,F?_S M)LS66S?0X7<&$S5X8=Q_;5Y2ATF728])G\F`R9#)B,F8R83)E,F, MR9S)@HFT>3P:I,VS<4BEM'FNXY!+:?-8^DQZ3,9,!DR&3$9,YDP MF3*9,9DS63"17H]/DO1Z-L=(6M(FO9[K.$12>CW7<0BE]'JNXQ!+.7/#=1R" M*6=NN(Y#-*77'WQ%8?"5:&^K[8]5_XFX;?*=B\(_]YN/P16_?-WOY M+L3#7U_DRR]7\F4/E^>"GS>;_?$?_@+"K]/\]B\```#__P,`4$L#!!0`!@`( M````(0`;:@:+HP,``'(,```9````>&PO=V]R:W-H965T'DE;*)!&T(`KXY9[5 MLLE69O>D*XEX.M0?,E[6D&+#"J9>=5+?*[/YUUW%!=D4L.^7>$2R)K>^Z*4O M62:XY%L50+K0@/;WG(1)")E6BYS!#M!V3]#MTO\4S]-X[(>KA3;H#Z-'V?GL MR3T_?A8L_\8J"FY#G;`"&\Z?4/HUQUNP..RM?M05^"&\G&[)H5`_^?$+9;N] M@G*/84>XL7G^^D!E!HY"FF"@,3)>``#\]DJ&1P,<(2_Z[Y'E:K_TAY-@/(V& M,0&71$K>@H3B#I)3F+4)-TB.@VD3 MO8D40Q^]WR:M[D!-G?-TBC=4KE%M^#:6T_*O5R\V7;H]3TXW6)_B#5:OQYOE MEU\#ZTS%V(+O/E1:C6Z=MYM$;AU/HA.;[6?ZGZ#-A+VXPW1?BXU-![?9>N5L MVCR^IY'+U@V>+;79L`^_GH!S@G,_A9%3WP_;`$Q\-=G1[T3L6"6]@FXA911,@4J8F=%<*%[K^63# M%9GL*&ULK%K; M;N,X$GU?8/_!\'MB4Y(O,I(,VI*H'6`66"QV9I_=MI(8;5N!Y72Z_WZ+*I)F M%6E):>P\C#NEQN)^.1]5I6^_VIY?'\9__ MD7?+\:BY;$Z[S:$^58_CGU4S_NWI[W][^*C/WYK7JKJ,(,.I>1R_7BYOJ\FD MV;Y6QTUS7[]5)WCR7)^/FPO\>7Z9-&_G:K-K24B. M^OEYOZWR>OM^K$X73'*N#IL+]+]YW;\U)MMQ.R3=<7/^]OYVMZV/;Y#BZ_ZP MO_QLDXY'Q^WJ]Y=3?=Y\/8#N'R+9;$WN]@\O_7&_/==-_7RYAW03[*BO.9VD M$\CT]+#;@P)5]M&Y>GX3]<_EU__*/:O[Q>8+AGH$@) M6^U^YE6SA8I"FOMHIC)MZP-T`/X_.N[5U("*;'ZTGQ_[W>7U<1S/[V>+:2P` M/OI:-1>Y5RG'H^U[?&K>_#Z) M9HMEVW@',=%$^#0-+CI;@GZT,N%3$X2XRNQH::Z)\&E:6@[K(W2H;1(^!S4Y MP9%I!SK?7#9/#^?Z8P2K!VK?O&W46A0K2&9&&#MMQ_S6D,-8JR1?5);',2Q[ M&,T&YNGWIW2:/DR^P]S::LS:QPB*R`Q"3225-N>!@@PF8\%0D6JSN>8DH;7",&%HD=\SE%9`9A9.0F<)-2&(2A2!.X22D-@@N' MGGU>N"(]CJ&65E0JV#1=(Z9+N$$8%3D&%NW*$,NI^H_6JN`4:0+7GK#RE@;! MA<,VY`KO'FD%YB/-IO`:,="<+0KK2F805K`)W*04!F$HT@1N4DJ#X()A^W0% MJSVL?XHK$A]IM@[7B)FUPQ:EL[DW;!DB$KLAY"Y%`#[U.`7G2)>SF$\7'J5T M*&1QPX[M*N\>:@6FBI-D0:?A&C%)JYA-TTCFHNJ4J,)>Z9%(1@[V_B^;IS.M+AA!G=`EG*=3@LOX7G",) M9R8BM?QI5TJ'0S2GG]&LP$SSC*]DQ&C-8@IVFG4E0X0CF5#FL;\&"DZ1A-+6 MB+52.A0B6,#)Y([RL*7:#RP`NAYZ;#&#L!8(ZMK&+<0N<1W!JJFQYQ.F\#C21F[OY!;" MMW*A;(RCOWN9MV@^\'S1FO0J;UY"DCJ#TX`;G=OU.W M@1@)>3^IL!!#DC9RLUBEA0")"E<>9KAP=#PP+ZWG3`4_S82Q15<06PZ9A1@- MN8W<)!468DC21FZ22@OQA"M'XP@?N*6C#Z(CS_VI<.W4;*96(-W],HU0YXTM MI)BR;S0YR;-,HL`A/RB1U*C@9EOVI:#317DB5C6Q4*^9>KZZ"C13;N%\FZM! MP7YF^F%?S8QI4V\[6-F+02FD1N$V$G;#?8EHS92M^J6:H1^C-?.V&6+KXKD_ M23*!D+[*D42+>.X?F<6@3%*CL(!W_O0O^]*0\D4!\SEHRK5$:D,2SWIKD.YK M%/"?&M%3/9IG-O55%Z%$J6#OXZ1&!==`&4KA[ANT<+]D6J.0:>6N78.P:B+D MVC6BKVK8&.8)[93%H#R2]">X4Y9]B6CI8,VY2[;;[T8*32=:&K&]9ZU!77;` M0LP!E]O(]9A@1VEA(88D;>0FJ;00?BI&RG(Z>U6/<#2HW7:@3=GM@RS$:,AM MY*:&PD(,2=K(35)I(9YP93@=XBVNA-)VB-XT^8?C65?)EK`@',?5D#?O`<,`8*"YV\6X<-NQ;E&Z3$0<:AT MP43LFY2DB8+?:,,]NB:BE0NX]_Y7\I%OW?WW>!ITHVR8H:]LB+J]3Q:ZD>X\ M4J,P3W"?+/L2T:HI8\RVMP%50SOMKM94\)=_$8(Z38&!F&,NUR2M+_BSET,]3F88XKW]M).`!"OOP*AT[$MR,2A=.17_*^\;H?=WU[7L7#0IV M)+,/3;]S'>FH3>&1I(T$:E/:A]`&%:LLI[.I]4QMA:8CFR3<>L0(PM[?"?5[ MJ??B2V/O8"V5^*/=#A1^2?J@D(=KS@"=3;^L_>=4K M]DV:^V*HO;BUUB#UPY=][9Q&[.5.=D5=-R9MX")[HZ+P4=(/E21$=2NWX8Q8 M^S7H%W2C::&*N,V*$<1TLS M&X.U!C'=[`>Z[(HR(G,_5/@AZ8=*$J*ZE==@XZV,UR?G.=RKY2=1&O&32(.8 M;O:F-;NBKKHQ.Q!-J/!1T@^IZ[ZJ6TA$W7A]%V]U'JOS2Y55AT,SVM;OZFHN M?(=Y>K!AO#<,ZW.E5@RT[3U)X4D:>I),X;)Q>U^82WS4OUS\WY97]J M1H?J&:HSO5_`5G#&J\WXQZ5^@ZK!]>3Z`E>2VW^^PA7T"C;OZ3V`G^OZ8OY0 M#=A+[4__`P``__\#`%!+`P04``8`"````"$`^V*E;90&``"G&P``$P```'AL M+W1H96UE+W1H96UE,2YX;6SL64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$ M;H<>:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8 MRTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L; M'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3', M3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ M`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K> M3!`6#? M!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`; MU69]>\W!&Y#%-Y;P]?O/R\1?E>%G$__K#)[_\_'DY M$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^ M%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0` M]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N M,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7 MZ0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P M:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1: M!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W M1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[ M6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ. M&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y M:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:< ME,7*DB):#QL,^NQXBM4*W%J:[!MP.XN3BNSJ*]AEWGL3+V41O/`24#N9CBPN M)B>+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N M_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H! MT0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/9 M94FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3S MS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD! MS`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4 M(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F> M,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;Q MT7UP]`Y\-I@Q)4TPP:&PO\#U&O2N:(&F*&B)LIGC0Z&HBYVB_WMG^9P1'[M+ M+46IR!V2LVAQ]IMOGCNDQ-MO7URG]\4*MK;OS;7!95_K6=[27]G>TUS[VR?C M8JKUMJ'IK4S']ZRY]FIMM6_O?OVKVVWXZE@?GRTK[($(;SO7GL-P?";M1^X9@@O@R=]NPDL<[5E)[F./NSWKW37M#TMEG#C+D6$N&;P M>;>Y6/KNQ@SM1]NQP]=(EM9SES?OGCP_,!\=@/HR&)O+5';THB#>M9>!O_77 MX26(T_WUVEY:190S?::#I+M;;^<:;KCM+?V=%\ZU87:H%__FW6JN76F]6.6% MOP(0O_MQYX??_";^YZL_?/55_]]??_//OUJK?WW_^^+OOO]:T]-ED$RP0;W, MRWZM6/AU+%E/-+B[7?L>4N0::&)LW7SV_)\\@_T.G`'48V^[N]W^W/MB.G!D MP.`M?<B%8&?2+CGBF:\7O6)B._1C8[&UKT[6=U_CPD!V('"-YGVN#F=A! M/5[AN.L\,C2I3E,&@^@T8D>P3BZH9+*#]3J9/Y3H1-::\-YYIA0`X9]/N,5FRPEA:;+?JPWM$6NYH<3;.1,3*N ME6I&?+%H-[;@R%!))6=!X\WUVZ/1J7ZQ*NV2-'RL"&`!IY9%&T*W)KZO#?;W M&'YRY(*FU&+0P(5O'/O)B\OM=K>!CFX9V)N0,5=&;ZO:1KJ1TA,E@#Q#OX%Z MZC!HA8)*^@'B]*J$IFQ,+OLS\B=*?PI0$X]6A9H)W6%;JA+,.!9T'U5+'GFY MU."H")5[/]OP^SKN?`O-U,(QZ1;$3MKYCKQB*IT74FR>]T>+JP5@\1.LB9*(H*H0: MQN*Z!:$/][.%>J2+V4RUT*$!?Q4+?3-A?Q4+->#/0AFG2<2,58',Y/5"F^VE M^Y?7D(RG@ZOI=#H;CP;C<43R8^+1MK>R7BRVO59&4Q'!A)6#T71V-00@_?$T M6NJH"$8`X'HRF4X&L^$8_HM25OL(5',ZT;JV*D+0D541@HZL&O4SNH+,GT0* M3+8ZCE6$H".K(@0=6?5:<0:&T5_'5D4(.K(J0M"15:,AI,)8A8EQQU9%"#JR M*D+0D565-9])!IYU;E6$H".K(@3'MFJRK7IX8\P>HH`M=F;*^N-D+=;$&]'X M2V:M:-<(^]1'/UC!("B]7C48PQXQ/G9WZUCK$':D@?WTS/X-_0W\_]$/0[@0 M=G>[LLTGWS,=^%%/STC_K3D3+A7"5<&Y%C[;R\^P&)FFQ-S$2[2U0I;UQFPW M,;X>]Z_'D^%5O&%3M+1KK>R=6]0N6[O4+X%&QBU?<<2AERV2N$,^#=69%1+S M"9X1F3JRM.`)X!.I2PB>H4+'_,J`J([H##$=T0F".J(S1'6$T"D+KI3)E;^# MJ]3[!C:,:;\?[?JD_:5<(`)>XC'<YN7];HWA*XX8?=?,%N76$_PN@Z^3$N]_$+4+[JI&'E23USLW%>/^S< M1RLPHKN`HB6BHVQ$GK^ZC_J4_'5T*72"`75N*`!PT1P!P:KSBD#@8H&P&/I`O">NW MM23DF%1+LF2+6E:E7UB_1DN#I-^#:$;Y%AP]IQE>U``X:,FJ%-M5BD%FATC+ M*8`7-1084'75E+Q!5<[OC!"4=`%#S@BD@3I&U'DERKFP9@Z@GI%[A7T(<@J6 MBKJ&`'`Z@8`,,>BH_@XPAHXJ,/:&CDHPAD!J\!%C`EN"5,B.,`">3J(B[Q,& MI&(2.JC:-8'AT]/C[5.\=01C1)LIM)=F']DSV><`V/"T]^P']L^PRV0? MW5O"`2O0V$<]0WN)C_P4F)M/U@OL1>/K3B_KZF$O($D''/O>2!%68LK7A]FZ MUI-97#D_!V`YG`BNYFRPPAW,[SD&'6YS'82+(9HL=`V"A477&)B]$PS*W5!1 MF$*53"$*>Z=J?\$T,3S)T!D.DR:"Y@H#B&7)AY/-N,Z*%AU`S(1 MVSDIY?F4L.#0^&&W#>WU*RYA\B4$VCBE9&&`[*X#R8IV6G"4NU*1G0.<:Z": M+)D0/P(U&$Z/?=XESHIPZ5VO:\F4TU(PF@R"T?[TH"[5&]&\GYOX"X!(U]B0 MJC:`8@N>-FFEZ%##B9V*PU1Y"T%K>@-#1S=D-<^F'-`'PXMR?2F+J`LA+.Z/ MM$XV,%H`VC@P6L!2GTU*35H5&/7H3C0PZD%W$!BD8K!+I>*1<9]I(,MCKMK;[7) M3@>@,K6H$A`O336*D28(JUL,'D3:DS4"++CA%0N20N(_CR`Y2J-9ON&)/^L@ MNC>D0$\_A=*Z5*.M4F.J`3$2Q&-DD(3A#B+*:DZ MF#+IK1I!P&Y:JVM(A3F2J3O*^3BEL5O!-NB:)!OHRG3CU%2<`!,V51MLM1)K M<0&F;YJF6P MY^B>U`]*LW]5"JAG\SQ2`$ECO,Z$Y@#A)JH]?SXV^G-T\-+\&WTGN_#%Y!'Q M]*,-#&AH*LIZ1T#?T$N$TDP1OGR>:12X#96"KF*=W"U7.7S@=!Y"G5$Z:SC` M9RKQ\=)B(SX5`#Z+V8"RJY'QS>>9,"FC.T544[24]!J*<4K!515?/!.K*@4DMW)MH]MNV>:HD\XO_!,SCPR M_9P9^KP#;2/5!':^M6K"&TD[9%*D!ETQMBB4/PBB'N%MJ. M[9K24Y$]JT*)C(_5.*M"2[>`KM50:AFO^E!J&7#34$+-41O)ON@#N$A*5*4A M\%?:,W$B2:B_%._BQ%JC`J;66B/Y],1XE*_T(@HT:.R;AUF5&O5A=G)JH&*! MJQH<5KO%D_<3A`SW7`29LOT*3@J\ZE^)!J`=O!4N..1I?=0[2U1YY3\M@+_P M%W^?>?0%.70J+%2):N*4/^E@(5LV5B@$AA"4S-=D@A.>'BJ(H0$YC1#A='&< M#B>/S;(-KD3/0Z#7%S;*9H-*7-$_DOL@FD(GVW1>S:#8A2^>U),N4U.HD[0$ MM]@7G[$"A:1?YO?G:(*3PRR3BDGV.$8(%GR:1Q\N%MU$77.$A9JJ)@/S`&&C M`H1\D\#+4\*)]"`K$D@8JRFP1QJCRXY2']/2^;-VR2 M,>"(4%[\5]FPB$^XOC1N80A!G-I"^:FL-&JP\/R)@FF?*-+K=4L4K)ZW*!PH ME58J>&U=16NZ1VW!NY3B!GSKLK$]P5VL:O(#;V'_Q.H=7BVJ.PV.V]#H4NQ$ MDI\<),8X(]PM9`SL'=Q.*`M:R4\*G0S?%;BK@I;P7:REOP1MR1?)BSN1Y'T9 MQ!CJ@[9)8SAL\QOY&TW1R:BFY;!+&9[K6 M7!OV?]N[Z+U9LM#)OK**M52/.]L);8_=*X[*$[S+WW?OX8/+@C3I9V9<0 ML:D:E@5)4U862(@OSP_9LWT0+OC"?EE9L'PL:P3:(EGPF&EI67#%,I'%GKR4 MXQI#$I;%!:16HUX^$O3R6$IN+^K?8T'_CJ7DE@)Y M2*,Q_$)W.59EWJ,*S.B,!8F,YRYYBA[7NI(#9(00JQCQ`) M27JVEI]["\MQ,D$T'E@9%1'T\+)Q3,\,_>"UQYZ1E8FC1I\(BONC[V<<40EL MIR$"Z$^6N;*]IQ[PDA1Q0A![-I&,F"P6*#WLB;DR8N#L&`WU/_9L4QDQ<'8L MAB95UC^)B'GG;7:9A6@N9:5;1,1[V_MLK:CGT"PQ!)`BDCY8NS`P,_^C(344 M).:#'[BY#)HB^NR+$O=[Q@]^:*4DLEND4>RP'EH$^%]V(:*1G86$#`7STB<[ M='(@1`2#)8+CDP_/KBQ82NGL^6J%1_AA`Z/Y7+^NL[X]X M#\U'Q_H8OCH6.MY;66MSYX2?LE_.M?SG/ULK>^>",R7O^L[^XH>1B+F6__S> M?GH.(8K!MI!NWF_#Z-_>+K#GVG\>[J]G;Q^,X<6T?S^]&(^LR<5L MW+]]:\SZP_[BOT"9ZWC;FY?!>*X]A^'F1M>WRV?+-;>7KKT,_*V_#B^7OJO[ MZ[6]M/3M)H"DLGVVK-!U]&&_/]-GNFO:'GO0X6!\LW7@74&B;`+^8WYLKJ$7 M,?SH*SP!/CRY)E5"WS*R/K)%[OX'``#__P,`4$L#!!0`!@`(````(0#S4LBF M#(T``$+>`0`4````>&POHB)(%I]ZV.7J8%&2B[9*4HLL5S@<\P$$+DFX0(#&!42Q/O4>9A:@%R?S^YV3FS?L`I++=$1/3W6Z+P+V9)T^>Q_\\,O'-OWVXG13ORWDUGDU_ MO[&_N[=1E-/A;#2>7O]^X\>+ESM/-XIJ,9B.!I/9M/S]QD-9;?S;M__]OWU3 M58N"=Z?5[S=N%HN[WW[]=36\*6\'U>[LKISRS=5L?CM8\.?\^NOJ;EX.1M5- M62YN)U\?[.T]_OIV,)YN%,/9+;Y[/A\K:<+@H(*5Y,%^/%0W$V]1D@O-CZ\?QYL?GHFZ\7WW[SM5[Q MU_8/BA]FT\5-Q3NC+@[W]P_:7/PSFN\7>$_ORJ/WE'Y=3 MWMSK?_-SQ/[UY+):S`?#Q?]L#_M5^X.PU'?E]5BOP(#7@]NR_=17WY>#R>+F M?O!0;<.6X6[[@3#,*1R<#R8\,BH_%'\J']K/?;7'_SS9.SK:/VY_=;J#FNA@SQEW(P%U.+YX-%EYZ=G?V#GS;L<.QD.2PC@ZY&3LHJ2V>TM@GJ^F`U_WB[.;P;S MLBK>+!>F6Q#6?BT)4<[PEZA!A\ZO^J2W_?K;06'O`"__LG+VBX>[[O;N M[^W\J?W&">HY,A5].1ET5O/5U6!2=09*1`;J5LE3V(FWR\O)>%B\G,P&B_;T MIV]>G[]Y=?;\Y.+%\^*[DU7DW&(^*\@-&M^H*\1NMIQ@V MJ&H3A<68W9;%8O`!D:SG:S_VO+PJL0$C/5C8^MI/7,P6F(;UD[V=XQ[FF&]9 M?EQ/2QFETM M[E&T-ITOE_/I>+&['DTGOE[[)_<-'!!8MTFD>_G M2Z2L&DP&%LPO9X26SGY?MRNNS,=PI`D#,NH'B"(;;] M+3]H>XO958&?DW]:]7)0+/,NF'=>`"9=[R"3M\6HO.SH:^10[PMK5M%4K34/ MOEH[??YMILUQO(Y[WO[Q1U8`CNXQ,0=;X-`])^B"'Q]O[P+W#O4.3N,/#[6<'1]M'CX\B)6LF/AF-$/;95%8":[R#A1BZ MU6ASZ5VY`/8@N.C&83S$95X&.<3X_:U'<&Z`B:#>2??O'; MF7"L>SV7T%]/>O/M7T5W[ZM?2'13)-`L1]>O`:!O7E9O'G[XMW) MQ1D/K-K9LP8>DP6^6Q0@0P?+Q6BP&/RC,*T3B30$<26AJP.U=^Y+.MI[BJK* M"53E_#V@HBJV6,=D:4K'Q[F'-Z49W"HL^<509%.H2V->KL%J,W-^S?9UC>E82NRR%X"VILL(C/AICXZZXG M>8/RPA$>9H5"IEL:MK,^L$P)0Q9Q$1VR\I?A$=F",HYH6'?%"X*W`4X76P%X M="9_72[B6/W4O0CV/1!?&Z2.3_QN4!'5?)GQ>CZ>@'='7_CT7_<[&8:?RO'U MC488D/,97)=R#.8S@[<-H'Q%5%*3NL(\YO2M>`1+E'FB$'MLO=(.;Q=B*VIP M,?BP79PL%O/QY7(AD%@L9H7[A_:F7=P8E"4[I""HG`\5NTD#A2]V+HDB1N;\ M\'RN90,B@E%5(`T%SJ9XP!%7I+RD1^2#RMM++$[,"9FTMC_=+^X'%5A$CAEW M"M[AUO)\M"5\N%60LQCLC[1PJU\G-?)DIVOHR[]BV/]OK M34Z;F6MH.7WSP]MW+[Y_\?K\[,\OBK/7_/VBV'KUYOQ\I:O^QT9KTQ0BV(;4 MK+4+DB$LRQ3A!A!<89H<7$HJQM%F*&%35/>#.X^`_#LS-F8:]/?FLR<'&.*C M9YACL\+[`,1G32/<)O8E-F9\#?JSN&#X`$(;3"O".R4I!Z._+:N%[&3[-4=4 M?4C-5VJ!F&B"N/YW(3W3JK7\^<>VI?A""?S5W`^T&MO;:^LG57#B]/N3UW]X M<8X@%N<7;T[_]/V;5\]?O#O_JGCQ[S^>7?QE%<:HP=^YQ1]__<$4OF,F,5(I M6U>L>BA#_6\#ZH^Y@E6O)/B?W,.J)Q/H6D]HCO1=4];8UY4K,?EK,_\[`O`I MB1$BD#Q1OM=^[FPZ5!B"F^8Q^]_J7U"NZ*8ES>=+@>,K;N\GLH30OJ_R'"Z@7PQ9?/9[?L5$2-.-_Q^Q7)IV2"*T$* MTFVSZ9`"@K)@$<_QN?ZR#*U2CWAXW/A#[P3),%^"\:>>T$N\[\E]M>#^*&9# M2&EK'ZONCI]T7KE<%".*,$H/MQF:G M&1N6+5@[QFB2FB5$VOMB3K&6U\])5?OUMJB/I^^)>RR:6B/JM1&0.6-.%*2= M=V_/]%V?&"*D M&)CW?[-]RKU6-^W7-'\T4\56PVP8(X3P[1^2Z!7A[ZE4N._!;2SI]7BJA*[I MFA5;VQ2L>9OP<_5[Y\N[NXE98'(XLOQD0U2[$NR)-H6EL:6T6[!A'8VPB:U* M./(O'\_5MTLN=GVU/_8N"?5D,!L//C7C_R&1#^CNC\MU7=/GB-XO5R^3QYV:-00Y%U>DNP8>TTN**T7R0<3+\^P;QE\K^C0,/LAH'533NX0 MN1F"'`NZQ=W-`XFO`57&\G:F)T.*TO9[4MRK2^2R9/7;RJK,2R`8;F=I]O\2 M&X,N@-\6C*WFER&HVQ&4D9^)C<$J]P82?.42Q6E_;2?F(A-49VE,8@CR8??3 M1YIEBM\O7-K++Z,O]TCHQM`)F9:^K>\ZGA,,FFRJF,5@P(H8XID-')P@=Z M4.MZKJPNT8G6=@KO;R_'@]WB)^*W236+5C92F175]17DW?I(*7'-/-_-![^, MV9X3UDK^>,S2-=E+7,NPF\EZ@ZG#B M4F,G+V?_4-@?G"E\2-^9:\@<+;.-L8#CB9"DJY,>8?+!AQVRNK=4@H39^%:U MA"`HD(H&XAQ4=<6?N7@Z**\H&B^\#)]A4W2Z$;%K:CU,U0GSI"H0?(@F%9]L1>5&N M"`4&,Q!N``_AN0_H1ZPL4KX:$'D;][ M#P'4E-,%9@S^L+(0OS;9&X:ZI_Z=/UOLQMF+6$41^!AD\?72A*GM9NR#S:8@=W?('XL0_;AO4Z M6VYKUBZ*1V)OG:6F>EDM95$J*[Z*$LN6>(<2[A:7HDU#V(+7/#@E7@ MKP1CY-U@J%'C"YD*_P+HAZ>'TU2P5("I?-."U:"0 MHSXXFC$`R$&]^,IS!=9A(L>`1Q'@QEM)]BTDO[F.9/R5(&&@4:WQ-N,I8W5TMS)^,I,CAZR MCJ_H5_,O)DK^1A7&65#1#6CK'I\_0]^O%F5D@[O[*!WB.YNJXF5#, ME0-<4B14V.SM@+;LKE1;G-O=8LNA]Q076<6!U1,WGV5DVP(W]_<.=Y_TD[V2 MC1'.PO>NH/T3/#YXO'M'RPOWM4?Y3SN.-"2Y'_QL3WQ/ID MT7?_,[#<+"&J73M.65#%DWR#MGD6Q8&E)2RP=W7.)G/X^W?E0JB`4)):!"JK9QTN`?V:?:'!(^/>`HW8`3/Q#0-HAMWM2.;N,[M:R!Y( MMRP9!S%:]<&Q:[E8AM$56PC)I/QWA`KL##2JAAYZ2MB&+GFKF"BOA\'%R&-U M`?O9ZVRA9$T9?P"7N/"*`X\B&7LGGP;'[G:HZOA7/@KSY6?H9_0<)OY2(%57P72_/TYT#JU\HP M'AD0P9>9`<@25Y*PSDYWF'VME<<.90Q'PVU?A\YEFT([JC8RC_=-OD+-4(:% MRF9R@,TF@5H5T(\(9:P+):,.U7*7:!%?+/]$T"&]<97MT&_TVJ8UB,T$/@@C ML4(XLZ(Z(^$)75_%5EWFJLIK2PT@XNJ+]>^M%4R[VWG.,5IKV[>RC*!0!VF. MOR])5#D8$`RY\O,^:D`&.#0MT_1IIEM:,I(.0`8MZ9RF#B0XXVC2FT'EK15 M)@\,84Y,54O4;<1^R@0/8,'\YW(10A?#[`SO]AE)BKC;NXL&U]?D2L62)D7: MK"9!EG31Q[(I*>GB;:(5I1"S'QBC`N,Z1$2J`P-]AP1EF,3Q]EZA)RAYTZ MQ&*M_DA&:,LJ*8LCTUO[CSY]5"-I)@+1VQ)9$+`M!:>)X\@Y*3$N##4IX372 MYN0C.TM)R-Q M/`1R=2A+]H/V2$Y0?M,ZUCC>!6I`6JE&.4R.&<$KE;$E?-E>7Y4@5GE3?UHE MWSD88*Z0&BO#QVH@)?[U!))D9<2P1.Y#S#]Q)CGI3O+7[*^WE/(]"(D^700A M!*SRGEC7F`T+T?N/6#">.?>4Y=;&C[OGN\4?3D[>;CR*[:F,)=\#RDELTJ;. M,WQ6+T,A!JR73=>BZJZ-+"AE\Q?W"CQXZM/'R]GL9],V/:]$A=EM5OSI8_!: M4L6LAIL<;`P)XV0-*X*EI?4BI"$T]-W,&R^PR:QH#':!SR`).=?)^&<:=[6\ MJ6U_PAV-%W7R1LZS0C));L`V_&+Y86"I.@NG/:''2V)V.""A+!9E*!9FSQNQ MPHI*5"!=I+ELP?H\DJ@57@0.IDZ`3)%BY@4+R78R#/20LT8Y0H#GV8$T7DBC MZ/@"1#1(H2>?L%"8P!H.?(?IWD%@L6:,JKV$*\=[OW$NC6^P][*>5@%`,KS( M4"SO8,9RXJDE8NO%PDMC'1WYVVXR3>\\JK=4!($&0F[9(2EA)]LD:"0EAF76 M"6K_5"*PV-IX^\/;'Y#7!)B,EO@<3A/#`227+X&Q+Q%/O6!S69ZHGFN$19FS MG2`0B$%C#>8[561K.0^V()=L0%3[%1\`K2$]4\ZA`I&E3C:^%3]#CG=*UA_: M89N31;)$&$>[@28S5TK597[?\FE!VA1<`L`;AA7/]>F"M0U)J"2H`>3 MGKOCD"W>1@LP9=5`#V)S$=VO4?8A*4$SME2^8#7^)2NRD4K=R(9RI+?Q2/P\ MN4,=/EBJ'.T^^HTH3/C%/2"PY"`J9D3*\.'?Z& M=#&/9)A*5;@)4\)_)>0]98MIYIW.^!VF6S03/60@6PC,T_75;P6YE"1/;L6V M]6K\`>JS+4F6TC3`-D?^/9BK#-+EC("A:F%@],#:AK+_SH8"G#6F;P"LP)Q` M-A@A]YZWVF3(%A;T%(5'6VY2LLU,J<^(8SV70=YDR:O)QT?[&,X%3,#P,N>7 M6"F.M0O0@VLIU))R`#7D=M]WS%V&/>:;HT=T<%AN-;3JV@4;2M9WQ-5U3V2RE41C0']V#<;YRL=JY@# M(L6WR*3:+B3PJ5%]#JPLX=*4U)9Q#=B4L3E&1Z`TI67@6R;#(2X@D:TS%TB$ MT+4P=3Y"PM-RSRJ_B>B[W'$;@JE)%)O8E8"#G#D#DMD./),O%9`(*3?+=*3^ ML*3&>#5J=Y8#BZP+U0D6>`M"7-[Q)=(20B<3W5CG<:,5^(Z;,O,,S\+VQ`&5 MRXGZPJAH1CKYA9B193;ZK=)Q`L9B5I96>P?YR3B4*I;6E&4RE M^P]SIKA5P#NZF9,9`CI:2`0P0^WQ_6`\L>R2R8=64>=N\%X+I/0V;!O^;WR[ MI->9*JH>Q%[0L+RTCT!/'1O1DF5C)EP;/"#?\*JT+ M2IN*N^I$\`IAB\T\J`Y>@"<%2HF&IR8\%=@`:BBK1FYTJ60;H-@TKUDG#;C9\K8]W0WL[!N+@D-'@%+R,LYA-1W[;*I-_.#QK6JTP>D$#IH# M9N5FVVH95_93H`@HAI%A_$BFZV_#O49'8;B3:HDG/F2(^CDJS?B)089;NSFJIXOD\.JHW7Y%\O+>TG5LE86 M`T>84%O^&14XNNRJ\0?18Z=7@R>KO0NNT$2E'B?(`[OBDPI5K-CAL!;69@=! MLA:]S&,D<"^G8:B]'Q\3&WB]4'%85Z*:,F-,EUH_@%.,^4YL\([B?8W/I+LF M:?56Y4+FTA1U6-&T(S'IA:P^%]@@(F;[4JRA*BZP0-E=%(X"4MD6ID;=4<*[!2:(U<2HU&'"*&.K+V/E1C6 MH:Y^I;N`'>B\L-7*'`$^3_B4]R,OW4M2]+5$K[IJL=RW#*E<1@KGM%9+W..X ME/ZB1^2;5AKV;9VJ36VDC>X9]Y;RIQ(_Q[AVPQ)93>U&,LV^L\;SF-M"^=U6 ME:-'++2N88+W+5@4U:1KUV^%N58_F>S./\F,7FZ9LJ8?R`H_3A[BK'RD88B$ M?2/NC7$9@;9%`-G;4I=@!713F?=PF-:IA?Y7])YCK#^BNP8G769&DEB_;M:DL_T_:V$O MTC%_.\&>W5?QG__QO^0Y2+\.[7XG"R])M\A)*G'0N1@`>"91N5]_0C\_>2?0CV5]$B.$(?$& MF[5KB3>R:5P51X=`A_X3]2PZ%9?WO;K<,4\(#]9,V2[$Y+-SU1)P]MY.= MWUF2X)1D6CK0&;8Z2;&94N4R8S=BZ/C"Q?`TX3 M4&%DH\XX$&OX^X<6]*$P;NH)EZ"G-Z68+I?9D894CL>#-L+G2)98RU^'_ MVMNP&T1(^=E]\PN2%G&BTWM$O3*=X"JVL.0ZF+,D?K)TP6OU.3Q6>@]M#(4Q M8UA-M$%G?34?J9)HWN[3QY>IUG)2'_Z@:L;UJ[JTXKL9__7I8^L#EC[WNGW.>:NC&W-D[.3ZEC7,S(]1=/]X\CZ((UQ*&<52F1@'IZ\:`N M+/-,(,9E2QMDEC6F">HE(K/UOI`:D'Z8X\,"B*G-K!4\#%5:.76UAQ#3L^3\,0$?(5%6"$46H,X M*B'"P`4A M>,,6T>:DXE6J1V\'ZV$SW2XQ%K?4A+)\ATA&.I<<2;#:E\G^P/R>)[O%L9CL M2)B/?321]FV+0HV)"?ZH<:B/[!,,4:R\ZIVF>3;928:C7FC*@`O[]!.5`A(M M*[3BIF)?_9+VIT88V&-%`TB1Q7^(##E7+[S' MV6.`C;/4'EG]YW_\[]1\)J9YW^J6&]/#X[U'/'"AI3.Z[EE&`C$0.Z]P<",^ M8#Z_?O-$%LY3T&>IU]%2)A"03R_&(ZB2%$OY(K+X.#Z4`*.^]&MQBL(]J.2E MJDQV>:8N,]/*QV9B1\C_?*X7(;.2DEJUY*55J%=>#BZMP@148]:'9T1JL\-+ MR.',JP<(M70.]0N=)Z8^BQOEVQQ"XFGI3(504[ZX3(EB;:!EP+"[E]#"ZC6D M+S_KH?.RB&:"N2D#T5R;!OW\XLP^]"_*]EZ7!;N,K:6%Y2G4CX`,O]7:9AYP M^"PHQ-[FG7=J9,)(VOEBSZF?J^G&BOWRWR[G1BF>:S)FJP,'#:0X$I3G8P=1C[M:D;W3.-'I&)4B0JA2(]E0^1/8@ M%&SR=EJ2AY8T8J/"]""P>GI]R?1@F32]%T8T<+TX@A0E2S&,;T[/U/[B2D72 M=;I0'UK6,]%H[Y^ M0-8:)![E+C;>@`MP.U2TA"VYN1<<$.AN6#RID2Q^;?$8*&X#CEOVK\V%KA%, M[0G1!LHP?=;$&9CV5DUXN\[*7?Q_8^,B9/FFE<*,GZ_!4F*"1U62V>39@P*@ M)JDS.TM'>=J9M#R.)NU2N%71G4A]BNM0@D#EGI^#L!)&Y_Z*K3,3);^IOW,3 MYW?>^[#=F:=S4=EF>_7A+HEXDUC[ZZW]IP?;1WN=<;Z_8_![=WO8K,=SL`_WB`U M32\U!W4:UH#M3-UE"BCI$0-($H9:%CN/L%(.%@N355[2Y0BR`YL'V3$XE\'* M.M$@.YH=RR);56!4'!T>;#_#O#3N%+&4E->J+$:LKXL+;M62[]9O:!DQAK)1T(@@]*D'ADZ)>S2J9U,8;J'+WPK/-QD3(=' MO:'UR^"!CX/EUDG%X:`>^YF=TJML^!XKX6G_A0`V?$X:^17!Q=^3!4Q;SO5 M5P]`Y"BD(0I/MV_PH)(1^+URBL328L<(V=LFE,?U><@OD,E];I+?>_:O%LGL MW&MG%TA"L=4MX.YQBOT:140PN0&/9<+-8PYS9D=J)83W5N#^]#&'BRU)@(^, MUA2;#EV=$+AM=3L/K/%-V;,6B6)X?LVA.Z6*.#J):$"WU"1=,M#Q07\0(I*\ MVOG`-LTGAJ\[G];(NO-5=M2X_=WK[J^\G&*;`>%9AU;[I9.H8HMT0+3]R%N" M,(H,[8_]WACP+:96&XV6Z#ZN^O!H^X6W[8.D@H?5DEL''D(K"IF40?NM?VJK M#I0Q^-*M^A4S87W\?`%HAO9@?F3BGSK,ZM?XAK'<+OU3Q]NQR&3%-_I2GJS77$0P#"5;-?QUE.];XG\<;7W_[#0VAZ"B\N>5W^/;UR?REFD;ME1.U[.BS*PX* M$4'9AP?ZX&L;>O&MJD-]_^LKR*BXY*5(R?Z>AO@G9P[YD8Q?S);]3%_X7J>@ MHKX0$E@:@N3:%UAG$[`7G6BCO3>GX5)1)NINW$L_*]=^9VM_^W"_@^/Y].!) MYU.RR=T;&E]Z6;$];FH2[B5FZWC[Z5$'\C/KWO[3]DA;1P?'G<^.MQ\?/FY_ MFN8,B16;&F1YI3NQS`XH06';8`4-\^=D0X!>ROZM.%O7C@GMK>".I6MYM4/0 MJ4[*91'^@J1H/Q:0,[ MS'^;7S:4[A3J3'QTM/WDJ#OST1,LP9/VTQV'U'Y@BY:GHQZM)6?UI)M;R':@ M>\E)9^C#[>/CP\ZG1T?/.I_M'W2MR>.#[?W'W74^/MS>/^R,(%'JUY/.7`?L M7`]9!T^V#_:/VD]KW%#9:8YO@M3W=!WP?B$]_)37X4%WG?RHSEZ73&_O"0GJ M4T\PTSM`A2K<^F7J[X<999J6BR4H$H4W6`70L>8NBZ7)9G&:3`EE9;C6GP`. M,WEC`CA*5VJ:]8HG9@/R*C]`B'!48^VN=.D*.%D]_'];P\C5]%Q#U(G0<%AF MYSJ->AI6EBTCR=(J`?7GQHKI]5TJ7!JU5X?SU@(*IJXC8`7XLORQ MT!80)(G,NG:@YI-L97(M8\L[K.@WXFZUU#GQR"(H_2!%^KT$62>J`K@@-34' MIV5(M0XJ0TY>7W?+-3+VCSI[>](C`":K:EXW>OTV#/@IQU@?1.GZ#FB&S1+% M5E%"\$!*FUDW?WL,?H@Z9MNTZGB100\9X39'4PH[09.R M342[X7I!;5A[AB=U4*49K/[4XR*#'%DA,X3&2O'UJ) M0"P.27U'2Z=#@*8!!_LZS3`EX/(K';VF?"&,)>3;PSWK-TK&DCS!):'H4N<> MXP@Q"1H,JZO$*37PZ(9%N*W8PR7L0 MT!:#O4P,5@"^72)H:VB)36%BLB4D2)/XJ"RK[B1@=702VAW]?(OLP4EK]$-9 M9":F,^\WBD*-O77^U1@7)-SL\[><+$N=EUPO4/P(B%7'H3-$2,T8T2"2'1-K M8(B=%QO17#4B!@?3(X58^;-B;)+HOP]^0E.P:0MM=8T M_2*LFD:173L,GM8>0P9Q0IG_=/XF^9?6(E)<0NW5>S-"VA>5N`S7Q@3QDH6= MX'F]5MI28U5Q;QY86/CE2NR;=WQ#VN^XW?E>YX5TJW%&4P]_:N8/WL<#@3`" MYBU)1#?.KXLYMABQ-Z'=CJV_X+$Z9&--?AM*O8TIV-;Z3*_RBRZY&Q?$0RFV MYPX9*;MLJBBI2[C65@LO4:-X_+N-WQ0AKQJV_>P6OW;ZN(M:CYYM/]WK!,'< M-[]#L7%)WE[IK;ZB2T@MM*<12=)>F&#P1L=!K)NI9^$!^;2'V'K\N(.7R9)2 MC%#AP/H)VJ^<>BD,)>WQ).V'WZ((V`2 M"ON'G9!FJQMVU>->('-OPQTWG>F?+ZW5RK$2%8,,?37PE$FUU6UDD76%3J8< MDNH(,3LTT?V;^QM0='L8\NYR]#SF298&!%4MG9UWE\G*3W8H_RBD569 MIA7A,Z%]PD0`0P_XH3_5_]JXKVURLA5XFP0-;;K4(=HD1K>>26\;M7I>UK$<+(&!1 M[UU=F@?ALHMA6KFR_'B@>U4Q7%`QT=2@(N(A+2KV;YF!:*':'I+:LBIS5M]] M-JP/1&E[8U?RNIT(,4G\+=9(L):(/U]CM'Y<(9TLI`NG.TE!\D=VE(GV%3LY M8I?%-/F1L8S":5#UCG)M'76"YU]%6<>4]E(VX$Z).[IVX*08VU6QEH:UMTDY MRFY2X5<1VLEH4%ZWV\TR*:%GBFO,3)Q%IKG#E\%3_0TK5''HWPR,W)1960<3 M#K3T8?3!^=-VS/XB6`EU<]T.:-\%H&1H)[^)RS$6W&H,$A5&,>.>,.>=$GUT MR[5Y]4J_U7Z!HP#0='\JOOGMREK"XMO]75V;99FCT^QZW',_HO+:2N7/.0,) M.1V_^29T2N\_]M9.KQ!'0.C`1XC;SO5Q3H=&!UVH8Q5Q1&1S_W@OB]1J_42. M.31Y!Y:JS<2PSBYV?P;)3FF*PF)+&[K168ZM@[X`3)4W0EZJJA2U6*I(DX0( MA"QQI/B-@DNS]U;P=S=1WO+S&KKW%)#.[E'/912<`6R(/:YF5:U]?%]C6=U+ M7H,FP-2$FS]OC#M2D$`@HB7FF^#[J=>ZJE5X'TS-!JND!>![CHY^FPX6QT26;50*Q MB8':VQ.3.@*Z8O>VE(P!I@G,P57+9@1":IXP'C@=>6D'F,]VCQZ;)%I&2T^@ M578(4@F?1VOE1OP4Z[`>VE)U4L$I9"'<:)?HY/(1W\P`47\#)5 MR)PYV;#;>:)0]1*1LI]AL#9.F`>\PDSIT@&,'0DV^JY=ZGI'DT3TL\O`5=ZO M9)WA-!O%7Q$Q3%&#H3J36?^<6@\?LZ02`Z1?.NDMWXLXJ8*&64UH.&^K!VKT ME>P)1[FXV[]ELBE;+HH/MY/?5G<8P=]OF&&G@K/Q[84TI+9O)I97W&S';GV& MBHZYLW>?DQ?S8Y$ZUI=ZOB_''+`*OZI@R:XUR^NQ$AS\RX_]?6/=H%GE=_RO MKOS6RW`Y#48!/ZX^:D+"C&8MIYH*$8VXS;4@;8- MI#):^!&*^E")ZW+]=\_.MS97;DM;R$DIDQ.U,)I17R^YUA;"CQH\C3G2J!+Z M(BV0?VL%V>^%RF"G\JDI67W,4U^)%'M!CM_JI#U+<+-NCLT7W)P"%O]7*Z6U MPQO;^)$P"BQ^LY4Z3#"-G7IMLC>60Z./0,V.,<>HQ)Q"7'NT]^XSQ3R&2E6$N@6[%[/:N1%`5I[0O_ MR*.QS9O[^X_S#B#+W;OM6W)[?.QM4O>^W>C#*C8/#^LVHF#FVET9\N/3D!"V M/E&QX\M$U)B.PR2T"L@%!RG\B'_);C#-@0+`@1[#SL]/?OK8L9"9!'*+)P=R M*_6+UDY!AG@GWJ42<8FVV02$;0U9-;E6-MU_3I&/4W;237DL.R$%J.D]*8AT M`4%^SL,.B!+?A]H-OZH%RU@U`X;EF1CU>TO'K:;^NF_?O;W]-+D#"MV?35CC MJ38?SDR(?>NBE%"1+BQ<;S><6=Y5EIL/'V@%A>$E89%D6I+M3+6-IK&TC\$K MV$\_2=7P/&9!#7;V6E'D/)TJ?FHF*ROSY0><=`^Z@(I.H*^"(T%`;,K64QU; M#)#B$7!T;<(QH?VIHA8R6'Q[5I\Y/33IMQO-N*R!GT[4^61D7Z"SJP-T8OCM M#R[G/X4_.6H5=M;J"9@D%IKN@4B1%@%;NZB15[8,=-H*.A#<=J>^97CM[KN` M1-+"L3X=#74+Q'@$?$?N8^_'XP&!SIDC-L.NPM:!X'X`,I^/T:#XNE7RKEF:FL^L2U_!5 M04;@%`LAP*QPI2ZE[E#J._&UUG`?O_-.[Z8XH;-CNF*#(=-O MX9&+4,`75$_C8X+].)O^B#OXJ+XBI)'A:6YC_D:+879WF[ZGO&)2`#EL?(V7 M:-TR[=F*!D&<4%B/Q_8"EG9:&[3M'.UY,B3R+*O(*?I>XD^\-4TX MJU$""^*76:W0G+`3FQ,<_U9C&BWY#\;#G760!94$T*:ULN".P;MWV^HGG@>Q MH)B1_^7])>%4;KJ?QQ51F0G/Y(+^LNF]#JQ1-A;*9"XI"AF7-W3?A7X`+6J/ M->NQQZD"%BQSST1D._P6I+3*CD&EV;Y\.9[CU$ZSK)9P9YM[;Z;%F^%BIJO/ M_7"9&^`&_&"'SJPD:ZFKDW3+F!O=OJ\4>/GIF$3(]UZOA*FO7IUR"BJ16.,/ MX"\J^FU6_A2-JF13*"!0A>MJ:QH:`].:?CDS$AXA9_FQ!QVTC.; M!W5/2,2$JT0$[REM)VT9DFFU<\J&8:D7S%_3WI8T=D7IP10B-+*,1[M/CO$Y M[(2G!V/].OR"CGFU/,/XPV#.M6(Z!?G')>>,#[$O]3'^PSW;M`S@RYZ:A4>= M2MVY$Z9I9"&SYSV!ZW9ZS8K"Y$``X#>[TGQ-V^S"I;!T;7M?26O6]G M.U5S-U+LIHA6=K5I"IZIMO69349G,S&5_O8ET"2IB"6DQ:P:#XIP;=36@`8' M_ME(K?&Y7CHEF%9&T[C\Z:,^>LEO(MHO2EM$-<"IT43J8LM]U^?31=M=HZ$U,=VSNAF5\&-XG=VN=]I^B@4$9Z#I_YF3*)I):9X?<.H]P'8D,"=^,A+*?9$G1BM[ MKY/#LFJZ;U5,JI>&EP^X)MTAKUQ4"&5#,&(UMYA83,^MJ]#T2$]QKI,.`!/V M64;??A))&*M;`FL&.WVH!E@-\G\=&7_[ ML<_-+3)D825B=$J:YB8/E&(O$\/_-^.63Q_;\&\)6_8\DY*%6T9 MVL\,1;_7)[G;J!?>*$^I#C`AU^H"]=ST.U7]JAI&H+N`C"1"5,&S3?)L*2-: M"&(A-.$;$AF-)@9*T=YL:OM+B(@O-@WQZX2%3,B_U;-;9X4%5_:;4_+H6"O# M//<4=TF^LCI,I;Y`]#O)#9F)&,2'^%JV+EJ/])&,\$-(MO8.M!6C(Z:7[>ZE MD=UYJ<[8\YTCS1+^_53_UO#@`]U/SE^FMXL9"ESW7_F]-G%DB;_8QI#!+5J^ MN$FE`8[5;\C_*J=,4Q=^C*E`-_ZT$NA`V*:(J0YI)4?9PW5"$[KFU!?GH18N MW;H,V`'AK7;X\(35CQ(6XF(/HF_+)_&Z2PS-RWV.598-&^F9A``T_BL+BY$C MS9)%`-(O!_HAH\5#DVF+;]\H14OD1=,%G2:TN;452L9G/32/T<3ZIT"J=HA> MYQ=="P?`Q[V\50;L,IN\ES*0^!3ZYS(L(UI>?J&R!&WWWIA2D^S;0V0F8#_T.,P_@MYCO/$H_R?S^:ZU].7N? M3$G8QM71[D*9>"? MJ&HNRF59Y"4YR*IY.VWY,;[<4\&[=FU>@0?E'@,Y$J0[0L_0%*M6>KNQ5ME$ M*3F0%=EML#3[$RNZ.(,%FP5-[&^?HYU`0 MS`";,G2.YYFO'H^CV(@GI`)A.1Q`!6H5T+;B53%#B[=60[F7Y>D MT/6."S!UW]F+YX]?O4%KXSW=PB7:SD]VSN=\]U@Y+.BD^!XU MO4A#JUTI["CR^W0%+.Q2;F[K/$[MUMVOPV;>9[Z\8EN!/T,]T=VOPYYX3![F MY`VO6Y<9;/\4L4-W-_7#[?6$_3X*KED=BDY-IQ7.NE5S`8EGKFN"HD7E.>3? M'WF1LI.-KXW9KOF+`"XV#0Y(#NJNCW/K8RWIGA9S!;X-25%$+2'H%4#O$(YJI47XAY](:G_Z,H)>I7[$15P(,M%82G@A[:HNF69RL(`YU1E1\6-]@[$!\5E3&;DO3TY5^_*"2MJ98P. M!)`>F*J$I+]:YB0'3_!]E1.->(%I89$K]8W7"1@'0.>G\X/?^C9KN&1F:/BT6J6F$/:5BN(L\S<7>;# M8N=/'S_?>;(E0CXZM9CT0CMW7?F?!.Y?[ M04?C,!=LR^"@9K:)=4.WS$CIPER?ZYHSUAG"R$Y$YDY*]-&YY%R#)OED053V M(#?`]1N"4!]AS>Q4B(V4 MYEUIG??O6!/>T9G@3>\IHM3`$&Y`&S(JCDK%16%4SI*3I2Z&KFLV5R'CNU\G M#IE#*>FQVG\*`YD3W@EF6LU[,#<#K6[VXW=Z+2!+SFDL4N+HUWH/`(3-9C-[P#&4DR0UYD=<*8* MR^G:X`J+(O'(DETM14CDC#1606YXN`MJ5"4P>JPZ4TPSU5$%FY'.>0/"V&&L M*YI'I5L)0\\H2\I,35,;,3GB!@H4^M\]^$G,L*:GY9I"\A.-9=O[20H&V?71 M19`__2+=J,;R&[:T$EB6+]&<>Y2/X%;.+:PK:2`C+WB-C$2XC6I-=,$26O]L MWSM$FVB$J[HV2-<8("=*7\:W#8TA-[]C%U\C-Z^;&)(RN91-HZF8J&<):'Y$ M(TQ`&957RE&_F[2/P>$N!TZ'@#>!9RH,=C\/-@O]1UW::N]D%W:B5\`6XZDS@"4U*F(>N6J56/V0'V275"@-QD%.ST.`L?^K%X%@EF?RH&RDS@XRPOG-[_L95[M<='ON MC^%069-)[#9"\$R73@R2BH*98ZG`AC_WIITR*VI"@>9>E9\)B@EWDDSP>Z%1 M#K_<#3NX0M%'8TV_\14[TC1=EY:WU!5!*0!?^H8=,6;D"%$ORX>PAKJ0%HSF M#"\/@MKL(#PZ2JLB``J+P1CUU+'K7[&SE"C+\3^9J=$97@T\?1>9K)X7!&G' M,1Q_ICM#/<.W_;TBVAK-W+G-'K%!\H00,EK-\=$[[&@8DI(-WFGD'RP[.Q3K MU+8'[R:6.BR;I99,VV2K$B`A:9:$0?T\0&#<45GE+.;HV3!'P&Y=-EU'W5', M52,>!U/F.49$N$&FU[GQ0%)735^G7]4OV"4($J,&OGJ3YFT!YST&IS*\A`/: M$H&2"?M2_KO8=G($FA>KNXK,5;Z\1]YYKQN\9(N@M509Z\-Q=..98YA*]90O M#.Y5\-';K!CQ*(@`8,Z0ZA!8J"L+5569%"S4$ES3\WT]+6ZB=K_[9C0,I_5X M)L).Z3!6\91_CY(*.I8DJP].;A$GDP!FN)>(Z\`E.@`3Q,/9,8%[,I0(:XFG M?J#?J7)@4[W(P4.T&(E)M27_F9]MFS7$#87R`O6S?(GN%K,$@+MW-A_>_5I0 M6;US[P%_F9-Q-SEC2]\FN^!-UES6W`;#XIP?W##GR!M9.DI]PDMFS@GO=,@: M;ZW>JQWTIAY8P)L38^\BB6:MW^%>L%M@L,$WM.1L??/%IKE*Y"^#\;B.@7/] M83V%BDNX M,_G6M&7M.DC7I9BYL2[=;SY&+HF[#&[:R"<1&)BXB]VO$5'RL'7#O@+!C5NA MDH$.%W(K,K][Q`%2RE>%*X@68@CV[*^;@FSYAD-V9$,B!@4KZ0@9V%=IXEHW MQ,:10A^^M8]J4W8OQV]`&,F5`JN\YU$H&6XWG$S#Y[<2I$0@[$N[-*.(3KFH MK)<_N!7)&_KE8I^=S76G=[C!49UW2,P== MG%\<6!I9`W12Q=$#>;I08*3F4AK,8Q=I*S-Y(C_]DA$VH;NQ$+"W;^[Y+$Y^ MQVO.7CI(GFJ0,SYM0%7"/%3.BD M$$!5)]05 MN`QTT='*$#F,G&JRP1XA>F"!'G:CC2_H*`@J*!=.0+2S'05A1^:5*EDII-QR M)X%3M,AKJ:VO8`5&4=NE^+Z,OU+_UM<)NC1#4ZMO>D6MNNK:S`/N;F*Q2<>5 MJN<[A\PDODU%PNU^*1B&16(]2;[=VGIM/$4XD6MW$+25XFLLT@^Q$G[UB9&3 MI9HMMB6UA9KK9[&9N$BJ`V`S[C;[=H+_!4,NT&ZG"*S M&%H>"U-Z>JPR!]=\+H<*"*TH$KQ:R@5-710R6_16Y=]7RA%2=/4_?U_ MDZ[ZXA7[)-SV;0CRWJH>^SM@W@B/&3#S9,@%CRDLRO6&I;AK3*Y![Q&4==%8 M;'&]\7F\3,?JJN-%U^C[&CK:VX'$VQY(O.=QY:%T']*$0YWQ4D&';:G<6XJ, MW<)2`+(=Y3N8AGJV6=]GMW_:1Z8/5AX^Z#J`O27JB_!!?YJ=D"YR[++F0"$9 M7$/N"`_%OAVP6GE3";UPV2GKKFR_6;@PK)T'`]G24N0/,U,0=\.-!3`HF9FL MQ9O4'UMJ3-*H!FZ1=\=SW5%L*K8D9C-.46]H0-.X.4UK.1GU8FR65HD2BAG8#7Q)I"(GF80O M'[!;T.>E:F+U'NA9)>)9&\G.G)2-4 M98TC(G9'CD5JV8Y/ACT<-T9!6+'=.+[FW!Q1N,@B0N'TS'",U^*2@!>C?*JM M0*6HE*!JJH;\UA2$6T*B?,I;VNFF]SW9Y9*V08` M2"@RJX9988=@FZ'/$L'QK&5,&7HG67WU^LHK%?INA!?DI2I7!_KL?JM'O_G(.Y9O5!UFNZ=G8HQ_L_+W MER0QS3UCMW.1+'AL20120J@*W*4\K04H-K#/1)$VH3-L95.HYP'1>)41D1T"A?"A-:[UMY)N7\Z-5&C%2AZ8:V(F\H(.6?`ZX"^ MF7J\8&)/[+&P@)R^&=+F3,5JZK:H/#/6KD6%K6GVJ!S'\L9269D(KQ[ME'B( M%3FGW43E-8NTU"K+SK@D>T#=N&-*8RT65D_[R>ON&$MU6G_A:G)507>I^3LL M^8?T(_M3\(@`J?+FE,ILV;">__"NDITI*J`-]'Y9H>D*J%LI&01$P9E#16CI:LG5?-J6XO]LV^Z0 M3M9]Y/>QN8Y\7Y!4?#Q9_1=0^M_F1$UTW1_(&]%K2Y[S`_;.R>H8#V9)K31F M([Q-YPQW^'-+OC[\6C^\T"45H]:2@QU$_FY,^V=\+/6Z]&)9Q>)1TJIS=/($ M7X8/_6<310309L=Q4XD(V4,JE[HM\4AU-P)F<>779V!TDQQ$2Q!&P%&2!M2/ M,G=^2A-%L,?RCRL<"_J!)(E0:3^#)&0[;)647U:%/>.PUZ[&X;\N^/_UI)HT M:"$#)ZY3]<7!Z2_%GK@+2TE(H;]:2@AA-$129,W`@])58:73!"DM267NA7P"_1L)-DM+ZQR9LCJ'-OC=*-K M9E_I4[W&-03'Y:/JX2N4K^G]IDNUP;)>[N_A\UG0V7)'`5Y*S>?OZ5SAM_FY M9O(YZG6;H?+YZG;0+H"HCLZH+8M/XQFP0;,M^7?HEN^5;XOU@HOJ\^"75>R= MG_Z(ZB2I$?8^6E02-4&YL+::<#NA(PUO9%TY,BH^WD7SI3L4X[4J31_(>>(H M2@0*8Y^E18;$?DJ1D88B]F>3*1_`!)5;/=:*X+98I^6`&YN4LF(2VP.KM?(B M?4PF'=NS_9H`'SJ%F^:(+LD]ZA&>+O/.@T*#_3P?KR$#'`W& MX$""EJ@N5+:J`6>XMN%))IW'->A1E'#]BX.M3DH:.$4Z1R014WC="H@170$T M,Q('KSBJ<4=,QGCT@$)5"M2J0'VH*C@[&"!E;&4:E/)-I]8_WCVV7.W=RW;! MKZ/]E5%PHK3GBY,"GT==TG6?_U8Y._]M*D_Y#*^:,Q_P!Q[[-%)FVB5-N7CQ M_D9_'R/W0][?[,+[@G@7MZBGR0Y@.(1XPA[N-X":&*^X5G&\ZE-]`$:SZ*'C MQY;X"T?T1WMG6R!^AAJL*Y*N4(7QD@2JYDJVI/SVB'MRJGM1!FHNIVX0AA+H M/!%U+HF+O:/[,'S!>Z45*>4OA/K=8?:G_[D+PTY47M,#&LO5X/&>AO9BU880G3XHX[(%"1;[%_2 M?70?\&A%HVJ;X^IU2[6$@`@&41BKKM0:.<0[I(ZC*+;J*,0>92KN@4IV[!T^ M`K?D.N#(NNV9OZTY?)>-:C#Y?D_W4RA#$QV)Z'YT-F>RK%F[)NU*8O@UPO]C M+0^@-\\&`A)B\#@]E"'*P(9O=7P0+\))7+8M+0-"9%1"SU0V"5-Y:0/P'<&4[`QRU*!GCQS$$ M-`6!]P(N$QB(GS.:@#"L1H7F:' M>,+^?(`:](/5F7("NPJ?'BVIF\.5JXMN4'TV"!'2!UC6"YXFM)#@96B+6-(,R/@I-:YX\ ML)*Y1HQ!EZM)G82[4C2&E=%6K0F6R(GTD['2%?'>:7,3`@JRL'1 MSW*-DA6OQ-JCJIZ;D94PQMC M81(KUH)1\J[UL/A MUR'@,]',WRS^!S:\8GQZ<^7RV65V"V(]&CZ();.QJUQ)$F>0,"?M)]=4:SAO M6VI5^]D*!M5CCQ"/Y;E#=E^Q!.&_-6JW0T!P3'Q>0__^/_F(LLLY]2LWIKK5PD M4G?^9YK"`?>BO3N+%\#H[WE^*1Y:^4YT>W&]@6E19CR.YE4(_:7F=E$>1_D> M249D&66GP@XDV^EF*77G*L M6M3=NKH\?I-4%J%/:8TY\#]61U#"JV"`T&V.2AKH!MG;\2[?B19E0(3(H]8 MJ6G[,4\0"1JF*PV1X`>:@S7-^,G9[;[7T5TY98;\+P3X*Q%ZM.S+CHM&;-R6 ME`N.-+U]M9F^&EZ$VZD3.P"V8HVUQU@XX^'9H3OW:GQ9K?!E&:P6L3^*[!Z4 M365J;A`&BUOI_B44+_K:FNIO,]C/#5);.- MAA-]Z.%%4-D&4`)<[,"89#*8*D8`4G['?B>;"\YQ(3/2Q-Z^5:@DP[/B.DPZ M;$4(I)J.M/1_->-7]#2&$T%JE39;RM@K7[[3Z4J^'`'K62"LN(CTTMJ7SK/R M3IA#H,0$I+G^;$?'Q`4?A[QK-[MA9%L;]X(A;8T@G;/ZA>>[$*H=X,QJ)X48@/X(#67*.3S^JK9X<5_8RVS(W&]3@0$,/)VO- MNQV*C>$LB+[8VY$P"R+NZP822(KDZ*,][V`ZF)"))-N`@*$3EO.!YFLYF.VMP#8@9=N MJ?>/>X8\Y;9DATPL>V MJ$+6Q!#':29'4@1):8/6&*QNQ'1M3!/#TI64IB9L%IM@J"304K2(HJ0"!>K9 M3F[1Y,_'N%>+:9B6"J+1S(X_ZEB>A4NG[=M$8:]PLH7'`QCCY/T<;+'J)38; M#2CL**.&NQQ#.Y78/SW+'^D'AB6!RTC;O$ M??BN^M04&JS*A5M,;\3(JY(DEKK`,9ZPB7/TX\R+#TEC=7*Q0Q:KLTQ8LPC- MZXW!L/L.,^,S,/WD]-,O"[EO0FT+=&>\AZ(]FCY*']T:WH`YYRHNL7PRG?F; MN"T4#R+,2JSD8/*\A'P4&6W/_K,&62(4P:6,[T[R(`Q]^L3H8-SUBI-$#![N M%VSH'?91/5?NLY)RAQ@X5$1"TH4FT;")L)H@-HD+G[.(W7>GV)8\!2[@O,7D ME7=,M4V')\(GUWC?[_Z#Q%J/XX,Q&/^$:0V"=D!@:W30$7O&5$.'EH/-FET? M4:PL_468)JF?^\7D0E,M*X)1_&ZYO"$(/,]"3B)P0!3'JNBV1N8FDJ#T#)7W M&7X`)\]WM0SJX$%P?:Y@UN$*QU+WY^#>IQL?R^JO/!;F'#T6.POQ25.)RQGA M\8F4>\/C^I*9W6.8DZ.^W)PI7W+[^;??;2&^#^A99\H5@/V`"GW[0+?Q610J M:J>$D=$YDJ,3SHB/[YB*_@51@3F_SUK!'X8,7+AQ8V2X^RN1@3F7(P/H##[@ MT!BVJA%'0Q"HC?5AF%/.Y@KI&2HA'U"%I1`&0G&^'M/]HK2N2?^($Q8FETR3 M)(8&+,*(BM@5C`P?:["[]!G"$3_KF;$U.6XX@5L:/-L@!7(;O<%J=R#)%(#U M3((JL*,D#.H&#EA&EARYS\1515)O:JXWE&V6!3ORNY)AHP8:?>`+Y10_JM-Q MT9<05UJU5:(M4X1>;W[40*Y^W[:U1E/-U96U\:_ M?3!$@8$EC2513!?2-% M.9%BD7,"+I"3LV3MUAXW4]%#ZZX)6\>[``3T1?[G`0$-T8NSX+<'`53##<:_ M[W8K5B]C"+ZI\`BBBF9RZTN=2OG9ZR^ M.2_I&?`G>3;B;A)RSE5U>X%YF=J97Q,'[@&5WQD+K@46=:B@24#X8JTMFS3M M/1IYO)-7,CQQ]/W$&RVUVJ")7?S3D0IQ4<(\%C!"`5PH/G0)N.V)#]?SF'$, M5,E`:H@@"-]:?;!>O%W)85F3XFY)-AI_GQM2$TI7?G.:ZFMGFK5)G)WH:KC9 M;0[3%G#WSL/T>F=-XP`F+]_4%1MM&[,2J,S(VYMU"LS2AY=X4C3H.2KTY,G1 M!=4H_<`8%N&TA(G!E]B18O]@/3:M$A/]?9TL+G`-X;;48]WHOFTM^.S/MWC7 MR"(#ZB^QB;&[*`<]QV-S;MY+KNK!(;Y[A,?:+B;%!8+[XU*/6]4HQMA@*C,A MHI^@+A-]Q943NR=SN=W6-LQ\P/:[SA(BC'="6P^(2].=[QT!$CXJBQ!8V+9VS_#,6%+=+L7WYP>EH;R&42J!(9X^),CI'A[Y M"4A:/;)"&/!/"TGDGY^SVUGD<7!;]&(V^U%O"Z%K1=C?J.]&7YZ7+'8Z^$!Y;3-5YM*L=BNN<:JAOF#_>GAW/36 MD#>G]"HMF#1J[<)6PE!ZM09['(:032>@:(/@CQO-#GIK?CC'K;WN5J*Y%7Q0 M5LE%HC/:F:@X<*YD)V*81X`\A5>N@1'NJZN7\P.FHP#-041/1`X\(KJ??EGS M==A],$^*D]0)4V[VFP0%##.D>9F$_9*Y2=]S#(K9+7+WD;U"Y M;&=-UW]PUO#4_.`((Y&EW>KDN_[T"X,&3>*8V`'*:52+J?WCE$$A:F43PEN9 MI!Q2H#G>0`XC7/'JZ&..[T^_\'UV?R''R3+7OM+H.KC9R2$IK<8DJD4K2$82 MCDX_N@W8S:RP>!))=/&'IX8S&"*P>A@\(`W6Y:WSG3(H6W.17X*R\*P;<*K7 M2GV@E\2/1+[V?]P5*:Y,GI_LWZ$1=OY-=Q;#9,HU*JLP&'<#YVOOH?%\?MZ$("DJ`V_>['ZD.X//)Y<<5F`91![FM$S4?[+X';N%X%=9) M+8#1BD92^;D(-1JHX2L7`8UD"K8*'5%ER$:?Q M/;4_T3T2I[K,WAR&,\X[[PV'9Z(E!)L2"?F'M?UT1+<("`X\4L!.7XJ:\6?P'\)B?@("(R-:?V4;U7C"SV>3Q MJ9K@,^@3',A6EI@NV],/7ZDR#./O6`3#I"0=P,^Y*=OPP(,0]C[O\HI(??"`"<^TGL1W^RRCUNIU,D2^!]3++8FSLDA,P.CDG<_-?S M.W0A1;Z_XS8\"J1LA%>FKB(&F/DUE&L]+=(6\B$($4O4O(ZW&:>I190M*?`7 M0K);8%,;4Q`Q74'"A%4Y`^?#W4:Z[SE=53M$`Z%U56N:@]8PJ&R.@2(5UMJZ M=+B#2$>!SM;W]RHUV-ZXO@,^6H]\Y!FZ%\YP^KZ8`;' MMH[R+OP:=L#J!!0\1AE`N-B$6OTK:F;%H8-#'Z)WR^X<`:UV,3E$9N?DV!GC MQ&D;KA%W0X_YF1L*H3J39$I+#M5[P:2B("&*90OSN)*!CN%:FN3]T04&DW1( M:0?U9KB1VKEF[`BP??K%43;8*&M63&N46!0%G)_\`T4#SC8[0?M3[@I$X&DA MQF1&031G0!1SUT(0^RLH?8 MQ\'D*X'_XN(K%\,7CG0L"_2J=U?4NOX$F=(:K%OJB"0Z,4$C3>GO(7MX0B>1 MB=10%*HR?JTE75*%?3+[>/&GB>GM^EUQ)?))+D)'*\216'$2UZ@7XV,$N<+E)BF!Y!RC*H5@[K=ZDP?*"2*P0F9(JFJUT+&*"9( MPRNB#+9S%YZFM"V0GA+VKMEU1N&K^>7QZ>F/K;@,C5YU"HQ6*& MAA/H969>"$N7#-993G0IXA9BL@EH%[47*C,C/!7_V[_!A#%O\&(@8_81:JY$ M2.]/M5*F1IANB!TA$I[[Q>J<;[+D.3]$RJ%)MC,R,9$NH*&LOU\X6*@=9-&-*0`R!-,_4#S=_H8NO:[--NZ=^P"O@S%:4NPD_;*6&CNS,[.JQ,Y.E%^.)'W MN10"W7XF^4S*$N.K#C666@V@C#6\B@)3DGYVYTB'&MN5*0[M)M_!"*HP?S8J M.(.UC=L6'B/:#8`.N5*V-J\!96HJ:.KEMW"D^9G6DBWNNW<]"6IW$B,='I^2 M!S8Q"X.4M1.R1\"!1>.D[%B)N5`^[4"LL8+=XZG[1G2JR1:6M\'G MA[IT-Q1RY:=SH-:^),_I;I&_O)X\%?1Q&7+&;^.-E5C";],;,Q7?*E8M,\5Z2-;5&02O*5"2[N:F0VZ2>;Y6\L/^3!//#_@5 MN%HVIVBQ1Z/YS*T#AL8HM6EW;/CX6/FI)M&X0]Y0UEC*_C-LXNJ6=F5K#^\7 M?[R!%/"5LP+'=2<'W$/"$%C*7\L#"&/VWZ:.EI,O9C]W].&DX(9RS\T4=_T) M08OF)$,9DG;JSX/#/TR:%A5419=[QD@P3$!XK:2(Y8[\7\AOW/D%_=LE#L#O M-0-=EJEN][:U^ M<9RR=U=HZ(<`Y1IQ@56B'PU4\I9@E6>,B>P1:9T'V?OP*;\UUC;`M+7->ZY4 MJP4#,FOF*9?UNL2QGB%N?B2A:F6R,Y,3$MVLP#OH;K@S_#,'&A,.KEK&!`Q.WPU#6PT MZQL8G(O8D:!YH6+54%FNABQJ@O71D7G\(,ET]:94!V;2I>Q2\T2,:W?7_&[NZV.P"3!1VG!YFYO=">J90P2F MNO(8,9A$'%UEOZA6Y+]BA1VQ^EB9Q-/2%&>!2DW]E$-E#E.Q!00#T95G3M@I/D-=X]GYH@;;QQ/)Q;APX:W5*F]:@T.Q\LPSLLUG_:OK$6&G;!AX MF8*:ZQD,"F(S6(MX@&G#RO)IK2%]%9^.ZQW,;L^%T56V6?"C$P\OH[F`**TT M+;$7Q'+,LSUR]#0"4P]Q0.?Q6N.N=L\<"YR32>-\#'+LIL=@/J*_-R5ZX3^L_`)( M.N186S1:NY,C@B3L?.KCPC`R([MCA\AQPZ\.1+ MU_K;LHK85Z3F=VV:MGW&CM.".+#.U%VTA"1<8Q_?2#O("Q23B(:#NV?H!.(4 M\$YY#OC4.6CU_Y6%&%R&#>8NCG*=GG3U975/COIK26M/.:`#LQS ME/S7[=N+GENBHE*3"V;G_Q:-T,X$AS&A*;V"ZPGJ8,!MHSH%LWPH+ZMUC1P%'B'1SEM&/YUM-6>)YPR-:X9(^N%N'< M97V@CYZT57@TI3>@@;97NB1UH-N@M(&0_BHA95B/D26OC+UN]R7,SI"^4>P@ MBF?^9"Y!7U`N/K]]U"+?FPLFN4FPEFP0(";WE8P6/:;V$H.9!2UQG[34N$H& MT\8K>L`7.!,[=IZ?K=5DG")8W./C>.&*N]2&>,%=9DPPV)IF?=.<&VX@]PZJ MWG!XI&E[RQ<7!R]5PT5IC7;BZHD.DX?62ITXRB7B54`0NW$AJ!E>>2>@F^%D MOX%0(5UAWXLE)*6KD'I%)YQ$0B-R%\J%GLM[Y>47L$."-U0$[7+H:49*'E+<0)6BO) ML>@Y1GI2X]Y(T0G\2U?D1>LJZ:T*+BR<.*6]F9G%I!"Y8UO/6/XGYXW/#-=) MR^#K1/[VMRF&9]0T7D0V<2N,%RVN'>IMQ<@'%%5K1Y&L5]"Q?04/./RZ/AMIQ.L6 M&`&OI?/>HF?#1CH>/7UIUZ3H/K",Y`-(&W334E'?4>[$,UCWHD-$;:U0.TF% M+)-&N4+8HX@.FP^+0P:6"6#F1+A4RS-;!!]*V\/-L5A[DB?:2*DC]+<6;`^> MVH(/.8K)C?#"!%=.6N0![QV=G+Z7%]!E5FD)$DW_IE_%\Y/\I'6!)G(O

& MKN"&T7?I>>!ZBJTF1&&0LQGD>?/D^Z'3>G_F$X5,"?_!7(\GU0^1P2K^H9M, M^&7N9B."!M+-HC9"*<:4-=D.+^2)DI4>B\G"G),X4'(&XV31BBZ%Q6+(HSD= M6,WFS6^1-6B+S`2;L?>.A-,*=+7SB?^61=G15ZI;P(A3LOAQ`@:R'M=!!>L\ M0AP95UL1$M#98C)Q_=7E[23W7,VTM"Z!(.4&[\W0*X_@RHJ[A#XTOM$.Q036 M=UF>A&U%8P&)`YH;ZI@ZU#4BN6TJ2X,B"3[)UNM>K3SS\F\;:`#%`9KW\>E9 M@W49&Y.(K,VP@%7N,9*ZP]]`.!E\981W1MOW+;6.;EFXD78,.3N+:)JY1Z*-]_>OVB_S.`=&7@]G)0<>*\Q-&)5/PP;A+)]S>Y)[K4J[:>;;" MQ+88:@`[*NC([AMGW090H0Q"`FT!8IPGN6UKT/D27C+/"*1Z)MT)2U71"WA! M!YY7KDRV*S,)>:&D(]+)P+1>;*?C:]_+H>1$=(WNWQ1=JA M,T`-C9#$WBD$'Z^OWYC8X`3-KDS[U7&Y3>B`Z"V.-\42=U5-TMT6]3I41IP,]3WJ)@:HO.U)KN#J M``[A<#&I9[X)`*@5=_)\H5QLUY=5M,]$=ZC6[`&Z[M&WY]:#.VL/$XI#`YN- M?WL4VHNU'*((YDYV68<[IUO]0H%7&B]GX=CLL!)Z">^=+RV$G1&7=W`JA"#& M<@V#N^,/N4DA4%LOF0P!O/NE*ND*$'Z7+2F7ORV(6^$X,?$S>2)CXEGI7;M0 MN);QKY9L?S.3KEW!=.UA)Y"FFUW-ZV"BJ\5.7-4QL8L\OE&JZ[AR\'31@TO\ MU<8$,EI"OZITPENC3J@>5PV)8]4JNQ@0=KQH?9AXY)GPF0<4\]KW'XZ.B_4/$J^-^[U)>.K&_Y.]$G9?#>28Z9;%9(9#IF%T&@1Z&DD\;TCMQ9` M*D0]X/_+.')E]C7+6EQS"R96G>J&4_G:>%?_O>9_4%TOM[[(A7.+FT.,EPY7 M`L_WX#+JGW('CUH4L9->1C)_X#;&P3T9[=UQ^2@SH$R(#2)>/GHL3M%B_117 M=<*5+UH+57KA><$32"4D?Q]Q#H_4]&GL_WS5FC(D MC*XU_2TQ0$UD:CCD"2M(#C6@N&$VYW:8M;T?OB2HDU+I>L#2,'/W9\KT$/A2 M;;#=5=[J+?$7&=.&*>@V[:6R=B2I3O3WA,U`A0IEB?DJT.@FU^T2+U^^V'WK"'QRT?/XIZ';>O5OO]QLH,[Z$+^>=A:U87A"N0=PMC- MH"O\3OB1[H^T\'G8-Z7QEL7BM^GFWTB2A;T4:B#`YC,)_"$CQK)],IL62R?Y`'TX.9_V5%G:FF9N'N MEFVBH9WZ413SU8:WCD?6^BM96-^W>[^4&$!YWC M#_18NW=OY-G5S>[;&KI6I?ZE8=KM=(1AX5&QC'USOY"\BAZPAX[1(RVY,1:' M:M#K9IRK4RMVG-^]Q.7\PX7'OP=!U1;2;R_A&19"@I'(_U-H[[F%;]L7PO+= M'E!@^U#F2(HEV(W`'4>BW5??`@QDN-]]Z^NH_8+M=$(,EH]#L/WE+?7/WZ'S M?/KEO@'VW9PX%IJ;ZD*]HX!>5+(%?F%GHF7)(8I+`L!;Q3RC+OR-TDPOK.*Y MFW3\L862'_^.G=TS4?NO!,7S,NR>H*3V>T?\+VCOQ&99!V[D[<$>WEI2Z&DM!\E86C%MU;O M;]P18*NBNMU^5%DAB-$D21)OG`(Z(K^R2RKP9M"_0BOH?=_=5)J9= M2_@J`0?1=<;9Z2NVH:6@3UGIO/XF-D\S?TLJ_T:;T6.[)67T\H/2Y^Q!!?A2 M6FC6[P8*?F1NG9Z`0G$;>WL0OE6K MG%1M@U?5"+O)PL,6$'R8S?4LJDWXAHVO3%8WOM9/=NMD\(O:;M1`P,F(1ZCT MQGE#X`H5Y896PU6&>:GB%6->*7$+OQAH@4C'NT>AT:5N%Q`E6/LD0=H689BV M<9=5.?>R1^VE,%#)%*!P6(O9R8A$0@#!FIE%Y72NSG*\[Q$5R/,3NT@*@IHA M$0YJ6!QHH%>9):FUUHPZ-YVQ<2#`3-Z[DCL`O47PP53H"`7.\<]JQ50?`68H M+(+Q1:X@EV'RF2WD@3";R3EAE0&>/7R[F36;GJ-'MP---9)8A`$^.%^'2D]3 MX[#'GH/42:+N@26,FC0;H][=R;V[J],?OR&^D_,)WQHEN$B()ACQT&NXM#IV M_(0^8"%+0`0?$O6JC!&8*8H61YF3AP7SM#8B,K`60+;#$U>$I>.`FY!RW+T!(Z=DA',QIBQ05BM,R)*@.WIO!;0"0ZV8:$I& MB5),RPG42&F4O&;1;S"R9F*/S+(F0A)U@*(O8EBO\K^2A;?4!S!68+$D[/DV M+N.EDX""9',";IUP[Q^Y#KZD$#]D!1F5LH*XUE<$SGF:+)V=D6SC.:@^ERK@ M1LLB4]9@HD[I,,21I"U<\0;3>>D.BI`9*^5*R)4)Q8O'8K^GU&+!<=SUKP%5 M^FCDBX`5WY+QB+K+E.\O[DR>N6ZEU:)::!/\PV.J`O3@+#M7!0TRC&K..50+ MLX.H5;@#FI2L5'GJH6K6J"#CZ-;Y75ADO#[`P!<(>B8/#;SC!$\\MFY1:+$. M6?RV6C@_,K5-VJ4T:^-KV^[J*G\-(V(>OF=#S19A>6EG]FH)7'N!^(*I[F=. M/AP/I2\U]$_#LF()1VY&"?,G``D(T=[I+8^,6)5D&,JK-&X'E7^;6YDJ3*B^ M0%+RWKT#4QHPS,E;GQUT49P;O+J$1@;.#R3\M0)(SU0GW=,F:-3EF^S\<'3> M??D,,KS\H1T`9SJL:YIZ31?-_UOK2$CZ!VV^NIB/X_LK&PSZZ MM;[R\-Z8:;QZMW]V8V6M]:?(3S7N834??W%:AQ\%8>$Y#WU[3WF*OU1@J6IF M77FZB$"L=H8V7][MO1<\V?AV%D,BA26R`_^_!"SNK:RN=IVDIW1O[B/9`E%C M.PL:_S5=^[!WURG'W/6A&Z)M[LOM+BF$SF.1%ICXX@-&"T^!FJ&;WU2Z/25Y M7>7M=X@F_L`G_:>`[&_I*A\G9=R\)K)1!3WI'M'C00<4AY/42#J[,;`(3NGE M9KJ`Y$44!F=PJ0?2'DV+T'14D"L(DB-5TNLE(/DB-Y\N?BFQ4Y-MJG5BY.AS M,)2/(6:`3"9M_E:'\N+>_H*P^QZQ'.A2HTAAA-(FZX3BV%1SVV67\40JQA[, M%.!=R-/@VE&*^0U,[2I9,\_E*([VQHV(UO<5V7U,CT%I-H0]0I-/`%;GTX\6 MHZPO4]W#K&2QY,UYGP^NF#_V]%K4)YG&>8\+C^1W[IO_&>B,'GS;>T<-\MJM MX3,P;E`[7:,"05C!8G)G@KZY%Z?RY*@=DR#:CSK>]-.^PI\.LAFXGUXLXAX/D8JYL=RQ`A M(QJGDFWG*>%N".:-Z_'MP/&U5JDR0G'B]I'7I?#R=N)7Q>\&7`'>,>JE7$@X MGNJRM7/Y#K%80W--ZCWF)^W34Z\@/'URCAW@)'.WC6T`KX'W_$9-Q]FK$HOS M82I52?!ULG+),+?&/7K4JR)Y6;.KIU=:!>#!6HDKC]_!/2$]F:"^/)T&6=\V M3++.DCV2LUBMPI2AJ[=EP57FB9NM=JI*N0J3*AGI@3FFICO"\SY_?SN'/>TF2D,5"]:)W@[C[7;4Y_A" M3@XMY\$1?[)H^.I)&(N*72KO1BTUVRG2C@@36F>UH8C%S8;;9=:^]-R9\L[N MSV(JBW:,)0<+U'WR;)%S3F5T"P:MF9>LP/(N/$,>'W?N*V$ZW0/[L5W8$VN- M.\AX[R\AJJ6K]ZQ0(HPSE-BY+765^W$?KQ& MMH-*/JTVR@8[KO6"EIBW=Y`-Q+908A;!\24A!?5"XWI%24APUYM1E5X06AZ^ MBKC>)PECGWG8VT5_L@3HKE2JM*&0",BL[R% M5K;QUM(G>BOUR'/=83SMQ_TX6M@VJHH9T!)7LOAR;M"G7[)R`N;IV1LVN'@B M5XJ'*)Y;L:4Y!(V3_65V8/WJMX@$!D=2(N@$0Q,*TOD*Y7DO;^+C*0!DG*J M;1W:H4D[1)1(U'QI[0I>(-2.)^L#CT]>[N3OQI8F._CJ)H_IE_7C_VK??^RW M]6KF-L&J,]V7/-M9]&\0W#>^-70A^1?!08S=;II&VC7C)V&'\C!6R/Q"SM'% MC+I2('^_GC,M\-_*TKB-9P?U:+OV[B_$'[H2DBG#XQ?V*BC!WQ(4.3!@A?7M M1#F)GWBE5]_^\L#!%I;&&:%@V;/5TZ+4\=]XX9?;>$M\>1C[%5!2&PA M.S!)9V4&]*MRYR7S;#OY2#.M%AMYQWFQ M!BZ[0>4`*^>21`O+YG(3L0LLU$EJLJ5C&/Z5JQ*!/&I6\:!;5JQ#'>1:K$J: M[-]?SH2='>X46X1,=%Q`*`KO.DW[3VMFI?6#[])Z%S5YT>!_6ML8?U'2Q]J_ MO3U]=TE7)8_M_X764?8AC3?YW[KE:.D4?UVRZO5?/?E5^[L_/@,!3:@.]LX4^K MUT:0A!,M@AG9ZKG]?_I^Y<>Z,ZDC#\5T:KS4(D0R#. M96]"LHW96'*`MTD4]W>VK:>QS&=; M@E4MS"HVR/?C@C8(DD1-*4=-/W/`J/GG9^3BS22__U4O"'OCE)\_/7[_'F_* MGXY_O?B;B7*9V5JG8`^?&,&MEZ!T.<-,^3K*SE^0>N=G53QA5M$"+ATEPT-Y M%:@S&?I"BTKB^E.H_[MRQ*V%9<,Z;BXA$W=!.-X=I2AS[O(HGEL4OR/!JX&S M+:>%DJSV2NK\-V&M^HQ`B5L/6(X&Y.P>;W_DG30"LJZS]=-D[3(97U8M+!>S M<^G@"[W_S?R;&$;9U*A8QWN4,M:WR._/+3W`/N!"[&H2HX>7I%K[/;R$'LO(VQK8KW7KU[TEF]P8 MM>P$VR_V*93#EUO`N&1`KQC0X\SL-M@P#"][5X->\JX"*G"%<8_HT*Y`8?08 M,6G4@RT:G&FI9;1,P%R:6_+#3UO_QF`0S)&:W_ZT@[R.&&9*NM37(=8.BP<7 M`!X$5M",C@M"8%)6_HJC/H-QNRZF9Z&L8?/?8782(QSH@(:>/@0<)DA>]J&` M*Z0[,9Y@21*J86_-PCIP`HG4[>JCCV+QY<@&%BT>WWD>1*31*.O>@N,0)GT9 M0Q^E3:M9GZWW(*;K0!U6$5SIPP8->T/,DCUOES(PRKAL?]V?4I;$MK;:U2"K MI6HWS<>3857A!4CGP)C@EC'/#!)`\O M*2<(N/_^Y"'0?N'L>G]\X"F*"K#*NT>9V359I-LR@?HO]R>AK[^4`[5-W,UM MR/NK)FY^AKW.ICMX8YXJR)9:D)B\S#2-:*K>8OJ;=,@#TY\"VPBX\<=RT1M+0D@Z@\K2.73[6EUQL^C6TF:M+D7-J+%';Z7W"#E#NS) ME0XOR;:WCYG^%`.^#U&JJ&K6.X?X\/YP%]B`5,DFBA4#<\\%+HTI%@687H.P MPN0]>\H"TK0E8^\[U%-6+GVR]4H\-)B">VO*G:O/:UBI3URBF$]X=9?]-]OK MA`7>-B0`J\:&4WZ[S&4IW21+($087'C2AX_DT=R?@?0??;/LJ7(TB`U<85WD MAMF`KY0JLJOD7$UB;_O909,#%E-Z>S*U%9A!"5 M+7>7=;KR9QY[E\+.)7!7U>*]Q7SX/AI9VYL:JV#P,+,_\N"^BGOM;7Y5V0WS M5I')72Q:=7=57J3LOV.`MMUG%&&93\W-4C:\LQT7FT=AC.QO2B)^(HC+-`H0 M_'ZJ<-.=+-.7,CJ!;?D*KDNB@X'J`H&PLW`_9/UX\D`LJZ^ M-)&Q>SF?G6%+8H7$OO#I7!!!;BH\IJY#%GF M=+9<\_);5PT-U(2YP&Q'4):BF1R48.`&,VCQ1ZUHF$KIZ#5U5L5K0)+)/(:2 MP>X;.^1[3@)*4(@?R)BY*D]&KL0_K'_?)!U`N7)S;BHESA>^G?%+*L@:E;LK M*`%<*.8PN_SY=>45W[3CU>.&K'**3PPCR[WRCCEPH;1MG@K.$6V.SV4'=K?W MCAYOB6"F,Z7UYAM/%H_0"CJ&51X4^(HSB*1&E2/H5SMLU*X+I(.]?(N[PES1L>QDAG1I M\LAJ;?MX9RR2J).F/-C(,Q?%5\-$?RC6_T9B>*7F23J/]JRF1CJN"I"0+4*, M*K8,,EF.DZZ2(>=G@*1H!WD##S]4@H29+$%>'JEVN_OJ[14_TCL MW:^X,]4Q9)EIQ`)C.E^Q\8=<#PXW'"DYOCEY^'%L)FTP M]L/%-'GIIY^-&\*D<@2V)5V.LQ'3HENKYMFQ_C#3B9C]V>20M'/F'`L![HKM M$N,&!"PV=]/3J3(#\*25Y\:PLQY]!X^1A-?`XTV M9OA(W2%0GJ0TED/Z\;[BL).VU*E0)O\)I/^91#'BR3^PBVBS?FNU MLG4Y[2*6S"@MR9A76B[[CX',T6P#[\!HS>VQDM5PDU<&8I8U#`G"82[O3&'" M[;?ED9#M/JC.W9._.)@(9Z6NJ^')C'G@?6Z^G% MD*'_D`A5VF,D)\!\KLV%XK?.A/Z4:\#4=]X1\EJTC5EI-O3#A=6.I+^5!Y5^ MX1TI4_1@Z[VHMA](YU1^J`0833/"4YRZ7?#O!99//C`,?MR3)3IHB%6^C(\0 M<=VEAT(_'/&.*V!%09ZG6&0FWU7>0O[,W>]H.$,7LVON3RNWZR-O`#L'3S*` M878#!AZG[]Q7\7&.@]FXNRL9'#Z/625[(P?UE/>LX:QD)?Z$6[4T*>;R[;U)M+14!0\B].2Y`8,(^[P;A;0`1N3%+`?W]JW>/ M4N!N3_K(U:ECO8'793RWMB.W1T77W+#UI/UM[IM3^D=C12SE"N2&X1D$Q&EJ MM.MM;'D%DF[LH)H-Y15T1=2]`.4'@XXK>R-D+0I,3E,)R3[)7>3N#5NUTQOC MWY]V-FM>R4\^V>MP_(\QZ0^[!Y]^1NO*B,]BQNOHKI_%A#\EM4*AYTOQF!W. MY(:8>T="JTNE75ZK9[(S9X+`$2J":O3916Z,S2:SW&0Y7G3<7GEZ?[+I:*L* M,S9$94WYT^N)&S7#9D.M*NBP%X8`UM:;,ZHPE2K:G+Q'O7X]\GO;&N%)P++3 M:$T-.+-!&P=^7S(?-PQI/:_J5H_Q==>$WGJ#W&I=ZBM+1J)F/UFKH=.PN$#[AC))Y&'XDXW)B[>S$V6K,$C"WEO5>*5-%LL) M6BW+%S4,"`V!'O*")+<3ILQ^8,_SRSE/91EWI_)BA]CJ\YFBR=,)M?^>5;@J+3'99=#S'\4FN3UN+I4+J`=\%[( MVTNX;E;AZ"SBP/'RR#@N]S91<$3SE[.)1BB\]VICOHD/Z6\WI"+I$G=X#MN( MUO,)KSK9`7=(E/D<#P3/O"! MQ5KA_C'0+`\>DG.II#/$4DRMOYZG9[1-00Q6E3$)JX+NF<^(Y(6 MGQDG\<<'*7=>1"@)';9T3JB3:Q]3SP9E!5P$&B2P@H[38*&*B85/Q>S2%E\@ M1V6(YNC8M2?&DO_3/KL`8#*ELG*JOETY\=?9E"PCVP=M2C6)GL-=:5<`7KX' M%`8X89+2DLFQ_$:9/\",I;KJEB/#(`W\K"*A?*0VG."II_V*>":N@E#0BXOC MTQKSD(!8(=D,]G6VFS@<8?-&I6LTQRNA4>IJ@(-'!'@"@L`DS**O+HQCSDXH M)6CRM[KL1S-!+N3+5H1X1#%!92H9`)6YL!0`%BC,J(,DN;F%IVPU#Q03$4(.3(=MPW1MF?Q3*OL(LIDLN^P%_OJ;\&D1QV MVD645SF!U'$BH++-@3!_`:]0_G9D*%^QX!C+K=SPLRLI#U5;.YN.#M$5R1-6 M-GKBN!L:/Y>$W88.FR\G,+VB/AM'7'/&T&#>+5Y9O5'[@LQ2 M%0QAS6$Q!L2+V)K)-7H4 MHO/P!`C)#E/26TB0<"C>IU?+#E[$LS<#!W!H2HJ`M[+A9T^!45;H7Y[47V[- M#5AE$&)`T7F[YZ[E3[;,9S!TW;,\,)JA\E":IXM=Q0HWFA!@39:D/J+L=L5"S6=6"[S0[QSRIW5H>$ M$.B25+6?1,)RG4K#`I/+9;((F1$(7_?)62BBY+0R`/KKONB3FG="NHT)U3*0 MY:\GWQ%Q_'LEN[MFWP<(7*/=P73QR[U72&T/2AA9B]TF[O_@P^E9BHCI?1H- MI8/XAY/R4)/=WP@L(]!I,*W$D]G\%=$FPXW89]-CC-WW7]VEM2P]S%:8HC1+ M0L-SN\S05Y'&[VV%^(FX4H_NNXE='[\&^0&,MXXS]+,8;[]\+./M\Q,:;SUR M6.,=A.6TSFV\@^H(#SH-.-?=CP2Z;S.9;!TEZ[WSG6<6FGP3K_77W_3>_VPI M51\A.Q$Y(!T=.WGXY]X^4N0LSWYP_"HN[_E:VG/?D8T+Z>+%Y;STB\6DH?3Z MO:U8U6XLTG2(_4=OIUQFYUH!N6\\FZ&,A;!Z&7DM5S/91%RT6;CPH`4I]`!C M,&'=(UO+[?+9].@HX-(MYL@T'8EPIA26T%:15NKM1E#%*XVT;*"1WFS(9[9G M!X:HG*@M7?%0A0XGST):QU8K5[5BG2A70,H-=O4(^WD@,0+Z"!W(1'FDG"Z) M=J.?E)\""B0;_']91A\%5II2_UJDMH\HV<:?3*ENV-WO8+VR(E7EHK'C!1W/ MSJF]SW9"!(*R%I^F'Q)VM?R/+XBAIH^F*36Q>K\JF3<>4FBN?G79I MDFN<`W;K6EOT_PM;(8L<$,99W]<7JB;@+&="YI(:D:W9P#T^H15W)EO?6MM8 M+W7\\W6(YN[!X0N\3:T;[+>S22X+?Q\YR91$OMO.P3KF)-B<_"CM-I2Q+3LF ME@KGMM4RK?.,_'@\[SS?FT-?5NF*B9GKNJU^S+NM?N3!**,%C\/V'0S9(97/ MW>L/W9M00B1\IGFQG;Y5R#8_/WZI0Z;:E>&Y3"50PVVZB`3I%A< MOG/>#=OK9H4FX0K(H!KQ>/KFTH)[\HJJZ=T#%U7IRJ0?R&6I-W\V8GW.V..[ M(D6D]/;(8D7]JC)1MZ*!K:VN?1`+#8S!3S&)2)3Y6%I-?T-714SD(,,6=_`0 M"LF-;GYDET,QB,]P2:NYO$`NK?S'2Y-6LVR_!A9UQ-;A:^*F4$T@Z)`:T+KJ MT=\FQ^[7%,T3`/X9%9-*M3&"ZOA_55VJ6^)KOUN-MD MZ0-N8G]::P^F&[(*+O6SL]?9O)6N:[L+40Z0C))INSU6/"#ET[9T8"?G4*J" MP)=SUS; M>7_62\F^'8\IP2Z[11%`SHX_E M8W+G"GZHO[:U)$@@\&M6E(9PBWMY?-4.)G?E=H M&2)X,-F_7U^X-OAT*)8_?JAU(6?EDS:,X)3&VN18N.\1/5EVX M7']/J=TT7J-Q^>=DHO=ZL^;&C15UR\8(]9"+2@2'6SNO3$L.B)C=W53Y`KD(VK^@$WT8=P`"W0^VC9`@``P@@``!@```!X;"]W;W)KN=>X)%Y3U.0I<'SFD+UE% M^VV.?OV\N9@C1TC<5[AE/WKGR-78?YW6ZX*%DW@,6&ME0^:E/D=.7B=MLSCCIISYF4>.*V6%84,5-D=3NH<706+=8:\U5+7 MYSW'T[(B&[3]S6GVE/8%B0YM4`S:,W2GI;:6^@F#O)/I&-^`[=RI2XUTK M?[#]%T*WC81N)Y"0RFM1/5X344)!P<8-$^54LA8`X-WIJ-H94!#\H#_WM))- MCJ+4369^%(# M/52P/$B*4TEH*]:GBB@:)1[@C8R0^3'C>38EAAR0,[*EZ6BK\0LCB8\EMF)] M3F&AP3K':*\KGPK*$:PQ(LZFB$:2Z=H&GR[^%49GL'YQVH*##-\.IX(F<#.[ M.H61)!HN\?7+5JS/*2Q$V/YO1U1!$\2Y#5`82:P1?7MN_?R^G"2%YLZXO3%MSL/7`JR(:;3^I2&(EI:P`7S'.-/:^Q,-7=]^:3105-,(-) M#8W$8$9)X,\B?_KSL"11%L9Q&H\N%F1F0YX_6I1X`C'?FS@OP*! MH]IW05PS)I\&ZIH;_WVL_@(``/__`P!02P,$%``&``@````A`#O#C`_7!@`` MGQT``!@```!X;"]W;W)KRU7IS8/!P>SI#G MB.+#AV_'P^)KV;15?5H'8AD&B_*TJ;?5Z7D=_//WY[LD6+1=<=H6A_I4KH/O M91M\>/SYIX?7NOG2[LNR6T"$4[L.]EUWOE^MVLV^/!;MLCZ7)VC9UK=KMJ4G^K-R[$\=1BD*0]%!_S; M?75NWZ(=-[>$.Q;-EY?SW:8^GB'$4W6HNN]]T&!QW-S_]GRJF^+I`//^)G2Q M>8O=?YF$/U:;IF[K7;>$<"LD.IUSNDI7$.GQ85O!#&S:%TVY6P_XMV7[_^TE3;WZM3"=F&.MD*/-7U%PO];6M_@LZK2>_/?07^ M;!;;\'+J_ZM=?R^IYWT&Y#TB3)2*W^<5S>%EP8S7&!;KB!#DE4J9#*/VS3EICN78FR0KGD/*@ADI M-FJ&$"05)68<%4GYS;&\1,HZER<+UU>\!3-2X\+`3"$$20D=LIV8^\TFE>&0 M2)*I=`XI"Z:D]!@622'$E2^*>*;\YB11XY0(*0%J>7NJ>C2C-9%.&W$=N&0) M6%@\72[*6SI%$EXBQ^3]>AT%2K(O79H-G3D,Z,"@(6RWYE9@+E MV9;/RK%'\@?E1?$FY+C\"\0X9ME!V+J M!YK[@<,@N3LIXCABJG8W8IN5D&(:8.8;A#.`P.;50D&?N<`*0(/;TDU.0LE^C1U"4,VXB9 MPR"U.!71N*`P;00`$N(]GE!JLSQ"HD?X(N))`);489":4DD2LKSF'!&EHQ!1 ME;+;W8'B<#9*0\?Z;49KF# M/=[RLC()RQP&J8<2&[@B(&1]8Z95G-70QL!^4=-Q,EQESAMHE#F,RYG46O`5QQ`)O(,8-(:2 MF^4,:NH,_&B0.8S+FHI-PBV5(N+$7-JI:I8S]&A64NX,#H/DE%+>&1FEEP*B MT%S8"&J6*_1H1HW)5^8P2,V(,!Q'=M2H*T27CC-JEBOT:/JBC3_89@X#XP^> M.UEP:"[O0^B*8\Y@54Y#[^NVKZ8.P=\T9`ZC^Q=<3&?R"XV4&G,&2RT"6?D! MM:E#>(\Z3DH0@]0\H7"5):WCFJ7DF#O\@-34%:+1JATI7_1EHD!(!I%PQ`C" M".6Y,B4WRQ?4U!=B5J_,87`[:'CV98"<`$QD]"C?A)IFOG";J_:]Z(Z-QP$P M?PZ#%.]D(B9*=PU!23*/N)'DU"MB)K:91@RNO#L=LD-W3MM3[VA&"<[R"3WU MB9C)6>8P3HI#&:6\P@0AXR218P4H.>83-V8/3PE`=5"UF&V`#*[#[#,SOLB/ MWSOF,,0[QQR\#\/KHF/9/)=Y>3BTBTW]8N^Z)*C5\"O>PV7B/I/V.H7]GL/] M7/_[:FB`Z[%S\5S^433/U:E=',H=A`R7,>AI@Q=L^*6KS_TMSE/=P<58_^\> M+D)+N*X)EP#>U77W]L5>X0U7JX__`P``__\#`%!+`P04``8`"````"$`H+"" MJZ,)```J+@``&0```'AL+W=OA!G`*R&3F[\^2Q9*EM6P@J7D)I-7= MEK5:LK%U_]>OW3;W,SP<-]'^(2\*3CX7[M?1\V;_^I#_W[)]5\GGCJ?5_GFU MC?;A0_YW>,S_]?C?_]Q_1H@_W MT/(2'7:K$_Q[>"T>WP_AZCD6[;9%UW'\XFZUV>>50^UPBT?T\K)9A\UH_;$+ M]R=E<@BWJQ/T__BV>3^BVVY]B]UN=?CQ\7ZWCG;O8/&TV6Y.OV/3?&ZWKO5> M]]%A];2%\_XERJLU>L?_,/O=9GV(CM'+J0!V1=51?L[58K4(3H_WSQLX`SGL MN4/X\I#_6]26PL\7'^_C`?IG$WX>C>^YXUOTV3ELGH>;?0BC#762%7B*HA^2 MVGN6$(B+3-V.*S`]Y)[#E]7']C2//KOAYO7M!.7VX(SDB=6>?S?#XQI&%&P* MKB>=UM$6.@!_<[N-C`:,R.I7_/FY>3Z]/>1+?L$+G)(`>NXI/)[:&VF9SZT_ MCJ=H]Z\BB;.5,G'/)O!Y-A'E0L7SRGXE`)<+RM)9"9^H=&Y3EL]*^$3EC<>$ M'L6G#)]G99"<\86^^F<=?'[QB,%9"9]?.B),TKBG\/G%(U;/2OC\TA$%!%#E M02;Q7.L;QU7H+,&7KQT5`R2,!'F%0#C5TI4`"4R0_'(^:+D@RHXO\WNAF@(# M)+_@F7HW*3%`QZ026>Y'R0 MBFJ1B->KP_1)\Y6,BAL,?WE;PLB)JTP]5&6>CU)VOY@75'NOPM;6(S M6%F.L&;^?!2.5[HO_H2%;GTFU14).F^01-DF-9`D%S9IW:1`BP)M"G0HT*5` MCP)]"@PH,*3`B`)C"DPH,*7`C`)S!(PQL@=H@0P2TZI)'6S\@;+]3?R)E5PBV)TTG?)F=45 M!U9U?2*DH@UDX+DW$%# M'G*LTU,AT[2N*(&Z+[)==8ZN(<+"Q" M$`A:G*5%J%0"8]RM-$-JOY=F*;33[)?(:EA7'$_%N5)R27M#M5MCP=-LFKA^ MJ4JJVDHS86$V342U2J_$G1035I6N9>(Y%7)I[MUBTC=-W(I+K]2#%!.>9-.D MY/AT!1BI=B/(EL`%A3U-)U0P-07"+SEDPLU4NU4Z-F!S=$T6*Y*`Q57&\A+# M2C+\\OE>DJ703G*5+%)U15%!O@L\FL&&:K=&@P?9-!'"(0M#*\V#Y=CTN(/% ME)2EDV+"RM*U3'RG3&YF>[>8]$T3X=$KV2#%@\?8]*AX97)7.%+-1HHM?E`B M_`GE3TW^75G063]3[5;9V&C-+1-1%@&Y:"],@B@'99+QI=E^)\INR4D+29]12K'5R>8!?:*.$BQX`$V^^$Y+IG2(SP"WJB. M;;Y'BC2A_*G)OW/AEL7NY$RU6U5C@S6W3&":D1%?F.T5QR4#L32;[X07^-7D MNF?%%WZ(L_A>_YTO579VX8D-Z4-=D:IQJ>Z<`KVA;:AV,@X>&:VFZ>(4'-+< M2CX2%T&6LMY-+GW3!;I"3`8I)E67D(:V!QW9 M4:H'R?GXLL?D%H^IZ2''E1QCEF("02'C.E^Z9(2 M^!03'GC;@P4^U8.49WS98W*+Q]3T2`M\BDE*X!7K4N"O,I:7&%;@9=ZLQ%]^ MA!O3[:A7R?)3/W,NG$!#4_`RVM1(YC1O:0J*VAK)%'4T!45=C62*>IJ"HKY& M,D4#34'14".9HI&FH&BLD4S11%-0--5(IFBF*2B::T2^4R$WCXMSX_F'?A"0 M:^+2:J\ZQG,".U[R#8+Y$NA*O-0+!_.!&OUA5I=O#F&UO1@OI."Y-J^+6IJ" MHK9&,D>UHRDHZFHD4]33%!3U-9(I&F@*BH8:R12--`5%8XUDBB::@J*I1C)% M,TU!T?R,J">?+%ZJ0JF-2TLIX"%3)5FL[73)-PA?2-?YA8/:CR"?!M;E.V0( M$QP1^]W@4)-#+0ZU.=3A4)=#/0[U.33@T)!#(PZ-.33AT)1#,P[-.;3@T-*" M[(K)9_)FQ;[[4E@]VS<7"O8KJ2[?\LOBVBSZC*&1T#`#30ZU.-3F4(=#70[U M.-3GT(!#0PZ-.#3FT(1#4P[-.#3GT()#2PNR"P[K]!\IN/2A-Q[DYUY=[LY( M*3BY=C426E)PK42HQ5EM#G4XU.50CT-]#@TX-.30B$-C#DTX-.70C$-S#BTX MM+0@N^#RZ>Z?F.'J*;$Y=]G#FKK<5)-2J=L&3"[]ZYBDW M0_&"T[=^C826%%PK$6IQ5IM#'0YU.=3C4)]#`PX-.33BT)A#$PY-.33CT)Q# M"P[)?:CGD8;Q4@57^TK5'J]=>'@-&^%V>\RMHP^Y9Q02\GBO8=S0ZL*.5E?> M7)$6N#A#2RFUI0PM\2L"IO&@)=Z8REI\:(EWSK*6VBR^N2/X7&ZU33NZ6X,M M1KR_3;<&FX@XWG9KL%.(XUVW!GN!.-YW:[#?A^-#MP8[>C@^=FNP9X?C4[@U'J\/K9G_,;<,7J(I3D'LB#VJOK_KG%+W'N[">HA/LT8V_ MOL&>[!#NAYT"D%^BZ(3_P(&+>I?WX_\!``#__P,`4$L#!!0`!@`(````(0!@ M]MASXP(``-<'```9````>&PO=V]R:W-H965T#"0D+0JIFJ!NDS9IFO;Q[(`!JQ@CVVG:?[]K'"@?79N]D/CZ M^/B<>R^7S>T3KYQ'*A43=8Q\UT,.K5.1L;J(T:^?]U?7R%&:U!FI1$UC]$P5 MNMU^_+`Y"?F@2DJU`PRUBE&I=1-AK-*2>M\*PB'RG*4T$>F1TUI;$DDKHD&_*EFC.C:>7D+'B7PX-E>I MX`U0'%C%]'-+BAR>1E^*6DARJ,#WD[\D:TZH2B&A0.,& MH6%*104"X.EP9CH#$D*>VM\3RW09H\7*#=?>P@>XMUZ,09L!'7L>YL`+A[M<%$2'?D!;%8C"')''(=]I"1V,7_B#7@ MD5@;&(KUO=#K;VKSM)^>2@:!D18H\>6),V!HU4&>H-/&-^\L!IY]+E=CQ/Y= M1/(68J0>7I;+U1MPC*!,O3)(G#\6M[.@I6W9\=Z^VWLAF%A+WD*,A*_&PLU; MMH`I]';?FD,S`Y-.W5F0'ZY;"YX+'B]@3K=3;1+?!Q'T\!R?!!&T,L1Q?P#F M:D,*^HW(@M7*J6@.$CQW#;60=C+;A19-.]T.0L-$;?^6\`&E,%8\%\"Y$+I; MF`OZ3_+V+P```/__`P!02P,$%``&``@````A`!/<:N"8`@``4@8``!D```!X M;"]W;W)K&ULE%5=;]HP%'V?M/]@^;UQ/H`"(E2% MJ%NE59JF?3P;QTFLQG%DF]+^^UW')".PM=T+Q/'QN>>>>Z^SNGF6-7KBV@C5 MI#@*0HQXPU0NFC+%/[[?70,[A=*26ECJDIA6?/3\$/YN09F4H=/FF1?Q$-![.A3*X`.Z4>'?0^=Z_@,+DX?=<5X*M& M.2_HOK;?U.$S%V5EH=I32,CEM9+X2#(!]YN%>$5=@AFU=+W2ZH"@:2"F::EKP6@)S'UF7L>0Z[]2A1P=R:UCZ;@@"P/E M>5I'X>1Z19[`5'8$;3P(1N(/:(S8]@CGH./-3EX0$#RH!B].5?^]#KTX!QZ+ MFX>+<>3-)28>([:7B"090[)+R'PZ0$;ZD__1[\#0,2>^S>(S=1N/@0(.WLZ& MR)V5VS<1V6N(D7H(<^J^ZYD$9NKU*KA#*0:+!H70(O.QR(T'+;H.2H)HO+L] MW8V#LQ+"_+L`_=ESX_UL^]:77)=\R^O:(*;V;FXCB#B\]5?*!JZ4;@#)L`$C MW=*2/U!=BL:@FA=P-`RN88:UOQ3\PJJVZ[>=LC#,W6,%=S>'C@X#`!=*V7[A MKIWA:[#^#0``__\#`%!+`P04``8`"````"$`)L.8'IT"``!?!@``&0```'AL M+W=OYJ@9$VI*]()WM6XF>F\?7Z_;O57JH'W3)F$##TNL2M M,<,R##5MF2`ZD`/KX4LME2`&EJH)]:`8J5R0Z,(DBO)0$-YCS[!4;^&0=E5Q4&!M1XK5);Z)EYL< MA^N5\^4:ZE?N/BE>?><_`;&B3;M`:Z/0-!5M>R>KYEFH*A0!,D,\M$90<%P"\2W$X&&$*>W'W/ M*].6.,V#V3Q*8X"C+=/FCEM*C.A.&RE^>5!\H/(DR8$$[@>2.`F2Q2R>Y:^S MA+XB)_"6&+)>*;E',#204P_$CF"\!&:K+`5__JP,)-F8&QOD0@&MH1N/ZR*- M5N$C6$@/F(W'P`88,DTTP^8@XD0B0J<2WF6R#2@QB1@.+],5"+]5CYJX%V?)L[_.[K'#-N@\>3J*\\D])G/)XRP)XF)ZC>"38O++8EX?-QMT7DPV M\OMB/*9PQ23%/,BCR77NC-_H?A\(IAKV@76=1E3N[":.@61\Z\^7#9POB1NH M\0/L[X$T[`M1#>\UZE@-H5$P!U>4/R'\PLC!#>Q6&MC9[K&%@YS!/HH"`-=2 MFN/"GD'C7\/Z-P```/__`P!02P,$%``&``@````A`#16GJ"G!P``WBH``!D` M``!X;"]W;W)K&ULG)I;;^,V$(7?"_0_&'I?V[KX MHB!.L1*Q;8$6*(I>GA5;CH6U+4-2-KO_OC,:2JLAE1'=/J2;\//X''+$0\MZ M_.GKY3S[DE=U45YWGC]?>K/\NB\/Q?5EY_W]UZJW+]>\FM#1:K\G#6@OSX5 MM[JK=MF[E+MDU>?7VX=]>;E!B>?B7#3?VJ+>[+)_^/7E6E;9\QE\?_6C;-_5 M;G^QRE^*?576Y;&90[D%";4]QXMX`96>'@\%.,!IGU7Y<>=]]!_4*O`63X_M M!/U3Y&_UX-^S^E2^_5P5A]^*:PZS#>N$*_!NY^;-\^R4O7DX-+/<*'*&QA\,WE==[F%$H,P]66&E?GD$`_)Q="FP- MF)'L:_O_M^+0G'9>N)ZO-LO0!WSVG-?-IP)+>K/]:]V4EW\)\G4I*A+H(A&H MU^/!/-BN_-5ZNLJ"%+4&5=9D3X]5^3:#KH'WK&\9]J#_`)4[9Z2C]_J>5?"( M13YBE9T'[0XN:EB?+T]QN'IATX8P:NNJ)O0'J-V+#0PA-A&&'%$VLOUNF(D-[Q&+,'3'0%L?>#^(E M_F?(GT841S:\"C.PN<<`PH:!R%"7$+,B`\N0OW6[9Z2$#-?(G'^)8/(QO@=[ MH[S-(&S*-S:XA)BHE6]82[NQ]_M>(ICNF.O&/3V$S)/UXXN,G2OX,3:_T?H:$>PI$>'J,;NG MI.O5?X^2MJD3/4[JU^L1[51`U"XA7#N&F[MVBL)>NW&Y)3Z-CW=]/_A^VXL( MUXVIYJZ;,K#7;0:5WV4D=I35*]V@H%M"N&Y8MCMT(SWH=#.D?!I_9[Z[04&W MA'#=F&3N\TVY-SP=!)'5Z%TXCDYZ-RB(EQ`N'F/,73R%WE!\%%L=0Y#>8X+U M:N0Z)02F^-WCC2\AW`(FF;L%RCUNP6H>@LC"AS`:<2#%ISZV2PAW@)DV<.`6 M53XEX=`)3#7?S1,-=8L1^B-6I$355B2$6\%@&UB1T]:G&.06S.."AO1B^/[H MQB_EJ?8@("RHPC M7#ZFH/-E$5!F]IELQH,>U_+]S7;DJM;,N#:Z(D2$RXC#[YE$HH'$M M?[E9C^ROFA'E4YEQA,O'.'2??0K/?O;-?,/;3&"ODS_>/%(`Z]F7$"X?H]!= M/@5G+]_,MH#&._F;)7YTY:F1:F9\:K5\YWP.,`?=Y5-JPI75[S[V^:@MV2U! M&`9KN!-L>9#B5WN0$+X$1D++L1;8R6P?DS1$Z["-8[R&+0]2[FH/$L(]W!7- M@1W-&^OCI(:$/DFG$24BS`)^?G=OI98V/LS;MQ&QY,Z3+.@Z`J)$A%LP,EGN MI)!B=G@UV/<2-:1O)OKKK1%WJ09$`U*>LZ7=$ M.TGIVDYUJNL(+I6(<`M&1CNNAIW5<62>]D*"*.>"L;.>)D0GSDD=&DF-3B+H MFHE]UD[L.+*V*2EJ]:),(JH5^%[@\$6Y*[!#"NR)OB)(F.I4UQ$0)2+,0G17 M8+>TN4V9W]YHB/HIPH.?=6S2B&1!1+@%([#=&BH:">[(/(IK2-"93B-*1+B5 MNZ([HNB6&TI#H@6J(R!*K,(M8(@.8D.^K".D)QN*(/H^<#WZ;9JN(UJ@*N,( MMP#,'1:0-BQ$UC5!T/B;T\X432)*1+@%([PG5H%"&R9(.$#A'CUQ#I]&E(AP M"T9HNR5>1+G,SQ]FXFE(?\+&KZG,SW6:$-9+B0AW\K^R.QK)[I6A,]&0H#.= M1I2(<"M&>$_T%87M1%]-)G(:32)*1+@%([0=^XIR>:*O"**^&KL+'DVFNQ(1 M9F1U5W2WM+%-K[FO+7/^#V7#3Q7V/[S!,^1YO!TW7(.\+$LF^X7?`*R?S+UZ3\` M``#__P,`4$L#!!0`!@`(````(0`";H!W+`L``-Q!```9````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`7\;/4_4`WP)2]B+C(?3(`D61(!)%1?$2&/8C+ M8`/9`./F6,:,46.&$5HBB([R(SKL0;PS2CIE&F!<'2Q'%22T1!`5=K_!5M#P MI+('\6I43`4P=3^IRBBIZ[+>53_;#N2?$V3E]O9PGSH658- M,-+0!PDM$23[V*Q`[MC+Z?]#\%"*"2BTB5(+UQ>D2P$6I!&X9,4`@X29>EZ5'@V3'N*Y* M"-5@O7&Z!G!2HJ%D8]S$`%TU%*E'`B!B&22$2K`>.5T"."J5,/(&@%!"LA[/ M=!5+SHQ5D!`B(9EEWCW-S+MD"V.#$$C(TL33#(A(5:!16,M3";,<.O$X=,E< MK$$()"3KU%X2L7Y&1)0`I_(C5(*9%.Y$FK:Z)O8H9A3E3QOMIT*#D#\)V'"$ M$2TB5`KSZXE2/+Y=MR:R3226YIW!'+E! M"+-+HX0!"@%!H181*H!9=D"`QZI+;M7VGIU1B0(R<\N/=P4`H@`)H0)F&77B M,>J2&S5"*"".4M8N"@%1`)S(CU`!U@PG^T,"UDG]@=LT0B`@R:-1`23_!7/` M$%/RMT[HY#^QE\$_B8Z*+9]-`A`6(H_63*A"P)\E"F$QG&:G9;!N.%\&>"B5 MP>TZ`0AEU%'"`(6`*&.R6=L-]WPA_5',)BINV@@)>:HPHD6$U"2=9=H]S5;7 MBILV0JZ$NN+][8'8(JQ%A(JP!NQ,+'F%32W-1;#^;1"B(EB&R@,Q1(L(%<$, M.R`"#-9\'6X$UQ6WB10@5P3+3X41+2)4@CG3C#I8FM=A-)D`@AU@G,:59PN8 M`F.^#F/!9&H1H1JL+4Z?2V"B='$:S26`0$-:USX)DAG#*IM*")4PRZ]3CU]7 MW*\1PC(D969O`[(]!V&2*AU?;VB"9!6])*$:F&5;RPO?2$[!=6E7,$=K$!*F MBPHC6D2H%.;>@<;VN';-AKI)`8)RE+&IQ;@:+E+`35A:,$VB]+/2B4(E,.<. M2!@[=L[?.6E2@$!"`G>5:7Z*(K[WD31!TH(.!)&0??:TWLC@*ECN#81$*=+5-"Q58A0J999S9Q[G'O4&0CBQ['T;9U;W M^2F"V)M3(T03)&,=1B58DW4,8V(UP)J)<=1\,Y@!)%8CB&@Q"I5BSO0!*?8H MOJ_EBVX&D"@EB&@Q"I5BW=*IBKQB66?A6Y'QQ`(()E;F?W?>15+OHHNGPBAL M4:,2F(U/G%@>.Z_YKBH#2*Q&$-%B%"KE0VZ>37%SA$0I$$=`M!B%2IGEYMD4 M-TC0V\=MXS[Q?1!B%A5%48T2)"!C[W&'AX M1]@?Q1:GT6>'$)*DA!$M(E0*,W!Y<BNH`?B%THB0D7, MLNX1<@5P?)3842+")5@S=,Q";O"VELG@7J`Y=)ZL#R;'"#H MS/Y]B]$NA"`Q;$/H#EA3A.UEJ!0S:!^08H_BVUM^%R$'"*3$2>%Y0Q(1H7!: M1*@49MT3J^*S<'X9FP,DY*G"B!81*N5#%IZ#]9)>&:]907]6&$=0JT6$2F$6 M'N@1L%S:(WQ/:#[S8V>?FY_=:-,>4!Z*-9L6$:IBEGOG8_?;8((2$_%4:TB%`)S-&G3:P"G-UM=5,, M=K^_00I-9-W;'6MT1`2Y6D2H%NN_CK7+RU5A:3JAZH*;!T(HH;+;;:X`PH@* M)(0J,&%F*+`T56"JP'>)!5`@X2:I/1_,0434`%'\"-7`K#Q0!8^%CSY;5`"$ M$OI/E_,J!$U>8Y`I"IB#!Q2`*;->8&[0%$"!A*J_N<0E!,U=8Y`I$IAS3VQK M,&GJT//$-(5*H M8!UES-(5`O[TH`0B0A7,I$/(/*$J!.`*BQ2A4RBS[+CWV7;,&:!!R\QO? MI_)`;+'3(D)%,`>?V"7@P,S^V!5$4P9]6H41+2)4B\?*)\PM,&G:)Z/+I1*H M7]L'`:HHJ6KW'VL[3>B8?,:22OJ0HY<^1^<7>`U2\/!2:K8OXRT[1=@M=%S& MX%P0I61OZE`MS-0G3C6P93;5^$ZK#)JW"B-:1(@6\S`[6<9D?^]I:BKC#0I" MOYYA!`C.,$+[9A@\3`\/>!_:TTNKVOW^O-AV7^V#\HEYNV7XZ_`0_Z?$/AK- M_MZ8A_O[)^%7PPOFV?JWS4O[K\WI97<\+_;MLPFYCNRR=(*G\^&72_?6/U;^ MV%W,4_7]CZ_F?U%HS0/=YFFZY>*YZR[77\R)5\/_R_#P?P```/__`P!02P,$ M%``&``@````A`%$CGW65#P``R5@``!D```!X;"]W;W)K&ULK)Q=<]I(&H7OMVK_@\OWL4&`;5Q)I@:#D`02`L3N-;%)0HUM7(9, M9O[]=B/.0=W-JR93>Q.GW[J^OMX_?5R_+[=7F;?6JWOFZ>7]9[M1_W[]=;]_>5\NG MO?3R?!TT&C?7+\OUZV79POW[.6ULOGY=/Z[ZF\;W[>]_HY<7+XWW\[77SOOSRK+;[ MKV9[^8BV]_]QFG]9/[YOMINONRO5W'7Y0=UM[EYWKU5+GS\^K=46Z&&_>%]] M_73Y>_-^T6I=7G_^N!^@_ZQ7/[>5GR^VWS<_A^_KI_'Z=:5&6^TGO0>^;#9_ M:#1^TI&2KQT[W.^!_/WB:?5U^>-Y-]O\C%;K;]]W:G=WU!;I#;M_^KN_VCZJ M$57-7`4=W=+CYEE]`/7OQ5?^]>?ZZ?=]T^7K9NKSFVCU53XQ9?5 M=A>N=9.7%X\_MKO-RW]+J'EHJFPD.#2B7@^--!M7=YU.^^;N5K528[8.IGH] MF#=7S7;C1G=>H[4/FGI%AZKO&D$UM]],]7H0VN?T!/5Z$%KG M#83Z?=Q_0/7*GH[[H6;+N@=1O6++:D>BJ4JLW..ZU@Y[LW[W-EDDZH>#TCEG M^)HH#/T#^JJ45\UF-5$9^H>C&MQUFAU?=311'OH'N,%9HZE_=M8:8K MF^#<)TU]:L[3K?RNF]DWIF:UK9JO__S<;#1;'Z__5)/LXP'JE9`:V2K4-J$' M0'I2U4WW[6!@!Z$=#.T@LH/8#A([&-G!V`Y2.\CL8&('.8+*")B;/P6!S9_9 MP=P."CM85()KM9NYK]5TX>SKEBJ^TZL:=JVVS%U[9^VS7HE4=VQ@;M8#"&Q6 M'T%E)!K-CFD-`,$*$1PMZZ,,04")$!P559DW9D>IM6!DS&>0<,W7VVD>=NUWAZ<:B.P?LG":AL?FFI2,S_H\$0C#A09C;2Z;>N3 MQ.U3'U28ZC<":$%/S[8XUJ6;5MS\$-S?64$U.?`1G M*'*CD;M.VQK/:?E^>W^*I@],9E7AKA%8VSVW^:+*?VAV;F^ZUI*RJ"A&.:NC M9J.=-$/AU[",0E0$(*"$"41F"@!(A$)48!)0$ M@:B,0$`9(Q"5U$MD7F("`MWF",1NIR"@S!"(RAP$E`*!J"Q`*,4H-'6R913: M>?.FMIQYTZKM7@G5%1P(;$7@G5E1H(C%,?@;A[!B"@A`A$90@"2H1`5&(04!($HC(" M`66,0%12+Y%YB0D(=)N7@5QJY?OF@9&]T,^,1EIW+6M1FI_32&$VXI:DIQ&C M3-5)K5&F]4NOIIVEUSH:Z95077F"P-CV$8B[=``"2HA`5(8@H$0(1"4&`25! M("HC$%#&"$0E]1*9EYB`0+`:HK-R(8K#X3<2<-B$`*F8C2D`BD MB(DHQ40@)4Q$:40$TIB)**5^)/,C$R+H.C\DO4U[>I]BOIU6-];L^9'=2G'.ICH':C:FBT;.I[U]_W2@`CV M3,CD..[6AQD2@10Q$:68"*2$B2B-B$`:,Q&EU(]D?F1"!%WG3,2NIT0@S9B( MTIP(I(*)*"V(*,DL/WU%NUI^>O)L^V?.\D*XNDK)7S=5AM894D_?QE7%6EN& M0+`U?;\T(`(I9'+\/$X9VCU%?BDF@IX2)F)/(R*0QDQ$*?4CF1^9$$'7.1.Q MZRD12#,FHC0G`JE@(DH+(DHRRU!?[[;+\,9[!T_?['=G0^O`H7>@:LNP=,Q*ZG1"#-F(C2G`BD@HDH+8@HR2P_?=':GOS.6(/+:]UJGJI=@TM*51HI M:V5\T%]BVE>_VL-^FN0SD+<5ADB$:6!(X5,1&E(!.,6,1&EF`BDA(DHC8A`&C,1I=2/ M9'YD0@1=YX>D/!F^O6U8U\VFCC%CHA=6:X&;\TUT4#`Y@2_XIL*-NM-?US?J MKOXT>(^;I\&W=]9!7>\`U:RC#T3P\?M,Q%TS(`(I9")*0R*0(B:B%!.!E#`1 MI1$12&,FHI3ZDG?!O"C,F)Q73.-X$73$[@"[ZI<+/L].V&:MEYUEZ-FVOOB=O` M04G5EAL0?/Z^7QH0@10R$??GD`BDB(DHQ40@)4Q$:40$TIB)**5^)/,C$R+H M.FDH$ MTHR)*,V)0"J8B-*"B)+,\M.W):JSWYG7:LJ[&>8LZ*[7WGL>#P$0;$V?B;@U M`R*00B:B-"0"*6(B2C$12`D341H1@31F(DJI'\G\R(0(NLZ9G%ROR]'WK=?8 M1[J)H&%--O-##_6-%'6?8^%KPBQ9?0NC6K*>&;.\XZ&^-XLQZ05.].!&?3<: MN%'H1D,WBMPH=J/$C49N-':CU(TR-YJX4>Y&4S>:N=':N%'N1E,WFKG1W(T*-UH8D5D#I^X3Z"\U_6H-E-?[ MJWNW:_]14Z]50G8-6'\"_G#$CC5`$]'`I4(W&KI1Y$:Q&R5N-'*CL1NE;I2Y MT<2-:NM',C>9N5+C1PHC,&E![[?\R#^AVS'G`>8)'KU5"=@U8WV!^.&+8 MX7TW&KA1Z$9#-XK<*':CQ(U&;C1VH]2-,C>:N%'N1E,WFKG1W(T*-UH8D5D# M^LIU=4'_IVM!>07G[>7CQN?NA'EZJO&7[^R+A\KFH1W*N'=ZD&K/SWH*O>Z)YXI]=JJ$>Q M[I^F:CEJ55#O[(\,G7=4-ZIDW7YZK18>[&H[S7OU.#W7R%4GI_)>*^>V$P;WZMEQ;AX%]^KI<&Z>!/?J"7!NG@7WZLEL;IX']]-3^2RXG^_S M:VZP>I#LV_+;*EV^?UN_;B^>5U_5WFI^OI>/HBW_L]N\[9_+]V6S4X^0 MW?_X73TR>*6>3=2X4O#7S6:'_Z@/=,V'$'_^'P```/__`P!02P,$%``&``@` M```A``S/'^^J!0``I1D``!D```!X;"]W;W)K&UL MG%E;CZI($'[?9/\#X7V$YB)JU),#9'9/LB?9;/;RS&"K9$0,,)?S[[>::L"N MYH#ZXHS6UT5]=>FO;==?/O.3\<[+*BO.&Y/-;-/@Y[389>?#QOSG[^>GA6E4 M=7+>):?BS#?F#UZ97[:__K+^*,K7ZLAY;8"'<[4QCW5]65E6E1YYGE2SXL+/ M8-D799[4\+8\6-6EY,FN692?+,>VYU:>9&<3/:S*6WP4^WV6\KA(WW)^KM%) MR4])#?%7Q^Q2M=[R]!9W>5*^OEV>TB*_@(N7[)35/QJGII&GJV^'3O5?Q4?O_/L<*RAW#XP$L16NQ\QKU+(*+B9.;[PE!8G"`!>C3P3 MK0$923Z;OQ_9KCYN3'<^\P/;90`W7GA5/V?"I6FD;U5=Y/\AB$E7Z,213CR( M7MJ=F;/PF3^?]F)A1`W!.*F3[;HL/@SH&GAF=4E$#[(5>&Z981P=UY]1!8[" MR5?AI?$%+"JHS_N6V:Z_MMXAJ:D$A0B"F>A!*B)J$2*#PF]\]8$%`7=10RYH MU"Y4=;@>;9!BD1JDZZ@!A#J$("(=X;JJDUB'+/I4*#3<1VB(1=!`UVFTW;D: M0X@@*&B7:X*()A'Q&$*A`8^YOQIBT<:$7'410LL$A`:"@J:CGI;.4C5'BID% M"V*/T0ZOW3/Z+"@,8`KO9R`6:0P6:H@A@CQDX,_[YS<-'J'91S-CH^ZI$V M#R5JK!33D'@4HG(1&G@_%U3."6ECB!KE,@F)1[VH7(0.WL\%U1,"Z;1G0-\8 MHMH&"Y9DA"(5X,"946W16`*&LZ'R`,P#/,0J.B@N48&0(0IW*D9U.)+FEJ9S MM9/*;!9L)<20S?L=$V9#VMI^TL8D[!].E$"I):,PGOTHPU-;K4C#;(V&&$C7<$))) MJ^%#@JNJVDY&Q-BR642$H]Z4;@X=\EY@Z9MI4\.'QKZ_D1RQ2BL"_3XA4;((^A<*Q3ZPRTK[+45X2+B=(>'V M2*N$$C4A:@5@2<]4!&QBA[3M;L"!U&C7"8A\:@7E'GC$3Z?*2(LW<1/.X$JK^Q1OZ4.XI6^NM*W.`)?DE^3`OR?E(3M7 MQHGO8:D]"V#62[QFQS=U<6EN;E^*&J['FW^/\',(ASMB>P;@?5'4[1MQD=_] MP++]'P``__\#`%!+`P04``8`"````"$`&PF_W2\$``".$```&````'AL+W=O ML:W[R83[=??C#YLKK]_$B3'I0(1* M;-V3E.>UYXGTQ$HJ9OS,*OCFP.N22KBLCYXXUXQFS4-EX06^O_1*FE>NBK"N MI\3@AT.>LH2GEY)54@6I64$EZ!>G_"RZ:&4Z)5Q)Z[?+^4O*RS.$V.=%+C^; MH*Y3INMOQXK7=%^`[P\RIVD7N[D8A"_SM.:"'^0,PGE*Z-#SL_?L0:3=)LO! M`:;=J=EAZ[Z0=4)6KK?;-`GZ.V=7H7UVQ(E??ZKS[)>\8I!MJ).D^S]8P5+) M,JB"W4^8XGR"-]$.IRS-Y MVKKA0 M"0$U>]_Y&^\=JI*V1*0(^-T3Q"3BCL`28-!$N^&!VEXR)%&7?+^0G3*$45D7 M-5(W="&!)61(A":1#(EY3QA2H62Z5,QN"--^7#(^!)R6JD4?OC:B37/XR%BBQ\C#/'+1\0C;(HGU@*+%&*HMZ?^$+'5CQ&&^M4C MZA&VU%MK+E*(H?ZVZ)IE$0\16_T88:C'5P9M6QR?]`A;ZNT5JY!1]4/$5C]& M&.J?'U&/L*7>&CA2B*'>6M;Q$+&")&.$H9[`#CD]^0UMZ;=VE*AE#`/6VH[O M,+:#4<2T@+U+FS_3-GZB.IZ^>P;6_A*UC&[%DAFWR*+IP^$B\)\6*VNA)Z-A M3"O8[#0KXTN!J-9H6+#WH9;1+026OO@.8]E,1A'3`O:ZZ1949S0LV)L1&7;/ MP-Z-[C`#"\,P-\2T`-EZP`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`:H&*W_7FH_'UQ^+[_.7O=/<2[YRV- M-L5)1>#+?O^',@T?%"+G:_#V3Q%(7R\>ME_O?CP>U_N?P7;W[?N1PMVG'JF. M>0]_3[:'>QI1DKGJ])72_?Z1&D#_O7C:J:E!(W+WU^G?G[N'X_>/E]W!57_8 MZK;)_.++]G#T=TKR\N+^Q^&X?_I?:=364J5(1XO0ORS2N>IU^L/1.2H]K4+_ M:I6AM*2A=FKGJ0OTK_;K-#>7YO[)@?XU%75&_79_H/K<4-.-=J1_N:;NU:C? M[PU&PV;/-@^1^D/[5L:YHJ_N!::8B:7'@DVS*4;1G*=P:U/>"*Z0\S M3N_K[9!=Z0]N<_]JV&[=='\U4!RWO#J7&X:]PS%6?VC?=S?]NKPN3Y?YY.YX]^G#Z_[G!:V=U([#RYU:B=N> M$N8+O&R(N>3?NN+I4EZN-FJ)O3$ST@4R!^$!F0`(@(9`Y MD`A(#"0!L@"R!)("60%9`]D`R8#D0(HJL:)/]X-6].MOR'E[5M:G('-P;DLR MHALH$_;N3<\.^]@8L=L$R!2(#V0&)``2`ID#B8#$0!(@"R!+("F0%9`UD`V0 M#$@.I*@2*Z9T(WQ&3)6U'5--Z/F,XS5&-$$T1>0CFB$*$(6(YH@B1#&B!-$" MT1)1BFB%:(UH@RA#E",J+&1%E2ZQ,Z*JK.VHEH2N5!-4(!,@4R`^D!F0`$@( M9`XD`A(#28`L@"R!I$!60-9`-D`R(#F0HDJL`-)3S1D!5-9V`#6AIWJSU';: M[E);&G4')LJ3DO1H!S!NW9N^O4)/C1%/#E\3$9J!=&"\JM+.'5]HC%AZ#M(1 M2,?&JRH]M%N=&".67H#T$J13XU65OK&E5\:(I=<@O0'IS'B)=*_5LJ5S8\32 M157:FC(4:VO*E$_55RHY=)WNCTN+ZC0J24_VA"D07Y/*G`&=`+Q"('/0B4`G-EXRU-V;D3W4B3'B MH5Z`]!*D4_!:`5F#S@9T,N/5T,3<&'$3BZJT-1O:E"5JG`[9_N6MZ4`I0YX/ M)QE[0FC4K]Z]=T?.Q!VSHSRV3S3JR:XR1>1K1%DN[N0,M0)T#!'-42M"K1@= M$T0+U%JB5HJ.*T1KU-J@5H:..:+"TK*G@,K+5/-L-5=^-=3*W`EUB3KT/"C[ MP=!96D,G5D[9RVI,6(D-<:,&FM,I$:5FH3>+5A%ZEHRDKI21HUUK:0NZ5VO MY:0ZUZRE=@1.F7;:SG*^82MI1,:HL1&Y-.+4X8Y3?<$JIP[;,U4EF\Z8J65N MBO('/.%N52Y!S4':'4W7>BTW+FV,Z9IF9VC%8Z7C%MUWD%-4UI?9$5R;Y#&;"6.$T9RA4TUTK=9 M_9;S/.^SBURZ,T8B'#`2X5"$I9&P4<[94>0C1B(?,Q+Y1.35\$.[%^PBPDM& M(IPR$N&5"#>T>\V.(K]A)/(9(Y'/1;ZVW06[G(3M>:,R>F?,&YT`E.;G/+GZ-TQ$XB'3.2 MEB>,WI1>H/22G40Z9232*XV:!V6-\AO6$OF,D6%)V[-'91//F#UE M\M%:=30JCT*ITQ#C-J`)HBDB']$,48`H1#1'%"&*$26(%HB6B%)$*T1K1!M$ M&:(<46$A.ZXJY7=&7)6Y[EQ'G-#L6+Y.2.1CU`^9BM;WKG73L2* MY1>,1'Z)\BE;V?).FF0E5BR_9B3R&Y3/V*HJCXE_L6+Y@M%)WII)ZDB@-9/^ M4>[_I&(O'(Q,]K\S=%\B:9/J[-*HFO]'Y#.2T9JA5L!6)L+QK]XHT`.\K=SD2CZAL!1+Y&U#/NY0RU`G0,$7E6=3;7#;5.<=K/I<[2.]:. M-S,#5F[5,"9>@\N?BF7)YY9EA;8,P::PN-637QAT^PQDPJ MC;#2V)@U5IH8L_HN+DRYU+;$VE)CUEC;RIA5N]AK.:OXVIA1?,V6C:D4;$=F M/!O;D1NS:CM@J`MC=NJ\/7E5KK6Z?C6_SE*I$W?REJA#CZ>FCYCFU8XW[H73`2*1#1M5%M&8Z@GS$CK).Q(Q$/M'H[98O MV$E:OF0DTBDCD5XQ:FSYFJU$?L-(Y#-&(I]K]';+"W:J6?!4QO2,V:/,G=FC M425UI_8Y925H@FB*R$0TK;&;'WTW=_L-/'=6F4%[P,@D&(^_;*5'U?#ZB":(I(A_1#%&`*$0T1Q0ABA$E MB!:(EHA21"M$:T0;1!FB'%%A(2NNZAC"&7$]F=N;N$;6%U*]EIM=$2MS"2.: M(O(1S1`%B$)$I8CC8.3D&Z9B MQ4N"KU$U:ZX1O9%DJT`<1;[7*?-LY2)6(%[YFAZ84PP`T8_"66OG6F3OU.%V9PD[F:JP= MJQDP1I*-F3*J:M7,5ITKE&3/3#OVY=U5H-%`7D"&C*H1`_DY6\DLB32JM#YF M)*U/&%5;WVL[GS,LV(JR!F:\X)W-DJUD4TD928TKC3A[-;IQGR[7["1CM6$D MTADCDNW[7C[^'BXN-__4#\( M-E`3U^#RU\IN.P-/96AH<8:2(96.6=%OT@VFGR0,EZJ?43L_=;DG/H]]AJ*F_[]&W_#6<.EG;1^IB70]OVU1` M1\YJE-K4P_(6P6D3W8MXZDX#?>@VPE,W"5A"=P">VM^QA#9O3VW-6$+[KJ=V M52RA7Y[[7,=O:1AK1[%#(:G1N>W2L-?PSSW2KQL4.MKCJ9,;V"0ZX>.I`QQ8 M0@=]O)S.[-24=%J>.KN!)73&AUI<5T)G);PI;>[H0RNFYL-B./O@-&^VSDT6??-9RF4YU]0==K':?O;3WU@2TJT=>S MGOI<%DOH6UB*9%T)?=GJJ4]9T8>^4Z5Y7E<2C3SZ&!L]XI%'G^/7<)I&=?:+ MD4??8J/]OWW;/AXO'[5?:OEJGC_5?RU^\+/_GJ+_2 M_K(_TB]5TNT2_5H>_3+IEHYFMZ[HF?#K?G_D_U$5F-\Z_?1_`0```/__`P!0 M2P,$%``&``@````A`%73'@:U!```0!```!D```!X;"]W;W)K&ULK%?;CJ,X$'U?:?\!\3[AFI"@)*,08'>D66FUFIU])L1)4`.. M,.ET__V6L0W&9J*TU"]-$4-*7"],9V9;1JHSO&QJ,\; M\]\?Z9>E:9`VJX]9B6NT,=\1,;]N?_]M?BN:^*O,$$G]H9N+-8H+KFE;6RP--V?2Q``4V[T:#3QMPY M8>KXIK5==PGZ6:`[D?XWR`7?_VB*X_>B1I!MJ!.MP`'C%TK]=J00&%N:==I5 MX._&.*)3=BO;?_#]3U2<+RV4>PZ*J+#P^!XCDD-&P$XX M>6#H<4-XX.&NS[;K!=P.F`7))KAF=+2<$;Z)B+.B^AK\J(=2..ME1 M+QL3QABJ0Z#O7K>+8+ZV7J%7B>LIO3@-230D ME9&1.)A=59RWI"L>7T.>'BOJJ-,GXHH8XL&D2HJ#L>)]3Q)FL88D&I+*R$@. M?$R6,[V8BY6`DLPZ2@?N.6D8M9@AH%2(2#0D98C+-B5Y_(./A$S) MXY`Y,@K95T/F)"EDAL@A:TC*D(F0Z1E(6H@?9YF2QR$SQ'6ZQ=>UM03SW]T^ MG3%'8$3[5G(=97@23O([M[`+V_:XUU).Z';S4==`\I[70\EC/0QQ%T*/LIOL M^>_!H(/"-X>O\XC>^/14T(U`:2,.#758CK^]%X1!=RP@N0[,L\OG`#I)+P2G3!2" M[H*2"';&FM$C7GLI\I<(PP!"^B=&WH/6Y21_0RG=662N#EK#<]*L5 M+$=J,1G+'0QCN.[0GO"A.KVAOLP)%LWWZ]9=3C4I]RW5E]V#V'&Z0LT9[5%9 M$B/'-WK'H?W>H^S^%2]"V,5@P%0\").N/@H.][5=IT7!(WJ/F_`3N2&<)G7_ MD1?"44S'=WZX8_=!]0-^",<;W2":AW!.`-SJ#>#^=LW.Z*^L.1&ULK)S;;N-&$H;O%]AW,'0?2SSH0&$\P8CG(Q:+[.ZU1I9M86S+ MD#29Y.VWFMVE/OR,;"7)13S^6/UWL[K8K&J2_O3S;R_/-[]N#\?=_O5NY-U. M1C?;U\W^?O?Z>#?ZSR_93XO1S?&T?KU?/^]?MW>CW[?'T<^?__F/3S_VAV_' MI^WV=$,*K\>[T=/I]+8%E?:)?#X_CX]MAN[[O M&[T\C_W)9#9^6>]>1U)A>?B(QO[A8;?9)OO-]Y?MZTF*'+;/ZQ.-__BT>SNR MVLOF(W(OZ\.W[V\_;?8O;R3Q=?>\._W>BXYN7C;+\O%U?UA_?:;S_LT+UQO6 M[G\!^9?=YK`_[A].MR0WE@/%]V2MVF>Q`Q\W>^_"=/R7B!J/(;663\# M_SK_RBVN\>G$TWWE,Y(G-CR_O=D>]R01TGFUI\*I;[\?3_N5_ MTLI36E+%5RH!#5\>#V:WT_DD\*C32PU#U9!^JH;36R^&?F"<[H66=,'T7=+/:T8:J6;T\[J1>A0*N"S@!C6"V@6-"UH7=`:PG$D7 MRM_A3"%S-Z+_ZV`-)K;W5M+&HVD]&\ULD_AL90PPD`9("R8#D0`H@)9`*2`VD`=("Z4QB.8Q2W"L<)JQMATD2TG*D M@\YSEPUI9'@U&6H6^/9JDYZ-.%8S1?3TY"!=G%L9(PJ<$95G(Y:N0+H&Z>;< MRI1V[N;MV8BE.U/: ME5[X;D33PH.(%3(G@:U$;^=L.PB<6=!6K)4Q,N8!Y0NVLN6GMGRIK5B^8J3E M:Y1OV$H6R.(&T2+J&/5:MO-%IFVN%:[S?]F__9'SJ=(]>U_(.-Y72&?9LM`AN6B"K4JE&KP88MHL[2LOTJDF[3KP/! M:_I/YNB4U_'\KT2.1\[RR6=&7,[MP(G92C=,&%$JJAMZS@6:LE78ISC3:#IW M5H>,+71HY8QT;P6CB[V5;*5Z\Z:>L\Q5;*%[JQGIWAI&%WMKV4KVMJ`]&=MK M'1OTG=GS)A+X*^9-F#MQ+Y%O9R`+>P2QV*X0LZOC/F&DKXZ44=1/DA^%;B:3 M*8O`O#)`NF`=+5TR4M+3Z<+98*A0NN9&>M0-(RW=,I+2P2($]\L1RD';[A<9 M_17N5P6`CI"5V'7!R\8YMYBM=,.$47"^!%-&,H[\=>Y`RP0N6: MVYBQ#V-NV4HJTSKGC+FSE.W8%S71%TQ):W]DJ4; M)@J%UF8<)EI*7NXE>=-Y$#C)0,;:.MYS1KJ[XD/=E6RENIO,??=4*M;6W=6, M='<-"UT\NY:M9'?3B>G/[+L[(RF'=-"[65GPM M)8A21!FB'%&!J$14(:H1-8A:1)V%;)>*RM4,U7=3@8; MPBZ;MN)8SACI#9@3\C]WS?%GE6A>(0KK,B=E*HT0A M<[\-4:80K8?LGARU"FQ8(JI0JT:M!ANVB#I+RUY@1"EF^O6=!5J8.]$KD5C# MC+ATLN!8O-TC*E>]LB>,**YU0T@#V4J6)M,HF#@QF;&%#JVZM8'2QMY*M M9&]A.)T[56#%%KJWFI'NK6%TL;>6K61O7CAWU[^.+?K>[(F[KNH5590[<:KJ MM9(5-\>.54.C5DD8Z- M0KI^3]E*U>]AX);)&5OHL,T9Z;`M&&GIDI&*47_N.X5*Q19:NF:DI1M&6KIE MI*2]&>PZL,5`^(OJ\`K_RV+2\K\J3*WPAQTW7UGI0$H8Z4!*&SF1,@%2K7W$:/N6&DE5M&ZKJ:N*?>6Q;^4*B57O?$?&'3>VTN&5 M*&3NN"ETWG&+W!L"MS%R)50NV$KOBY6V-K7C'C;;^AT M$5PS=&'N7$T*64,/G5=?8AI@W]`5W52YY\ M&02>;<:!,M#WE(31Q?H]92LN8+RY\X@N8XN!>XI(_Z\X+UDM6.>E"H@9GY=S MLXX#J#`21GJ"4D:JPI@OG"4R4P:4^]"FEAU6(HN_XAQDTF^=@T14!_0?ZTS< M[9^84DJW_F6DL^F4D9R(Z60"YZ!D6`DYR$( M)HXK,C88F(?WJRY^3$MZ!8HCNBWKN0^=8BS65OQL(T&4(LH0Y8@*1"6B"E&- MJ$'4(NHL9+M4)"@?OZ_1Q]X0D@KILB)F*XT21"FB#%&.J$!4(JH0U8@:1"TB M\8U[?]K&PSKYS;K\LO=E>WCR2D(Q3V0T>F=*1?8:#-C+^]=X\LEO09RX"6%RW%*R$#1_S)4KS9,'2$OO"G M6^7`D<"GL^GS2+?_(*`C_:W2.4+)_5)D\ZB6!#,ZTKO7:4-_8N#+8"\TL,%Q MT;`&[<6@!GK^$BZ_T/3BD%9B3H8X^7W0?KZDSZU0AQXW+\7#9#Q"S_>7XIDR M'J''_$OQ:!F/T-/^I7BJ*[3.FY*+:AY[,TMJ$C]+25^ADZ M0M]C+,4'&`-J=$1\3H%'Z%N)I?@X`H^L:-2KP5''="0>/$+O:]#Y#$UR0KY. M!]O0JQI+\7H`CH#>V%B*MP3P"+VX0=X9ZJ>(EO1EU$`+;T(>&+J0JF@I/M?! M)G6T%!_MX($F(I<-'>C$93QT8!4M5X,'XF@I/FO"/I)H21^/#7`ZCW2P118M MQ5=-V"2/EKD\,#Y?P?2G.-[6C]MV?7C:%H7``!'>P``&0```'AL+W=O.Q]^W:K^#2N_'$N^DRO:I:.[7VMHZ>\ZS(M.V*I+H MDI0X^?:+G@;8#?Q'%.GX)8I_`Z![T.AN8&Y\_\\_'^[/_M@^/=_M'C^<3]Y= MGI]M'V]WG^X>OWPX_[]_Y?]8GY\]O]P\?KJYWSUN/YS_M7T^_^?'__ZO]]]W M3[\]?]UN7\[(PN/SA_.O+R_?KBXNGF^_;A]NGM_MOFT?ZGFYO'BXN7L\]Q:NGHZQL?O\^>YVF^YN?W_8/KYX(T_; M^YL7ZO_SU[MOSV+MX?88_!J/G9P^W5]67 MQ]W3S:_W=-Y_3N8WMV)[^`>8?[B[?=H][SZ_O"-S%[ZC>,Z;B\T%6?KX_M,= MG8%S^]G3]O.'\U\F5_UZ=G[Q\?W@H'_?;;\_1_]_]OQU][UXNOO4WCUNR=LT M3FX$?MWM?G.BU2>'2/D"M/-A!/[GZ>S3]O/-[_%>T!FY M$[OZ]%>Z?;XECY*9=].%LW2[NZ<.T'_/'NY<:)!';OX<_GZ_^_3R]G]W^_ORR>_B/%YJP*6]DRD;H+QN9+4\V,F,C]%>, MS-[-IXO5>NC*@>;GK$E_67/U;KI>3!9+=PX'%.GH3^>5;>DO6 MH[^LMPBG>Z"]%>O1WQ-/D:;KT%/Z>]HI;EB1_IYTBA.*1!\8+B3]H!]WDI-] M2-'_G'B:$XDD]S^GG>A$XL?]SVFG*O$S"0%T\%0O_!P:IF1Z\W+S\?W3[OL9 MK7-TPL_?;MRJ.;ERQF0R^I#83\_79B=-2V?E%V?FPSD--4V\9UI2_O@XG:_> M7_Q!R\`MRURCS$1+)"+AYKPSFUJ069!;4%A06E!94%O06-!:T%G01^""7+OW M+P7%S_"O,^/\*YZY%A`YW#A3)$0EM2"S(+>@L*"TH+*@MJ"QH+6@LZ"/@'(F M39.?X4QGYL,Y_3<*UK7VWK67<0O#7FBI19*]R-[#0#(@.9`"2`FD`E(#:8"T M0#H@?4R4LVDQ^!G.=F9H<:$AW3L2EP86.N3MOVT`R(#F0`D@)I`)2`VF` MM$`Z('U,E+=I/U?>'D^&9+EUTH-3Q1G7GJSI3^3FC8G8O9"HI4`R(#F0`D@) MI`)2`VF`M$`Z('U,E`\IMSG!ATY:^Y")3Q3=_I,`28%D0'(@!9`22`6D!M(` M:8%T0/J8*(=14G>"PYRT=A@3LA^";G%I@FXOM`\Z(!F0'$@!I`12`:F!-$!: M(!V0/B;*AZXJC1.HPQ/726L?>C);[K?V!$@*)`.2`RF`E$`J(#60!D@+I`/2 MQT0YC-+Z$QSFI+7#F-"?$'23N0DZ+S0/"5/JR8I*@Z"V,`EHMA>26,V!%$!* M(!60&D@#I`72`>D]F6]UZ1R=..^Q(@,XH M8^<\WEG1_AX,$PJ^3!@MACJ?,W6ON)KXY/]R,M,CDK$.">Q]*V8"*AA%`U<& MQ:&LN)Q,M>4J"(CE&BTW:+D-BFS9A$,7!,1RKRSK`7`E0+P2V`'XU^[;:P-` M1?]^!)P9,P(>+50.M3!N2%RN2HJ1ZU)&J^%BSC!.&:)<%(>8&J0*06',2U2L M$-6B&&PU@H*M%A4[1+THCL2Z*Q!B5X_$=.Q27T]0#BK#>.WR4>_N">&$6J5RDU/XY,4E;(5*A$Z6@@YVH1$IW M8J%G3RU2!SO1B%3H1"OH8"FB_0<"E2P7`EB`VO M3)34YT/69R:2*K%X'!LG:]JU-.<+T3-VN61V:"F4M" MB;OBY%P?PBH5--]/UDR0CZ')8F[YF[CWB,5]XS" M)IVSXC)$9(&V2I$*$5D)"K9J0<%6@[9:D0JV.D'!5B]H))[)$Z>XU(D;EWID MXMD$8C+Q4BJ>&878R$2*/!LM2V9VYB)%^D$*=P=HL13%T&(ER$?C?'UI.EZ+ M0!SG8+D5J6"Y$^0M3VERZOVE%X&1.'\L%:_O'JDX M9Z0R@J4I9G-ND4+_X*!`BZ4HA@BN!/F%?VXSYEJ.AQ-N&$5;52M2P7`GB`W/ MS,3OY?C(/'%56SPD-H<]KHCPM1_M["'?\LA,'[,F)E1CP';@T3*$7,922YA7(N58+@1%&\&T.,N&(ZB9FGZW8NM MUR:\WJ%=(0@C1;]2.#,0M\31"FC^6I_AAFBG)%R#9@O4;%"5"M;VA>NK#MA'CIQL[1Y MI*]*+LW5B\0]SN04@V=21M$MCPQ1SDBY`6R5J%@AJI4M[097Y)S@!B=NW."1 MSFR7-D=RI3@ITKR6.$T%T52,)IS)!S*1FOMD=SY9F-F5BX1_5,[=MBP$A=9* M00=;JT2*6[O<3$P!5(O$T)IVI2MZ3G"E$S>N]$B7A/<"6C$&29 M2/E,:[:9F3TW9X%9O`*!Y5+,!,N5($X8%QM3Q=3*LG:1*PU.<)&O)-3FYY&) M-M.#9.JE5+0Q"H5*)E(RV/0$I<[L"V/1T"L6M2(S$D$QVL&/?YM%ZO5"M3T">L M&$<8HUFX%I4QFE_R"F]+PEQTHI4*+9+A)QG/D.1*V5(A5,5X(X@C>3I3%=B\1( MC/V4A'R&"3DC$V/FZD3"4BK&O"T58QZMU(JX@GG*BK2ZA.D&5YRQQ9)1U&+% MR+1HLL-:%%]K43F3^0IDZED(N5OP,W6"WL3 M*!?3<<3Z/D4=*,7.P=8JD>+6%AM[H:Y6K6G7NLPZWG-_<+IS@AY6]>N91RYM M#)Y:V?18I**]6%#8,3-&J[#$Y8QH"Y!-O!#%8*L4%&Q5:*M6MK1[7/8>N^?P M10NJ;&QJRTCOMRL3,`E+16.?"J*I&?P'SQNPE-DHS2*6BRT:DLB6V?0+D0J# M6`HZV(EJO!,F[:K%UFN=T(YW&?D)CO<)?)P+SCPRJZ@YYX2EU"KJ%2E/EHLDSZK=:U"YU"?P)+O7YOG*I1SJ6 MU[`Q>2D5RXS"SIO-/-*!NX:-B15?BQG_T!+;BEHL!846J]$6,:?JU%[>+1`NEON=A71O%ZX18*=^U+ MI0#V.;!$I,*"F#)R:4MP,>Q]++56,;4V*WPNMI04Y+;8B5(4#W:B&NW$QFP- MM=AZK1-Z;%SIYJ]=Q70&I`/%(Q#RAE1;J<'F+>2]%J+2@7J2B#%11' M,YL/MBJ6BFS5HHA%UMQ5)K$O#B=@@[B9Y[ZVT4&XL:LK*T9K72J(-H1#0H6T7UVY$B\E;ZS)OKI1:P8CE1AL3,Z8T.W2(>S#_?X4488H1U0@*A%5B&I$ M#:(648>H5TB[U%4=)[C4%RG*I8SBD`24TCLB@TN#5(8H1U0@*A%5B&I$#:(6 M48>H5TC[SY4JL?_<5/^A1WGH!2M8:QGI:+67<$0QCM:]HF1-&4KEB`I$):(* M48VH0=0BZA#U"BEOT^M?VMN'%X!!7&]?@D(<)HA21!FB'%&!J$14(:H1-8A: M1!VB7B'MO['B:[9V'[WA+\`<_>39`JLN03I<3;68!"F)S111ABA'5"`J$56( M:D0-HA91AZA72+O;U2#QXO!&N/J2)5Y,=+B:B\<)O5AA(>UN5Y*<$*Z^@E$N912VHF0!*$64(H5TOYS-<()_O,EA?(?(QV2YL)2LMA+A1444(92.:("48FH0E0C:A"UB#I$ MO4+:I>2)4USJQ,V&SR@.24#I`E"&*$=4("H158AJ1`VB%E&'J%=(^\]63+82 M/>K6P0(+*4'A7E7"*'Y0EY$KL<-E%?@$0I"2>,X1%8A*1!6B&E&#J$74(>H9 M^4=$M:==@1-/_L'3?^?BB[LM8X.9$:7WP9_V*:Z$%2D-%'^FC.@;B_S=`7-I M*PL"HI,SHFQ<4"$HC'H9%-FRN0!7!0$Q4XN98+EA%#VTVXJB?T1F>CDQETZ[ M(""6>T9CX^-*(AB?Z,&LXZ[)T`LX,"B,@E,2EJ*R47J6,HH_C(`H%\7@F4)0 ML%6B8H6H%L5@JQ$4;+6HV"'J17&PI>*>7FC4?CVH5FI*[CSB[-C8Q$ MI,)5U50096C1;##E<<92ZG[O#-[@$UMJI8*;-2(5.E$*.MB)2J1\+"\F]DV\ M6@3"38U&4&BL%72PL8ZES!F;>=F+K=?.6(_R6.%(GP%UA>,;`XYUXM(C=6,$ MGG)-1"K5DM3:7(GME6@^)+2Z'*T]'#0G6F>[M8MIKS!PT=R,2D0H1F0H*M]DR M1B;\S(GEHOA:^/E[*2(56BP%A1:KT.+PTHY]&K@6E7AR\0D'PZU(!<.=(#]M M)XNI695Z$<#[ATM7-\;[S1O3Q(F;==$C,TW,\I8,[=#(A4!+!85`RQC1-'$> M6L[,R.9\7$T0;CX8+M%PI0W/[$WP&@TW8B48;@6%'G?:\-SVN%>&]<0XK8RE M][S!\QZ9V6`O9+%B?&=14`BAC!'-!N=Y^!A-+BHA-@M!(39+0<%PI0W3EYSU MFQ2UJ`3#C:!@N!44#'?:\&8%&P=[9R3F:3*?$O-.W,2\1R;F[349>@]_6*U" M!*6"0@1EC#CFZ8/5VD$Y'U\JU]/6&VXW`V!<.W>N,<=P%YZ$*F@F`H*$90QTCN`?:\K%T7R>92^ MF18+D0HMEH)"B]58BU.;!M2B&$\)/NU@OA6I8+X[RGPOBB,3XZ>4X>[;!G:^ M>*3F"[RED+"BVB.\(CT=)Q5*QE+J";Z9+;IREGKC;CRV6(IB:+$*+;JU<6+? M9JE%)12R#1IN12H8[K3AF7T+I1<5?`ME^=/+^,&B6>5\&>^>S=I'_@8V=B^D MMA?6H]QEKT??O]'K6L8-KI44?.."I5P"']F"V0>=*%G1/3D5*9I.5"+E+SB, M?.,BM"\!V`B*Y^(Q9]SIQL:^<2&F1Z;FS[DNL,3K`H*B>S>(4D09HAQ1@:A$ M5"&J$36(6D0=HEXAM2.YSYZ>L",-XGJ6,%K3"KT/-/K!#1WM29"2.$H198AR M1`6B$E&%J$;4(&H1=8AZA;1+;1%^N*2@[Y[:[4)0%)*(4D09HAQ1@:A$5"&J M$36(6D0=HEXA[3]7\\5)TE`Q_\AG5U;.DHE61CI:36J8B&*X&Y$BRA#EB`I$ M):(*48VH0=0BZA#U"FEOGU8`TX51<"FC.%H!I:(8I#)$.:("48FH0E0C:A"U MB#I$O4+:?Z>5L73;!?SGT9I2O6@!-:5_PHHD%1;0O:*@#*5R1`6B$E&%J$;4 M(&H1=8AZA;1+77D7+P!O+*"^&HQOT+I/6]/$IS?*Q#,)HA11ABA'5"`J$56( M:D0-HA91AZA72/O/%4LG^,_75LI_C"A;VH?D%&Y@T8=TG)?CVR>,:+D1QV>( M$&TBD6G;W+G3*3XJN/, M/M.>BP!FLZYXP]-T"\#1WV,?3)CSY2J`AF7?[9FM.Q)6C*M,1G&5RU;]]1,^ZI;^8$*?+R-U+6%F;X$E(A5M%XSB46:D1]E>/<]%\:A1IJ]] MC9UT^+*&#/3QH3Z8-$[P2;,>]*FY\YRP8CSHC`Z7Q1E+46WNKGA,[2MIN1@> M&?.QY#7^L(B<_N$]S5T5,)FKH)!`)8A21!FB'%&!J$14(:H1-8A:1!VB7B&U MI]$C$3JLWO`?)Z!A'[H>+-`OI:DTRW[3,PE2LH&EB#)$.:("48FH0E0C:A"U MB#I$[O^B4CT[HC-? M7[FW$L:.4#O^F1UK;4'M^(>"X`BU0X\QCUA;D-_H`=VQ(^0W>I9TY`AU;;1G M4VK?/YECVY]2^[3DCMB:4OM^F;4Z<_(TO2HTHC-?T9%A?S(ZZ6IYY=)&U*$? MH/UE]"RI8^/]HFZ-V+DFIXSYY)?YU2_C048Q-AYBY-VQ!NBLQT[@FLYY])07 MJROW(!N>,CT3=N4>^\(C]$S7E7ML"X_0,UED;>P(/=]$UL;"FYY6(FMC1^C9 M([(V=H2^\'GEON&)/:`/=%ZY3W#B$?K6)>F,^9*^7$DZ8T?HPY"D,^9G^LPC MZ8P=2:G3HWV>7%ZYGQS"GM'O"5VYGPS"(_1[0%?N)W_P"/V0#ED;"SWZ61RR M-G:$?N2&K`U'+O:13S]C_.WFR[:[>?IR]_A\=K_]3$OQY9`U/?D?0O;_>.&? M"OIU]T(_8$Q)$?TP*_U@]98^[GCI/DS\>;=[D7]0=R_V/X']\?\%````__\# M`%!+`P04``8`"````"$`OPZUW%X*``#C,@``&0```'AL+W=O/G\UR2:+Q;4M9V[&XX]5=%7Q\+-;U/6OWW?;P;?F<-RT^YMA M<3$>#IK]NGW8[)]NAO_^P_PR&PZ.I]7^8;5M]\W-\$=S'/YZ^]>_7+^VAR_' MYZ8Y#=##_G@S?#Z=7N:CT7']W.Q6QXOVI=FCY;$][%8G_'IX&AU?#LWJH7/: M;4?E>#P=[5:;_=#V,#]\I(_V\7&S;E2[_KIK]B?;R:'9KDZ(__B\>3GZWG;K MCW2W6QV^?'WY9=WN7M#%_6:[.?WH.AT.=NOY;T_[]K"ZWR+O[T6]6ON^NU]$ M][O-^M`>V\?3!;H;V4!ESE>CJQ%ZNKU^V"`#*OO@T#S>#.^*N9E,AZ/;ZZY` M_]DTK\?H_X/C<_OZM\/FX??-OD&U,4XT`O=M^X5,?WL@!.>1\#;="/SS,'AH M'E=?MZ=_M:]_;S9/SR<,]P0946+SAQ^J.:Y1471S44ZHIW6[10#X=[#;T-1` M15;?NY^OFX?3\\VPK"\NB_%5=8E>[IOCR6RHR^%@_?5X:G?_M4:%Z\IV4KI. M\--U4DTO)I?CJL#??,NQ3]_QJYT??GJ_B]ED4D]G%/4;D:*U M2Q<_G2,5ZPV'J7/`3^^`I2,=1K:NW3"IU6EU>WUH7P>8^ZC<\65%*ZF8HQ,_ M/K:'?L3^;,`P4M3)'?5R,\1?QE@<,!>5`IT"$P&6`V;=3\B! M>KD9XM]H:&H>],+:%"AF;S3E)LO>I$],$"V(B0G+#2OC)^1&O6#BHH!]W'+> M.:.WDNM-^N0$T8*8F+#DL&3CY/)[G5\Z9-SEX/_VPI&J6T?I.+C&RS])F<6! M]?SQ.,B8Q^&(W4MI/2X%48)H04Q,6'Q(XN/QD3&/SY(9NH]&?Y+,V][(EU<) MH@4Q,6$AT[DDVB[?'EHRYB$[$I54$"6(%L3$A,5WQ>/KMO.ZTU8G"A_>TJDG M'KPCO-[I_.R-^GH+H@4Q,6'Y%#AQ?+S@G34/VJ.HY!(IB;1$AB$>)NE0-"^Z MNA^M0O$% MTH5`AB&>%>E+E-4[Q7=J%$<>"U1WH%H6`BF)M$2&(1XF*5(4YO\S]9VXQ3DX MQ*M_E5:_MPK5%TC34=HN(V]E&.)IX2_&:;U3?;).-AZ'PCQ?T@(FJX"41%HB MPQ`/DY0JJ7XU^]34MYJ'5>:KLR@<0MA!8:MQ6OS>RCNJX.B1EL@PQ+,B?8NR M>J?X3@WCR!WJGFS=U!=(%0)IB0Q#/$R2K8^'Z40N#M,B?H2IQ&-1;^6KJ0J! MM$2&(19Y>9:L=M9\=GL4IO)2(B61EL@PQ,/,R>KGCC.EE%6/^/06#W2]^/;5 M#XX>:8D,0SRMLV2UE++J432])5(2:8D,0SQ,4JMH>M/./D$USCS0E$[THGGO M$:]\\L)@&:Q\F95$6B+#$$_I+$TMI:9Z%%?>606DI)66R##$PR2E2BI?3%#' MO!!8TM&)2Z622$MD&.(YD?A%.;V]IY=DG6PY#H4Z+[U5 M0$HB+9%AB(>9$=1I]9F#?"D%U2,^[]-'UF`5YKW06"VM#$,\*U*ZCQ??Z6(\ M;1R*]WN!5"F0EL@PQ,,D68O"I!VGG%Q@,IX[\:T^QH>9TDDF*AD=9M+'UV`5 M:M\[>J2EE6&()56=I;6=-9_X'D6UETA)I"4R#/$P$ZU]>WU64DX=FJ%<48'3 MI]1@Y:NI)-(2&89XY&?):27EU*.XP,XJ("6MM$2&(1YF1DX_M[-44E$=FO'9 MG3ZE!JM0?-L7'#W2TLHPQ+,Z2U$KJ:@>A4HO)5(2:8D,0SQ,$K1D9RD^]X*F MBX5]*I"32$AF&>)@D7VGU MQUAB9V[KE9/!N/06\=+7Z3.J9.GU^#59AWKN^PL%-2RO#$,NJ/DM3 M.VNNJ1Y%NXY$2B(MD6&(AYEH*A7_B M_+1$QB&\_4`5>.1G:6HM-=4C%GDM(G>.<>06L<@%,J[[7.2)S+Y3JNYZQLV/<2(2QEMT]U#X@)PEL[64 M68?PV.G22I_YO$$XABF/PO!HCZYL#I>9'.S?QC%?3*I$@]\9&JFTM45A:)(* M+[U!/#3.I^I7NO96=AQP'4N.@W/*C,-9FEM+S74HC$/Z>.(-XG&PW>"IU>]6 MVEO9<9A6N`_$7XH;9Y$;!Y*^2)#?&06Y/2\67]9M`2RMX;H6H.]--1UPF79(7H]$Y9R MG11WZ:VB07(()X9^D!R".MLU)_/S3G*QT&O.>)"Z_'!G#&%1>G^T+UUZ9^0J M];O[&_B@$M.KSQ7;$I](2V>%M[0^,>40*5_O*/<[;V6OD92SS"3U?6?&-Y'X M='Q]`=Z>O!,I_1Y%YRZ)E$1:(L,0VZ_I56DZ?)\[=W4])7/4G13B.5K5Z/'3DTVP"HO&]17&0TLKPQ#/BH0URNJ=F4_6R;1Q*`2PQ,7;]"V[ M1%HBNK$;'&V8]@:NO=JY:PY/S;+9;H^#=?N5;M=BI[N][K&]^KN85+C[VRF" M:*G14M..(UHF:.GV"]$R]3>)TY9J-J<'U$QOU15:NBT[]:G'RI M.HVMND1+IV1I2PD?*&&FMQ(^>-F?:T&M[4E%](9:XR5UQJ="K>U!)?6I4&N\ M=\WXE/"QY__4IX0/SB8Y']3:ZICP0:WQH5W.![7&YV2Y%M0:GS9E6@KXX+Y* MK@4^N/*1:T&M<P-CZQS>D;-M=1HR5437QVXRZX<"BS3TX*& M/\=IH67X73V_PT8G0UI@?',!+3"&67N,8#>`H[X>^(K!R^JI^\:721I MP``&0```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`CCJ6HY(F:#D%@V>,Y.5G_H%J^/N]DY.UG]P1TU M.R[\Y^Q9]0>7G6[R13]A=///]O[U_N/[Y_V?9S2I4^TO/^[5(V)VJ^1XYND[ M^S`7_6PJHCE(J?RB9#Z<4U?2+/-"\^]`V=V@S,RTV;*$F M."6[M8%C`]<&G@U\&P0V"&T0V2"V06*#U`:9#7(;%#8H;5#9H+9!8X-V`"[( MQ0<_DVO_/_RL9)2?V4-W#,3Q<\NI;,%%MC9P;.#:P+.!;X/`!J$-(AO$-DAL MD-H@LT%N@\(&I0TJ&]0V:&S0#H#A5)J>P:D+FHK&EPT\5E6I;JDP&*M7IM/N M>AOU`#H862:;@\G!L4`<("X0#X@/)``2`HF`Q$`2("F0#$@.I`!2`JF`U$`: M(.V0&+ZF!ROX6CUD3YRHE0S-]111!\?B3*V-IKQ_,#EX'X@#Q`7B`?&!!$!" M(!&0&$@")`62`+HS-UW-:#!8$6T1 M.8A<1!XB'U&`*$04(8H1)8A21!FB'%&!J$14(:H1-8A:`YE^59OS8;)E>@I6 MNR]K"&MT3;$C0WAU:0UAL3H,840.(A>1A\A'%"`*$46(8D0)HA11ABA'5"`J M$56(:D0-HM9`IJO5EOT$5_<[?-J6L8A\1`&B M$%&$*$:4($H198AR1`6B$E&%J$;4(&H-9/I5[<^'?E6+YL6U.I4Y=2>NLNSV M\.Z1N6Y>09;T8,61L=5:5)"1@\A%Y"'R$06(0D01HAA1@BA%E"'*$16(2D05 MHAI1@Z@UD!D&:J,^#(,W9G*]KQ\.[^%6OTMV;]39B0H(>6AO$3F(7$0>(A]1 M@"A$%"&*$26(4D09HAQ1@:A$5"&J$36(6@.9?E4)D!/\JO,E0[_VR!K"=DY< M)>[4Y"[C=8O(0>0B\A#YB`)$(:((48PH090BRA#EB`I$):(*48VH0=0:R'2U MRHN+J\.DNU$GE^37`=HB\]G27GOW5DM5V^$H=+4PK;9:BZQ8WD'D(O(0 M^8@"1*%&ZRY8S0Y3"0>[P^9KZ;!Z_Z/KL!-Z3^@Z0JZWH6)ZM/"FH3J>7L_G:JMP7"RX4(`HU&NM(M:.W M.W)Q@QTY$GFT?CR$GDX,##NO1_/A@6RUC"RYS/+/QY;22-\1I.-"-AJV;E^?CFWE$,VZ,:, M$<'J[0OH^!6]IT--G>[KKB0%M[3V3J,YS>2#SI`SD'ZMQE:#!S@CBL9#0>QK M;;4F7QVL%BLK->YJ*W66>[#"ON8:I1$^H\E&!..-L#O\K4:8/C@MMZ%"64VF MPX[72):_&[82M$7D('(1>8A\1`&B$%&$*$:4($H198AR1`6B$E&%J$;4(&H- M9/KUM$2&>H7(]JM.9!BSRY6=L](%ARMB1`XB%Y&'R$<4(`H118AB1`FB%%&& M*$=4("H158AJ1`VBUD"FJU5>8?C\>F/N[-,0QA#62,;K9@YHB\A!Y"+R$/F( M`D0AH@A1C"A!E"+*$.6("D0EH@I1C:A!U!K(].MIR8HY)BL8F4='5W9B:F!V M6(&,,&>$N2/,&V'^"`M&6#C"HA$6C[!DA*4C+!MA^0@K1E@YPJH15H^P9H2U M)C/]3\N@4\:U,K<>S1H-QS6@K&H?"O(< MX*"5B\A#Y",*$(6((D0QH@11BBA#E",J$)6(*D0UH@91:R`S"E3"81@%;SRU M^_R$\=362,;M9@YHB\A!Y"+R$/F(`D0AH@A1C"A!E"+*$.6("D0EH@I1C:A! MU!K(]*O*:@S]^L]'=Y\?,5S>(VMT6UFJS?Q@Q4-YB\A!Y"+R$/F(`D0AH@A1 MC"A!E"+*$.6("D0EH@I1C:A!U!K(C`*5TQE&P1NCNT\!&:[6:#BZ`6WG@!Q$ M+B(/D8\H0!0BBA#%B!)$*:(,48ZH0%0BJA#5B!I$K8$,OZK,S@E^[1A\A'%"`*$46(8D0)HA11ABA'5"`J$56(:D0-HM9` MIJM/RXPM,#.FT6"5M4&T1>0@L-AJ9ITI7U@'`5JQXL#N(7$0>(A]1@"C4 MB#+%7&.D$1V3$#([S,XO=2N:_^J@:8$Y*$;T0!NDSF%>[`O>_/R@2>N0!=^: M@\C5:-`!GEC][*!)+%@Z0!2B=*31@M9EAWM;7,E!C=G==MK'CD\^UYM>4BPP M':31BD)WT`S[B$1;+>5T8HO(0>1J9/1IWXB!EH\%`T0A:D4:J3<#!JV7$QBS M$U5.8[C^ZF+VJGO?ZXU^T]F0P0G'HDC);:21OB,)AL1C#5B;CT5`I#[6O/G3I8FWG-]AJ&,.ZH,S.CK:B,ST>SZY&M"I@Y*&6STBT M`M0*42OB@K1-'[1>]F]F9ZG-_#^+89T&D"BX6_3(C&'[*'W#5E)PRV@R?!RV MZD^!KV^NK8G;90.)'(^15.8SFJPLT%;&@!F)57W'4F.D"QX9JVH7/>S^-V*U MWW0/MW!JOC<3JQM$6T0.(A>1A\A'%"`*$46(8D0)HA11ABA'5"`J$56(:D0- MHM9`YK!26^:A7[M'0_>9S!,_/[?0FV\)X#M&YO1D+?@V8L6SS!:1@\A%Y"'R M$06(0D01HAA1@BA%E"'*$16(2D05HAI1@Z@UD!$%R],V\IVYN9%G)`O-#:(M M(@>1B\A#Y",*$(6((D0QH@11BBA#E",J$)6(*D0UH@91:R#3KZ?MVI>X:V=D M#F%9K/0A\A$%B$)$$:(848(H190ARA$5 MB$I$%:(:48.H-9#I5UK]P0-ZMI+W,8]Z$WBI5*P96R-9$6ZTU7IYB("M1M<_ M33$X8L%AXR+R$/F(`D0AH@A1C"A!E&HTV)-G&O6)GFXRRZ7@3U(?A5CP+9>( M*D0UH@91J]'(R[G+L6S(3[[MH'O1F;,CQ[_UW%5A18I.GDPGHW1!(WCZ@M?T MSV"#9Z58'%V0K+@W78T&CO*X7;++]*7@4%YR()T[`[%B^1#E(Y2/I>!0WDIT M)&+%\BG*9RB?2\&AO-4YA5BQ?(GR%C"GI%+":GH:1MCBVDKZ;-A*0F"KT2"EYB!R-3+"2=!VT?"P8(`I1*]+(\'HO/VA7@EHI M:F6HE6/!`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`SP M7HIF&A[S#EO1T)>$B9V><-E*QH/'2,:#STCD`T:3\B%;B7S$2.1C1B*?,)J4 M3]E*Y#-&(I\S$OF"T:1\R58B7S$2^9J1R#>,UCH-M;0VEBT;=,IF#*D\K#UU M#`\=CTKPKOIL[O#T2:,WEAM].?J`*\?15I<;)G@UFLYCNEQ01I/';1!YGZUD M^QF(O,K`KBZM%RA#+B+"$0K';"7"B0A/#(F4"XI\AO(Y6XE\<91\R05%OD+Y MFJU$OM%()Z9G\[EU6L0YMPF>[M_'BAK70GCNRPH*X*ZZJ/JJMA*WUG-U?6BD7]-J>*(?JN M#`J%/E[[W]KL?^ON:??\9;?9??OVE2NE#FAJYT@\Z^LJ1Z:.R-J"VI'GI1<>3*[.I6?>GE MR)4YE:&G_-B5.5WI1H?=@OF"KG0/'KBRI"O=\P>NK.A*U\'VE1G=#WWK_4@+ M9M2V_OM@H`RUK7^FP!5J&WWS\I@:M8V^NW?L"K6-/M"%5^B'6W\9[0'5L!'[ M.]5E8YP:-=:F7Y:WOU#P8<5WU-;1II(?1]VXOJ6?;AG1H?@:#2^*KK%ZZ;V> M6_4B#RK16SJWZK4F<$K]#[,K7H!!J_0.R;4@K%[ MI#=&J`5C5V*ZHE[X0#5ZFX-:,':%WLV@%HQ=V2R6M^J#A:CFT17U,4&\0J]K M4@O&7$QO-5(]8U>V2ZJ'7OI"-7K!CNYT[`J]&T?UC%VAU]KH3L>NT!MIU(*Q M*W=+BE=Z!&$+-K/UK?H>V+$KU[=._^Z--?3H.U*IS%BTT0>0J=]&ZUDLJ*_' M>H<^"$MEQJ[&ULK-U; M<]LXL@?P]U-UOH/+[QM;EFS9JB1;8_%^OY]GCZ,DKHGCE.W9V?WVIR&B"0+_ MCF)-[+=^>G)[OO]T^?'KY_ M^7#:=\$_KD]/7E[OOG^Z^_;T???A]#^[E]-_?OS?_WG_U]/S'R]?=[O7$\KP M_>7#Z=?7UQ^;L[.7^Z^[Q[N7=T\_=M^IY//3\^/=*_WO\Y>SEQ_/N[M/^TJ/ MW\XNSL^OSA[O'KZ?CADVSV_)\?3Y\\/]SGNZ__-Q]_UU3/*\^W;W2NO_\O7A MQPMG>[Q_2[K'N^<__OSQC_NGQQ^4XO>';P^O_]DG/3UYO-_$7[X_/=_]_HVV M^]^+U=T]Y][_#Z1_?+A_?GIY^OSZCM*=C2N*VWQS=G-&F3Z^__1`6Z`^]I/G MW>%3]O!]1Y\VM9-J@=^? MGOY0H?$G153Y#&H'^Q:HGD\^[3[?_?GMM7GZ*]H]?/GZ2LU]25ND-FSSZ3_> M[N6>/E%*\^[B4F6Z?_I&*T#_/7E\4%V#/I&[?^___>OAT^O7#Z?+Y;O+]?ER M0>$GO^]>7H,'E?+TY/[/E]>GQ_\;@Q8ZU9CD0B>A?SG)E4ERH.)25Z1_A8IO M7/I*)Z%_=9*W+9RV;[_I]*^NM[AY=W%]N;B\4MM^8+6O=,WU5'.Y>'=]>;FZ MNEX?KDF[W7Z9]*]>)N4XL*0;'4__ZOB+U;O%ZOQ7:[B@CC2V*[6N>_BS5-U\W$;ZX]AMY"9G%^L_Q%ZR^X^=4?;]M&[@`+TP/>VHX7W`?4'WII;VO' M"QX5U!^Z)O6[-[7C!?<>]<>A;3P;1Z+]P.;=O=Y]?/_\]-<)'2UHF2\_[M2Q M9[%127A(&W>3:9#[V1A'@YO*\IM*\^&4/F@:OEYH8/[7Q^7UY?NS?]%@>J]C M;C%F84=L.4*-G"JMYX+O0N!"Z$+D0NQ"XD+J0N9"[D+A0NE"Y4+M0N-"ZT+G M0N_",(,S:N*IG:EI_QOMK-*H=N86NF4P#7_A-"I''#LXK>-S(WSJV6]?Y8?6WO[%M= M2`L7^X2U(O25[H@54='VBF@9SW'407\+XH'X(`%("!*!Q"`)2`J2@>0@!4@) M4H'4(`U("]*!]"##7*P&I"_61S2@BK8;4`OEGW66M=.CIB#N@!Z(#Q*`A"`1 M2`R2@*0@&4@.4H"4(!5(#=*`M"`=2`\RS,5J4_HB?D2;JFB[34>YMMO4'26F MH*E-07R0`"0$B4!BD`0D!D1;:JB M[3;5,AMH03P0'R0`"4$BD!@D`4E!,I`:;#(;E=U)GY$NXXG[G1RQ7OBK3K14DVM)E[-]Z6; ML$ZP4; M;+/;7YV-']'^^N1]WOY\/F^W/\R$FC!N:T_-\^NNP^8+%@@6"A8)%@N6")8* ME@F6"U8(5@I6"58+U@C6"M8)U@LVV&:WOSH?/Z+]5;AS"-?D[/_NI*DJ=MK: M$\P7+!`L%"P2+!8L$2P5+!,L%ZP0K!2L$JP6K!&L%:P3K!=LL,UN_^.F7=1% M,[?]-Y6 MW2>@&I':DH\4((5($5*,E""E2!E2CE0@E4@54HW4(+5('5*/-%ADM^MQ4V3J MYBBU=\YV8B;:;Z?Q^F+ACMKLGN9-RXSUL[]3]@:]?'^[_N'VB9J;^ M(TS"+NGZ]W@'F[KYS>U@FLXO]U?)5XNKI?,Y;'4MJW>-M5;F,.+KJ!D%3.;3 M"C%7Q%$F5XR4,)E<*>;*.$I]*M-->C?.1;W<1/$G7S"9]"6FKSC*K&J-U#"9 M7"WFZCCJX*KV)HI7=6#:I[<[B9H\FW]G<#M)]_3C9YV$;E">>HF>@YL/0R-= M4K.;S_7:Z=';"UW1W#KG:5J9XY*/%&BB@92W,L1<$5:,D1+,E6*N#"OF2`7F M*C%7A15KI`9SM9BKPXH]TF#ELKL`C3E6%Q#&@WE3JW#GB#.26H1IZK4S]&XO M=)3I(Q[3O.+%PCDD^#IJ/=Z4LU@[^V;`6B-RNQW^`+9_$#9]EOL-U3:8V.Z:DJW.FI(UW0R>K4 M4U?G[BRS^N4%5;PP(Y#'9,8I7Q/]L,;D@JX2Z*CE?)R"]!&FCYEN]@?9B_7Z MRMDO$DR=I"TQ='NE^,<^,$I/7->B3UE6OJ/,IE<$9/)%6.NA*-,KI3)Y,J83*X<Y-*]&;E=@?T)PO M"X,N'AO3[J:T<<=T4Q7N',]&/WZGT2IKT*>LSNW% M2&H1TY%L=>Y>EN,HLUMZ3.:8[&LZ/,`$.LH:TO1*F/01IH^9?GK(3S!URI5, MZHS)K'G.]-/4!:8NN9))73&9U+6FPQ]*@^E;SF72=TPF?<_TTS4?K-16[U'# MX!&]9Q]NCSI,YLK\%LE#\I$"I!`I0HJ1$J04*4/*D0JD$JE"JI$:I!:I0^J1 M!HOL=CUNYGB),\>:9K-V6R0/R4<*D$*D""E&2I!2I`PI1RJ02J0*J49JD%JD M#JE'&BRRVU5-G+Y]M%_JV=G9:,]$X^TTVN,5`1TU:WU/TR^N")BHZ52&RD+)I.^Q/051]GI MG6F2VD1Q^H;)I&\Q?<=1\_1X1[DDT,6/U)'>R]TU7!)8JBW-` MT#1=$;A8N]>;="VK=XVU9M/_OHZ:47C/2+*P)PNH"8HCSCBC/.9\^F3Y4C.>:DS]&YU MU,W^T43CDRTT+<[M;!]>BGL/EZP$<]3&'[C;<[KYIK/:+SCE.S5N?5L[7TCQG_89J7 MCF1J@+M931.X'I,9V7TF,XP'3.8,+V0RN2(FDRMF,KD2)I,K93*Y,B:3*V?\Z)N(:6J8YEV.49=F\L9CFG\[PVE>CAIOE+BX=*?4N-QL;,IG4%9-)73,=7/.&HTSZELFD[YA,^E[3 MS]=\X$K"@*=F3(_H/>,$J]5[-,VG[H"\)9"/%""%2!%2C)0@I4@94HY4()5( M%5*-U""U2!U2CS189!W(5C3@'-&N^W#[W(I)_T8]I?A3OM MKVFV7Z^`/"0?*4`*D2*D&"E!2I$RI!RI0"J1*J0:J4%JD3JD'FFPR&Y7=^I6 M3;@MK]53YS)=`'Z,"I!`I0HJ1$J04 M*4/*D0JD$JE"JI$:I!:I0^J1!HOL;J`F.M]^V%[IV53SI?E6T_RW&D@>DH\4 M((5($5*,E""E2!E2CE0@E4@54HW4(+5('5*/-%ADMZN:T#RB7B68SN,6V=)E#M?Z,/"0?*4`*D2*D&"E!2I$R MI!RI0"J1*J0:J4%JD3JD'FFPR&Y7.G@>TZXJW/GFI>F<3F6G;]YX=74UAEEM M/9+J=%/%U;ESGD7 MSLUON8GB]`6325]B^HJC[/3.O>*UB>+T#9-)WV+ZCJ.L].YGWYLH3C\P[=/; M74E-*,V'B+]U=94N;*.,KDRI$*)I.KQ%P51YE<-5+#9'*UF*O3-'U\ M\*NVWD3P9S58J>WNH*:V#G6'MUU'78TS9-:19"3K-G3\$8.N.)MG]3C7+RZN M36%T`CD-3#!W%TQAYGMJB`N-IK"#DZKQ%#;^RF=YM;YTQI)D"C$+3'&!V11V M<('Y%'9P*XLIS"RTQ(564]C!A=93V'RA2_=>V&8*.SR%C>O1334/KD<_A8V? MMO#KDF$*V6^XW;75]."\:Q_^)<5*SR::3_!6D[J#?^IA>/^ICII/8C.9'=YG MFN<2>NNX$C=FOC;4%2_-$!IINC*_UHF9YBT&Z1..,MN8:IJM?<9DUCYGFJ\] M#=WVTS4*CJ(CP?1YP677DJ/,5X6*R2RQUL03T-&.>:PL!1/]L8JZ]=4D<^HJ_MP^TO:$RSJ3$D#\E'"I!"I`@I1DJ04J0, M*4:;#(;M?CIC7I M]@EHUY&LI\.M%LY=$EM=[LPB/-YH6VET`> MDH\4((5($5*,E""E2!E2CE0@E4@54HW4(+5('5*/-%ADMZN:'7S[R?BEGDPT M)ZJW3#3'9,XN5POW*M041@?MZ21TM3#SU?9JN=-?O_C2A]-\&D](9[WZEHD&4].-+ISISZV)FHZA2#Y2@!0B14@Q4H*4(F5( M.5*!5")52#52@]0B=4@]TF"1W=3JI/.(IM;GJ+.Q]@I.6[=('I*/%""%2!%2 MC)0@I4@94HY4()5(%5*-U""U2!U2CS189+>K>R9KCAU'OO#W"D]RF>R]V[F2 MN3519N_6N6;?D#$J0`J1(J08*4%*D3*D'*E`*I$JI!JI06J1.J0>:;#([@7' MG>1>X4DNT_P`C2>Y&.4C!4@A4H04(R5(*5*&E",52"52A50C-4@M4H?4(PT6 MV>WJGN3^_;T;SW^OIM/8^;';N7ZS-5%F[YXJ,OD8%2"%2!%2C)0@I4@94HY4 M()5(%5*-U""U2!U2CS189/<"=:IZQ+%[/+.UOJ9IFN_=0-X5D(\4((5($5*, ME""E2!E2CE0@E4@54HW4(+5('5*/-%ADMZM[_OOW]VX\-;[21&TZ^V;N7-#< MFBC>E3TD'RE`"I$BI!@I04J1,J0CZ9I*9KNP<\O#UD2977C,1169?(P*D$*D""E&2I!2I`PI M1RJ02J0*J49JD%JD#JE'&BRRFGI]W/S8/MR>'V.:[<)('I*/%""%2!%2C)0@ MI4@94HY4()5(%5*-U""U2!U2CS189+?KD@^ M4H`4(D5(,5*"E")E2#E2@50B54@U4H/4(G5(/=)@D=W4Q\V/K7%^C&F^"\.4 MF8=1/E*`%")%2#%2@I0B94@Y4H%4(E5(-5*#U")U2#W28)'=KN[\V.&C\!HG MP9C42R1GAV'W.O$LS.S$.AM59?.%N$"P4+!(L%BP1+!4L$RP7+!"L%*P2K!: ML$:P5K!.L%ZPP3:[_8^;&5OCS!C3?+_&F3&,\I$"I!`I0HJ1$J04*4/*D0JD M$JE"JI$:I!:I0^J1!HOL=OVOS8RIEPHYMPLP.;N\>Q%U%L:[MR>8+U@@6"A8 M)%@L6")8*E@F6"Y8(5@I6"58+5@C6"M8)U@OV&";W374--;;I\O6>M9K=JF+ M:39N;P7S!/,%"P0+!8L$BP5+!$L%RP3+!2L$*P6K!*L%:P1K!>L$ZP4;;+,; MVYU#^\7Q'2?*Z*GQXQT3]O'=W!RR?[S?=A9F=G93E_:WY\;5@^S=X[LFY_AN M[G[2N[P)X]W;XVRS0X,O6"!8*%@D6"Q8(E@J6"98+E@A6"E8)5@M6"-8*U@G M6"_88-O8-ONYVK][=Z]W']X^[YR^[[>[;MY>3^Z<_O].)V8)^53KSD^?= MYP^GM^N;CQOQH.2%97L3]F@Y))*]K\:@Y(K*MG?[@`E:RK9 M_QX-2JZI9/_+:+?DBNK0%0-AK:^H#LTY2R6TI31%*92LSVDY^]\%NLM9+ZAD M/_!!R065[+\2N2575(?N,Q*6R5$)K0/>U"B57]%G3 M#7="R8K6C1ZT(Y70NM&C6J026K?Q\0EN*ZQHW>C9$$*=2UH#^O&:5$(M1[]U M$DHNJ,[X]&EW.4LJH1_2^54$^D)\8))2O*1@\3DTHH&SV-2BA9 MT&K+%13U+`$GJ^QD8]4`%+Z#$;&_40#:ED3252'7K"!FV*5$)/--FHQTY@ M-GIDR48]?0)+Z,DE&_40"BRA!YALU(,GL(2>4+)1SY_`$GI0R48]A@)+;JGD M5BS94HEZ7`?6\:A$/=Y%*EE3B52'GOVR4<_LP#KT")B->G0'EM`+)S;J?0)8 M0N^=V*C7"F`)O7YBT].;)*22)95(=>C-$]1KI1)Z@O_&I^?-8S9Z'O]&/8`? M2^CI^AOU.'TLH6?E;]3#\;&$GGQ/ZR:5T/M!-NI=#UB'7A-"RY&VE%X$0252 M'7I#R$:][0&ST8M"-NJE#UA"[PNAM99*ME2R%4OH!2STN4EU`BI1K\;`Y="+ M5C;J#1E80N];H<]:*J$7JFS4RS&P#KV^?*/>3HTE]!;SC7I)-9;0R\PWZE7E M4@GU*K$.O<><1D(I&[T/>J->`(W9Z.W.&_4Z9RRA=S5OU,N9L83>O+Q1KUK& M$GJ/,JV;5$)OF]^H-X=C'7KI/"U'VE)ZK3B52'7H??,;]>YPS$:OG=^H5XAC M";U]GM9:*ME2B7K;.M;QJ$2]81U+`BI1+UK'DI!*U/O6L22B$O6.=2Q)J$2] M:IU*SJ9CZ\O']S_NONSRN^CX/Z_Z[>*_ M/[V^/CW2Z7/3T^O_#]J`7\]/?^Q/W_Y^/\"````__\# M`%!+`P04``8`"````"$`J5F!_8@&``!@&@``&0```'AL+W=O>LBJ8MZ\O&]2=3URDN M>;TO+\>-^_R M^\&,NDZ5K[X<+W63/9Z!]W=_EN72-OMBF:_*O*G;^M!-P)S'';4Y1U[D@:7M M>E\"`PR[TQ2'C?O@KRB9N]YVS0+T3UF\MLK_3GNJ7W]KROW7\E)`M"%/F('' MNGY"T2][A$#9L[0IR\"?C;,O#MGSN?NK?OV]*(^G#M(=`B,DMMK_2(HVAXB" MF0D)T5)>G\$!^.M4)6X-B$CVG7V^EOON!/\M)^%B&O@@[CP6;4=+-.DZ^7/; MU=6_0DB8XD:(,`*?PD@P'XS<4`R$(GP*13*;S$BX6++E;VC.A"9\"LUP0I:A M'\[1[QN*\)01AD^YI#]9^-,H6-Q6G`M%^!2*L+:]D,<#S/*59%VV73?UJP.' M`$+87C,\4OX*;,A$<0M]ZM[*'*0,C3R@E8T+IQ>2TL)V>]D2WU][+[!%'11F'.3:.X$$[!P% M1A[$P\4;E#4_X#S?[P<*ZWX(Q.^W?VPAB86D%D)51/,/2*C^8>TAX008OK/Z MH!W==8'`RLK&,$/9"\G()Q:26@A5$8T-SBY*);V==1367>9(P)HRJWZQA206 MDEH(51'-O^@]_J&P[I]`X$,)Z]JB0P[N[WP.Z6DE MT]X+7ARDE)I6H:BF54`\K4$0!I'1^ZDP-)97;'`W&-Z75]$E58(2IT(.2PK_0$8BN]0>_.!*(5XUQRR$B@$?<87X=P M=ZL)%)":0`')!"[GD55AN,A8`K'SWF!X7P)%^Q[RL/,Y9"30B'PLI0;%1$!: M`KFM@+#"XT\M=F*MD?QA)S;9P0N>J#HR?>\H0:*U#P[O?`X9J32[GI124\D5 M`]B>2BFQ^H>0PGKPL@V"Y7)JG',J;(]E%SN]R3\@]`UU M5T!#_8Q]"TIL*+4AJD'Z\<.N;[@?+/$ZX+WCG\_G!XV"@&#S#.$GQMZ*I>(P MO&0D!)\&TIL*+4AJD&ZFS@!?$CPL0@8]4]" M>O"-O1\/4G+C)3:4VA#5()T5S@(*JY\$GT\.ZK8A`E*#;T&)+97:$-4@W4UL MRHJ;."^%$,9WOO40WMLU_P6D1]Z8Y&*IJ&Q[&TIMB&J03@G;L$+I)Y'G35OS M7$!JY"TH(1:4VA#5(-U-;)6*F__[C1.KE+GK!:3'WA@Q8ZFHQKY7E`L%G`>C*75]KF$W^YPCXT8LV/ MX$DT]H1,P1I[U3&M$;PZ9]O4>D+@">NCUI,`G@0CZR31"MZ';<_@?OYAU!(L M/KXV+#!B9P<+CZW[,`/[++FFJQ#YTOP#<[U^S M8_%'UAS+2^N_P,)>_]O0]C\```#__P,`4$L#!!0`!@`(````(0![A7E9-`,``/T)```9 M````>&PO=V]R:W-H965T+KG1 MH"150M7=2KO2:K679P=,L`H8V4[3_OW.8$`8V*J1^A+"<'Q\YLR887/W4N36 M,Q62\7)K^XYG6[2,><+*T];^_>OAYM:VI")E0G)>TJW]2J5]M_O\:7/AXDEF ME"H+&$JYM3.EJM!U99S1@DB'5[2$)RD7!5%P*TZNK`0E2;VHR-V9YZW<@K#2 MU@RA>`\'3U,6TWL>GPM:*DTB:$X4Z)<9JV3+5L3OH2N(>#I7-S$O*J`XLIRI MUYK4MHHX?#R57)!C#GF_^`L2M]SUS8B^8+'@DJ?*`3I7"QWGO';7+C#M-@F# M#-!V2]!T:^_],/(]V]UM:H/^,'J1O?^6S/CEBV#)-U920$286)J_W5,;@*-`XLR4RQ3P' M`?!K%0Q;`QPA+_7UPA*5;>WYRED&WMP'N'6D4CTPI+2M^"P5+_YJD-]0:9)9 M0P+7AF3F!+ZWG@?`\<:Z>;,.KA.;CQ>Z6GSMQ3U19+<1_&)!@X$\61%L5S\$ MLM8$S=#9\C]7P`XDV2/+UH:3`0E+*.7S;N8%&_<9[(\;S&&,\4U$U"*P:B"O MTPCF?(!&9$&-6$D4?6@#/=$#02UB*`B,^@!!R`)-8YAV:RHX:(P/SG3.KDQ( MU$&&*AT^*-[IL=8T.!)LZFH@^WMA?43]B[!28.^&9FWN`OO+0(8VIH8D`52_= M]<"3#C0L!`ZVWJO@[4(@V-R\B:RZ`Q;U(X8!:W.GVH`EZ+K2`*0Q-301PP#? M&QC0@88&P+2YPH$:;6[?AGH>&"%M@IY(^BU<4'&B$TAA_."P"*/%5'P5 M0N-/X(,P"J;BMR'TR01^'49KC+M=9C!\*W*BWXDXL5):.4W!+L_!22GT^-8W MBE=@(XQ@KF#LUG\S^,RB<"8]!\`IYZJ]P0VZ#[?=/P```/__`P!02P,$%``& M``@````A`/<]:'Y)"```SBD``!D```!X;"]W;W)K&ULK%K;;MM&$'TOT'\0]!Y+7)*ZP79@*T@;H`6*HI=G1J(L(I(HD'2<_'W/ M+G>IG=FQ*Q)Y\65N')Z9/1PN]_;]M^-A]#6OZJ(\W8VCF^EXE)\VY;8X/=V- M__[KX[O%>%0WV6F;'-R-$.-5WXWW3G%>3 M2;W9Y\>LOBG/^0F:75D=LP;_5D^3^ESEV=8X'0\3-9W.)L>L.(W;"*OJFACE M;E=L\@_EYOF8GYHV2)4?L@;YU_OB7+MHQ\TUX8Y9]>7Y_&Y3'L\(\;DX%,UW M$W0\.FY6GYY.995]/N"^OT5)MG&QS3]!^&.QJ3E93A#I M_G9;X`XT[*,JW]V-'Z+5>A:-)_>W!J!_BORE]OX>U?ORY9>JV/Y6G'*@C3KI M"GPNRR_:]--6B^`\";P_F@K\48VV^2Y[/C1_EB^_YL73OD&Y4]R1OK'5]ON' MO-X`482Y4:F.M"D/2``_1\="MP80R;Z9WR_%MMG?C>/933J?QA',1Y_SNOE8 MZ)#CT>:Y;LKCOZV1N:,NB+)!\-L&P5]OV,?6'K][7W32WH#!XT/69/>W5?DR M0I,AQ?J4(P>E+O' M8:2=T"<$HP6]X&-K$P&(#L@9-5EW)CRI)$Q*MW3/2NHHZ`7<>9=!6$IK]%:: MG0E/$REQ[%1Z\^K:<^AI-Y-75SXKB=MV8RA9);(0;X.TUXQF]'85M3'-PTK: MM:T;:^U+R)7F]$IFL6=:-81 MS)J("`IZA?M7TS`LEOI9T[<33"262U304L_AF/@`*2XVJJ\!C9$44"D[S%ZN@*S2->A%F%#*F$_E8O,J9D4": M`]DBI$T3'(5")=!N=GA;I!R*5XE3]2).8TW;PHD\*(B(M(42B',86YA(+!.1 M./D`YAQ#XE2]B--8LP0LE_I0^"(*A4"<40IASUE"A;3I1+0GV$"_OECQY:%Z MT::Q9D"$M.FL##84"($VHREPZPM$R)GZ@:Q9C`+!IO;UQ2H`0O/;U<\/I:T9 M$%;D=X0OHD`(G)FBI_OB$/*EZIC0)PD^7EZL`AQZ\:4*^=*)?!Q>Y4LE\&6D MY@.F3!.)5:1C0@^*)9\SG6-($OI%\?J6,-8T`2?R!DTB(BT1"WPY:-XV@5@B M$ETN^9SI'`4D>M%E;(G0&ZZ% MSX_MR.VL!"@$RE13@-F3,^.0,YV(]@2?,2]604_TXLPXY$PG\I?'JYP92YPY MX"%JXK".$!F33YC.,>R(I!=C&FN:@!-Y0!`1X8E$8,PH2H:\>)A0+!61,_F( MZ1P%+'IQ9A)RIA/Y6%BK<'4D/XPS320&A:51NC[XD.D(+ M).U%FL::%<-G2-L7OHAB(9#FD"T*O:8X$`)IJBD?,YVCT!2:X*XFS=32H;=" MG:`ZVHG;TQJ/Z6*U1F<` MSD"SA&8I:693'/$PIS2XSZP[_,$UJ4(TTWJ!)H8FEJZ3)M`DHB:%QISN"*+- MH#&0!)HY-',I6@(?S%8"!@E\,+)(&N"&\4+2`#<\W05-"MSP))8TP`U/04&3 MP`=O/)(&/GC;D#3`&B\+D@988RR7-,`:4[6D`=:88`5-#!]L54@:^&"?0-(` M:[S32QI@C5=J20.L\48L:8`UWCX%C8(/=AXE#7RPQR=H8F"-_3A)`ZRQ&R9I M@#5VKB0-L,:VD:!1\,$G!$D#'^S-2QI@C7UT20.LL8TM:8`U-J8E#;#&EJ^@ MB>"#/7-)`Q]\?),TP!I?Q20-L,97*D&C@#6^%4D:8(T/-8(F@@\^S$L:^."K MN*0!UOB"+6F`-3X?2QI@C4^]D@98XV1.J,&IMP?Y*G`0[!]U"TARW32"_"%9 M/;2GZCBMZ74K.#RBCF(9446QB*BA6$)4T!1PTET8I^G.V5/^>U8]%:=Z=,AW M>+A,S1Q0M>?QVG^:\HSG&L[4E0W.T9D_]S@WF>.&PO=V]R M:W-H965T&ULG%5;;YLP&'V?M/]@^;V82^X*J9J@;I4V:9IV M>7:,`:L8(]MIVG^_SSC0DFQKMY<$X_,=G_-=S/KZ4=;H@6LC5)/B*`@QX@U3 MN6C*%'__=GNUP,A8VN2T5@U/\1,W^'KS_MWZJ/2]J3BW"!@:D^+*VG9%B&$5 ME]0$JN4-[!1*2VIAJ4MB6LUIW@7)FL1A.".2B@9[AI5^"XC;)WD(GJ;X_M%=,R18H]J(6]JDCQ4BRU5W9*$WW-?A^C":4 M]=S=XH)>"J:5484-@(YXH9>>EV1)@&FSS@4X<&E'FA"+1CDOZ*&V7]7Q M(Q=E9:':4S#D?*WRIXP;!@D%FB">.B:F:A``OT@*UQF0$/K8_1]%;JL4)[-@ M.@^3".!HSXV]%8X2(W8P5LF?'A2=J#Q)?"*9@/K3?AS$BVDTG;W.0KRBSF!& M+=VLM3HB:!HXT[34M6"T`N;>F=/V35?#H2&X<2\<%+@R4YV$3A?,U>8"< MLA-FZS$P$<^8,6+7(UP"'6WVX@4!O8-H2,6YZ`2*^OMR]!I=T%AC$H\%;"\A M9XC=)2))QB39)60Q'2`C&\G_V'!!T#\OTKB8#?1=VK8>`M4<,GV&V+V*R/Z& M&)F`8_Z]%BXHQ9"I06$4+LY<>,R\ZZ9D%BW.\KP;[X?+R3@>[@-W1A\?3Y[Y MO7X_[7X8)-29-B`(6]IR3]378K&H)H7 M$!H&/KS4E?&,&2>TV9G.TC8-W&0T)\UQ9_[\ M\;B(3(,+U.2HH@W>F:^8FP_[]^^V9\J>>(FQ,("AX3NS%*+=6!;/2EPCOJ0M M;L!24%8C`;?L:/&6891W3G5EN;8=6#4BC:D8-NPM'+0H2(93FIUJW`A%PG"% M!.CG)6GYE:W.WD)7(_9T:A<9K5N@.)"*B->.U#3J;//YV%"&#A7$_>)X*+MR M=SY[UCK[?6 M,^0TNV!BA8&)&#`Z(KDB9`(E;3IZ8('>7C2D8BIZ!47]>SFN&J63KG'EZ@+B M.62"2.:(U4HG2>>0R.\A6ABK_PE#.D'_C-/HV#U_E[=88:"S*V1[;KZ>9T;%XX?ABL MAP)INF'RWJY;@J=9GPB+%0;>W\O,831IO%1S#IVA-IKV<*[]_OA*IZGVH;*J[Q5&B5N$ M_C!VG3D9FV?2Q\9%.`2F*9?[?/*UO*]<.DV5#YE1RA5&*??=24V2L34*!FV= M;ZJLEXH%WD"M25_KTF\WB@1/)4^R&2O,=4YM9_*]3\;V*(H&64KUV`QS&MC> M0*"$JW6LME6-V1$GN*JXD=&37+4.M&#_5)T"8C@%=#O3Z@VPA5MTQ%\1.Y*& M&Q4NP-5>AC`J3.UQ=2-HV^V&`Q6P?[O+$HY;&+:0O01P0:FXWLB30G^`V_\! M``#__P,`4$L#!!0`!@`(````(0#V-I1&C@(``&`&```8````>&PO=V]R:W-H M965T&ULG%5;;]L@&'V?M/^`>*\Q<>Z*4S6QNE5:I6G:Y9E@ M;*,88P%IVG^_#Y-XN6QKMY?$F/,=SODN>''[K&KT)(R5NDDQC6*,1,-U+ILR MQ=^^WM],,;*.-3FK=2-2_"(LOEV^?[?8:[.UE1`.`4-C4UPYU\X)L;P2BME( MMZ*!G4(;Q1PL34EL:P3+NR!5DT$PJ&+0G*1:;Y3HG&!Q(B: M.=!O*]G:(YOB;Z%3S&QW[0W7J@6*C:RE>^E(,5)\_E`VVK!-#;Z?Z9#Q(W>W MN*)7DAMM=>$BH"-!Z+7G&9D18%HN<@D.?-J1$46*[^@\&V*R7'3Y^2[%WIX\ M(UOI_0@2'O:YZ_9,)R2"C01(.19^*Z!@'PBY3TG0$)8<_=_U[FKDIQ,HY&DSBA M`$<;8=V]])08\9UU6OT(('J@"B2#`\D0U!_V!]%@.J*C\>LL)"CJ#&;,L>7" MZ#V"IH$S;Y,ZS=%S@PD)YGI:4CA?D"7+*#YA5 MP,!$_,*<(]9'A$^@I\U.7A#0VXN&5%R*3J"HOR_'4:,/.M>8#,X%K*XA%XCU M-2))SDFR:\ATU$/.;"3_8\,'0?^'L\LBG.Y2&L]ZZB`]3'H8!"5, M*=:BKBWB>N>GF,*1_=MPP:S@@NG&D?0;,.`M*\4C,Z5L+*I%`:%Q-(&)-N&* M"`NGVZ[M-MK!:'>/%=SD`AH\C@!<:.V."W\)]=^&Y4\```#__P,`4$L#!!0` M!@`(````(0`U1K=N`@@``+8I```8````>&PO=V]R:W-H965T&ULG%I=C^HX$GT?:?\#XITF=A((J+M'$_(UTJXT&LWL/JBJ?ISZ*:_OK\KU\>/\O+M^J]*.H)>#A53]/WNCZO MY_-J^UX<\^JA/!?E;5Z=+T6^:XR.A[ETG,7\F.]/4^UA?1GC MHWQ]W6^+J-Q^'(M3K9UP_U7[_MS=?5VW(YQ=\POWS[.LVUY/(.+E_UA M7_]LG$XGQ^WZ][=3>N,YT_/S8"_7=??%:=[Y/JO?Q,+_O=O_>G M`M2&YZ2>P$M9?E/4WW>J"8SG=]9)\P3^N$QVQ6O^<:C_+#^S8O_V7L/C]F%$ M:F#KW<^HJ+:@*+AYD+[RM"T/<`/P.3GN56B`(OF/YOJYW]7O3U-W\>`O'5<` M??)25'6R5RZGD^U'59?'_VF2,*ZT$VFB6N2@,FZN.F5B05K%[CI5)D*E7K5T]6S>F7JHO-2-**NB"9AC&#)1HS.DIW$9"'ES+& M&35>M3TCF6!]'B^3(A.9W-:OEDES^F7J8FV^:.PBC>G1>L%=0NN:DBX3!DL9 M+"-=#JQEL)!W%1J7P90158J,.-2[H@\'@@_,;P:,.,O8@&9`#JWZ$LXX16"P:->')B5EV/>P6*I2'B^6 MKJN16'J8.Y(-3+U MZ3(;2T8&'@JF3M]P8&1`+=G,=SQ2%L6<=<*!*0=F3+]8-%4Z?UTT77!CTF')@-=XLE4R5T1S++6J`+;BP5"8)07"MV MIC:V4B*[E]A.2>R4U$[);A2F-I9DDS%NPC969'&EF2@TI/X%@0,C!/IDT8X1 M2C,V/$\!=^YQULTWN""+UU,;J_V8JN^QGR()=!(-M4@;6#^=>=LR-#35G9WO1* M3>+J.#LELE-B.R6Q4U([)6,I6%:RV["$I-X=H%1X5Q;+ZQ8")XXF8C8<&'%@ M;$"S#@<]PZ*.4,:F,':@P;; MF=%H&1E+K8B02^]N_G:M[W(=`Z;<365W_;8Y%HM%M@DCIVS/=L$E0P_5_]R# MVP4.C`QHPLB5LJU%&U5CSCKAP)0#,Z9?+!K9+HP4K6_;0((\E-RV@0,C`VK1 MEJ+SZL)HQGA..,\I!V;#W6+)R+;!DL/ZM@NTG)/<=H$#(P.:2>D+G\R[F+-. M.##EP(SI%XOU?VT79-]VH7T[T$1!:$@#F8S92T3(TEOIAIT22*/D*D,7$G_ZXT1PPLRC685_[1JSA&,L]/Q)K.,URWQZ+-1QJN6]/Q!K.MMRWIV(-1UR@ M?7Z[(3@U=\[?BO_DE[?]J9HRAO-RS==W M.!]9P,D;YP'(KV597W^H#FXG+I__`0``__\#`%!+`P04``8`"````"$`CJ:) M%Y`(```J)P``&````'AL+W=O=N/, M(7W.<#B'LOGPZ?MN._M6-FU5[Q_GXLZ;S\K]JEY7^Y?'^3]_?UDD\UG;%?MU ML:WWY>/\1]G./SW]_-/#>]U\;5_+LIO!#/OV M(INZV14=O&Q>ENVA*8MU/VBW74K/BY:[HMK/<8;[YIHYZLVF6I6J7KWMRGV' MDS3EMNB`?_M:'=KC;+O5-=/MBN;KVV&QJG<'F.*YVE;=CW[2^6RWNO_M95\W MQ?,6='\70;$ZSMV_&$R_JU9-W=:;[@ZF6R+1H>9TF2YAIJ>'=04*=-IG3;EY MG'\6]RI(YLNGASY!_U;E>^O\/FM?Z_=?FFK]>[4O(=NP3GH%GNOZJX;^MM9_ M@L'+P>@O_0K\V^_EM7+:P?+'8(B+>Q^_4.5[0HR"M/TJ71J0D>)[__][M>Y>'^=^=!?&GB\`/GLNV^Y+I:>98F,>H&JZ(JGAZ9^GT'5P'NVAT+7H+B' MF8_*D,=)ZSFIH%%/\EG/TL\%*EI8GV]/PD\?EM\@IRN#R1`#6\)B*"(_(G0" M];3*^<,2^)Y(0RHX:1\6=7PYCASU(,K1EY1`-H0P1#Y$^#Z=1`TA27B"$!D^ ME3%-7X.A;MST!=YIWCY?&6)@&4\ICB@BOXA04PC"'M[&781I]AK\.(?4G)BE M,:66(23NJV>1A(&@\=R-)YX,:%BYX84(XRBU"T-XPXYS>>N*#\[NY6/QZ$$\ M^XQ@AAC@<=+(LW\1H:801$5$54QG7X-9]GGI("3LLQ_*.&7B!.>YQ.LP93OB)@ M#21#C'GCR.D,_0[.W;"4"<^R&Q9):L,DR>DMI#68D[8[!_L*8I"T+WC;R3$\ MN@AJ/$;H"FC=;I+UCKSC%KESD%"'^P(RG`#V-;BI2\-BR'_)7I1YNC M(JS/&1$(PLI8Q,(V!:QV0>)!:AGV<<7BCM52!=JS;E>`3D<5V`4V"A!D]FOJ MI>Q4DPL7L)!^P,\]BB+B(+0JJ0KM8+>K0-^C*EBM9`)!9AW"=+`.&$>5,AVT M'3,>XU$:V4Y+%6CWNET!>AY5P!AF^K0-;0H9I)*[?V[B1F&:LDI49+P((KO. M5(&VL=L5H/E1!:Q0,N$ZY"*,$YM$LQD(0,`R,(2B4R2IT^ZH"NUNMZM`3R0J M0D8A$ZYQ+H1(;2*-"A<@?.BIIX.`V=,N0$:QG8!JT%;G:)AV7H'&2+CS=\X, M"&O$3YC)Y2:,)08=ETM3%"#2T1(9LK3^>_1['SL]#GLI08$O>;L`?DR1$U"J(2;7%F. MN'+(:B0S(%,C@?"=$P'6/T,DJ;#M'C<`0Z0RM9N,\H=:N+V.I![%SD4A/UT8 MD&F7B6\9&!4XR5&G^RQE1!"`]$-I4T5%,&^^4$I@QGQA$=!K(4<.?]NF^Q1F^B,G*+/)S7P1HB9GH1(^Y,QRQ)E# M5BZ9`>%20"4GW/5R@HA#^&$;1A$$G`$C:5LWU:'MSRFI"TN!9DE+B?7\3+J. MN@CAX!"S_9Y32`RVS`M244@@XN!L7[K)FN6(-4N[WTPU(0C[$`J08<`V MO3(`7E24N#8Y9Z]>=Y#ST1K)GG6>F+#@#L1I(^N!AC2"CJD6O'?G M/@+.D!X/4M+,7J^L$[1'FG%V",A\!)E"]Z-XR/[HLOI;%U9$R@SGTBC[#SFK M/^*L?!=F!H1O#[N4ESC.8<()6SA%1B]BSS8!RI\YZI79'W'6R#8P4SK$604< MT@827(3T0GZX4#X!I.?>>J6($6]U/MHP(EQO7:1BT"K=N."':=4STP<] M75]2V@JCB_`A=_5'W#5BG3HS("3@FDPO+Z?AP0<_)+R`GG6J0<(_8/9Z7?[[ M4TC1X9X3IP*8R5XI8.2A-[+[#`LH0!`*D"'_ M=#`G<3$0J$Q\*)`*T+;IV-65`O0H]L%#;-?8"$`0=/+3`PW?Q\%%B)J$4"G: MZ!PITR86H"T"@1,[P;^(R`S(%)'G\<\&K2A`",^F@)+7AN>0OW(= MT":I"-;0L\#UTFC@9"9LZDP._(#$8_O0%*2.6S)\$L\#U7+91\JF@,D%<'E\ZYRS*71L>JY\KN*-- MTOKA=AP@"!O)@+L;#%D35F>&4N8C'GP%\Q$/=C[4-AT(07BY(>`6E\/=)5U? M&&;"],6FL2!2QRM+>*-G5S8O95YNM^UL5;_IZT@"3/OT5[PJE<%5J?Y>T?(4 M@)M*A^*E_*-H7JI].]N6&QCJW<50<`W>=<(777WH[\\\UQW<4>I_?84[:27< MU/'N`+RIZ^[X0M^F.MUR>_H?``#__P,`4$L#!!0`!@`(````(0!$RR;&#A$` M`)Q5```9````>&PO=V]R:W-H965T7[\=3_M:L95$M6S+)2G)6F\_#0+-)O`SM)S9-Y'SL?L' MB&Z```CIP[__?GZZ^KD[GO:'EX_7WLW=]=7NY>'PN'_Y]O%ZO0K_U;F^.IVW M+X_;I\/+[N/U/[O3];\__>__?/AU./YU^K[;G:](X>7T\?K[^?S:N[T]/7S? M/6]/-X?7W0M=^7HX/F_/]-_CM]O3ZW&W?>'2^2>M\>_?KS^Z^'P_$H2 M7_9/^_,_N>CUU?-#+_GVZ MHGC/W=ON+2E]^O"XISM0S7YUW'W]>/W9ZVV"[O7MIP]Y`VWVNU^GTM]7I^^' M7]%Q_SC:O^RHM2E.*@)?#H>_E&GRJ!`YWX)WF$=@=KQZW'W=_G@Z+PZ_XMW^ MV_J`6)9D;OZF4'@Y/5`'Z]^IYKU*#6F3[]\=KGPK> M/YZ_?[P.6C?-]EW@D?G5E]WI'.Z5Y/75PX_3^?#\?]K(,U):)#`B]&E$O+N; M3K/9:'7:I%+CV3">]&D\*3%K[$DMKRY]&GN_?>-WFEZSI>I;X]DRGO3)=;QI M>W?=X(T:MHT??;+?A?=&=Y+7E3Z-9^NFX3?;G;QI:ZK:-8[TR3?I7W:3'N5/ M7J;Z@ZM[T6UZG`CJ#^/Y!YG@41[I"DA">?YEN>!Q&JD_*JI0TV(>YY%*?;[O M"\/D<6:H/]C7N["].3L\20^?ZE)754X+3\)[:6_Q.;SJ#U-5*KBF-)_#JOXP M'KYW44;X'$KU![=+?9O>ZL$E'ZL&V_/VTX?CX=<5/0"H\-/K5CU.O)Z2XU%* MU[P8MWXW;-%XI50^*YF/U]2`-"*=:*S]^:G5[GRX_4GCXX.QN4<;S[;HLX4: M#)7LP`5#%X0NB%P0NR!Q0>J"S`4C%XQ=,''!U`4S%\Q=L'#!T@4K%ZQ=L"F! M6PIQ$6<*[?]'G)6,BC-'Z)Z!!-YW@LH6[#)PP=`%H0LB%\0N2%R0NB!SP<@% M8Q=,7#!UP5%DXE27PT: M+3MH]]I&/7&D0]LF_<*D""R0(9`02`0D!I(`28%D0$9`QD`F0*9`9D#F0!9` MED!60-9`-F5BQ9J>71!K]4Q]YT"M9&BLIXR2P+:[=FCOC5%=]`N3(OI`AD!" M(!&0&$@")`62`1D!&0.9`)D"F0&9`UD`60)9`5D#V92)%7T*M!7]^AZNK/,@ MG0E*0(>]!T1^K"B-T&0(9`0B`1D!A(`B0%D@$9`1D#F0"9`ID!F0-9 M`%D"60%9`]F4B153FM2^(Z;*VHZI)D&K>!CW@0R`#(&$0"(@,9`$2`HD`S(" M,@8R`3(%,@,R![(`L@2R`K(&LBD3*X#4FZP`ZKGSC5JVGK_O'_ZZ/U!GHT&T MHK,&-$?6,V2I94K%;3!.__(@/FDT[?_K&R"]N=F`(S5**AO8]9_(XU$9MRHC" M*&@Z1J%1*B>P[SD1B:`"\2452(Q1(X^T?^<[LFE1-D7$RE6U.0/-W:15.56S MOH5S3[N)#?)I_"BU0]MI8[9J2R,SHJ0H'+&5C56;;J:P"IK.HCLT5FI54%AA M.W.)4HF846TEDNI*N.W]5B7L&%!.0@S^8*:K%B\ZZ>7.6YT[N_GOV:K<$9Q4 M[8L-]^`!HB&B$%&$*$:4($H198A&B,:()HBFB&:(YH@6B):(5HC6B#86LI-" M+8'+^U1O]$:]8J9E#D?L7BUY*!WL*7#+&:O[8L6.`T1#1"&B"%&,*$&4(LH0 MC1"-$4T031'-$,T1+1`M$:T0K1%M+&2'6BV!RZ'^HVF5VJEV'GF,9/>J;Y`] MC6HYC\&!6'%2#!&%B")$,:($46I0:9J1&>3EM;<;3*T:W0;[[V98:M?>;3V# MRH\;G)8:Q^[O)UEB(8VII/O)EIBP3H)HA2E,X."\K,N:,EC MP&YNF@M`M%GQ4(C>]+;=G>:U$LY%;%R#ALDH_/0 M6-$,ET,=&D336481:L6,1"M!K12U,G:DND@.MV59;3>66K25&TL]J/R+P<=I>2?1K]\W:3]!DPJDV?(5OI)5&GVW$F/B$;2.9$C*2PF%%M88FQ MLCI,1:Z:>Y$2,^-X8:ZJ55RY^=_(5;WHLW+5H-(.FGKUJR(C:(!HB"A$%"&* M$26(4D09HA&B,:()HBFB&:(YH@6B):(5HC6BC86L;D7/)SNN?_A*.M?).YGT MY59'!KY\^^V>K>K6?V+#@\X`T1!1B"A"%"-*$*6(,D0C1&-$$T131#-$&=IGCY>G0%RL)M=&2(6&(5B&B M"%&,*$&4(LH0C1"-$4T031'-$,T1+1`M$:T0K1%M+&2'6BW4+Q_7U:$5-]0: MT5*?@]@W5B4T0#1$%"**$,6($D0IH@S1"-$8T031%-$,T1S1`M$2T0K1&M'& M0G9<:=)@Q?6/UO6^4K&G3HQD(M$WJ-TH,F!@4.>W*].A6'#:A(@B1#&B!%&* M*$,T0C1&-#&(QDNNZM0@FD(QFHGC;U;,<[%@IP6B):(5HC6BC4$5KS7443Q( M!K]Y0ZLG.-"0OQAZ_UNBO`@G4R[:PS".5O)HQPY]E!X>SLI\:!S)BELS-*@4 MJ(CK)8&*Q;$L+TOG_-F4B!7+IRB?H?Q(',ORSOIX+%8L/T'Y*>X1ZI"ORUHD8B1EQ8QJRTK8BL:/XDYPEX:MI,2,D90X8E1;XIBM:DN< ML)64.&4D)7D.#VF1<2$'* MA.PHD],(Y6.VDLW=Y"+YE!U%/D/Y$5N)_-B@QIT^%M)NE][PY/1GJ+T MC*U$>FY0?<,LV%'DERB_8BN17U\DOV''7-[.+;6K";E%WR:C.*J#:G\PN3;[ MI+(W?.]K9(V,[HFT/AN)W\"@1OD%1<7(J-4[_N]&1E.Z+`(C+"N^J*S$6%%9 M-6F>LKR4F#&2NQM=5.*8K=2QP)^?_*K4A/N;8FDSUK%J[I[/FALKTY8X*D)1 M2RQJ=5%1:RFJIBDW+)\WI96YZMP29NZ[7[;F,O9:T"#J-+Q@Z!O4E)XW,*@E M77;(J/2VFI'$/4*MF*U$*V$D6BDCT@;OD9%73<%Y#&JCQ# M8R1W,V0D=Q,RDKN)&,F4(68D6@DCT4H9B5;&2+1&C$1KS$BT)HQ$:VI05])Y M9I!W)WDS+Y@DSJ)@DCE+E%L59B*W+IC(;0J6R]D!5WNU[J/IHI>H@?)T^K1! M=_4+,>-I]7/M:?5S@^0^0N/8DE:)4"MF*VF4A)%HI8Q$*T.M$5N)UIB1:$T8 MB=;4(*N?ZQOJ2M;,V4JR9L&HW,^-HV3@BJU$:\U(M#:,*OJYNQE2M$>F-U%3FSC"DD=J&*)9)[J'"?J"-K$%((VL0,JB\ MW8`K+J-EC4L@'[.5C"4)HUKYE*UD>,D,*M5^Q%8B/V;T^VDM6XCT%*5G;"72 M22"-ZA2+S4XVLT,I'M%C$0^9B1:"2/12AF)5L9(M$:,1&O,2+0FC$1KRDBT9HQ$ M:\Y(M!:,1&O)2+16C$1KS4BT-HQR+3NN:F/TSZ8K>DNUO#-#VZMYU)WIBAPW MRWF&\9(IO4#(U7>X#6H?A\S9$?I39%!M+W-3ZN8 MK63YF8B\VN9JWCE?M$C9180S%!ZQE0B/1;BF2TS84>2G*#]C*Y&?7R2_8$>1 M7Z+\BJU$?FV0V9CV?-\YI+AAGUS93BJU5P=)]=_L[%(Z0(*9#<'R9"AP3Q#W MC2,=`.(4&!CTQM:NL3+;D;C6@NW("(N*+RHJL8NJ2$`H*\.R1A>5-6:KFLDO ME#;%TF:L0XMP&>YA3]=8F4:L6&%!64LL:W5166NV,G?6;3DS%O6S>BJ'Z.T[ MI8+.5_TS>?JGIYYWQV^[_N[IZ73UX.?JFE'%*I5(J(H']+N%%?QS@YJKLK*-'OVP2$55FSWZ<8H*WNK1;QX@ MIS,JO:&.J7-K=.*DIXZ8H`^='^FI`R-XA4Z#]-3Q#[Q"9SMZZC`'7J'S$E2# MJKK1Z0>J0=65$5U1AQ=0C4XF4`VJKM`Y`ZI!U96^1VU`7W%"M8BNJ&]*X14Z M>D@UJ`H9G="C_:U!A[P74+E7WV/?H'NFK=^A#W_4CG_S* M;5$,_3;FZ_;;;KP]?MN_G*Z>=E]IX+C+OW9WU+^NJ?]S-K\G\>5PIE_%I$4U M_:@=_0KJCKX,=:?>>'X]',[\'RKZMOA=U4__$0```/__`P!02P,$%``&``@` M```A`"5*WQCP`P``L@T``!D```!X;"]W;W)K&UL MK%=;;Z,X%'X?:?\#XGT"A%Q1DE&2JCLCS4JKU5Z>*3@)*N`(.TW[[^<[-C#& MT&XZZDO3G)L_?^?BD]67YR)WGE@E,EZNW6#DNPXK$YYFY7'M_O/W_>>%ZP@9 MEVF<\Y*MW1>)Y,2*6(SXF970''A5 MQ!)?JZ,GSA6+4^54Y-[8]V=>$6>EJR-$U2TQ^.&0)>R.)Y>"E5('J5@>2^`7 MI^PLFFA%+^?/"2_."/&0Y9E\44%=ITBB;\>25_%#CGL_!Y,X:6*K M+[WP19947/"#'"&2),O#`^2.9?DM)!&>OYWVO,O!GY:3L$%]R^1>_ M?F79\221[BEN1!>+TI<[)A(PBC"C\90B)3P'`/QUBHQ*`XS$S^KSFJ7RM'9# M>#\P(>\S"N4ZR45(7ORGE4$=0CN/:V=\-LZC8.+/<-);;F'MAL_&;3::SOTP M&';T-&9%P5TLX\VJXE<'=05TXAQ3E081@C5WUXA;-EXC`RQ0D"U%6;MH"-Q7 M((-/FTGHK[PGL)[4-KN^3="UV#<6E"S`:S&"FP_`2%$((R600.\:P4_08PM0 M8V$#`E$?`(BBH%8ZI%F4[+1-`&9:9F<6R-;$1CGY$)04!<4!*EH$_=S61F_! M;$ULF"ATD\SAKFL*C8P5FC:+M2145;>TN*F5\U?`=ZIL]AX<9-S%44MT=U-] M[4U)YR3`,6],/3=']S8-?W/749PNB%J"DXUDV57=&MF9H`?-F`5O9X*,NX?7 M$H,!4])A8-D]24\=%/([QPZ%Z6*H)5T"0JLJ6B.;@`!OQ^T,*.ON\8W(X*`C MZI!`76V>IE@8SW^A$%0D"XD>IG@WS5*86$PTCNIU[8*CV7=S,=!XL#+1B$PJ M:BLEZIY&0\PXC:A8+.FY?6])!/4X'/^<\[5H@;HWNF)J4Z$=8=6K"FN0OMT7 M03LPVQ'5B$PJ7AV'M'G85(2+7Z*BGGXF%;6H6Q7VBZ(@H)P&J@*.)KC_H8*L MK;*L12JT>H9IM5-6QFEZ5=-[2L&J(]NS/!=.PB^TA@5SS/I6K'?$73!KEL2> MQH=&;8`]#2V6*BD]S1@:Q5M/$T(34HWT-!-H)H.:*31J<[1\L-ENAT^!PU`D MP!JT!Z@A3-M)M-59M`[>`>L@5+"H\F#;SZ.]:@Q;OHCV:J.RY&PO=V]R:W-H965TZ6]TFJU>^\S)4Z""C@"VK3_?L\83&U#T[#:EZ89SXS/G!F?8%9? M7[/4>>%%F8A\[;*1[SH\C\4^R8]K]Y^_'[[,7:>LHGP?I2+G:_>-E^[7S:^_ MK"ZB>"I/G%<.,N3EVCU5U7GI>65\XEE4CL29YU@YB"*+*GPMCEYY+GBTET%9 MZ@6^/_6R*,G=.L.RN"6'.!R2F-^+^#GC>54G*7@:5CY_B45V1HK')$VJ-YG4=;)X^>V8BR)Z3%'W*PNC6.667SKILR0N1"D.U0CI MO!IHM^:%M_"0:;/:)ZB`:'<*?EB[=VRY"R:NMUE)@GXD_%)J_SOE25Q^*Y+] M'TG.P3;Z1!UX%.*)7+_MR81@KQ/](#OP9^'L^2%Z3JN_Q.5WGAQ/%=H]0454 MV'+_=L_+&(PBS:B&$8L4`/#7R1(:#3`2OW#0$1+Y-1TV;4N-JBP"XK&>6`G*0MF`96W M"+JM;)RNP6Q=;)B`I'-WG3-REFC:IC66L1PR9D]0LSK[`+TQ5=,A0,C9!-)8 MZN-,\[33+<9.@'-[R>1L[J0L"Z.JA347[UXVX_2#I1WQZXR3L[E]8]$*U2U& MH4"H[T1B,IX`V,`9I#0FAL8"AM^G1I(!ZQ6*)/. M1>/5LQNIU>V[-=H6M#1OF3*AN5KK;:'6W#K-MW3QD^:W^M>]70#@3JX3Z@@;VOX&I.F M!32(Y"5-)A6D2!H5G^RF]$OKO3*9O0_M>M_=.KT?)'VLJWW*I!?\H?HQ$B"M MX/I9"@,\M/.-D.F=;TP@6SL%$YN)ULLF(ABD@-+;[+PR:408)J/S@:6`USLO MO:W=&I$+4)!6K_THU$8N:&A,"(-D+NC*G#+I!3=>W5$/+)FCSL\7=&T8VGN9 MR2*CD4"S]];3]4X%=D]],$@`I;<%H!%`3?&55\]NI#[6(0C8]+_\^A%]E@`I MD\F%]11-MT9;`>M;8'WSR7AQY#N>IJ43BV>ZX053/$ZVYOKZN0T"W#_E&>RL MC+$RIIGKK(18"7M7)NHV:\>PZ7)7BW5G98:565\V-L>*O,IT8A98D>?!7@E\ M()!7XLX*W;3E5-LK##%XTNFIE"&F%OU.#'C#0T)?#'C#+W7?"GC#CVK?"GC# M+UIW!:\'[OIW04"/_Y;:V6<'J#Y,=R'R]VV\!=9>J.BC/`\V(>AB;Q/1P]X6 MHH.UH+6)\-KA'!WY]Z@X)GGII/R`H?7EF2KJ%Q?UETJ<<73Q\D%4>.$@_SWA M!1/'[<0?X5`&PO=V]R:W-H965TW,4DO3YGG_NOU\_??V>/VO+__\QZ=?^\,?QQ_;[>F*++P>/U__.)W> MO-O;X^./[+-_V[Y2R[?]X65SHG\>OM\>WP[;S5.K]/)\ZTXFB]N7S>[U MNK/@'X]?>//U^VKZ?.R&'[O#E1_X\_=F]'MO;R>(ZYE\WACY]O MOSWN7][(Q-?=\^[T=VOT^NKET8N_O^X/FZ_/-.Z_G-GFD6VW_P#S+[O'P_ZX M_W:Z(7.W74=QS/>W][=DZMS3;%"<1@:_[_1]"-'X2B)1O03ML(U`=KIZVWS8_ MGT_-_E>TW7W_<:)PSVE$8F#>T]_^]OA(,TIF;MRYL/2X?Z8.T/^O7G8B-6A& M-G^UG[]V3ZNKQY_'T_[E_SLA1YKJC+C2 M"'U:C(PH3J4B?5H4S_0^DT;H4QIQ;Y;S^6RQO*,AC'BGUG;L]"D5'>?FSIG< M3S]07$A%^NP]NLNY,U^(21OQ>"<5Z9,]SFZ0C/5JM;4_ILW=XUA#OI2)] MLL/SANA0)G:)(5*R"[I[<]8@G3ZGZ`_V>M8P'4XD\4?O]*R!.IQ*X@]V>N90 M.8'$NF'5\_K+B>`,,^&\_G(J.(-<.+._G`W.,!W&0G/;+?IV#_$WI\V73X?] MKRO:F"E`Q[>-V.8=3UCCW:-+X7X_>6\[H7U$6/E=F/E\3?JT4QQI#_SSR\)= M?KK]D_:M1RGS@#*.+K%B";%)";.^"0(3A"98FR`R06R"Q`2I"3(3Y"8H3%": MH#)!;8)F`&XI/'V,:"G\+V(DS(@8\>P^,%!!&B:?W09)I>S%RC'6VDJW4#VM8M3[1 ME5WKTWA/A+3>DXY,%_W&NP+B`PF`A$#60"(@,9`$2`HD`Y(#*8"40"H@-9!F M2+2)IW/1!1,OI/6)[\APXH'X0`(@(9`UD`A(#"0!D@+)@.1`"B`ED`I(#:09 M$FWBZ1QWP<0+:7WB.S(E^VIU32?&=4RJJ?.(+]740@F`A!UQVUOB]HRX!CL1 M:,5`$K"3@IT,M'(@!=@IP4X%6C609FA'BP7=MUT0"R&MQZ(C%`O>&5=29C#Q M4F8P\4#"C@PG'NQ$DLR5H1A1`I92L)2A6HZH`$LE6*I0K4;4#"UITR_N@B^8 M_U9<#X!$VFJ83\P+$DNIJ?,EFFD7J:EQSQ0H*0YPR$C96J/YB*5T\\8=0*RD MV'S"2)E/T7S&4KKYJ;X)Y$J*S1>,E/D2S59K)<7F&T:M>3W4XOX+ M[X5O1"GH]&/W^,?#GK8S$K(<`,0Q0]X)"RM&!G2([(@;XYFSF$+T.XG!I2S8P%J%FC"BQ&$O16(::.:+"8JQ$8Q5JUH@: MW9@>-7&3-A:U?^_?WHL:U>KZL'7W>G30YTQY$(=^BH"KT`J1SVC:*P82.7.W M#?AOQI(-^W:EL^[9K+<365C<,[OMI&]7MM.>*=N9A>4]D[:-O:#HVY7MLF?* M=F5A=<^T.ZGI7%^P32_6IKT>:'&K-PRT91D.`RKO#%7T'D1A4`24#IS]N61Y MI_=@Q4)J0?F,Z!K=Z[G.0E<,6.J^#;JSF--_ND@H1:A4P$FV9BWE+F(TZBYF M*7;GNG?&"2M!=REK*7<9HU%W.4NQN\7",497H+N2M92[BM&HNYJEV-V]BZG2 M1;.;3#U3Z*)P2:8(<6/'[I!+>W`?\<74B/C*D5(JQ7Q&U+=>T9(J4G'6I:&RG7K'>LV:/J1,1HM!.QO1-& M:3\YJQ,I>U2=R!B-=B)G*;D;.!/#?Z'\\\9:LHYR5C$:=59+*6/:C1-;HSS: MIUW?D$2)XX),ZRHB="WDT3R(KY=$I@TWI'LC%58LI/1\1J.K*)!2=]H-^\RX MG(1L2QR'^5L>2Z;)GJI.1*PXVHG8W@EC\TC8UF@G4I92G<@8C78B9RFYG]S= M&W$O6&"X><&(*Y8:=59+*6/:C5-7P[;>&[&>::*FV(CPJV7U&H_D72"DC M_XQ[Z)!MO9=_716.I50G(D:CG8CMG3`NH@G;&NU$RE*J$QFCT4[DJA/B#GUR M,S'\%VQFN.QAVBN6&G56*V=J'UW,X-PBS;\W8CW51/WJ@F4O*V!JGAX<60&C MO:S?W!0:IW41V<9Z$1T5B=B*65TP@AU M(J7&.Y&R1S43&:/1F!\MV;)R5C$:=58K9RHXEE3K/2JIX85= M2S6J`%^2:JVXOJM)-*A/K1#YB`)$(:(UH@A1C"A!E"+*$.6("D0EH@I1C:C1 MD!X+42,\?]F+ZXAQA9'H@^(T2ZF2K"_1!\5I)<6Y'#)2MM9H/F(INE'N=Y7% MU#@:Q4J*S2>,E/D4S6^4CBO..T*,\8FVB'RS=7:ED%HI/J/1*WS` M4EPHG;N.41P)I M<6.P$@^8DZ*VS"4:O>\(6%'6-A;3B3&XD"74^EHS4NLK8C3J+6:ISMO4G2S, M4@Y+*&\I(^4M8S3J+62E92WBI&H]YJENJ\N4O7,6Z4&I:P M;"BB6G3!AM(5EX85&K&3B`08WJI!U9F%U!KP&8VN@4!*&3=)L*=T?1B_25JS M1]6)B-%H)V*6ZA;B\LX\^2528+"GI:RCG&6,1IWE+"6=S6?&,;-`9R7K*&<5 MHU%G-4O)+69N?O_8:,[T#4:4SB[(G*[2IF6.++X--QBH(E.9#_87B49712`5 MC7*2L0Y#-D_+L=_DAC>;73F)I=32C!B-=B)FJ6YISB=S8V4F+*#V@921!QQQ5(*^8@"1"&B-:((48PH090BRA#EB`I$):(*48VHT9`>"[.2-_XC&9YV&0W7CI12R$>I`%&(:(TH M0A0C2A"EB#)$.:("48FH0E0C:C2DQT*4;(:Q$-]%B)O&"]^(I>^!8(-CI"\J MX_NT5:^I%I!O88&%A1:VMK#(PF(+2RPLM;#,PG(+*RRLM+#*PFH+:W2F!U)4 M8X:!_.``T15OM$4ED5I!*_$-L+AL*>0C"A"%B-:((D0QH@11BBA#E",J$)6( M*D0UHD9#>BPHXR^)A1`W#@>,]+5C5'=6]`M"G>9P[2`++'*AA:TM++*PV,(2 M"TLM++.PW,(*"RLMK+*PVL+$KRT-YJJ+5_?S2=U/G[QL#]^WJ^WS\_'JUW\1#RQVUM/=OT+*DEC9$9HL[\<23''2:,%NF MX@>BVG4'+2ZUM"4&:)E22_L%)[3,J*5]&0=:YM32EA6,%OHVUXOI*U#L&WTS MZXEO8K&%?M7J=VO/:##6L=!0K/)B(#;[,^]W^T32^*S#HVA9@T6QLH6*'@OQ MQ`,$.#1Z.H0&;6NAQS\\\>P`ZM!3()YX@@!;Z&$03SPU@"WTM`?-B:UE12WB ML0O4H>=NO,#:0@_6>.*)"]2AYVL\\=P%MM!C-A1X6PL]1^.)1RY0A][U],1; M@=A"KWQZXDU`;*%W.CWQ0B"VT*N=GG@M$%OH#4]/O`J(+0VUB#<"L65%+2MK M"[U,ZXGW)U&'WI;UQ&N4V$(OS7KB94ILH7=G/?$");;0R[&>>(\26_RE1Z^S M(X^6'KV>CCQ;>O2Z.?)JZ=4V[M][0?LPAKFX[SUZ"1OM9/<>O5*-O+KWZI;? M]H;HU^+>-M^W^>;P??=ZO'K>?J,M<](^Q'+H?F^N^\=)OFGY=7^BWXFCRQS] MG!3]+N"6BD43\1,>W_;[$_^#'-_VOS3XY;\```#__P,`4$L#!!0`!@`(```` M(0!I.$!13@8``+$=```9````>&PO=V]R:W-H965T3XC-)17?.M_Y8W_???S3YN/JGYM3GG>>N#ATFS]4]M>UT'09*>\3)M9=RLS%79G6KV_7;UE57L'%2W$NVB_FU/?*;/WC>*GJ].4, MNC])E&:=;_;!<%\665TUU:&=@;N`+]34O`I6`7C:;?8%*,"T>W5^V/H/9/T8 M)WZPV[`$_5OD'\W@_UYSJCY^K8O][\4EAVQ#G;`"+U7UBJ8_]C@$DP-C]C.K MP)^UM\\/Z=NY_:OZ^"TOCJ<6RAV#(A2VWG\]Y4T&&04W,QJCIZPZPP+@KU<6 MV!J0D?1SZU,(7.S;T]8/DUF\F(<$S+V7O&F?"W3I>]E;TU;E?]R(L$5Q7VQI M3VF;[C9U]>%!O<&ZN:;8/60-CKLU<0]RE6.+A-6ADP?TLO6A42%^`YE]WR5Q MO`G>(1N9L'GD-O!7VA!I$!W5#$8BG]\Q5PFVA@DT@+12B8N`M%8R@2R)/Y2^+>,0_-C1Q" M0\,,0Z/XU:1XG,26(),M1N`?N2BR'"EKHH:\G66=S(0?!*#8V":;*<30K&>:I@ M,:(*#F4AE'XFT$'NBIFU(7DE7?,:"RL'S00!,\@W$QTREDZ4FQ<`MK219#$2/U$(7$`JGI?E[%D*JZAZ:J^BY`$0NA*#6ZUQE1 MQ,(HDL#[?8I1;*)6;"NE>GJJLN_"%)&D]F_?9*KJNRA$30J)(;.0 MU$(A0I<.+U`V4]-D(]&JQX6J":FA,=WIS4TY;@"LLD^[(269J[[.:F"P&@:^ MC4`\29@([%V+%N)6+BVDH0@1Z)APB:5>MQA2=8^<6:B&H0G=`C302_*M0J,> M-$(WMW+1K;&(O<+C>+:`M4^LQ.02%4.J[I&C"]58-1%-`JK7G21]2H5N;N6@ M&[]W#+O-_>C"9JH;K!M2=8\<74(-5K=U,VLM&CK8^B8T0@U'K(==Z,\F:D$$ MK%1)(Z>74*/5A"2!HP$HF`.K)(2*1B.W;1GB3$V3&%(UC9Q-0K`:1I[0A-9: M-#YD*9,--1$4=2*$R9G0RID>!@I?P[LXPZPU01U4@'.J9QM#R&+ZU!&:".F& MU!J-G#K"NQ#"K#5)'2]T29$-#_/(`8MLIAJE&U(UC9PIL!'<^XY9:]'&\!!9 M\$"7Q.%,P69J42Q\@!\WY5<0I4&BN_C`K+5H\@1C%,H"".KT%30R`=$-#0M% MY_VA0A6%^WN`IMN[-T)K310?,@$1V0#A\L6$3=2"6!"1)".OY.@N1#!K%JU_ M)<=QW];\E2RL(-GRO#)"W,B"$1*'+GO.Y`AS!HM32SFF^RZ.1!P:RN^"\;QW M+71W:)G4'5M8X_2EC4U4R]T-J;)'3B+Q7:AAUEHTCAI(LKXM8XTUMS<'L]8Z M*30.M<+*H9-BC3=X$`IQ!TXLPSR8,$]&&XT<@V*-11/13/XP!RR:D4]DA3-L M8K36\IDD?1?P#A56+OFT`7W,?\G/Y\;+ MJC>\KH&.VVWDL+A+BE;K!VA22)W^)*;PA''6>!+#$W8!I3\AR?H!?@*Q>*/S M]0-\L[4]`6_4ZHTNX`F[,M'C4%@U<-OB+8(Y@#'+$P+.;.,1B+&-@Y2%;7RY M?K`J)*`0?M&T18808KM+(7!A=DV/^1]I?2PNC7?.#U"A.<-VS:_<^(>VND+E MX-JL:N&JC/WW!%>C.5PAS?&L>*BJMOL`H0-YV;K['P``__\#`%!+`P04``8` M"````"$`5=MU=?\$``"!$0``&0```'AL+W=O6.`E:P!&PF]U_WQEL M$]OD.'*?-3[3*V@D[ MTQJ^.;"FRCKXV!R=]MS0;-\[5:5#7#=PJJRH;1XA:AZ)P0Z'(J<)RU\J6G<\ M2$/+K(/\VU-Q;F6T*G\D7)4USR_G3SFKSA#BJ2B+[KT/:EM5'GTYUJS)GDK@ M_>9-LUS&[C^,PE=%WK"6';H)A'-XHF/.H1,Z$&F]W!?``,MN-?2PLC=>E'HS MVUDO^P+]4]!+J_QOM2=V^:TI]E^+FD*U02=4X(FQ9S3]LD<(G)V1=]HK\&=C M[>DA>RF[O]CE=UH<3QW(/0-&2"S:OR>TS:&B$&9"^C1R5D("\->J"EP:4)'L MK7]>BGUW6MG^;#+WW-"?0Y0GVG9I@2%M*W]I.U;]RXT\3&H(0D00>,H@P60V M=WT/WGG/T1>.\!2.7OB0XU0XPE,X3B=D,?-FP0_>"/GT?.$IWSB?3,ELOOA1 MKH'PA*?>5#J]T+UR2==EZV;"+!;L!:MF>,]Q;7@3!I&*\OH.&WY,0RHY! M-AAE9<,V!G5:6'>OZR"8+9U76"NYL(G'-IYNL946J":&34Q@9P*I`CC`:*`% MXG\`+8R"M&1"L02N/(G!05I(E\0$=B:0*H#&`=;A!W#`*+"/%&F(9R0=?A785Q>GHRK5@@L%$'PL3S=<+;P4BZ)2-D-T)2%='8 MP,M4-K=[N6P$:*RGS!$_&#;1=H0D(V0W0E(5T?*;_TQ^:*SG)Y!0*^G4**DP MNG:"A",*K=T(23E"^,Q4NQ.>=Y2F>[^D:*RGS!&BKFCB&>UV*XS(4/=$(+`G ME<5C[):=,)KV37P:!L3LXZFPZ.>W)@24\'%6:*RSX@@!G97TYH80PFA^9260 MJS0[@80]!2@,,8*DW,`?Z^+!B4>EP*?A!`\?W:G(GV,&J4'9;PCFP]O$+,0@ M.K4^[LK6%`M'TX_[$44QX>?S`PZ.Q)V$U)Y'O(5>IE2^$!.7$YEXX6"EZ89] M_Q[K;^S\/=9POAEH8Q2#-H=T28D[9-'7:]N_'HJC:"HA150)<55]?^:'QA1+ MA>L+HZ)@+2!.16/ND%]-P1.Q'EAGXX M>TUV<&<174?*]Q,M"`,:>Y%#AI3FG,/+&BYH54H.^9"]TDK,L2$P'N'H7 M"]?8YWCQQ-BJNOPBR>\C%6V.=$O+LK5R]H*71%PI`\HOL,D\@CD+^\_`X6*[ MZ=4Q\!@OO#?L8Q+!L7L<)_8C.+..\&PO=V]R:W-H965TJL2R7I)E)WGX;!)H-H#FRE"07D>=CXP?8 M:!P:).]__7W_.OJ^/9YVA[>'L7,W'8^V;YO#T^[MR\/X/[^EORS&H]-Y_?:T M?CV\;1_&?VQ/XU\?__F/^Q^'X]?3RW9['H'"V^EA_'(^OX>3R6GSLMVO3W>' M]^T;7'D^'/?K,_SS^&5R>C]NUT]=H?WKQ)U.YY/]>O+3?A,67M\-Q_?D5[OMWQU]O4+O[!Y/?[S;'P^GP?+X#N8EL*+_GY60Y`:7' M^Z<=W(%P^^BX?7X8?W+"UG?&D\?[SD'_W6U_G+2_1Z>7PX_LN'NJ=V];\#;T MD^B!SX?#5V%:/`D$A2>L=-KUP+^.HZ?M\_K;Z_G?AQ_Y=O?EY0S=/8,[$C<6 M/OT1;T\;\"C(W+DSH;0YO$(#X/^C_4Z$!GAD_7OW^V/W='YY&'OSNUDP]1PP M'WW>GL[I3DB.1YMOI_-A_S]IU-U1+^(J$?@=$+E0T%,%X5<5=&=W[F+FS.:B M^@LE?542?E7)V9WOSH)%U^X+!4&VNV'XQ2HOW]Q<%0BHP)5MA#'6506_M[5Q MJ0K"[W5M="!N9#?"O6"1*UOI8.^)/VYKIX/])_Y019W%G>-//^H^!_M/_'%= M@R[EC/1`HO$-DALD-H@LT%N M@\(&I0TJ&]0V:&S0:L!P)@R4O\.90@:F:BU876]J>F\E;1SH5HIHTR3J37H/ M,Y(PDC*2,9(S4C!2,E(Q4C/2,-+JQ'`V3`9_A[.%#$PNT*7DR/G"=.5*&5WR M=F_2>YN1A)&4D8R1G)&"D9*1BI&:D8:15B>&MV%%-;P]O`7!Z598=TY%9ZP4 M@?6V=[/KV?-K;X3%8D821E)&,D9R1@I&2D8J1FI&&D9:G1@^A)N_P8?"VO2A M)-Z\GV4C1F)&$D921C)&"*5+)ETQZ;HO MI4O/S9MM>B.4;G5IP_DBB>0[K[L`POO\LMM\71W`J3`C#LP$'NRPY+Y+B)A] M(@GT";8@DD3O`&4C:L+MFNMYYJTDO1$*I8IH'<"D\[Z4+CTSI8O>"*5+)ETQ MZ9J5:AAI=1W#VY`-7/3V;X?WGWD;DBETMU`QW:T([[KLV83LY*%8R43*=B.C4KU3#2ZCJ&(T6V9'AR(#XUCW7FILL4Y5467C:B,!"))TC(ND"D9*> MS19+TTDEEZZP$$G7B$BZ022EO87/W"]O7C;:=+_(:?3I_H-A(U,@V#;C%+D2 M6VCA6*A"<[]U;Q%:4<$8D==K)8AD'+G^S+>&7XH6%+49(I+.$9%T@4A*.[/I MPMJ%EFA!TA4BDJX1D72#2$HO_;DU]%LT&(A^D>;];@16A%16,$5$4)8AD%'E3^,^< M'U*TH`#-$)%TCHBD"T1*>KFP`K1$`U*N$)%RC8B4&T12V9U/[6UVBQ8#L2\2 M)MW]\HSOQIVF.!>WAX1$QI!P^$*NK"B\8J7E+;4925KY4[EJ3P,V(4D#8T@P MY9PK%PHI96]AGTN66(96FDHA;1&KT8K:W)C*CNM8@=1B&?D40C\6=$1.QOH$ M'A[`Y"XV_[@=O3X3Z!2M*4LF?O`$A58,..$WHSU2!5T*P%@A7S^TJ?[]0/_R6S0\)]"QA[6WL9%3F^%CH\Y M2CA*.C>X5.:%ADLETLX7(H>AF*.$HY2C MC*.RW]J MHR,2+&NCHY!^J*:0T1^RH"_6\)\?JZ$6K5$I(G)8QN5SM#+EK=6\("MT6(F( MY"LN7Z,5M:OAJ$4TX'R1GEYR_G5K'FQ#F/<5HC0G0BM"L4+Z*1M'J4(00^B> MC&OEO&#!4\UR9N>D3M$*BZ[2XM/;7$5K1 M9B-&!))4D&T#T4JF)K.E-[5B,D4+"JT,$=66([I86X%6LC;?GP56%EBB!=56 M(:+::D07:VO02M;F^($]_[5HT=5F=IS(66_H.)GB&ATGD9%?N?8>.W*5E99? M(:+AD2"2Z;N[=!=6`*3*0D^PL!!)YXA(ND"DI'UW:1T-E%RZPD(D72,BZ0:1 ME/:7"^NTL3643?>+Y/`&]PMS:V&6R!HWUKU%XE4K<31!L14CHOP]0:3R=]^S MT^04+2AL,T0DG2,BZ0*1BE$W<*U$I40+DJX0D72-B*0;1$K:F;-3![08"'\[ MP_U@WI+)I!'^$IGAST["W$]`/G,\33?!GYU9CT6`G;FA% M810CHC!*$*G@7_(3-[2@",T0D72.B*0+1$HZF%H31(D&I%PA(N4:$2DWB)3R M'*9,\^"D18N!V+?SU#^W$>7IJRN1Z/A^1>8G;FA%X14KI)^X*=2?N"W9@B`K M,X:$JI^4C!V#8AG:A54*@4]Q8U:CE7;B9BK#(;2U^+=8AI^XN7:B MV_7)7SEQZQ2M)4,FOA^VUI!#,R^C'C%>7 MH]#%Z@JTDM4M_=G,2L]*E*;:*D3ZZ+KFYAJSMKGC!-9,VJ(T'W`0H^9B;P^X MZY*/3J;K41I>;$)?H94^-5J.B<@&NR'F*.$HY2CC*.>HX*CDJ.*HYJCAJ#60 ML=9X(NW5-UK"]_`F.NR+;GR)N%,R!Q0B?<)S?6N#$Y$5>5NT"K0HZ4VX56RH-%RAE)5<*CE(D6Z MWN)K@]6F"N@7+P1$:Z#VCRM!F.T$KV0VSZ93=@BHST`MB2WI] M<,D-K!%<:D_;]X*U#XX\MNF-$>F]H*QD+WB>O4BEJLQ0+XC]T?6W('=3QBU( M!"<5JA>L+"B"?7\72'HO**3W@D*R%SQO:GDB11G>"Y!%&+=@[[^N>IFU$S&' MB$)&P@.O*YF96(16VCA12$]X%((?Z:49NS\LQ`>*V-'K7?27DX=.T+I7N67Y M('E0!?7D0:$/'M>CU4\?:*;*R<(Q2-9UWYY$W#3]"N`36X(G:E0U?@ MLU'800U=<>%*-PBL>F!U#L5RS,O$G@]7NM>IK3+P=>JG(:T55#]8.U0^:.]! MHP9J_N2#_I!35CY\%CM08#4+X>,(?@NK>0C?`'`.CY1"\<"(7X%G>*%X;L2O MP*.\4#P^XE?@B5XH'AGQ*_#(#NY\Z`H\M0D3&%.:\WH9PIO/G*^@O:O!]D9P)1J\`D]CX4Z&PC$&+R>#9>!! M;"@>_O$69'!%/`/D5^"Q+/AEJ)X\".'+AH$2BQ!>N.>\#$)X[9[S*@CAY7O. MZR"$%^XY;V&\#_%5$*Z&>!2$\$D"UXF#$#[Z&."+$+Y%X#P-0O@B@?,L"+.. M3_J0@F^VW]=?MLWZ^&7W=AJ];I]A\IIVK^,9```&0```'AL+W=O./`+J)1J,;O/G]/_]\?#C[8_VRO=\\?3B/WEV>GZV?;C=W]T]? M/YS__V_E/^;G9]O=S=/=SKB8GO[;?UXLWVW>5X_P9$OFY?'FQW\^O+U8OO\LKZY&Y0>'R[B MR\OIQ>/-_=.YMW#U M'F/N\>;E]^_/_[C=/#Z#B<_W#_>[OP:CYV>/MU?UUZ?-R\WG!SCO/Z/)S2W9 M'GXQYA_O;U\VV\V7W3LP=^$[:L]Y<;&X`$L?W]_=PQDXMY^]K+]\./\47?73 MV?G%Q_>#@_Y]O_ZQ#?Y_MOVV^;%\N;]K[Y_6X&T8)S<"GS>;WYUH?><0*%\8 M[7(8@7^]G-VMO]Q\?]C]W^9'M;[_^FT'PYW"&;D3N[K[*U]O;\&C8.9=G#I+ MMYL'Z`#\>_9X[T(#/'+SYX?S&!J^O]M]^W">3-^EL\LD`O&SS^OMKKQW)L_/ M;K]O=YO'_WBA"$UY(PD:@9]H))Z^FZ?I9#J?@94#FA/4A)^HF1ZG"&:'?L-/ M:O)P'Z>H`#]18<+G>:"',]2#G]30D><&4VSH(OP\[=P6J`@_JF MQQ8F_A\?I[/+]Q=_P&2]19EK*Q-)B8PDW,QT9G,-"@U*#98:5!K4&C0:K#1H M->@TZ`-P`:[=^Q>BX5?XUYEQ_B7/7!-@A\?*F21!*KD&A0:E!DL-*@UJ#1H- M5AJT&G0:]`$0SH3Y\2NNO8Q+!!S14B3;B^P];$AA2&G( MTI#*D-J0QI"5(:TAG2%]2(2S(1G\"F<[,Y!<8$C9D3,U\:]1Z)"W]R)[;QM2 M&%(:LC2D,J0VI#%D94AK2&=('Q+A;5BZA;?'MRR4;IWTX%1RQC426-#W;HY3 ME8&SO1"IY884AI2&+`VI#*D-:0Q9&=(:TAG2AT3X$$[^!!\Z:>E#3Y+I/LMF MAN2&%(:4ABP-J0RI#6D,61G2&M(9TH=$.`RV<2P=_([*F=$>AL).S+S)!V*(K]A\F06#5NP M^#)*Y&`4^^-[KZ(-7\.X3=?2DV#`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`ZX M+#N843'I+`/BOF21DNPA46E8B$:XSYRBK6%C7"EHPC5_J%OCB\ MLL2^4A0!XY&\6CE55S@R4@S=X!6#&Q\%2@6H1"3<@)U@6Y55K"UJA"WI!E<( MG>`&7S<)-W@D=[]3O8^*O12,!\5I3@A.*IAP:B$N2&KB-\23*%6SJR0)_X31 M<$F=$+=6$3K86DU2V-KE(E)%4D,20VO2E:Y^.<&53ES-(H]DR3=5'LG9.[BD',1CW].B(N9@A`--CQX)G>*)4F$H65,5R3%IFM":#J. M30%,$B-QY';[)SC)%P=B2GJDXDA5RAD$D(DC1#S:!4GYT9XGUD=>1\21L5R1 M&;9<$_*69PN]UC8HX"W+.-+EPAO)>U\64/*YCCU2<:122X92(HZ\(F14LE60 ME!_L)-6W6DH2",,(S7"$5B3%EFM$,_`GITC]H%=#BB.AY#;182C]K4L>,6[% MN:_7B&2$Z<=,,I2"<21?Y8@2OEY5()I<8H;796-).F&F\ET*+%.VZK-)B1&0Q1$%.913DA#H:"D`^S":04E?9*D@CBC!"/ M746(3=>$,((7T529;DC"QECR2S;D@Q7E*+]'5S&FBOD,%8-(R!&%,89H!K,N MF$@ZW9.B>%(BN$CE[QO;%BM2#&)OO$6U.VQ(\;4694R.;M]_YK)8@OMJCHYK M1"(\O52`'BE&*7 MI,BV*D)LJ[:V&F%+NN>T*B&Q50(BN=[.]-86I42D8>$`#F+_V4CS4FJA5$FL M)/.PS0ULJ45_25(\B!6A@YVH44IU0FV[&K+U6B>DX]V./(S+PQN=Q&_@P[T@ M(I5%U3EG*"6RJ+<%FPN*K`*E(/X"_\U5A52BE%LQ#GD9S8=1:EJLQUM4-Q>: MMUJ4+G4;^!-R5B>FX7)2XE81L0K;P$5O]N$RYB9FX4)%<%!AUQJ M6JS0?+!;K4=;-'M*4AQ9[]WF/O3?W]I3)KY$$&[U2$6J&NL,%46D>D6QWGLD MU_NY6GU+M/56I'I;08L5*7(BKA&I%E6>;TCQM;DA(]75",;3/[7>^ZI#>-T4 M(EEB4(X(UGM.!E[*K:DB%S38F5;K`G)%E62;]YJ4;IXM$#Z*1?; M8@D"%KO*G:A( M\6`G:I22G5BHI:$A6Z]U0HP-%(0CX1]#"1;AU,K27&+%9GG M9%X3DBVJ];(A6Z^U*#WM2AKCZ9])K1-?)`FO>Q3$:X92`BEUJ4&&E2HN6%E46U18U%JTL:BWJ+.H%DBYU54X8SF^X MU!=%(FD@"AZ@F!B46U185%JTM*BRJ+:HL6AE46M19U$OD/2?*V="__VM^@WN MX9M(1<07##*4"I^60.3&E]=)\S8:2U$\EQ8M+:HLJBUJ+%I9U%K46=0C\O?I MI:==56,\_5,KH*^31#`C@HT[^U/?2LO@;2DW7.&K:XCF^`:%?7>-!7@,O!G_ M#AZN=(AXU"M6Q#?-U"ZH9@&RW"`*+*\0!<^4M*3H[U/`FW%J_]JQ`%GN$8V- MCRMVS/BD,]RQ&%[ZU95)(B7VM8$F);E56L+6I( MD6VM"+&MUBIV%O6D.-@2<0]1)OUZ.$,/XG+10R0VT\FEJB8SDN*M;4[HX(7: M`J7$1;?$/&I-MD2F,A4S27$G*D('.U&3E(_E-)JJ6&Y(@"O+%2%NK"5TL+$. MI=09JWG9DZW7SEB.LBY)W3H"G]YQ3W^\,>"^%`TG3.J1J$[-HP8927'!F!/B M\"T0R:O4^@)GB5)A/4JVV'Q%B,W71YEOK/D5V6+S+2$VWQ'RM>TTFLW5-<1> MF)9#,E;<'C=]+P1/>X%X;EQ-`E\!L):E_JTEI]#:]LCLP&=>TY(RD.H9P0 MAU"!"&:#\[QY:[@D%8[-)2$V7!%BP[4T'.O,T9`*&UX18L,M(3;<2<,+_49% M3RHC,0^36>RQWO"\$U7WU/$4ICJ"<$$=0@0AC/IJHN5OB<1'SQG!E M#=?2L'G!H;&&5V2%>]P2XAYWTG"D/S'3"\,RYD^KD^&-,N-YC]0*H"\]H&)P M,3TGQ!%4()(K@'ZXMB1%\'E0S*@6ER3%,5L1XA;KL19CO0UH2#&<$GC:;+XE M*3;?'66^)\61B?%+RO#4EN&(Q'PQCXIE),71ER.">S24]0I$XJ9FHHNNDA1? MNQJ)Z[;O:G!=MB)%;K'F%EUNC/0CA0VI\/,N*T2!X9:DV'`G#2?Z4<">5.RC M@.Z&M$AAPP63GRGC!XLJRV$9'5XW79B%W0N)J89ZL'<)9HQ2++#!N9`R+R.B ME-O`![;,[#.=J%#1W1X(%%4G:I+R%QQ&7D;D]BD`5X3"N7C,&7>RL;&7$>:I,*!5Y[+6(8"M=3G9#N\7!G$YDQ#-(=WL@S$Q%\18:N]2BPJ+2HN6%E46U18U M%JTL:BWJ+.H%DBYUM75XF>L-E_I2/*S.IQ[!,T'DK,RBW*+"HM*BI4651;5% MC44KBUJ+.HMZ@:3_7%UX@O^VG"?>M`STR.Q64[T-=X,%<48>T4QQA[),=:7ATJT!24F M1U4&76>4HN'5YY>Y.6AVX]0C6QH[`;3RP M-C;P<%,.K(T=@5ML8&WL"'Q-X,I]+\#V`#X&<.5>][='X+UZT!D;%GA+'G3& MCN1Q`CIC?H-7RD%G[$@.#AWU)[ASS#,5.'.,M^#*,9Z#(\=\4H$;QW@+3ASX MQ7X8X:]+/-]\77_@,,O]G^9Y.-_!0```/__`P!02P,$%``&``@` M```A`)13!=2`$```!%8``!D```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`\;D!60-1`?2``D!!(!B8$D0%(@&9`<2`&D!%(!J8$T.C'B2%ZQS."(Z3-X$A"^K5$N+6RI1?B[%H"60%9`_&!!$!"(!&0&$@")`62 M`U*Z>$2\A;<9+$FTQ`5D"60%9`_&!!$!"(!&0&$@" M)`62`N8S&R@#@9JJ&[`R-%12;"!B99J!F,54Z!(6TVRF+&8>E!6H M3$FQS9R5:38+%E,V2Q;3;%8LIDY1C:CAF9T!,Q7$5H)>#=J;4H)M'C3[E[?R M@+[+[A-!;D?H1;U#0\HA+<#VGKWX:L7FPYI2S60NH:JYH6,;MOK MW,UX9*5F)`7HVS&N`C&BA-4H^RDC92R3:$:;%6\?2X[J"T0EJU<6*T;*8LWH MK<-K#,UF'H@ME3/R0.[`Z'D@D;#1'^]X;'UEN!`_0:!TN547A:5$WD"=]57/ M]$KER`1I=*`<\>54K7H%C$9]6$.)C%(U'EM;X!%/U*\=0\^2BJ64IWF1\$SE M6,I(>9%)9'HQL;(RYXDGO2BDE.Y%R3.5%Q4CY44MD>6%U:DU//$M+XQ\$C_P M,/+IMUJ95HO9RC`RR\W$:E@7O9B69\SH+Z_N5<].YUDOIDZDWS-U)@/)NI_O MM3U5*-%,7Q:0R%&O3-7'F)4I=Y->3-E,64P=:2:187,\L?JXO%>FM["0W44O MI@=^/+&:MK(74ZY5DFFGHY;HM&M-K^PMU\QDH^!!L@WI9TK"8]$WOZ]?$EV1 MN)*I&-\Q,HO:Q&H>%U),+VH\DXJ:*H?8,?5BO\@_Z9I687PY5:]SC$ZV"R%+ M=>W"S7AHM7$1"Z@+,7Z!].V M??%F,^O$K7F2:A-\B?3&B)'J'$*)3O/8:0[.9")301H$YW24/A;A52"0R"PET1W*F M44CD3+T[8@.#7U0-GJJ6B"^GTK'RV@H8J5432F1U!%`G.OUMF>UO]Z`[8O4J MDQ-&RHF4D7(B\,--) M;)KJS?;O-4="BY5E$IGE!INC3LPH-ZQ,-1NK(;-?9)G4IE:?+V<:1:>3TEJ! M4$I9K8!5GB,I)7ZPV-]60'SCWE?]SG$\M3KI!!U+6;_>/G6^FHY-K7XXYXDG M'2OU MKED+43UHIE:0EHQHS6HAMZK/BJ7DE=UQ-92:5>'Q>8Y:\@&CD\9"*44%4?SB MG!Y4,?=$(]:B;,6($D;*?,KHI/E,2DGSTZ&U2'+6HLP7B$I&RGS%2"]X\K1U MYW5X.[%.?,-S6F-F,HG]8[VP_>(ZV6TW&PVW1&8%PX:I$].6RW(HD;KBKR0Z MW6.LI9368_BL2Y6T@)%2'[Y+?83J8T0)JU<64T;*8B;1Z0/*47V!J&3URF+% M2%FL)3IML3'4FQDAMI+/R(ANY]G("(G,,H*=4R=FE!&)5&ZO*&%$L3'[FJFU MF-=22N2Y5G^L->>SE%I-`2-E,71;M&X@(YYXTF(LI?0=GH1G*B]21LJ+3"+K MN*V%G?/$DUX44DKWHN29RHN*D?*BELCRPFKH&I[XEA=F?HE]7SV_?J^5ZG:/ MC;23R"Q$V$IU8N0SM]-+VG`6.:9U.BN)S.OV`-).3GSKNMWN)_E2EV8Q0(NA MT^+4ZEHCGGC28JRD^!@3B30G4I92[4HF$1TV3\PE\D3%Z-?6>&JMK8*5J6ZT ME$@S6;&4,EE+9)YI^QNHAB>^==QFBHD]9CO%R`US:^G]W\\.Y9ZU6BMWC,P: M-[,ZSH44,VI, MN,I-7U4=[D82Z2L1T!*E5HC6B'Q$`:(0480H1I0@2A%EB')$!:(2486H1M08 MR(R8V.X[(V)"W%J)C,R5:.]>C)087PJ6#K9RL+6#^0X6.%CH8)&#Q0Z6.%CJ M8)F#Y0Y6.%CI8)6#U0[6F,R,J]@F.R.NW:Z:WM>/)-)7(J`E2JT0K1'YB`)$ M(:((48PH090BRA#EB`I$):(*48VH,9`9,;J-.R=B0MQ:B8S,E6C=/2U&2DRM M1&0KA]S:P7P'"QPL=+#(P6('2QPL=;#,P7('*QRL=+#*P6H':TQFQE5LMYVQ M$KO=.6,E2J2O1$!+^LEMFQ!*:H5HC36#N8[6.!@H8-%#A8[ M6.)@J8-E#I8[6.%@I8-5#E8[6&,R,ZX4C7/B*L2M"MLA2AV.UV($:(EHA6B- MR$<4(`H118AB1`FB%%&&*$=4("H158AJ1(V!S(C9.TJ_N$_$#2/:7&R#2,51 MNTVT]G,72HKCND2T0K1&Y",*$(6((D0QH@11BBA#E",J$)6(*D0U(O$B/GFB MZ11V0>Q>K->]VNII^_IMN]@^/AXN[O<_Q$OSQN)!C!YW;_2[&]W0*_W:>W48 MN>67_<'(D$;:6T@8&=%(NZT.(V,::7]!"",3&FGWGF!D2B/MRH>1&8VT&]OV MB$>O**1'/NF4P`AYW5TR8(2\IN?57'/(:WHNRC$R&I`'[1ZPK6TD7I+H]("4 M.77183J/D@[2>8P4,F?$*&#M?K/MD4>^TF/.>!3TB-%3S_ M3`L%7:+'O^;B"2_7R)1&7,[2XU]S\;@/SJ&GP.;BH1\OWW;/AXO'[5XMG]Y^C?#CHR_Y( M;]^D*SV]:H_>MKJE5_`,Q"N%ON[W1_Z/,-"_O_73_P0```#__P,`4$L#!!0` M!@`(````(0#VC!R1)`,``'$)```9````>&PO=V]R:W-H965T[*^?BIRZY%)Q449$FSN@+ M'DNA1*HG0&?70L_WO+)7-C!MU@F'':#MEF1I2+9.$*V(O5D;?_YR=E*]WY;* MQ.F;Y,D/7C(P&\J$!=@+\8#0NP1#D&R?9=^:`OR45L)2>LSU+W'ZSO@ATU#M M.6P(]Q4DSS=,Q6`HT$S<.3+%(@BMQUB3"=Y,X6TSF_G3V2J)= MJS8FW%!--VLI3A8T%NA3%<4V=0(@:W=?:^[\>,T.\`%)ML@2$C@1L&,%)7S< M+%QO;3^"[W&#V9UCG"$B:A%8+I#7:01W/D$CLJ!&+"&*WK6!%]'N2%"+&`L" MHSY!$+*$!#Y[ILV'"G8UQ@%G7D!#2-1!QBJ]3U&)+-`<8,6+@K/:-J"W9':0 ML4QH]+Z9E\]=VV@(-FJZ*C:1F>DZ9SDRIWD+BU]4/VBSQ4>$('@HI(G4!QP; M+.I'!BOYPY7,H7.\B0]J/WCPD&DHHXG`VKT=+T:V=*!Q,7"H]:Z#MXN!X.'B M3:3G03\R\``NR?Y*Z($/5]B''4">H8@F,G3`'SG0@3H'Z@E17XX%DP<6L3Q7 M5BR.>/L[4VBP+MQ-IJV+]\DHOH.)92P8Q]T@NHB?!7"*SWFV7K`UDV_,XP61 M=P&_6P30<^<\.S^(_$OQ91"9^W#,OVHFKMV]@(E7T0.[I_+`2V7E+`5/IJ9C M93TSZP[/TN8_````__\#`%!+ M`P04``8`"````"$`!F$"%4`#```""@``&0```'AL+W=OR`"58!(]MI MVG^_>S&0`%G52'T)X?KX^/C<:U^6=R]%;CTSJ;@H5S9Q/-MB92P27NY7]N]? M#S=SVU*:E@G-1J92OB]]`55#X=JIM8%!50['C.]6M-:EM%'#[N2R'I+H=]OY`)C5ON M^F5$7_!8"B52[0"=:X2.][QP%RXPK9<)AQV@[99DZD#`BGNVNE[5!?S@[ MJK/_ELK$\8ODR3=>,G`;\H09V`GQA-#'!$,PV1W-?J@S\$-:"4OI(=<_Q?$K MX_M,0[JGL"/<6)B\WC,5@Z-`X_A39(I%#@+@URHXE@8X0E_JYY$G.EO9M\29 MSKQ;`G!KQY1^X$AI6_%!:5'\-2#24!D2OR&!9T,R=?SYE$P#)'ECXFTS$9[M MZL%I]?%$UZBOS;BGFJZ74APMJ##0IRJ*]4I"(&M=,`R=+_^S!?Q`D@VRK&PX M&K!C!;E\7@=DMG2?P?^XP6S'&-)'1"T"TP;R.HW@S@=H1!;4B*E$T=LV!88-%YI+?2K+\2'CJ?!,X,U%YY\)"I+Z.)P-IG^5H,;.E`PV1@=SN[#MY. M!H+[BS>1,P_.(ST/%OV5S,4#M7RE`4C3U]!$>@;XWL"`#C0T`%K.%0[4Z/[R M;2CH+AIL8[7(.F1,,&W)W,0%DWL6L3Q75BP.V'+@O*^77=CTPRWQVH8X&(%. MN?%QM4%\BQWT4MP/HXOXVQ`NDS'/9A)N8`OC@>TDC":7XD$(M7\!/PNCV:7X M/(SJ>WFX@448+1#O=@/0@2NZ9]^IW/-263E+P2ZO/CG2]'#SHD4%-D(?%AIZ M;_TW@V\M!L?2<^"8I4+H]@47Z+[>UO\```#__P,`4$L#!!0`!@`(````(0#W MJJK'U@@```,F```9````>&PO=V]R:W-H965TZW[XPXE$B.UHG; M?8F3GV:&Y/!/'Z=__1G]MII. MFC:_'/)3=2D>IS^*9OK[T]__]O!>U5^;8U&T$XAP:1ZGQ[:];N;S9G\LSGDS MJZ[%!9Z\5/4Y;^'/^G7>7.LB/W1.Y]/2GW15#M MW\[%I15!ZN*4M]#_YEA>&QGMO/],N'->?WV[_K:OSE<(\5R>RO9'%W0Z.>\W MZ>NEJO/G$XS[N^WE>QF[^X.%/Y?[NFJJEW8&X>:BHWS,Z_EZ#I&>'@XEC`#3 M/JF+E\?I%WN3.:OI_.FA2]"_R^*]47Z?-,?J/:[+PS_*2P'9AGG"&7BNJJ]H MFAX0@?.<>4?=#/RKGAR*E_SMU/Y1O2=%^7IL8;I]&!$.;'/X$13-'C(*86:. MCY'VU0DZ`#\GYQ*E`1G)OW>?[^6A/<)OBYGM60NPGCP731N5&'$ZV;\U;77^ M#]E0)!'#H1CP23'?XRU47Y4;S'GG")WD.([CA M!N/K1@Z?Y&:O9BO?]Q:K);`;G@ORA$_R]#[GN"1'^)1C7/7)OM$@+-:NJ_!Y MSPC7Y`:?LCE0PI3--XK]F>"!:5BE"\8YG$*XPL=(P$C(2,1(S$C"2,I(IA)MH)`-;:"XQ2_< MV7"(?GJ7QTAZ$HA`VT/"U^:VWAO)60P8"1F)&(D921A)&"NL-ZD*NK3`L!(>A*( MZ`(PEV5OU`N`D9"1B)&8D821E)%,)5I>L-[1$G-;`9VY/GJ)%`UP%'`4/I=,=@Z=*2QT\H6%A[_"B M0U\*`4_VN@E`,*A!7Q6)8QLB M":754KQQV6OC6B>2!L.ZCPDY0P<3B6"_[[/)&DNEE2<:<^WU2E\2F;3H\JTG M%^L\-;DC0E232&7AT,>M+9"_DDDTUN-.&@R++R"TZ!9,I_%0(C$7"R.AD7P\ M-!P3W(0%68 M1,-Q&$JDKBIG:=P"1=)*T10A55,2#9I.)2(!6RA[JF9L4.6H:HUAB0L4N)>.['ZA, MN&HJ$TA3F4#NH.N4XGM6MUNYKK,P;@4RLAA3&=;,+(/P/RL8.)8:\IC\?-WA M4!4^S/J6$&J]/Y&\M3'-.[+2U"AB?7!N2D3G)L7RQ+7H:KVVC1TU(PLX`$'VVKF)UT"_.-D8T=@9!7*@[.V'X9F'^Z[K M"E0D@XP"0K8F78JO2==CA0FY@G2'-AW;*%]BLM+43)U5]TR!ED//,G(V3D%2G:Y02D0RCJI/:']90 M0E:PDN5FFA):#K5,)JU&M(A..8WK"09UG\O[9+\6H` M5T9R7K?0.TRRLC?M"&E2(T=77W1&K1B2I^V*#8OOC2*,KZJ/M9_(+JGJ$U:: M^LA149_XMH;X/_BYJ%^+77$Z-9-]]8;?Q(`*\>FAQ^)K(G"KM\$;-$@'>^+" MDZX+[(D'3[J:A3WQX4G7(?/)8@/_R!EI9;F!?V2,\-4&[OU'^'H#]]XCW+:@ MY>[]P&S9AF_"P+TH]X'+B@U>1?`G<,^PP5L$_B2PE^`SUN,$GN!;,_>!K^)\ M&<\P=&S$?@M3,FH/$S(V'U\\B#^:+)BG;IKF?4[@*SC7_+7X9UZ_EI=F M0!A6MR_5XDL\XH^67MB?JQ:^?=.]NQ_ARU8%W`-86*Z\5%4K_X`1S_NO;SW] M%P``__\#`%!+`P04``8`"````"$`P8H?@?(6``#`?```&0```'AL+W=O[GY^I.?^?;JXNV?M_C]`_NGA_F7WNOOR-B&YB^%&\9EO M+FXN2.G3A\\/]`2FV<]>ME\^GO\T77>KF_.+3Q_Z!OK?A^V/5^??9Z_?=C_B MEX?/QZ!Y.?N\_7+WZ^-;M_N1;!^^ M?GLC=R_IB(#*W(O2711;.K1RH?F%+TE];\FJRF"VOKOOJ#Q2D)^R?GO[:@C.J M_4"!E2U`?VV!*;GL0($K6X#^GOA0%*']O='??563Z^5RL;J^HOL]4.>-+4E_ MN.-`0?,L0V\P_=`Z^O#S3?<=B/[!M1WIMBEW&_,/6_;JN$><7- M_)TN,.7>8_YQG%LNAI&A'VB"N[>[3Q]>=C_.:/0FQ[Y^OS/O@NG:R/$0,W2D M_:#S9V,.#39&Y2_T>!V;VUNT6;J6VS8PHQD M1C;0(-0@TB#6(-$@U2#3(->@T*#4H-*@UJ#1H-6@<\`%N6?O(PJ@?\)'1L;X MB%OWEH$X;:8T&S\#UP.]B8@7@?62O?9+,WV7L)2`@D`A(#28"D0#(@.9`" M2`FD`E(#:8"T0#J7>$ZC%\(_X30C0X,E=8V]0W"HLT:'O+8WV7L-2`@D`A(# M28"D0#(@.9`"2`FD`E(#:8"T0#J7>%ZC=[+GM?&I+[^&C'7O'&[4VX%"0+]&]D;[(``2`HF`Q$`2("F0#$@.I`!2`JF`U$`:("V0SB6> M+VB.>X(OC+7O"TN<(``2``F!1$!B(`F0%$@&)`=2`"F!5$!J(`V0%DCG$J_A M*>'U&MYD*K/EA$:K$W,5(^3[Q!(_/J[42V)OM(\/("&0"$@,)`&2`LF`Y$`* M("60"D@-I`'2`NEGPZ_L7MSWQN,G!!!%"`*$46(8D0)HA11ABA' M5"`J$56(:D0-HA91YR'?%R:C=+/[=WPQ)*`TM^4N?FL2#Q,LJSW:(`H0A8@B M1#&B!%&**$.4(RH0E8@J1#6B!E&+J/.0[PN33)[@BR'W]'QAD3],7:MARF0F MOL<"1"&B"%&,*$&4(LH0Y8@*1"6B"E&-J$'4(NH\Y+O'Y(TGN,>FF6ZH#&CN MA@J@P"QIDGL\GUALD'7%\.B MY,0LB[Y]>[C_Y79'[WX:F4:&LSDM/MHE29M3NBZR2-;`-F:=V(2+H,"BA:E- M5C-O_#@+Q8H'RPA1C"A!E"+*$.6("D0EHLJBJ[YG^BUMI+9)VW9B%=MW4%LWIK[3U]%*WM9A)8P]LUN^@]1Z/L8*$T>$* M4L>,*\@LW M5N*\P&QPD!8%A5GI^*`;\S)%%3@O&%CGAEDA!JZP6H5,Q8.4,E7.Q MLC+JH0HQ8)D246716*R8E/"03XZ,%9M9NK$RH!F-:(Y35#-LS#X1>6`F!0-& M]$[9%YQ-56(?6JNKJ]YU5Q/5,!&K##O(9ETF9B1U)8P.UI7Z=:TF:CD[8Q6I M*V,.?#9;E7N_ M-9MHQDT4+WN?+'6T;-CJ:C^O#AA)T(467=T,03=1[Z#(7I^[8Z"M7H03%$Y] M8=52&?7X'C'II?;(G.#(&]]UA\U*77<, M2,66ZI:;J;62@@&C^=Y#H44VD&B+V']-15Q$.G?,2(031B*<^L)SC!I[>R*< MLXH(%XQ$N/2%%Q.U\%UQ$8P)&K31`T?%1%_2?^M8I&)"W,1#X]2CY#^9RU1+Y@)/*ER)NWU.5$AX0G[(6$ MZ<%>2!P.A=Y<>6'(Y54HJ#O8V(+N:X:1=*S0(AL*LXG*0B,N(CTV9B0]-F$D MPJD65ITDXR(BG#,2X8*1")>^\!Q;WK;.2"B56`*$04(8H1)8A21!FB'%&!J$14(:H1-8A:1)V'?/>8 MA/H$]QAS-9)9Y(8*H,!,NDQ!L0H118AB1`FB%%&&*$=4("H158AJ1`VB%E'G M(=\78ZG]7]I;G&%VSXC\X"2$*I7;B)5$D=62=U"(5A&B&%&"*$64(8,H0!0BBA#%B!)$*:(,48ZH0%0B MJA#5B!I$+:+.0[XO3)9ZPH@V)+7NHO',(B]49BJWVXB5A,J^(*,0K2)$,:($ M48HH0Y0C*A"5B"I$-:(&48NH\Y#G'LJ%3W%/;^Z_<"QR]JXVB`)$(:((48PH M090BRA#EB`I$):(*48VH0=0BZCSD^T(G\W]IAVL^I*QN!#&2)8>-15>+_4)6 M8)&WPS5;JG7A4*PXJ")$,:($48HH0Y0C*A"5B"J+1E;MYSIY[UN:/K]$;V.S ME*PZ_P M.:;T%ID5'IEAS=2=;MA*$IR`$4GN"^+^B;7:[Y_,U-PM8AE9DXH9264)HX.5 MI7YEM(2N'B-C&:DL9R25%8P.5E;ZE2TG-VI=O&(97!2;GY;I]^8J:(:TGN9V MW',VULI!`2/IDZ%%M`+,!2.+:,!E%'-!D4\8B5:*6AEJY5Q0M`I&HE6B5N5I M^6^`T[)SLW^MTC^+5*]7>Q(;MI*^$3"2Q='0(NKBW'X16TD_BQF)5L)(M%+4 MRMA*M')&HE4P$JT2M2JV&NF2)M,]?OY)TQAHT@$M*278CP?+F=H>V]B"7B\= M"M+5'P8Z\WYG\,?T>CZ@A3_XJVV#C;6BA65V4,!(NEMH$86!N`3W MEKB@].:8D<@GC$0^/4H^XX(BGS,2^8*1R)='R5=<<"1^3LNEYYA+6Z3B1^\P M62LO?@8M+WX&Q/'SSEYR9$6]-X`5E=Z<<-72FU.+CJPGPWIR%I5Z"D923ZGK M4:U2><)^C)R65YMMK5EG&!@S7E;"4U%8RDIE+5I,?/BHO\65V>PQ:G M9=J]N3\W8B23\PVB`%&(*$(4(TH0I8@R1#FB`E&)J$)4(VH0M8@Z#_F^T)GV MX1>,"1$5/(SH%>]T:+T+(E8<*0&B$%&$*$:4($H198AR1`6B$E&%J$;4(&H1 M=1[RW:/3\W?<8Q-M">;;Q8!HUL$-OT$4(`H118AB1`FB%%&&*$=4("H158AJ M1`VB%E'G(=\7)K,^?OZ\,.9JV!K0@C([)U14NKRQ!1V/!1;Y!>=JX3<4*W9U MQ$B\'Z-\PE;>?+[RAB)?([R!5OY\BJ/*,6*Y2M&(E^C?,-6TEXMHH[1B,?,`H`; MG']IQ=BL^&I'#HBN\!-MK)7G2+`*K953,&(D31&C5L)6).DX4J61J5CQ?66, M1#Y'^<*B*24Z7+(<816JU:C6L)4T3XNHLV@ZY#1^J)FE@4..XQ7H=]Y\PPJ# MN]:_L(L.7N8[U[-ZMI)79L!(YK\AHV&=E[Z%2@W:$1M(.\2,1#EA='#9,;56 MG$(L)RL59AGK2&TY(ZFML&A*DW/QM&TGAU5<5-1J1J+6C*BU(ZSCHKV:[^K3 M%C,6N)AAD3FIX(0&S#6'@FX"S04EX0P9#8?'IY?7JI$C:^"FS%Q&0B=A),JI M139EGLXG,_4RRE`Z9QV1+BR:TNQ=_&<;Q6$5JM6HUHRHM2.L\]1\_YD%`S=4 MWPG)87W!"TF[Y."'I(JE#6W=F%'83;09N2$Y6'F+44QD MK;S5X1&_0HT)UIA*C69[<#J=S-7<-)/:V&$YZ\C#%!;Y\3K<@#E*%WLS:3SEB.LXJ). M&#.2&VU&2K8CK..B&,:T53WB[K^SE=\K*M(`H0A8@B1#&B!%&**$.4 M(RH0E8@J1#6B!E&+J/.0[R,:'DZ8JRV-N1K!+?+G:CHMYH*REA`@"A%%B&)$ M":(4488H1U0@*A%5B&I$#:(64>CXJ?32F"OW6.2&"J"`"XI5B"A" M%"-*$*6(,D0YH@)1B:A"5"-J$+6(.@_YOC!+'2?XPI@K7UCDAXI>;ECNK7C` M#Q"%B")$,:($48HH0Y0C*A"5B"I$-:(&48NH\Y#OGM-6@Y:X&L1(@F"#*$`4 M(HH0Q8@21"FB#%&.J$!4(JH0U8@:1"VBSD.^+\SJPPFA8AW'^K,/+>*DNU<+D1*XZ+`%&(*$(4(TH0I8@R1#FB`E&)J$)4(VH0 MM8@Z#_GNT8L@[[AGR/G=M/VRMAL34\X5%?JCH=64N*!X+$(6((D0QH@11BBA#E",J M$)6(*D0UH@91BZCSD.\>G>Z_$RJ8UJ\&Y*R3;A`%B$)$$:(848(H190ARA$5 MB$I$%:(:48.H1=1YR/>%3NO-TLN??,+Z^(]BK3#[M\B<0Q(K?6A%K273&%CD?I$JDH"._5`MEJ5BQ?.;)^VUJTN;]\$.O M[;^VG+6RV;V!Q,+56=@?S9G*C&CAC&5P<7)DLUVW-=T8+FQ3++=[V"OJ;W^8ZFV8K MV5<+&,D^2V@1;[%?J_7ER%YW]^Y918031B*<*N'Y9*IB(_.D_0[G9;34X=YI M(LQH5P-2'4OOKK"5M&W`R.U8@Y:_/[Z$AK(UNF&-^Z@L+S4FC*3&U"+>'[^< MZ"W!C`N-="\O`QT)UJ.^T7.%B:E%:L,*IA!#07?#RA9T#LJ$%EV1\3[(EDNU M=!IQ07J(O=5(DT*-"1>4XSJIU-AO35].IJHS9%P(MWOHEQ?]B/W;VSV]HDIF MAI11]5@(:FLE_2>P6NYVCT5VF^1:GQ^([/5AYV+X2EM&(IR(L-O\JM^G?EU3 MZJMJ^,Y8VNFKPP]1#K\/][1]^;K=;!\?7\_N=[^:'YFD;O'IPQX/OX!YNYK1 M3V#V=P=7YG2ECQY]9;E:FW4S>L7!E2NZT@]@<.6:KO3C&%RYH2M]E])75I=T M!WV_@2OFASO[M0)]94%EAK-'<(7*T$'VD;M>4!L,?M9EEM0&M-BA#+3I\X`JN4(O2]TB,J,VI M=89WCBXSI=89OF,(KE#K##D/7*'6H6\!'ZEG1F6&XU&ZS(S*#!]'@BO4HO1M M6"-JID''.#7::)M1DXWV06JPT1Y(S37:6E-J+?IQ!KPC.EJQ-DCXWMHH;/YI#9VA0[?4Q.,7:%CJW1O8QV/CJ"2 MVM@5.OR^-D?;\0[H-#5=&:N'/KRP-D>FL0Q]AF%M3D[C%?HH`]W;F*OI?#Q= M&;L#.G!-5\;4Z'M&UN;;.K`>^BZ,=4C?$X%7Z+LLUNGH%?HN"E(;*W-+=WT[ M>@?T69.U.H<^4K,U)=KQ"'RU9FP/M>(4^84)>&&LW^C6! MM?E.?BP33)?KD+X"'J_0M]:OS5?2XQ7Z!GI2&[M"7]!.:J-]AZZ8[U`?4Z.> M.%RYV(^F]/O1W^^^;LN[EZ\/SZ]GC]LO].J_['][X67X!>KA/][L+P/\O'NC M'XZF21/EG_1+X5OZ^O!+\^TJ7W:[-_X/JOIB_]OCG_Y?`````/__`P!02P,$ M%``&``@````A`/3IUJWN`@``1@@``!D```!X;"]W;W)K&ULK%9=;YLP%'V?M/]@^;T0(`DI"JF25-TJ;=(T[>/9,0:L8HQLIVG_ M_:[-1Q.25:W4%PB7X^-SS[V^9'GS)"KTR)3FLDYQX$TP8C65&:^+%/_^=7>U MP$@;4F>DDC5+\3/3^&;U^=/R(-6#+ADS"!AJG>+2F";Q?4U+)HCV9,-J>)-+ M)8B!1U7XNE&,9&Z1J/QP,IG[@O`:MPR)>@N'S'-.V:VD>\%JTY(H5A$#^G7) M&]VS"?H6.D'4P[ZYHE(T0+'C%3?/CA0C09/[HI:*["K(^RF8$MISNXL&I MDEKFQ@,ZOQ5ZGO.U?^T#TVJ9<X18\*F0 M+M(><-M@V^/(R4[QZ4[NT,'X`+'O/'>6Z%1%%X&MCQ*.1JX,H*$6[9QL)X-@ MJF!;5E4:4;FW,W`!Y@[183RO0WN61O$-C&UGP3@>)G"<+N"C9!M=B*^GR=J- M_S'/--E.+^`W\P3\OL`?=Y\1?R"",=Z0@GTGJN"U1A7+(<6)%X/]JOT0M`]& M-N`MS')I8'Z[GR5\KQF4=F)KE4MI^@=KY/`/8/4/``#__P,`4$L#!!0`!@`( M````(0`'`?(&;@L```PT```9````>&PO=V]R:W-H965TEN M^)^_HC]FP\'IO#D\;%Z:0WTW_%Z?AG_>__,?MV_-\%@OUVD3X?FN/G\`N/^YOB;+6JW?S#Y_6Y[;$[-X_D&Y$:R MHWS,\]%\!$KWMP\[&(%P^^!8/]X-/SF+RG.&H_O;UD'_W=5O)^WWP>FY>8N/ MNX=B=ZC!VS!/8@8^-\T789H^"`2-1ZQUU,[`OXZ#A_IQ\_7E_._F+:EW3\]G MF.X`1B0&MGCXOJY/6_`HR-RX@5#:-B_0`?@YV.]$:(!'-M_:S[?=P_GY;NBY M-U-G//>FH/*Y/IVCG9`<#K9?3^=F_S]IU(ZH$W&5"'RBR.0FF(X]!Z[Y41%/ MB<`GB@0WLR#P)S/1E0N7]U5+^%0MM2%<:`>J[=CA4[6;W_AN,)VUW;[0<*(: MPF=W0<K).QZ;VEM'%@6KN(GI@FJ\ZD\S`C(2,1(S$C"2,I(QDC M.2,%(R4CE4X,9\-B\#N<+61@<8$I[1S)EP9E=,G;G4GG;49"1B)&8D821E)& M,D9R1@I&2D8JG1C>AGW4\';_:0:76V'=.A6=L53$:]=>Q[="57T+5^^=!*,G ML,5?T1-A;?9$DMFT6ZM6C*P9"1F)&(D921A)&$]:F M]Q29D/,863,2,A(Q$C.2,)(RDC&2,U(P4C)2Z<1PF#CN&QZ3Q]X;47:=GW?; M+\L&-#2F`F)9G(K=<>.U294;<"`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`E<:=S\7)E M9V:.VBZ)Z9KD&WW49@R(*I7%P*_<(7%EW6O$@T+6SF(MV2O5TD@]V7*B'Q[X M'1+5<`(;[Z5H4%JFDZU38LP[D:#\Q4ZD:"7WN[Y8Z*Z/QY*<7ZQ`F8L7*]'* M'#&+A.Z*Y)G4M4P[9?X6;R.V6\>![)*N,1 M63N854.LE)F11E+,V,$4HITB4@VU(U/,M1*THETG141:&2)]!Y-7U/I5H!5I ME8A(JT+4LX.)FECW[3NG`EE"&[&ID*_G&SQ&9M7CKC0SXE4ABHL0K:;RR.MZ MUG80H0%%7(R((BY!1,HI(JGLSUUK[4NJC>/.U]]3R$9<^&$"Z>( MI+`SM\XQ&7Y/PCD7+M!*CW6CQ_[$&G>%37H"7]28>N!_].Z@*XM3(P44,E-@ M9MWR6*F61@K(EOJ]5[22X32=CJW5*4(#"M08$05J@H@"-44$JTBWR;,:.D,K MDL\1D7R!B.1+1!?E*[3J2091$NHS\LY2)"M(8QX4,I+!\^SZVY5F1C)(9"2# M0C)F9W.KS(F4BK'6,^$$K2AF4T07;S1E:*6G!),OT(KD2T07Y2NTXHD!A?PU MT]":FVN20AY%T(JC-45@8QZ`)YW-_W7+BRP M3EWY&&VK8SE62`L$JT:7P<',CN^N)?V_>=W#PAX6];"XAR4]+.UA60_+>UC1 MP\H>)MXF0!=`#2`=+U\/D(\R[^OC4[VJ7UY.@VWS53SZ#_?-[V\[+-]+6$X6 M\`P7"-A\NH#GDGKX;`&/W/3P^0(>+.GAWAA>?&B3TKZ"U[T287VS=L8+\?`$ M5UL[SD(\:<"_@<<(%N))`?X-/`8`:GW?P#L9G]JLMZZ_A([UV2_=!3R$RZ^P M]&"(/?R3O_@$L]33P%_`,X_`1]V5X5V,U\U376Z.3[O#:?!2/\*$C=O_)A_E MVQSRC[-Z#.1S%T>.NFAG],CL4MW,>F.>,?X@+=>SSW_P<``/__ M`P!02P,$%``&``@````A`%2QSG=$#```!CL``!D```!X;"]W;W)K&ULK)M93RL[$L??1YKO$.7]DG1GCX"K0WK?-!K=F7G."0&B M0VB4Y&S??LIM5WOY-R%<\4+@U^6_[?)6Y=#7?_[:/_=^;`_'7?URT_>NAOW> M]F53W^]>'F_Z__DK^F/>[QU/ZY?[]7/]LKWI_]X>^W_>_O,?US_KP[?CTW9[ MZI'"R_&F_W0ZO2X'@^/F:;M?'Z_JU^T+/7FH#_OUB?X\/`Z.KX?M^KXIM'\> M^,/A=+!?[U[Z4F%YN$2C?GC8;;9!O?F^W[Z';]]?_]C4^U>2^+I[WIU^-Z+]WGZS3!]?ZL/ZZS/U^Y[ MS:$^U@^G*Y(;R(9BGQ>#Q8"4;J_O=]0#X?;>8?MPT__B+:O1N#^XO6X<]-_= M]N?1^+UW?*I_QH?=?;%[V9*W:9S$"'RMZV_"-+T7B`H/H'34C,"_#KW[[ZOW_I)6GM*2*KU3H M4ZF,IE>3V7#D4:67BHR5"'TJ$<^[\L;#J=`X4SD];;I`GUSY^&KL3V;SIO8S M):>J)'URC1]N-2VDIG;Z5!J+JYDW7(R$^\[4O5#EZ)-;38-_IH!'C^50B4FB M1N'#S?7:`:=?N.*)X:X+1]SC(1>_*!WZ[=+2(^X+_:)*3]NQOE2$)XQGS)A+ M'3*0ZZ!95L'ZM+Z]/M0_>[17D5N.KVNQ\WE+(6F&TM(3*%R%S MTZ=)06OG2-O"C]O)W+\>_*"EO%$V=VCCV18KMA#K5L@&+@A=$+D@=D'B@M0% MF0MR%Q0N*%U0&6!`KFW]2Y/D,_PK9(1_V3-W#+3#'7>OV(*+!"X(71"Y('9! MXH+4!9D+AA(""0"$@-)@*1`,B`YD`)(":0RB>5LV@P^P]E"AC87&M+6D;@U**-SWFY- M6F\#"8%$0&(@"9`42`8D!U(`*8%4)K&\3:>GY>WN@(:W6V'=.)6=<2?)G#X, M-X^=&=L:<;$`2`@D`A(#28"D0#(@.9`"2`FD,HGE0XIK/N!#86W[4!$9ZXGS M9P4D`!("B8#$0!(@*9`,2`ZD`%("J4QB.6SV(8<):]MADLSIPYAT$V?2M4;M MI`,2`HF`Q$`2("F0#$@.I`!2`JE,8OE09)9F`'5^X0IKVX>2C*;MT;X"$@`) M@41`8B`)D!1(!B0'4@`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`1O@@NX(S@UCT8AXRQ: MBT,+F,5\]"`N@JV.EM7J>O2;ID.(510\F]UV!YYD5;#R%^40LF$W!IOB9S@ MSFG?RE-6.@0+&.F\(U2(4BBSKTX(%BDKBO"T5$'E+*)[4C#2/2FUKF[C=`@9E&SCFSVQ1LT_>^5Q40;52-C'O$+O9%!LI3?B M0"$S@V(D$Q%_Z#O]C5A&KXN8D59.6$:G."DC,U3$#(JUM'S.2,L7K*7E2T9O M-;QBF4;9'A5Q-P!K:88!V.49E-@ZG6!,(6N138=NGLM6>FH&"ID9E$*4Y\C- MRYGS$16D28X3(I9_ZP"0)QY;Z>607-2(5#>B MV2?ATI"%S:6GW*+K*BZJJ]1U:7].%LX96^D:M95Y"MBK5.3C[BK]>)HD=DEW M\"6BEDDGC+16BEH9:N5<4&L5C+16 MB5J5I67[5:3"IE_/AXN^S)S-\('1Q%P]HYESYJ\,,W97T,'"#A9UL+B#)1TL M[6!9!\L[6-'!R@Y6V!_3>(6LKXRG0_<.3%OIV2FUJ""C$*TB1#&B!%&* M*$.4(RH0E8@J"]DN=3/[=Y8\IO`BQZ3Y9]Z,(`H0A8@B1#&B!%&**$.4(RH0 ME8@J"]G^$YF:N67^K9L1$0FZ*UTA?02OE)5UYS$=.I<2@;;2,U5J44%&$5K% MB!)$*:),(;I^8_ECM@]%W@0^I/]HIL+B&WF^O/A`S"TS,>MD M4DB(ME_6PDV3+ZWFXR::]H>>33T=45J^%LDI^OK#-\R-C'TT*22B"Z,93IRW4E9TU\*]#+H* MXDT16\F1\1;N]P\1&XQ:Y1@K2[25;B54EK*5K&PT4*+2A.;ON_ MT"FS/0I=::89P%Z4_U.R[NX:"M'R8_>N%#(BTT`A,XUD*WL2.7,TTO*ZCV:4 M+M,2UM*Q<((UIFQEU^BLM^RB&G-EY4W,2Z2I]Y;W12KSJ?O-2"9'YGZC$"T' M/1+2RIK[$KV3,RJM\5M?"4=86:R045G",E1G.T,[YKYJTENW)QE6EBMDS?VI MIR\T[,G_.=G;"+,W1CH47B$*$(6((D0QH@11BBA#E",J$)6(*@O9?OU8]D:O M2<'N(9$=';L;[4H5-$+A`%&(*$(4(TH0I8@R1#FB`E&)2+PP)CPA.R1=*E\` MDV^J[+>'Q^UJ^_Q\[&WJ[^+E+@H';Z];+-\\N_,G2Y&ZT&J')U-ZTGS?!$]F M]*0Y"MTGHQ&]R-;L'?!DS*^XN4^HFLY:J)+..N9+^B_)CO9ZU!,9NK@U>%0% M?4O84<:G5E'FBT\H:EV*H+'KR6(I@B=\0L$2E>EZ0N_W?6ENH*!EU+`.I3N? MFM7%A7L[^)?Q\@M-!VS2'?6ODY.ON@8]H+YU=2"AGG7Q8K&D?YC$>@-OM@SI M6S]\DM`3\0TD/J&O%Y>E?#)H_41O(;ZN'[?E^O"X>SGVGKM"^P7K[?P```/__ M`P!02P,$%``&``@````A`-W;N5.K`P``?`T``!``"`%D;V-0&UL(*($`2B@``$````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````````````````````G%=1 MTBHF_/I1CM0!NNY"0X/QL'(Y!,%5QN)L'W_/K3'\'(6"H+ M*I2$2;`'$WR+?_TE6FE5@;8+<@"BD_5T6'0>;S%:`ZT*=J*<6P%FN5Y1 M;1V4OWSM38HZA.,F5,U=(ZH]P#PP8^0%#V)&MGA"Y. M-'L\^3^5*O[A`GOMN-1HOU/2C43;#7\40*;&O))]#\54"22GS^".L5!RDX,N MR0P>W:QGH/D.9\`.4*D[,+:90J85\!P*)[=K;&?R0$4-Y!:HJ36T-D[LTFY! MDR.-!:>/7/!F0CKA]TA`U\SBJ,'Z-5UT#X):*$BRI=IIDJBRY#W6B<*^DQL< MV$-!%DAZ('Z&4>`*MS&@*G%8FW8\.@.G5$L,9#`[8\@*TVRMG5C435W672;+ MY,:)R:QB3ULE"O1TSS=;/(65H-*)37'-)L7!4_&AL^?O#W;D'P:->4==N*F]T[P>_R-^'.\JO MZ0(?T-\,[JP&NL$7QJ]R=YA.M#ZO`]KUF0Q(V&?R2LD^J%]6[C3]NKIP-L-1 M5S.PE(N?%98?W5.6#W@JK9]'+KB$YN.2:"BX)=29F%^.[F(,R;&CY@PS/*/Q ML^'^:O@5[&;F'=3$R>Q_T?O*.J1Z3[Y#JO>8O%:]C]&;V=Q4<5"7CAGMQ?N; MZJ3R)]?<5Q=;U-^3^5[E:H9?U\/-_70Q:DM;X)WVL/^R$,WQTJY%XR39XD4% MB@/F[4;SG_'0_4S%YY_/QK^-\1>BMQ:%+[]-\7\```#__P,`4$L#!!0`!@`( M````(0#_+Y6^,@$``$`"```1``@!9&]C4')O<',O8V]R92YX;6P@H@0!**`` M`0`````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````""$X=W,3G;@DT:V)D66DP2L;)6VFYH\+^?I#4DP"*M$TUJHR1Z0S/CE124=DZV'1]\Z\$$# M)I%DD4E7DVT(CE&*<@M&8!8;-H;KUAL1XM%OJ!/R76R`EGE^30T$H400]`!, MW4@D`U+)$>D^?-,#E*30@`$;D!990;^[`;S!/R_TR5G3Z+!W<:9!]YRMY#$< MVSO48['KNJR;]!K1OZ"KQ<-3/VJJ[6%7$@@_[*<1&!9QE6L-ZG;/=V^^21"W M%?V=54KV=DQZ$`%4$M]C1[M3\C*YNU_."2_S8IKFD[28+LN&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`#HJTRM;"0``L#4``!D`````````````````]A8``'AL+W=O9)W\+```D2```&0````````````````!) M.```>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#A:L(^X!@``4"0``!D````````` M````````Z$@``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`/$HS]]G!P``3QT``!D`````````````````\6T``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`$]-XKKD"P``5#@``!D`````````````````A9,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)$,(A:."0``&2\` M`!D`````````````````JK$``'AL+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(````(0!:[[Y"G@\``'2J M```-`````````````````#3"``!X;"]S='EL97,N>&UL4$L!`BT`%``&``@` M```A`/-2R*8,C0``0MX!`!0`````````````````_=$``'AL+W-H87)E9%-T M&UL4$L!`BT`%``&``@````A`#E:4>C9`@``P@@``!@````````` M````````.U\!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!/<:N"8`@`` M4@8``!D`````````````````2W8!`'AL+W=O0$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``)N@'&PO=V]R:W-H M965T`0!X;"]W;W)K&UL4$L! M`BT`%``&``@````A`!L)O]TO!```CA```!@`````````````````W*0!`'AL M+W=O3`RQ`` M`#!5```9`````````````````$&I`0!X;"]W;W)K&UL4$L!`BT`%``&``@````A`%73'@:U!```0!```!D````````````````` M0[H!`'AL+W=O&PO=V]R:W-H965TMYH6A<``$=[```9```````` M`````````!_.`0!X;"]W;W)K&UL4$L!`BT`%``& M``@````A`+\.M=Q>"@``XS(``!D`````````````````L.4!`'AL+W=OX5Y630#``#]"0``&0`````````````` M```B*@(`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/[-=#B3`@``9`8``!@````` M````````````#38"`'AL+W=O/`(`>&PO=V]R:W-H965T&UL4$L! M`BT`%``&``@````A`#5&MVX""```MBD``!@`````````````````(C\"`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%;$,YCK!```]Q(``!D````````` M````````C&4"`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`%7;=77_!```@1$``!D`````````````````98$"`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`)13!=2`$```!%8``!D`````````````````2JD"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/>JJL?6"````R8` M`!D`````````````````T\`"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A M`/\OE;XR`0``0`(``!$`````````````````+P$#`&1O8U!R;W!S+V-O&UL4$L%!@````!$`$0`CA(``)@#`P`````` ` end XML 19 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings (Loss) Per Share (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Numerator [Abstract]                      
Net income (loss)- numerator for basic earnings per share $ (5,290) [1],[2] $ 1,799 [2] $ (1,101) [1] $ (3,949) [1] $ 604 [3] $ 5,028 $ 5,057 $ (2,665) [1] $ (8,541) $ 8,024 $ (157,693)
Denominator [Abstract]                      
Shares used for basic earnings (loss) per share (in shares)                 34,489 33,597 33,677
Shares used for diluted earnings (loss) per share (in shares)                 34,489 [4] 33,836 [4] 33,677 [4]
Earnings per share [Abstract]                      
Basic (in dollars per share)                 $ (0.25) $ 0.24 $ (4.68)
Diluted (in dollars per share)                 $ (0.25) [4] $ 0.24 [4] $ (4.68) [4]
Non-Qualified Stock Options [Member]
                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive (in shares)                 3,234 4,926 4,845
Restricted Stock Units [Member]
                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive (in shares)                 334 193 469
Warrants Related to Cash Convertible Notes [Member]
                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive (in shares)                 7,707 0 0
CareFirst Convertible Note [Member]
                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive (in shares)                 892 0 0
Non-Qualified Stock Options [Member]
                      
Denominator [Abstract]                      
Effect of dilutive stock options and restricted stock units outstanding (in shares)                 0 [4] 37 [4] 0 [4]
Restricted Stock Units [Member]
                      
Denominator [Abstract]                      
Effect of dilutive stock options and restricted stock units outstanding (in shares)                 0 [4] 202 [4] 0 [4]
[1] The assumed exercise of stock-based compensation awards for this period was not considered in the calculation of diluted earnings (loss) per share because the impact would have been anti-dilutive.
[2] Includes charges related to non-cash interest associated with amortization of a debt discount of $1.5 million and $1.6 million for the third and fourth quarter, respectively.
[3] Includes charges related to one-time termination benefits associated with capacity realignment of $1.8 million.
[4] The assumed exercise of stock-based compensation awards for the years ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive.

XML 20 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt (Details) (USD $)
 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Jul. 16, 2013
Jul. 01, 2018
Cash Convertible Notes [Member]
Jul. 16, 2013
Cash Convertible Notes [Member]
Dec. 31, 2013
Cash Convertible Notes [Member]
Oct. 01, 2019
CareFirst Convertible Note [Member]
Oct. 01, 2013
CareFirst Convertible Note [Member]
Dec. 31, 2013
CareFirst Convertible Note [Member]
Debt Instrument [Line Items]                    
Notes, Issuance Date           Jul. 16, 2013     Oct. 01, 2013  
Date of Registration Rights Agreement                 Oct. 01, 2013  
Debt Instrument, Maturity Date         Jul. 01, 2018     Oct. 01, 2019    
Debt Instrument, Interest Rate, Effective Percentage 5.66%                  
Amortization of debt discount $ 3,140,000 $ 0 $ 0              
Debt Instrument, Convertible, Conversion Ratio             51.38      
Debt Instrument, Unamortized Discount 33,600,000         36,750,000        
Deferred Finance Costs, Gross       3,939,543            
Interest Rate for Notes       1.50%         4.75%  
Aggregate Principal of convertible notes       150,000,000     150,000,000   20,000,000 20,000,000
Debt Instrument, Convertible, Conversion Price           $ 19.46     $ 22.41  
Payments for Hedge, Financing Activities 36,750,000 0 0     36,750,000        
Initial Conversion rate           $ 19.46     $ 22.41  
Warrants Strike Price $ 25.95                  
Minimum annual principal payments and repayments of the revolving advances [Abstract]                    
2014 12,500,000                  
2015 17,500,000                  
2016 20,000,000                  
2017 63,625,000                  
2018 150,000,000                  
2019 and thereafter 20,000,000                  
Total 283,625,000                  
Conversion price premium percentage 60.00%                  
Warrant Shares Initially Sold underlying Cash Convertible Notes Hedges       7,700,000            
Debt Instrument, Carrying Amount             116,400,000      
Debt Instrument, Unamortized Discount $ 33,600,000         $ 36,750,000        
CareFirst Warrant Shares Maximum                 1,600,000  
CareFirst Warrant Shares for one year period                 400,000  
XML 21 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt (Tables)
 12 Months Ended
Dec. 31, 2013
Long-Term Debt [Abstract]  
Minimum annual principal payments and repayments of the revolving advances
 The following table summarizes the minimum annual principal payments and repayments of the revolving advances under the Fifth Amended Credit Agreement, the Cash Convertible Notes, and the CareFirst Convertible Note for each of the next five years and thereafter:
(In thousands)
 
 
Year ending December 31,
 
 
2014
 
$
12,500
 
2015
  
17,500
 
2016
  
20,000
 
2017
  
63,625
 
2018
  
150,000
 
2019 and thereafter
  
20,000
 
Total
 
$
283,625
 
XML 22 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 23 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Benefits (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Employee Benefits [Abstract]      
Company contributions under the 401(k) Plan $ 3.1 $ 2.9 $ 3.5
XML 24 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholder Rights Plan
 12 Months Ended
Dec. 31, 2013
Stockholder Rights Plan [Abstract]  
Stockholder Rights Plan
16.
Stockholder Rights Plan

On June 19, 2000, our Board adopted a stockholder rights plan under which holders of common stock as of June 30, 2000 received preferred stock purchase rights as a dividend at the rate of one right per share.  As amended in June 2004 and July 2006, each right initially entitles its holder to purchase one one-hundredth of a Series A preferred share at $175.00, subject to adjustment.  Upon becoming exercisable, each right will allow the holder (other than the person or group whose actions have triggered the exercisability of the rights), under alternative circumstances, to buy either securities of the Company or securities of the acquiring company (depending on the form of the transaction) having a value of twice the then current exercise price of the rights.

With certain exceptions, each right will become exercisable only when a person or group acquires, or commences a tender or exchange offer for, 15% or more of our outstanding common stock.  Rights will also become exercisable in the event of certain mergers or asset sales involving more than 50% of our assets or earning power.  The rights will expire on June 15, 2014, unless redeemed or exchanged.  Our Board reviews the plan periodically to determine if the maintenance and continuance of the plan is still in the best interests of the Company and its stockholders.
 
XML 25 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Other Long-Term Liabilities (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Other Long-Term Liabilities [Abstract]    
Vested amounts under the non-qualified deferred compensation plan $ 6.8 $ 6.6
Current portions of the non-qualified deferred compensation plan 1.0 4.1
Estimated future plan payments under non-qualified deferred compensation plan [Abstract]    
2014 1.0  
2015 0.3  
2016 0.4  
2017 0.3  
2018 0.2  
Accrued performance cash amount 0 0
Accrued performance cash amount, current portion 0 2.0
Estimated future plan payments for performance cash awards [Abstract]    
2014 $ 0  
XML 26 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Summary of Significant Accounting Policies [Abstract]      
Number of states in which customers are located 50    
Property, Plant and Equipment [Line Items]      
Property and equipment, net $ 158,198,000 $ 156,494,000  
Depreciation 40,100,000 39,100,000 36,600,000
Finite-Lived Intangible Assets [Line Items]      
Intangible assets not subject to amortization 29,000,000 29,000,000 29,000,000
Revenue Recognition [Abstract]      
Percentage of performance based revenues (in hundredths) 4.00%    
Percentage of performance based revenues subject to final reconciliation (in hundredths) 3.00%    
Cumulative performance-based revenues not settled yet but recognized 24,200,000    
Net increase in revenue relating to services provided in prior periods 8,200,000 9,200,000 2,900,000
Minimum [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Estimated useful life 2 years    
Maximum [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Estimated useful life 25 years    
Computer Software and Hardware [Member] | Minimum [Member]
      
Property, Plant and Equipment [Line Items]      
Useful life 3 years    
Computer Software and Hardware [Member] | Maximum [Member]
      
Property, Plant and Equipment [Line Items]      
Useful life 7 years    
Furniture and Other Office Equipment [Member]
      
Property, Plant and Equipment [Line Items]      
Useful life 4 years    
Furniture and Other Office Equipment [Member] | Maximum [Member]
      
Property, Plant and Equipment [Line Items]      
Useful life 7 years    
Leasehold Improvements [Member] | Minimum [Member]
      
Property, Plant and Equipment [Line Items]      
Useful life 2 years    
Leasehold Improvements [Member] | Maximum [Member]
      
Property, Plant and Equipment [Line Items]      
Useful life 15 years    
Computer Software [Member]
      
Property, Plant and Equipment [Line Items]      
Property and equipment, net 99,100,000 103,700,000  
Depreciation $ 26,500,000 $ 24,900,000 $ 21,400,000
XML 27 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Leases (Tables)
 12 Months Ended
Dec. 31, 2013
Leases [Abstract]  
Summary of future minimum lease payments under all capital leases and non-cancelable operating leases
The following table summarizes our future minimum lease payments under all capital leases and non-cancelable operating leases for each of the next five years and thereafter:

 
(In thousands)
 
Capital
  
Operating
 
Year ending December 31,
 
Leases
  
Leases
 
2014
 
$
1,199
  
$
13,198
 
2015
  
66
   
11,781
 
2016
  
—
   
10,764
 
2017
  
—
   
10,198
 
2018
  
—
   
10,707
 
2019 and thereafter
  
—
   
33,262
 
Total minimum lease payments
 
$
1,265
  
$
89,910
 
Less amount representing interest
  
(34
)
    
Present value of minimum lease payments
  
1,231
     
Less current portion
  
(1,166
)
    
 
 
$
65
     
XML 28 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Contractual Commitment [Abstract]  
Minimum remaining contractual cash obligations $ 42.0
Total minimum payments required under outsourcing agreement over remaining term 142.2
Estimate of remaining payments pursuant to outsourcing agreement $ 297.6
XML 29 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt, Line of Credit and Term Loan (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
LIBOR [Member]
  
Line of Credit Facility [Line Items]  
Basis spread on variable rate increased (in hundredths) 0.0025
Fifth Amended Credit Agreement [Member]
  
Line of Credit Facility [Line Items]  
Initiation date Jun. 08, 2012
Maximum borrowing capacity $ 200
Expiration date Jun. 08, 2017
Amount outstanding 110
Availability under the revolving credit facility under most restrictive covenant 38.7
Interest rate description Borrowings under the Fifth Amended Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month rate (or with the approval of affected lenders, nine-month or twelve-month rate) for Eurodollar deposits ("LIBOR") or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company. The LIBOR margin varies between 1.75% and 3.00%, and the Base Rate margin varies between 0.75% and 2.00%, depending on our leverage ratio. On February 5, 2013, we entered into a First Amendment to the Fifth Amended Credit Agreement, which included, among other things, a temporary increase in the LIBOR and Base Rate margins of 0.25%. The increased margins are effective through December 31, 2013 and apply only in the event that our total funded debt to EBITDA ratio is greater than or equal to 3.50 to 1.00.
Commitment fee description The Fifth Amended Credit Agreement also provides for an annual fee ranging between 0.30% and 0.50% of the unused commitments under the revolving credit facility.
Letters of Credit Sub Facility [Member]
  
Line of Credit Facility [Line Items]  
Maximum borrowing capacity 75
Swingline Sub Facility [Member]
  
Line of Credit Facility [Line Items]  
Maximum borrowing capacity 20
Term Loan Facility [Member]
  
Line of Credit Facility [Line Items]  
Terms of periodic payments We are required to repay outstanding revolving loans under the revolving credit facility on June 8, 2017. We are required to repay term loans in quarterly principal installments aggregating (1) 1.250% of the original aggregate principal amount of the term loans during each of the eight quarters beginning with the quarter ended September 30, 2012, (2) 1.875% of the original aggregate principal amount of the term loans during each of the next four quarters beginning with the quarter ending September 30, 2014, and (3) 2.500% of the original aggregate principal amount of the term loans during each of the remaining quarters prior to maturity on June 8, 2017, at which time the entire unpaid principal balance of the term loans is due and payable.
Maturity date Jun. 08, 2017
Uncommitted Incremental Accordion Facility [Member]
  
Line of Credit Facility [Line Items]  
Maximum borrowing capacity $ 200
XML 30 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net income (loss) $ (8,541) $ 8,024 $ (157,693)
Adjustments to reconcile net income to net cash provided by operating activities, net of business acquisitions:      
Depreciation and amortization 52,791 51,734 49,988
Impairment loss 0 0 183,288
Amortization of deferred loan costs 1,685 2,284 1,894
Amortization of debt discount 3,140 0 0
Share-based employee compensation expense 7,116 6,371 9,246
Deferred income taxes (5,077) (1,334) (3,572)
Excess tax benefits from share-based payment arrangements (718) (492) (433)
Decrease (increase) in accounts receivable, net 19,099 (23,439) (7,452)
Increase (decrease) in other current assets (598) 2,984 6,960
Increase (decrease) in accounts payable 9,224 (995) 1,466
Decrease in accrued salaries and benefits (5,780) (12,980) (8,932)
(Decrease) increase in other current liabilities (1,196) 13,637 2,676
Other 383 (5,096) (1,144)
Net cash flows provided by operating activities 71,528 40,698 76,292
Cash flows from investing activities:      
Acquisition of property and equipment (41,346) (48,912) (49,290)
Business acquisitions, net of cash acquired, and equity investments (830) (4,693) (23,523)
Other (7,717) (6,872) (6,889)
Net cash flows used in investing activities (49,893) (60,477) (79,702)
Cash flows from financing activities:      
Proceeds from issuance of long-term debt 352,850 755,550 439,621
Payments of long-term debt (529,874) (736,355) (417,490)
Repurchases of common stock 0 0 (23,690)
Excess tax benefits from share-based payment arrangements 718 492 433
Exercise of stock options 12,748 2,835 4,825
Deferred loan costs (5,264) (2,547) 0
Proceeds from cash convertible senior notes 150,000 0 0
Proceeds from convertible note 20,000 0 0
Proceeds from sale of warrants 15,150 0 0
Payments for cash convertible note hedge transactions (36,750) 0 0
Change in outstanding checks and other 526 582 (709)
Net cash flows (used in) provided by financing activities (19,896) 20,557 2,990
Effect of exchange rate changes on cash (914) 117 220
Net increase (decrease) in cash and cash equivalents 825 895 (200)
Cash and cash equivalents, beginning of period 1,759 864 1,064
Cash and cash equivalents, end of period 2,584 1,759 864
Supplemental disclosure of cash flow information:      
Cash paid during the period for interest 10,080 12,001 11,106
Cash paid during the period for income taxes 650 2,282 7,874
Noncash Activities:      
Issuance of unregistered common stock associated with Navvis acquisition 0 0 3,262
Issuance of unregistered common stock associated with Ascentia acquisition 0 58 0
Issuance of unregistered common stock associated with Ornish partnership $ 467 $ 0 $ 0
EXCEL 31 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A-30W8S'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E137T]&7T-/ M33$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DEN=&%N9VEB;&5?07-S971S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D1E#I%>&-E;%=O#I. M86UE/D9A:7)?5F%L=65?365A#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQE M87-E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-H M87)E0F%S961?0V]M<&5N#I%>&-E;%=O#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5M<&QO>65E7T)E;F5F:71S/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/DQE87-E#I7;W)K#I7 M;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I. M86UE/DEN8V]M95]487AE#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]T:&5R7TQO;F=497)M7TQI86)I;&ET:65S7T1E M=#PO>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-H87)E0F%S961?0V]M<&5N#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C8W5M=6QA=&5D7T]#25]$971A:6QS/"]X.DYA;64^#0H@ M("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I.86UE M/E-E9VUE;G1?1&ES8VQO#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E%U87)T97)L>5]&:6YA;F-I86Q?26YF M;W)M871I;S(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I3='EL M97-H965T($A2968],T0B5V]R:W-H965T3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A-30W8S'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO'0^)TAE86QT:'=A>7,L($EN8RX\'0^)SQS<&%N/CPO M'0^)TYO/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO2!#=7)R96YT(%)E<&]R=&EN9R!3=&%T=7,\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$P+4L\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT+"!G M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D+"`S-2PQ,#2!S=&]C:RP@870@8V]S="P@,BPR-30L.34S('-H87)E3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!S=&]C:R`H:6X@3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO"!E>'!E;G-E("AB96YE9FET*3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'1087)T7V$U-#=C-S5A M7S`P-C)?-#$V,U]B9#=D7V4V,F8W,3$T864X-0T*0V]N=&5N="U,;V-A=&EO M;CH@9FEL93HO+R]#.B]A-30W8S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS M<&%N/CPOF%T M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,V+#$X,SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^ M)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XD(#DW,CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO2!;4F]L;"!&;W)W87)D73PO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!;4F]L;"!&;W)W M87)D73PO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!O9B!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]A-30W8S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!O<&5R871I M;F<@86-T:79I=&EE'0^)SQS M<&%N/CPO"!B96YE9FET6UE;G0@87)R86YG96UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M/B@W,3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!O<&5R871I;F<@86-T M:79I=&EE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!O9B!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPW-#@\6UE;G1S(&9O'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-3`\ M'0^)SQS<&%N/CPO M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%M! M8G-T'0^)SQD:78@F4Z(#$P<'0[('9E M6QE/3-$)W1E>'0M86QI9VXZ(&IU3H@07)I86P[(&9O;G0M2!R961U8VEN9R!B;W1H M(&1I7-T96US+"!H;W-P:71A;',L('!H>7-I8VEA;G,L M(&%N9"!G;W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M'0@;W1H97)W:7-E(&EN9&EC871E2!T;R!(96%L=&AW87ES+"!);F,N(&%N9"!I=',@=VAO;&QY+6]W;F5D('-U M8G-I9&EA6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M2!A;F0@:71S('-U8G-I9&EA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M2!I;F-L=61E(&-A"UE>&5M<'0@ M9&5B="!I;G-T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!2!R97!R97-E;G0@ M9F5E2!R97!R97-E;G0@9F5E6UE;G0@86YD('1H97)E9F]R92!C M;VYS:61E6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!F4@9&5P2P@:6YC M;'5D:6YG(&%M;W)T:7IA=&EO;B!O9B!A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M2XF(S$V,#L@1&5P2X\+V1I=CX\9&EV/CQBF%T:6]N+CPO M9&EV/CQD:78^/&)R("\^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R!T97AT+6EN9&5N=#H@,S9P=#L@9F]N="UF86UI;'DZ($%R:6%L M.R!F;VYT+7-I>F4Z(#$P<'0[)SYF+B8C,38P.R!);G1A;F=I8FQE($%SF%T:6]N M(&EN8VQU9&4@8W5S=&]M97(@8V]N=')A8W1S+"!A8W%U:7)E9"!T96-H;F]L M;V=Y+"!P871E;G1S+"!D:7-T65A6EN9R!V86QU M97,@;6%Y(&YO="!B92!R96-O=F5R86)L92X\+V1I=CX\9&EV/CQB2!W:&5N M979E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0MF4Z(#$P<'0[)SY7 M92!R979I97<@9V]O9'=I;&P@9F]R(&EM<&%I2!W:&5N979E6EN9R!V86QU M92!M87D@;F]T(&)E(')E8V]V97)A8FQE+B8C,38P.R!792!A;&QO8V%T92!G M;V]D=VEL;"!T;R!R97!OF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M&-E&-E3H@ M07)I86P[(&9O;G0M3H@07)I86P[(&9O M;G0M3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/&9O;G0@F4Z(#$P M<'0[)SYI+B!);F-O;64@5&%X97,@+2!792!F:6QE(&$@8V]N"!R971U2!O=VYE9"!S=6)S:61I87)I97,N)B,Q M-C`[($=E;F5R86QL>2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@ M:6X@=&AE(%5N:71E9"!3=&%T97,@*")5+E,N($=!05`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`S-G!T M.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M2!O8V-U65T(&)E96X@2`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`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M2!C;W5N=&5R<&%R='D@:6X@=&AE(&-O;G-O;&ED871E9"!B86QA;F-E('-H M965TF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M'!E;G-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE M/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W=I9'1H.B`Y M,"4[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&IUF4Z(#$P M<'0[)SY);B!*=6QY(#(P,3(L('1H92!&05-"(&ES6EN9R!V86QU92XF(S$V,#L@268@=&AE(&5N=&ET>2!C;VYC;'5D97,@=&AA M="!T:&ES(&ES('1H92!C87-E+"!I="!M=7-T('!E2!P65AF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M2!C;VUP;VYE;G0N($EN(&%D9&ET:6]N+"!E;G1I M=&EE6EN9R!N;W1E2!I M9B!T:&4@86UO=6YT(')E8VQA2!T;R!N970@:6YC;VUE+"!E;G1I=&EEF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO M6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0MF4Z(#$P<'0[ M('9E6QE/3-$)W=I9'1H.B`X-24[(&9O M;G0M9F%M:6QY.B!!6QE/3-$)V)A M8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY M.B!!F4Z(#$P<'0[ M)SY);7!A:7)M96YT(&QO6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3,E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&UA6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXS,S4L,SDR/"]D:78^/"]T9#X\ M=&0@;F]W6QE/3-$ M)V)A8VMG"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXS+#,P,SPO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY"86QA;F-E+"!$96-E;6)E M6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@07)I86P[(&UA6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X M.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S M='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY"86QA;F-E+"!$96-E;6)E6QE/3-$)V9O;G0M9F%M:6QY.B!! M"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M2`H(DYA=G9I7-T96US+"!F;W(@)#(S+C<@;6EL;&EO;B!I M;B!C87-H+B8C,38P.R!);B!A9&1I=&EO;BP@=V4@:7-S=65D(#0S,BPY,#(@ M=6YR96=IF4Z(#$P<'0[)SY792!P97)F;W)M960@82!Q=6%N=&ET M871I=F4@9V]O9'=I;&P@:6UP86ER;65N="!R979I97<@9'5R:6YG('1H92!F M;W5R=&@@<75A6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M65R('-T M7-I8VEA;B!P6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)W=I9'1H M.B`Q,#`E.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0MF4Z(#$P<'0[('9E6QE/3-$ M)W=I9'1H.B`Y-24[(&9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O M;G0M6EN9SPO9&EV/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M06-C=6UU;&%T960\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1EF4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^06UOF%T:6]N/"]D:78^/"]T9#X\=&0@ M;F]W6QE/3-$)V)O M6QE/3-$)W=I9'1H M.B`U."4[('9E6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]T3H@07)I86P[(&UA M6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA M3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,24[('9E M6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXR-"PU-#<\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXY+#0V-CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY$:7-T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X M.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S M='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`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`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N M9"UC;VQO6QE M/3-$)V)O3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ,##L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@ M07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y-24[(&9O;G0M9F%M:6QY.B!! M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1EF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1W)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^06UO=6YT/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG MF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B!!F4Z(#$P<'0[)SXT-"PU-S$\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I M86P[(&UA3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXR-"PS,S<\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXQ,2PV,30\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@07)I86P[(&9O;G0M M2UB87-E9"!D871A/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I86P[(&UA M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@07)I86P[(&UA6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O6QE M/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[ M('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)O M3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O M;G0M#L@8F%C:V=R;W5N9"UC;VQOF%T:6]N(&5X<&5N6QE/3-$)W=I9'1H.B`V-24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^*$EN('1H M;W5S86YD6QE/3-$ M)W9E6QE/3-$)W=I9'1H.B`V-24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^665A M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\ M+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T3H@07)I86P[(&UA3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXV+#6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXR,#$V/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[ M(&UA6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQD:78@F4Z(#4N M,31P=#LG/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.SPO9F]N=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M3H@07)I86P[(&UA M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M('1O<#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0Q,"!V86QI9VX],T1B M;W1T;VT@3H@07)I86P[ M(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O#L@=F5R=&EC86PM M86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/CQD:78@3H@07)I86P[(&9O;G0M M"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q M-C`[/"]T9#X\+W1R/CQT6QE/3-$ M)W=I9'1H.B`U-24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[ M(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY#=7)R96YT('1A>&5S/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=CX\ M+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,24[('9E#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^ M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@=&]P.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P M.SPO=&0^/"]T3H@07)I86P[ M(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S M='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M M#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O M;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A M;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0MF4Z(#$P<'0[)SY&;W)E:6=N/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@ M=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@ M07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V M97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXT+#@P,SPO9&EV/CPO=&0^/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0MF4Z(#$P<'0[)SY3=&%T93PO9&EV/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T M:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXH-2PV,S8\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F6QE/3-$)V)O3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M"!P=7)P;W-E2!A6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M#L@=VED=&@Z(#4U)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@"!S;VQI9#L@=VED=&@Z(#$N-3$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q<'@[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(@,S$L M(#(P,3(\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q+C4Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q<'@[('9E M#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T3H@07)I86P[ M(&UA6QE/3-$)W=I9'1H.B`Q<'@[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,7!X.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[ M(&9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I M86P[(&UA6UE;G1S/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXW+#DQ-#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M-RXR<'0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,7!X.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXQ+#0X-CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M-RXR<'0[(&9O;G0M9F%M:6QY.B!!'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG M;CH@6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXH,RPR-#(\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)OF4Z(#$P<'0[)SXS."PU,#<\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!! MF4Z(#$P<'0[)SY$ M969E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@;F]WF4Z(#$P M<'0[)SY02!A;F0@97%U:7!M96YT/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXH-#0L-S0P/"]D:78^ M/"]T9#X\=&0@;F]W3H@07)I86P[(&9O;G0M#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!! M3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B!!#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@F4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R/CQT6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`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`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O M'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\ M+W1R/CQT6QE/3-$)W!A9&1I;F6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B!!F4Z M(#$P<'0[)SY.970@9&5F97)R960@=&%X(&QI86)I;&ET>3PO9&EV/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,2XU,24[ M('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)V)O3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,7!X M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY M.B!!F4Z(#$P<'0[ M)SY.970@8W5R6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG M3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXH,S,L,S(P/"]D:78^/"]T9#X\=&0@;F]W3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE M/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXH,C,L-C4S/"]D:78^/"]T9#X\=&0@;F]W3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#1P>"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M6QE/3-$)V-L M96%R.B!B;W1H.R<^/&)R("\^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,S9P=#L@9F]N="UF86UI;'DZ($%R M:6%L.R!F;VYT+7-I>F4Z(#$P<'0[)SY"87-E9"!O;B!T:&4@0V]M<&%N>2=S M(&AI&ES=&EN9R!D969EF4Z(#$P<'0[)SY&;W(@,C`Q,RP@,C`Q,B!A;F0@,C`Q,2P@=&AE M('1A>"!B96YE9FET(&]F('-H87)E+6)A6UE;G1S+"!W87,@F4Z M(#$P<'0[)SY!="!$96-E;6)E2`D,3,N.2!M:6QL:6]N('=I=&@@86X@:6YD969I M;FET92!C87)R>69O&EM871E M;'D@)#$W+C<@;6EL;&EO;B!O9B!S=&%T92!L;W-S(&-A'!IF5D(&1U2=S(&9O M&EM871E;'D@ M)#$P+C<@;6EL;&EO;B!A2P@;F\@52Y3+B!F961E&5S("AS M=6)J96-T('1O(&%N(&%D:G5S=&UE;G0@9F]R(&9OF5D(&1E9F5R"!L:6%B:6QI='D@:7,@;F]T('!R86-T:6-A;"!B M96-A=7-E(&]F('1H92!C;VUP;&5X:71I97,@87-S;V-I871E9"!W:71H(&ET M7!O=&AE=&EC86P@8V%L8W5L871I;VX[(&AO=V5V97(L('5N"!C"!L:6%B:6QI='DN M/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN M9&5N=#H@,S9P=#L@9F]N="UF86UI;'DZ($%R:6%L.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`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`C96%F.64X.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O M;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M3H@07)I86P[ M(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY.;VXM9&5D=6-T M:6)L92!G;V]D=VEL;"!I;7!A:7)M96YT(&5X<&5N6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXV,2PW.#4\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA M&5S+"!L97-S(&9E9&5R86P@:6YC;VUE('1A>"!B96YE9FET/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXR.#4\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY5;F-E6QE/3-$)W!A9&1I;FF4Z(#$P<'0[)SXH,2PQ,S<\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W!A9&1I;FF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^ M/"]T9#X\=&0@;F]W#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@07)I86P[(&UA M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!'0M M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[)SXQ-S$\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@ MF4Z(#$P<'0[)SXS,S,\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@07)I86P[(&UA#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O3H@07)I86P[(&9O;G0M3H@07)I86P[ M(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO M3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M M3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0MF5D('1A>"!B96YE9FET(&1U92!T;R!T M:&4F(S$V,#ME>'!I65A2P@;V8@=6YR96-O9VYI>F5D('1A M>"!B96YE9FETF5D+"!W;W5L9"!A9F9E8W0@ M;W5R(&5F9F5C=&EV92!T87@@2!I6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M&-L=7-I=F4@;V8@:6YT97)E6QE M/3-$)W=I9'1H.B`Y-24[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W9E3H@07)I M86P[(&UAF5D('1A>"!B96YE9FET3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B!!F4Z(#$P M<'0[)SY$96-R96%S97,@8F%S960@=7!O;B!T87@@<&]S:71I;VYS(')E;&%T M960@=&\@<')I;W(@>65A6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@ M07)I86P[(&UAF5D('1A>"!B96YE9FET3H@07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY$96-R96%S97,@8F%S960@ M=7!O;B!A(&QA<'-E(&]F('1H92!A<'!L:6-A8FQE('-T871U=&4@;V8@;&EM M:71A=&EO;G,\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&UAF5D('1A>"!B96YE9FET6QE/3-$)V9O;G0M9F%M M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V-L96%R.B!B;W1H M.R<^/&)R("\^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T M:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9F]N="UF86UI;'DZ($%R:6%L.R!F M;VYT+7-I>F4Z(#$P<'0[)SY792!F:6QE(&EN8V]M92!T87@@65A'10 M87)T7V$U-#=C-S5A7S`P-C)?-#$V,U]B9#=D7V4V,F8W,3$T864X-0T*0V]N M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]A-30W8S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M MF4Z(#$P<'0[('9E M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M2!I;B!A2`Q M(&]F(&5A8V@@>65A2`Q+"`R,#$X+"!U;FQE2!O=&AE2!C:7)C=6US=&%N8V5S+B!4:&4@:6YI=&EA M;"!C87-H(&-O;G9E&EM M871E;'D@)#,N.2!M:6QL:6]N+"!W:&EC:"!AF5D M(&]V97(@=&AE('1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M3H@07)I86P[(&9O;G0MF4Z M(#$P<'0[)SY);B!C;VYN96-T:6]N('=I=&@@=&AE(&ES'!O6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M2!N96=O=&EA=&5D('=A M&5R M8VES92!D871E('5N9&5R('1H92!T97)M&-E961S('1H92!S=')I:V4@<')I8V4@;V8@=&AE('=A2!S=&]C:R(@ M;65T:&]D('=I;&P@8F4@=7-E9"!I;B!C86QC=6QA=&EN9R!T:&4@9&EL=71I M=F4@969F96-T(&]N(&5A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M2!O=&AE2P@=VAI8V@@8W5R2!T:&4@ M0V%S:"!#;VYV97)T:6)L92!.;W1E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY4:&4@0V%R949IF4Z(#$P<'0[)SY#87)E1FER2!T:')E2!2979E;G5E(&ES M(&=R96%T97(@=&AA;B!O6UE;G0@:6X@86-C;W)D M86YC92!W:71H('1H92!T97)M2!S=&]C M:R(@;65T:&]D('=I;&P@8F4@=7-E9"!I;B!C86QC=6QA=&EN9R!T:&4@9&EL M=71I=F4@969F96-T(&]N(&5A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE M/3-$)V9O;G0MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^/&1I=CX\8G(@ M+SX\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU3L@=&5X="UI M;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B!!2!F;W(@;&5T=&5R2!T:&%T(&UA='5R97,@;VX@2G5N92`X+"`R,#$W+"`D,3$P+C`@;6EL;&EO M;B!O9B!W:&EC:"!R96UA:6YE9"!O=71S=&%N9&EN9R!A="!$96-E;6)E2!O9B`D,C`P+C`@;6EL;&EO;BX\+V1I=CX\9&EV/CQB M3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B!!2!B96%R(&EN=&5R97-T(&%T M('9A&-E"UM;VYT:"!R871E("AO2!T:&4@0V]M<&%N>2XF(S$V,#L@5&AE($Q)0D]2(&UA2=S(&%C M=&EV92!D;VUE2=S M(&%N9"!S=6-H('-U8G-I9&EA3L@=&5X="UI;F1E;G0Z(#,V<'0[ M(&9O;G0M9F%M:6QY.B!!F4Z M(#$P<'0[)SY/;B!&96)R=6%R>2`U+"`R,#$S+"!W92!E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0M9F%M:6QY.B!!2!T97)M(&QO86YS(&EN('%U87)T M97)L>2!P65A6QE M/3-$)W=I9'1H.B`X,"4[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]TF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^665A6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[)SXR,#$T M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P M<'0[)SXR,#$U/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT M+69A;6EL>3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UAF4Z(#$P<'0[)SY4;W1A;#PO9&EV/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!! M"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M&5D(&-H87)G92!C;W9EF4Z(#$P<'0[)SY4:&4@1FEF=&@@06UE;F1E9"!#7!I8V%L(&9O M2=S(&-O;6UO;B!S=&]C M:R!A;F0@=&AE(&%M;W5N="!O9B!D:79I9&5N9',@=&AA="!T:&4@0V]M<&%N M>2!C86X@<&%Y('1O(&AO;&1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B!!2!M;V1I9GD@;W5R(&5X<&]S=7)E('1O(&EN=&5R M97-T(')A=&4@2!C;VYV97)T:6YG(&$@<&]R=&EO;B!O9B!O=7(@ M9FQO871I;F<@&5D(&]B;&EG871I;VYS+"!T:'5S M(')E9'5C:6YG('1H92!I;7!A8W0@;V8@:6YT97)E'0@,3(@;6]N=&AS(&1U92!T;R!T:&4@6UE;G0@ M;V8@:6YT97)EF4Z(#$P<'0[)SY4:&4@9F]L;&]W:6YG('1A8FQE('-H;W=S('1H M92!E9F9E8W0@;V8@;W5R(&-A#L@=VED=&@Z(#8S)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T"!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=VED M=&@Z(#8S)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^1&5C96UB97(@,S$L(#(P,3,\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&-O;'-P86X],T0S('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`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`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$ M)V-L96%R.B!B;W1H.R<^/&)R("\^/"]D:78^/&1I=B!S='EL93TS1"=T97AT M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9F]N="UF86UI M;'DZ($%R:6%L.R!F;VYT+7-I>F4Z(#$P<'0[)SY'86ENF5D M(&EN(&]U6QE.B!I=&%L:6,[(&9O M;G0M9F%M:6QY.B!!2!O<'1I;VYS(&%N9"]O M2!F;W(@:&5D9V4@ M86-C;W5N=&EN9R!T2!I;B!T:&4@8V]N6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0S M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@07)I M86P[(&9O;G0M6QE/3-$)V)O6QE/3-$ M)W=I9'1H.B`S,R4[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`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`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[ M(&UA6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`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`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@=VED=&@Z(#(Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ MF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1EF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(@,S$L(#(P,3,\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1EF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(@,S$L(#(P,3(\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)O#L@=VED=&@Z(#(Y)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)V)O6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1EF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1F]R96EG;B!C=7)R96YC>2!E>&-H M86YG92!C;VYT6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^26YT M97)E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`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`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9EF4Z(#$P<'0[)SX\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,24[('9EF4Z(#$P M<'0[)SX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9EF4Z(#$P<'0[)SX\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,24[('9EF4Z(#$P<'0[)SX\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[)SY/=&AE3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@=&]P M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SY/=&AE#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,3$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@;F]W#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@;F]W#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,3$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SY4;W1A;"!A M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M3&EA8FEL:71I97,Z/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X\ M=&0@;F]W6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE.B!I=&%L:6,[('1E>'0M M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@ M=&]P.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SY!8V-R=65D(&QI86)I;&ET:65S/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!F4Z(#$P<'0[)SXR-34\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,3$E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P M<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE M/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$E M.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$E.R!V M97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA M;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$ M)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[ M)SY/=&AE#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`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`C9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)OF4Z(#$P<'0[)SXU,#4\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B M;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)V)O6QE/3-$)V9O M;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXR+#DV,SPO9&EV/CPO=&0^/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQD:78@F4Z(#$P M<'0[)SX\='(^/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0M9F%M:6QY.B!!3L@9F]N="UF86UI;'DZ($%R:6%L.R!F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1F%I6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M2X@5&AE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&UA2!O8G-E2!R969L M96-T(&UA;F%G96UE;G0G6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0MF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SX\8G(@+SXF(S$V,#L\+V1I=CX\=&%B;&4@86QI9VX],T1C M96YT97(@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<] M,T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)V)OF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M*$EN('1H;W5S86YD6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[ M(&UA6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3&5V96P@,CPO M9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$ M)V)OF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^5F%L=64\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F5T=&EN9SQS=7`^("@Q*3PO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M3H@07)I M86P[(&9O;G0M6QE/3-$)W=I9'1H.B`S.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA M6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E M6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T MF4Z M(#$P<'0[)SY&;W)E:6=N(&-U3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG MF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3`E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!3H@07)I M86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P M<'0[)SY,:6%B:6QI=&EE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXV-SPO9&EV/CPO=&0^ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SY);G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@,3`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@07)I86P[(&9O;G0M M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V-L96%R.B!B;W1H.R<^/&)R("\^)B,Q-C`[ M/"]D:78^/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)OF4Z(#$P<'0[)SX\='(^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=VED=&@Z M(#,Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&UAF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^*$EN('1H;W5S86YD6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^3&5V96P@,CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M3F5T=&EN9SQS=7`^("@Q*3PO6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE M/3-$)W=I9'1H.B`S.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T M.R!F;VYT+69A;6EL>3H@07)I86P[(&UA6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`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`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!3H@07)I86P[ M(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SY);G1E6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG3L@9F]N="UF86UI;'DZ($%R:6%L.R!F;VYT M+7-I>F4Z(#$P<'0[)SX\2!W:&5N(&$@;&5G86QL M>2!E;F9OF4Z(#$P<'0[)SY4:&4@9F%I2!D971E3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY4:&4@9F]L;&]W:6YG M('1A8FQE('!R97-E;G1S(&]U#L@=VED=&@Z(#(U)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@6QE/3-$ M)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^0F%L86YC92!A="`\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(@,S$L(#(P,3(\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^4'5R8VAA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M<'@[('9E#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P M(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[ M(&9O;G0M6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M3H@ M07)I86P[(&9O;G0M6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3`E.R!V97)T M:6-A;"UA;&EG;CH@;6ED9&QE.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M#L@=F5R=&EC86PM86QI9VXZ(&UI9&1L93LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@;6ED M9&QE.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@,3`E.R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A M8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@,3`E.R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3L@=&5X="UI;F1E M;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B!!3H@07)I86P[ M(&9O;G0M3L@9F]N="UF M86UI;'DZ($%R:6%L.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\ M+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1"=W:61T:#H@,34E.R!V97)T:6-A M;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@9F]N="US:7IE.B`Q,'!T.R<^)B,Q.#,[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[(#PO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`X-24[('9E M6QE/3-$)W1E>'0M86QI9VXZ M(&IU6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY$=7)I;F<@=&AE(&9O M=7)T:"!Q=6%R=&5R(&]F(#(P,3,L('=E(')E=FEE=V5D(&=O;V1W:6QL(&9O M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S M-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0MF%T:6]N+B8C,38P.R8C,38P.T5S=&EM871I;F<@9F%I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S M-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6%L='D@ M6QE/3-$ M)W1E>'0M86QI9VXZ(&IUF4Z(#$P<'0[)SY);B!A9&1I=&EO;B!T;R!F;W)E:6=N(&-U6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'0[(&9O;G0M9F%M:6QY M.B!!2!O9B!T:&]S92!I M;G-T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`P<'0[(&9O;G0M9F%M:6QY.B!!2P@=&AE($-A3H@07)I86P[(&UAF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'0[(&9O M;G0M9F%M:6QY.B!!2!T6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'0[(&9O;G0M9F%M:6QY.B!!"!A;F0@:7,@=&AE'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0MF4Z(#$P<'0[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M2!O9B!T:&4@0V%S:"!#;VYV M97)S:6]N($1E2=S('!E2!C;VYT2!O=F5R(&9O M=7(@>65A2!I="!A6]U="!D871E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M2P@;F5T(&]F('1H92!C=7)R96YT('!O'0@9FEV92!Y96%R6UE;G1S(&]F("0Q+C`@;6EL;&EO M;BP@)#`N,R!M:6QL:6]N+"`D,"XT(&UI;&QI;VXL("0P+C,@;6EL;&EO;BP@ M86YD("0P+C(@;6EL;&EO;BP@F4Z(#$P<'0[)SY);B!A9&1I=&EO;BP@=6YD97(@;W5R('-T;V-K(&EN8V5N M=&EV92!P;&%N+"!W92!I65EF4Z(#$P<'0[)SXF M(S$V,#L\+V1I=CX\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$ M)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&IU3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SX\ M(2TM06YC:&]R+2T^/"$M+4%N8VAO'!E8W0@=&\@:6YC=7(@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M MF4Z(#$P M<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M#L@=VED=&@Z(#,R)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@"!S;VQI9#L@=VED=&@Z(#$N,#DE.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4F5S M=')U8W1U'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q+C`Y)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=VED=&@Z(#$N,#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@=VED=&@Z(#$N,#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@;F]W"!S;VQI9#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A M;"UA;&EG;CH@;6ED9&QE.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`C96%F M.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[ M(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@ M6QE/3-$)V9O;G0M M9F%M:6QY.B!!'0M M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@8F%C:V=R;W5N9"UC M;VQO6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SX\"!S;VQI9#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&UA3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$N,30E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY!9&1I=&EO M;G,\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$N,30E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M6UE;G1S M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG M6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M,3$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M M#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W!A9&1I M;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE M/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B!!F4Z(#$P M<'0[)SY!8V-R=65D(')E3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[ M(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@;F]W M6UE;G1S/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG MF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXH-C(Y/"]D:78^/"]T9#X\=&0@ M;F]W6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&UA#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`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`C96%F.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[ M('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$N,30E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC M;VQOF4Z M(#$P<'0[)SX\&-L=61E&EM871E;'D@)#`N-B!M:6QL:6]N+"!W:&EC:"!PF4Z M(#$P<'0[)SX\&-L=61E&EM871E;'D@)#$N."!M:6QL:6]N+"!W:&EC:"!PF4Z M(#$P<'0[)SX\6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M2!FF4Z(#$P<'0[)SY);B!$96-E;6)E7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQD:78@F4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG M/3-$,"!C;&%SF4Z(#$P<'0[('9EF4Z(#$P<'0[('9EF4Z(#$P<'0[)SX\=3Y#;VYT6UE;G1S(&UA M9&4@=&\@=7,@=6YD97(@=&AE(&-O;G1R86-T+B!792!B96QI979E('=E('!E M2!R97%U97-T960@=&AA="!T:&4@87)B:71R871OF4Z(#$P<'0[)SXF(S$V,#L\ M+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6YE($-O=6YT>2P@36EC:&EG M86X@2!I;B!T:&4@9&ES8V]V97)Y('!H87-E(&]F M(&QI=&EG871I;VXN)B,Q-C`[(%=E(&1E;GD@4&QA2!D969E;F0@=&AE(&%C=&EO;BXF M(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SX\=3Y0 M97)F;W)M86YC92!!=V%R9"!,87=S=6ET/"]U/CPO9&EV/CQD:78^/&)R("\^ M/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN M9&5N=#H@,S9P=#L@9F]N="UF86UI;'DZ($%R:6%L.R!F;VYT+7-I>F4Z(#$P M<'0[)SY/;B!397!T96UB97(@-"P@,C`Q,BP@36EL=&]N(%!F96EF9F5R("@B M4&QA:6YT:69F(BDL(&-L86EM:6YG('1O(&)E(&$@2!A;F0@=&AE($)O87)D(&]F($1I2=S(#(P,#<@4W1O8VL@26YC96YT:79E(%!L86X@*'1H92`B4&QA;B(I M(&)Y(&=R86YT:6YG($)E;B!2+B!,965D;&4L($IR+BP@0VAI968@17AE8W5T M:79E($]F9FEC97(@86YD(%!R97-I9&5N="!O9B!T:&4@0V]M<&%N>2P@9&ES M8W)E=&EO;F%R>2!P97)F;W)M86YC92!A=V%R9',@=6YD97(@=&AE(%!L86X@ M:6X@=&AE(&9O2!T:&4@4&QA;B!A;F0@=&AA="!T:&4@0V]M<&%N>2=S M(#(P,3(@<')O>'D@'!E M;G-E2=S($UO=&EO;B!T;R!$:7-M:7-S+B!/;B!&96)R=6%R>2`R,2P@,C`Q-"P@ M=&AE($-O;7!A;GD@9FEL960@:71S(&%N6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0M2!C;W5R2!O6QE.B!I=&%L:6,[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SY792!E;G1E MF4Z(#$P M<'0[)SY);B!-87D@,C`Q,2P@=V4@96YT97)E9"!I;G1O(&$@=&5N+7EE87(@ M87!P;&EC871I;VYS(&%N9"!T96-H;F]L;V=Y('-E2`D,30R+C(@;6EL M;&EO;CL@:&]W979E&EM871E;'D@)#(Y-RXV(&UI;&QI;VXN)B,Q-C`[(%1H92!A9W)E96UE;G0@ M86QL;W=S('5S('1O('1E2!C97)T86EN('1E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO3H@07)I86P[ M(&9O;G0MF4Z(#$P<'0[)SX\='(^/'1D M('-T>6QE/3-$)W=I9'1H.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B!A=71O.R!F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0MF4Z(#$P<'0[)SY792!M86EN=&%I;B!O<&5R M871I;F<@;&5A2!F;W(@;W5R(&-O M&EM M871E;'D@,C8T+#`P,"!S<75AF4Z M(#$P<'0[)SYA;F0@;VYE(&]F(&]U2`R,#(S+B8C,38P M.R!792!A;'-O(&QE87-E(&%P<')O>&EM871E;'D@.3(L,#`P('-Q=6%R92!F M965T(&]F(&]F9FEC92!S<&%C92!I;B!#:&%N9&QEF]N82!W:&EC M:"!C;VYT86EN'!I2`V-BPP,#`@ M&EM871E;'D@)#$P+C,@;6EL;&EO;BXF(S$V,#L@5V4@F4Z M(#$P<'0[)SY-;W-T(&]F(&]UF4Z(#$P<'0[)SXF(S$V M,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M65AF4Z(#$P M<'0[)SX\8G(@+SX@)B,Q-C`[/"]D:78^/'1A8FQE(&%L:6=N/3-$8V5N=&5R M(&)O6QE/3-$ M)W=I9'1H.B`U-24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[ M(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^*$EN('1H;W5S86YD M6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^0V%P:71A;#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([ M(&9O;G0M9F%M:6QY.B!!6QE/3-$ M)V)O3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1EF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3&5A6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T:6-A M;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T M:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXQ,2PW.#$\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXQ,"PW-C0\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXQ,"PQ.3@\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@07)I86P[ M(&UA#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`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`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W!A M9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$ M)V)OF4Z(#$P<'0[)SXH,2PQ-C8\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)O3H@ M07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'1087)T7V$U-#=C-S5A7S`P M-C)?-#$V,U]B9#=D7V4V,F8W,3$T864X-0T*0V]N=&5N="U,;V-A=&EO;CH@ M9FEL93HO+R]#.B]A-30W8S'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M65E65AF4Z(#$P<'0[)SY&;VQL;W=I;F<@87)E(&-EF5D(&EN('1H92!C;VYS;VQI9&%T960@65AF4@86YY('-H87)E+6)A#L@=VED=&@Z(#4Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78^)B,Q-C`[/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0Q,"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^665A'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W9E M6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1EF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(@,S$L/"]D:78^/"]T M9#X\=&0@;F]W6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=T M97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B!!6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^1&5C96UB97(@,S$L/"]D:78^/"]T9#X\=&0@;F]W#L@=VED=&@Z(#4Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^,C`Q,3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXW+C$\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!F4Z(#$P<'0[)SXY+C(\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY3:&%R92UB M87-E9"!C;VUP96YS871I;VX@:6YC;'5D960@:6X@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXT+C(\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXS+C0\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY3:&%R92UB87-E9"!C;VUP96YS M871I;VX@:6YC;'5D960@:6X@6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,24[('9E M6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O M;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY4;W1A;"!I;F-O;64@=&%X(&)E;F5F:70@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`S-G!T.R!F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F"!S;VQI9#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L M"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@07)I86P[(&9O;G0M'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]T"!S;VQI9#L@<&%D9&EN9RUB;W1T M;VTZ(#)P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/CQD:78@3H@07)I86P[(&9O;G0M M"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=F5R M=&EC86PM86QI9VXZ('1O<#LG/CQD:78@3H@07)I86P[(&9O;G0M"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P M(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[ M(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B!!F4Z(#$P M<'0[)SY796EG:'1E9"!A=F5R86=E(&=R86YT+61A=&4@9F%I3H@ M07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!F4Z(#$P<'0[)SXT+C`Q/"]D:78^/"]T9#X\ M=&0@;F]W6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@07)I86P[(&UA6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY2:7-K+69R964@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!2!AF4Z(#$P M<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#)P M>#L@=VED=&@Z(#,U)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@07)I86P[(&UA6QE/3-$)V)O6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M5V5I9VAT960@079E3H@07)I86P[(&9O;G0M#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)V)O M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,30P<'@[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8V]L6QE M/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR M<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY'6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,30P<'@[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)V)A8VMG#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8V]L6QE/3-$)V)A8VMG M6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`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`C M96%F.64X.R!W:61T:#H@,24[('9E6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/CQD:78@F4Z(#$P<'0[)SXQ,2XS-#PO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@,24[('9E6QE/3-$)V)A8VMG#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,24[('9E#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$ M)V)A8VMG#L@8F%C:V=R;W5N9"UC;VQO#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[ M(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R M;W5N9"UC;VQO#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O M3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ,RPQ.#(\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F3H@07)I86P[(&UA#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,30P M<'@[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R;W5N M9"UC;VQO6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[ M('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`S-G!T.R!F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M3F]N=F5S=&5D(%-H87)E6QE/3-$)V)O M'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[ M('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^5V5I9VAT960@079E"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[ M(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY.;VYV97-T960@870@2F%N=6%R>2`Q+"`R,#$S/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B!!F4Z(#$P M<'0[)SY'6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O M;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY697-T960\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,33H@07)I86P[ M(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&)A8VMG"!S;VQI M9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O M;G0M9F%M:6QY.B!!'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@07)I86P[(&UA6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'1087)T M7V$U-#=C-S5A7S`P-C)?-#$V,U]B9#=D7V4V,F8W,3$T864X-0T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B]A-30W8S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W=I9'1H M.B`Q,#`E.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3L@=VED=&@Z(&%U=&\[(&9O M;G0M9F%M:6QY.B!!6QE M/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M65A6QE/3-$)W=I9'1H.B`Y-24[(&9O;G0M9F%M:6QY.B!! M#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)V)O"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C M,38P.SPO=&0^/"]T3H@07)I86P[(&UA"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI M9VXZ('1O<#LG/CQD:78@3H@07)I86P[(&9O;G0M"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=F5R=&EC86PM86QI M9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@07)I86P[(&UAF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M,C`Q,3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@'0M86QI9VXZ(&QE9G0[('9E#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O MF4Z(#$P<'0[)SXH."PU-#$\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`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`M M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY$96YO;6EN871O6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[ M)SY3:&%R97,@=7-E9"!F;W(@8F%S:6,@96%R;FEN9W,@*&QO6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I M86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@.24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I86P[(&UA6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXS-SPO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG#L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[)SX\(2TM06YC:&]R M+2T^4F5S=')I8W1E9"!S=&]C:R!U;FET'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O;G0M M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`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`C M96%F.64X.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC;VQO M3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B!!F4Z M(#$P<'0[)SY$:6QU=&EV92!S96-U6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O M;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\ M=&0@;F]WF4Z(#$P<'0[)SY#87)E1FER6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SX\&5R8VES92!O9B!S=&]C:RUB87-E9"!C;VUP96YS871I;VX@87=A65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M M9F%M:6QY.B!!3H@07)I86P[(&9O M;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!! M3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M M6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M#L@=VED=&@Z(#4P)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD M:78@F4Z(#$P<'0[)SXF(S$V,#L\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M"!S;VQI M9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[ M('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^1F]R96EG;B!#=7)R96YC>2!4'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^5&]T86P\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O"P@87,@;V8@2F%N=6%R>2`Q+"`R,#$S/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@07)I86P[ M(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SY/=&AE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,3`E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R/CQT M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)O M'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,30E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE M9G0[(&)A8VMG"!S M;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F3H@07)I86P[(&9O;G0M M#PO9&EV M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,24[('9E'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@ M6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ M(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,3`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY!8V-U;75L M871E9"!/0TDL(&YE="!O9B!T87@L(&%S(&]F($1E8V5M8F5R(#,Q+"`R,#$S M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I M;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3`E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R/CPO=&%B;&4^/&1I=B!S M='EL93TS1"=C;&5AF4Z(#$P<'0[)SX\='(^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,G!X.R!W:61T:#H@-3`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)V9O M;G0M9F%M:6QY.B!!"!S;VQI9#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T3H@07)I86P[(&UA6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,30E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXH,2PW.#D\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R M/CQT6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M M9F%M:6QY.B!!#PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,24[ M('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`C96%F.64X.R!W:61T:#H@,3`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[)SY.970@:6YC#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,30E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXX-C`\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F3H@07)I86P[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,30E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQO3H@ M07)I86P[(&9O;G0M#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXX-C$\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY M.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,3`E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@;F]W6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&-L96%R.B!B;W1H.R!F;VYT+7-I>F4Z(#%P=#LG/B8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.SPO9&EV/CQD:78^/&)R("\^ M/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT M+6EN9&5N=#H@,S9P=#L@9F]N="UF86UI;'DZ($%R:6%L.R!F;VYT+7-I>F4Z M(#$P<'0[)SY4:&4@9F]L;&]W:6YG('1A8FQE('!R;W9I9&5S(&1E=&%I;',@ M86)O=70@6QE/3-$)W=I9'1H.B`Q,#`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`C96%F.64X.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY M.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXS+#,P,CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)V)A8VMGF4Z M(#$P<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY M.B!!6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W!A9&1I;FF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@8F%C:V=R M;W5N9"UC;VQO#L@ M8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O M;G0M3H@07)I86P[(&9O;G0M M6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0M9F%M:6QY.B!!6QE/3-$)V)O6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#1P>"!D;W5B;&4[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@F4Z(#$P<'0[ M)SXR+#`R-#PO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W!A9&1I;FF4Z(#$P M<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M6QE/3-$)V-L96%R.B!B;W1H.R<^ M/&)R("\^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y M.R!T97AT+6EN9&5N=#H@,S9P=#L@9F]N="UF86UI;'DZ($%R:6%L.R!F;VYT M+7-I>F4Z(#$P<'0[)SY3964@3F]T928C,38P.S<@9F]R(&9U'1087)T7V$U M-#=C-S5A7S`P-C)?-#$V,U]B9#=D7V4V,F8W,3$T864X-0T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B]A-30W8S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W=I9'1H.B`Y-"XV-24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M M:6QY.B!!6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M2!E:71H97(@2!O2`H9&5P96YD:6YG(&]N('1H92!F;W)M(&]F('1H92!TF4Z(#$P<'0[)SY7:71H(&-E&-H86YG960N)B,Q-C`[($]U2!T;R!D971EF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)W=I M9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3L@=VED=&@Z(&%U=&\[ M(&9O;G0M9F%M:6QY.B!!65E($)E M;F5F:71S/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I=CX\8G(@+SX\+V1I M=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M2!A M;&P@;V8@;W5R(&5M<&QO>65E2!M871C:&EN9R!C;VYT2X\+V1I=CX\9&EV/CQB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO'0^)SQD:78@F4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IUF4Z(#$P<'0[('9EF4Z(#$P<'0[('9EF4Z(#$P<'0[)SY792!H879E(&%G9W)E M9V%T960@;W5R(&]P97)A=&EN9R!S96=M96YT6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M&EM871E;'D@,3`N-24@86YD M(#$Q+C4E+"!R97-P96-T:79E;'DL(&]F(&]U2`Q-R4@;V8@;W5R(')E=F5N=65S(&9R;VT@82!S97!A'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2!&:6YA;F-I M86P@26YF;W)M871I;VX@*'5N875D:71E9"D\+W1D/@T*("`@("`@("`\=&0@ M8VQA6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W=I9'1H.B`Q M,#`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`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[)SX\6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B!!F4Z(#$P M<'0[)SY2979E;G5E3H@07)I86P[ M(&9O;G0MF4Z(#$P<'0[)SXQ-C4L,38U/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M3H@ M07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ-2PP.#,\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ.2PY,38\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA&5S/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG MF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M M:6QY.B!!3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ+#$P.#PO9&EV/CPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I M86P[(&9O;G0MF4Z(#$P<'0[)SXQ+#6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B!!3H@ M07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY"87-I8R!E87)N:6YG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE M/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG MF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!3H@07)I M86P[(&9O;G0M6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&UA M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O M;G0M3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`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`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`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY2979E;G5E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M3H@07)I86P[ M(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ-S4L,3@P/"]D:78^/"]T M9#X\=&0@;F]W3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I M86P[(&9O;G0MF4Z(#$P<'0[)SXS,BPP-C$\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXS,"PV,3D\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I M86P[(&UA&5S/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXU+#`R.#PO9&EV/CPO=&0^ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.2XR-24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M.24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O M;G0M6QE/3-$)V9O;G0M9F%M M:6QY.B!!3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXP+C$U/"]D:78^/"]T M9#X\=&0@;F]W6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M M6QE/3-$)V9O;G0M9F%M:6QY M.B!!3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXP+C$U/"]D:78^/"]T9#X\ M=&0@;F]W6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M2P@=&AE('-U;2!O9B!T:&4@<75A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!2!R96%L:6=N;65N="!O9B`D M,2XX(&UI;&QI;VXN/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA2!O9B!3:6=N:69I8V%N="!!8V-O M=6YT:6YG(%!O;&EC:65S(%M!8G-T'0^)SQD:78@ MF4Z(#$P<'0[ M)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M2!P M3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SYC M+B8C,38P.R!!8V-O=6YTF%T:6]N(&]F(&9I=&YE2!B:6QL960@:6X@=&AE(&9O;&QO=VEN9R!M;VYT:"P@86YD(&-E M2P@=V4@ M:&%V92!E>'!EF4Z(#$P<'0[)SYP2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0MF4@9&5P2P@:6YC;'5D:6YG(&%M;W)T:7IA=&EO;B!O9B!A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M2XF(S$V,#L@1&5P2X\+V1I=CX\9&EV/CQB3H@07)I86P[(&9O;G0M'0^)SQD:78@F4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0MF4Z(#$P<'0[ M)SY);G1A;F=I8FQE(&%S6QE/3-$)V9O;G0M M9F%M:6QY.B!!F4Z(#$P<'0[)SYG+B8C,38P.R!';V]D M=VEL;"`M(%=E(')E8V]G;FEZ92!G;V]D=VEL;"!F;W(@=&AE(&5X8V5S'!E8W1E9"!T;R!B96YE9FET(&9R;VT@ M=&AE(&-O;6)I;F%T:6]N+CPO9&EV/CQD:78@F%T:6]N+CPO9&EV/CQD:78^ M/&)R("\^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`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`S-G!T.R!F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M2!O8V-U65T(&)E96X@2`D M,C0N,B!M:6QL:6]N+"!A;&P@;V8@=VAI8V@@=V5R92!B87-E9"!O;B!A8W1U M86P@9&%T82XF(S$V,#L@1&%T82!R96-O;F-I;&EA=&EO;B!D:69F97)E;F-E MF4Z(#$P<'0[)SY097)F;W)M86YC92UR96QA=&5D(&%D:G5S=&UE;G1S M("AI;F-L=61I;F<@86YY(&%M;W5N=',@2!R969U;F1E9"DL(&-H86YG97,@:6X@97-T M:6UA=&5S+"!O2!C875S92!UF4@;W(@65A'0^)SQD:78@F4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)V9O;G0M9F%M:6QY.B!!'0^)SQD:78@F4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`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`@("`@("`\=&0@8VQA6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[ M)SY4:&4@8VAA;F=E(&EN(&-A3H@07)I86P[ M(&UA6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I86P[(&UA M6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG M;CH@6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B!!F4Z M(#$P<'0[)SY"86QA;F-E+"!$96-E;6)E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[ M(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY/=&AE'0M86QI9VXZ(&QE9G0[ M(&)A8VMG"!S;VQI M9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC M;VQO6QE M/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQD M:78@F4Z(#$P M<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0MF%T:6]N M(&%T($1E8V5M8F5R(#,Q+"`R,#$S(&-O;G-I6QE M/3-$)W=I9'1H.B`U."4[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/"$M M+4%N8VAO6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M1W)O6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^06UO=6YT/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/"]T6QE/3-$ M)W9E6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,24[('9E3H@ M07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXR.2PT,S$\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXS+#@T,CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY0871E;G1S/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXQ-2PP.#$\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@07)I86P[(&9O M;G0M2UB87-E9"!D871A/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@07)I86P[ M(&UA#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N M9"UC;VQO6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0MF%T:6]N(&%T($1E8V5M8F5R(#,Q+"`R,#$R(&-O;G-I M6QE/3-$)W=I9'1H.B`U."4[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^*$EN('1H;W5S86YD6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^3F5T/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,24[('9E6QE/3-$)W9E6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SX\(2TM06YC M:&]R+2T^0W5S=&]M97(@8V]N=')A8W1S/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B!!F4Z(#$P<'0[)SXU.2PS,#4\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXR.2PR.#<\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXT+#DX.#PO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY0871E;G1S/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXQ,BPW,C,\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXV+#8V.3PO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXR+#`T,#PO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY097)P971U86P@;&EC96YS M92!T;R!S=7)V97DM8F%S960@9&%T83PO9&EV/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`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`C96%F.64X M.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)OF4Z(#$P<'0[)SXV,2PQ-SD\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF%T:6]N(&5X<&5N6QE/3-$)V9O;G0M9F%M:6QY.B!! MF4Z(#$P<'0[)SY);G1A;F=I8FQE(&%SF5D(&]V97(@ M97-T:6UA=&5D('5S969U;"!L:79E'!E;G-E(&9O65A6QE/3-$)W=I9'1H.B`W,"4[(&9O;G0M9F%M:6QY.B!! M6QE/3-$)W9E6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXR,#$T/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!F4Z(#$P<'0[)SXQ,2PQ-S`\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!! MF4Z(#$P<'0[)SXR M,#$W/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A M8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X M.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S M='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC M;VQO#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!! M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S(%M!8G-T"!E>'!E;G-E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M'!E;G-E M(&ES(&-O;7!R:7-E9"!O9B!T:&4@9F]L;&]W:6YG.CPO9&EV/CQD:78^/&)R M("\^/"]D:78^/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)O6QE/3-$)W=I9'1H.B`U-24[('9E M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!! MF4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^*$EN('1H;W5S86YD#L@=VED=&@Z(#4U)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78^)B,Q-C`[/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^,C`Q,SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1EF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`Q,CPO9&EV/CPO=&0^/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,7!X.R!V M97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M('1O<#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=CX\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q M-C`[/"]T9#X\=&0@8V]L6QE M/3-$)W9E6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY M.B!!3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O M;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0MF4Z(#$P<'0[)SY3=&%T93PO9&EV/CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!#L@=F5R=&EC86PM86QI M9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXQ+#8Y,SPO9&EV/CPO=&0^/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B!!F4Z M(#$P<'0[)SY$969E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^ M)B,Q-C`[/"]T9#X\=&0@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^ M)B,Q-C`[/"]T9#X\=&0@;F]WF4Z(#$P<'0[)SY& M961E6QE/3-$ M)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M#L@=F5R=&EC86PM86QI9VXZ('1O M<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T M:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M M9F%M:6QY.B!!#L@8F%C M:V=R;W5N9"UC;VQO3H@07)I86P[ M(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[)SY4;W1A M;#PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[ M('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQD:78@F4Z M(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M"!P=7)P;W-E2!A M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@=VED=&@Z(#4U)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M"!S;VQI9#L@=VED=&@Z(#$N-3$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L M6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q M<'@[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^1&5C96UB97(@,S$L(#(P,3(\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q+C4Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q<'@[('9E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/"]T3H@07)I86P[(&UA6QE/3-$)W=I9'1H.B`Q<'@[('9EF4Z(#$P<'0[)SY!8V-R=6%L6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,C`E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6UE;G1S/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXX+#,P,SPO9&EV/CPO=&0^ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXW+#DQ-#PO9&EV/CPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXS+#4U,SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X M.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@;F]W MF4Z(#$P<'0[)SY/=&AE6QE/3-$)V)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)O MF4Z(#$P<'0[)SXQ+#0X-CPO9&EV/CPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!'0M86QI9VXZ M(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\ M+W1R/CQT6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,C`E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR M<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY$969E6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M;F]W6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,C`E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]WF4Z(#$P<'0[)SY02!A;F0@97%U:7!M96YT M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I M86P[(&9O;G0M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B!!F4Z(#$P<'0[)SXH-#6QE M/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I M86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@F4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,C`E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXH,RPU-3,\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[)SY/=&AE6QE/3-$)W!A M9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXH,3(R/"]D:78^/"]T9#X\ M=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,C`E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY.970@9&5F97)R960@=&%X(&QI M86)I;&ET>3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,2XU,24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)O3H@ M07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY.970@8W5R6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,C`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O3H@07)I86P[(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXH,S8L,#4S/"]D:78^/"]T9#X\=&0@ M;F]W6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXH,C,L-C4S/"]D:78^ M/"]T9#X\=&0@;F]W3H@ M07)I86P[(&9O;G0M#L@8F%C M:V=R;W5N9"UC;VQO#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#1P>"!D;W5B;&4[ M('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M M:6QY.B!!#L@8F%C M:V=R;W5N9"UC;VQO3H@07)I M86P[(&9O;G0M6QE/3-$)V-L96%R.B!B;W1H.R<^/&)R("\^/"]D:78^/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$"!E>'!E;G-E(&-O M;7!U=&5D('5S:6YG('-T871U=&]R>2!F961E6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY4:&4@9&EF9F5R96YC92!B971W965N(&EN8V]M92!T M87@@97AP96YS92!C;VUP=71E9"!U"!R871E(&%N9"!T:&4@969F96-T:79E(')A=&4@:7,@ M87,@9F]L;&]W6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$ M)W=I9'1H.B`Y-24[(&9O;G0M9F%M:6QY.B!!#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0Q,"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^665A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@"!S M;VQI9#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ('1O<#LG M/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^,C`Q,CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B!!F4Z M(#$P<'0[)SY3=&%T=71O6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I M86P[(&9O;G0MF4Z(#$P<'0[)SXH-#DL.#`X/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M M9F%M:6QY.B!!3H@07)I86P[(&UA'!E;G-E/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@ M;F]W6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG M6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!! MF4Z(#$P<'0[)SY0 M97)M86YE;G0@:71E;7,\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXS.#@\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY0"!A M9&IU6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA"!P;W-I=&EO M;B!R979E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B!!#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;FF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T M9#X\=&0@;F]W#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)O M3H@07)I86P[(&9O;G0M#L@8F%C:V=R M;W5N9"UC;VQO3H@07)I86P[ M(&9O;G0M#L@8F%C:V=R;W5N M9"UC;VQO6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B!!#L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P<'0[)SY);F-O;64@=&%X(&5X M<&5N6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)OF4Z(#$P<'0[)SXH-2PV,S8\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F6QE M/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF5D('1A>"!B96YE9FET'0^)SQD:78@&-L=7-I=F4@;V8@:6YT97)E6QE/3-$)W=I9'1H.B`Y-24[(&9O;G0M9F%M:6QY.B!!6QE/3-$)W9E3H@ M07)I86P[(&UAF5D('1A>"!B96YE9FET3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B!!F4Z M(#$P<'0[)SY$96-R96%S97,@8F%S960@=7!O;B!T87@@<&]S:71I;VYS(')E M;&%T960@=&\@<')I;W(@>65A6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&UAF5D('1A>"!B96YE9FET3H@07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY$96-R96%S97,@8F%S M960@=7!O;B!A(&QA<'-E(&]F('1H92!A<'!L:6-A8FQE('-T871U=&4@;V8@ M;&EM:71A=&EO;G,\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$ M)V9O;G0M9F%M:6QY.B!!F5D('1A>"!B96YE9FET6QE/3-$)V9O;G0M M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V-L96%R.B!B M;W1H.R<^/&)R("\^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA3H@07)I86P[(&9O;G0M6QE/3-$)W=I9'1H.B`X,"4[(&9O;G0M9F%M:6QY M.B!!6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^665A M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\ M+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[)SXR,#$T/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! MF4Z(#$P<'0[)SXQ,BPU,#`\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXR,#$U/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXV,RPV,C4\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXR,#$X/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W!A9&1I;F6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A M;6EL>3H@07)I86P[(&UA#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I M86P[(&UAF4Z(#$P<'0[)SY4;W1A M;#PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY M.B!!F4Z(#$P<'0[)SY4:&4@9F]L;&]W:6YG('1A M8FQE('-H;W=S('1H92!E9F9E8W0@;V8@;W5R(&-A#L@=VED=&@Z(#8S)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)V)O'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/"]T"!S;VQI9#L@<&%D9&EN9RUB;W1T M;VTZ(#)P>#L@=VED=&@Z(#8S)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(@,S$L(#(P,3,\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0S('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI M9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/"]TF4Z(#$P M<'0[)SXH1V%I;BD@;&]S6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!F4Z(#$P<'0[)SXH,S,R/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SY,;W-S M(')E;&%T960@=&\@969F96-T:79E('!O"!E9F9E8W0\+V1I=CX\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[ M(&9O;G0M6QE/3-$)V-L96%R.B!B;W1H.R<^/&)R("\^/"]D:78^/"]D:78^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^)SQD:78@F4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M M9F%M:6QY.B!!6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F"!S;VQI9#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M#L@=VED=&@Z(#,Y)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/CQD:78^)B,Q-C`[/"]D:78^/"]T9#X\+W1R/CQT M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA3H@07)I86P[(&9O;G0M6QE/3-$)V)O6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4W1A=&5M96YT6QE/3-$ M)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SX\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,SDE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0MF4Z(#$P<'0[)SY. M970@=6YR96%L:7IE9"!L;W-S/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! MF4Z(#$P<'0[)SXH."PY.#0\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@;F]W6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I M86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG MF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M'0^)SQD:78@F4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0MF4Z(#$P<'0[ M)SX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,G!X.R!W:61T:#H@,CDE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M"!S;VQI9#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L"!S M;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0V('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^*$EN('1H;W5S86YD"!S M;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M M6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^1F]R96EG;B!C=7)R96YC>2!E>&-H86YG92!C;VYT M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^26YT97)E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]TF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^07-S971S.CPO9&EV/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9EF4Z(#$P<'0[)SX\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,24[('9EF4Z(#$P<'0[ M)SX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9EF4Z(#$P<'0[)SX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[ M('9EF4Z(#$P<'0[)SX\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,24[('9EF4Z(#$P<'0[)SX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T M6QE.B!I=&%L:6,[('1E>'0M:6YD96YT M.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXQ-S@\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\ M=&0@;F]W6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,34E.R!V97)T M:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I M86P[(&UA'0M86QI9VXZ(&QE9G0[(&)A M8VMG"!S;VQI9#L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A M8VMG"!S;VQI9#L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A M8VMG"!S;VQI9#L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL M>3H@07)I86P[(&UA6QE/3-$)V9O;G0M9F%M M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)O#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXR-RPW-C8\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O M;G0MF4Z(#$P<'0[)SXF(S$V,#L\+V1I M=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$E M.R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE.R<^)B,Q-C`[/"]T9#X\=&0@;F]W M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE.R<^ M)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X M.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M,3$E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T M9#X\=&0@;F]W6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A M8VMGF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^ M/"]T9#X\=&0@;F]W6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@ M=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q M-C`[/"]T9#X\=&0@;F]W6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[ M/"]T9#X\=&0@;F]W6QE M/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X\=&0@ M;F]W6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SY!8V-R=65D(&QI86)I;&ET:65S/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F M;VYT+69A;6EL>3H@07)I86P[(&UA'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M M:6QY.B!!#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\ M=&0@;F]W#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SY4;W1A;"!L:6%B:6QI=&EE6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[ M('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M6QE M/3-$)V-L96%R.B!B;W1H.R<^/&)R("\^/"]D:78^/"]D:78^/"]D:78^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA'0^)SQD:78@F4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0MF4Z(#$P<'0[)SX\ M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=VED M=&@Z(#,Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(@ M,S$L(#(P,3,\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)V)O6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^3&5V96P@,SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@07)I M86P[(&9O;G0M6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^3F5T($9A:7(\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^5F%L=64\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[)SY!6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\ M+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O M;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S M-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I M86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X M.R!W:61T:#H@.24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[ M('9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P M<'0[)SY&;W)E:6=N(&-U6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O M;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I M86P[(&9O;G0MF4Z(#$P<'0[)SXH-3<\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^ M/"]T9#X\=&0@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SY#87-H($-O;G9E6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@,3`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@07)I M86P[(&9O;G0M6QE/3-$)V)O6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^1W)O3H@07)I86P[ M(&9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[ M('9E6QE/3-$)W9E6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)V)A M8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B!!3H@ M07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@ M07)I86P[(&UA6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M.24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T:6-A M;"UA;&EG;CH@;6ED9&QE.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!3H@07)I M86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`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`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY M.B!!6QE/3-$)W=I9'1H.B`Q,#`E M.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T M.R!F;VYT+69A;6EL>3H@07)I86P[(&UA"!S;VQI9#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q<'@[('9E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@07)I M86P[(&9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG3H@ M07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXH."PY.#0\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A M8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T M:6-A;"UA;&EG;CH@;6ED9&QE.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3`E.R!V97)T:6-A M;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG#L@=F5R=&EC86PM86QI9VXZ(&UI9&1L93LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!! M3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$ M)V-L96%R.B!B;W1H.R<^/&)R("\^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A-30W8S'0O:'1M M;#L@8VAA'0^ M)SQD:78@F4Z M(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@=VED=&@Z(#,R)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@"!S M;VQI9#L@=VED=&@Z(#$N,#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4F5S=')U8W1U'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q+C`Y)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=VED M=&@Z(#$N,#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8V]L6QE/3-$)V)O MF4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z M(#$N,#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@;F]W"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0MF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4F5S=')U8W1U'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)O M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M5&]T86P\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXW+#8P-SPO9&EV/CPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S M='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@ M;6ED9&QE.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`C96%F.64X.R!W:61T M:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!! M'0M86QI9VXZ(&QE M9G0[(&)A8VMG"!S;VQI9#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)O6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!!'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$N,30E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE M/3-$)V)O6QE/3-$ M)V9O;G0M9F%M:6QY.B!!3H@07)I86P[ M(&UA3H@ M07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY!9&1I=&EO;G,\+V1I=CX\ M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG M6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6UE;G1S/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)V)A8VMG M6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3$N,30E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)O MF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^ M/"]T9#X\=&0@;F]W#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F6QE M/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC M;VQO6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V9O;G0M M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY!8V-R M=65D(')E3H@07)I M86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6UE;G1S/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXH-C(Y/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&UA#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R M;W5N9"UC;VQO3H@07)I M86P[(&9O;G0M#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`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`C96%F.64X.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,3$N,30E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[)SX\ M&-L=61E&EM871E;'D@)#`N-B!M:6QL:6]N+"!W:&EC:"!PF4Z(#$P<'0[)SX\ M&-L=61E&EM871E;'D@)#$N."!M:6QL:6]N+"!W:&EC:"!PF4Z(#$P<'0[)SX\ M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M2!F3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]A-30W8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO2!O9B!F=71U6QE/3-$)V9O;G0M9F%M M:6QY.B!!F4Z(#$P<'0[)SY4:&4@9F]L;&]W:6YG('1A M8FQE('-U;6UA6UE M;G1S('5N9&5R(&%L;"!C87!I=&%L(&QE87-E3H@07)I86P[(&UA M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M('1O<#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL M93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,24[('9E3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T"!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=VED=&@Z(#4U)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`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`C9F9F9F9F.R!W:61T M:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`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`C9F9F9F9F.R!W M:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@;F]W6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T M:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B!!F4Z(#$P M<'0[)SY,97-S(&-U'0M M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE M/3-$)V9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O M6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3,E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)V-L96%R.B!B;W1H.R<^/&)R M("\^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R3H@07)I86P[(&9O;G0M M6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O#L@=VED M=&@Z(#4Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78^)B,Q-C`[ M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C M96YT97([(&9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0S('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY M.B!!6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M*$EN(&UI;&QI;VYS*3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`Q,SPO9&EV/CPO=&0^/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V)O3H@07)I86P[(&9O;G0M M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXV+C0\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXT+C$\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXT+C4\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`C96%F.64X.R!W:61T:#H@,3,E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY4:&4@9F]L;&]W:6YG('1A8FQE('-E=',@9F]R M=&@@=&AE('=E:6=H=&5D(&%V97)A9V4@9W)A;G0M9&%T92!F86ER('9A;'5E M65A6QE/3-$)W=I9'1H.B`Y-24[(&9O;G0M9F%M:6QY.B!!#L@=VED=&@Z(#4U)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78^)B,Q-C`[/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F"!S;VQI9#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I M86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY M.B!!3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXE/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M3H@07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXU,RXP/"]D:78^/"]T M9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@ M07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S M='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,3(E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[ M(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXR+C0\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG2!O9B!O<'1I;VX@86-T:79I M='D\+W1D/@T*("`@("`@("`\=&0@8VQA6QE M/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I M86P[(&9O;G0M2!O9B!O<'1I;VX@86-T M:79I='D@87,@;V8@1&5C96UB97(@,S$L(#(P,3,@86YD('1H92!C:&%N9V5S M(&1U65A6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1EF4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^5V5I9VAT960\+V1I=CX\9&EV('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^079E&5R M8VES93PO9&EV/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q<'@[('9E6QE/3-$)V)OF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4F5M86EN:6YG($-O M;G1R86-T=6%L(%1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q<'@[('9E#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD M:78@3H@ M07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`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`C96%F.64X.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL M>3H@07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=CX\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,30P<'@[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY&;W)F96ET960\+V1I=CX\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXH,38S/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,30P<'@[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)A8VMG6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY%>'!I M6QE/3-$)V)A M8VMG"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXH,C`Y/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M M9F%M:6QY.B!!'0M86QI9VXZ(&QE M9G0[(&)A8VMG"!S M;VQI9#L@=&5X="UA;&EG;CH@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@F4Z M(#$P<'0[)SXR-2XU,#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W!A9&1I;F#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`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`C9F9F9F9F.R!W M:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R M;W5N9"UC;VQO#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#1P>"!D;W5B;&4[('1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY M.B!!#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,3$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@07)I86P[(&9O;G0M M6QE/3-$)W!A9&1I;F"!D;W5B M;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,34E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC M;VQO#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@,7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O3H@ M07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO2!O9B!N;VYV97-T960@3H@07)I86P[(&9O;G0M2X\+V1I=CX\ M9&EV/CQBF4Z(#$P M<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG M+6)O='1O;3H@,G!X.R!W:61T:#H@-#4E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M M9F%M:6QY.B!!"!S;VQI9#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M6QE M/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T3H@07)I86P[(&UA6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,33H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXQ,"XT,SPO9&EV/CPO=&0^/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W!A9&1I;F6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B!!F4Z M(#$P<'0[)SY&;W)F96ET960\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,34E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M,33H@07)I86P[(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[)SXX-#$\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B M;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F M.64X.R!W:61T:#H@,33H@07)I86P[(&9O;G0M6QE/3-$)V-L96%R.B!B;W1H.R<^/&)R("\^ M/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R3H@07)I86P[ M(&9O;G0MF4Z(#$P<'0[(&UAF4Z(#$P M<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG M+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([('1E>'0M:6YD96YT.B`M,3AP M=#L@9F]N="UF86UI;'DZ($%R:6%L.R!M87)G:6XM;&5F=#H@,3AP=#L@9F]N M="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#LG/BA);B!T:&]U"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0Q,"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^665A6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY M.B!!F4Z(#$P<'0[ M)SY.=6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W9E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`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`C96%F.64X M.R!W:61T:#H@.24[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W M:61T:#H@.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`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`C96%F.64X.R!W:61T M:#H@.24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M.24[('9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I86P[(&UA6QE/3-$)W!A9&1I;F"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O MF4Z(#$P<'0[)SXH,"XR-3PO9&EV/CPO=&0^ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R M;W5N9"UC;VQO3H@07)I86P[(&9O M;G0M#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)V)O M3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!"!D M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY M.B!!6QE/3-$)V)A8VMG MF4Z(#$P<'0[)SXW+#6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V-L96%R M.B!B;W1H.R<^)B,Q-C`[/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA3H@07)I86P[(&9O;G0M3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M M9F%M:6QY.B!!"P@9F]R('1H92!T=V5L=F4@;6]N=&AS(&5N9&5D M($1E8V5M8F5R(#,Q+"`R,#$S(&%N9"`R,#$R.CPO9&EV/CQD:78^/&)R("\^ M/"]D:78^/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)OF4Z(#$P<'0[)SX\='(^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,G!X.R!W:61T:#H@-3`E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M6QE/3-$)V9O M;G0M9F%M:6QY.B!!"!S;VQI9#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@3H@07)I86P[(&9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@3H@07)I86P[(&9O;G0M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T3H@07)I86P[(&UA6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,30E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SXH.3(Y/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY M.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@ M07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[)SY!;6]U;G1S(')E8VQA#PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!B86-K9W)O=6YD+6-O;&]R M.B`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`C96%F.64X.R!W:61T M:#H@,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!! M#L@8F%C:V=R;W5N9"UC M;VQO3H@07)I86P[(&9O;G0M M6QE/3-$)V-L96%R.B!B;W1H.R<^/&)R("\^/"]D:78^/&1I=CX\8G(@+SX\ M+V1I=CX\=&%B;&4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,"!C96QL<&%D M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E M.R!F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^*$EN('1H;W5S86YD6QE/3-$)V)O6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1EF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F5T($-H86YG92!I;B!&86ER M(%9A;'5E(&]F($EN=&5R97-T(%)A=&4@4W=A<',\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O M"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY!8V-U;75L871E9"!/0TDL(&YE M="!O9B!T87@L(&%S(&]F($IA;G5A3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@,3`E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M M3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SY/=&AE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,30E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMGF4Z(#$P<'0[)SXH,2PQ-C0\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R M/CQT6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C96%F.64X.R!W:61T:#H@,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,30E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ M(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F3H@07)I86P[(&9O M;G0M#PO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O M;3H@,G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,24[ M('9E'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M9F%M M:6QY.B!!#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I86P[(&9O;G0M#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3`E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@07)I M86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY!8V-U;75L871E9"!/0TDL(&YE="!O M9B!T87@L(&%S(&]F($1E8V5M8F5R(#,Q+"`R,#$R/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F"!D;W5B M;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)O M6QE/3-$)V9O;G0M M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!! M6QE M/3-$)V9O;G0M9F%M:6QY.B!!"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`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`C9F9F9F9F.R!W:61T:#H@,3`E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&IU3H@ M07)I86P[(&9O;G0M3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY M.B!!F4Z(#$P<'0[)SX\='(^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!W M:61T:#H@,S4E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@07)I86P[(&9O M;G0M"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD M:78@3H@ M07)I86P[(&9O;G0M6QE/3-$)W=I9'1H.B`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`Q,CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^*$QO M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ+#DQ-CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)V)A8VMGF4Z M(#$P<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=B86-K9W)O M=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY M.B!!6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[)SY);G1E'!E;G-E M/"]D:78^/"]T9#X\+W1R/CQT6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!! M#L@8F%C:V=R;W5N9"UC;VQO MF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`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`C96%F.64X.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F M;VYT+69A;6EL>3H@07)I86P[(&9O;G0M6QE/3-$)V)O3H@07)I86P[(&9O;G0M"!D;W5B;&4[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@ M07)I86P[(&9O;G0M#L@8F%C:V=R;W5N9"UC;VQO M3H@07)I86P[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!! M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[ M)SY.970@;V8@=&%X/"]D:78^/"]T9#X\+W1R/CPO=&%B;&4^/&1I=B!S='EL M93TS1"=C;&5A3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M M9F%M:6QY.B!!3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!&:6YA;F-I86P@26YF;W)M871I;VX@*'5N875D:71E9"D@ M*%1A8FQE3H@07)I86P[(&9O;G0M MF4Z M(#$P<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N M.B!C96YT97([(&9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E3H@07)I86P[ M(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('9E"!S;VQI9#L@<&%D9&EN M9RUB;W1T;VTZ(#)P>#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@07)I M86P[(&9O;G0M6QE/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1EF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1FER6QE/3-$)V)O M6QE/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1EF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4V5C;VYD/"]D:78^/"]T9#X\ M=&0@;F]W"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O'0M86QI9VXZ M(&QE9G0[('9E6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@07)I86P[ M(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY2979E M;G5E3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG MF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B!!3H@ M07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@ M07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ.2PY,38\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXR-BPS.3$\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@ M07)I86P[(&UA&5S/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ+#$P.#PO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M3H@07)I86P[ M(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O M;G0M3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE M/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR M<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY"87-I8R!E87)N:6YG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!! M3H@07)I86P[ M(&9O;G0M6QE/3-$)V9O;G0M M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M M6QE/3-$)V9O;G0M9F%M:6QY M.B!!3H@07)I86P[(&UA6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`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`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`M-RXR<'0[(&9O;G0M9F%M:6QY.B!!F4Z(#$P<'0[)SY2979E;G5E3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@ M07)I86P[(&9O;G0MF4Z(#$P<'0[)SXQ-S4L,3@P/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@07)I M86P[(&9O;G0MF4Z(#$P<'0[)SXS,"PV,3D\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXR."PR,3<\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&UA&5S/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!!3H@ M07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M M6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@ M07)I86P[(&9O;G0MF4Z(#$P<'0[)SXU+#`R.#PO9&EV/CPO=&0^/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.2XR-24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@07)I86P[(&UA6QE/3-$)V)A M8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0MF4Z(#$P<'0[)SXP+C$U/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C96%F.64X.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B!!6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@07)I M86P[(&UA6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!!3H@ M07)I86P[(&9O;G0MF4Z(#$P<'0[)SXP+C$U/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B!!6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0M9F%M:6QY.B!!3H@07)I86P[(&9O;G0M3H@07)I86P[(&9O;G0M2P@=&AE('-U;2!O9B!T:&4@<75A2!B92!E<75A;"!T;R!T:&4@9G5L;"!Y96%R(&EN8V]M92!P M97(@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B!!2!R96%L:6=N;65N="!O9B`D,2XX(&UI;&QI M;VXN/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A M:6QS*2`H55-$("0I/&)R/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@4&QA M;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XR.2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`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`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M2!;365M8F5R M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE M;G0@9F]R('1H92!A8W%U:7-I=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6EN9R!!;6]U;G0\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XQ,#'0^)SQS<&%N/CPOF%T:6]N(&5X<&5N'!E;G-E(%M!8G-T'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XR.2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E(%M!8G-T'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPOF%T:6]N(&5X<&5N'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XW+#$Y,"PP,#`\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(&5X<&5N'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO MF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XS+#@V-RPP,#`\'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M/B@U+#8S-BPP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!A'0^ M)SQS<&%N/CPO2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO2!O;B!#87-H($-O;G9E'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!L:6%B:6QI='D\+W1D/@T*("`@ M("`@("`\=&0@8VQA69O'0^)SQS<&%N/CPO69O'!I'0^)SQS<&%N/CPO"!E>'!E;G-E(&-O;7!U=&5D('5S:6YG('-T871U M=&]R>2!F961E'0^)SQS<&%N/CPO"!P;W-I=&EO;B!R979E65A"!#;VYT:6YG96YC>2!;3&EN92!)=&5M'0^)SQS<&%N/CPOF5D('1A>"!B96YE9FET"!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#`L,#`P M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO"!P;W-I=&EO;G,@'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPOF5D('1A>"!B96YE9FET'0^)SQS<&%N/CPO M"!Y96%R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`Q M,#QS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D('1A>"!B96YE9FET M'0^)SQS<&%N/CPO"!Y96%R/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG,C`Q,#QS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D('1A>"!B96YE9FET'0^)SQS<&%N/CPO"!Y96%R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`Q,#QS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A-30W M8S'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^3V-T(#$L#0H) M"3(P,3,\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO2!$871E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`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`N M,#`R-3QS<&%N/CPO'0^)SQS<&%N/CPO'0^2G5N(#@L#0H)"3(P,3<\'0^)T)O2`U+"`R,#$S+"!W92!E;G1E2!I;B!T:&4@979E;G0@=&AA="!O=7(@=&]T86P@9G5N M9&5D(&1E8G0@=&\@14))5$1!(')A=&EO(&ES(&=R96%T97(@=&AA;B!O'0^)U1H92!&:69T M:"!!;65N9&5D($-R961I="!!9W)E96UE;G0@86QS;R!P3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!;365M8F5R73PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG5V4@87)E M(')E<75I2!T97)M(&QO86YS M(&EN('%U87)T97)L>2!P3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`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`@("`\=&%B;&4@8VQA&-H86YG92!#;VYT&-H86YG92!#;VYT&-H86YG92!#;VYT&-H86YG92!#;VYT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A M-30W8S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G1S(&9O'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M/B@R+#8Y-2PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!C;VYS:7-T:6YG(&]F('-H87)E+6)A'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`D,2XX(&UI;&QI;VXL('=H:6-H('!R:6UA2!C;VYS:7-T960@;V8@ M2!F3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]A-30W8S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6UE;G1S M(')E<75I6UE;G1S('!U7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^075G(#,Q+`T*"0DR M,#(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'!E;G-E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$R+#DP,"PP,#`\'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO6UE M;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX.2PY,3`L,#`P M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`H:6X@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&EM=6T@6TUE;6)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`H:6X@'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6UE M;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D(&-O;7!E;G-A=&EO;B!C;W-T/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,B!Y96%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E M9"!V;VQA=&EL:71Y("AI;B!H=6YD'!E8W1E9"!D M:79I9&5N9',@*&EN(&AU;F1R961T:',I/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XP+C`P)3QS<&%N/CPO'0^)S4@>65A7,\7,\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES960@*&EN('-H87)E'0^)SQS<&%N/CPO'!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES86)L92P@96YD(&]F('!E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO"!B96YE9FET(')E8V]G;FEZ960\+W1D/@T* M("`@("`@("`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`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO"!" M96=I;FYI;F<@0F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO"!%;F1I;F<@0F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!4 M'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO"!"96=I;FYI;F<@0F%L86YC93PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA65E($)E;F5F:71S(%M!8G-T'0^)SQS<&%N/CPO2!C;VYT3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A-30W8S'0O:'1M;#L@8VAA M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M/B@W+#4Y,2D\'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2X\+W1D/@T*("`@("`@/"]T2!R96%L:6=N;65N="!O9B`D,2XX(&UI;&QI;VXN/"]T9#X-"B`@ M("`@(#PO='(^#0H@("`@("`\='(@8VQA2!N;W0@;F5C97-S87)I;'D@8F4@97%U86P@=&\@=&AE(&9U;&P@>65A M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]A-30W8S&UL#0I#;VYT M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U XML 32 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Goodwill [Roll Forward]      
Balance, beginning of period $ 338,695,000 $ 335,392,000 $ 496,265,000
Navvis purchase     21,527,000
Impairment loss     (182,400,000)
Ascentia purchase   3,303,000  
Goodwill, Other Changes 105,000    
Balance, end of period 338,800,000 338,695,000 335,392,000
Business Acquisition [Line Items]      
Goodwill, Gross   521,100,000  
Goodwill, Impaired, Accumulated Impairment Loss   182,400,000  
Navvis & Company [Member]
      
Business Acquisition [Line Items]      
Cash payment for the acquisition     23,700,000
Unregistered shares of common stock issued (in shares)     432,902
Value of common stock issued     3,300,000
Ascentia [Member]
      
Business Acquisition [Line Items]      
Cash payment for the acquisition   5,500,000  
Unregistered shares of common stock issued (in shares)   14,409  
Value of common stock issued   $ 100,000  
XML 33 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]  
Principles of Consolidation
a.  Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned by the Company.  We have eliminated all intercompany profits, transactions and balances.
Cash and Cash Equivalents
b.  Cash and Cash Equivalents - Cash and cash equivalents primarily include cash, tax-exempt debt instruments, commercial paper, and other short-term investments with original maturities of less than three months.
Accounts Receivable, net
c.  Accounts Receivable, net - Billed receivables primarily represent fees that are contractually due in the ordinary course of providing our services, net of contractual adjustments and allowances for doubtful accounts.  Unbilled receivables primarily represent fees for services based on the estimated utilization of fitness facilities, which are generally billed in the following month, and certain performance-based fees that are billed when performance metrics are met and reconciled with the customer.  Historically, we have experienced minimal instances of customer non-payment and therefore consider our accounts receivable to be collectible, but we provide reserves, when appropriate, for doubtful accounts and for billing adjustments (such as data reconciliation differences) on a specific identification basis.
Property and Equipment
d.  Property and Equipment - Property and equipment is carried at cost and includes expenditures that increase value or extend useful lives.  We recognize depreciation using the straight-line method over useful lives of three to seven years for computer software and hardware and four to seven years for furniture and other office equipment.  Leasehold improvements are depreciated over the shorter of the estimated life of the asset or the life of the lease, which ranges from two to fifteen years.  Depreciation expense for the years ended December 31, 2013, 2012, and 2011 was $40.1 million, $39.1 million, and $36.6 million, respectively, including amortization of assets recorded under capital leases.

Net computer software at December 31, 2013 and 2012 was $99.1 million and $103.7 million, respectively.  Depreciation expense related to computer software for the years ended December 31, 2013, 2012, and 2011 was $26.5 million, $24.9 million, and $21.4 million, respectively.
Other Assets
e.  Other Assets - Other assets consist primarily of cash convertible notes hedges, long-term investments, long-term customer incentives, and deferred loan costs net of accumulated amortization.
Intangible Assets
f.  Intangible Assets - Intangible assets subject to amortization include customer contracts, acquired technology, patents, distributor and provider networks, a perpetual license, and other intangible assets which we amortize on a straight-line basis over estimated useful lives ranging from two to 25 years.  We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable.

Intangible assets not subject to amortization at December 31, 2013 and 2012 consist of a trade name of $29.0 million.  We review intangible assets not subject to amortization on an annual basis or more frequently whenever events or circumstances indicate that the assets might be impaired.  See Note 4 for further information on intangible assets.
Goodwill
g.  Goodwill - We recognize goodwill for the excess of the purchase price over the fair value of tangible and identifiable intangible net assets of businesses that we acquire.

We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable.  We allocate goodwill to reporting units based on the reporting unit expected to benefit from the combination.
We estimate the fair value of each reporting unit using a combination of a discounted cash flow model and a market-based approach, and we reconcile the aggregate fair value of our reporting units to our consolidated market capitalization.
Contract Billings in Excess of Earned Revenue
h. Contract Billings in Excess of Earned Revenue - Contract billings in excess of earned revenue primarily represent performance-based fees subject to refund that we have not recognized as revenues because either (1) data from the customer is insufficient or incomplete to measure performance; or (2) interim performance measures indicate that we are not currently meeting performance targets.
Income Taxes
i. Income Taxes - We file a consolidated federal income tax return that includes all of our domestic wholly owned subsidiaries.  Generally accepted accounting principles in the United States ("U.S. GAAP") generally require that we record deferred income taxes for the tax effect of differences between the book and tax bases of our assets and liabilities.  We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
Revenue Recognition
j. Revenue Recognition - Our fees are generally billed on a per member per month ("PMPM") basis or upon member participation.  For PMPM fees, we generally determine our contract fees by multiplying the contractually negotiated PMPM rate by the number of members covered by our services during the month.  We typically set PMPM rates during contract negotiations with customers based on the value we expect our programs to create and a sharing of that value between the customer and the Company.  In addition, some of our services, such as the Healthways SilverSneakers® fitness solution, include fees that are based upon member participation.

Our contracts with health plans and integrated healthcare systems generally range from three to five years with a number of comprehensive strategic agreements extending to ten years in length.  Contracts with self-insured employers typically have two to four-year terms. Some of our contracts allow the customer to terminate early.

Some of our contracts place a portion of our fees at risk based on achieving certain performance metrics, cost savings, and/or clinical outcomes improvements ("performance-based").  Approximately 4% of revenues recorded during the year ended December 31, 2013 were performance-based of which 3% were subject to final reconciliation as of December 31, 2013.

We recognize revenue as follows: (1) we recognize the fixed portion of PMPM fees and fees for service as revenue during the period we perform our services; and (2) we recognize performance-based revenue based on the most recent assessment of our performance, which represents the amount that the customer would legally be obligated to pay if the contract were terminated as of the latest balance sheet date.

We generally bill our customers each month for the entire amount of the fees contractually due for the prior month's enrollment, which typically includes the amount, if any, that is performance-based and may be subject to refund should we not meet performance targets.  Fees for participation are typically billed in the month after the services are provided.  Deferred revenues arise from contracts that permit upfront billing and collection of fees covering the entire contractual service period, generally 12 months.  A limited number of our contracts provide for certain performance-based fees that cannot be billed until after they are reconciled with the customer.

We generally assess our level of performance for our contracts based on medical claims and other data that the customer is contractually required to supply, interim assessments of achievement against performance targets, or metrics available from our operating platforms.  A minimum of four to nine months' data is typically required for us to measure performance.  In assessing our performance, we may include estimates such as medical claims incurred but not reported.  In addition, we may also provide contractual allowances for billing adjustments (such as data reconciliation differences) as appropriate.

If data is insufficient or incomplete to measure performance, or interim performance measures indicate that we are not meeting performance targets, we do not recognize performance-based fees subject to refund as revenues but instead record them in a current liability account entitled "contract billings in excess of earned revenue."  Only in the event we do not meet performance levels by the end of the measurement period, typically one year, are we contractually obligated to refund some or all of the performance-based fees.  We would only reverse revenues that we had already recognized if performance to date in the measurement period, previously above targeted levels, subsequently dropped below targeted levels.  Historically, any such adjustments have been immaterial to our financial condition and results of operations.
 
During the settlement process under a contract, which generally occurs six to eight months after the end of a contract year, we settle any performance-based fees and reconcile healthcare claims and clinical data.  As of December 31, 2013, cumulative performance-based revenues that have not yet been settled with our customers but that have been recognized in the current and prior years totaled approximately $24.2 million, all of which were based on actual data.  Data reconciliation differences, for which we provide contractual allowances until we reach agreement with respect to identified issues, can arise between the customer and us due to customer data deficiencies, omissions, and/or data discrepancies.

Performance-related adjustments (including any amounts recorded as revenue that were ultimately refunded), changes in estimates, or data reconciliation differences may cause us to recognize or reverse revenue in a current fiscal year that pertains to services provided during a prior fiscal year.  During 2013, 2012 and 2011, we recognized a net increase in revenue of $8.2 million, $9.2 million, and $2.9 million, respectively, that related to services provided prior to each respective year.
Earnings (Loss) Per Share
k.  Earnings (Loss) Per Share – We calculate basic earnings (loss) per share using weighted average common shares outstanding during the period.  We calculate diluted earnings (loss) per share using weighted average common shares outstanding during the period plus the effect of all dilutive potential common shares outstanding during the period unless the impact would be anti-dilutive.  See Note 14 for a reconciliation of basic and diluted earnings (loss) per share.
Share-Based Compensation
l.  Share-Based Compensation – We recognize all share-based payments to employees, including grants of employee stock options, in the consolidated statements of operations over the required vesting period based on estimated fair values at the date of grant.  See Note 13 for further information on share-based compensation.
 
Derivative Instruments and Hedging Activities
m. Derivative Instruments and Hedging Activities – We use derivative instruments to manage risks related to interest rate swap agreements, foreign currencies, and the cash convertible senior notes (as discussed in Note 6). We account for derivatives in accordance with Financial Accounting Standards Board Standards Board ("FASB")  Accounting Standards Codification ("ASC") Topic 815, which establishes accounting and reporting standards requiring that certain derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value will be recognized currently in earnings unless specific hedge accounting criteria are met. As permitted under our master netting arrangements, the fair value amounts of our interest rate swaps and foreign currency options and/or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets. See Note 7 for further information on derivative instruments and hedging activities.
 
Management Estimates
n. Management Estimates – In preparing our consolidated financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect: (1) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements; and (2) the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
XML 34 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Financial Information (unaudited)
 12 Months Ended
Dec. 31, 2013
Quarterly Financial Information (unaudited) [Abstract]  
Quarterly Financial Information (unaudited)
19.Quarterly Financial Information (unaudited)


(In thousands, except per share data)
 
  
  
  
 
 
 
  
  
  
 
Year Ended
December 31, 2013
 
First
  
Second
  
Third
  
Fourth
 
 
  
(1)
 
  
(1)
 
  
(2)
 
  
(1)  (2)
 
Revenues
 
$
165,165
  
$
162,270
  
$
166,615
  
$
169,235
 
Gross margin
 
$
15,083
  
$
19,916
  
$
26,391
  
$
18,326
 
Income (loss) before income taxes
 
$
(6,044
)
 
$
(1,650
)
 
$
1,108
  
$
(7,591
)
Net income (loss)
 
$
(3,949
)
 
$
(1,101
)
 
$
1,799
  
$
(5,290
)
 
                
Basic earnings (loss) per share (3)
 
$
(0.12
)
 
$
(0.03
)
 
$
0.05
  
$
(0.15
)
Diluted earnings (loss) per share (3)
 
$
(0.12
)
 
$
(0.03
)
 
$
0.05
  
$
(0.15
)

Year Ended
December 31, 2012
 
First
  
Second
  
Third
  
Fourth
 
 
  
(1)
 
 
  
   
(4)
 
Revenues
 
$
165,218
  
$
170,214
  
$
166,559
  
$
175,180
 
Gross margin
 
$
16,300
  
$
32,061
  
$
30,619
  
$
28,217
 
Income (loss) before income taxes
 
$
(4,116
)
 
$
8,732
  
$
8,542
  
$
1,587
 
Net income (loss)
 
$
(2,665
)
 
$
5,057
  
$
5,028
  
$
604
 
 
                
Basic earnings (loss) per share (3)
 
$
(0.08
)
 
$
0.15
  
$
0.15
  
$
0.02
 
Diluted earnings (loss) per share (3)
 
$
(0.08
)
 
$
0.15
  
$
0.15
  
$
0.02
 

(1) The assumed exercise of stock-based compensation awards for this period was not considered in the calculation of diluted earnings (loss) per share because the impact would have been anti-dilutive.

(2) Includes charges related to non-cash interest associated with amortization of a debt discount of $1.5 million and $1.6 million for the third and fourth quarter, respectively.

(3) We calculated earnings per share for each of the quarters based on the weighted average number of shares and dilutive securities outstanding for each period.  Accordingly, the sum of the quarters may not necessarily be equal to the full year income per share.

(4) Includes charges related to one-time termination benefits associated with capacity realignment of $1.8 million.
XML 35 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accumulated OCI (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Accumulated Other Comprehensive Income Loss [Line Items]      
Accumulated OCI, net of tax Beginning Balance $ (929) $ (1,789)  
Other comprehensive loss before reclassifications, net of tax (566) (1,164)  
Amounts reclassified from accumulated OCI, net of tax 1,088 2,024  
Net increase (decrease) in other comprehensive income (loss), net of tax 522 860 1,644
Accumulated OCI, net of tax Ending Balance (407) (929) (1,789)
Reclassification adjustments out of AOCI [Abstract]      
Reclassification to interest expense (16,079) (14,149) (13,193)
Net Change in Fair Value of Interest Rate Swaps [Member]
      
Accumulated Other Comprehensive Income Loss [Line Items]      
Accumulated OCI, net of tax Beginning Balance (1,790) (2,570)  
Other comprehensive loss before reclassifications, net of tax 189 (1,244)  
Amounts reclassified from accumulated OCI, net of tax 1,088 2,024  
Net increase (decrease) in other comprehensive income (loss), net of tax 1,277 780  
Accumulated OCI, net of tax Ending Balance (513) (1,790)  
Net Change in Fair Value of Interest Rate Swaps [Member] | Amounts reclassified from accumulated other comprehensive income to: [Member]
      
Reclassification adjustments out of AOCI [Abstract]      
Reclassification to interest expense 1,916 3,302  
Tax effect of reclassification (828) (1,278)  
Reclassification Adjustment on Derivatives Included in Net Income 1,088 2,024  
Foreign Currency Translation Adjustments [Member]
      
Accumulated Other Comprehensive Income Loss [Line Items]      
Accumulated OCI, net of tax Beginning Balance 861 781  
Other comprehensive loss before reclassifications, net of tax (755) 80  
Amounts reclassified from accumulated OCI, net of tax 0 0  
Net increase (decrease) in other comprehensive income (loss), net of tax (755) 80  
Accumulated OCI, net of tax Ending Balance $ 106 $ 861  
XML 36 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount $ 157,338,000 $ 155,735,000  
Accumulated Amortization 107,225,000 94,556,000  
Total 50,113,000 61,179,000  
Amortization expense 12,700,000 12,600,000 13,400,000
Estimated future amortization expense [Abstract]      
2014 11,170,000    
2015 6,783,000    
2016 5,003,000    
2017 3,343,000    
2018 3,307,000    
2019 and thereafter 20,507,000    
Total 50,113,000 61,179,000  
Intangible assets not subject to amortization 29,000,000 29,000,000 29,000,000
Indefinite-lived intangible asset impairment loss     900,000
Minimum [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Estimated useful life 2 years    
Maximum [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Estimated useful life 25 years    
Customer Contracts [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 59,574,000 59,305,000  
Accumulated Amortization 51,512,000 44,571,000  
Total 8,062,000 14,734,000  
Estimated future amortization expense [Abstract]      
Total 8,062,000 14,734,000  
Acquired Technology [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 29,431,000 29,287,000  
Accumulated Amortization 25,589,000 24,299,000  
Total 3,842,000 4,988,000  
Estimated future amortization expense [Abstract]      
Total 3,842,000 4,988,000  
Patents [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 24,547,000 24,337,000  
Accumulated Amortization 15,081,000 12,723,000  
Total 9,466,000 11,614,000  
Estimated future amortization expense [Abstract]      
Total 9,466,000 11,614,000  
Distributor and Provider Networks [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 8,709,000 8,709,000  
Accumulated Amortization 7,190,000 6,669,000  
Total 1,519,000 2,040,000  
Estimated future amortization expense [Abstract]      
Total 1,519,000 2,040,000  
Perpetual License to Survey-Based Data [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 30,000,000 29,000,000  
Accumulated Amortization 3,986,000 2,708,000  
Total 26,014,000 26,292,000  
Estimated future amortization expense [Abstract]      
Total 26,014,000 26,292,000  
Other [Member]
      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 5,077,000 5,097,000  
Accumulated Amortization 3,867,000 3,586,000  
Total 1,210,000 1,511,000  
Estimated future amortization expense [Abstract]      
Total $ 1,210,000 $ 1,511,000  
XML 37 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill (Tables)
 12 Months Ended
Dec. 31, 2013
Goodwill [Abstract]  
Change in carrying amount of goodwill
The change in carrying amount of goodwill during the years ended December 31, 2011, 2012, and 2013 is shown below:

(In thousands)
 
 
Balance, December 31, 2010
 
$
496,265
 
Navvis purchase
  
21,527
 
Impairment loss
  
(182,400
)
Balance, December 31, 2011
  
335,392
 
Ascentia purchase
  
3,303
 
Balance, December 31, 2012
  
338,695
 
Other adjustments
  
105
 
Balance, December 31, 2013
 
$
338,800
 
XML 38 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2013
Intangible Assets [Abstract]  
Intangible assets subject to amortization
Intangible assets subject to amortization at December 31, 2013 consisted of the following:

(In thousands)
 
Gross Carrying
Amount
  
Accumulated
Amortization
  
Net
 
 
 
  
  
 
Customer contracts
 
$
59,574
  
$
51,512
  
$
8,062
 
Acquired technology
  
29,431
   
25,589
   
3,842
 
Patents
  
24,547
   
15,081
   
9,466
 
Distributor and provider networks
  
8,709
   
7,190
   
1,519
 
Perpetual license to survey-based data
  
30,000
   
3,986
   
26,014
 
Other
  
5,077
   
3,867
   
1,210
 
Total
 
$
157,338
  
$
107,225
  
$
50,113
 

Intangible assets subject to amortization at December 31, 2012 consisted of the following:

(In thousands)
 
Gross Carrying
Amount
  
Accumulated
Amortization
  
Net
 
 
 
  
  
 
Customer contracts
 
$
59,305
  
$
44,571
  
$
14,734
 
Acquired technology
  
29,287
   
24,299
   
4,988
 
Patents
  
24,337
   
12,723
   
11,614
 
Distributor and provider networks
  
8,709
   
6,669
   
2,040
 
Perpetual license to survey-based data
  
29,000
   
2,708
   
26,292
 
Other
  
5,097
   
3,586
   
1,511
 
Total
 
$
155,735
  
$
94,556
  
$
61,179
 
Estimated future amortization expense
Intangible assets subject to amortization are being amortized over estimated useful lives ranging from two to 25 years.  Total amortization expense for the years ended December 31, 2013, 2012, and 2011, was $12.7 million, $12.6 million, and $13.4 million, respectively.  The following table summarizes the estimated amortization expense for each of the next five years and thereafter:

(In thousands)
 
 
Year ending December 31,
 
 
2014
 
$
11,170
 
2015
  
6,783
 
2016
  
5,003
 
2017
  
3,343
 
2018
  
3,307
 
2019 and thereafter
  
20,507
 
Total
 
$
50,113
 
XML 39 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)
In Thousands, unless otherwise specified
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Balance at Dec. 31, 2010 $ 0 $ 34 $ 232,524 $ 206,210 $ (4,494) $ (3,433) $ 430,841
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) 0 0 0 (157,693) 0 1,644 (156,049)
Repurchases of common stock 0 (2) 0 0 (23,688) 0 (23,690)
Exercise of stock options 0 1 4,824 0 0 0 4,825
Tax effect of stock options and restricted stock units 0 0 (2,719) 0 0 0 (2,719)
Share-based employee compensation expense 0 0 9,246 0 0 0 9,246
Issuance of Warrants             0
Issuance of stock in conjunction with acquisition 0 0 3,262 0 0 0 3,262
Balance at Dec. 31, 2011 0 33 247,137 48,517 (28,182) (1,789) 265,716
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss)             8,884
Repurchases of common stock 0 0 0 8,024 0 860 8,884
Exercise of stock options 0 1 2,834 0 0 0 2,835
Tax effect of stock options and restricted stock units 0 0 (5,043) 0 0 0 (5,043)
Share-based employee compensation expense 0 0 6,371 0 0 0 6,371
Issuance of Warrants             0
Issuance of stock in conjunction with acquisition 0 0 58 0 0 0 58
Balance at Dec. 31, 2012 0 34 251,357 56,541 (28,182) (929) 278,821
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) 0 0 0 (8,541) 0 522 (8,019)
Exercise of stock options 0 1 12,747 0 0 0 12,748
Tax effect of stock options and restricted stock units 0 0 (3,225) 0 0 0 (3,225)
Share-based employee compensation expense 0 0 7,116 0 0 0 7,116
Issuance of Warrants 0 0 15,150 0 0 0 15,150
Issuance of stock in conjunction with acquisition 0 0 467 0 0 0 467
Other 0 0 (368) 0 0 0 (368)
Balance at Dec. 31, 2013 $ 0 $ 35 $ 283,244 $ 48,000 $ (28,182) $ (407) $ 302,690
XML 40 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2013
Income Taxes [Abstract]  
Components of income tax expense
Income tax expense is comprised of the following:

(In thousands)
 
Year Ended December 31,
 
 
 
2013
  
2012
  
2011
 
Current taxes
 
  
  
 
Federal
 
$
(1,311
)
 
$
(1,271
)
 
$
9,388
 
State
  
741
   
774
   
2,109
 
Foreign
  
1,693
   
1,754
   
1,707
 
Deferred taxes
            
Federal
  
(5,842
)
  
4,803
   
2,169
 
State
  
(1,018
)
  
413
   
438
 
Foreign
  
101
   
249
   
(425
)
Total
 
$
(5,636
)
 
$
6,722
  
$
15,386
 
Significant components of net deferred tax liability
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.  The following table sets forth the significant components of our net deferred tax liability as of December 31, 2013 and 2012:
 
(In thousands)
 
December 31, 2013
  
December 31, 2012
 
 
 
  
 
Deferred tax asset:
 
  
 
Accruals and reserves
 
$
14,159
  
$
10,910
 
Deferred compensation
  
3,933
   
6,597
 
Share-based payments
  
10,703
   
12,213
 
Net operating loss carryforwards
  
8,303
   
7,914
 
Cash conversion derivative
  
3,553
   
—
 
Other assets and liabilities
  
1,486
   
1,533
 
 
  
42,137
   
39,167
 
Valuation allowance
  
(3,630
)
  
(3,242
)
 
 
$
38,507
  
$
35,925
 
Deferred tax liability:
        
Property and equipment
 
$
(44,740
)
 
$
(47,317
)
Intangible assets
  
(13,418
)
  
(15,700
)
Cash convertible notes hedges
  
(3,553
)
  
—
 
Other assets and liabilities
  
(449
)
  
(122
)
 
  
(62,160
)
  
(63,139
)
Net deferred tax liability
 
$
(23,653
)
 
$
(27,214
)
 
        
Net current deferred tax asset
 
$
9,667
  
$
8,839
 
Net long-term deferred tax liability
  
(33,320
)
  
(36,053
)
 
 
$
(23,653
)
 
$
(27,214
)
Difference between income tax expense computed using statutory federal income tax rate and effective rate
The difference between income tax expense computed using the statutory federal income tax rate and the effective rate is as follows:
 
 
Year Ended December 31,
 
(In thousands)
 
2013
  
2012
  
2011
 
 
 
  
  
 
Statutory federal income tax
 
$
(4,962
)
 
$
5,161
  
$
(49,808
)
Non-deductible goodwill impairment expense
  
—
   
—
   
61,785
 
State income taxes, less federal income tax benefit
  
(669
)
  
453
   
1,520
 
Permanent items
  
634
   
389
   
434
 
Change in valuation allowance
  
388
   
285
   
972
 
Prior year tax adjustments
  
140
   
263
   
150
 
Uncertain tax position reversal
  
(1,137
)
  
—
   
—
 
Other
  
(30
)
  
171
   
333
 
Income tax expense (benefit)
 
$
(5,636
)
 
$
6,722
  
$
15,386
 
Changes in unrecognized tax benefits
The aggregate changes in the balance of unrecognized tax benefits, exclusive of interest, were as follows:

(In thousands)
 
 
Unrecognized tax benefits at December 31, 2011
 
$
1,392
 
Decreases based upon tax positions related to prior years
  
(44
)
Unrecognized tax benefits at December 31, 2012
 
$
1,348
 
Decreases based upon a lapse of the applicable statute of limitations
  
(1,060
)
Unrecognized tax benefits at December 31, 2013
 
$
288
 
XML 41 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accumulated OCI (Tables)
 12 Months Ended
Dec. 31, 2013
Accumulated OCI [Abstract]  
Schedule of changes in accumulated other comprehensive income (AOCI)
The following tables summarize the changes in accumulated OCI, net of tax, for the twelve months ended December 31, 2013 and 2012:

 (In thousands)
 
Net Change in Fair Value of Interest Rate Swaps
  
Foreign Currency Translation Adjustments
  
Total
 
Accumulated OCI, net of tax, as of January 1, 2013
 
$
(1,790
)
 
$
861
  
$
(929
)
Other comprehensive income (loss) before reclassifications, net of tax
  
189
   
(755
)
  
(566
)
Amounts reclassified from accumulated OCI, net of tax
  
1,088
   
—
   
1,088
 
Net increase (decrease) in other comprehensive income (loss), net of tax
  
1,277
   
(755
)
  
522
 
Accumulated OCI, net of tax, as of December 31, 2013
 
$
(513
)
 
$
106
  
$
(407
)


 (In thousands)
 
Net Change in Fair Value of Interest Rate Swaps
  
Foreign Currency Translation Adjustments
  
Total
 
Accumulated OCI, net of tax, as of January 1, 2012
 
$
(2,570
)
 
$
781
  
$
(1,789
)
Other comprehensive income (loss) before reclassifications, net of tax
  
(1,244
)
  
80
   
(1,164
)
Amounts reclassified from accumulated OCI, net of tax
  
2,024
   
—
   
2,024
 
Net increase in other comprehensive income (loss), net of tax
  
780
   
80
   
860
 
Accumulated OCI, net of tax, as of December 31, 2012
 
$
(1,790
)
 
$
861
  
$
(929
)
 
            
     
Reclassification out of Accumulated Other Comprehensive Income
The following table provides details about reclassifications out of accumulated OCI for the twelve months ended December 31, 2013:

 
Twelve Months Ended December 31,
 
Statement of Comprehensive Income
 (In thousands)
2013
 
2012
 
(Loss) Classification
Interest rate swaps
 
$
1,916
 
 
$
3,302
 
Interest expense
 
 
 
(828
)
 
 
(1,278
)
Income tax benefit
 
 
$
1,088
 
 
$
2,024
 
Net of tax

See Note 7 for further discussion of our interest rate swaps.
XML 42 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Leases (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Operating Leased Assets [Line Items]      
Lease expiration date Aug. 31, 2020    
Operating lease term 15 years    
Rent expense $ 12,900,000 $ 12,900,000 $ 12,700,000
Tenant improvement allowance 10,300,000    
Total sublease income 0    
Future minimum lease payments under capital leases [Abstract]      
2014 1,199,000    
2015 66,000    
2016 0    
2017 0    
2018 0    
2019 and thereafter 0    
Total minimum lease payments 1,265,000    
Less amount representing interest (34,000)    
Present value of minimum lease payments 1,231,000    
Less current portion (1,166,000)    
Future minimum lease payments, net of current portion 65,000    
Future minimum lease payments under operating leases [Abstract]      
2014 13,198,000    
2015 11,781,000    
2016 10,764,000    
2017 10,198,000    
2018 10,707,000    
2019 and thereafter 33,262,000    
Total minimum lease payments 89,910,000    
Minimum [Member]
      
Operating Leased Assets [Line Items]      
Lease expiration date Feb. 14, 2014    
Maximum [Member]
      
Operating Leased Assets [Line Items]      
Lease expiration date Oct. 31, 2020    
Corporate Headquarters and Call Center [Member]
      
Operating Leased Assets [Line Items]      
Area of leased property (in square feet) 264,000    
Corporate Headquarters and Call Center [Member] | Minimum [Member]
      
Operating Leased Assets [Line Items]      
Rent expense 4,200,000    
Corporate Headquarters and Call Center [Member] | Maximum [Member]
      
Operating Leased Assets [Line Items]      
Rent expense $ 6,300,000    
Other Call Center Locations [Member]
      
Operating Leased Assets [Line Items]      
Area of leased property (in square feet) 160,000    
Operations Support and Training Offices [Member]
      
Operating Leased Assets [Line Items]      
Area of leased property (in square feet) 66,000    
Office Space in Chandler [Member]
      
Operating Leased Assets [Line Items]      
Area of leased property (in square feet) 92,000    
XML 43 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 2,584 $ 1,759
Accounts receivable, net 89,484 108,337
Prepaid expenses 9,228 9,727
Other current assets 6,857 7,227
Income taxes receivable 1,402 5,920
Deferred tax asset 9,667 8,839
Total current assets 119,222 141,809
Property and equipment:    
Leasehold improvements 37,463 40,679
Computer equipment and related software 290,392 267,902
Furniture and office equipment 22,881 23,552
Capital projects in process 25,228 11,799
Property and equipment, gross 375,964 343,932
Less accumulated depreciation (217,766) (187,438)
Property and equipment, net 158,198 156,494
Other assets 53,629 21,042
Intangible assets, net 79,162 90,228
Goodwill, net 338,800 338,695
Total assets 749,011 748,268
Current liabilities:    
Accounts payable 33,125 26,343
Accrued salaries and benefits 20,157 24,909
Accrued liabilities 32,065 39,234
Deferred revenue 4,496 5,643
Contract billings in excess of earned revenue 17,411 14,793
Current portion of long-term debt 14,340 11,801
Current portion of long-term liabilities 2,822 5,535
Total current liabilities 124,416 128,258
Long-term debt 237,582 278,534
Long-term deferred tax liability 33,320 36,053
Other long-term liabilities 51,003 26,602
Stockholders' equity:    
Preferred stock $.001 par value, 5,000,000 shares authorized, none outstanding 0 0
Common stock $.001 par value, 120,000,000 shares authorized, 35,107,303 and 33,924,464 shares outstanding 35 34
Additional paid-in capital 283,244 251,357
Retained earnings 48,000 56,541
Treasury stock, at cost, 2,254,953 shares in treasury (28,182) (28,182)
Accumulated other comprehensive loss (407) (929)
Total stockholders' equity 302,690 278,821
Total liabilities and stockholders' equity $ 749,011 $ 748,268
XML 44 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Current taxes [Abstract]      
Federal $ (1,311,000) $ (1,271,000) $ 9,388,000
State 741,000 774,000 2,109,000
Foreign 1,693,000 1,754,000 1,707,000
Deferred taxes [Abstract]      
Federal (5,842,000) 4,803,000 2,169,000
State (1,018,000) 413,000 438,000
Foreign 101,000 249,000 (425,000)
Income tax expense (5,636,000) 6,722,000 15,386,000
Deferred tax asset [Abstract]      
Deferred Tax Asset on Cash Conversion Derivative 3,553,000 0  
Accruals and reserves 14,159,000 10,910,000  
Deferred compensation 3,933,000 6,597,000  
Share-based payments 10,703,000 12,213,000  
Net operating loss carryforwards 8,303,000 7,914,000  
Other assets and liabilities 1,486,000 1,533,000  
Deferred tax assets, Gross 42,137,000 39,167,000  
Valuation allowance (3,630,000) (3,242,000)  
Total 38,507,000 35,925,000  
Deferred tax liability [Abstract]      
Property and equipment (44,740,000) (47,317,000)  
Intangible assets (13,418,000) (15,700,000)  
HWAY Deferred Tax Liability on Cash Convertible Notes Hedges (3,553,000) 0  
Other assets and liabilities (449,000) (122,000)  
Total (62,160,000) (63,139,000)  
Net deferred tax liability (23,653,000) (27,214,000)  
Net current deferred tax asset 9,667,000 8,839,000  
Net long-term deferred tax liability (33,320,000) (36,053,000)  
Tax effect on interest rate swap agreements 972,000 493,000 1,109,000
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards, expiration dates Dec. 31, 2021    
Difference between income tax expense computed using statutory federal income tax rate and effective rate [Abstract]      
Statutory federal income tax (4,962,000) 5,161,000 (49,808,000)
Non-deductible goodwill impairment expense 0 0 61,785,000
State income taxes, less federal income tax benefit (669,000) 453,000 1,520,000
Uncertain tax position reversal (1,137,000) 0 0
Permanent items 634,000 389,000 434,000
Change in valuation allowance 388,000 285,000 972,000
Prior year tax adjustments 140,000 263,000 150,000
Other (30,000) 171,000 333,000
Income tax expense (5,636,000) 6,722,000 15,386,000
Income Tax Contingency [Line Items]      
Unrecognized tax benefits that affect our effective tax rate 300,000 1,300,000  
Reduction resulting from lapse of applicable statute of Limitations 1,100,000    
Changes in unrecognized tax benefits [Roll Forward]      
Balance, beginning of period 1,348,000 1,392,000  
Decreases based upon tax positions related to prior years   (44,000)  
Decreases based upon a lapse of the applicable statute of limitations (1,060,000)    
Balance, end of period 288,000 1,348,000 1,392,000
Undistributed Earnings of Foreign Subsidiaries 10,700,000    
International [Member]
      
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards 13,900,000    
Changes in unrecognized tax benefits [Roll Forward]      
Open tax year 2010    
Federal [Member]
      
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards 11,000,000    
Changes in unrecognized tax benefits [Roll Forward]      
Open tax year 2010    
State [Member]
      
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards $ 17,700,000    
Changes in unrecognized tax benefits [Roll Forward]      
Open tax year 2010    
XML 45 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)      
Net income (loss) $ (8,541) $ 8,024 $ (157,693)
Other comprehensive income (loss)      
Net change in fair value of interest rate swaps, net of income taxes of $972, $493, and $1,109, respectively 1,277 780 1,714
Foreign currency translation adjustment (755) 80 (70)
Total other comprehensive income, net of tax 522 860 1,644
Total comprehensive income (loss) $ (8,019) $ 8,884 $ (156,049)
XML 46 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Financial Information (unaudited) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Quarterly Financial Information (unaudited) [Abstract]                      
Revenues $ 169,235 [1],[2] $ 166,615 [2] $ 162,270 [1] $ 165,165 [1] $ 175,180 [3] $ 166,559 $ 170,214 $ 165,218 [1] $ 663,285 $ 677,170 $ 688,765
Gross margin 18,326 [1],[2] 26,391 [2] 19,916 [1] 15,083 [1] 28,217 [3] 30,619 32,061 16,300 [1]      
Income (loss) before income taxes (7,591) [1],[2] 1,108 [2] (1,650) [1] (6,044) [1] 1,587 [3] 8,542 8,732 (4,116) [1] (14,177) 14,746 (142,307)
Net income (loss) (5,290) [1],[2] 1,799 [2] (1,101) [1] (3,949) [1] 604 [3] 5,028 5,057 (2,665) [1] (8,541) 8,024 (157,693)
Basic earnings (loss) per share (in dollars per share) $ (0.15) [1],[2],[4] $ 0.05 [2],[4] $ (0.03) [1],[4] $ (0.12) [1],[4] $ 0.02 [3],[4] $ 0.15 [4] $ 0.15 [4] $ (0.08) [1],[4]      
Diluted earnings (loss) per share (in dollars per share) $ (0.15) [1],[2],[4] $ 0.05 [2],[4] $ (0.03) [1],[4] $ (0.12) [1],[4] $ 0.02 [3],[4] $ 0.15 [4] $ 0.15 [4] $ (0.08) [1],[4]      
Restructuring and related charges                 0 1,773 9,036
Impairment loss                 $ 0 $ 0 $ 183,288
[1] The assumed exercise of stock-based compensation awards for this period was not considered in the calculation of diluted earnings (loss) per share because the impact would have been anti-dilutive.
[2] Includes charges related to non-cash interest associated with amortization of a debt discount of $1.5 million and $1.6 million for the third and fourth quarter, respectively.
[3] Includes charges related to one-time termination benefits associated with capacity realignment of $1.8 million.
[4] We calculated earnings per share for each of the quarters based on the weighted average number of shares and dilutive securities outstanding for each period.  Accordingly, the sum of the quarters may not necessarily be equal to the full year income per share.
XML 47 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2013
Fair Value Measurements [Abstract]  
Assets and liabilities measured at fair value on a recurring basis
The following tables present our assets and liabilities measured at fair value on a recurring basis at December 31, 2013 and December 31, 2012:

 
(In thousands)
December 31, 2013
 
Level 2
  
Level 3
  
Gross Fair
Value
  
Netting (1)
  
Net Fair
Value
 
Assets:
 
  
  
  
  
 
Foreign currency exchange contracts
 
$
178
  
$
—
  
$
178
  
$
(57
)
 
$
121
 
Cash Convertible Notes Hedges
  
—
   
27,766
   
27,766
   
—
   
27,766
 
Liabilities:
                    
Foreign currency exchange contracts
 
$
67
  
$
—
  
$
67
  
$
(57
)
 
$
10
 
Interest rate swap agreements
  
505
   
—
   
505
   
—
   
505
 
Cash Conversion Derivative
  
—
   
27,766
   
27,766
   
—
   
27,766
 

 
(In thousands)
December 31, 2012
 
Level 2
  
Level 3
  
Gross Fair
Value
  
Netting (1)
  
Net Fair
Value
 
Assets:
 
  
  
  
  
 
Foreign currency exchange contracts
 
$
73
  
$
—
  
$
73
  
$
(73
)
 
$
—
 
Liabilities:
                    
Foreign currency exchange contracts
 
$
255
  
$
—
  
$
255
  
$
(73
)
 
$
182
 
Interest rate swap agreements
  
2,963
   
—
   
2,963
   
—
   
2,963
 

(1) This column reflects the impact of netting derivative assets and liabilities by counterparty when a legally enforceable master netting agreement exists.
Level 3 Financial Instruments [Table Text Block]
 
The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):

(In thousands)
 
Balance at December 31, 2012
  
Purchases of Level 3 Instruments
  
Issuances of Level 3 Instruments
  
Gains/(Losses) included in Earnings
  
Balance at December 31, 2013
 
Cash Convertible Notes Hedges
 
$
—
  
$
36,750
  
$
—
  
$
(8,984
)
 
$
27,766
 
Cash Conversion Derivative
  
—
   
—
   
(36,750
)
  
8,984
   
(27,766
)
XML 48 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation
 12 Months Ended
Dec. 31, 2013
Share-Based Compensation [Abstract]  
Share-Based Compensation
13.        Share-Based Compensation

We have several stockholder-approved stock incentive plans for our employees and directors.  We currently have three types of share-based awards outstanding under these plans: stock options, restricted stock units, and restricted stock.  We believe that such awards align the interests of our employees and directors with those of our stockholders.

We grant options under these plans at market value on the date of grant, except in the case of certain performance awards which may be granted at a price above market value.  The options generally vest over four years based on service conditions and expire ten years from the date of grant.  Restricted stock units and restricted stock awards generally vest over four years.  We recognize share-based compensation expense on a straight-line basis over the vesting period.  Options, restricted stock units, and restricted stock awards generally provide for accelerated vesting upon a change in control or normal or early retirement (as defined in the applicable stock incentive plan).  At December 31, 2013, we had reserved approximately 0.2 million shares for future equity grants under our stock incentive plans.
 
Following are certain amounts recognized in the consolidated statements of operations for share-based compensation arrangements for the years ended December 31, 2013, 2012, and 2011.  We did not capitalize any share-based compensation costs during these periods.

 
 
Year Ended
 
 
 
December 31,
  
December 31,
 
December 31,
 
(In millions)
 
2013
  
2012
 
2011
 
Total share-based compensation
 
$
7.1
  
$
6.4
  
$
9.2
 
Share-based compensation included in cost of services
  
2.9
   
3.0
   
4.1
 
Share-based compensation included in selling, general and administrative expenses
  
4.2
   
3.4
   
4.5
 
Share-based compensation included in restructuring and related charges
  
—
   
—
   
0.6
 
Total income tax benefit recognized
  
2.8
   
2.5
   
3.6
 

As of December 31, 2013, there was $16.5 million of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the stock incentive plans.  That cost is expected to be recognized over a weighted average period of 2.0 years.
Stock Options

We use a lattice-based binomial option valuation model ("lattice binomial model") to estimate the fair values of stock options.  We base expected volatility on historical volatility due to the low volume of traded options on our stock.  The expected term of options granted is derived from the output of the lattice binomial model and represents the period of time that options granted are expected to be outstanding.  We used historical data to estimate expected option exercise and post-vesting employment termination behavior within the lattice binomial model.
 
The following table sets forth the weighted average grant-date fair values of options and the weighted average assumptions we used to develop the fair value estimates under each of the option valuation models for the years ended December 31, 2013, 2012 and 2011:

 
 
Year Ended December 31,
 
 
 
2013
  
2012
  
2011
 
Weighted average grant-date fair value of options per share
 
$
7.29
  
$
4.01
  
$
5.94
 
 
            
Assumptions:
            
Expected volatility
  
53.8
%
  
54.4
%
  
53.0
%
Expected dividends
  
—
   
—
   
—
 
Expected term (in years)
  
5.1
   
5.1
   
5.6
 
Risk-free rate
  
1.9
%
  
2.0
%
  
2.4
%

A summary of option activity as of December 31, 2013 and the changes during the year then ended is presented below:

Options
 
Shares (thousands)
  
Weighted
Average Exercise
Price Per Share
  
Weighted Average
Remaining Contractual Term
  
Aggregate  Intrinsic Value (thousands)
 
Outstanding at January 1, 2013
  
4,689
  
$
15.65
  
  
 
Granted
  
1,085
   
13.26
  
  
 
Exercised
  
(1,077
)
  
14.25
  
  
 
Forfeited
  
(163
)
  
11.34
  
  
 
Expired
  
(209
)
  
25.50
  
  
 
Outstanding at December 31, 2013
  
4,325
  
$
15.09
   
6.4
  
$
13,182
 
Exercisable at December 31, 2013
  
2,032
  
$
19.21
   
4.3
  
$
3,992
 

The total intrinsic value, which represents the difference between the market price of the underlying common stock and the option's exercise price, of options exercised during the years ended December 31, 2013, 2012 and 2011 was $3.2 million, $1.3 million, and $1.9 million, respectively.

Cash received from option exercises under all share-based payment arrangements during 2013 was $12.7 million.  The actual tax benefit realized during 2013 for the tax deductions from option exercises totaled $1.3 million.  We issue new shares of common stock upon exercise of stock options.

Restricted Stock and Restricted Stock Units

The fair value of restricted stock and restricted stock units ("nonvested shares") is determined based on the closing bid price of the Company's common stock on the grant date. The weighted average grant-date fair value of nonvested shares granted during the years ended December 31, 2013, 2012 and 2011, was $13.12, $8.29, and $13.26, respectively.
 
The following table sets forth a summary of our nonvested shares as of December 31, 2013 as well as activity during the year then ended.  The total grant-date fair value of shares vested during the years ended December 31, 2013, 2012 and 2011 was $3.1 million, $3.6 million, and $7.4 million, respectively.

Nonvested Shares
 
Shares (thousands)
  
Weighted Average Grant Date Fair Value Per Share
 
Nonvested at January 1, 2013
  
1,013
  
$
9.93
 
Granted
  
186
   
13.12
 
Vested
  
(293
)
  
10.43
 
Forfeited
  
(65
)
  
10.15
 
Nonvested at December 31, 2013
  
841
  
$
10.44
 
XML 49 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restructuring and Related Charges and Impairment Loss (Tables)
 12 Months Ended
Dec. 31, 2013
Restructuring and Related Charges and Impairment Loss [Abstract]  
Change in accrued restructuring and related charges
The change in accrued restructuring and related charges related to the 2012 Restructuring, 2011 Restructuring, and 2010 Restructuring activities described above during the year ended December 31, 2013 were as follows:

(In thousands)
 
2012
Restructuring
  
2011
Restructuring(1)
   
2010
Restructuring(2)
   
Total
 
Accrued restructuring and related charges at December 31, 2010
 
$
—
  
$
—
   
$
7,607
   
$
7,607
 
Additions
  
—
   
8,430
    
—
    
8,430
 
Payments
  
—
   
(4
)
   
(5,124
)
   
(5,128
)
Adjustments
  
—
   
—
    
(900
)
(3) 
  
(900
)
Accrued restructuring and related charges at December 31, 2011
 
$
—
  
$
8,426
   
$
1,583
    
10,009
 
Additions
  
1,773
   
—
    
—
    
1,773
 
Payments
  
—
   
(7,368
)
   
(822
)
   
(8,190
)
Adjustments
  
—
   
(504
)
(4) 
  
(132
)
(3) 
  
(636
)
Accrued restructuring and related charges at December 31, 2012
 
$
1,773
  
$
554
   
$
629
    
2,956
 
Additions
  
—
   
—
    
—
    
—
 
Payments
  
(1,700
)
  
(366
)
   
(629
)
   
(2,695
)
Adjustments
  
(73
)
  
(29
)
    
— 
   
(102
)
Accrued restructuring and related charges at December 31, 2013
 
$
—
  
$
159
   
$
—
    
159
 

(1) Excludes non-cash charges of approximately $0.6 million, which primarily consisted of share-based compensation costs.

(2) Excludes non-cash charges of approximately $1.8 million, which primarily consisted of share-based compensation costs.

(3) Adjustments resulted primarily from a favorable adjustment to lease termination costs due to a sublease of certain unused office space.

(4)  Adjustments resulted primarily from actual employee tax and benefit amounts differing from previous estimates.
 
XML 50 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accumulated OCI
 12 Months Ended
Dec. 31, 2013
Accumulated OCI [Abstract]  
Accumulated OCI
15.            Accumulated OCI

The following tables summarize the changes in accumulated OCI, net of tax, for the twelve months ended December 31, 2013 and 2012:

 (In thousands)
 
Net Change in Fair Value of Interest Rate Swaps
  
Foreign Currency Translation Adjustments
  
Total
 
Accumulated OCI, net of tax, as of January 1, 2013
 
$
(1,790
)
 
$
861
  
$
(929
)
Other comprehensive income (loss) before reclassifications, net of tax
  
189
   
(755
)
  
(566
)
Amounts reclassified from accumulated OCI, net of tax
  
1,088
   
—
   
1,088
 
Net increase (decrease) in other comprehensive income (loss), net of tax
  
1,277
   
(755
)
  
522
 
Accumulated OCI, net of tax, as of December 31, 2013
 
$
(513
)
 
$
106
  
$
(407
)


 (In thousands)
 
Net Change in Fair Value of Interest Rate Swaps
  
Foreign Currency Translation Adjustments
  
Total
 
Accumulated OCI, net of tax, as of January 1, 2012
 
$
(2,570
)
 
$
781
  
$
(1,789
)
Other comprehensive income (loss) before reclassifications, net of tax
  
(1,244
)
  
80
   
(1,164
)
Amounts reclassified from accumulated OCI, net of tax
  
2,024
   
—
   
2,024
 
Net increase in other comprehensive income (loss), net of tax
  
780
   
80
   
860
 
Accumulated OCI, net of tax, as of December 31, 2012
 
$
(1,790
)
 
$
861
  
$
(929
)
 
            
     

The following table provides details about reclassifications out of accumulated OCI for the twelve months ended December 31, 2013:

 
Twelve Months Ended December 31,
 
Statement of Comprehensive Income
 (In thousands)
2013
 
2012
 
(Loss) Classification
Interest rate swaps
 
$
1,916
 
 
$
3,302
 
Interest expense
 
 
 
(828
)
 
 
(1,278
)
Income tax benefit
 
 
$
1,088
 
 
$
2,024
 
Net of tax

See Note 7 for further discussion of our interest rate swaps.
XML 51 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 52 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)      
Net change in fair value of interest rate swaps, income taxes $ 972 $ 493 $ 1,109
XML 53 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Dec. 31, 2013
Dec. 31, 2012
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 120,000,000 120,000,000
Common stock, shares outstanding (in shares) 35,107,303 33,924,464
Treasury stock (in shares) 2,254,953 2,254,953
XML 54 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements
 12 Months Ended
Dec. 31, 2013
Fair Value Measurements [Abstract]  
Fair Value Measurements
8.
Fair Value Measurements

We account for certain assets and liabilities at fair value.  Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.
Fair Value Hierarchy

The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are:
 
Level 1:  Quoted prices in active markets for identical assets or liabilities;
Level 2:  Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-based valuation techniques in which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3:  Unobservable inputs that are supported by little or no market activity and typically reflect management's estimates of assumptions that market participants would use in pricing the asset or liability.

Assets and Liabilities Measured at Fair Value on a Recurring Basis
 
The following tables present our assets and liabilities measured at fair value on a recurring basis at December 31, 2013 and December 31, 2012:

 
(In thousands)
December 31, 2013
 
Level 2
  
Level 3
  
Gross Fair
Value
  
Netting (1)
  
Net Fair
Value
 
Assets:
 
  
  
  
  
 
Foreign currency exchange contracts
 
$
178
  
$
—
  
$
178
  
$
(57
)
 
$
121
 
Cash Convertible Notes Hedges
  
—
   
27,766
   
27,766
   
—
   
27,766
 
Liabilities:
                    
Foreign currency exchange contracts
 
$
67
  
$
—
  
$
67
  
$
(57
)
 
$
10
 
Interest rate swap agreements
  
505
   
—
   
505
   
—
   
505
 
Cash Conversion Derivative
  
—
   
27,766
   
27,766
   
—
   
27,766
 

 
(In thousands)
December 31, 2012
 
Level 2
  
Level 3
  
Gross Fair
Value
  
Netting (1)
  
Net Fair
Value
 
Assets:
 
  
  
  
  
 
Foreign currency exchange contracts
 
$
73
  
$
—
  
$
73
  
$
(73
)
 
$
—
 
Liabilities:
                    
Foreign currency exchange contracts
 
$
255
  
$
—
  
$
255
  
$
(73
)
 
$
182
 
Interest rate swap agreements
  
2,963
   
—
   
2,963
   
—
   
2,963
 

(1) This column reflects the impact of netting derivative assets and liabilities by counterparty when a legally enforceable master netting agreement exists.

The fair values of forward foreign currency exchange contracts are valued using broker quotations of similar assets or liabilities in active markets.  The fair values of interest rate swap agreements are primarily determined based on the present value of future cash flows using internal models and third-party pricing services with observable inputs, including interest rates, yield curves and applicable credit spreads. The fair values of the Cash Convertible Notes Hedges and the Cash Conversion Derivative are measured using Level 3 inputs. These instruments are not actively traded and are valued using an option pricing model that uses observable and unobservable market data for inputs, such as expected time to maturity of the derivative instruments, the risk-free interest rate, the expected volatility of our common stock and other factors. The Cash Convertible Notes Hedges and the Cash Conversion Derivative were designed such that changes in their fair values would offset, with minimal impact to the consolidated statements of comprehensive income (loss). Therefore, the sensitivity of changes in the unobservable inputs to the option pricing model for such instruments is mitigated.
 
The following table presents our financial instruments measured at fair value on a recurring basis using unobservable inputs (Level 3):

(In thousands)
 
Balance at
December 31, 2012
  
Purchases of Level 3 Instruments
  
Issuances of Level 3 Instruments
  
Gains/(Losses) included in Earnings
  
Balance at
December 31, 2013
 
Cash Convertible Notes Hedges
 
$
—
  
$
36,750
  
$
—
  
$
(8,984
)
 
$
27,766
 
Cash Conversion Derivative
  
—
   
—
   
(36,750
)
  
8,984
   
(27,766
)

The gains and losses included in earnings noted above represent the change in the fair value of these financial instruments and are recorded each period in the consolidated statements of comprehensive income (loss) in selling, general and administrative expenses.

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

We measure certain assets at fair value on a nonrecurring basis in the fourth quarter of our fiscal year, including the following:

·    
reporting units measured at fair value in the first step of a goodwill impairment test; and
 
·    
indefinite-lived intangible assets measured at fair value for impairment assessment.

Each of the assets above is classified as Level 3 within the fair value hierarchy.

During the fourth quarter of 2013, we reviewed goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment).  The fair value of a reporting unit is the price that would be received to sell the unit as a whole in an orderly transaction between market participants at the measurement date.  We may elect to perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.  However, we elected not to perform a qualitative assessment, instead proceeding to the quantitative review described below.

We estimated the fair value of each reporting unit using a combination of a discounted cash flow model and a market-based approach, and we reconciled the aggregate fair value of our reporting units to our consolidated market capitalization.  Estimating fair value requires significant judgments, including management's estimate of future cash flows, which is dependent on internal forecasts, estimation of the long-term growth rate for our business, the useful life over which cash flows will occur, and determination of our weighted average cost of capital, as well as relevant comparable company earnings multiples for the market-based approach.  Changes in these estimates and assumptions could materially affect the estimate of fair value and goodwill impairment for each reporting unit.  We determined that the carrying value of goodwill was not impaired based upon the impairment review.

Also during the fourth quarter of 2013, we estimated the fair value of our indefinite-lived intangible asset, which consisted of a trade name, using a present value technique, which required management's estimate of future revenues attributable to this trade name, estimation of the long-term growth rate and royalty rate for this revenue, and determination of our weighted average cost of capital.  Changes in these estimates and assumptions could materially affect the estimate of fair value for the trade name.  We determined that the carrying value of the trade name was not impaired based upon the impairment review.

Fair Value of Other Financial Instruments

In addition to foreign currency exchange contracts, interest rate swap agreements, the Cash Convertible Notes Hedges, and the Cash Conversion Derivative, the estimated fair values of which are disclosed above, the estimated fair value of each class of financial instruments at December 31, 2013 was as follows:

Cash and cash equivalents – The carrying amount of $2.6 million approximates fair value because of the short maturity of those instruments (less than three months).

Long-term debt – The estimated fair value of outstanding borrowings under the Fifth Amended Credit Agreement, which includes a revolving credit facility and a term loan facility, the Cash Convertible Notes and the CareFirst Convertible Note (see Note 6) are determined based on the fair value hierarchy as discussed above.  The revolving credit facility and the term loan facility are not actively traded and therefore are classified as Level 2 valuations based on the market for similar instruments.  The estimated fair value is based on the average of the prices set by the issuing bank given current market conditions and is not necessarily indicative of the amount we could realize in a current market exchange. The estimated fair value and carrying amount of outstanding borrowings under the Fifth Amended Credit Agreement at December 31, 2013 are $113.1 million and $113.6 million, respectively.
 
The Cash Convertible Notes are actively traded and therefore are classified as Level 1 valuations. The estimated fair value at December 31, 2013 was $148.1 million, which is based on the last quoted price of the Cash Convertible Notes on December 31, 2013, and the par value was $150.0 million. The carrying amount of the Cash Convertible Notes at December 31, 2013 was $116.4 million, which is net of the debt discount discussed in Note 6.

The CareFirst Convertible Note was issued at its fair value of $20.0 million on October 1, 2013. It is not actively traded and is not based upon either an observable market, other than the market for our common stock, or on an observable index and is therefore classified as a Level 3 valuation. At December 31, 2013, the carrying amount of the CareFirst Convertible Note of $20.0 million approximates fair value because there were no factors present that would result in a change in the fair value since its issuance on October 1, 2013.
ZIP 55 0000704415-14-000015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000704415-14-000015-xbrl.zip M4$L#!!0````(`,V";D3A.(X2]HH!`-D^&@`1`!P`:'=A>2TR,#$S,3(S,2YX M;6Q55`D``P%E(U,!92-3=7@+``$$)0X```0Y`0``[%U;;^,XEGY?8/^#)D^[ M0#F1Y5P+735P.4E7ME.5K)WNV<9BT6`DVN:43+DH*8GGUR\IV;(LRQ],O?WT:N\8*93SSZZ:AY;!X9F-J>0^C@TU'H-Y!O$W+T M]\___F^__*W1^!53S%"`'>-Y8EP3WW8]/V38Z'EN&/`1?..Q^W![=W]C6,=G MQWPTH^.-)XP,AH'1O+HZ,QJ&939;QM/0&_D>-;HX#/B[C;9M8S?TCXVVZQI1 M=]]@V,?L!3O'C89X^]LSBU^./38XL4RS M=4*H'R!JXZ-I?Y?0'VNZB^9GY"?=WY;ZO[:BWGP&5R=1:]+5)WD=^;#-D__Y M=M^SAWB$&EEZQ.N=^8-I:LY/XL995^)[IU;S8MUDXQ[)`_0%^\'BV#ZVCP?> MRTG<=B(DT#";C59S]A"7\P"AF[:*!ZW%!RDBMI__5-0D'FDN/N(3._\!WI#7/1BS%?UY2\X#^,T>YC\@ M6G(F/WQ%\XD/,7(#\8M_;'NCJ'?32OINHYY!RI0%^"PSB?#JR13^S M:38#+R$OZIOTQC0@P63Z6_(K<<3O?8*9$1&&%V8S8U+G[K>CSR;_WX5Y>MH\ M^^4D^_#L52Y3_TV^_ M$?^O)X813P(GO<"S?WS#HV?,#L#!.;KP0)":_#QM<#@9;V.7V"2(:30\TS?FX=J)'GV?=11I[+8>CD)7%`,>@B%FHIGAH6#I M"[ZC/"7`M0##UGRH'T2Z.$"$8N<&,4KHP*\%'O(G73_A\W^./%H?I[`TW_J) M_)'A/F8,._61>MZ4ZR?XMN,04?Y'[B,BSAWMH#$)D%L+!*R=NUY0R)12`11R M@T+B*G)!)$&J(6>J(3'",H4QJ&'(4\.0N/Y7##60X@!BBB$&*B*55T0DQDZQ M*`BL#40UQ:P-Q,TJQ,TJVR2(F\$N[6"7H#(D465(+OM3#$FPX@"XV<5O01YV MV#Q,+N]5##M@9(;7/DVKA;##L0,@)N=+!#4$A6H M):J,,*@E`FJ*HP96Q0`QD+5+%_=4\B3B@<6/H2&&@H>=E1*E#O*$P)"-B!/-G!@[8=LH)86`(Q^[30= M$D#Y$\`#5PDA`3QD`EBB\.'TK[R10/.P8@>W(+];.#!$(%C43^2J7>]Y8!6` MZJBNB@"E,F5*90>&`F1'A\R.2A1^]N33(_/X0,'DT>5O:%-'<&@LYO%E\C09 MXP@,]SQUP$//=>YXF.B]1)R<,N>O+J*#N-]$1U>EZ`:FU0?1MRWQ6$#//V6_(F_E+<>1<" MU.KI`YYVPI.(E<07^WI>/WA%$5^_(N:(/\%65F(KQ>?//FX4`\"[?'CK$.!6 M"+DJXVZ`=\%H`,QV12$N1"3K,+TUDE-6:/;G-7[!KA=U['A^4**`3C*`T?F,\D[Q&>`-G70)E?DE+TU$]"F%]KDOFL3DL>Z MV9LU"-"A+`;UI\+1])?0)Q3[?MOF5M:/-L_$NXA\6\P7?<7(#88=;E9[GAN* M9L6]RXH)3\NE&Z<-(?)2T+(*0M_1RPOQ10$:T8G.H,F9*$0;8%^DMB_5U&[` M0!S:0%2T'S&2\RV/M0)\3UZP,=NKAOA8PP>](&(!1+2`2.E7QD&DH4*D4?K% M,D5@T`G]P!N)\_,T8,BN)2!6\*#N3N2>V(*]=-`>,)P^UU(K<*SD0MTM!\!# M-GA(93V@QB51C4NJR!.*&W(5-Z0"!\2C,L6CI0<<\4U=3^BM'09#CW$*XT,_ M'L-D0#M>R#F@N./(GV+J=$W.7/4*'M:*.KK8I$V=>\]&[G^%C/@.L855U%OJ M&Z9=(P!PNX@916X7OV`:XAYF+SRFONOV]`;`AFEK!H#,UDLP^P`U#NDUU,_>X'B M-W3G`R:^<&7MA`\%FZN&=570O)@II.WWM@@`BUQ@64R`TG+?9P)T:9ZWS,A< M7`H'`VY%&K=RV3#/&RVSB'VX7/1$^[0/5^;5%"=78"DDLQ0+L+D2;J48;*Y* M="N9K`?,BRSF1;KL!G*:PZ)C(=Y82$_V6W#E@E;MHR%E\F.-601O>OBXN]R5 M)S!XLAB\RE:8.@P[)+A%-G%G-=\N?O'<%T('BVUJ"WYYGNF/@:R9,$1#JY'R MNRBCCT@0B%T[-HNV=2*W;=L>.3;%5LG(E%[U/%H MM!3^C.B/AWX?=7]Q[2/?S+GZ;> M-@*D# MW'KS9@_%39VS9Z>/?L7.@$=@U]CG?=#\EC!NM*<_84=M"*YCSM*VV'PN;8)E M$7+R&3XG)(?S^WQ]/K`6^)"#,,VL<$;%Z\M[]> MAZX3,;;]:9?YLW70J2),K%+%MA",9H#/A!UKH1]%ZM@/1(3>>T7CVH*\`ACM M7^?RI0=Q%2`?D*^!(3\`B%/?*[CI][$=OY<3:L@2FWMJA'8]V1TEF6OEY9-/TV`7)X!XMX0XT"<)DUT)KHRLQ,R MQNE.WY>Y3[VL756K?$"ODF?F+M05"M!N4J_U0:4JQKG57*-5@Z=@OBP MB')Q2-B@7Q)`JP1%RY=M_?Q7Z<$AK&/*ZY0J6$95,>0"`Z\L5NL3NJP%:0?Y MP\R)K*@B@P&M,J!U>G1NK8STPNP6L0`85AFA*IUA+?V&Z3T77.H>XDJV54^. M.HP:N>&!:YN[E%_JKFTZ5S\DLSIJ!6![4;B%?>NI&`UR$9EU01J;4'Y2M!LU M^;OF=2T?;!/EPLJ'BOJEA,^M0R*Y186N[H&J$EB%^!!J'Q5X!BDV?:A\6%(M M52LK``-M@SA,7=^FVD9**&O(EOSD!U$$/))2U_4_C,[J* M1>IRWKEPX`T"XO;DZ"(D@I[%+4@$0_54[7WCD>E>+UO)`QFMM*QMVRS$#NB7 M6OHE?7R^"E=Z*=>&7'@WY8)<&')A577M<&LJX,C`D8%RE5G4W3$7@[*$!O>^ M2+"C?`^)(^@DW..G@3(J7KY12POW?M8.M$D';8(Z1>UWR$@6.4$F)86_*&NW M,K@-N=R&;#N^5*N\[5CE!C6H2@W*,^AR+05HI8OO*0K`NI-)0,)MNAIK(.RK*E(9@N44C[5]L?6O32N_YE- M4#6I:A>PCT_G'0-0K%#2H=4^J)1F[1=B2QECR\IWU=;.[TFC@`?;?"'G?KT: MZ1PXP<.G69*%H+4[Z2_?HK7&6BF-&LBUFJZF4JJYDZ3NP:G.T:!D`8):.B?- ME3<:^S]E:B%2*B.1MS/L_$I:J^K&%`ZO,I13A1%6`X M*%APS>F.(6,V^7_)V$E;YB%,G?DC"RB;M>PET$I09@'*-$*951QE5GDHBRW8 M+2+L#^2&^,LD^?,K%Q]B]G!RCU^P&^>W.`@XQ+GU+,^J1Y^%XO+U_FHLX$(YI.V.CL/`CQHLT%YMM;>@SJR!ASI&16/?"^J[=_65T;_5VI#4S/NV(/,M M1X&KWE:AO?ZV:N]^;_R`C'@F\=!/>B5_7!/?=CTA2_#'X(]ET^4>2"NI[&/6%Q>,# M^]Z*]E9(G3O#ZM-NROOHL6BG7"!#HLSK5 M<-6J9[+L+3GHRG/^>7K0VT.XX?*OH*YP05[C+GO2FP MG)N\I#(KRJHK+`_70(%KJ"JJA`=JJ;2Z"\*@T:#1L`2LDX_6M.BEDUK)?G9Z ME\JA6@Y;ARW8H-Z'7CN6O.`NM_>61;L/NH%+4VU65&&JVJP%]3$]M%>SY%E2 M;:EA3J^6PJIS6:ZV"BMAT"SI[I!RK(G&U2TYO@NC57@LM=XJ&KM+M?M2ENA8 MJLJ5MLZWZF*,_K9&.FIXJ+%R1L[@,P`VS;I.",A3!IUEOWJ^]9(ZPWW"_"##"KTE MOV[.>DG?C*3?Q8(-=A"*JKMN!S)SH5^YKI'D#FICPR-^LE M99XM!H/%R:+S$):!F`IDF&`R)#,8"9)K%(=.LKN0,D)$0 M,G)9&2N!C`7IAT3IQP)DK.*0L61T3`"9FCJFW:T,.":P,I`QR9HQR65E=@]_ MP3%!^`M61E8K(Y=C@CQ))MM2Y3%*,`YR&(-^61 M.?AS]64.RR.2VG:)_#G8]OKY<]#S^MEV\.?JV_98YH_,XX\'$S'3H$V=FY\A M&0OJOTR>)F,<(>"AWR]H9XBHXV*F-@*VF/84#VLF7U<\=)#K=K"X M8D'Q$Q3;HV!IRK65O..6]$OR>& M".6^,V92;2S$UJS0#"N9]>/WV9"_NH@.XD[?..=&X4AM^"33F5\$M#"O35C0 MU8Y)O+I='J#1F_J`K@)D[U6P-)\!T$N`;K\BYB30O1F-76^"<2_P[!\/8^'` MU$;HPO12'Q5:-4]`R`:$1`418@?8B7CW.R6!W^W]KB5*ULX5D+*K+='-"^[; MQH#'*W4;-'B\PWL\N78]9[>P`D(.CQ#)=JRN10C$1(>,B>1"RGIO`T@Y)%(D M\SJ;\5$'7.BX::90"@U"KE$R`G@XK-)7N/9U1VUOQ*-I#AU!_;UG1PN"TR4" M/WCH]Y"K^HKHFDG.A;\T6S`$2W$BH$4NM$@6*V;R3T"+7&B1.P==AY8>=EU" M![]B*CX"V*9.VQD12KBWCNZ&OWD;<['4`DF%.`$VJ1#*%K91=X:(#6H!J=73 M!OP4\FF`'QGP(Y>7*Y)O`7YDP(]<&=CZ-9VH3-'Q1L+I1YP5>]S4ALR*TLR: MF8*5V5#*!92`+=F\Z@KZ!K:XT-000:P-BN;+#*@,.`+$V()8KG(CM;[*? M4MQD%TP$USW*_QF#KVW;X2B,@S,>J?ENO.72^6?H!^(AM4&X=N[S*L-V3*@* M4=56*9T`Q&H$,8FK(=E$ M$G!95US*E1ON;"\A7I,C7M/1Y@&V),267'8+O&CMO&B5GX0"4Z68J:KH*\&9 M:*F+;1?Y/A=!?$7!0Q@\]%.,>0B&F`D&,CP4;'[!\=T&T]V`NST<S\Z(P.\VK M1LLLN8ADMEI-]=BYDPE MINVTBMM.:W^V,Z0DYN7O')49YHTP\D.&/T\)$YM=_=E0L[;T\&*L56-;*\8F MOG=J-2\^_MZ[WG7H5F9HA[QP&679)Y[X'H[$A^&]I01H:WK2#,X?,?6Z:TR] M$:'K7[B)N=DW+@\Z:TW->QNVG:Z5]IC_N:M`SE:,'`;LH_^S'^PZ[OF*<:,] MUKTX%]QN[+\U&FW>VQ%/&+D13084YWIXGYN\>7HC,)C9EY73=,0L^U MQS-T0=!C9"%R:9GUB;ML34C:/;],^1T\=AC`:$#0Q1APAPZICV3CG&_S>3\*8S.IF&R9$7$&ATNRH'' M)LO$1.VSYLTTM&T;N\**B&\OYDF)S5FEI@N'D2?*^#R^HY&>)F> M>0?1OIDO7S%R`V';_`_&';6/TW0LCK6$&RY#QDW-'77PF_$;SI'1M$O4@W?8 M3$TZ$%HYS!(AWFCD<;46-R)\,*+C,K[Q$`9BOB#NGNJ]1.2I MV3(O%J78S$BQ=6:9EV<7U@+1:]ZQ;"739ON6_^CGVJ(TO=8D/MEDMPO M'-,0D7!'9P1,ERX6H'F6@>:5%1F73:05YTH'N:YA6Z6Q0"/<01A+%PL\:AO^.%8^'># M0]7@UIN(XXQ33E6*ESE)O9@BWN]I2D_,MZUP='Y>D&6V[?&HRS<8MC%Y0<\N M_F!0'"S->-JOFW3[CH-92)8[ZS4!18-GJ9=7IY<9\:YY1;GT6EO0VS0O6ZV+ M=Q`\1A/1916ACW'S>TBTSENGK5P*%P??-VW;B+O%.YT5I(V%7(E=@IZ)&QTB MSB%/=+F?]W@7A99YOD1A_OCE$+F-B%M75FM):S83.5N$-J[QF"L.B0S-!_$O M%XL_(^O7'HD\YU_3MIFEX'\)J_4AZI(8KIQ9SMZ1?D7R`O$-L]3P*PWB3I*S MFA<76;NW)WKT8.)6]NWRXK1U61T3/;%7@U.:VJQAN)Z?IS^;MG>(/17<\C[T MG]#;3@!JG)I+EKW(2P\ZP6V$V[BRKJJ;X*W',!G0:<7&GABI#:?&?,?IFO#J MG2S9XPT*Z_EZ<=FLCJW\J2BG&T39W2TBS/@#N:&(ZXT[D6A@/S"Z(M#OO:)Q M>=RM[*3F!DPW+ZY,9;6VN8W6-B\NZZ2V>SS2MB'W.*^AVE9VAG\#J*VSBPK5 M5A;N5W8`:@/WSYI+&:+&%F6/IX,V50=6YA_%V.HX1+P>N3PG)TZ#8]9&8Q(@ M=XDU2<]'WO&.=N)NNR50ERWK-)-6Y@]?(J%;53@X?,\N"A'ZY(F7D8CE1L`Q M\HPI[I-`%)"\`27_PLXRQ3/9/WDKAH]%R"5WT^]C.Q`Z&M]_)@J/G=3E[<+^ M+%GBQ:L6U\WYC*?\YV;&7NZ7/)DYE5TK6<\IZ[*^G,H<==O$J;.*.)4V\H%G MI*R&&#M:I8I'GRZ(-IZCRGUZN`]&%W.[[1/AHS%[$4L8TV6_;LQNT:O1Q0%W MF/S9V96$JYW*G*:5DXV(><[.+"%D2D=,1HJ*.+38H.\;_-%L(K-Y;.5_1(^/>KNO]A3N=\D:M(A0#?N]FMDE^)KKRVS_9F M*Y6Z2D'@4$0,`EP\)"M__=?=@Q=!@`1```2E224Q10(S_>Z>GIZ>1[%WWAW& MENN8$&)!2$BNGIQ[)4PF\&(RG"HY)O/)<*2K>E;.@$H]V^9J7):]NI.5(BR?A,[-_K1/W]N9J^UW&U MOK1Z_4\.7W+'@9?/FJD1&I*O9[U,*<=UN4QY*LN4DIF*(Y8ISR%PZO`RI1RC MY3+E;!+,Y2RW3#"?0V!=+GDD`^NS"*S+,54&UF>AJ>7<.G8ZUQ^UQD-%RC+ZWKU4@$46N%*;3ZR M"D\ZE0WN"D<:\G%5^-/>CK0Z5>:E75E7.%:GCVJ>3G%IGNK9GU16^G%YGNE<=TQ7>M+=1V$*P<)K]P,ZPLCM!7GOYBO$@W;!) MPQ'!NJZ3969\2QT[NR[NV@=H4WW79E9U':TA56GCJ2[UHBMBM\.7&^ MM6-%!EWA2K<-WUF<0NL**T^C2$\YQCZQR>K8P=NN<.4TU'_*&P8GW73K5/U) M5SAR&MH_Y=7W266\4]60I3ABFK9.P:&;(*R^3U3#-[)'?OL=/QYUA'&,E?CI M#DJ%9BV#UFO;];!-X1?-W'<502W8_E-(NRX\C/2B#HNZXC+W3-0EYN3R"HDX[`WFY98VR&X!7@)PD_M9C M"\.EZ^#VH_`&'GT3//G)X6O#7Q^;451&^Y#(F+`M/,H9GRYB4,X%5,+@C6'Z MM%YPN0XQ`5Y_Q^S$)>BM.KMOW(J1Y6`NUX8YP\>R6ZYH/ M'AJ>-AS&*57)#!?6*9ZQ"&>D2T7QEB),,W8M*/G!%L_/EKX"^RRX_?_EU MWT9V8HXO$5)OOPL<,&'Z.H;_XS(LC?K$'?+[0#H_ZQJ]5(QUY"RO'K,'B&,T MPIO0)JP!YZPP3=E1Q_3MAG500TI+26E)+_*Z*BVCR?SI2\MOFH-7V[L@(:)( MQK,9WOS#7MO6/0<["1Z6?;"]?0NSLY>2OSYHCR$A`CI\M9$*"2(0#0K)S5,7 MF0^P)A771!F1.?FXP1G:EI%T"J1)&2$\DTM>O(BTF!V9JY.G;TBZ(Q5M1B/5 MI6*X<]6RE(JGXD^.L!6ST?CI2T7G0]0V'ELB-JFE,@0]4F( M3)NQ2;TB,YVF;[%_BH+S&OYY9SBNMR,I3]BV(-)+1#HE&-*4=$DBV@Q@I42< M@T2TZ4R.DH@9%2DV)18WZXUF.%C,(>X%3],>]P?C9\(RDV,K"H;J;+:-5.8\ M-4-9;ONQ;>BJ;RKNATYL\68"E4&B(E<$C>;(\1WV59RR"+;3T4R=9$A,>LI> M<)_][@XI_1S\6`EK19FKJIH!0C!H/9`4(88R4F:#>0E(WH%D,.J=V?^,!H,J MQB)K^X%[WM87.;'^7_GB;H^1IKEP)IH(-X5!%WR'QS-F4OV?T2NO'J./?S6X MHSGZZO$]O^6R;]@IW1N>A\=3I]/)Y.3Z M]];U`"985\+*-1Z,)[WC( MBH6?\."`;5U[77"$1RTNU:SD9^L+%,G6KL-@MCL)HLJ9V884 MN-1BM%,*W(D0J4@VJ)40Z>A\WQ,.;872@(W41>\VE\I>#=?U^0*8J@-DA@9N M5#,]\*]8J_#%QDWS?<73KWS7L+CK7NOB(CH\FT\]V&Z`+PYWO1L:_J.#_VK@ M8`@(`!I0I\8#6>S+&%0TI`U@%"`BA!&`A3IQI+M5'0=\,;I^T.[O#9?]/^J> MIUF/;5%2V4M)`54`4K$&1<-FB$?!W$9[)"^]M!VJHM'B,8\53,#Q%C00'P85 M<'X+UJ,8*XD_5AY,@3#TJ@?ES!FZO>*=G"HE-2(0W!4$I&O M*]`R;0FZ5DD^XM=;$8]XNBK(]D`@OGO@V[D);N$7@'=532N.K`B>EW>`Z2)= M4:P/5.<0$VUHU8,'>IW@[)UK+[T'[&V8C9WQ;]%*$$?X$CSZ%\=VJY59JY,I MQ-!9..7.TSH>13@#*X'AO"H>N/Y$R.D#!JKWFAE8)>X8]@*],MZFPMGE&RX^ MO=S%REWA7B7\DQA!O!^^'KY\Y#&%F9J.PHI/W2&DRYU^F,V?!-+ECLWTT^V? MC\-:QP\\?J\89M<>+`>=1\.Z$[ZYT@&&Z3AM.`M,U18&A0S,>):.@CN$P:`( M#P:3#F-01!UF]2"0H?RV:>B/[!_!OU\QTGAEVOJWG31-C@+2>_@:O770OO_\ M_TSOQX5QSUSOT>0_72SA^?Y26QOFXP_LVC$T\T=&W[G@O7Y@RF#C_7CQ_^Z\ M'U/OX21]<'%WU@_,Y$OO1T;?&-8"H/J!#2?P'BL\^.W5_]/6FQ__6YD,?F2Y MU&)]EBL*;.,`NQR8*3Q82H_TF*=][_/O?+WQ1%M+(]I+`NIC1HT[N,7$-MJ& M.ST:VZ;;!]V5[7A]<-UK>.>>A[BMF.<6?@;4!KS8O.MRZ!$!!#>"L- M#[3BHG%-L>(5DNY/0+L$&<./MP[[4_@Y^4CX^:#]W69_)'%!-P%Q"9$+O@5@ MU$P@SA?;7("H+[ACHISF]5J@.H9=_3(UU_VX#`;_Z'PV[E9>E#^+CH>^AIGX MXE74TB!X,.N,Y%29[$_O3=/YZR-A2%/(95\\Q_C&815HZ+L!8]9D;[^CR+B< MWHA^W(/EKGT9)K%4T<1?S<<'<#PP;3(V7AN!L)(6`3C`:6[I**7Q+B?[QSYC M$P]"97")(>(1.F!UHH<\3.4RG9OF1EO@&7.4'OK;W6AZ]#<2]J>+-U\^O7MO MN-Y7?.DB'/S!6'@KG'SPAQ*FBR9WHD^+U&C%#2$C%=0U,T30LS?!4P\<6?P# MNP7E_9$%/SOXG8!!482-\1:[<.P:Z@`RS??L>B$C6/:*7PK*/\6$^Q,Q,,L4 M%K"6>_V2P`9__8'1JDP_SE?AA+[`-"C"`(W`-9[`SF\"AV/@_0W40J0!P/SC MCA!X,]N\%XE>C507L?#!FRT$(L+'O<)8Z34MB^GCEY7!P7>`F_O%L"SNVIX& M"^X[S:&.#DL.QF6#=^-Y-O.!]?B70_=/:;BSN@Y2/>%4M%3'/9Z5L;EBL??_ M:+'_T2Q?`EJR*>)QA+P MPR9,3:TU"'($M\!;HY=-(@+0#4?8AONW`.9"#_LNV$: M.?CAP]H=Q#)1C@7"&T]LD[LN=P22!$G0QB-)]H`9*'0XM.U[#.GOI1A^[=_Y MKL>&Q&ZEA^"*P9&?$*HYMH]>UD@LI+78))`AQ-0?TW, MMM+@S7_9!AD#JLARJ>E6Q-0`[;0S-+:85^DEWE\"=\%(^887JOAKP]'QS]=@'439S&_:HX55B:"B MCSU0/7UEW&E69-D6VEK#+B3"Z,,7(,;P,]E+&/O6X9J^$JXBLDRQU2%\?#>I MARC2.B:YP$3'SBT`CRXN@)#ED6U6^`PNS&!-<$(QQ_:/+0OMB MD49RB_S9O7%GHQ&".?!:%K*"6">4&K#KTM=8)/1).!?R(==H*-A[[0$EIIL1 MT9;(CT*)_\4P/;!FGY;<6"[A!](3D`'XZ^)E3PA&(+NW'"45RW!6$/?"LX'= M#RJ(>H'.:$QT1KI'.7-@R4X?A=A$'BSQ7N!?.7ME(PUAT#<&!`5@C%UVB=]? MT`\7+U'2WX`NX88"WL8%=`=I%^HH'J3/\&`4DD06/MGLEHE@W>,\Q$#,O`V' M4$_R$MAW:VDL?(B68,*%+ZP]/"TB'O%,B`YHDSH83(,>L6![L,P'"(`M=@,P M\2-`>?O([G`QBX"^XA;[?,7><[XP>8_]CW/5`Q0-OF2P`-9%CZ^/RR78"(=F MQNU-8Q$$35M,0#O@<,03@=TD9)2<63)J(I`"\X%/4>BSB5SNQG=T,B5HM.[N M,.H51R;&@T%O,!@D:K2V\4]6;/7048*9T[':CKPN&;P=N!".#V"_2#HQ((II M\XL3$H;FH17@%GS#R3@)#\4IV3.\X[>.B+)!^$O,H`RW9@C8F-9_%SU+;*4B M10I,OAN+X^ZKC'_7`0*@SP,^A/W=?(@='=Q-0TF)^+45C29E#A""$/O[(]`] MN#NNAR@+\N=,BIJT$)D-ONCAK$O-)(XOV-IP3:[A,BQ@S(&#\8T#-2 MHQ4.GJ5$#QK*)%Z;#8Z&6[!060F4P0APXUZH<1;TV6#!-($#[N'R`=ZV@^`* M6[2)*!1X"%&K4$@Y@J=]`6RQ74O0N4AD1']6K.P3>C6#K@] M$<:2DZ;@TK!T4F$,8H)0`9[84F8292N07P3-`[-H\4?WCV+IB;\'MU^YJ>5% MK$RAJ<^WN:'A_L4F^PA0P.(>^.]&S0=C^BXU>AB>66O?T",L^!I'\S>VE32F M+@7:AB-X&=EM^"<9C"0!G8F51P@HFG4@C[%C7G>@I'`N5FV%QAEM(RQ0-"@] MXSX$5E3$.NZ>8`?%0"Q"JN2S3Q.7?/0]T[:_=3,*">)Y,AZN?_LO;&8)Y!&"M"3*Z=.PU\XPUI0?HW\"WV9BL0=&`U;0C M0F-"U`Y:\![-1%D&1:ZTZM2H^9\L9BOVB/<=HPQ78P2X);VF8# MNA!0CSP^UU>6;=IWCW'&`1L4@P[KP@9M6)\S77]M5A3"5Z%"$4Q M?(Q_1!LR\;C>1.84Z``K(W$: M.?0Q<>XIRNU2(V7F/=CLD8J9*75/:Q/,=CY&N?UP>;"T0@\D_; M@6U-M0&E=FNW=HKCU>D&].2>"F3P3-$".Y\XB>[;N\5H]#8M[C]ISD>'+NI> M4.%+V/ZY2,'6UE;XS8=W%S\/K@8#91NY`_.<$*-#F_LU8?1%8$3/])@XI+0' M_.KE=,=OUQO3?H2HY!6W^-+P*(?F'BH"BL8`OQ*.$`Q`[Y^V!`A#'&/Y M**N`1!70M%@54$BUA@N!T@)WDN*?(Y>107)A-%`NO[UDG[D7A//LBW9/.8O$ M7D;P4+"EH=UKAADF35S_%A4T*,&D\%,D7GA`HZWE04@X%W?'18QOW.+&+JPE M:5D3!IT0R>">BG87;M\8#L7F5-(1*[^+>3S#BF]:24":CIW#)"&$J_HJ6H?B M]&+IM)T)P:I84;F2O=`)1]L>)$X-)P"!X6!1!#"^&%XI863?@TC_:A[_A78, M?A]'Z]ZP98,(SKF%D?D;KHLLZE`)TZ@BZXMOBY4BV,P-H&#`LJ2^"+RPJ=RR MT0Y?P7NXJ06K/7L-H2KFT+*\2OSH#3WY@7L?EU^U[\<>]%#&D\%HGG;S>;,U M#7RY\TC]V4#I#.@E3Q7-TJB%2F;#&_*09"[!Z+#SDF-?YX0C&_/-+ MN+_=U$";=BV4_84(`:/ZVI2:YMCT! M[HGXOFW,(<+1*%((+_(Z`?HA#"$(Q5K?*N/I)'7%;N?$H)QM.*$8M&\VRXE( M7693F8SJ]<$-V,UR0G-2N]EP!%)21KH1@7QRN&BF=C)W$D'PA#Q*.:6HYE%F MXY%2JW%H0A3*$:)M4=CV$^+>U0/YQO0$\$XWJ*L:]:-K;QZR@ MRUQ_C>?5_RT*;45U4'C>+(E8CUE8\5)_J$`0 MD4HG,H"R46'%!9#?67`G2JKO2[+7FTZ_#P"YM3W/7D>C!P#TQ=<_,'7S/4IK MCW'&=,):/%BPHT'%RI>Z)/SR!M.UMN\"&]V7>P5\.^>?0RS!O(A6_RTV]Y!F MS+5-8Q%13CE$N&WMWII;MU$*+#S57AV.BEP34EIP*R.'Z-C[[754JI?HF`\: M&+5*_(Q5)%\>M(V[GQ&6_>!HFY\NQ+]'$"3W$/X_1>Y3>=[9LC:QK5K$@]YJ^K<[Q_:M11_X9CL`)=>66?"[M<*_WQ4BB:#PLW0UBH6H>\R!Q&M#` M7?K5`$;%==&+2F1+8B#J$XJ@,&H(ATNE-YT/:M'G+K'FI93HYRK1LXG277$N M+QY2)EN4R9+.O+B5G:OS[@IE`S;V^#AK2?\Y1;[B8W#&,#=7S6[Y$M9`>$@7 M:R6-97AX)AEIU>6`4G0XE;*W"T:^QJ;A:,J+*+,6%;9YXIZE4.Z%H['X9#R9/"NA+!F?9.ZDM)$<*HSL-75`=!,Q"5^(3@=[=LPJ M:6U%6C3AU"HD$,\`T-,OH97>8#9KR!YT1WRZ`XD4Y(8$6:`X4Q7UP*:P%&NIT>F+E;YXKW8%$"O+Y9<":DIY6TV)2!3JC`DT%PJ:EFURH&22)X^R7$Y/B18M5F3 MND3OI/Y4ZH_4GZV%U:"IO:_N2%YW()$Z<(P.-+8!/!JTE5OHL`_);;J6F$@W MN>80**L8D#WG)@\](D\2RI.$S_`8D3Q)*(5`GB1\UMQ_0B<)0T!6`9+*%!SD M10%7\50S7]OG"P\D.^7)E].??&DL.:7VQE-YOE!*]).1Z.E,GB^4,MFQ](W2 MF[9Y8*D#5E:>,*S+!P.U*7O0'?'I#B12D.4A0RG.70?T]+FD MIV27G_0APQAK><3P>1U+:6YKHZG%?W>$ISN02#$^MQ16=V2G.Y`\>REN*@Z; M39Z*&,LS@B7."%:KE9+G.RIJ6YVY&=Y*?)PW+E`+#KD.SW30[Y"V'X1PO9V1]CV8U_RL'17 MPN2],C:OCD4=#/GB@4'`4_5H(EYOU0O<4+U`?2N?3JK:R;N&1!H]/$^-/MS' ML.M:^P0X<&"7J.L$1`IXIP5\ MV!L.BCGF+E&Z_BV!M%MJR2]O.R;^?0/+FJ97,X^E2S^VTW^*`# M5Y[VG=URBR\-K[GPHV"!S/F$'\U4_)S>8";+N;H4]Q=<8=6"5*M9AH-W9)Y, M`*5"284Z.X4JN=J@1?/[SGWRW?Z=IFQ^V]L)%)(?3?@70 M7YFV_NWG__P/QO[\7_W^)^X@6[0[NJS`X??<\KDK^B#9%F<`#;`6(+LT++8" MP7`XR('[LM\70\036CB.0_M$GPWW6SRPPG0@!B"+;ANK#73Q4W-GP=7BC).8I8_T6FQ&D98#0MA-3@+K)0( M*^4`5BIA-2V+E&-8NK$QN2MJ."Q:LM(K&7#'/WZ"3_IC)-`'N?%S2K5+U6(5 M/VE9TAYH5[$E8'M(P?H,J^CTZ#OL5698&CROF0!:4`;C8IL,TU]PJHW3=%VT M.$,;"G^C4="L1Z99"V;`UZY_ZQH+0W,,[O:89IKXX,/*T%=,02.)>:QO#`ZH!4/_B.M$,/P,0;I;$>8Y/\-Y8GQS[ M#DRQ^Q?'=MU=@=M5#S6I'GW0>G6LJC.(D+8ASIFA:8`S;.\.P(HRG<_+`VRC MUNN>#T!_O`5=(7[TV!N?+LCYP@&4!?L[^.0,^,,WXQ?AM1M+O(3OE*?\^.+G M(46F6V@%K6)D3K]7R%!B#(PJ(80'6YQ5!-T,59(VF^4O4^JML)Z/ MFRBP#@^U'9UXK+4=0XDRSK++PCW+6,_>9*X\R][CE#]N/4O'/.H$;G0_62H? M-SF6<">]6NN$A88?0ZO6/E_*GO4I5-AX5-7GF=@9BA&XA6B4./]P.HM3O@"Z M+9OTGCRY-$EG5K1>(]M.?MU?`9MVN%W5B>R6,KH:Y?:K@K7#@51_K;=(':-2 M=;7_R#-;=6W[U'I_U+`)!)2>,N_6W5''R(6\S^S$\E@'#LH09/+`+GX7K]FK MOS5,1[W$N"XO4:`*K7$OT2(,Q1M`-&+J)P?.W[3<.:)F.R];BI26J%J,-5X^ MV>*=J"=J2WN^(?T!I7_"(7U3JM5*7/[_&K]71D;GIP*C`R'VH#=M\SX^&6*7 MM-I3&6*?8XA]$JLM8^WG$FL/VDV,R%B[I-4^P!L9:\M86\;:SS'6'AR(YYY` MK%WU^L2.FO)YJAJPDF6O\33V4;:@M5NZVH/RR0?Z'9$=>==QUQHK=;BY6*>G+JVHH::GW4 MR8&]^RYW/EW*Y"?)XKM'V^[CUW7::M\;0N M<_C&X2Z,C=7UX>E_N5SK%I0G7JY=#IO:[&Q$9BIBV6IOM5;2A]V$+1#FJL`= M]&U-W.[4\778>2ZY/@G'@TCYU&.DQM774UAHG?6N$*R6ABT6-LK]H'/;#VKI M$CZY6JAEM:#[CH.V>F,[!ZYFD0N$9[A`4'I*8^S49H)[I MCDF+J><3;:JTFG<^_N"=W'0YV8*CF[#E>(>BP'7".[2XNU%/G^+,]I?56_`5 M[G9H8Z_BLNT.Z:46NC?&$Q7%YP-VS=NZV;DX6OBN>#6X$[H*VX,Y`=3`?G2NJ M>_MR9Z"JS(8UH[H?ER/%<*P,INH^YM0%5CF1&0^'LUG:!C0!5CGVCD?3X6Q: M!"RZ6WX'%I%UH]^`^^]M<*U?M>]OQ?V,K\0]24=2;CI-<;/(G$V`78ZRTY'2 M#;#+J8^J#.9'P!T\#5&1PR$69/`D"QYEE\'#NPWXQ4O!.W5CI$P'TRR,\J9K M%Y=R0J5,YL/NXE).KY7I.%.Q#^+RCB^X`ZN-'&C%KW5+T5R8[UUH/`91KNX8&R^X,N9OFF-07^W/ M>%W,*\TUW/[[FU:]>WCS!5)HCE'6"XQC&^/FX$ZHF9 M\?L057RI/YCVE4D>NEMS'\!.<_@[PX$`*HDG/EH3GG-U'K!W,%!R\`08E@A# M`@2$8`MA9=`?*.40OKZ[<_@=BG%P,8I&%Y3H"40MI,GQ1'BGZ?Q:5%]FKG4K MX9UO`0;A!0Y)`Y`'405R5)/XBD3(%/(#"8]QD]@W*@Q5E>!DPE`95;1K^\&N MPL8=]P5T$H(-8", MAHF7L=1(BG?AW5'Q>T0-`B"87TP?SEZ0,,-)(X1YK;FK'85VVZ`(SIS2:?>T M0G*TA3N2'A4-77]RV-(5)DD\=_@'W9GX&?-PE6U(_%H\)(UX\*Z_RJ8E?8'> M6+D:SG*IDP]@>5*!W]`K1\>9D-"(F;%RN0AYBT##%(&4^=4H-W#>`U9E`AVM M;&5(54]\D::9JEZ-)*_IMH_83ZJOUJ:2/�WYCN/HQ44IBK'"HFM5EV^*. M<#MC.MYG<3-`*DF+XS$NL@%\(*XX'HVW0,P%1EUON&/<:R3-D0],O)X(.MYP MU[@+;KQTV5_YX@Z]=/QHG5)!7B8&+7X;[U4EZ0@1B!_*<.%!Z/+/`-@0`]S+ MPC%BC*[=X)'XW2)+F6/$;-3-:50K<>59!C9T;0F^M"%UHLXM=?_S.]M\QYUJ-K*)SG]5\#Z<+IR M>XE#U(F`R%S^_/S*=ARZ[3&\NQ$O7LQ`0X3 M\7'<'K,,*S&.1P4HB:%>DI2_]1U[89LF8+C@&]O%&X8O+RC+>_$2W[M4!;!` M%T26]GPO-?'=%]_ZZOCPW2O-^L8VCK'F-#T*@T,QQN6M>'(I,N1L">1W!28; MTW?9X&H\^$./R@@N]91'5RIXS\($&4HB8::1E_'>LG8(' MAR!(^"\*RU412T>F)C_:B.[2/68[(AP$Q]BQ:K/!9#@@JS;#?8FRNQ$SW(W( M3\XGIRZ,Y;&^;B^^\\$\P'=^U*[$?/^N1!7$41;8>QM$JJ3OVHMP`;>%$^.\ M:7^%O;?[@TE_D)M5R$%SR1TT*;AO_AY<%`Y*U\333=\]X*45G$#;Q4N\"F\F M7J37XIC80;DZ='C>BI1S98+EOBY&6WIC]1Q-J'WSMH0["4K'0=* M=T`O)]_J*,=&%0,]$F]#**ZG?<_*^J7L>JO9O!=#2<9>)99.H.(5VV+A>3$D\`[9(> M7\EV^*60_L"]J,M+M+`!%66:Z_)]*]1K_-U-!+PP4N65&V`SF^6L"?;/U2XB M1:1Q/IED6_F"B$1BZ&#&T<_8XQ:_?Q8_'P/J:#2?9(*Z/7;=H!4ZV34994OW M(=!02P69#\2N$3MR`M;\>MM4-9*/DS5PY)Y#:47U::P_MBFRAL MQW<0/O@0?A>8FF0N`LQ18'E<&AV3]UO)"CJ?5P4[155S[&"=H'6/-L7"_6G. MHK`1VGRD71RRMRZY3S,V=`=I)%ZN)`'CX0$D:>PFP2S$C-$LV]CF@'FMZXX/ M;Q.(V#/3N2\`WRX_/P>OXCGB<,AJ\"OC`QZZT.0G0;"0'`WF2F[FOPJ"D;4O M'H8T'GOL"SAJ`;.>6&\?F$G?B5$?'4@S?9&&OS9-^P&S1D5PJ+9!-!L/#A.Y M5;`+10'C>4[>:C_8R4V.^AS=V_7&M!_YUL_5N#$_9/R/@JE3]"BTMS*>'Q#. M>NA!$KSA6.E@W3&38E.LJU_:SH/F+`HXTO#E]_#NZ^2KE>1@-CP4Z>1/>!*D M"C5IF"O9.;J6:QDZ&![SL[D0G0::0555S]I5*([.UH4F1 M8+'R@"/B9C47]/3X;8!<,&%1&F0LW.ECYX1/I@:`X3K@[>^^L5D7+HX)AZ`!P'=%KU<4+^J*. MIC(6VFD3M7\"*I.!-$9UN0Q@69JU4S-=6G$8_S@&)8GLU*%:QG3=ID"12H4)[MGS*I2`-XT M+*RRQ[:7QJU/F*%Y[E'Q#OO,=?O.PF-0&:CBF\D7\3U\*W[IF*UH/$TWWD7T M\*0G0Z[$EC,BEU%GVF'D2FPL`W+J_$CDXN:5N^`GNG$>*5\9FA0/?CPTY6@V MG.]*Q"%H4.-]/![RQ5YZ#W@Z);^,OSB@_\P-U%X]1@<7PAGAY_#C&W[/37LC MCFN[7K'^$Z(JZR1HI\\KM(KV9->XU2E[Y8S1:'`RV4NI;+M,4'9;GQQ`F]H! MF[Q0+^#D>]%;]39W'LWGLW3(?7C2TV!6KC9IK$QWR@6[BEG)WK[J=)XNHBV% M673PG]9(>!X(']#,J#U3T$ST[7=]!:LI+H($34^8AXN&[^[L)0%R\B$A1 MJ%N%,DEW^M^+=Q;KDIT:4"9#\E_CT5*Q"L3.`Z;M^FA9\?H#1O,!XO.@RA8.2_'/5RU<.W3<7/41W3#"=FV9PTP56]-/?[D;3H[]Q%?/3 MQ9LOG]Z]-UR/KH2(+LT(K[P8#/Z0?65=+H1;]Q]MCS:%))[$T@`F.9[=KV`$2BE9+/HG2')>T`2'_.N M"LD1F'_YKF^BXT<(C2-!)J>S=::16?8P9:XS.$F&4;X M/NJ#0(?XW0=MP[3P-+K;PYX"9&S%TEJG3$]XM#Z['=P5`U@T7710P98$,4PN M'A7'GYP%;2A1XX-WUU]>L>LOK]E7>V/H;*:,@S/P`!00VW!7\%XP'K))%,/0 M"43X"YZQ%K1_Z'`(I1S\CHZ@YU#B%DC`$0#1X0'1N-5,@@8FXA[ZBJ"M@V:) M8@\\EQYM)K`UU]#&++!OQ%(S''%-[Q6[!NT65M%\[#%AH-WP:'P,S!_=Q%LP M)3P>PA0N34420YRKYYIC!6TN3&PZX6[`4B^!3"L06IXDB^X8P$A#HT/\:^X! M1"Z#4'-M>,AID?W!<_EKS<6PUN*>(*?C(*@!NZFW0PQ?F#NRE_3JKJP(#4H) MR2.S-^)X*/SX)R1?L.=*]EAX6(1R(RXZ#GMM`$38>L-PL?D#X<6=C0:Q)ON>"31W>*:>]6`.@H]PP=^8(8'O^HES:^_Q_`#L\NWVG&590YFF#N4,32?U>R,32 MJ20T,_[:%R[##O:FUZ"]*VZY`ELZ_X%V$DM"+B^2+WQ\?7/Q\BKFB'`;2631 M2:`=!&MEV&#)8[N`J$$\A%>[(*[ZSM!1(9S1?_OA'QYH[; M0Z\HK(YP9F@7DW3"MP%B4?82=$P2#4V6QG%,P+ZK#>X M/-D!/_02,,G2QY5!_#L7E4=7[-?0M3$A".Y->V&QAMS1/U,A)]82Y! MV!9!;A5OW<)>().7PJ4_T-WR,)K`:6?L,&-3`N_&\_>P4$X=Z"%2X+$T[JA3(:7PT8 MJ*H9KH:Q,,`0RR&VV(7Y@WTOFMO`FF",H$?=;N"+21+,CZ@NX)S$=#WV8IZ< MZ@'CADC%-&^W:XX@\HOQ(/F60>Z?M"=^&^B0A&),G9$@DN59'CA)'Q`:PP&9 M^4M:I46DX_(#[P=6)]I2V5*40")#J^-J`+/06+;P*>X2RH<_DF+#ZT!J%R2? M>$'HN7%$8XO-J&`(&%6\CH8`[4':3(F`1]`*XZJ(7$D>79,49)`>VS,!_#KI M;(3B(WLQN!I%W(!7,0:):;:?6B0_*4N723$4VX!J%BYT%9514RQ019^'?:'< MX#K`Z-3$ENX!N#9F4.!G4@(T2&B"FHA[CG&!V%=J:6,A%]D^LDGNRGYP$SXH M-*@[3L\^Z,]"259B;^Z$"Q00>P966.O7YNF#BMMAH M.;]O>5_#0CX<8Q6L;%5E\SWQ>[D[M@-`)@=O_#R0Y=@6E?X\3U1$?[$^OO,# MBY]*KN5SENV7-R@3MN\"^]P#MXSK-A(=2##-O7_T\.WQ%! M1=RZ!9.])<&NXZ;?P\CG)F7:NHS[,(AG+L]OMG,AV^LFM&R?,3.#<>3*V.PL MHW+D?7B>\KYCHQNZS[J&RY>?&JG59V-0#MXDW2&C(3P>!N\OQ4(ZD:;-7+XG M,ZN)#&)JQ0YA:8_=T>EHC*6U[\%@^V6@,D%;N8"]!C`J[OR\J$2V)`;!->UU MW,A>$8?+X;`>"]`EQAR(#J4\/UUY5GL#==Y=@6[.ERWI/YWU9>\K.+$X^50T MO]*H)B723:PZ!LHH!.472>V>[Q>'!%B9F=()J$K%_D=BWL.@2D?`'W%"U MK6`71]S](!P@W0N"H[KAIL#V".%.<;SV"S?(PIV6Y`;)F[WY\YRK'C!A0*4A M,-4#_I]E![O&P8ZOR-WOY/.WP:*4?S*U[V(;/K&50I>F9NPH7^+H+['WC6]Z MT9Y=)BG/K@*D2(UJLU4@Q\C\1^!FHOZ+[NJ+$>WEU(8%Y2&]PU5#F45#"QMW M?:/"B66D/8DZ*`]O%"%5$25/OUY]N6)_N;[^)&XMH>*HK`HNL:^V4PR1E.'U MFB]P#\[,KD@J+,]T_4I^L1ZBN-@2C%4@&,FG%L:"GEQI5`&`Q2'(KJC6X"B% M.WZ;K8L;D_GRBE?1!#+$%Z(>!0L7$@R*"P`10VQZ8NS6`-[@'394KF$#A9=8 M.X@DI.J2]`ZNMQ>@W0N%]BI4N'<.THU6N`\S>V909J0%925DX&GW>^'K?*<@ M9@/#@0:!!)$=#UOWB>HE`.;!]LV%*%7$.DLQUEK[!H,OV8JJ$T`\@MN;X*>@ ME&9/H2A23V,>7C+U`&)($+D>EFUO\.)+NF>+$]!"TT(JT:_B"J/]1$',]W.5 MZCM1]%!FM@*8RE9_.US&9_#K?*'IH)YD&,$M_YLJ;HV1B>X#V:-I^XN'DZQ+ M5J!5-[;(`>W;9QT67.CL)\/3VKQO:M.^D>W, M*CR?U\SSDLG/.N3QW.I8GLAFL]S7/[-]_39MSG$5/T6M4E/T_[(5A;S>BD*" M2Q$NWU,4$O8IT:FZISZ[V#T3&!\(R8ON=N*PTDIY%*:E8J5N*I,D455[4X/A M*$NB&,C]GPK:A'0EL#(L5@E\>".[:T8$N\WZEL-A"LR_X7*NKDTP6>-1UR98 M&H6F<+B<]>:S47N;8+)JJPH2+5@P4Q6U*3=Z$C$IX&=:BMI%B,Y-$Y8/ M/7;'+;J8E'+BB[5A&:[GB)QD4$A47U1^>%.]:[XV/V-[(%I_\H4GQX%1O'KD M&$!.6?U1BX60LB%EHZCEK):)KGD5]@S66[@-**/3YQJ==GRYU41<*J6R\U(I MUTQGN69JM(8WPQ66;YZGF:XM"JY$N57YXD0C4?R%E%K#)*+**NQXDBRW6IJ^ M[HE[C^C5G?EXV-V4&NUL-:+QG3V/QP`%A5I1/7#0:06"@6]]S^[CO]CO+BJ= M#)I%:=9C4.%#<,4%DF%?J*`K%=?T5:)[RQ$5.O"V6USBW"MVG=E>YX&SE;;( MX`RAE=TN:'(UC-J_X`&ED(I9;0\WC@$T`V$B7*]]!,PT-(LM;-/4''%1C>_8 MO;!FSDF5\"4E1-2MXC2ZY@;E:30C=J!)%3!9"W'F"6F(W*'&+]@V"2P&,$YT MN;(,SQ8-_C)D0\A=T`?RNQ!-1,*^1V*;J9+RL.%5>AP!,XQ%C0[=5`^GH#B7 M?^>Z[_%D[Q]1YFZ;BV3IW=*P-"`L5JPFJEJQ2`_>Q`U??$DT&]OX#DS*ZRSQ M/MYF8*%"LP"[?<3"[HWI6L:=^WI%::4& M"-]A9TH02""QSJD$+=T),FQM!+."UE&/,:R@W%L_=XC^9U_LIIYDI[#2LNM@ M*46=.\_*X&F4S'2X.FG_%G8M7)P\#28^FWXFS5JJ3I5!=L+*J>>I'^\.+P^> MM=D[4[;>[.M'*1EZ?@P]<`@&0OG\?5G)[_/CM[3+3Y*MYVB7J]69GT&,*6[6 MK5:UTHXLR])L27Q)?$E\27Q)_&=!_%/%&EF='.HMF4KV\R[4MT7&)1V544E\ M27Q)?$E\2?SG0_S:*[H[E!ZAZ3Z*R_J"`C!1(5(I`*E6%8D7\IZZ]JZ;84QZZ+HS*6\BCEL4/RV`@"TZ8J M$:482C%\#F:QCE+*P\>/N[G$.V)I5Y$.)^D%V)5#ZJ4`K?&8?V=UNCM"U!U( MGKLXES244IJE-'=8FC,7H76(LSKM32=-W5?6'?GI#B3/7I)EF"'%N?.`2G&N MGS='KI!'.>!U?!/TJ^UAVX?Z5L@%Z=">"@%`;&'[MR8OJ.R=[CA4$LG3-R5J M;H.U.Y+7'4BD#ARA`T]G32Y50:K"<>[@22SHI1I(->AF5-38?G9W!*\[D$@5 MZ*(*/+VHJ/9[$,ZHO5JEO$SC12TMPG!<2JX0%"TWJZ^YR$G*0_&=8"D.SU8< M#M3S/F=Y6!N+!<0QIQ:)&L$XSFD4!:1EP3B2/B=GBI2-$]/G*9\\S&O,]#[N M2EW;G6)G5U;>E,*4JPUO25OD,8.NR$,G(G`I#ET1AVY$X)V4AS:BK';!.,YI MG"+*:IX^)V>*E(T3TZ>KF6SZ]I3PVZZ75\5C*H93#D\OA^=K%#NZZ--&.S[2MN[['G743BSJ9*ZVTE7). MNM;)A.NS%*JGL\Z2,M45F6IFL=3HL7,I3UV6)^GXI%!)H6J6O!W>S M2Q7(2W/4#SMM>HY;1#)!$A7A.KI ME-M(F>J*3,FS"5*HI/>30O5JRA,1Y"/7R06O"^S:.OFK[6EF[:MC>7NGO+WSAS9ZLG5'\+H# MB52!(U3@_)?C4@6D"ASG!9I:RS?:5J$[PM<=2*0:=#$8:J[U77OP$ZW>WQBN;MJN[_"O0)=7IJU_^_D__X.Q/_]7 MO_^&N[IC;#S#MIB]!'H"?P!:YF@>!_JXAHN/&/%!NV!T%L_)_O$+7]]RY__Z M-Y;''>YZ[#.^_>5!V\2_]<64N\`G(/BX_%LP/P[P"F=G.D@*0/V9+X%@ZD`9 M#I2!XMGX25&'RC^SJ/#9<+]=?S?$!Q*5A`5$,BWVP`=_)RRS>[$: MX;"_::;/>^POCNVZXH>]1!8%#J]]QT&^T/-N_"M`R8HS,Y=A"!C!]7$9?TES M[3!+)1:]TDS-TOF7%>?>>UN/"4[@!M`*8`,&U/'S((N-^4A78&$Y1NQG:B6=*\'"H61A-2T$J/7.*&(1 M+L8`/R=&EN/%.]OA\"A[^UU?:=8=9Z^!T(ZF-V(W]U(^@"0$)(2C;@9,AQ`S M=HP)[9@\*?<)DK_6W!7*.L7"&!]BQ"->X:T3'X%)P$*@$"1U3YR?_ M!:S/^F^5N.=6$'LO=94M`27P,8GC5'FX@R6N'M@4"C M&F\[&&@\0[5MA+5/2VUK7+6G3`^QL(MNL'T& M[;-W[2<13E*_?L;>:J_%:R)->AYKR7.+1XMQJL/)OP:CT^X69+2KZJ?0YF[J M9L<952"0>6:!ZKF9XWIBHN>2G3^>N\ITI+:MS[77AY(;866PP_*<_] M3%)A#=CPUG<6NJ/\73?S-7.ZO!J<[4$)U;M:[ M5M*WF08&5#3#8K;%XN_Z7[AI`L7A-VYQ1S/IS.OU8FU8!O!`$.;M]PVWW$)+ M!ISAHY4@ZJ$^7C>6;J_Y%P_XC_S>DKX`M@"R:VNQ#5<(5B$9FBX4M0WI5O+1R^\%;NRWS2B,'"?GU)1_:9!BI@Q$=)K,8@"5<#933+ MQ.G`;!&*EZAM+R$R!,EPN$F1A6,B&AV?U>T[R_BWZ%:H MZ;J_]L7;'U_?]-@=>39XQ].^!X/E4R;1;!)9\3D:^L82A_7L]<;A*V`V/8P" M\S:$[U,`W@'E/.0,!^H\1SAJ`.[)$SNEU(=4<3C,VZ^JD]CO*U#9U%S76!KP MPM*QUVE*XRB1">#"^AQ-_6C*=S#C=3PAS`=::S;*AI"(H M3(:JVY'-IC,4*90P0.>`2F8RI; M3Z2R76X9ML,LRFA34V7#U7W7W6JK?!5WV0:@P;[8/A`+YMFR1,+7VLX",QCL MP?!6\6OO#`N^!4(",>AMI`N$L=9"V7#/_'3J1_8Y<6[ZR^O+EXFFGU' MGS+'>VTO0/=%;$R]NY%[1W$:8*AGH.LOKR]>LJ_VQM#93!GWV,/*T%<,V`D: M:[@K;'85HX1\!WWDKSF`[LQ&5QCBS=Q>OF`PUQ(S,O>8[KB"E<_" M0!IKIOG88R)73(*`4\3`_-%-O`6289HA2$&8%O0,,1_Q7:XY%F#F@@DT.3@I M=P.V#[C)5K3ADJ".[AB@"8;&-(<#C%Y"3J]=MN'.VO!09\!*`VJV[X!*N?`& ML[@GR.N0+0\4!X%.P*FM<1YRDOCJKM8)+4^IVR.SJ=@A;@,5,\3#-$0(-'LG=UB?LK'N3::XSV&Q(2WZ:Y!L@%;S'.OV!*QQ)SBBP>.EU?@50KF M(KB$>M MP+DS[W'#R1BY"5'5'L@=V+Y'O@%U6!@[,`!N,/D/`4R!7>HQM&*.H7L1M!AK M!D%"^K<49+?<-#B!!)[`]<%Q!1`0D`HOLNT[1$;/"-KR#>RX\!Z!GT6#C>C1ZSU8?^E\XT5&71.XA^X;/!99 M;+3M`5U%=+#6'M%CTB#""VO@00Q\[!:D;FOF),>^PB0AR'#%Y# MWP14?P2'ZS(A3P"URYU['!D,E'#N@F^P<@3.`16MX`5::^Z@F)S]KB!D0"YP/U0=X8-B+Y$P? MJ^C-+D)H'XP%)U,`,0PWN4,.*)S8WQ"00=6`(5;+CFTR"L]!*N@3D`'&76,!A$XI8394>@S]#\2D:.D(*1`&%#BT M;M]A`>IQF'UPI3+0&1,)3)1W@[`#^Y\RC$PA;B%IVZ8[Q!.+C(S6,U7-RFVT@]&%H9Y-[R=?AB](IW:@OV%N-/7@#Z M=Y!T]A8%O98;S:K<5G_BR\^?@/"IN?PXH60E[69#M^6%-$0.UGSUHF1/?>RI M@X9#2<-S,8X%0\/^]$HME%%)/E>`*96YQ,F';QWNF$.@*;_:'N:<U2[N'#>$P MO:I'<2OQI0%7)X7R"0CEY&IT.J&L7SRD3#X!F9Q?-14_-B@>QXNB"=%GU,IGC6FD MV@E;I&2=1+*&5X/3258KL8<4K),(UJC-E59=Q'T6N9%"`80;GMV\2YS=U+;/ M;@;U0K4%%V>Z2FA*4]L*]4>G#/5E3N0)2]90)C:D8#5CLL;G)U@R.Q$&%U3_ MZ^N>*'84%<'B@(D.K]_)=,69Q_[1P4WU1YFVD!+V5"5,IB^>KH`-KB;G)UC/ M(GTA2CL,:DE!#3ENN<67AIGV_,.[29/F&/[&9S7<&GW M1`_FWF[P0L>L-2;JCO%`,790N`O/@R)NZM4@/.1=E1V"SOCK#XP.J.HE^/&% M,`W.>F=,>S)!"=I$:0S8"@H1<)-=7@3/QT_2 M#Q%S MG!#G,>T'_,5?4[L`S]&H'U'0G@`E/#PEGFYA$,L5-F.G(]!!3X-`8`U7=+<) M6^#A;+;O;7RJ&**Y,XD1]E<2S7A<>C(622!1T.DB/1^>X4X)>Z(%1XIF/K(K M09R%YFE;/(A&"EC)OW-'-Y#G`-T&=*L?]@@0K33HW#^2PA#-NV'ZE7:/;;RP MI49P@#P;X:R#U\V([0G.V*.H+*-S]N*\N,O%X7=J-<)W#1!QM$\M+%)JD&CC ME/VJYKK^.GCH(6`SL'7![[EI;]+=I$)NART1N*:O0N',5N%2A_:C,_L_5+!= M]1ZMGX];/UD_;NUP\^'C+?+L??+L/:O]).D9'#!Z"K+JV9L2@GK,F<),:N6# MTZSDUG8\M&8Q+<2.\H='GR^7ZRD0.@\NE_8[YWM$6!YB+>UIVMSI^*U0_)T, MOV$Y)K(7SWP'I&(6K\V#6VIC)US5%L^*R!RW%,I"]7J#$YZ[ED(IA3(#A_'5 M_`S+D^NO(FUQC7WJNJ*S*V\Z*/M[`.EBA9*4#2D;4C:D;,CU?F:50[1'MK,Q M]S;W5HLN8[M1CQ: M-8O!H3RR:0,BH4T,+$! M`R]D-Z:.K``JBO1)3K;+):84,"E@4L"D@#VS1`B=$;LT@FMJJ]V3=/+@6L;X M447+&?9F.NO(51YC`\W,DWW MC'MLDJ-E-X.*>H_H*VS2Y+*%:"\=]@3!#U;0%\1P6=#&!IL#<=-^.'TG$&4P M:*(52,7#Y@%0PR,BT_"0W1DHMY7`P/C!1T<37\;M.%J<>I/#K;L^@0NX,OA(^_RGOI.2RP+ MY*A%\?G,UYIA883P&AYP(+SP-9-]Y<[Z?"7IF*'/792N[^XIJKBAX`TP MUK!<0V=_HU89=?NW)]'ZY)@8KZFC4!_C!I%,\]C_:):/JX$@U)>+[%86V4TM M2$>]R:S#Z MJ2^*;<(-!7NYWWLF?2PAQIM/N M+B(JHE7;T0DIEJ?*_HRN5)G]DF[4Z5*7#GFL].PS1\K5\(0MC63FJ%N)"IDYZAA#6HJ-,BO%SS6=M#&<OHLW:@W;&RKJ#L"U!U(3B7*%<6C6C5\8UK0:,%\8VNGJM+70+0B%:%#-KUD M(%%8EB>-=?YX`I+6-F>1W:9B2=&?INVE MS>S'UV,/*T%?,X4$G3I`^<6 M?0TKGV_<8QMJ^68OZ3L@+'?,1]R^T>WUVK8``UO_%O4!%7U#_^@R'AP=$Z_W MXIZB\4^+=+=0-^@4NK-THO]7:1+XH+`'S64OAE#71,[`XI2;U:BDJ)>34,R7"6Z=*&,!.W7/.T[\-WB M2\,#2`"S?\>LH8&6-C5RI0>!/[XN^)@-+`D>7VQQ)#GQ;YP9KNMS9O$'@0^U MEMV2)G^3&!)_%5\'`E0[_P1C\-SS)5*%G2]_M0QO MIU'J*>4.^;_4#$<8!J2Q$\,(D-?A<<+SP MA:$6M,*D)_OX9`JK-)SBR>JVIQ>HU?!*4<'LS*[4>6AO\*3_84O3##M37JLU M";)-TWX@.E+>R^4@'&`NO!73MMI)^\XN)W)[2KO`7S!V\&_4?SJ_KW3:J`G' MERL/P=P!)$U?Z^T5_22: MOQYC"YO:O8KMHVS]>J(V"TVE(I7>01YVL4CV.8A6J]G#:E(Y;0B'^=7\#(6R M]L8&7?0%LJUEDV:_K>(Z97:&UWQ*P:I/L)JRW)3[.C_1>A9A_-\HAIGHLQ;*QJS^X&K48:ELN=O&&43QQ[4GJTB(D[<`Z-[QF]*] M"MI:(%PV=O%*4\+3JNN1&M`9#6C0IRGGI@.G/7C314>WM74AC]W($NV"VC\; M=>VP@3QTTYGE:L<*M)M;@+ MC9\4=:A<_%Q5,/;X\7_YKF&Z[W%5_: MJ:<9#(XJ3-L>K7A!XX[`>?8FJ_"%;2FNT*#1U:[.[*%:*.::[]GU`B=.(8>2 M=?G>=MV7J?*;`LI2H'9T6P!:K3P-HT)'X*U6ON:-YMD-5F@"`O38L^AL>N-7PL`3]8)@^QI0\(JA)!-T`0:F(-"J++U`Y MVHM*1W\X+962YH[ELRZSVK2S):9'%L%MKTB46:$%2>*Q`K5RES=8T![40S+^ M7><;+R%)"\W3*N;'2U<(HO$H7INH#&HL3HRG/LR48RH3_XX5XF]W]+&6,*=* M+J8\"^K(6E>A?F-+]-#F[IB_3DAYG16X;0GYX=Q&IR0ZG[G/M7X:XX+.,/#( MQ?TY\[`%]X^!WWFQNIUL\F24L=8_J9_B'C,LW5[S(-P_=?;X&,/:8L8MCV=G MFFZ;-X'BY:PW/H>,\]&(2J612E,7BK/>0#V#_/0Q$M<1,*3@=TKP+Y7QM#=I MK`[T7/Q%[>=M"H6<^_/:#1Y7.$:!ZZH!J@N&PN4]^_5G#Q`MGS(XRKI*<9#B M(,7A68M#[0>0.I<^>1-OIE9,]+<>]M8?T[9TT*,3>M'TFD2*@Q0'*0[/6AQ. MLP*LVVLJHZM1KML,.F;YV#`1BXI$$5)NX9%J-9BW<>RP7, MTQ:G86\\GTIQDN)4ESA-INS M'5^U*Q?C,MR6JR\I#E(X%_G0E\I4UV5J>&YK:*D*'55E,[7/#74=*T+R_6] ML0/.^5_]_K6EKVRGW\>O/F0XB#%08K#LZX.V7?`,>JN&R4+:BNME%NK3_W\KQ0'*0Y2'*0X/+N.BWO3 M\Z_PL&,M>779.$LVSO)^O!Q^"KAJ84F.=I:-K8K^Q"4-H& M*YL-2J7./">=Z4!0VG)YBI1[*??="$I/[2MD54R]J7NY[RW+(*0XG)PP4AR> MH3@\_:J8-U%O,J[[CN$9?*O[&+"$;E4S?;R1U;#HTF3=7F]\+[J8F>\4UK!; MKFN^R_%IPV%<=$+#>YTMS^B'[=!D^8W<8&_"+$MQD.(@Q>$9B,IJMF$`9]M1A4QE2N39Z;M(TZLW5IHZ#2FEZ?M(T&S6UX2D7ZI5#@.QN M9'(-?:NV&O;(D!O3F@Q;[3'O#,?U=L(!F1DXPPA\-F^JX[)\-UOK[E#ALJ M/:8.E"'=/9K^5F$/FDL%?[IMN<:"._!JHI*/&>N-IGOLP?9-_&&[FN]J1QZ" MSW_^D^_V[S1M\T/8@>L3=ZBQ]U<@W"L3T/GY/_^#L3__5[\?]>BZ?$]]O>%) M1H_V^^*9O*$^V::A/T8#(@;(EL]\"5Q%C`?*0/%L_*2H0^7BY\H*4"K&&T[R M(KS42D47:J_S(?N,,]$?W,:=$[,*!CP(BI2Q'CW>+W67R M6[TSW\4"U0>.!A$D50.;H-U1=>H:U,$5K>.3M:P+W\%_4)1A%,->)*F6I,?A M/O-B\F[2[1B*L(WIN_0WCZXOUDPSOL)X`RL+4'O-+#6J;YG<=8L8D9@A7[A8 MQS!E1$9-8PX'M=8-TXA*CX6(H#$[R+&K'>*FS'GX\=9A?\IZY+`]2QFAR*I1 MFR1V:5AL89LFFN4(JI>'#)MX-VW.U,BL`77C;5FNC]= MJ!<_XV',?*!I@@9!35O>O:#V\:SUZ6!5(EB5`K#B6;^BL(8="ZI!&[Y]#+S, M6/QT<>/Q=5\Y"'LP7\/0EQ'B&/J#`MT.\&7$.@9^>%#$T]#'M\CS[_I*L\"< M.^BAQ&>PNQ:X+7>U@P:]]G'Y-GCI,[SST<)MHVMK@?^\_=TW(";GN+%4"C9>*[&#IJH.CD?S6M<='PN5-%`W M/%*$+OJ66WQI>.X.0@LQ$ZQ._HW7)SGV.B@9C]:3BWXX*/M")64? MQ>__^(46AO^7A^H7[MP;.@_]'%^\3BQ$8?978O+/P=SO8.JWP90?ES33Q^!6 M[@.FYY_7N*C]^KCAU]\-]Y_1_/$0`M)#JJM.LD6A-D1BVML>Q,:^A;'JG464 MWUJEZ[;K)7?R+$$]"7U+TQT'LR'@S*$[P*?!'A?TNO>H*E!RX=`F:$JX;]W&F- MM)\(P'>V\SD&3SF+@LO-9AI4=V:X?2-&JL=JANV1A%H\6#'>G=1W-U6V"/@>6LZ%0NVILJLV=* MIW)AU&@X[`2=WAF69NEUT2D:K0/RE`'+6=&I+7DZ=SJU9G&=7WX$:`S M+`C:WO-[;K)A/U&&Z6+X\`:=*\$/J=9CA_TTR?_\(UUWNR[W$*C#^O?/`"_-O+%GNH7ZB");]E2_N6J%_#-;Q M+"`$"'X"OQ`/&F5!A%S$!1RCLC>'JIHTSN.P?F.]FE/#.)W;BA9;VZ&B+ ME^G<-(.^:3]=#"[H;W>CZ>'?P2NW5;967IT8ZJ%2L"AOA"[/?@ MMK6Y"*J(=C=CMS;GMP&=5P7T7[[K&?M,3V&:QD.1CM!?,WN!FGF50DH`4S,P!EHQG!KYZC6>Z2._1$ M!,\CMO6!%ZC/HODHGM)T6@_?!V/Y6&%/L3%QQ.J150@8 ML-&T'X!PKH>"Y'`.,X`/=5$08CED(MZS!7M@* M4!*P;T$+^'&0(/I)@"JD!I3(!9(:2[!M`AM\.GL^G,[PL&;&,QP.\H4U.&XT M7]:%<+152YP`(SVE"*N4'Q+6Z']]&S-J9'>(&ZC(]R%'1:V1@?BA MYPAM74)%P=25@[^00I9#2,U'",%W#1A;`S2BR"P#T1_9[SLOQGCGCQ+221@P M4`XLKA)#_T@^86TON!FLLU`>11;2X_K*,G[W!Q;VZ'4\^UC\I7@6;#?FJ"*?XO5'%CG@1X!5<8'`#SNK`-MS.$V M8G5JC@^3'$^&OJ$-B]CA^IN-[03D``P\])X.<"DDB":6@H_$+.]Q@_P&@CA\ M:>(VWEJS-)&8_R.8#0B&UAJN0-"])MA#TV5Y4.'$L;H.6(:B%3K-8K[N*.>2 MY0X+6Z?K.*I);$.%\=L"0X.$@\0M#!8M,1BM,=J#M;0EC:+:8_WOTC;!+1%/ M4?I<8#&X$]!=='DY@>$Z0<*$ER(2.A$)L>R)`K!BA9UJ4;]5"^I;(IE+?+$^ M"XJ"=9@'E[NBUW>T4FMOY5:N][BZ^$VB(V[T]3[M+#MR':E`TU[:L:W6+&G*%^W4?(LJN2I+"@5 MY4!HQG$K["`.:JA>OP8"2];M9UU3#3XDZQIDW5\I)ZG6&>K6WLJO9<99,`[ZS'0A.+*;3X03],3[P@G4?CJ;7U[NV0*^@(^6W MKI9%>ZA?F+#5KE&LK9U4'2@HTZ8N23R)=$B1/'^1[&J3,RF:9R.:F05_TEQ* MF7R"YO)RW*V>M77@M.]28RG-3UF:%57IKC2WUMSTM.O%?:, MHSH&GFULW3R-3\Y8*5_B/77:FTY:O/],BE;G1*NQM9>4K6=+BKK;,Q$B)E$E"*9J-BV9C>R/2 M6DJ1[):U;+4LK26VU%:6)J7YS*19&717F,]U\Z;D8O$&3V1C9T&ZI<=]T#9, MNW/XP1ZE,IW27CJEHG:-!^/VU$NFZ9Z-7,F31%*^&EUV2L)9:B=8[;2%*VGKUL2;LM< M3=>^*]1"@'23:PZ-MXJ))"]V:.`\4:*A[[X#18G'GMC5#@?N)LAA8@TVID!3 MR4XWF)97.YPYZ^35#F?(.GFU@Y26XHR35SL\4:Y*"U!YFZ2C!_/EU0Y/VZ)( MZDGJ2>I)ZG7<.W:]*+I;5SNLC<7"Y">OU-D"HV(Z^<2M=.M`8=I41N,DPB$E M\OPELJMEC5(TST8TE:9PD-92BF2WK.5EET6R(DYM7NP@I;E+TGS6OK_KI>>= M[(-:H$*F#15M%XRCZJ"*PM%R'5/]L8@4#2D:4C2J5'X?`XB4C2N-IGO,7C)+',=GBZCS M*=/HV"_3K`4SXY(T=OL(0_FX&MIHCO?('E;<8AI0_DXSS4?&K:7MZ)S:':TU M%QZ+QH[62XQ_-US/O.O8WP/UWW_:`G+9%([H&`*(Y(6EM9XNR!M!1)]*O-><;1P)% M8L@RX#/V+4D)HHUCP%"`._`5GET;%L!WJ[GP_[9%$K"!`9`C-"HA[7L^O*EC M1]RE:3^X`3XTF:69;&TON"G$PEL9SJ(OQ`"FPF95S.7.O:$#@`^&MV+V+?Y- MPF!8&]]S>_"O;OJ+:,@0?OCET>#F`JE\S\7XVF9C@H;BV[K#%X;'7(!76[A7 M6>1`=!*-?#T#W_M@P]#LKWQQQT.8MYY*M?LEJJVYY@(-0DX&+6D"!&AJ%]%Q M/<>/26W97L`]H#8(Q0+>)QS2@J%9S-Z@1$0D(XH"8)H'CR`N,=%P!-]*?"$D M@RTT3T.YC*CJ^OH*Q`I$

?`G`#XFS# MMLU)P;EP_DR10`83HDEA`U.^ABGN$-(L"[K7FQQC(?.;VS4Y*RFZ;8(E0KJ( M-GJ!T7))^):&I5FZ@1Q-4"G289"06"#0ZFG@`M&2DY'67",T<%G,N0QT_^5. M(78!5W46+?_V-?13QYTIC*_6SJ_8BN!@/QW9U^?'5YH)2L91FPHJ?QVSEFR( M^&S;0'1:=#[Y#KA!5\1H82QU$YOJAGF*]JPAIAXS]+ES]<9U?;0()^*JU-0& M>/H7#2*H/UV^A\B6NR^#A1J$4!"]OM4<"\($R=8S9&LW?'=76[K67K[>H:B9 MIMN[\*ZK<$&6%-65?D^C,'Q*^SNR>/-)R6;6U3=UX#"<]*;C%F_Y3N.5%=@W M+Y<-S"H%4QI-:32[)9M-.?3+66\^&W57+"NB):O>GZU$MWV-5&[U=2Z[++M MC$%9`I\Z^)7^]"3^M.4E65<]J12M!DQ>!R_9;=KDM5Y\?VSAXAWNJ(L*>MI4 MW]I3Y\&>.I8.8Z'BK7W/F^R.6]R!J6FZ!1;6`@BB6A>KA2W`N/8: M?T%K_/4'9GCPDUZ")]?QD89$EUWV2Z)8%&^O8W^+BT4_V%;_^AJ)E^XZW8K_[FH,G-H*Z[J7A@G:S M1Y#49-V^ERS)K5X9VV[]:VJTK(Q*WC(GP_!OP?'E<7UK'ZB:G@V3+F?OIYTJ MC6V;OHW(K"HBY0\8@6FR'4^42AOY)=:A1!F.Z\'$?(/2I+$[VUX\&*:HNS<< M.@;D<1=H"=I8UB[74+->(%\G1>98\J-1`P]E>+QO@E=`W^.!1Z,RE,!,Y4@1 MG6V))04?=EW\N.-0"L8'QSN=(@B_13\;G+0)[3#Y=3R`9\(WQM)`7-VH9A+/ MI.SZ]Y4!CM715X^=.B/WQG=B^Y]V&%CCU6,/&'3<&_P!L(Q4/LU,$=QLVQ,` M#PER:4.4HGGB)-D=/0XOVQ8/?K_EX';$&:K4C9%/<$I'@,%$@9Z6-ET5H3@P0I`'`300'4@:1K@`#H#S%, M?%Y3Z`@^$QWXPP.:=!Q+H+JV(50PC6]T3`W"2SJX1ECOAIA9I#)A#O$B^@!= MR03^K_8#<,XAT2`,^$+,>1B/'@6U7%L`+*`N(R M.H*[B,]I!D?&*!0/!*XO3GIJ&Z`>#-^C'Q_$J@#6#&8`B'9WYW`\3I8""2/` MM,\'XHL#?XFU0R#=NK:A>/S?!&BF*+P5!,#A$E,Y_'??@$4/PZ-]8!]U8"SX MFL5=<#(Q#CS7FJ7=D:[\T8VHF7EH%:1M9>#!.1>$`E8B"S(D5GR*%8_LP>,X M?C!00%VDB&E;=WU4'P9KX`NO;(?FW;(YPWFNA! MHY5V,&%T#MK?!">A$X`(<](I\W%MNF#3"_G??68&1>U@4!8J#VHYK.CQL#A: M'3K4S"QMS7N1:=H^/NYQ?649O_L\'"%0[<5!S06*!Q;<%RM$,O7H MGA,S%]56%#+'?M1,[S%67QHMF.L(93R!SH0Z')/B.+78'NNDRK&]K*B:VDGF M;9;L(T4\[Z+DV)Z3234`?EQ?088Y$!(_D/<"O29Z^QL_]`XW0N@5.&_?VY+& M1;K9@M!OS#%B,&+:;IC!S'\O"G-H(43RG9V\]-C.X1$24,T-TDZ[]V+5:IH' MA MF)$$*6\A>('((]1D=P7^,M7JP4XUJ;B,(W=OA3T>U@#ZRGW9K)L[FI;O(^N^ MX+?>#@'S!,WV/1>\&H6-M[;C4*[2A7@"5FE$LG?&$ES%]1ICPP5[+=J+7(=: M%,6/(E_OTE+HWC;O<;R@%\E2TT47#!%S$XRF#>0-?]BKB;$&.OP=Y?)B^%JN4T<)U[8#(.>RLIWJ`1F MT!!G"X=@%4$M+X(N.0GI38.>R78C-63HO0,EH04^K#)@EMM'X=7`)XM4N/6- MW0$ZH=WUHD6-;0G;+!AF""]I@7ER7=%8!P0=5BRT"@WS/D*5'WC@YQV.JR*1 M)TB/'UKWJWRLA!W9,1-'"GBVE46VO5"4X9426R"8GKZ*C%(/,'*Q%PSQOV@+ MDB9L0^F.)$T`L:>Y#9*SFIXH"3W9)QMYKO*%,IK%3$RLAK<4!";VJ$,57P3I MK_UME"A`2$T7QQ*P$@W`$A",!U>#$(*K/&^WST+F(Z=,KD89R%D\&I.<19@G M21A"4$)A43ON]K[N=PU(!K1>(F^.F9EM]_="31`?^?91]VPD9$#'*W;CA=8L M2T*#GQ*K`&Y02(V9SG0WJE[0[RF(+;9L>;H]5$^D]^$E+72YU=PAX*`PCD$6'*LL.^UZQ>"<_RBG#-[[I!:X@ M;W,?UM:@BH8G6$QGMS,X6$%^P\]__I/O]N\T;?,#KIIHT?1&1/&P%G>_@B"_ M,H%7/__G?S#VY__J]T5C`+:W,T!_WXJ#_>,7XLS_]?MBT)WY?XGSX+^!I/V: M:,9T0[V8/@=)2X,8'^W(TX8\;>M_HNJ&&PMB&9!:D`7ZEY9-@-!GOOSI0D?" M#92!XMGX25&'RC^C-6*\1+S^;KC_1'02V!`RA(O`Y()24S3JKX.!>@$&1\>V M8NY/%_WAQ<_]V7PV&@P&&91N"M/*W$HW6CMG7B$N,2J%6'5"3L4YBQY+3";Z MU"6G8V(^MCUACZ4*4WJ,9A5#GEPA13(FS5.U0:UKAHDT3/L\.X%:'L>Q"KHG M&=8$PQHTEGUU.IU,FC*7)V)Y)W41;4C3ZKS3*>]QC/10C?,:@FJ@53!?0YN=/ZOCO"=0+S'4('6PDVR(Z M8KH8G:K8_,6!P!"7/V)5=$VKHOZU'FS5T2:>;=IWCQ4P<\7@N6*=]]JKQU^T M?]G.:USP$;8A.%\C:(K)^'PT5+9E_`"L!\CR"=B.V?,3DB(`H1C^H_%H6B?^ M;["D&S=DT;E]QFW1D](B"8Z`IEB,/QW,ZZ2*V%X\(1T(@/13A4@Q'DQK%9": M2:&V2HIYK:2HW5:4)T8Y6S$@>`%H9CZ?#<9U0O_9=SUZ##+\.-]A/ MJ=@A-!$PQ21Y/IZ.ZB3*>T/'TS_X17RCQ`GE.H(G!J=@/"!:<9X)8HCQ1JGJ*X:"B M^P0H9R7P!*(Y7E`-_E:-(X;C79]N9DHZ*UGRKSP@%-9>+5%?Z5$IMV(N7IH'`(<3;D:S&>GL^: M5]V:8NSFJ%:9]+2-!>(FZDSIL/"5I>"[66^9I,)K413[S:IW=9_+(HIG%[[`.O M*S/V01RX.4D8-1M,"D=1`&6(X4-CTG5J2&5QS*1"F\)UN6$I4CZ'IDHWJT#$0OG*7K MD'EI+>X9S6>%TW!EZ5-7]JT>`E5.5$[4^3E:X-:"/W4P:DS%:K4[;:[2P2T5 M7FF6)4H-5#@4SRO*M#&OVJ19:"\!KTX&S;G;&HAP<#=840KG)\N"W]SRK*U, MD3*:#BMQ%V",V_:]QB*,*&=3!^*A*ABT(DHB.CL/L`R#R]8&; M]_P7Z@Q3+>T%EJKX-NQA()+X36NH/@FZ%U:H/AD=6ZV!SCAIIF+Y?82@+;'FW0?N^@&3Y];2W>&=_QTQ'%;ZHZ M2^]8Y(W?.+Q%7+DZ'(_5DO#^)>AAV`OZF@6MYM*`AH_10V$[N@,'C`YFL;=3 MV%E39(!Y$[>+PU/H>8#&C[W/(J<2@:H<`G4,H,[44:JD-7N>'7A)"C)<9\97 MGVS3T&%5&?R+K1(8]4K8<:3AX,#4M$:E_PX&.\2IGZM>J=%H8\IELC73#L58 M/_F=)KYS_=M_!9V,M62Z/&A4P/0P7$FTO--VU_8]MA'IF![V=Q$K)=LA9FX< M^][`1D@6]QYLYQL.@-V&-]SS-3R^AS%FT`%2]"XQ=J`4764>>`AC<(<"WG"! M:[&^B;V5Q24*U/>5[QX2O`?]KDKW,`#./F`\K;G&"ZUYH0Z5N.+J_Q@92.GU!/:QX7L-( ME]I/4T,8T3T8&VL!#)WJD+HK9PAP'GFRVU^!.*`9#SN?ION>BL8P\T1;HVT& M!FVH=YFT#Q+1#$>S+)3,0)X+,BG[U\#L@P*SC^83==(([@?]-^$^'J82>[FSL[A=$?M'`2<@TWZBB\U>SE.<<.;>8V(>$KT4,:+N,S%CVSK M*A2"(6A@E75/R:Y?"`#3P,'7"QB!$DI)T=M$NN+QOF[=$);1YBSJ?9YH'$Z! M!Q--(=,>4/R_V@L=X1#;L;DK^\$2%RI4O^LIN'<.PBX/J46:@.8?"XIPSGB>GF#'>-LWP4NN=5N"-US MA]\6OGLN2=1M9!,,K>9>*UB`E)F!0CU7&!Z+X_&WN*?ND^^8>-&4KS03P\?> MCBDX<)=N92(<(W+'W%Y9%HR*OO]%);(5NUDTC4+6S:)UX`!A8`_BP(;4LD$1 M*:FQ@=?IBZ]_8"K>UGWXXM,NJO$'[?X>7/7&=R`><'DE(:Q(CE,I=+M@''?? M;QU:J2J]L3IM2"G;YOVS\*V))#A>G7L^#E5$YY$P_+?H%(%"P>C6KX!8;9GU MN@`]O6>]5&9J;S0X$%N=TK561*S@I=T5=?T,''!N'*W4I?;2[9[$[0Z'X]YP MKK:GL=+%EE"[:U>G;;+C(M\S\%W2R1;7V-YP,.RNAVU.7\_931XPL-)-=MY- MSGJ3>8LY(^DF2ZB=J!K3%GAA9>8=F-)-/CLWJ0R>7X9W=+X9WES/>2#4J9D-`,06MG]K\H(:7A;25C=X2B+9#7\^:RQ1U;;TY59R)$BCFUQS:+Q53+K6 M2SIP<&Q88>DKV^GWBW]U8[%K_P[\>U#'@76K8J-9C^SR M0OQT\1+K8Y>&LQ;5@T'YK$O%KAZ_,W2\RM1RN2B5#FI.XCO=&5X60I>K>C9; M<;.D^NAY?NSVJ+7RA#J^FT8UZ5+#BKK:+AZ.;L`G^X'[#T5#MS0UYZ\8#"JVX7YJ7AU$=ZPI]W=P0AT-[S'7@ROAG$5 MYRY[3R8!OW$L5,;R2[SUD/WN:Y9G>.)&H:B>9^.`62:<845SO-HYA!H532;6+ MDE-_)8V@"R?9%]OT!5DO+\('TNKG^IN-[7AN6,J^IIN)-O8&N[0@_82*)120 M2N$-)*.HL*+[7.T[1T/EVVB/(`:A*@=73V]6CZZA&YH%#^(%H'@`QEIAB$'< MB-\FU1U?C2MHKC+JC0;SNA5W$-]KVREYN2:L_D>S0.\>V=8-I'=T6BBC+L^S M/)5P^<-SI8'U[DE-&>"3,PI'->>1A4/&0&4((X*3E0 MYITLBYIGO!&>1%Q=F7NJ*7A:/"R>W84TJJ@N5GF?ZH>];ZX=!$HSXS`&DLCN+4Y^@UOW@[.F\`KM[YK6)SLDKC[./**G;+8\8F=+4(EC&MP MDL;AZ(]1*U""86:\AOK2ACA-HV]=?B<.:.'5UCSXG2JFZ9[K]',OL\[\7.Z- MX-!9+L%FPN-8P/VRIB-"V\>\A@EL24*P=I>!$LG+;@;O2\(1/>*P_"1QW>">Q9Y*O#9A@BE(4UQ(&80C%.Z MD3QE<`^[KFU@!6$&!\X:/[NU;5]3=VH$":^TM<;?/CDVBL(>>SP8'O(B8*!^ MNKB!16=_))K9IEQ*/,_1<&$CJ\+>+88+O+,Z4Y5I8W#A-1DAO>;#05&X)MA" M93A7FJ-7!)=Z&*Z?AX-)JH]#ZVB+0]OW,HU1/.K'Y>YAUW!`&B\:+?\X9:G&"/,4TL>`$E$) M;_[5P34Z%OP*T0LN0U]BYDJL\-DEK-T7MFGB8;/HVUVJ6.!`.:Z-WD$`@"V! M#,N'`3^*D`E\&83[--47&K64K1LF"7'SX5U"&)3!Q<^#J\$X091RD'2.#GM\ MY#XZP/*F/[A2U*="B+W&81\A5"+$8/9T"+''V^XCQ!`U0WE"FK''B^VCPT@( MQ/"I$&)O:+&/$..G)1![P_9]=)B0RW@REG)O"+R/#E/A,FH0"/$>NWQ/!*`4 M0/PRB]]FMWR)N8ZWO_N&]\A^X=[*QH9-]SPH9\*8C(;ZJGWG\-?;[YZCV0X$ M+IB*OQ%[D!]@88T[54!9'/Z&]DGJDVDYI]RE2=5]LRZ3Y"JN\K#0;5=Y7.@2+5*'"RPKU")LX\@$-@4[0\?14)=:1"/ M'1J,Y6/\'`Y09H*\IM%C4?:+O^8.+8897RFCC*,][7XZ"&M%,B37"3N3=.5< M0@"D!W+,Q85;V(<=OMLX!I75+X-3`J9I/X!FG+XM^[S)MNSC<:?:,9RF+3O> M7U"\)[LR*-R4/1XXGXI"/HIQ.(\\>&<<>[MS[4!#'0:.HF0=?:1+RNZ!X54I!8:O2D>A8RC=M+\Z4H?6TY>P@0]&"/$N.'FB7 MVU6.EO08W0QL:,K7ON/@T1 MU_)4QDH978URK=4[#G9>,ZO%RY7:%!XCKW6U2LSSQYV\I4AM`H%+I3>L*5;H M#%.JI0RD%)^U%*M3*<7%I+BRD^\ZQC.>]X6S642ENK=M^)\.C+Y[FU78E M1H%FK(WK8XLP%._!VXA234[4*R*;5J)8Q6>I-YM^ZMJME,2W%J5YRFXQ:]_NG%J?L)@G.7 MIT%3UT_+5?X1.[9O^)([V+B[^I:M7*#5%5+O@:)S,;&4!RD/*Y+YJ? M>0W!64>EE^/>;-3B[>QGO84J1;%)41SU9AV[=UPNN,]9GM2>,FDQS2X7W'); M_8SBZ*KQ@M(;*"T6JY2B[*GC!2F*;8KBJ*;S:%T@JTP0G%R:AEVU:DV>LCW7 ME,,1^_05Z5"[QE&0H-LI!JR.Y''6\IWKBJ^U5W/NI2(66=`V@80O; MOS5Y09/01J:BVE&GDAB>.L,T[DV&DY8,2BTRUVK:26J-U)H,'">]J=K4-FY' M1*XJ&"V%D%+T3R3ZRK@WG)V5PRB0T?L3]9?,((MNZ)!IS+)7SE4L]-OM[8#MXHL##@6X=;.L>[";P'SBUZ M2=<&:7@&O+:T';8T+,W2`4J8&4;V\,V- M[VQLEXL7<,QP*!\[?^);,B(5V@HK$$WEH> M=16U+1X`:_L.8;Y(U!1'8#\"+OA0LGTCP[9Z!"NV8\MJ1-H,`_-[)=;;V%09 M#)KH;%I'R\B6:LP;;'=:O&/EU3C+(FT1I>VF>`4Y4D=?O!V%:\A9[(LXBM*Z M0JNNY\K&3G:O+,2,9ML=[K?OI<2M<;M1%!VIL%VF7S?UX%2'R$3(NA/+2<63 MBG>FBG>F92+7NN[XFBG6@@YWN7-?WP'/])[3<1I;8^5Q5I)E#R>ZV&=-'32$ M@S+J*>,3%H4W8.].,VM=N^12,,/:I=Y<&9Q.,$_G2#JRR;W7D431'6;[N.72 M-5IU.9)TZOATCB0%R4%'TE+!;V-*-^S-AR>L(6_'&;0P:UW;74]*N":]\;S% M?B]UD?=YK`S$)8ZW&NX);;1'NI)9+@Q:.N[99!`U/>418AG=/VGI4GMJFT?. M9(A>QJ)_X!ZSQ0VWUATS;=<5U01+VWG0G$5C?;UDM-Y60#7K#=LT[C):?T[1 M^K0W5[K5XUM&Z_&=>IJ[PMO$`2[7L"VVX(YQ#X;^OK8F$C)F/U54->R-QS)D MER%[(\(E$)BIBMK41JR,VX^T[1^]%7=RBGS/*F:OZ61I\U%]78=+VPK-E-ZH ML?+^YQ3W-R.@)]>D+@CH^)3;2&>W=LB`2H;P9QQEC=2>,CSAU08RAG_*TC6< M]Y1)MR[.:,*\%FUU<0XQ_=\TTZ<2&:;A.3K-TJLE:BK21,;W9Q4^70Y[DV%3 MI6]51>B@=:^(;#U-'VK#HBMJ<')][80:J(UUXJ\J0`WAVF`OI9K;6M:P5JG: MQ*K+7JS31PX:ZI[67(0[ZXT;NQJNSL9[1\I>AT!IKPV@5(/":C#NS<^AD^#S MVKPI?.@UZG)2[>"K++5J(A8]T6UI3V;/I"-KF:W8=%J\NR3@V6LV"S* M6C#^NV]L\'2"W"5I-7;J5F1T.1KUIJ,3G@[M5C;L"6W./&NAGO:&2HR=*S-DO/.G/[ M9G/*.U%[@.")];?;ZRM9>_8<]TX:G#N;.;YOIS*ZCW5>1]B'W[JU:K$;1 MV]_:])_'WCO8K<*+IJX>;,[HJ,/>I+$\9IUW7G;'^=:&16>4J%N%'F>H1-.> MVEC_M1KO\.R8Y^[48E/NKC41"[=4HRM[*ISE%M>)I$.>BCFP!M%]6(%8J;4( M;4W595K/MQ:NU5"H6W'.O#=ILY5)&_'TTZF$>\9R.>O-&LN;=>=`4,/[-6W[ M&-,&7#SNK)O,>,D=HR>9*1\.>T-5[AC)':/GK@>3WJ"UY*W<,3I=Y8/M#->S'229Z#SQ?<-U#QY<^I[O<%Q: M(E8,,+"`)6Z//7!VRTV#WW-F>,QPV=J&YTSC&SWW&%# MI0>"KPRO,DA[,NJ_LQT"BD!3B=3P`2!%E!#3!#GT`DW?11-79> M<[BI(=L\FW[:)2*`Y6R-'-Y_"AS57'A?1QNT@(<9:A_.!R*QT8P%H,QT;6-X MFGD5&W#V&T^\1//PY1)D!S%XH5P-&!#%)*A?#*[&\5^(.ORNA-\P&#ZF3"]! M&H>[*(S&/4A6+XFA[3OPEL?A`<`'$+EW.V0<;?IF^Q#=` MQO5O*]L$*^O^D=JK8*<50)4(;%N8M`>X-5WWU[Z8QZ9S)?BSPU?``@,%WH*_ M.;O$>P9?=DJ^KC,4@'1UI2T$K2PMX*EUX,I$H!>P&G_3-AO'_FZL@1Z@VR]` MI>81UQX,;P6\8@COTK`,('5R%`83&/:BMS-&0C*0XDL.+`&@,L``JW1G6`+* MI6.O@3O`-Q1J(!`=[Q'"DIYA>C5-SN!Z*""[XZ=D>:4!?V&@>T,(=(:90>.I M@W_1#"O+2N$_MFZ0\!!U(C$M3/HD3%]!C?=0!Q29N?[MOU#C0,"!$YIE^?BL ML095)&L+'5#L.P%I#E,B'UQC86@.R"33UA"C!,BG17.0$$V-!MSU6D!>VXT=+A%4 MM\'^`"\CDL9:!^,"$-8]F$*46PM53D>S#"^CV;1L]NO5EZM(E-`+$.\"6P;R MBZ>K4?IO.;=BFX[FC]O6%?MU@W?OA00)M,K;!M(080409(V_`F<`7(N46!C2 M!\/EO>V`P/;-!>*2D&(,D02X6]!=I@1]\2_?]=#0DU,+N8":J`.)#,]]21*] M`?L/ED(S8]E%O40W0"Z4Q@8W2`%.X#CO@8FV'[-61V8B7Z^`59AU-X0RA\(@ MN(U_^1:2[LX2,AZ:AQ0R<9H>(R=4L(VCZ12Q`BETS0>B!B.CYS$A*O)(J%*F M!7!DJ\<-DE:\#/_3T7$!:#^RE?T`JN[TMF'*H%/,!.U>,\R0$/"C#^9.`PHZ M260)F2TLLM2V&9W,3PPU-B7:N84!08W#T?K?,$^*+!XZI!IS`7(CA_PXVG[VUT$,D?5=#F8"3[0]W M9^,WCQ&7-^ASP5>!'7$K=I\H+6B>O2DAXVJ-(A[/W*Q\8PS6DC`7(F;.Z,^2 M,4V=56Z2,:4=0YV\:=$O8,KFC)U`.]N336GM(9W,6CV?@>Y(\DCR'*G7A^LN M)J/NU?E]V;-XK!;IG?KPPZG;\[;8.GG>6,>BWGS25`C4S?HD*=!/6:#'/672 M5,QXFCI(*91G+Y27HWEO-FBQY74'S&SMY_.Z&%-]L*W^`C4$V* ML=YHAD.[24$ZORZ'U'R_N8ZTO:M4F]:4`I^DCVOS-#XY8Z5\2?F2\M6\?$V4 MWG36U'V8W3F5>;Z)F>W2F1[,Y;I9F_Q!:>8S7]ZVU#.CL>7`9-+B">D.K`6D M3'9>)D>GO#]#9DV>K%PIO7%CA\//J;M0%P./3]Q9:W1,P?#XNK&K]62(WTJ( M/VSJY)Q<.CYGN1K.SK";CY2KSLO5Z!SMU;/(1[Q>:=8='=K*.*\F5WGG'(T/ M9QW>A)2KO+.5*[7-Y+*4JV$T_;>H$;W=DISN02"EN:*]]>.K+8#J2KLKKM-^1=)4RNAKEQFDWNWTY+X,S M.,W>@G&R"Y9*7X+1Z38`M5V"T5:V;-R;#"&M],8>G8(>6!W\RL$ MC)^"WS=8&.([K:X-5.=#_"5M?_Y"5!"S^\ MYR#F(%W[L7VEP68#I*2F[Z*)/:>;*N)[1>AV!'I4'0SF-`,6EUVQZ^PK+<(K M?=3H0IH7@ZMA>!'0,+X::/O"G_2="@E,7+I?JH>7E,0/](+;#+3@&B+?2;36 M#[ON7[&/\/T&UJ`Z7<$`Y#`LO%2)QS<*T=T1W-),NGHA<>]0/CA&UK4`R3M3 M8EYN77'TP,/I%W29SAJO"D&12%PL@9?&Q+<=):')VI]W,ZXUR@*M-CG'8D)C M^7C\50O:W9W#[["_@DZG&J);16XU4UR_LT<@@KNQZ)8FPEC0"RGL\`,7*AQ" MO+,7('1GHZ3!)O6RZVWYM,YA%S^;=6^C[==<\YIQO=^!M/.3/RW0:E#=K8BY M-YS+HP;=5&'04H=K+OAN<';8NB7F?Z>8V9VB:^P'(WCY1*(]6RIR2+ M,9Y<(*#T!A-95M=2*4<7K4NIJ.%`Y8[M"M'%NNW)J8\U7GNJ67"W;`+]Q MMC1,OG55,O=\QXKV`N@*ZG=!L^5_^8[A+@RQ]X6;*M0'25S@+2XYQR_#>Z^3 M3[M;]]D'&UB8FUAK!MYHGKR4G'_7HEN_!100XVP-%FTA@3D:B,0&/&-Y.[LL MX><__\EW^W>:MOE!%*T!!&\,5S=MUW?X5R#@*]/6O_W\G__!V)__J]\/*ML0 MSK=A9=NKH+*MWQ>/[0P8/!D\AU?((V<^\R7P&\TF@*IX-GY2U*%RP7S+$+_^ M.ABH%VS!=6.MF>Y/%_WAQ<_]\60X`8W-`'Q[GD9A5B*8E0(P*^/A[/0PJQ', M:@&8)U-5+07RW@9@N3!_!O=JZ89IT`MBC!OK37!I/3QP[;K<<_\6#GD=CG@D M2^;3'.PJ`]090I33I^%L]E0)44[@U=FX*4*D6N861/V#;<6W!`5*1R?`CN3X M9#@J@FCN]*VA58Y_P]G\/-`J9ZA&=7'KM>:N(.8S%FPA*D`PB-EPB%$H,-FZ M2B(79^Y^PA&.U#1UEF-\Q?"M@%Q29]`VG!CBKT429 M%@M"B\#2,4J4D^,G28)R6E`S"6X2D0>6*G/C'G-P>X*0S]%#NY@4\W6Y45X\ M=#/P%1&Q\5S-C>DRX/M"&X>V\YAQP5I!H4&;)W^YOOYT\9+=16,Y_'?? M<+@`,CIF!!(I4FU;J^?HY`^=)0D.VBS9PH"/#K=T+`CAW@/G!`!M>2!-CZ)_ M:FOKZ/%N;?L;;0S1SC(5L0AN=!-RO;(=![0T!+4&0_^(*AEK""V1CY\[\8* M7]JW\BF79QV.ACL,/CCIJ7`KF0`?C7?6/9U%K:1:*O/!O!:^+9+(:2%R&^VQ M'&:?Q`M'2F-_/M_)?NV?L'V,RC%JKJH[FS!=PZBD71Q-=BI92F.TI5)BD_2U M#Q$^Q*1B+_TP5O16\))XYUCA4^>S0[S:G?1DR)63P_%\9PG?7=1*)B@F\\F. MIZX9N??Q:J<KT M?%$M:7QG\^&A(+L`JF\3Z3O3IRXYKH?Y77L3-)(!=+&)BF/HF$84/R)D+K-] MS_7@=\QV7`*IW)4&3[[L?XX?_T*/XQ@[7_Y*8UQ^_O*K^Y+]XQ;OGN%N1N(>_#A:\?!2D&1]CD@4?^\?M"< MQ=?'#;_^;KC_C,$D*`E(`%&`M\T2)<429BQ^NL"=\/Y03>\A'HE$H^S"'=K_ M]3736!H1.TI@Z.#,Z M)WWIMGG;KT;UF+(D#;=K:=CSCWR1GN\1<0'B+^\;O@<^+KXZVX!^T=59X?BA215,Q M%P<]DWCFC-\V^`<#[6Z#?W#Y5Q?X/>P_N0MG^)1(['S@WEMLOXAJ_I>PS*]* M>=A\H*KII-GAJ=J`OL@:=#I7=JJ^JD$?).GB0Z'L'[BCRVA+-\,";L^2<9;T M=$4[<4=+D0@_T#=3-X%S/UV\^?+IW7O#];[B2^ENFLI@<%0[S>W1BM<1939N MS&A]R;:.L1,,HZO=,^2Y94X!8)KOV?4"%MR3D1*SHB?&N](7>=?$YIC7S'81 M5+,%DL478:6):`T+`EA;$M/Z+8[LN>ZTYSB-(6D'5K&/B:^I;W5#S MC.:ZL$B1^?%:U_VU3^GB=N4ELM=2:LY/:B"B[2C;2O;/*NDD,Z;NIILJBDLW MF2BI)ZEW)@;D*6>X(WY`'7>&PT/W/ETR@M":O$!4K9.(UOC MWG@VE[+UC&6KJ2!AV)N-6@P2ZJ+NL\A\?-(\K)MZYNF.IA2LK<6A.NJ-1]/S MB\.E;'5?MI1Q;S!K,>B4LM4YV6HJ,(#ES&1R?I+U++(';PQ75%W;CK@+WK'O MC05WL);TP7:^G=%EI><]Z4`N]Z1H-2!:TYXR;^KJ.BE:YR!:S5V1 M.E;.T&@]CTP"=S;<\S63F89.UT9Y-G-]YYX_]D5CP87F:3+1<-:+P>&@-QBT M:-OE8O`9R59O/CO#U:`4K<[G&=1);Z"<84E7.U>K=S&8H,93E6(%>35Z5ZY& M;ZX4KC>8-K79T1WQZ0XD4I";VQB?2$'NJGP\/4%N+BVC*DTM"MN6GB-CKH(W MV9\JYE)&5Z/HHR?"):D-LI*D$9 MW>2:0^.M8LJ=5\LH]BG;1K55_=Q6F9DZ M[ZFS%KM#R`-YSTBV1CUU?H9'\J1LU29;344)H]Y\UE3)4'<*",\S&R+;1C6I M8"VVC1H.9=LH*5M-K/'4WE1MJL9'RM8YR%9CZ0.E-WD&QSG/,WT@^T9U(BB7 M?:.D:)V;:$UZDXD4K>QYI!)DWZC.1.Q-;D'(OE%2MAHR M[M-!BWEB*5J=$ZT&^T:I\Z=_O97L&U6=""=O_O'TNI0TV3=J+MOM=%4^I""7 MZ!LU;JQ39G?$ISN0/'=!;K*==U/%R;)O5)TQE^P;)?N$G*1OU+@W'S$>]\;BMB$^J@52#3K:-FB@]9=K4!K%L&U5#VRB'LUL.5`R_QEY10!W& M7<]88\,4YKM\Z>-6WSUWF8/CPM-+QUXS[\'&`=4Q>P2LW:N8D9EMK4 M7AW?4=4\D,V2I:0U52DWI5^3WG36XKFFSM:2=E2]#F3)GKSG:ZN:KRGU&O<& M@S,\-OA!^AGIO3KNO8:]X4AZK\ZJUX$Z9NF].NZ]0+T&9]A0H9V"X8[J MW#R57J^D@K)8K2O%:HWIMCKHC1M3[J=9KG8JC9?E:K(^X11K5WFOE=F)`@7+ M]LK<;34,*P.B2ZYP(UYCGJ,M.+.T-<>_7ZCSJT%8#7#5&G8I!F7LK_WY3[[; MO].TS0\Q):Z)$&\,5S=MUW?X5X#@E6GKWW[^S_]@[,__U>_?8`T`!U2#(H1^ M7_R4&(M^?QO4*&"3>QCD,U\"WY%H`V6@>#9^4M2A:8;#_J:9/NE"-.EG&(Y]>=`V;OSB<0S[9QK^C[[W<9D`GF#? M`EU`?OW=<"N_+&#_YQ\1WS0MK#3(0V>&`>(\Q?-L-[;KOO. ML==ON`OJ3A,X_^N#[B_Q.K'7FKMZ9]H/?^6+.^Z**0[PO3\<#M3GP?>4`7GF M?%?F8")+\9U8@%,QG(O19`R!8Y<(WDOT?+>]W"6+7Q"]+_:KWAR;#$TCJRH8EP4I!VF'[)]HXN?1Q3G[5+B.%`B M`A+)-IJQ8`M!#:RXVW#'L!=4B&<$T^51Y!.^>J37`157,G'$P9N%M*3?'@QF MV=QH'M*2'A.>S]:@+4C?S1:#!)1>=%(74Q*GC/8;7!6;S:8/_`]0:C!4>V6+H?E^*MC"7*8?Y77:`? M6JC%YO<>%HU?\:6=Y-5 MA\JVLB>B@DR]VLU;'"K)U'S/KA#5ER3@N2)'RTQ'`TZYMI6#WVE5L6 M684>>U@9^HHL`4SKIC!<<6V!8R+@Q%0DYE&$3V59CAZ/B&G1FJD@`[9/E!AN M0%%8I,"C.L3N0*E?-`>(`L'CC%A"OA5,,-*0WSI`$*#Y0!VF6`-FWL[DSUPM MPAY<"RY,[O00X7_;EI;F#5I(E!?-3+!(MTV8\L[GXO1*=5K<6-$$(!6AH&T! M&:J`R^\YZ`VM<0_/PL#7!'*^I&;%H&&@8G="A5*D`E"R:"7F?S"\50`7C+MV M!6-(5RQVKT$4[+L4_;CBJ!/&?W36"<*8)*H?BVM?2/T4F)/)#I1&$B\<:J7= M\VQH,X!+*T-7+.S'+(N7LI.QA'(7^"Z"4/#9OAL(9=";6O`?SY\YW.(/(,;V M1G``.)PXA44GM#0/US86O,OO-<-$LJTUYQL0&B%QT^?"L(,E#NM%)]6`C1[@ MQ91Q'X?$NV7BB#&)"4B7&XCC.86<$K M8(P*1R?^--`#ON0.WB]&5$$VA(<%$84U/@*_^KK@@&>+Y\*3($P$@)FX8%2F#<4#(@, M-C[Z,=!78T.:)HC:(XD('J.XP;2MNSX9B@6_]<)Z%Z;[#J&.7H82QLO4DUW8 MY6ILR@/'=E$IE[Z'J]EUD!T2S-EHCT(DA*100)'DGO`MEFWU=32G)@V\(_C' M'_EM;ND2&D*6SY5ZSQ//QPV>)QYWJ^SL-.>)<8W=Q/'/>-Q\(@KQ*)@"HQ%0 M>DJ;=TDW+!71^[CT3E$%O.I'7N7?7:K?9\T>&V.=MM66L_5QB[4&[B1$9 M:Y>TVFVVDI*Q]GE;;1EK/Z-86S8H.[<`O&L=RHZR!:VU)VL/RBB=LM^H.XQY[.77SM7BO([J?=6NQ4E%/3EU; M44.MCSHY@XM=ZW17LEVD;!>91',V[\V5IF[J.6&[R">X0MOGZ["/27#RDCE\ MXW`73[OBN?.@_Y!2H5Q58$[ MZ-OV0-<%.7U>>S[[W-`GX7@0*=&KL\;5UU-8:)WUKA"LEH8M%C;*_:!SVP]J MPDS+U4)3JX54XXU3ATIR@="M!8+24QH['R'7"'*-(-<(7=^KR0#U3'=,6DP] MGVA3I=6\\_$'[^2FR\D6'-V$+<<[%`6N$][A["[#VKV[Z6!;]+CQNJ'=&J;A M&=CJ[[582NPT68^?"9ZHU,)>44>CU+TDNR/7#5BQ&S1FZGA6";#$C38QE7MX M3PJ\A4*%]Y8D'HJN5XB>B+]Z9SLHP^_M7@#O:%?GS/[[E)5S=\$NO*:R]Z*&.NX.J;Q)"_@`C" M#Y@G?.?PWWUNZ8\T7O1,X@DW@C4!7YGL'?W?N.XM^(W$P]+:>CWVZLC>^Y](/:%F>3%_,@;0JQ=#P8 MM\C3?0S,X#>HOK?U14T\5-EW%G*S%0@AAM<+R4 M'H<@?UQVP0U7TFQUGK[!J&T/7"#"$AH_[)YZ#\\AQ&J-N4=J<'NA]ADK^3&" MH([;#,QV(JV2D=HI=%P&9C6%V65,P2D8W2VE/H-E5I&E5$=S):=4ZF/,=7\\ M/2V#=Q9:'?70)UUXG8]#+I\IR4R2GH+#G4IWGNDZJXQ++I*&D6[[J)R+.IU. M%IUV+DUV4GS+F?%Y2H!>4G#A# M5G`%U4C%R=GD0,^C-*&:W9;['$]2U4L4B+80H)UODN0,-K:JZ7U3%2E'Q^*R M(N7H@M_GS-43+IBI!>[;WWW#>]Q#=XA@OGBV_FUEFPL(*,3SE0X83$U4.CM M]XWA:!C/L@5XI)JD)Q[U#0RJ[!)BH`P4SZXN/C_CG4K]P:0_F.TG0`J2".\; MH*U1.][QJ`WBK1;!.P5)A/>U:+)H0]SC@5\5(5P=J(N!/\;CMF,IR%$?UH,= MZ"*"O";?1WF$)>=PD2L!PMELX]CW!F#*EK8#T17\U_(A$D'\'5AJ(,:WW'O@W&*#J^'@ M#Q2!#:[&\`G,I0>S^);OPO!ZA)L+7T$\1#\Z$=UT,?TR@/-J/Y/R*!4+[[UF MF"(2>RPR7_#,VG:QK2B$X89.F4/=ON<0G7LUSJ8% M5"`?RHB^;_BMQ^+U2G+YU\^4J\/DLJV[K]Q9X\C1! MX=/DR8*J$!42Z6C/N#4Y^V![H$=-HA\G=VE&FK`8XJ-9G8@[_)WA@"*EL6\8 M>8M&5'B']@V@%'?@+VX1=T%#EGTBY^K=APYU&0M M>H@:*S"=FV;0WN&GB\$%_>VBKH=_FYH+-'KSY=.[]X;K?<67HDX189^'P>`/ MV7W:P/*G'5'WK&`;_4++"XW!/='B_V/;SXR9=)#V(8]B@\@ MKMAH%CKC]<;DF'_1(`3"/3+.-J:FB\@((IL7RGAP-6`PCXD!FG8'8=,=/>48 M8)TV$",%3HXPKJ6$2=14`==HD07&3[C8N7O;A="GM8&?H*`B_- MB=J>,PW^"S&9V/Y"KK`_L`V$-(_P5`\;TFIBYK4A8CC`W0#`'0=^A[4MD$.# MKQV@",5P@C@X%M=@+C'*+8>(#P.#K>>)@*,KAC%ECM=[`#JQM>;Y#J=7:7!Z M;]8#RVQBFT:8P30`8(=O?$=?:1@U`I$"NL$?@*HM:(F`4]()/`&'P2'<`-J! M!T*3["(/X$5XV/4!=%RT[04.',<6=^)Y;@40%LF&'F\M$YE=[F%4["$C3/N! MJ(9#`5=WA[-]AT)@>-G%G""C-E:OAC+DK`(/2%3NSHD"\4'K8,2M+4',(=,E_]T$'3)1] MP`66`1$@,0PPGDZRIVU@T?"==CJ!RR^4^=5H0A,37*0/"9!>'F0-(A$HC&\1 MI9`GMV`(:-$JDKZP&/D6/@720:8>IPH:,0NP'T.:H,VX!9&R4.Z\%:@.$(]_ MQ]L$7(#9];'+&,090NHR1_-R@;YBURZJ(G=]TQ.K(!C=`PA=34>(>^P!5R*Z M?6>!45I`*++D#B)EVAJN]5S/S:#C\&H>FIM>8`"0.K<$4L= MBDZ"-5@.=7T7W\4'^'+)Q8(GLB=K[JWLQ567;#8*2EKTESRP*GLQW3&MJ0J1 MBY>Q=<4-'`,5Z-98@B$2F9^E8Z_W39!AD:Z_O&9?[8VALYDR[C&D#&*U%=%5 M];HQY$+\_\H7N!;O$2OP#7R(?@'10U%S%D*4A;TQH_#53&Z>H-@NXJJ9\+=' M&D@'5V&@0\1%,YC:>PR(A?+&?V>P(5V+`^^3>!IK>MIP79]HMI^!#P#'J9-4P;P'^9&.[PB0BEWQQ8PC^A%/2"^CQ;2OP[ON4 M^VOX1C0%D+AI+63O`EB]!V["[V`^O168+%IAO^$ZK7'84`ECF<#`$%'`C6$APMB@1%?,G0@!#N>'P:A*^ MT2E[=T.9/XN3UXC"G((J0T+`B0]!Z!0$LN!,+'YG8\Z7\G+Q>QB/LA68$IYT M5VY,X7T1*MD@"E03W@FM=1\")<]$[0P")!0.$ER`"8#S=>'C00AI8QJ_WL"( M5ASJA-K'`JM-@ZZU;S#+D@4;KXR;0$+Q4X#N?G$#(T+F MZ6'%+1%^B.")(AS^7>>G75)B&V<3]LBV(MFO>]D9%P4M(RUW;#NMU M[NT:<_HZB"[?77]YM>V>(MYD6_F$_GWA02YG)E+"BX6!0@+8&A9\L1;&`A=# MSB*T:P?0$+?M[O49XA&`)P:*4`3B[AB$KJDP+78BLTQ9=1<$$Z+5C>8$2\9= MO7P`1F@H\D+G?@O^O'@92A<\3N8:W3YRGPQVN`SM4<"[%4!.KZ:1[=^S0B`) M,1\+L4X(:0@:6VG$JDC\,8O^C>NM<%EB\1*:LMM'LL+DPICED_P! M-`=67L'`\`.$^RXX3:$APMFB77'=$*>UYGR#60646XNGG9$O00_6HKR(UJJT M7@_$!T;ECFZ`:\=5<&(C1"R4@\E"A%_&<0OP"B)2D3)(L3'Y1HI@:\Z]($I8 MDA2(N&&1B%9C$.Y\0T3+(+Q;QNA',-P/'"#!A(.N^0`]/._B@V'&-Q"V6]QW M6G!$QK"$@;_EM+K[+OY"8MD/(:70C$0@ZK#@!K@T,F,\J`'";*>Q-(*@7\"Z M!5M_-.AM42`!2!!:PLQD&5W:+UO\RW>]<-&(X"0LYD8S%F!8^KJVP15`MPS7 MEAR*X'Z_'`K'*%0U2V9"B];;^DLHF3`=$):9/AE\8010FE'W#"P[XDE3$?J, M"\\AR7\4,%P$\7*DN;3U"/*E:Z;N"V,IY'-W(JXYF-ERXVFR^-$,L?.;SS>7 MN,W?INF2&'ZTV$?=L]&^)A39N7,/ M.A=E/&(X(N0AAD@$=)]\!U<344XKBUQ$UDV@Q<_1I>L4$U M:5F1CE"8[1AW!EG!C$3D"S7.K8>+CCQQA9"(["T+T\:QV4D,DT!91-:YFY2W ME!#/SJN/KJ;CK+3Z[[[F>!@WI7+JOV`],46F_^-;G`W!>7SA&R\(6`?$Q$0` M&Z7;=4RV+C0G*^^^&_"R`QBMM4!,A%%9+CS`),J2D]=<^AC*QEE^&W<`%BAX MBZRLFH&K0`0)@EXOO:^P;2KFR77+`1*!3B?$=U_25VPNA%\:`@%\[E)["=&] MN9U<#D/48%^)J!Y#Y1VLPA&N[O+VY=9N`:6Y*1.S/7YHH731D5U$T*:_X(DU M/'%_3X*KO`=JT,,=FRW>S_&=79H]\7N0MDQONB2"3U@3`"X&Q?0H"Q0'^5'V M+[A]+/HSLGHB:(T5@);BNN[XP6??(JV-#!*I`:X?,'`)-[GBX0`,%)?,!1.$ MN6+"%ZIZ-5+V!W17;-MD[HPF=.9?`1B)2!?-L:":"ZL(C/C$7T0>D'/XPN%! MT!ND%^DKV[G3K.07V_&XL$(NF"P3+",L$'`!TO48[9@I8^E=B=6$O4$IPDJ6 M1R0YAJQQ((UIL]`#[A'D1$C#$EF%:*L3W(\!M`TWNL/0)O9PW@J&QM1:&&1\ M1E;`\N!K]$/@DIW@!UK_X;((-U'PQH[09NW&)L1B>L[B#^P6<^.T1V=CT!1L MPA@.A!<`3;1G$6^U4?;!<^R%+W*F!`3NK@FQAS%`/6+\+W7;-,-L@UB77/QO MA&B`%X1+;,>[[3R%V@!8X&E>S%+2U)&ZI5;4.P0+JBL?0RIC8C_P]NAKPNWL M9.A`'FY*,%L8GI$GI!AM)T0+.!BE*9(9\T!V@C0!01=NBQ1*:V1($_M"CX,, M)(QC]H[]=AHB,X@/B@,NC9T,<7RB$+P`)]QRP=(K:A]VLE!0VS8B^TX+[7N`;PL M#)K$,IN-!@/JF0[[=S6-VW M;]!/,.4UYIMWI8E2QEF;2V`)=#\9J&0N"!,F)+T8!^MV!ZO@X*3(9XRBW80L M;2^W>UL"&.SHP"=\$;DO:++"%JEI.<'18T7B#" MF-FD=&V0UGMP\!@;8KD4/V19-S2%80HQR.ZA80@M9/35DJ86VTW99C)'_7JJGLPT'CM=$)VM\5QA%#=-5 MR:+2_,,JI,P)R4V`+B0T7/;#H&YT"!86:_$0(CN6+&'%92=[,1TGOMMZ`ZV> M&1^%%#"51'K[3-$.QJ(D":O@ME$5&9X=5'M8[I%\'\`26NC0"19#,';>P#Y'YN%M6 M?*_!7.@?,./A)E:*P3WLZ*#<#3AF"L;B?4QND-.[5(2UM"TNHET(%A_LZ".L M@8+O:1SC>_`'I5DX'XX*4GOXRI@@C",0SRM5@ M\(=@9?T*U_+8_@$W'\`=NV$ER^UC,NV75D(Q6L`6#O4#A:!?9VW8:@+[>V`Y.'M:RA#MA0DF1/6G-(\$; M7*GC/Z1U*!QC$3WY@-F)N.X2K*GMWZUV_9QP8*JH%OV6 M*/#VUW-<2C)O`OVJTDO!^W2VNRB1[70E2D?V`Q*(.6S0-1 MR!H.GLAH6I@M29[Q%2E4S%AY.W662+ZH"C%5)IM3?R3.A]]B%O_6I@H\(`&H MJ.8FZIH"85@'W2>B*D:TI:;(4.UA3YPOBIQD(H/(%_&NHRB,B[ESG5T[!R0L M>W":X*,RXUFBP@R0#+,R6"`,#.V$![_2LPX.^DRF%)A[&=K@&$-:6JJ*)'1!S M.#SWN\6KQ> MV%,_%B%+I94[:H)F_Y$J9(*QP!3H!I=)Y] MW_GV[;/GL^,.LM\'<-S:GF>O,P=/GPP7CQ8[NK\=!_?G>7&PB`W[^,X/+'XJ M>4`]YRSZY0V&([;O`F/PZ@>(UB%&5P#&-L$+^R=7E0B M6Q(#T2^E"`K#AG"`J!W"X(9TKT$).5XME_2?+JOEN"ZU3*%Z*K5L%XQ\W4K# MT9AN3=O5K;KH^QQQ'=[Z#&S5,Y]$H*6)$<#:B# MR-Q'@/RWZ,J+`&'/%&,14/#T/K$W?FKR@WG8Z-5H2R=-[%=2P5&\9-JY/%IQA=7M0@X,'`:@,PZ`7$CT6J`K/9;:3*`NCJNH] MI6%42**^A%FQ%9*^`L,CBJVP0K=0)1@>*J6SCY9HAVW$1R@3E::[6(7X;)4C M'#HZL@]=YR:5`'O*!E75:%(1W#PB:'CQO4"ZIT#FB(]?I1 MN^#'S3:7*/[JI-@?A:=*HJ"@ZM"]@3W:ST#6+4?MVIM/B7*XACM?W]] ML/?=`1$/%0_T<1D-"NKVP\BTY="QG>V;YS-!W>B9.4Y0DQ M&8+G.XX0.'<]E``3<#PEA!VI(!+CO7>;%)[\*%+0VK06:ESC2$<19/]=+V6F MK\=DB>9#R88W<;]QC%+V(1N^7.426469#91<3(*1 MFP6SD$*.AJ-\@J?!3(O6V^]XX(3N(0M@B%FT#^(/MJ4?05MU.AL3V-E0QZ.W M"7@A\1Y.QS/U&,`+*O,'K&W]*MJS_T+MV8]2:AQ.C"8&JR9JZE'A0!J&B$0? MN"?J@S^%QV^PZ]2OHAW'R^#$/;+Z&@]Y9+(8AL`1P@%>/>+;-U;T:OSF#N9* M=%>64H`&_>E\.M@6@.)S=P1C-<*XB*[V)X/1='K>&*?O0SN`\6@^FP\;QOA= MN$HKCW'T:FU2K<[G@R+X9LS<$7Q+3M1Y(J'+'S='\Y`NM3)9-R&R(=4 M&QZF6@+".:JE,FA#_F&.PO(?0S@:7/P,(7@;%)Q&%#RH"PGX%$P44P#9GE4K M(X0C%5@\G(_:@!!8K!:UNPD(T0B/U=T8/`O"N(^JIP5W!89MNET/GG;$54ZF MK6.SA!WXZ?6/RR_T\HWU&[[ZUO(,[U&XR:S`:Q<7)8G+`*U0`N[#4V1@XW!, MG06WRMY1]B`/]L_1HU^")\LYP$D2^)L/[T!^=Z'?G20"&K"PV%?M.V5<^S=X M2EC2XSOP"N5H#P#[3\%U>/K:]U8V'J(7U]';#C?NK->XE>:$5]#_ MC)8YACXQ30ZXQ)4FP:0)KJW%>Q!`\W]\QW`7!G4%K0KQNZ#]58,P!SPT@U;* M7\2U%S>?OY2".0B-WU,OEAY[Y]-%`K\$1^X_!3FQ'EU@_36JLT*_ M!"]^IA:)KG+,:F9R\7,^3GOF/(*78J_L.&;2&$=Q7C?>_QD:I8'/N7M[[ZQ M0>!?/7Y]W'"RW1%`'PF>+PB.`.:?G['#.CT4H!&8\SW4'%_\/%)3NQQ[<<@F MVU%4*)%4&..NS/3$\)98V!.\\Q/#6\*>U`7O(:WY)>C8UG4U$F`64J/)L!+9 M"AM@M+^]`OND!4WA47OPPXK11'I[/D;^)EB$OL]:A$:/U9B95.>*DN-#,E:A M-0):+E>IS`%CFJ`H+0'RI9@KQ_]&,"J`?[V/#IP3XB>%*F,Z5B M\!3,6\UX542W$I*S^5S9:XWS9BLDI,5S(#FRE(U3J43(`2<^S'?B:6"*H7PP MCU(+JH>2*0>PGN:'AM6P+I"+J07O0PF9`W@KZ2+$(GA3-?SKJ-5W9)\*A!CX M:OPFV8;C*ZY2:]D"@Z!^/8#A\A:W)[_EVQKM'URAA M7;_V/0_1^-W8G<&<'Y>8M#LN$E$FHU084F#.;B)>+K(9J^H3P;OD1N]DT`&\ M`Y\25)/JC^RKHUFN*>*NZ^@R2C??\M4@(<+Z[J]% M#^P$=#%PAVTC%3".QQV@-Q6:B!OP,!^J&0[[&]T*#[_?A+>%4!?[+P_:IF:R MIP2T.-EAQ+]HAH6#OW/L]1ON@LS@#Q^=__4UTU@^@HO!$I1WIOWP5[ZXXVXA MIDQG7="!D_*DLBHTQ1-%356]/B?#5%E#JANF8U0`40AO9USNW/3;_YSZ`OO? MXX,)N%D4_B6X$F0-(LJVH2!I6&,JHG1??WQ]\]%Z@S?@TEE0MPCSTD-^](%\ M"=SSP"'>5GTYR!V>7(W[H,>SPI)5GOI2!C-E,&W.G[<,SM161##T%7KH*[R$ MKXAO5"\C"F&N)1B1S+M&&8AK*]O8U[4L*.X.JL-X)I0K>T1)DJYJ)729Q5$- MM-MC\,56!9X13/F->#AQ"1Q:!+QD)6$3<%N,G`O,]90=3^'P]7E['S5=2M\` M"Z1(-RS2,J#:"NH'L\8BJAR1%G=<9K+^FGXZ\FCY>#A1Y[LXI<>N$:I".]G* M8)21ESX`53CC0>B.J;J8S,89"9JM<>L&JPC%IJI:$JRL4W4]<0P/]8)%ZI8) M<<;IME"CHA>/#(N&L^$N1D7F/3VB9I$Y`ET>5:L\B M_[E$_WD?^L_HRF^J>G/1?T9YS2#;Z6G?10>Q%_.IVF,O1O/@`O472D\9S'MX ML^=&7$5K/A;UN;]:#@?/\F^^"#W/EG&_=@P7L'M#EQE^@N_M14T+UJ(Y_.H` M/A>ZE]PPGJ;KUB3A*Q*^9"E>T0V24Q`^2?'F*%F#]`+?&R+BF=*OG!""(DGR M'=%#89X1V=5./E@1.CZLR2&V6-K.FCJ_ZA@*B;Z@O2@P#[JG95+L#5]R>&J! MT`%H8B7G.,@4V@!];P3WC%<.WL=1^[H40#"C M4P@]^C[^_=BEZF22K@W/G:!A<`NM]Y7!($/Y]H.[M\U@"=B/67>KLZQ*M=W! M6P.ZB'",Q\.,S/X>H(5@)!Y@;PQ7-VT7R[G_@3U^&37YS4X&)MZ+7XL:`Q\N MQ:_:I/U00^3XIFDZ:7_H/FO*F_UT\>;+IW?O#=?[BB_MW*@[..Z:Z^W1BO=H MWFD&[]F;K*N$V58'?8)A?K7;N?[0I;J:[]GU`D:@!&*&ZH"-%),"5[2-?5\QI2CP+@@07CB/U]&;CU'C\/A>>-?82OFS2Y<'U\2S":V2IB][H-7"+S&R M!-$C3%'A1RW^64_X+;8Q-4LLM+0\AWQI+`$XWH=`#FAKN*O40VON.88N6FO` MYY>=ZC'_&VF/8C!WJO MM4?Q,@R9L-K`,(A\7:IV-+>3)RCG'K!Y/Z+O(' MC*'#Z9R(\[C]Q*V&7<9L*]5//LD$[0[;Y'L05CMWW'.3'>W#V9-#N@R[,S*. M!$&)`QD#^OD.>\1#.\FW@8`+&XCGT?4'!`%1"3&D`Q#,P*PQ(\*Y'+PR@@IR MF:-D`)A61_88(CFO[%X&JX]=FX#A MKIRQ?#Q.QFZPZ&1A>`2H8#HJB[B/`H0#QD2:"I<`I#-7#% M3&`"HF+K3%/1S9M$"BP?XK046#)"7US(XR;"JR#@0HN!K<+@]TBPDW9.MUW/ M[7\&`7-\W:/T#<,N`4C[P?YZAZV77N,X!H=[3X7L0<,2KKAL+Y8MJ8VKO,IY`O_S<74"W9-7$1%R?=.Y8E]M1:!E= MD3KP#,QFX2T4N3ZK%O;'#5*GRN2?F+7QPDN_XCXZ$4!T*\9!/S9J4E(N/SFV MSOE"K!-?LJ_B3KUKT[0?*-C-IU+X)M;(B=>BMX[MJ#1(MP8J-FTVBI^CV^C0 M<;\65\5]P7!_#W+Q2Q^7XA5ZHQ'9SYGK!-B4O!1B.)GGLJD[2)4SRC5@D]8I MD?P+Z>+DUFJ,N#,L2^GNY/9;%XO]J"X M[VU8&+[.6@"%3WUC9( ML;A"^)7O&A9WW<3Q"]JO"7[?:2X>CO'5#IZ(!Z"*+GPY?/?8PI7T/1IEYNX. MTN482F789X]SV2ADK-;):1&/))(H.=DOI%?$\,/UBNE>D1VDF75<[AGP;)RQFBL MI`[RU\^R_*Q["W:G0-I]R^Y@EEK-#32[(\35*5),B)5TG\7ZJ5"#/ZIN?SM9Y>E0W;67I,875^'!2G^FH">-#X::R+__3%6M77:K+6KL9.8"F!;L& MDC2Z[[I%DCE(B9J;9SE`D<0").Q0WR,R>*+H)&I3?W#YD=O@_L@0;:0,1]EA M]>&INX%ON?AF-$]?0G9N^);,(LSF2K;TEL'7"4O(J,BHQS9:>#SHTK#8PC9- MK-^"4419P4[_^6@`2CI_TIR/#IVU75`SBD_<^8*O%=EQ'N[<;#:X&@P2[=R+ M375RU#)TLV'4V`L<+<:OQ\8]$`S\GT#-Q0IP[%#];[[`HB2+8]<1U].H+&\_ MWJ*I2)5C"X,\_&C(#B%3=N^E.#*]79!)^,2W!R2.>.Y>QV]6NMLP'=SOG>(T M>&0(4]-X)"2F+"(?$Z]6X,@!'!*CGPJ)`NRHA@35=`:W"NUN(8C?@UMUCCGC M-5?3B8ZLH6L&K(A!G$]3W57V`Q9W=THR6E]Q_9LXOT#UH;O@QCMDB7"6-LOJ MKQ,:JZD0L]SL)\:U=&_"^1DC6RZZ',_46G#=VG/&XS=41O&@8:6@Y_:_8FMI MWWD4%17YJ\?$[#>NZV-%SVYK:11DL3P(#@W5@!,L7SB6$D7A-5"H\\<#S&`$WRK.18(6WY+ MNT9)$X(10G$:@8E#@A,JSK;K/PTAD@59IZ%"HN;J1,:C6.=(T<'R1/:D:'O& MMFE7*Q%.9!B/PZ%ZE6@'@*]>\E0%>''Z)E&T[7++L!T\>YNU;,B:X1/50_-/ MIJ;7T0CO($;I^4Z(65EE&>PN^3N.8. M;K@9M7>)\>F5X(WHA6,K;V>I3CD')VP;G])M"D?I7%;'$"HI%F+TQ)B9Y#W,@96$ M:O=FSG3:&MN]M__J2,:R#1.Q]6\'3#,>;< MWAG?\?/I*1*!!;^'0$6(CYH0#5R-^1[N@]I+[T$+"++2G`7]<6J"A.!]":"# MQ_X:P'904*8UT*LH>7:,TCG0*V5ZADW(U]DI6@,"E2HBV:XAZ;&_.+:;M0S) M'I^>KK0%-82@;[B3V=\S2YL(%%IB3,?S],F@6A#X9)N&_LC^$?R[ITEB[GSB MU0YT2CRJX_6"(2]>Q.97F4<,1>B#H:N.*3=:%(0R` MM](2%XT&38D=>,:#9Y@?FI1[OM7OK%@CKHRO?N/8\..A&YGJ-AF\.^:5C4T&B%;]!<]F(T2/8B>S&<)_^DCE_#/1W/A"PBP[4U=CK[ MMQ:V"!17JY"0.`B.Z,"E!QMQA'YFXZ63-:"BUMZ[XN;MZ4DE*#A/D"QHXC\8 M7DT/-WC+9*7#Q>8#MAK;@>8(/JN3JW&"S^KH:I[BLZHD6[\=V]IMMZ%545-? MU,D`PPI[$\'<\AY2&<^4^4[2('>.MD`O$ITHX\EH7M"YEP0]"N+#J+A\^)G+ MD$+19B(:#S^^`?-OVO0@G6L_HU%/;G(WNWKG!V]&[V:>/.T(6'8FE+VS\:9E8(-M*.&GLWVT#XD M^I4&T`N[U97,]M0\](@2&L`&QY7AIR,5!^=GF[7Q\E*#&`0J],K,S#:FL>R'QQM\].%^#=WKMU0MRIBDDZ23I).+=,I MX5XZ;HGW="CN/MOSN5;*679%:LZ)S+7(GJ2]I+VD_3EYJEM,[CI]\>T/[+]% MF2%3-]^9:YL&+!J#54WT"/QT`+1FB?UWKCGL+69."V:6ZYAT)T?;->=ZF(\G M9-D[PW&]6I3D,)KG;,(ZS<0O7+>M'9V37#PO+G[%6V]LW_%6Y\7% MLG&)IG^[>S*`4]5O]0B`DU+(H/`Z,<@J6\<._2O5DP M]LCJX8GG&1-CHC]+&THMY5U_0_EE162/@S\;"KAK('`]BE]')J<:(XL@&#)A M&[XD:\X*/BGX4O"EX'=.\%4I^%+PGZ/@@\6/2PR/4H/:Z7X\GD4D_/BEPI+^ M4WJI4+`NM3^]4O-J<]::P($FA?*H%25DP M*LK1BZ,-I"B"*H!"EK[7@8(R&??@?^TYMN8E1(KE4Q!+M:=.!U(LI5AV2RPG MO8DBK:44RXZ)Y;RG#L]0+$^6CF\SQA8':\7CSSSQWT$5+;"NKD5%Q[W![$"] MQBGS1[4X#BF5YR:5\]Y8#3J[M*X(EK5CK%*@7X" M`JWT)N,.9\:E0$N!+A=8]93!K+OR+%/JSU$H+Z>]<9MKT`Y8V6>1C,=N2$9R ML2`S\EW3\);6\Y?#WGPT[^YZ_M1QE!3H!4=^">@\<,DTC14.*AA0-*1I2 M-)ZL:#R+-.DKS35TQL-;W8.ZBKB3,H(4GA0=EC@;*A=&3W=A-+A2U&>U+I+R M_,3E>=#A@GTISU*>2Z$`XMSB"3&93)4R62QFZ+!0/J5<:INKAS>&Z>/ER3#(59!6_GA?/,]\;N\*>:X2=,WQ1P(K'.( M7=7XZ77<;!`JV6!X8@:>]MZ8@`S3@T20%U<49:B\0^8I<%'>(?,$F/B\[Y`Y M60EL(0`:WAVI.O<>22RPD9$93#S%JS(.!PQ5<>V<-!8Q@LN,;&^_5!+^ MS`A_?O:W49,[.K')/9F9?1:[R?*.BG/)\EZIXP:OJ5`5V25&2F:G]A^4Z0#$ MLL/=Y:18/DNQG$QZXW&+1^>E6$JQ+&(MQSUEUN'6A<_ZR-=?Y#45'5;1=!ZS MR5"[-QQTN,&%/"G0:<%L"(6AVAM,.MS<2DKELY3*06^BR!954BH[)97JK*1S98W59R=VK:7YKX<]90V[^/J0$&SE.E.R'1#*,QZTV&'#_7)/.3S M%,KQ2`JE%,I.":72&\]:C-EE:EQ>&O&4E]8-QNAJ;S)Y7DU+I$QW0J8;0F'< M&XS/,%LDA?*)"Z7:8KF?%$HIE(=1F`Q:+/4[^ZQZ!E3/-P785K/M`G'OF?7; MEM+17NY"BH84#2D:4C2>M&@\BY1ED0L<_JO?O[;TE>WT^R&4&5_):Q[.TR`=IELCV!97VWFY#+5).422F34B:[().##E_PU+G\9YOAOKQQ MX2F7'#V94+XEWLAZX\Z+]),(FV2R4LJDE$DID^PF3VOJW_JWF]CW7@Q]AVG@N(>Y7"0L0?;K6==O!I\W' M'DT-6K4#VUI[)#VQN,Y=5W.`0B#2C,,#)LH&/KST39,]XJT<04U_A',WJ M+NJVQ?N>@2>'N;,V+"'0M]SB2\-S=\1>U_`*%^\11B`HUSR2]5DHVCLD"#__ M^4^^V[_3M,T/_RN(;3Z^@QDMF,"\L8"!:YK]*]#@E0G&[>?__`_&_OQ?_?YG M8(5QC];:[;%/MFGHC^P?P;_X-*/'_Z_?%V^$LR1>$P]'(Z,11%)_YDLP]^I` M&0Z4@>+9^$E1A\K%SU6]8KG$S7"2E[;)'1Q_*`V5GE`'AEH`)LIE,7UZ(.T> MZ[-7P$%@M1,3CFT<8RV4P.$;4$9D^)+##]Y*`[,(6HZT=,`'@'[`4PN?AWZ% M=$US'N$)WQ%.:^/8]P;I*WP%JNS<&SHR%:>'GQ-#,6WQ+]_U4,"$`8#1[0<0 M%BY"LFV:P/+#.RC]8'O,A+D'Y;#`.K`E M:(-)QJC''E8&F!^DR!VHCT/4",`("+*T$0?$?@V(KGJ$EPYAC`8/@`DA%0`, M`Z^^3>9@J(<5WWJ6K;GG&+I+S\!G&M/!ZTD`LE!MR#1XPG!Y>B405($NS', MV<`/(%@@([ULL0Q%@.DR0L5LDNY,BE1LR0TLRX_5-''L^36?>\A9,.2R9+3\F M;BM8WQ[=E#`]SWMZO@IA^T4(V]L=8=N/?4HB.L>=*C)6,C-3-T.^>&`0P@`^ MRSKOP;CDCF@G5:UL')!'Q\L;C.YLWP5/'YSKSO/".1H]/$^-1N]PWEK[!#AP M(`?;=0Y4IGJ7+>OE>TJ8OMZ*QNJSIHD_X&=I.(0#]HCM]*;'VI1UT%*=TE(I(!W6L"'O>&AS=$. M4KK^D]9IM]227]YV3)C.M-RF5S.']ZP[F%,X#J$.VZ^#X6.CV#7L6.I`KD5C M>#D[U(;E9&)8DE$'BD*E-G6!24]=FY2>.GT>^E2S^VTW^`B[L8>U%,V%'Z,< M_$^7$S@R_"B(T-D93,"+]H=-WC!ZS:RP:D&JU2S#8%;-4#8O@%*AI$*=G4*I MO8%ZH'O=4U.HFEUPFR'(!U%2!R%(L="CT7+X6DIAOG#./M@>CYDWI5*6)=9- M*KWW7#4KTL/#,V-V<*%"=6D_)4:)$*BB1H]JY]S;(#=;:LC?\UMNM=@J? M_;C$)[_"@_C<3OV2&M4OJ52_Q'S+$+_^.ABH%VS!=:S;UZ/?I_+,OP'4?4;;^!'W?Q20QR;2V"(?!=_%_X^E<;7SY&I,87 M/RNS09HS)2;?@W=8FQ[4JN_%\750SWX%ZY)'J+J?<'DWX\'10X]F; M']E6F!F-5:QE7%W%60;IV#,KAUE^8\6UH&A7Z##"+;_3L.S=V:)3<%X+XR_->F27^,<% MOL.VZ'GQ,CR1@0MEO8=#(--S1U#X,``YTJ+D%QT.W:)M[8?7CA$<$(D/]GTD$DH%D5".%`DE1R0(Q_`04T(^ M?O<-A\-8'_X_0+Y#9W[V>V8! M2BM2=\;`]N[97<<(@H,##M4:,:9(A9>9G7SZMZJ;-TG4C6*33:D/ M3KP:B>Q+]5/55=55U6S8?)7A4\(`A2FW#4(N^]00]@1MJ/6C&1<1ELQ]9*F= MIF7Y$3)*G1[YU0H3[,(C,O)(A#8W1I7 M[U_8(RO('*;N-HBK67J%O'.1IPM`7NEB"<=#-N]/*"[E'8_4(S5 M)&/U+H>Q#+D8JTFN:I*EKIB?OGBAZ30.O#-D6O4IAG*9$:S+NZ,M4S/F%:)A76I=>[PN:`U^"B:$;U>POI=9'C"VB$%HK0D756;\`A`H=F1!S M0_'.1?#.6!OUVGD_O:3#4E?T-,\L>E9 M*`5HH@WZ!QP<]0.L"1UH:V0UF0T*^DU!7PH)*RGZU->H!K?7JE?SW%% MPVK\QS@EK-Z#ASJT^".L[5JT^&-.#UJKQ=>RW!?E`:T+9L*N6CV0?=^P3Z;D MK`X$=]9_:*!8YH)89JCIAXI6-.EC;Q_/-,(PBEOJR0*NHGBE%=2T3:-7(B<=I`+^_,0M!"-02JIIR_]<&]UH%>G@.Y M5KC+X&5N*!-$,>*%,>+MM%>--[NA%6K4UFO7G/&]XEO'SZS<6$LM<)VRD)01DS;&8&;:4H7]\!74D`-IT9)*.UJ\[V9'*D7T)VPT0; M&`>NTY,T6EOE!"FN:8IK=&TX.7!]L:3)-Y(.2YWNR7^ZI_>T7F_:RKU"9?94 M,&>5V5/;*9FNC<*96+FM3X%IP[J,P>E=FCO/\7Z)H1%MHRUOJCJXNZ5NY_Q3;GL-KS*RBHGRPL85)D7H*3"54@%O2_*7BP+ MH"L1"6W+$Q(U3R4,9#I&NQWU105.MTM+N(I3N;.N!SJP;UR#M[@D[II.`FKA M>;NZ&.@"L2E*J1T.Y2X+J))_%,_(QC,CH\$D"$D91J7^7/3AGZ%-A^W,$E69 M/Q7,6<6E'W6@5HE32H:X]+I,!@6SJTY_D$?_+W$(I1A`,8#*_U'Y/X)P+U"9 MEP+Z*@M(QBR@:S:?16GTM[HVKJB(8(L"9Q4X6^'+O.V/Y/;KB(&FNA=(,VRZC,H?DR!Q2$9359PY5(A6$Q42U*WI2 M\4$[^$"8,BE,EVP='\B8:Z1R!"^<;46$G M3K+YT\#Z"V8T"D*I!J,XXAR.$':7RK`N`[@>\-4_W#JL6,6XBG%;LY6UB7OE M8=W+X5OA(Y7B7/6B-LZG-B;E:^=Y7>PEVIO-"ONEU1V`..X[M MN1IY7MC6@JQ\^-6'`1#+3*GYT[4T9T1.4BCC&YSWUL2D\S- M)\]'UB%F^CP)/9@@$!'$E[^TW1P)R2RB^+-)`A1P^`R0W0+F-6V71&X4L(68 MVQ8EPM?@,'A!2#UK8`51J9#Z'+E>"\4:&M^9>ZF!^K2N1T2 M4.:/8:RN?/ME>%!`:A(Q/@N,(O=-E?[R?K3_:Y64K),*]F_G) M\&IKX&`*U+!P[YS!5(F]7)FVSW#G>`'C_V_T2;_;3W@^9ODU1C?)H^?-GN&! M'>\;W4'Z_FT`A/W%"RGIOV+$Q5[=T'0?;0;\(*`A>?;MD'8`NJR!7G>:O+XE M-9+/W[^.@LZC::Z^^Y3W%MZGX[ES9Q_"!?7OK-!^LD.;!N_LP()!1C[]`B1] MXWC6[S_\\0^$?/^G3F>M$0)_4?^):H1Y)`$A&9@VGOSHP'2`LCWRSY\9F?^W MT^&-%@XO;CAN-FL5Z8OK_(G.8=-$;R8TJ8<>?M*-OOY_:ZU@IW=?[6#[6QP) M'\<-R`.;M_=KKV?;3O^&V+._W-R'=-D9]FY^Z.T@YJ[1EJ!: M)4314Z+H2)3]4_QARA1"\5,K!H0N#2#T$P&AW_Q@3!NDG"$-Y8QC*/?#N']! M,#-28AF"86;<_##L#1HD7=4B>T,Z"139-0HW$1QX@)_TGG%!#%4>%:F5V>:L?)[(L1.N7E]:E"9PB77V(IPJE$8BYWZ:*G#VW$_=[\=- MH/$8PUN'Y3AL0#8A$\0(>GU\A`G8!/>)=AU-SD6@$+X3;;A.P7`='C9FMD.[?_G.:U>19'0^2__AZ'P9"1Z?@"5IRF$M8C%..ZZ12B;4=GPYVN-]*3OSL_;!VDX?1WNL M_D983_3YOE3+7-MYSVA:K]`Y+;;G-'4$PR/IC%#3=^'7@M'Q!WZ,?[^SK&@9 ML833=W1N6W;!F]FECUYHLR1LUKX/'_$M?-*-V*"\>3P\Y.XGZL.C\`#V MA9:A;5$,8/:3YMDT\T/_C9+P985I"-`=!H6F_:3OI6-.1H,WJ)!G&^AE14'H M+;%O'H`.M,)>GDP'E@3(0+^N*+R(HUGYWJ-O+@,,I;9\BA-A<:DL@!V[@8F$ M"S.,7WZ@X3.EO+FD%_8"?O'66ZY,]R4_CWM8T_AV%XT$\#2VEZ<"?!M9"V(& MK(6_4=,)%\_F2T`^VPZ0[;-+S=]A(G&3XP%`S@Y=&@18NR'B[=HNB^#GB\<& MB_CB4]\#E(HCP,_AF`\Y#,9KN&"D("O8L`)&81M$P://0,=_LW"6P4L`.U20 M0[9ONH^4QV:'"Y^R(/FY_43)"XC/N'$S!U/,3O#I@KH!/@0[!W3Q:%O$?(27 M><@XS(RZ,P96#^;IQDW9+DS=?5Q'[MOU:034F0-5,-!XEL26PZL9N!VR8@(P.MLW"_8,N^9Q#3$8?>,][7H<@&Q?/$*"X33@O4JUO\3Q@;2V*,L_S MF8",'^`2,B2^'?R>,;!I+6SZQ!@_SG$`^3CW_*7I0B-+&OJV!=R$N1$D,/%! M^`MP\QJ$H.78+I(;F@]AN:%Y&]8VVI=JX7_C&0:P!?Z')B3#@<\]Q'#P'<&TK.?\0TB^N?T5\S,R M6*2[&),$[`-0+Q&BV=FX1@,2V-\/68V*O"=X_LZ8P&2K??;;HVPL4=Y$] MLK:Y+!%XT`Y&U6`>0Q"P`)L8T[G6DL0IGX+8"1@`\7V>7L+%]QIK/WN1,X.E M>.2Z`O#1`ZP.DX.`C)7Y0NSYVA[-T9.*@UD,%'P$-348YH/I,*X)%A2VUAE\ M*1MHUI4C+C?239V"+(@U(T0!3@RZL?V4B/%L&4[6-1=,FDK>60$\8@WKOZ!1 MUP=,XIHE"Y3)Z'B#S2^4AE2'S5[C*P9:V39@$&!+DZU9CI=].H_@AV#!UA7` MYWHAR"]8B+Q`"S$%#Q/E\#M'CJ^QG8\4D[B+?33'*S.:\082%H&/`C$!U[MN,2/1:0$J8;0;NPN?'J-8P981KU&F M,UFFBRL!BQ73$%;9=C+BO3"B)3(8?F?[>YY5Y64B+I`8@1Q86`>IE4<;TFB= M>JEL6](9VSHMQ[277/YZF$J%8L,L$%?V)LOY]-^1[7-I%40K,"HTILOY]C(G M*'FV*=OCV:X,ZA`-P!KH&&$^/8& M=$`PVLMHR;")+\#(7#2%.,S^BT_-SFMIZ2204A&S%I;41*TN/\!-S9_-CAD1 M6UL`99(AT=QIDCN86@,;9(<'(\:7#U'(!`;L'K`]KC/OFK$1]P#&O)>R0I[? MF!*)@^$R)>7>7*;D;3(81H\-[8.G05)LX!4^PS*%0:3*MIGN*^CAF MQMILA_:1NF`$.&`2[UA8C3_%0;NN=[)GL4E<+VP`.0*(C\(BD>Q`V$+%(@,T MO##SXH5--*$=PFI[*\G4GX#A`_F&FK-8,T7V7.*&8!*&(%@6 MVS%1((+\H1.=$%EVT/W)@>_#R[;*KF`?\)^LEEM[6], M#`6)TX"ZLV33CBG*9$"R%V1\Z+E+O``JFXX/Q'[)%FZ&JL':*GM,QTHWY8(9)EG$**L? MO*<$&706$PK=!`\!""%X"=488+452@/*+,'U9_/S^)L-8MGGQ$-SZ"46,#DN M9P;H`SHU["7*(.0E'#(SQ4"#!)Y'.>2Y7++$)?@PAYH!(A:VGEN8U"^&IQM( MGGZ7V14!#8%5^/+Y'F,,P!GZ@5(T)BIDM@-[%C`?,*_]%6E+L0!)O-WDU+.8 M#;)V8JP_)YVR%=PA%_BZQ-I)WD62V[E30Q@EX=J>6&Q+@CW-_;OH&MEI$<7\ MP("$S/Y"0PXH/NA84UK7X5%.96^QI_,,E'C8N+S"H7-MG3M>0B\TL=V-ZA3& MH&MDY2EB?N<+P4RBG"^!;8&;1'BW?YO3V$:9M'=H4^7:([,MT5Q)O4F<&,!` MJUB(VXA'>V[CM(,@PGY`%8WU[IW^QB@M`)%^S7:W&>7[&OP/]:0E-(F\F;I" M^$-V8($"8;*GI-JM/^8PEM3Y7%-)N,;$[8R7M"9#5L4@\P3$,AK6'7W9,4;X MGD!GKS2LH7V^ MOMB$0KN$-9/:9HE=EO@RS!C[N;?74,N?XNS*SD\1'T:^P$/,529Q*6H'Z.<. MV-"246*AA4F>>;Z9KK$2-/B-D15BT!+\@EAP$A,X6:["J?`9H.0SK47N[7@V MIR.PJ/3#@=.D]&CJQZ_4M^P`C8;-(ZG/6+:&R8FWN:(U=SYS*B,$W[QDC\27 M/-X]F_[LPXKM@;FF[T$LP-+:UM_QY$`O=0+7GT[7L^S$C2^ESN=?BG@CK2B/O3=LGK%G86()HR?O6R(_LW`6>_T+]966DQ]Y89[F^DIZP MHP+2;QXC?AS^0_]Y]*X".A\?,<'^D\5G2NG,Z;$7-MQ?.'C+"IF-+` M%D-M&9Z^@ZW5?,1#]25LFCS`)-.]*EV#;7&9C"(>1#J&W!".%3:#?_1_UB=5 MK$[Y80I9M@]1&(0F.REM=-ERXSB2'L81RS;ZQ^!G8U#ALI489K9LUH+.(H>I M;N_AT9!V?@)]:D;NLW):=UA."Y;E?12B/^MNB0=J_^&KBSSL@A+XSR_,=XI* M$F%:TE8@6M*3-^?]L&ZR7G@GO(M\#W$'K/FV!_3<;Y0H6W/"F7FRLL`+RK1V M_C4:G+"FJ8F!EAO8(`YQ@(P!"U:PDU)R<12`,>1F;E[)_X(6[WI7-%[!Y#B+ MF\8[#IVY9:#E30,PE;[1C>XXI_3#GZ,-K5_O9^7;UM7^M>'A:1L[TF5.$@8I MV"ZPO-Y_XF.SC``[9\%L@]A%YR(@>`=,NS#TCSA2!N5&7FHI-,F!IL-EHR4#&NL2MKA!*00U?N5S.R\_D.N2 M'E!O]'%/$/\)1,CYK+EQ:9FDK'G@,O'2TVV*->L=1O-W/X^T\434[<\"R7LM M.]_HRG<^4>Q5U_8UU'J]&ME+[5ZGL==8[5ZMWKWZ6G^@=B]IV6NB=J]6[U[` M7KT#(O("=J^2MTA+RG/3#?=Z*194-[-+MI0&'/7C9]ZKE9OBN/U M07>PD^79:6(E3'Y]EU/6ZE=MW?WHPYZFZZ*TZ[K!5_FEEMM!JU4&5V2Q(:9# M@Z0$B48^IZ4F?J%;UP2P9^-'DP?AL7,O!AB/]?%ZZ9@='0D=]&G%RT:COC$9 M-C[HTXH?C2:3\:CY08/.GU"Z-^WWCBTL-<8BTJ/12&]^!CF`]_J'R)Z;`59( M'@T-?=+X#')H/VD&!IN!+@6*!ND,1B>@",M`C@Q#`HECI'Q@'.8#A/YPHUYP M(V3786S'BLD+%QUB!.#]=#%X,#A[9+C&$#6Y^:Q0%30J;>EX-)KOS=:L-R@0I M("(J\[";IM!W$0^J/ZW6`S`]ROZ?%AG_Y0(YFQW;%KA+&=+U1`8>!DI)''#. M.`[:NPCY$RO\8@BRS<4Y>M32Q4LGRJVBED[@TOW5]X*`*5Q'BM4J.F4*ET)+ M^]`""CLK%@2]!-&*Z4ZW.M^0X[_5JK9R594$.#>?12(UFG7'[=DMFTHBGFAW MGHJBGJ*>HIZBWK51K_(XSXHWSA/]@.\]'Y03-RZ!9;U@*4E6>"NK-5LN,J+I M2,MV!I24BA8Y$4#'Y^F-#P3[RA@HJB!YR9#D*S`Q=$/4_J"@>>'0U'M*7"I, MRH5)4>+R=BAQJD?).94K9*/0W'XTZX8N+YIK2[MMUEY\:P8+K`_(!H"Q(;]X M>"W&W^CLD59F*:K,VWWCN"C=NH8DKJ875N&+OV>,M?'H0/$+!:V+AI8PVTMA MZ^JQI;9%A:\VXJNMHDOV@["S(TARB1#EPD@NQ^=04]&3@P#8,PX9;7\%#04- M!0WAI9(.&A4*&]>*#24V%#2N!!H7=M!08V!:2^U>"0\":S*91S6>:BM/C$*D M`4I\& M(?'-D)+@V5P1\]&G[)+7:\]?DL6=4I*[AKT#UU')Z(M1N)(>5RJ32.%+J-FE M!-=U`TL)+H6O-N*KE7+KP@Z_VYY!WU[2"]#RV,]U3&! MPI>*)5;0:N,QDL+6U6-+;8L*7VW$5UM%U]D7G*F;':I,*,I5]-V7491[[,+N M=CAP.<&.1:Q`R!Q155+J"M/J;H>6+YVZVZ&%2Z?N=E!H.7[AU-T.%[JJ2@*4 M/B>1-#-?W>UPV1)%44]13U%/44_RW5'VJ&BY[G98VK.90QL/U5D;1DE_TO)49DB7G5.?-#@K- M,J&YU7N_[+'G4A9"/2)$I@X6K7<89P5"'3N.F@.9JM=%%#04-!0TRH1^GS,0 MA8V+QH82&PH:5P(-=8HCT&X.O57C1G,VAG9:S&>/WQC*E:)]#B@4#%L+0UF] M-O7#47D3I3JND4T^JO.:UF!2G=>H\QJ%YH,E3R>BD MK/ZB34+EB[QZ=RA5AB0<$&)O5R95DB\.7%Y M.CZ9I:5/B<+RG3O+A=+]3,T@\NGL@_N)XMD>#.B-&=C!%QSI%Z#\&\>S?O_ACW\@ MY/L_=3I)JTB;7[`R+,QD1CXO3)^2.POH8\/4_\E>)O@V8:__;Z?#6]@>7-H( M:R-I8KUW=L0(?WRBX[C/>,J M\TI7##J`A'`!V`BBY=+T7Y"67@1X2.D9("T`8@'^M%G^J(_?/U/'P7_-A.:S MR&>]0)\OP&;XP070S>BLFS$MP2&%7F@ZY-$W8<@S--KG@`\4(A%;U;CO>"0; MS0:\R>TQ\<),C"G@@TZ>86S?]+LZ2`_'L3U7P[]&V5_XX#?C[B#[!CI=49P- M=5[*<$"UE<2F0Q&%Q/:5"1L,R[MQ*BE1L<[-)7TW!XMPJ&(@?^;T);>[ZZV5 MVN\/S_GR$KVE7N??V#?`4'[7XTG4&>R99NOFM!/1,7Q MYTC:P364\;:):X"6_(>;^EC0'*;=:0M!6?GQIHQ[`=O(Z:S&X\TZ>+/>81Q_ M2"!,[$]:6(Q;`:LZ8(F2W'J_>ZA(M8S0N@HU_N],AU<*>ZL5]EM#9M6HY*3J MC&.\9E`*D_J][D!B5%8D]0M=V.W4XM][_IS:97>#DH00H?B5,!01O=8,?P6F#SK!U=;!W=5\+[1U*G/I:" M`9&9%STX]$CFEVZDS9M9DX%>$^\W!Q]Y1M(4D&L]8A'&`R*MNL&%<$'E09K[ MH@Z/">PK#"MDSW<>S`#VJ[?>?; M9BW'#4L7@WAT2W=K$85L-EF`X,Y@0G?&POMX-9=@3R`AL0.R\FF`H3$S\D`= M[WFK$&/M@7IR7OE902Q?I6K@KA"E&/*E1+F*\!(5R:?B]!J)TRN09:*Z3"(" M?_Q*?MJH,.=P,6A:)"K.C(TAKA\XDN3=M%#>%M7/Y%T3M-MA]+=XZ-/'\V0YK)$[F%A;3>PK3A"^1(BU:LOQRBAH^]#%`8A MK!/+*E-1RLV<+XMRN`RTT63:OO/E:X!6K2ZT^'J)5N!8OB#21_#)J3"J27Z1J=$RYGTJV(*TW MJ7$+4K'\\D%+H'[3[QH-)HK4LY]6N*SEMM-D`-)MIW*L1_WZ36L61'F$]N@W MR0&#RGAIM_/G%E2<\5A>(Z+DM%3.2SVP%*@=#;J&\OXH9X/R_LBY(,K[(RP# MK''KN'5&NCCM2+*:J5+I1@J437F.]&Y?5.RXM)X*Y3F2:SV4YZAIS]&QB8ZM M<">M;+]-SJ2*,H-E&Z@$#BFC)W$P4M,JEVQXN4!@BU/;C&%WV*L$VX(6Z1*= M7J=NDM(I%W(LDF!M[^)62;)B$BWPF6W$F-=;3J*&R)N*LO"E&VGS7KJ!UA=V M5"0/@.0925-0+@F/A@M*U.@6'':%V4YET2=`6U&,()%,%U4B:-1MNCB*Q$@6 M80(HF7X&%_2%%?S6Q-U%7[<O3J$IYTOD,SZ\2)DK.&5JO MWS3_JUIYJE9>TZYS?=HU9*L9V:!">+F,()%,%V7:#+JB8LHN`,D2FS;7*=-% MF39];3J]%,VFUOJG90N-'JR)^M%\89?%WSV;_FRK*"I6;&(]D;L@B);\ZY(5 M4N.>6$?Y@:=]Y+J0IEKJFEE8[8WM6!/U.2F]9L8E_`HO4@^R"JQ!6F%UZU4S MMT+/E$2XNJ%'9O2).MZ*O9.[FYT&H;V$;@("O`%6*36M!7:#C\7%7I_2Q5]Z M,^JP<9]\=WOS-5WKOWQ]>*0242!>*MH!!%V1KO?:69;N'UAZ^,]A1V`Q,CUJ.`X4RU2KG5KD:K;@=JWSROM/2 M:JBH_\BXK"+VF,.&UK$[39UG-+\=I7_GU>\5J`[!X5+7,@5WM]_/46@VQ-U5*)`J4!9;@[#[K3&C&5IBU74:6,WG2G?NH3] M@]C?,Q`9TXD5-A0V%#84-I2]7W2G879&MG4P=65J:5W%`F7A$V6R*&PH;#0] MC.O%1F-69=7[JS[H#O:5]*$6.M2?/,<,;<<.7Y0=*X<^6M:'T^].ZO/AU)1) M]JT"9;M!.1"6*:I`J4!96E)64^BI+:"\&)?!<2H-=&Q#P[-R%]PWKGI?G@50 M$M)\`A-#-PZVR[-F5!G^ENOXW1JC MK-2QKP*6`I8"UIG`:O"ZV:L/1MBK(WRR@]\["XTR&J1W+N6 MMZ3DB_F5H)_##2BY?4-=.K?#5R=5A\F:_3#GC4*;<9-Q@Q=1"B8F6`@$HS'! M[`#FLESY>)UZ4G@EK19SJ553Y`P-WI6_?7OOPK)X46"ZLY*>N\IJ'>PIO=)4 MU0*1554J+E.@"J;46&%!U49I>6T450:E^@7=7U[F@E=4R@HHE>\8]CA4=0/FFYT*4:A-(A@!8:0A(H%HIHK9.6;:7:=9R)O*<@YTVG1B??.7BM MR@FU:S]N3;60LR=PJVO]BG0%:1:ES@N@%8HE0;$Q5B@^#L6E-WG9*=9Z&$^U M_J3&I+]*Q-MUA)5^#BN,%#DB6DUT-EOIVF@JZM:W^@FK MX-0XG,9#N6+G!,-)?@=!V_'4&[<,3Q=CY>\[L7U'Y]3W,7>T])&M,M"J4JGE M*>.J#':%!V5S*T`HHUG%$%RN5GH[U"8#47=$7]H1JH*B2"@.M$GOJOPWRN`6 M[68?R94D?D4&MSI6EUR/+JLOZ%I/EZM"M3SZ@H)BG5`<5)2/)@-9E8.@<33U M995J(K-LV^IR...MVC".\.B)+UYZ"7&?%I^F=<;].G3Y[S!-0DYNS)="T:["Y5^K,91KX= MVA1&]Y/G/GZA_O(=?6BT/NE:-=*-E?R2KR=*>''0(%J"'@T-!VSZR\K(1@!Y MU&<_OK?GX8+?4JQ#8T]\]8,%N2MYS)`XL!^\4(::*P[ M_KM/W]M^$&X]E,UO[OF$FM8B&92+]6;G]A/E%^TD;?E@B874_VX?**NMG#KI M":R_!J"WR3D*V/."FKS30J0ZVK'<8QYNYPGAK7"]O547?:]CR#C@@+G[+JRM4 M7!1O&3VMI_8M.7GK0-J\VKU;TF^;^G#Z]BX MC@T%DG\WFVXXRTLQ8$ERB+A[NIJ(.MD&VORN*50CK1L_%[*5YBXBK"X0KI%= M;`K_CB?4RO$<^O_N^5;QL-0KIC$0!"XB`%X,0EBWT_!2I MVB@P%.:&R/TZW]'K52[K*IH"G<#K3I M2*[BI55,J\[ZI0K0,@%ZJ.DCN>XS/?>408&R]:"\'4RU24^N"TI%B]G*H^ID MU*E^\=S.C,XBBR?\/7K>[-EV0+-:KDS;Q_S!Q)U?U8:DXN_VC4,4`_/Q3PS= M$&6T-!//T?3"*GPI?"E\B?*3^ MTL3Z5<0.Z;+.>UN5BB\@0[#&J[:5Z7@UN.I/:M15%:ZN!E>#-LJKJ_!'O%V8 M[B,Z)'!:$<_E,#%S`"LG*BNOS=IX?R+Q(:2R\EJ+*Z-.Y[+"U=7@:CJ6.#;M MNGT'ONWYK'(Q.Y@G7'%G5+AJP]VT#6] M?Z#\I`RW&S87`Z'P*S-^Q8=FRK/^\HQ$(?$:D%A/`4L9]:`/6+Q2Z&Y1@PUT MY64KA6E,_;:5K)1279(-5XH!CK^D0U0&KSS8D6DE<>/O;" M5TG<5?J@.]BII]UOU^6\C7-PQ%X^WECYXI,O89:Z#$!E]S#7Y2T;:J-^TS$I38=Z!E:#O'-5>2OO(`&:77]I*DH@.'B6[D,_>3A;@9H M@D7_>?%]5LF?K3L;`;P;+GAI?Z"B/0?F<$-6^=_#O#PV6"_RVHOA!.VV";4/WA]PNNI61=.7MHS5F`YE7*HU.^E.%&S[Y?M) MDG)Q_4&2/P+J_P,95U2Y=3C*<8KZ6,=]ACT!1/[CT0NK,L M/S(=;@OZ-*#^$ZTLY6G397(>QU886F=(Y8XKY6LS3KSM](2,*4T?-EC/38"\ M:Z;7]ON))0-F3YOJJO:6I!M)JMVAMX^Z`7,M5[61;$9^-+>1;(SDX$924SJ: M,*;K:U-A<3]'+'0]FT$-O4H2^+&66@:?%Z9/.P\FG@FM MS)=*:R&TUS"H*>=&I!(U[C58&E=I]Q>-+D,SA!T=*17]3(G^"PV)MZ*^R:(` M'"\(>#3!W/.?37\FK-*-TM;K4J@F6K].X:ZT]6O2UL?:5%:/FH077+72Y-2I_][15?1E*V=HO3[-JE/MWUM)%T5M8/2 MO>1DZRVCIJR(5K&!,:BK&H;$Q03KJ;=>HZU2ME"KS+N8U"D'57%^;1KN1!OV M9*NZ+F#KD&@H8MA`K@2'UK'!4)L:HJZFD[Q:MKR&WM%)KVF5DW*)KRK42H0N MNF<@ZLSDZF.E&D)'ZPXL:G6>??0QC!6+1;DS0O\=V2O,3E"G)+7J3G)I1K># M@3:N\Z['DS7P6KUA%W0X<]6@'FM]7>*#G>9]6_):!0?JL(>F^VBS,H(LKDL9 M!-*H?&695>]K`WU2'[/*?1ZCC!&)D#G4QCV)[Y65B$- MR(+.'E45I_;']=S*GOG1]([25INF[<"\IJ212XHZJSR31(6?747VT5,*O1,A9[5&7K6'//69DF-#`TFV##_RFU?J=BS:^"# MOJ;WFU;FVG?,=.PE<9(8@?LBTG[9>?=6)5+C2,K4NG^>?'OCJ29@28`V?'MC M;9JST==&POR890$H]^9;V2RD82*Y`CU:R$1CS1!6?ZTL_.3?N:4R-M7IF@A= MN*887553H95'7`VA0V7%'+!!K`@L$'?#%F%'4U6)UO;&PM6J"LFEYTRU49VE M3.K0IR\G$NZ*<3G1)L+\9O(D!`D^KZE[CW$\F$M(_:5(CY:/AO*(AO(@T]>IV_FVXX_?_\Z"CJ/IKGZ[K.UH+/(H1_F2>&=+^;7 M.Q;O?N?.?LJBW;]@_U^`FF\8\NS'!& MH!GRAKIT;H0Y#GG/;TTC_V1-$6R+L,;^M]/A[6T/*M\DM)@TB.W%S:V/ M"W.[<,D_T3F0QNCI_9[>TT,//^E&7[_YH>PZ[3'(_Q4%H3U_V;#)^Z-=%GEA M^U\6E)B/CSY]-$-*K(7I/M*`V"X)X8<'T\&"MTCD*$]DM,T?8IIHA'ZUG"BP MG]AS-M#!IT&HD6?XEY@!=(N%6F MQ_\.5J:5_!U3*N:?*>II)U'[&*51'A<*_^*9HO3$<3BS6)C=XQ)Z46"ZLZ#< MAKDYR=!;'=[Q0(S!8D!CQD[9N+O==50($,*G3ZGR4^S)1#X7W*^[F)N8(7E' M+;I\H#[IZQILOKI>U;%/O2>53=?2J+'.R538Y2#]J:C4BC:=U,K(PL"E/C4# MV+OY3>#1RG,9*Z^\P,;Z]0'QJ0-[/#"X1U:^[?GD!50X805-FO;(75[&E"BV MOAU(?%MH\P["*]C2#PAUM:5?\I8^J+$44KM*`\C(UX7[O$D<$0-/[JU($CL^.F:JDE\5&FU-I&9:23W;A#Z$9;S#C3R&?0*RCYC,^]MUW0M6&+R MD?ISSU^R,P2L8I3[)?9*:.0GS^+WZYUR/L-&FALHC#,;YET0#S(WQFR$'^;I M*'+#NW-GV=?QV)*127#44R#O3SSGJ>,@BNK3(')"A,O<]Y:; MITMST_:1?2,:))HKJY/XEM5)#!`3V1*S9C<>X:44?V&E%/_&2BD2TZ?0Z\KS M$:YQ/[!@3-MB$`[6H&IYRY5/%]1EQU>V"W]3LVK,,)/Q..QNO#T*$UX6J0'5W&@FK)"OYVL M<**FWR0C7!JI19VO->GDJ$(JB:+_NNKZ=DT?N(_U@9^8/O#6,8/`GMM<*:Q. M+LHG`EEW>_6L`_>B'<&49\WT)%U)3F92)"HK;RH0'*>2*!OD_D]'RH1D2(M8 M&NE]$(@W1TC:@\X*V80(YO9AY"!T@1Y%-*S44:/D1XVZJ#G<3K3II,90`PER MD12B+QK1K2ZO?]8^4Y/6SE5TZCA@/FCDD;K4-QWF"C1G2]NU@]#GWD'Z=05* M.ZU.*S]\,BG;7KO;=RKL%F,YJK3("*H&0XH* M@['^'9D^K+GS0N9IU)3MLL:QA=VQ4?^3O)CV?I^]5G,LTR$\7%J"=Q4GDFN! M!BR[GJY"LJ(^"188WC0S0[.:A.Z3SZJ.S^G>IT5[=NT4Y4,A&R0V/\`T[TXTEV>X.+Z MT2]UO/![VP\.7+QQ)).4R:)NCPB3>A$_4\MSJ\DN4:O87,+0PO;5(K9\$=][ MD1\NVK6*U=^L=V3Y[0J,XLLYP]LSC#U8+9=9OUDBLY0_/HA6S+^L<^]Q_*<@ MA;OR0]*SCL/.!&VYA3QF@LDBK(\OOS2M&I\"O@*^`KYTP#<4\!7PKQ'X(/'3 M>9"SV*!RNI\_SWHB7C?O/3KQIIXZJI9]HD_4C6B+2AG+5"JWQDL_A54Q'0TU M^%]]&YL,4?0*EO+#TM",L:B"F@J6"I8E83G21KJ2E@J6DL%RJAG]%L*R,7=\ MG3KV7WTO".+'K]SQ+R&+UG5;P%#K3405@Y,T;4>A4GI43K6I/E*H5*B4"97& M2.M/#]R5IU"I4%FSK)QH?:.%LO(J_-CW:_7''^C<\].BY*'Y53FXY6/;NF[F M&6F]*[NE3P'ZH@&M:Z.AQ)YQ!6@%Z-,4*TWOU7B1HG*I*U`>(67'VK!.&U0" M*7L5SG@L\[9V69'RR,O&X379\[=];3J8RFO/-ZU'*4"W#="H2$GL-E6`5H`^ MT3`83R46T.H8X!I!>3O4C&F-[A<)I&QC)P@%B+]>!U%-Y=8/\LT555M7T%#0 M4-!0T%#04-"X+C?I&S.P+4)-W[7=QR")J\@J*>.0DDS1_@FYH+QS/==H/"L\RD^T"\%RO_:`<^0J3 MTMD/$LC8RN\5;>@>R:2)15Q6OC]=?96P M'(VTX;#&U'D%2P7+8Z3E4-,G$I-=%6B2J%2*E0:$\W0Q^U#Y55XL]5-%:UC MV_KF_+ZFTK=-3GNU#04-!0T%#0N&AH M7(7+\I@+'/[4Z=RYUL+S.YUDE`5?J6L>VFD#"?2`]KIU7MBN'*`RD^T"S'JY MBY`K5Y/"I,*DPJ0,F.Q)?,&3=/[/.M5]=>/")8<<78PJ7]/:J'ACZ2%]$6J3 M' M3CWK]\Z#&5"LHKE<43S0!6)(1GW<"> M41]>LUUX@A*@H14Y_&5H>';0$'B@EAG!*/!E>[DRK9`\>Y$S(POS"7^E,`@W MM#NL)?N)=@N(5C]=C76ZWKN6$\UH0"R8TR/\ZU.@`F#YUJ,)Y@12VDG_,B!P77C3[R6P:=/%PRG.`< MJ6DMD!HXUWAJ`>&H]3C\>$EO^!O`XYN/E+@1NW<",8[-!(PZ"99(0*W(MT,; MOO>B,`CA1^@VZXO#O9N3`.FG.\OR?'S:>=%8U\!56V-;FB^,3UQJT2`P?:`0 M0)I0>,!!;.##\\AQR`O>RA'']*=SEF.A!L=#W7-I)[0Q\O$*US"%VB!C7))4ZQ/$FAOD2#Y_/WK*.@\FN;JN\_6@LXBAWZ8_P\G MN_/R'OIVH2OGWH6E7+)Q?$$!_05(\L8!6??#'_]`R/=_ZG0^X>4+ENW8*??A MF@!J`#XAP(#!A;H>FX['@/3`SC)3'.V3;IT.[VA[K#_&KWRD_F=\DAV0WKFS MV'.R/EJ4L[B:G^@<=A2CI_=[>D\//?RD&WW]YH>R&^]IOJ'^:)=G:+/QQ%7D M\PK[>G>:](A;T-QS'.\9.0VV%!/67^0:I-(1>2P@%*^^(9L7TO3YM30::Q(^ MZ=^=Q%B54RG/XF1WU&)#MR4=UBY%W'JT[J;4)T=Y*7./'7'_P^T];B->%``, M`"I?+;H*Z[T*+]S850Q;W%54:_Q8B2%0Q?4; MAY?@1&?^45QQ#/6%918F,G=+_$F!\BIOE:D+Y+BYM`C1NQ>WK`=%R.J=N'6< MN8#5^";4O4ZR;_^H^+5KJ<_<@`:X`1T^[!X-"EQDC>Y3E63`EZ1&D;_P',&Z M`RPP&C+S(E#PB]!R[C!K]36?.,.S(DO.GN(MUF,15=I3".1*3E0QC6*:JJ8X MT7J&J&1421`GR3`4\*4"_JT^'&NC:34F7GOWB\JC&H]2.0M8J)XHJW,8N*HC MZJK&<-;A_U&#J/GL_BSIJN"@X*#@<-5PJ#PA5SKWR;OL,+6DH[]VM;=ZG584 M7YRD==;$%Z)M$@4'!0<%AZN&0S,68-6[IC[H#G9NFY]Y!&&$\8885/2POZB% MLD>;U#A+.CGZ`VTPD>NJ4F7`M!A.?6TXE:N.NH)3J^$T&K<-3I=A3^_5#'Z< MSZD5I@DO++4`4VJ(M\*09IYU@+D?OFUAL#+_,7(Q+#Z7>*",<:5N*^M+P4'! M0<%!&>/$&.X+`?3<#J;1V7,[W5"3W1;'4YP!JVSR%FJ]?/`30S<.K)]TJJ_" ME*R8ZK?-BE)0DA5*[15/5:2O26JN[]4=L,^-TM*?BHWSBC6)DA2L*89T;WJ* M[*-L-@Q4O`R0!#J2#$,AN&H$&\(J,$D"&4F&H9"K9&\32ID,#IV3HBL.%G;) MZ6:D3N5,M#E7C8"0:I07'-,A"6HD&88"KX`C_TE_I,`K'2P4>!N.5ZD5-%LU3A+';5GR'J'JJV5,U2/*-XYI0I`LNH(HL*]U>' M^]M!=R3J6MBV[!6"]$X9/#E[]<[D*FGL6V`D[I'TD570G#3,=@J:.LXK95!* MZUA*L4JIXIEKXAD)E-*:PU,4[A7NY5!*F]XK5%1,M:Y[=>ZMPB`4'!HGC(+# M%<+A\J-BWAVX]AQO*K?Y]=XS^,`N3;:\Y2H*TXN9"RYF?Z"6&05X^3RU?4)Y M)32\U]D-[4Y2#DV%WZ@#=A%B6<%!P4'!X8K@FD5H+@:F;*AF]22R^[^=>[] MRN*Z:"SIPNX95EBZ-BP-1FV[Y>@*3/_?3-\WW3`@/G5,W/U#C[PU@P5YZ[EL MH`\.);]X(56>@#9JVV-MW*NQ[K2RW2X:3>+K'BI,*4RU!5-7X!5X:_KTO>T' MX98ZH#P#+=3`)U-1%9>5-7=M6&I$;BM,*4Q)B:F<+O`Z-&&3+""#Y5`3.H0Q M+@I;R\UV[SY_/#F=70F,Y,N"$C,(HB66N_Y*?W3S6YT\FP$+ M^+,\-[!GU(=7 M=NV0=GZ"GF?DW@U-]Y%I/G=!0,.`_),U0;`-PAKYWTZ'M[,]&-X4:REKB+>S M/A"D"R[V)SH'K"`=>WI/#SW\I!M]_>:'TFQUDN;8'^W2&PL;SU''Y-0)HH=_ M841FZ!%SZ0$G_2>&4%@`%0:&`!U/0':$P=QS'.^YZ&K:W,<'G[S>1`(3#6Q= M8F%@P72H?T-XCL]?;GHWQ**.$V>ZI'\'`+OD[YA"B8P;?GLBMQUC!\2-#R<% M@H8_>G#5^,R.&QO_XIFB8,<.G%G6_,:-1`5?W=YC4*X7!<#20;DS8N$-6P2M"TL5/4'ZY1W""M_^I[04#`F/)?`&E'"OLJ.KY;PE87"MI+*UA8 M!9F=*V=9T3)B+OEZ\9+*:X6:]J'F%RHKLY_H+#MQD]RO34N$GF/G(NJM)HCSF[JX--ZAW'T&9VP/<"8:H.^7A^[B:=O MXXNJL)5@:Z@-A5V=JK#5!FR)4A+ZVF0@5P"4\GPD:_/1#*&Q:W=WU!3(*TYX M#[3A0*Y\`V4<7@BV]*'6F]2H="IL28\]8?0@<6GX[/F_UUFCX(IU\K<4]`2`*VQID]["EI7#"U1 M"@.>@;50:%V')X'Z*QI&ID,^,@S$@5D<0?C(P5D6?%Q>4`6YY8Q M=%%&8=WH$73[MB0.G+T7<'_Q0M.I1.DZXVIU,9QS\M6I4H>`5W9[:GTQ!&.M MWV_Z#E7QZ)-G)(H/I.2#WE@S&K]W7O&!XH-&_7'#GJ;KH@K4:'O)#*DAHTI$*=2H M$E&J1)14BZBHIZC7$@$BKW=\7T0"=KE1I%55C6I='1215:/Z/;GN5SW70SME.]X&J&R6%4J[J1BEHM0U:(VTT4M"Z9F@) M*P"A]08MK$AV':X$53=*&HU=Y!&$JANEL"5(N(][-?J)%;2D@Y;`NE'&]/*O MMU)UH\H3H?'B'Y=7I41DW:BI*KCK-S^4!=@>Y?E?41#:\Y?S"G!]R1?-(FS5L0;7$E1M>)+5 MU+(6L#KPK>T2,T_VM_<:1E"QTEOF5PV:\=GSX3-U8`F6T-TB(!3&-=LJW=5G M@5A8PZOY0EUZKW=ZI:Z2OH+$9NJ=:S,=/]PU;L='3L'@"96^\,E"(5"-ET#5 MZ\%Z/>0M8T;DQ?>F[9._FT[$!.(]-D^#D'P"YB2?G\W5@:C&(W>E,GZFMI<^ MD1H$[ST?OG/)V\CWJ6N]D"^^Z08.+Y)X-\--87DX#T:M?CM7_PB_EL1+6WWP MV-G[J(AD]3TZDAG@Q_\VW2]M M34M3KO2K0O0%('HR4J5]%";+8?+$S?QX*3LU:LSAD$#&5I_55Y^_@GOSK#5O MGAU[\QSFS7N@<["!B$\MQPP">PYC0N,GR&M:56U`*C=F[SA$[2+Z1"5=*6") MV`K&PQHK8IY*W:;5;07*O>,0II\,1S5>,BX!*`4E`U3N'#IZLOSFC""GD]`9 MF?O>L")C\L!'GI$H(`L",I_BQ-"- M`X?""LX*SM7!692:=DERN:9TS/HT,(R-L%W+IV9`R>V,\D^O,%#".^11JDTI MDRW;YO+2@@0J9<98)6K*B@\%9!D\8*+04ZM;3+&`-"P@2I$;&J(*:%QHAF<[ MHZRV8LXKD0 M7;X%B?>0RM-/529AI2Y6E4F8]MWV-"*52:A`H#()KWKU+RB3,!G((IZD/H8- M\N:(K>)2/5_K^84'G)TJ\Z7YS!=ASBE#&XY5?J%"],4@>CQ1^84*DY*Y;W1M M7&?"D@125F485K4%J9R;9L)@=,T8U'AAI]0Q+XWC0<$R*9_0PBOA%*ZJPY5` M%44?79>X4TF&*LE0UH$V;T<;6L\0)0_D@8\\(U%`5DF&"LZR#[1Y7](ER>6+ M3C+,9JU2#*\K+47\,@S$@7CMKFPY,&./".Y>A2+TL,FHTN!L

XLR/!0'*0Z2K:R\/,B39R2*!Z3,$A17QKY% M>TB;(\\V6%&%Z30>IK-G("K41F%#8>,ZL7%P2V@9-HY)K<\/*+U:N&AKR^?@ MK^US!=O<[SKK],,\ZY7VR+M,)-G))=8%O[\0;JM^GMU/#](D%\#?Q)NHL&"ZAL^WR MZZH]EWF4F=LO".$?EL6,B^*MJ,\C^=EEU4%N+:T<2:$C'W/C^7O)M=8O@/J= MUUESYZ&6W&JM=S-LD]\HF=DH%T)BF2L[!,K\A\*3+[L'8#&LS"*?7%ZKYVIX?\`I),?$>B5F)N-YX=?)?AVER5H M$%EYN2G(E9'0$%>PE54CKF-YJJ!A7]&P+<*QIF/??46FH#$'5;]R!U2J8LR? M#Y?0O5ZA+?O"B2IX78\XEYVZU9Q-MD!//B(.2*X-@77)2EWM-+:K.HI1=3NJ M\L9N3J$O*N"ZVV`M&0%;G0+E!8!RU*TQ35L5.%*8/&(.TZXH_5&>[+,C`D4D M5&T^[SI!L%W+B6;\5`1/$_#X(^#G2`<*NJI#Y(H.D45QH]&ML=;8YJ3J45L4 MLAI!5K^KR@\I8`D`UJ!.2ZNAQ*EV^D:.4B`"ZCBV^ZB11^I2WW18F(,Y6]JN M'8084?%$"?V*[U:G7+342A#%J76I^H,F57WE$[E@9/658T,!2XS($G6AL?). MU*!%0ECC"%/NB\L%6*\K MZHY:Y;ZH(K0C+K47FE_)`W7IW`YS>2'*(=%J[=[H3I1#0B%+"+)::#[8=YZ24V^2EMB?-?L%$V/2"9\OT M_1?F76%9LTB=QX0Z69+IW@Q7?2/#M4_L@`0+[]D%EBVI8H.!`CH*M>A7YH`\$M!0(Y:EWK=R318:LK@V- ML2"FE+Q<=3OWUOOERK1]K"]#\'J0]FRH5W_OCR@>OM4GAC;HU1A_>XFU/&7D M]9UZ](&06'4J*/FVV^\/M?ZTQG!)M<6>,Y5NOW M1)4PD<=XO;!MLMR5+(WO3VJ;3+?)B3::UN@S4MOD"6S'ZN,2NS\.[Z\:+-N^RJZAJ7,_GPAS5-6-OEK# M7K:B2]+`E;=IK(9I67Y$9X?38G8'L7S*OWKGSC[Q%R^B&OQZ8,O1Q$K_#CT6 MZH)V!5FC$W?);7X71[OTUK^'?D/[R0YM:'A&`\NW'Z!I\\%[HIOQ-+L*QI-G MZE.\A'+.RML'S"=(=,J]ZM+9D;PX^>C+5,SK"_" M6HB&*5.TT24$63=2SJ`6I"B$UHO0H4)H';>T;HU,B+FA>.&>LC7JB8O7% MGFY+.BR90A*NE5GT[N'KU-O)+XW:.1N'G(5VSM*>S1S:G)TSF]GL1N6J3);- M@]WB!5B;=7.!>A4.X[R#_3THD%NKJV6Y2_=[S?&@HA2@B3;H-WC-@#QFP];( M:C(;%/2;@KX4$E92]*OZFK?S>PS]92JD]$(N3LW"_E@/%MC#NAJ4I7%GTA4 ME:K-MYPG9*0E#&#,)J MQK;W@*XD`)O.#)+1VE5G>S(YTB\ANV&B#8P&+S^3Q_!4.4&*:XXON*@-)RVL M2RSOL-3IGORG>WI/Z_6FK=PK5&9/!7-6F3VUG9+IVGAMZN+@2X0FZ*4VN%0[K*`*OE'\8QL/#,R&DR"D)1A M5.K/11_^&=ITV,XL497Y4\&<55SZ40=JE3BE9(A+K\MD4#"[ZO0'>?3_$H=0 MB@$4`ZC\'Y7_(PCW`I5Y*:"OLH!DS`*Z9O-9E$9_JVOCBHH(MBAP5H&S%;[, MV_Y(;K^.&&BJ>X$4TYS!-%*?`+2/8U3F4/.\(C)0RM!&T^&U[3(JD^V9+U6FJ&#'9-KP0G:61D[!VR3:JE7Z]8/ M8R(S+WJ`E3E.OD@=&7[B))L_#:R_8$:C()1J,(HCSN$(87>I#.LR@.L!7_W# MK<.*58RK&+UKT0!G+H:;/VEMD ME'OPR>OTS1PI]EJ;I6K$Z*](WF?VXU?+B69@/KJ>V[',8)':D]ZJY'GA6TMR,J'7WT8`+$\-[`#-$CAQ0#:H)T',T#[ MU%NNJ!N8F-H%?P1AT"V89?V$,,H30N].+H@0&U6#-MVL*TW9)Y$8!6XBY;5$2K$R+`%+?"EAA9#J$+E>. M]T*!MN97YFYZH"Z=VR$QER`\D>[V?$Z9,XJ]MO+ID^U%`:%!R/@D.([0NUWV M\>?O7T=!Y]$T5]]]MA9T%CGTP_Q3WAEVY\X^<5?86P3$%UB3-XYG_?[#'_]` MR/=_ZG22]Q`8[V#(3P"?)TKN76R$$P.@\CF$)AC8X+'W@#'7`D*2CU[`DE(U M\MZT??)WTP&\_?,+`RAV15A?_]OI\.ZVQYKUF.OPWDV[^S!/.TOZPIY81^E< M4*@@V#[1.6P@Z-GKZ3T]]/"3;O3UFQ_..579@6C$BCU_V?!J]D>[?)JGME_@ M,CVQ\2\+FN)M1F!;#P*0'[!,3T@])KEGV8+;N04O&(7Z;Z\(,`HJM0T..;3[8#JPGC.-Y05V04`Y]-!W@,^K./=^B M#$-+$[8*/VW+?/0I1R']"IM(`-L+];%=((#C>,_!=R4D5LC%*5>;+&B<^C>$ MZXI_N>G=@+1TG%A92O]&69G\':]=HA_U>M^>"(#2H6-QE\:)9P[GR.7SBN8= M/F2J0/L'Q166!SK7>SO5X<,#*4E/CI_C*,J_>*9H9V`'SHPW?^(Y16D+0)RE M5>4JCBYC$:LYJ2QSG'SN8E01Y%J9I%H_0IP>=8`X+3H^W+5NM_#$G$@L/C"Q5Y+E_4> MFP"ED_B@=)+@V5QE2IM:T!8NZ%OT];SU7#8$5)1_\3R12YK&^7RB8IG>W3,.^8'V?)52(3EFKP)%]2&8T@/[9D9`9D`78<7BR MDCO]47J)I!A5Q%?$5\17Q%?$OQ[B5UX'4R+W".ON0[B@?NQM#.,(D5(*2+F0 MXM!;E89_56'-V1B<'QHK;I)F^X5#!4,&R]6*RG7JB<)MX9IITJYR1/.:>+R3-7UFGE*F MLEG(7[S0=*JTD*^O'%2MSC!QE:1$E9$2=L`J#_+D&8GB@3-XX')L&LDV`%AZN%PX%XWFO&PYFWMEQ`:@;& MF?1I?%$4-AJFSR5G'NXJS/135I6Z7!6$2P@K%\4PI\6&U\0M*LU`%CQ(H8$K M.,@"!SDT<"GQ4(>65>\PSMLTFM"RQ-.G\451V&B8/K)ZLMFO+2]7IGQARE6N M\*!]RYTJHKH_'^&5R\ MVTW!L$J'?LGQM[?VCX*C*M&G\*CP*':7-H9#A4.%P\9QV%ZY*.&IBXAR?([G M/G9"ZB]%&'7*5UKJ**5-O":EP_4J074Y=I;"E"R8$F,L"4T[5WB2&4]JXU.@ M4J`22UX)CZ$:S'QNG:M`Y5THUY'*NU!P4'D7"@\2X4%M%PH/EXD'"3W]]>97 MJ-P*R4U8>>(@E4M#`E^^@L.5P4$.95SA01H\J.U"X>$R\2"A\UKE4%RVK=JF M`R+E`)$%5)<3;J,P)0NF5&Z"`I7:_12HKA54NC8>&"V#TYDW%1YYD:)L5DS5 MR0/JDE+!`U67E-:Y-O*,Y-KA+.H:P6%/5(*E/-B19R37CF)A-P`JH2P_2BX0 MSDK'4'"6?J#-PUG7#$._$""?:25V@;';R%R\TG4";COH7P@4YQ\'KT`1B%Q#&$>?/(Z?3-/AX+/W[^.@LZC M::Z^^VPMZ"QRZ(=YEB)WGZ7"W;N?0S.D^/G#_+WMFJX%R_#1"\"Z]]SWINW_ MW70B^@7(]L;QK-]_^.,?"/G^3YU.UAK)-:>1OYJV2VY_\H+@%?GG%YP?P9<) M>_M_.QW>P)&CP\:PJ1VCI/[<\Y?P1S8^8@%^X(]/=`YD-'IZOZ?W]-##3[K1 MUV]^*.V+W>UI^5<4A/;\9)1E-]*`>"Y["B;/''\L]_'!=)`TT`BE84!FD<\: MAL?"9^K`NBUA&(N`4!CO+(/K.VK1Y0/U25_7")*-F.X,/QA;:9.YC[O`R><1 M\Z(%=*'^#>'RYR\WO1MB4<>).3#].UB95O)W3.V$Z7J];T\@*7?.)6TLXGMQ M#1TX_.;T38EY%..!C/K2^.5V7?I[>X^8\*(`EB]XM5]X@HP#H@,)QCL%YV%? M\QFPOW!@_\R!_2,#=A6[1ID3@9H=S(>'V'(\YS.\88MY MBR+P/8K`O\4)WI^H8^*F%2SLU0&_=(KW?COQOB6C!>E&%>C9ET;J:N(YVR!0 M#JK`$@D-ON.ANOB*.*`P$A^%`2A!H1>K3JBHKCP?!01J4;.<-/&IY3VZT-@, M!8MI6=$RXF]_>'NO$2`"-`COA.;7N+%R5E<3]FS[C=5RENB)T#QZ#K?]OEP1 MW55,ZH!VJ/!\N7@VM)XQE1?0M=4XDFTO^ZG$)N:806#/;7AA[GO+S8T,6[%1 M'Z)!2.C7%74#*G1S$Q__)"0,2T)AL#D%89N;KDUUN0J92[6]*42W#M%]K=^K M46&3`-'"SA>./E,XW6N?GBI\IH_X./E$V3;G/I)W=F"!11?YE/QSWT$"?S%] M+WM-CJ.!S-_,'.*'W-YL+__+S;O/']__9`IQ!F>P_UZ:\>?5A0FE1:X M3\B:%.`!P)/N-O_M.U")!V=&H5?MX-AP$K1E8`F.9:83CT&.UQQ//#7ZC9*% M"5JA^?CHTT>FZ^$!D;>BOLGX)^!S1)\I*(">2T%31![AYTO\1XT\`_XZ#Y35 MR5RN?.^)<2W\[C_9%@VZV59&/D#SJ$<^^JRW`V_"HY83S2B9V0$U`PKZKVL^ M4M[K@II.N`"^-*T%-*"QDR9LT*6@E.(?*Y\^P:.H[T+;T.4RZ)+WD8_INCCJ M>#*$/19!=TSS10H`3:GOF@ZQ`$O>DOKLD,SV-B[_Z5OWGGSN[6WON1OW9P;R*1:_-??^WUC!L@ ML05T=6"/Z/1O?ACI1F_8Z_7RTSNFVR9GJ*PML`C^R\S`0%[[I$#^^3,[ M--E6T_#G-]AU?H2Y`;YYR1Z)!\?&QD>6&Q@;UQ<85CPJ/J9[EX_H$#_]'VOT MR\N*WGVU@__[!(/W;0LF\#D$QN>#7U\O?7.]],EH?;5JFIH$ZZV1WY@N!0W> M@;X%^SE_A+Q#&8Y!0X1%#74RNA)&6,9T6U_^"F0.R.VGS[]BS%##R$EF%D^, M_8C32D.A#K'Y?FBQN<),BR#6ST/,N/EATC6F]>/K(`$4`"4#X,9.6AT`]7[7 M&"D$*@0>0N!)N^N)"-0-A<"S$"B=!*_83+-DMK/?,?+(/#2(?`A;=L,51FA"(]ZK-"-*:F5/FZE MJW(W3`;ZU2STW_F:2N5?XF.JT;]D3.OB[/6I'5SOXVA^ID=[K.O'N-=$#?8T MY_34�YV!/]S/WQ,9(D'2S#$$'VPT.7%6?('Y`0.)^N^VWZ&FB;-Y"8XAZ< MKKF?9%S\E45*GB35"M2UR;`:H;Y[B,TJ9NWQ2:1#*.'QK\8),>U.^[4J=#*Z MM:X-.U4YL'K=P2EV_F6")^>=:!-\O*]NOSTG+NN/IX^*=M,:P.SR%O!4//D=C_FV-5.8=UN$( M'W2-4Z1:I4/?I#`&VVI8:`4#%;D=6!7)CQLV#N`T6A]!X6G7T*LS98X<:5Y` M4&8PSVP,PG5G`2/I(G)G(#?"187V8+HKW05!M$QYCG7_+N[]$PM?/<4S,\C3 M\_Z7]S<_5"%RCQUKJ^BXE_,5'8^FXUZWIB1TY"7&'U$C[&"4/IFC[O[$=&&0 MGMS70[A6)H4S[43_.IM?#=&$ZX[?X#^1:Z`IL]=0:S]DT.7N\3C MP_@PYPQV]V3:#@X6>)9[^D^FXA"I6-$.>F!P&\J0[0(ON8%M96J0QU>!T-0I M%Z?5UAMRL?;5>8M:K M;*C3`7.Q,AE89KU2M]F3A^5['=Q#FO";_3WM_DP/)&S-O>ZP/Q'L.UL?;]O( M>;PCTN#D5-3<0\WCCQDX."N)'"E!SD]V\'MG[H.,9<4^ZJ0D=OT>>KZ/*R"> MB4I&QYXABHY%HVT-%4\4E3V]BB3WBZ/B\3QM<"PV0<0J/5"E\UN%1OV>[479 M[R$95U/BH?DDYHM;QKW\M[F,`Y!B:AEE7,:]6_KF,@Z[TRIV=(F6\4,4!J'I MSECEJZT53`PUPB)KJEZZ7-\GA1X=L5#ZL#NJ(F3UM)&J%3HA.&S8[56XLU6U M0@GAV:GRO8L7Q&#AMX^.Z0;DH^?8U@OY9_SOOFJSA=/A3=^YL[1AUF[<7!/5 M9\\O)^GD2W]RJK[9QCU_9F+H^I\!P]F%*L1T''X,$*_%BB]MP$K:Q_XJ8`)> M)!2=3DV/OB?*;P7P\GL!XXO5L M/,*'!5/`KY>LL2PZ(2!FR-YF40O0,AO=&D5@?+]X\*/>C\]"6&E2&"2K<\OC7DZNL6+QCCC7YP$W'$45[`;;1W%#4:3:D_] MMX9UN?0]YJAST#>J39O<3=_<+P)I<9'+1"D3`3:&/.S;,K-WLU>3-U6-=HEJM,M5HCU:+DW_!3??`^AK6^7V MO['BY\_F"TABV%*[3"7%J,;GA>?AD7`HY M\+#)7!5T#34?G\)>`FI3A*AG]T60&:A15AC7;K=`GL`(@I"7:P>&P&9"IN;@ MEZR^-VI03GS-$'^MD]QLE"IY,#CH!+0*.WS)*UCW+NA7H%.1NR4H;):I\?N/ MTYKN27GYN)3\"E42+6G69^IB6JH^-^3@)0"%$7Y>>,'*#D&J:C%E;-8`3N81 ME4>7[9RH[X0V#XU#E7;8XRHGGS7.[YW-HZ-PCF]A#98/MME%71B:]M*%BT>9 MKR^?E+7GBY!5S2=O?/,_-BS3780%GQW;Y*-Z[^/-&5*5G+\+2(1Z1KCPO>AQ MX45,:0:CU?601`#$+85]GMP&DE/=-=CP'"S\'S^-0^+EWY_1`H;!P?J':"ZP M.ZRI#T2[>:;:#;F)`OPO(`/^B:\"OL%-T'1?;@"^#!YX5M+0@R*U\1PE<$Y%&NB?RHDZLPJ&,O840X,FR*W7EFQ3T"M\UMA!JP M%"A(%A>5.([XMO3"56Z,LQ[R\V,W'N-0V0>,B00CE=&ZD_W&;H:GN=]6/BB- M/O24K@@^HN%];QWZ%01E"(KE0PB_IM&5;$]9HEL%EG1EKO`Z!FR;7\40+$`> M=Y#]X!VTIOEZL_L:/-`C;-Q1P/2-?"XR82ECKC;14!OQ^$;ZS M@B(.*(U,9(!91!/OA^>#6HIZ$?3G!\PWP?<8W*9QATQV$MX]_)QKBI@SU-[X MNK%MVW&\9X9^YL28>=%#.(^9OB3!2X#^Q MKV0.TB1DU[_,0=-V&(2TG"R(;V^`GN)AQ`29>S@'G#T#%P>L!8JF"0^LLBNG M8I-XGWK`GH'/K$WT;8&P8\\CY-EF%:LC>3K]#10"#S46 M!^]1>4YDTU?T.U%H?$;P+H=.)Z;B?VEB5*!FQD'@<%2$N, MQX5U3D5KMARXNSW0=,-C&'R(\,(:QDV(XK,0O[$[G=U>HAS%0<5LN6$AV.4Q M`"S`B%8,2T87_`77#Y<^C^O;($+(!.B[,]-5LSG,9O8<=`)?,`;@KI;$Y5%;,W6MVWT?(9\7\7]8<70TUG_@:8_V`'L!;Z/ M%X::(5/8^8[,]XF`7X/'Q&/D<*+$Q_EOXQ1S8K>'4>^2ZC M36YO].9S/"])29PGQ4](.-!D9GGUG\N6='YTEGFLV3[+H^[7Y:5CSVGR+1A< M*-[Y&_D?'.PM$9S,`Y088\\>SF9NST.:S"<_S'=Y6L<7XK#Y8JM\]K#@,(QW M('"81Z^O:^RZ*2V^:RJ^=4HGS\!]WPQZ71U$'3`HGKY\TY_F_\1'O^F/NJ/L MJ_7[I[*#`7.)]S1EVP2;.;^[WS1GK;(RZP]PZ&X/N=&.=#;T[V#5HB=:) MKEUVQ]CZCF.M$_\90X_MPT&84WYP_T;]V\)<,)]MO;$-O*"S1]S9',]]W-*= M\U^G^[^=G++$WH@96K%X@.5XIAM[5V+5+G_1(TB1%9"&T7G&O#2@ M#'E^?+T@4SU\I.2SY_^.#:`&N*),3W9`F+-;LC,);V^-DHM84/#B,=)8H5C; MG)@:P65[3O'-[U(HHU'.Y86T,=R6S[_QCF,WR#[!6C.ENT#MA+]-''!<&6`:;Z@/[S@L./STJ7Y@HA' M_1,E,Q[1PQBD`N(VSG#`N\BS7SXG(@"9$%T*`$K77+)-^!MCVNTEXFYC`7WZ M9-/G@D7:-Q(F_.'_741FC*?X]L,YGFX#+4`$%2WG@36,^UXB6G'A.)+HK/"< M>[#OF'MK0E(M_&-^0G_UO-DS+`X(GC55\S'Y/MD*Z5>+!JGG:A7YP!T!^JM1 MT4N5M?6*!AD54)V.#0IFFN4HA,([)CV\\H!J+47&3F\7C4695#3,P+M&J)SP MB4'EIQ=>%<'_-D[@XO8_0I+\ M.S(3I1G5]KD=@`'.A.BKBKAE7>+M%'CK`MMQ/-9*2C1@[G4*;7A'-LA'DSP4 M9MJ[=`[?I4ON<]Y78KK(J+N5=NTLNGAZP'0SY@`%0C"UXL=4J/YH^NC5_\0O[D5/=O+\ M0^[Y3`A3_GQ\T6^AXW&'MR^WK_J@=S&7&A>TZ)F3TS6&DB7=F_!X-;LY^8%: M)BB0A-IL)[[57\DY!>9^RV15:M[@N@81^DOL>!\`M1X,4H>&S%.S!`L>G2NY MU?PS/G5K2#I1=LYD+S<$S^A#A*3E1^^!YO'X8S@&W@B!>#3F'&UL#.&`'S(7X]&O+=DQ,E61Q MUA1"T)$C-SGWPE]77F#']AF>`<^)S1S_3!-V[-]9-`2>S*(P2I79P@KZ M;0"R&UJ-PZ6_FLM$I8J/Y.$EIFY%X<+SXX.[-:66N63P1(Q@+$\6#I#TE)_I ME_7)!?EM,#GR*PH[8$3@1S_9#/CY'1/%L_4A.2C+@C"E(:,`&'CP-BAU9I@4 M"1_VON74LA>>Q\H$L1@I&!4/PR+1"H\FG%@]A74,'N('4^_OSQ9Q`XJ7."$25YSL2@/WME M;J[T>W@07V1]LI/2K,\91:7+#=>'Q)_OR8;8Q2-H$R:(J5CT\:-8!E8/YIF<58*T=*C[N([:VU\QHRV#1;J+\;B!C?BGG/6>7X0X#^TY)?::X/TS M:PILWK7NLT7?7J"XB^R1M^3V:HR<5![,8*%PI"YE.QB,R M88\#RYBEX,D&FG7E:",RG3DDN6:4GB6`^>:G1(QGRW"R'>B7O`.VGA=K6/^% M1_(^8!+7+%F@3$:G5F>V4!I2'39[+;9+@P*.1H"A%_N!%KC(@@5;UV?NK$`7 M!2ET!>34N03V:_LXV^NSH:['[G$BF?,PB7Q)="]\*3ZBG:T'-L0&:RK>0`L* MXNTTD]QLSBM$6`@:!OSHAEFH&(8'QA%R<=PA7P=09Q+6C)1"OQIJB#6FT3KU4MBWIC&V=EF/:<2X%/Z]G[L=M<65OLER: M'XR17M%JQ8./N$.J;F]76_L;$4)`X#>("T6S+XA1=QN=-;"_(^!!/M%&YUGCZRJ9C8DTU2C9: M9GOXB<SN6'G,T^$\ MG>-R9H`^H%/#7J(,0EY*3E,S1R#0>6:G]3T`\9&S61+BHH_(WV5V1>:"1,'* M&(.'R)HI&A,5,MN!/0N8#YC7_LH*=+"((+[=Y-2SF`VR=F*L/R>=LA7<(1?6 M4BC6DDBSG3LUA%$2KNV)Q;8DV-,\_A%=(SLMHB!Q[CYQD?="0PXH/NA84UK7 MX1^B,/<6>WK;#YW(*QY0B-HZ=[R$6/4V"1]([7*,C#5RD;'Y9#=F$N5\"6P+ MW"3"N_W;',^52(,2#VRJ7'MDMB6:*ZDWB1,CCM%%+"113#CM((BP'POC<9C> MO=/?&`7,ED&O9?(UV]UFE.]K%CLD\);0)"])$;M"^$-V8($"8;*GI-JM/^8P MEL13KZDDN;!U3'-3\P3$,AK6/3D\8)(<]P0Z>Z7E8S%3]8OM\P>T M':96\0@!K@AF.[;G;VX5Z_MN+F@J-:'0+@EX%D1LFR5V6>++,&/LY]Y>0RU_ M*HL?3\/'M377!CJU,3(NS32QW724&%4YR3//-],U5F)!YOFP\[5<@FPP;%*Y M./CM.?&IH`CD445),_&T)()BZLUM5E>W2J[+)MV$LNZ!Y M^_835[/SEZDC,_V-SECZRAVOX8*)_QOP0U5DEC60JS?`W!FFBW('3]."_-YL MQV6G^>E]\&RN>3-<%T>7&N@M7)Y.#[JU4K("ZN*WSC*Q;]!B!KA(%`5?E M&6!&^1.UW]+*%3S_.!T\KP-CH3;'3&=4EK/7WJ?F:*Y*T6>4=*8_"\@;#_[) MGM[X@=S>O+_[_.;F50X:Z:?"]MYZLS1=N9K=`,9034-WG]_>O")?O!5(W(D^ M3.Q-6$[SP;&#!;)R-B5N&B;QTD$Z02XD^/:`'O#82[X#2P\TT[/C0Z_U@R18 M]SAFUG2S_-G,V90&"D%?F=#IDKO8:3#P)/8J9Q^FT5\ MHDZ?[#WQ=I>FH;.$P3QU+-]F7H^D&$$.IW=!?,H1IGFP:,8NS2#DJ6V]84"X?!<".<-@)8A(\A.H]#Q%Z M8/4KL"\\+'HIW$36%@^##1+9/MXGVG>`@R5WQY+*3"75P7U>"7^W2WYF$IHY M!WY,#P+R,O[>Q95>Q0%)FUD..XH$X4.X01JYJ\9[`>ER";0U__YX_ MA(@+CB47%<0Q14P'Y2?V62(-3XQ-$%X<9QGKA($%6B`ZUN.:*3"9Y+"\Z)UU M36176&)ZC"^G^K^+4-GQ*M:-X`GD:Q%QF;C>MH[NN+,I<<):3'OG'HHD[LD+ MHWMKEC@LDNKWK!"FMG8W6)!6Y]Z^*!4?XPWQ M=G@SK)'<]5SI35DG7H.Z70S4&`\FZ\5`3QU!%51XR^T[_O/.F]/.ILWF-8.? M$S[C]X2B#>2YR';L6C0^J)UWEF[3\FKHN'G]W\71\:.?!(J()N7FS7S[29F. MZWAJ-DW*3S2._4]=A;+@,AE9,K!6D#,S)LA'TYZ!/D?>QJ5K9)&;V1!QA/=N M/+ZCR#N8&(/FV?\N5Q>%5VYYNQ9%'>=ZQ3YO681#;M1LT&MCYD-N!<2_^,R0 M?I%L&TN&U1[1*YI@!Z9O3/I#"7BY"8%Y(N.>(3!1@1\W3^6:%,_3Z-I"Q5.6 MG>?$'5_M/"+)V[Z=IS[[Z;0]O(7V4WVD/`V4+21EG:;H:3N5,D7%\/LYFA6H MKQ*8HG5B]C0!T$K,UK;#G\;_[=OA18/OL)](!MM2$FW]1*'8,FW]#LM9\H(L MP2FTR[]WYC'98'2\C9WOMO0T*Y!3>ZNK$EH)HLF!&0Z//S:M9)85:UM[ M*5&?O[]OC(QZZ5B%/54A:XDSHRJAUME^O0I)=:H[[Y+DM20.H]9)LOK,Q;KW M@VH,PPJ))](>K`9WPK7U*J%8KY)^"026^LRB+3POCP](*MO@-._$!6JULAP. MM$"K%1ME>E&HDB7ZL06H$AOZ<*GZ?WV!.+6["&M0!N0YQ&R%D2[)F<\EZ/)2 M1[X6$AB?9?F&WAPZ\>FCC4F4/$&&-<`#:G6W3ZHP+OXO80CZ+(24I]Y62H0(]3=O_*IWW^9E]R MUM7,KDY\GJC75KY4E:BQ)>=^O`E9^;3/M1A+SKA"/;-ZD2U(K3R15.0NY'=/ MLS+0H0<;&=8!.4R#;17EF*R=\61B%&1"K+5B-F!2J?OXE]]A24S]U4RV*.#]_QN4U_E*3KEK%+R<3JK#[R@F`*@PT8>9)A`'1QKXQZ1L#(1BH3D$0$S3<,2;ZI,!#V2(-H<[0GL[4F$JO M(`B+'!N.AF+4Z`HE94T!P/+H1"(<#45%)&3=&X3G)`[U_K#`;R[3WB#&'2IN M;Z@*^R)"V,78`[7MAG4ZV3J#GA#&J'0W%.9_9D4H]6`V0)\&4CL(R<\T7'A'EW]8VX:RD"]H#AOC;=6>HF?T1Y/U M4_9CAEF.3L?CI!2I:D@LZTQZ&XY4<=0J(65J(-LY$J@6L@E@NL,LM'%4+&YV M1RE$-0B:4Y4EHRZFJ42]KH&``J)`Q%'U6"6O!OESG@)XDV7V&HKXY++603J;W76!"II=*_S@S@-JIEM16SD5LC/RT-IC.93*HP MTP*VGK=VV:9OTZW: M$VMO)R]_F,>OYM\\G<1#EE"U<0)T?(?I#-]1?GEZ$%^D&ZWP)DSS*UEY2:9F M[HI5?MDYWFQ>,-GLXLHOYM6@D+N8$PGT$#>7OTR0W67([[9&PP(?PVLQCZ35%VCH-[S[ M[I[=8OUCT@X\\@EO#2P#DOX61,IT+3,5#B(#6:5B,GRBL\ABR9E^@B%^4:%C MK@*6A&JN5HYM,6<\WNT8\4L??[*7H&`7%JK9,:*TIW6T_H3]?)C?I;U\YIU\ MF.>Z."?'"XFF'T>TG]J'#-#<:,\1JSI_8T+&VL? MY7$;_JF#3&YGSN\V[!Y1/S"=(X?*!?:]RR5Z(MFKR]0^J=MFYG9BXJ:^>=#8 M@BF>YO.O8&[IM>`P3<_-7#>1;RUP@!\>'/N123`PI]CUWBC=[]AUN'AK.!>$ M^-W?0=UBNT!F#1;3!KM;ZRWI+.N+]P0BE?5S%XO;#_.DCZR+4JJ",1V/"B5^ MI4,K1>72)'O#KP3_C#>"Q\M32M4>&$99TFP/(25!T3W96U/%332[1?L0]_^P M<2GX2?=]J\O$U67BZC+Q\R\37^?9E-W?F(%M[7,*_09F^@)H<0>;*"#PEPC= MA!_FW(WS(0IA84'0N(^\H9.4G*UR+/W^<+JN")S4>UV3.JW&3'\PV`AVE')2 M>_69@I4:C:M8J7>VP]Q8IT\K?G.K_?,F1NS97V[N05)UQJ,39KEK,'7.\R16 MR\USC/.<]$=MF>=)W)>;Y^0$5CPXS[?PPWO;AXWX-Q-+884D]I?#_DU`J63^ MR'@CR#W\UG.AH]!&Y?L7#_;)S;.?Q;/Y\AT^/\?GX[9YT^\]_X-+_P'M4[^A!^>5E1?N*3M)T;"HZDZ/AGT[$_B-7-$P9Y MF&`_FU_M9;2LB$AQ:_731A\=)DX\N)0F.(@.CH+@,#30`"TG8IB/7-`\8`#H M+$$U#+60M=GCJU_B\=\GK_V:O?4N?JFDVZ0_BB^V.JFS;+$9_0(TOE>^;5'4 MA991"-9/YQT-P.9DEIL9D+_1 MV2/RZ+T+%(W8`J;K?N]BA4>@$CL5^/QLKHHQL6.\]^Y[UN..C*UW(%*?3/Y@ MTO/-ID"],J>SJ9T%\2/9&T>#@6`)9@>M0+)C$ZB M]X_Y[V#VPXR(U[D4__<)/5GLZ=P`D3)'+56\4B*6JIKU6%OP7[PG]C6N?/_2 MUBR9'`[JJ+4[=='VQ))B*"EY0T%#I;#%68X9!/;NRJD']5D[BSMY'O4]=Z M(5_`Y@V<[7?:P*:YL6?]'+5@DYY:K_K9K_QZ=<;#85,K5K42(5Y],)),UBK& MTBHZG::AZKTXZ$A*.@G?@"]CZU5KV'JU6&YY)6X+;HFRI!9&4JVHZH7YB3Y1 MA_3)^S04*/.4`16_L$#$+S!I\L;QK-_7Z[J>OYMYD[^%K[*U&0M!PSB"> MSHQ"6P]?6H_R$=;K%XS-\AR0J"QZB:T!+'3`U@3#U;+`+3NW6DN6E(2^WI#, M<=]YXON.2TSB4PM8!IM[,`,[(%'`#S*]AX#Z3ZP'VUU%T,IM#(E7WY4(;.)C M9;2`E::XW=V0!XQY]/$``=_O5WQ%A]_3.)NS2&T",[NK-,)UE4_F"9H,?. M=-?"+TW_T78[^,YW)'LJ-R?^Q3,+@<`Q.#,^@MM[%P/2HL!T9\&KK="R<':8 M`GQ%4@+\/WX`@80@+`PR)8=^B!KK_+'6M^7ATD+G(,1*CZ/D4G#H'8>=771. MCE*!F]Y1BQ]Z]'4-#SZ,_51WO6??7/WEAO^[<_;;V*F`ZCOZ4NOYYR3.FL6+ M)OM>;L\2O*8H9`0MZCE-MWU5DVL<&UI5Q:D"UA0MSN`U*ZY#@U=QX!7H-6!/ M)RG*:EG;MZQ[-M2^I.OY.J=/'J%9/IC6[X^^%[FS#BR6Y\,*4',^I1,9]4O6 M';INMB+E>*@(/S9S:&GNVB93!<,H:9-^4XIL^1GXR#E'3:$O M:`YILI2QG;M2#6AMVH<756-X7AH%:G.V2C:C*LB^^H< M^I;L\IKEEBB[[+9NC\&I!&Y:^57[:2/[:60TV?64>+;""'JW2=%.V8!;VN*-9T6!^\"]Y!_&+R7MPX:_O#'%K>^#UNM509%$R8S24;5S88 M823\Q7,M(53,&BY%R-&P2BIF@\EJ5L:D\.G2M-VD:)1O\JI[%KH+O+3V9;!& MG/C53\F;;[,7TRL.K4> MHL[>2NO5)`-BX^'#V2J/$(\J*6'S4>\EXN>X(66DRN[G3,KV?'1,F/^N\/+< M"_QY?+RFH'(>R%QON/)Z:\-NO\BQM\O:WMZESPG5T4?=_;K#^EBG@^ZHN<'N M`%9)5>&05B"LXNT'E_QWY%*B3S$DJM?36*C_&P]XBI@S;\6JN/!K8N+)^GRR M*^0B4,;@F^>%;2U(?`DNKPO+KC+BE\N8["O62;_'.\'$`&H_H?1*[X7B#Z^2 MFLIQ+_"R26#R-DQNEE23]>.:7%A3CSV'HHZ7%EPKL`KO@H"(8_C8`*#S`2O6 M^M^1\X)_C4!BFC!XW@S(WQ!(!3\!*>W0H0'!,O/QQ/%>D61XV#7\K[,`"L#H MPP6KFTL^4W9+REU^7DQ6P\B_T+?)`P4J MXK9%OU+?L@,$S-I@GVW'(2;F:S"BQ(.\]5C24[@P7?8U4":`UCR?H.Z\@K7" MHK(FOP>!+$R\]P+:>Z0X5GPA[0Y+^+XD17OY9>)Y;M6]$2 MJR%:J+#`K!XB(*#-QA%@!@@O!1RWA.E#ION"(]K^T607*O'-FC]V.Z,KRHL^ M>GQ&6`TY>3[$E"8^F5B6YOBE@1J MDCE_PX+/2?UZ^M6BO)+S-@P86&@>*D`M@/$S3MO<`@$G,ZZ6YS-FI2R6V83! MLN6%;Z&WI%X\*TCL^1K1A]_B3TN/5W]&0>&M%>7,N#X/YU@ZQG@-O*+1VGQM ML9XR*T>?3'I)_489H$)N-*]\ESV&JSP3"T#WO?)J.*BU'C-'CD+EEY MS]3/#^I+NN)\8$QO8FE+7!P.683H``$/'>+E0C.LC3?+TV:MG/.'5&SZ],FF MSP%G/Y227!'#+0J6!/AC1M$FLZ$;FT,/-3\@/8]3=6=Q76T689Z@DS5D!T!= M'&U,K@?,ZK7C]-XM#L.64'SEA'Y7N%)%[F-,Q$3A[3## M]2?/Q'1GBPNK0ATV>3%6%W<4`GL+"VR'24O\*D7H`-M/ODR4T=]@D7RL[I`$T$L-WE-\.07B_5)YLGP$_!-&/;&7;*S)U8@E#<, M4/AW9/KP#8`+!)IKV:LX10_PQG/TS,='GSYRKP`6?M>[1LPM."`/^,!F-=WB MQVBNG;C.6R)OLW[C*N=,$L6_,ATI&4T`Z(1F&?>QPO7X1/P;X;OR9Y!G<4!V MCVKD:8^ND M@\UJK1?C-$NK[$#3Q.1SQKH'8VVSMN[=Q/)`68?<]_[N\QO@NR`">5C(1;^N MV.49MS=WGW^]>45^\;KL[4X/&KBY=^&Y1TRA"'+GV7_UO!G7MMSD(O';+]X* M]L[^L/:!'HK&S;LCB"3 MF([GV+]35)]0U7.]D-]FPNR!7-+Y'#NUL]DX;#9V-ANN1$*;3*ECC;&+Q$S? MQYHBO)V\6G<_3V4I3`0$$LL*"Y+N;28T\0F+.=OM^"J69+KL%VYVL.V9!I9O M/\"8@`K8)">#G1*6L'K*#R_<_DGO$5F?(WYS>))L1]L_.8:-9YN=$O"M;_>8 M8)I(]D07Z6XM.SR058-%N,SM`,0%OX4SM].:<]Q>LWTU5K4!SFS$\+1CHXF) MSH?8C0EP"M>U;=2,8N\$6X0@YA?6,;]E)NT\U_=_FZ!5^R\DSO_JDJQ)-`C2 M/AF1\\W.[!F;/C.83=R&J<\J(;#[%W$WWKK0)[G8!6T2?F3"3+>LBD)R&9G& MO=%SL.2Y1>:R;"A@"(:>0Y<$R:#2BQ28[^F#SQ8-5ZQ`:&8P['.A6%CP)1:` MAK$F`#^E]_.DUZ+ER\)`\Q\BIK7ERJB0W65EM)M8!XNY)(C= ?SI7OH2,+ M6!5E`W?2FP]@-7#?1]R]G^_>X]V;N>ZY@\=:Z]Z.)WES]^'M/>P2L0!A=6"Z M>/$4:C@<:TR2L:N9-BR+N-:'EKAN$G>+F:F**>A00/NH48=)UW:0-,!MY-A" MA8%S:Q1IS'"M$2SFQ,K$X*G%GDGC7'`F7"<.5K%H<9CA#.-@K)4-02,/^!ZZ M/6*S.E:ZU]JV@[5)/]#UG^&K_*3X[L`5:1#_\:0"M9S.A]^UA23* MRME^5X0=)B?$=TW^!6'1G9'5SR.!'<)"$!\P%9KV@Y? M8^80Y./N;K+3NE2'AI)E`"JCJ-VDPK:@3Y-N$SF?%[H'Q3AS;MC+N/5]DES) M[^I<,L<::*D9F&B<&KG+,':'7L;XOLUWW,SE9N2:,9B\FKV8>X^_MN.4\;3; M-@U]:(RS4]>CN\T[H)*K1P`2L8+'#&E^$)M>!H?W'*7G`ME=1XD='3?R8?XQ M:X*=9WZ*&[AW_Y:^?5KAR;7[3@R\[Z0WR`SXDSK.`A+XQL/8?_>*XNQ*T_70@[3!7>/XQ0L_\[;^0<,W$4POO26XU'VA`R-_WGY._]D] M"%Q"\VM@;3]WKOQ4#[% MS7WQ/L>-?8S;NG=S%\$7W"I]/&^P&U77[H(X8R"M(=`)A6[Q8A/CZ@ATVAWL MD^H)=+2\S9VGSID#%@6/BSYUKF*?*X\_\_:_>!B%YWQ::[Q26=T_058?.ZCL M(JOD0!IK2OYDI^>[+ME;C6/]VJJX#6@B;>&#B^]O7#T5\)=+72.?@.C4SN2: MZ3$QZZC;EN),2M3?1O\)^D@=#\REQ'J,Y:Z9NS],4*)GE* M=Q),\!2\EIP:%Y-!+-2B%2NAQGV;I2##@TZX1.&7`/(CUGOO^ M^MN1F_R7?D4CRC=Y]A!.0]]@E+-6*QU'.30='H*Q:PA&]4,PSA["::LA9`BG M87(X*<1#-HPD<)R\L1T'RQ6RTH5?+3SI@@T#BQC"^&(%DOR3^W)VEME.6DL: MNW=Y4Q_FO*&XG5J/[,5YQJ!Q_.'D42VZY#2R=[+G'W+/T_1YRI]/S$&P]I:F M#^-`5VN<\I&SA3I<;9C3=3O(IW.P`+CW]YDRKR=S\^$SQU M[YA!9M8]4,N,`IH<1]SJK^2(/26>'2-ZQI$\[EMV2RHT>!<\4`QY"FF$L./[+3[R6EZ`"0 M\ZN4DZL9M%G$XQB'IS1[FSUZ&A-Z.6TA(T8G_ MC(-^\;S%Q@B,5'!B.#':BIO:;4`6S)#6B)->NF[#(_&M%?FO,ZYVT3,#%ES` MPP!GB6F*`730`X;AXNG=QIEM?"TZLW+*1)AO(&GWZJ9H23>C^W0S^K"Y&:TA MY@`J2YG&^F`\S1G_![JH;^Q'W=DU'H":>MK8X8G?OYM[7HCP^@G^(%_95[Z' M#+$(P]5WKU\_/S]WOS[X3M?S'U^#C=E_C3^_Q@=OXN?#EQ4\#R-F<;(WK/'- MYN-''?.!.G^Y>1]_V[D/Z;*CWYS0<=+@>N<@T[W(M_#;I0.]8#@D=3N_?K[Y M@9VT@NZ)T?!I*@4`GL69QPH);G34#>(8AV<6R9:3;Y&1/C[AE+5DGT`W9,S(]QG[W(P1\(QC%U9K83(:MVOW^]1KDU<@+3Q/-> M^`B%_[=.P)B\_,O_$:W?D6B:\AT;N]Y%73MPZL2_S$ MZSE,JK.Y/JAJ%([(VPD#/EAH=7.@Q;,WBF9O2#=[0\SL^T6S[TLW^[Z@V1^+6O[B]9<0`*(0,"@DP$`^`@P$$6!82("A?`08"B+`J)``(_D(,!)$ M@'$A`<;R$6`LA@#C0@2,Y4/`6!`"QH4(&,N'@+$H!$P*"3"1CP"3LTC)`NLI#ADV3(=*XIO+(6&F6F$G<47&Y%;QPN"5UD=A=W6%8N@ M?:"85WZFD56H9\BG9AS0,HRR#%;(7]+-_H!X*3O[0NDBGW`Y(%O*SGY:-/NI M=+.?BIF]7NQ=D="],"S7!L7R:X%B0)C@N9(&Q?"PP%L0"XT(6&,O'`F-1+%#H M$!G+YQ`9G^T0.>:T)86#D-.6^Z2&E[7`0-^`IUSSHBI8TYD74&25R/B!R0-U MZ9Q5-`L"S[+9LZQ6E65BI<`08_-9H.LRKE[[C=Z=D"5&#'INB8.10KM(/K/H M@%74+\D+>J%5I,MG%>D'K*+2!"A4"77Y5$+]@$I8E@!&(0$,^0A@""+`H-`L M',AG%@X.F(5E"3`N%(%C^63@^&PA>,Q^F&H'M>^'KN=V6/)$4F5\:P_,IS;P M2Q!F]"%D1P'0Z3[9#%=\,7H_2+)"P\7-AXYX0[8S6:H>6X^K&6*_[F MO)383@OW$_FVDP.[R>!H)#4<$G!XH#NVO4*AI\LG]/0#0D^>E3IT>B?/2`^= M,I4%E5&H7NH'Z\KF!^@?<0&4),"@DP$`^`@S. M)H`L+LNR2S4NW*O&\NU5X];L58<\2\>/=)\FG=H50C3IW[)`VWQP;195.V=7 M$F57?607D;`8W[CD,K\"`=.&GZB/]>_42'!Z1B:0(4'E\,Y3N^&!YP"I0F0*$0',HG!(>" MA."P4`8,Y9,!0U$RH#`8:"A?,-#P@+99E@"C0B$XDD\(C@0)P5&A8W`DGV-P M=,`Q6)H`A>ZVD7SNMM$!?T-I`A2'\,BG"8X$:8*CPEU@)-\N,#I[%SC&/$RI MT;AYF`OT/LL\+%,^IU`J#.23"H,#4F%L\$!CUEI`A2J1@/Y M5*/!`=6H+`&&A6$80_G",(8'_'NE"5"H&@WE4XV&!U2CT@0HSI613P@.!0G! M8:%J-)1/-1H>4(U*$Z!P%QC*MPL,!>T"HT(A.))/"(X$"<%1H9-L))^3;'3` M25::`(5.LI%\3K+1`2=9:0(4RH"1?#)@)$H&%&J"(_DTP='9FN`Q]F$*!R'V MX=WL7U%\1PRF)D4.6GB9U<>N@@(R8)0D7:X<[X7BE4)?6=!FG$J,65,1OC^S MYW/JLW!-?&WETR?;BP)"@Y#9F/L-0UF\^Y-*5FW:_*J1N?GD^>RJ53-]'F-= M'79-=SXIG-_U,XO875XF7K[&G\';AJ@?FK9+(C=B4;UX!Q@EPSJ:UYMTCW:#S3_`'?/_]:QP'?/C_`5!+`P04````"`#-@FY$\QZ8=ID6 M``!_7`$`%0`<`&AW87DM,C`Q,S$R,S%?8V%L+GAM;%54"0`#`64C4P%E(U-U M>`L``00E#@``!#D!``#M75MSXSIR?D]5_H/B??9M9D\V9^I,MCR^S+K*,W9Y M/)OD:8LF(8F[%*$%2=LZOSX`+Q(ON#1(2&PZ>9F+V-WH;GRX-1K`;W]^6T6S M%\*2D,:?C\Y/SHYF)/9I$,:+ST=9_?D___5??ONWX^.O)";,2TDP M>][,KL+$CVB2,3+[0:,LY1*2VUK254+CV2/)4E[V[,+W290E)[.+*)KEY,F,D82P%Q*<'!^+ MTJ,P_LSEY`9USI./KTEX>>C99JN/YV>OKZ^GKQ^/*%LIMDA.?KD[%YU->)]DJBT1MW_OA%4F],$IX MX;F@=+,FGX^2<+6.2/7;DI$YE\BE'(M*/O]0>.(/"D&G/?6Z(]Q?R0!]6@)Z MZT'C!0?OZHH\IT.TD8GIJ],M;[HK\N2];>V[]"+_[+R/8FI9[K1SH]<0C7@3 M683/$;E($I(.4TLAJJ]NE[P[I5$8B';S(^5_KDB<)O?S2R]9WD3TM9>6`*'. M]:6K-2-+$B?A"RDJ[XXF;K57%>':EONU&/[$0.=2_;I4%QI_\2+1\?]8$H[# MH8JVA-7U\WE_(/IUKOD=_W^C(/*6DC@@05644+*G`7F)59D1]1OE1&(@IZQE M45%,/A[.O>0Y'Q3Y9&;A>>M38>DIB=*D^B6W_?CLO!RY_U#^_+>[T'L.HS`- M27(1\PJC_C^6-`KX?.7ZGUF8;JHR(^^91)^/H.1IF`I7F,E/QS+\/ET25M/O M.XW]C#$.UI;)9L+26!UAT\P:IBY8TV*/^958_L\&H+JSGY+B-,E6JUS:<'* M!7S\A2`$2EXZSTP^#;18FFV-&;/\$CD?\2"GINBE%"MJ@FZ7>2G'PP'-X:L: MEI'`:)61KC1.0X<"\VVM*=PT%;Q+:@%HC:@2R;\X07)GJB-^^=N7,.)$B^0V MOG[S2<*G9-<>BTGP2%Y(G)%6C0*I2^.-U%AKU\Y,0!T;!>+KL]ICL[R)&Z@4 MOZ3WCJNIIG MET.4O*[U1*V539L(:UV#C`+4M4I.6==_Q%/7(A#_5`;B%0L4-46U0I%18*UB MLSF`^I4*`88ML*[>>P]MRO7ZWM$G&-KE2?_6BSH)>35":(R,8#\IZ\!J-:0!7#E69#%F??CSR M3#P(0F&&%SUX87`;7WKK,/6B]E1<3U7-Q5546.L99A:@LI6"\'5,#ZR<32J; MLH:B](B4`FLEF\T!5+!4",IU]39-2`2,%)OZWTEZ/W_RWKH+[C[`Q@6.]>I/)A%?UUBD M+K:'UL:/U8A9_CB:JNU\2S[B7+_Y428RU[]2&KR&47LE8,-2F@EC&0_4K;JA MO8QL@+G@$I"%2<*7HE1HJ]B7D7UK0'K\S)):#K?VNY[8_$)^&+V!_K]&(:FFVW):5!6-$0:_15K)"`KU_B MZ_"U%P;7;VN^6E+L)6II=A$,&0W"RH58HZ]=0$]?P@[1B$ MHDZ-=N@K5,:.+^]+'(?A4WGQEYBLOWB1.*EQD5YZC&WX]$<:-[#AJ8(),!Z$ M,.ACK1X90(DH`Y=Y.LMN]%%.V""DK>0@.2E"1%C8I@>"7A`P`C7N(LRR?\RM MEO:)B`)M#XRN"4LW#Y$7I[RABD:Z%B?8>.UT9C%FTNUD1D>*S]BOK'9VT61N M@]AD<$D\FLDW&8O#-&.$*W43OHE_)3)KC72EH1JZ\9HJL*HHW,Q&<]:+%\U< M(Q;?BB4_*2^"EK>K-:,OQ7E5&2;,A%5BD(9P"J@`&VH)"YU)'Z9Y<:(5G=SK( MN@M9[N>XBVZ+5:=B#:Z7@&\>5@NFZN_H4-%T0\\XLO6[E0LQ0U&K"E9\$R1% MVH)BUQYG^H%=BD$GC4`U(_GMM&W;'?__(>XB4ES4-!9&>$_4O4.K!(KT6UD! MK6\C[W`+)6XX@KBCTS#.PGBQ<^T7,J>,U'9UOX4Q96&ZN8WY*H7=-_\H"4W=N,/5/)X@U%A3;Q0XE-#40U$,HIQ$XEN5VLO M9,*YETN/+8@T.TY)5$\MDA"-UW/KZH("K6ITZA*!VVT-B2#9-M[(QXDN:9+> MSW\0]A+ZG6J6?]Q&(9H?T5:KU@I(=;8%R"91(U?C(RGB'AGCVLO;K(YDF_0M M(T%;L0"+(-4K%R/;BQRYDG^0_"ZAXC[J2*QD@U48AUQ[;M4+*?.%6M5NQU0= M904RH85&+ZLA8($*1GAR%!(/:8''AF6;=`MA00N<'A9#8`,3"PTY';+/\2*1 M8IK?8U*-@-WCUB MQ/L)VOHH+KT`4.YN+5!3CM;H]K*9<ET;0T\D1#:\G!-^7270ER MPP>/[^YHEY<>+YY>(O_U]9:<'?LV*@4*!^OX74M\3W4`AZK![$NS:@ MWY="^/;_59;^C!DIF$L[+Z/KP@+7_(X6W+!PH1/U*[RH.T#_YT&EBUG M>`&&5C.D@,FV&&=>==%:ABB#;[;>XX*P'M=A8;\*S,JD4;IVB(8'Z.,Q743L MJM+VT[L,K3`'W0SN%+#=0XFXSJ87SN25(*YN)5>D^+N]7NS!JCVIKF(=[_V. M^9SX'%#7;_[2BQ?DD=?,&'L9?\WKAN\,.2<1<9`3.. M=[C:V^2]Z1.]\'D%,O(EXZ,"21)2C#%Y!1=?@I9C^K!6!Z^M6$<-U=K6/1WD MF'9P%UAZ?F#"JE2$B2`=`Z!GI.P953!$><[)$0A[G6L:"$'S.:8_(@0@7^5P MQ7U"@GSG3)W&#F=H`4[',%6@@9W@`&"ZLA"FP2K4SA=NY@E(3VX]Y-3<[P1_ M0/>X!Z.Z8(Q'-_LN0WK/B@GH-#^)HR]V.^Q!-$PZI<@4L8Q[W?: M-IY:F\K;D=DW/;EW-T#9<:/K'74VTJ'N@?2.$BGE^6V[@O&%#(JGD9^\MS*) M1ICR8^GQE17OCO*[7DB&E%/1`T,W;FGDF%J:+1VPI`^%%`6QG5T?6F6)!DWC6M=?W-1 M,X;K&23#MHIAG^'IL7@C*%N$%DXFLNVQ4A79U*`#-'@` M8-0E5##!=#KLH::K%XMSTJJ8BH2B-78U**8&#+.9#D:GAO`2#O^!"0VUSBX? M-._7^1F*ZS?"_##I[FM!Z26#D8)^K[+J[K-K_H4 MOP-B5[T%=!=88`&30]Y0)[E9@('++G'Z*](1<#?=_R^/,4^RJ0DBUB[$=L23 M`YN-\\8LVW.Z@.Y4/7\>FJG/9W":3ODQ1='H.'%HEOW_'_;\3JC[6A%V79 MPRK+>V`:,%?K2Z=-T`&`]40S:!''G%._G;+/KA"7RY MA1T^%'==()K$UCO<^_EVYBW;^H&05E=%:TFG!@X+PP=@15^*+#@V^F53K9EB M]>;I@[>1/_D.HU?.ZSOT4P.2K0N>7N&N04M:[[ZW0@P MOJE!K:]+!D#.HLAJ($2$O6Z#N5ZM([HAY)'DST_91"[,K,I.3L>DW/K1UXL MI^7ZMU_.$:55J.=\C\0GX8O5I+S+8IR7UUFF!J,>CMC+[+Q>&L+GA:[(G#!& M`MA-PT#J;5S=0#TU3-F9/RB:;B@(W^:I?I^I^20C:(.P]8HC9&^P8ID:KGHX M8F\[@E5I")]7:@;41-+]59CDO>P#(ZLP6[6G35!Z:9!32C\U9-FZP%FX4UI4 M-<4RKF$TWGV%-V', ML7`7O@CW-57[WGD]"49+3N4Z/85];='(22F\TNR<=KX\#ZH]9&-]JR MOA31>LW298_&C#OH:G3F2YQLE>41.$U"3G\!9F0I!4P<:S#'N$.?LCQ<;Z74 M7OD9>_RH5FA<&?4^@IZHM4IN$^$)"9@-U)&J@@&XC&TJ!+UOL2>WMN91WKP( MJF@ZU"&-#DU79#U&`BX*8WJKS(2OE`:O813E#Y5.% M;'^G.0"Q5>'X0H%RH_(@$PBP#4HM%$O*J8),9J@#^)1BG6Z$RP^+2\K?%%>A MMPXM)W\A07=?LR^[&A,&]DD"Q<8E0]%C*`OA6\B&.;9LUP:8I"*7+-V>07^, M9FN)*L2E(^DV-PSAK(XZLB"6GDAEF#1@-:9I_!_5;^5.8#VOA4\3RHW!1)[X M(E*.38YQ6(3*K4Z*0-'3R+!$#^)450]5TZC5M3O4!%]J7<=.PRQ30J1"*YJY MI07>P!-*`&*:LTA$]R\`L/U($L+$RUYQ<.'[+/,BX\!@)03>PTF%3`I3?1SC MKI>2EC6!&1:XOZU2F36IP?L1/GB4E@N?.+;[.W+O([-B=[RDR&2K%4_UCC., M9SSLFRJ0]K.[T1H498CF`)2-=YAI:&YWULB&M37PP%A1HVJ`%Z#@LBL"W^73 M9>.X(5PQ>JU2FC*L30R%BH&Y!1$D]"8C` M;+6%B%(JWIVD$M9V8Q2,J34ZF9A0XZ:7Y;8CDDDXO@N/MIH7R+=$$8BIC2(# MTS109&.Y-8H,P@T[G&,?<;CDXL_.1SOH\+X7N%N-'HE/8S^,BAMLY5-AV3U1 M?;C;WH!RHV[*PWP!;=/6I>!+7U"8<+GTX@6YC>T#L^X$ZH%I)7"*6.WOL8'P MM2H87Y!'856>0+3]*5[<\JH"]J!:5CU*%:Q3Q"/$"P.1IR@"WSUI"OV_B\W' M(//S5/72ZMW=7F)'&SIHVTC2(Q`F:8J`[.&C@?B$E8@OFJ`PYX&%E/T/\9CU MG%+'J8>CG'.*\`/X8"#=G3&_VDT/UTR] M1A3>4MB@L/JBVB,0R[.,J[39\7N=YV3W(EN/V+ZRIPAG)WX,L*L.1%#=0A?H`"T;(,0_+B84/!=S1>I(2M M\JOT^E]W(T^[%<*?2N'<#U$6\-7?S]@K;O\A075W7PN[MFQE=<'91FO1=16_ M\6Z(Y;EHCV1=/GR(-S=KSJD$R)*ZRD#%>2[>&!'7CJ$87 M`%5"]`D]"\>WR+0VY(F7WAZ-A@GI"]I2R#M'K+&]):]T,&IW M(GIC5HAX[XCMN.F`>!5EXYOJ6]AQ,>?SM7S$Z!Y6&BK&'K4M,>\6N3IW'0*] MK?+Q10NM6N)WODYY>B71"_E&XW39#D\[D=6G!^[*>K>`-CKN,'UR5PE\MQ/; MS^4']^[3U8ZZH"KMGIOC.,2_#L191K]ZN+=@>]2F]>9>U68LE5/<@)Y1KOB5*8AK>QP)/`57M$["_`SD<-`>-U'+8XH`X\ MU.@T@-+R!TQ[%(QO^@:W@F9L&$+;`JP1NA/P3A&J\-#^$;HK&-^V,-@*OL0? M!-`VORT^=_SO$YX*_^P=G;MR\44;X4:(>.DP>'8D6`.T)N&=0E3EH_V#M%8R MOLT<2GWS)XAN2T47]`;:,'3DC#BB?AG/T!V^>TP M6>=_C[!4^F?/R*R7Z_0$E3P9Y=);AZD7:71Z8"3A?XOS,.1^_IVDK>_?:>Q+ M>\9]B*X._CL5C;MRWJ!0N_5NR:XS`CO4(!@WO<+1J0?LK@8D]N&]_@""S:53VH.8.#BB!1L$:*/J`( M-4$53NS-;PE)%*'$O8$2%$9T#DO4(42@$:IMPK[L=K!$L46X+U2"M@==@Q+U MUB#(!F48L2>W#2)QA!#W`TA8^-`M'O<6.CP<'/N&OY3["':L[PV%3@)0-A!$ MO*\"[=(5N69]V2V':`QY9GL;HB$Y9LZ':.O\,ERN=ALDZD8@1HD&Y6H`NXAI M5<>^MA*FM8=@K-S#)G]?^'ZV$M)(<.^'HR>!BRMFQ$MRC"Q)G/#^J;A%05RI M]4C\R$N2*#OV=)*GQZPP%Z<7]Y>Q]?;9]\$D^SW,^?O+=V"L#^2JB2 M!/91PHAWZQ3!Z?(2BY8W%5^W]]NTOHZ8#+'':J5[;==[;=*2UOR.VL%>:^$0S2TR,#$S,3(S,5]D968N>&UL M550)``,!92-3`64C4W5X"P`!!"4.```$.0$``.U]67/D.)+F^YKM?]#F/&?E M45,SW65=.Z:S2F-*22,IJ[>?VB@2H6`W@U#Q4$K]ZQ=@$!$\'#<8`"/C)8^@ MP^$._P`X`(?C+__UNLJ.7E!1ICC_Y=VG'SZ^.T)YC),T?_KE75V^C\HX3=_] MU__]W__K+__G_?M?48Z*J$+)T>/;T5E:QADNZP(=W>.LK@B'\NCV[N;B\NK\ MZ/,//_U`N!V=XN>W(GU:5D>?_OSGGX[>'WW^^.G'HXOZ>U9VG^SY_I'X]1B8Z(U'GY\VN9_O)N M657//W_X\.W;MQ^^_?@#+IX^?/[X\=.'__?EZCY>HE7T/LW+*LIC].Z(T/]< M-C]>X3BJ&I4[Q5\?BXPQ^/'#IBXN!?W?>T;VGO[T_M/G]S]^^N&U3-ZU(M+/ M"I4P\M<1?:L3:;T_?VB^;D@)HU3`NJ-V0U]]VA!W"7]J_I=4[T@C'QVMF[G` M&;I#BR/Z]]>[RTVY)8JR:ODM>BM_B/'J`_W\X7_JJ"`VS-XNTIQ4ET;99;[` MQ:IIWJ]Y5"]^AIA?)J"^K20F8!,U/YSDF]^`VA$](%%VEE(QV7E:ELI/O6 MJSJC`\--G%I(QF%DW&91D9.!K+S"97F+BOME5"";=A.Q,\8=Y4*'@.04KYY1 M7C:XML&>F*&IG%>(L+1!W8"!J1Q$J55:T=Y5'N=$Q;PB)B%35FHEG`I74XGO M4%D5=5S5!>%)N-^A!N"GQ$Y/B%9WN7J.TH)63I%EH85I3:::W51+5%SA_(F, MSZNK-'I,L[2R,X24I:FL%T3QWZ.L1E\(#LF(W-C:0E`Q/U,ISU"1OI`.^X(N M\Q=B38;(WU#R1&T:DT^V3:Q?A_&8T=KQ##U65VF.;A:G!2+3-:GL@9H71S8# MG0YW%QHX$M5:IDOBGZ_00_2ZL=!IE,4?/YD(QN?E3CHW5J6R_8IQ\2[/,0J81"V-/I%ZMHN+M9G&?/N7I(HVCO"(.&:Z;R?`6 M9ZGE)*M9@:D>:@N&AXA8<<(%">/OQJ0MV9 MA[H#W]3];JG+;5+'/K,S;WD'?O*D'K(;W]C6*W;B#UMZPNY\8!?>K[W?:^/Q MVHQK,>KZGO=$K20J$L,1C,ML6E]\.A_<9E;+2\(DH6,X:8AJ/?[<+$ZC_U&GU9LS!22U.+<`\9<*M"0N4S/>TA&E M<>Z(/Y63Z:PB4##JC7;U[4C+'2CF7I>;9QKM1>.Z)C,2MXKI=)E&?#<2GT09 MC=FZ7R(RN3EM=!%GYY([%=;"=\1D34NGQCPY)]-+]=;9+#%R%X7\NE)&11M6[U=H]8@*E\+V^3J0=$F$*N+Z M$;W?-(1#>4'N7:D)2-(\I?WMBORW5S%ZK5">;+=5J;@6H\-4M2H./]"9_@/*JI+]TLS][S]^:B/Z_ZW]^>\;\8C6Z)+\<^/N9-$CRGYY MQR<@HPQM!XC@@R]UB*D+NI-\AM9_0VU]A[/L`A??HB(9Z&I8NFT([=+]5MH" M\+CHMQ>9KEA5[6M`V9SE',<$DP4]\RRK+ZA:XN$\H%.D;2FU M(D'"P4!;.2[4F+8`^7?_8_ME6=8H.6O.36]1D>*D$;KY=O/<^-;GKV0YEY9H MB!;C\MV90:]\D#BR;0?%>46OAA9A/WE%V''RC[H]CWW`QTG2*!EEMU&:7.:G MT7-:11D9,,\7"Q17%Z2IF[B,$UZ$1XL[QUQ;*SCC&B1&IVDS.7*=U=OB^3^" MQS,<6G2'R"10IA6Z1\5+&J-U![Y#,7Y:-V#3EPV`[J(ZC1Y@5]ULNX;#5G;3 M9^P$:CO3?WKM3+<%CA%*2MKKZ=Q&=S1O%G^-BB+J!"VU74&-N&UB&7&0,-32 M4`XB&;L6`G\*U@-MW.8R[1WV*CB>4#$%?[-?+$B`&&IMYUWV&;>@^;-_T/0V M69HX2NF^5(^*NSG54H6+`*E.)MM4+1^VY?C1LX%;H9N[*+QM^=['X99\^W%* M*W9.^=5L)Y!;Q63]XLQ2S>YP]>EG>D4#);^\JPHZO],?<%ZAU^H\:TK]\JY< MW^8(P:QKR%&_!>=-J.YKRCU\$=$.C0[33HD!P3GZ`!-]JV,]#4%X-!Q[T(`Y M!7&,,!#MK!?/T=I<2-.V!(=FTM&:$X4R,+#0C%A-.]#.$&-J=@[#>9O[[Y^# M,G@_4,J%Q4<*VMN?>;)9Q?)+-X@TB\>2/B7LM M5E*H:V&0WWJY!O$)HC/3*V$XY]N4^WU[3CC\'JHU9:HHF1)@$D3WY.PD@395 MHMUL&PII0[6UCHI*=IHH&15D$\89:N=*/]VE`0)/X"%N.+JLVN1[JLG[%N[0NJX1O$[NL07QK MVFU-G(OB+BOA7XEW>CW$+#>`2Q$44BFXK$XMJ83;WF:1>\/MB*>8O,0ICH$$ M+D['4H54-2[KDZ?L<5F;*&&1TU:49VIRVHC"7%5.%9-DZ7)9ETG>LMV[%=.[ M%Z)<>5/.^-/7%XM2)4XU^T]=EU4&SA5H1;[M7?/&^EFA1 M9U?I8ACAHU-$V@C=(IZVJ[2,BHWT[VY)8))K[K"Q%U5:]`ZX#?6B4'WSRY85#WP&+! M1]994U'[#(H%T7>^1*]\^T#?F'WZWP*SCT!PD7WZQ8+H/[<%)E-U]4:WGIM\ M97_4Z;,H!9%Z@>W%-VF!\-3GK@0U2L@:((!UH(8UL8GNW=X@KZN](RBO(XBA MC2OI-:I40=,AE:&E(9TW3,;:.L1'PSR(,?4,/1)`QUUX>+>D7=&-AY[.IP-3IY M>R!U`_L]&B5D\TRW1"![1(I0$DT]W':`]X[$-0KGH6Y-8?LI5$[P&IQ&"1F: MNB7\[4WIP$*$(J[^2N/7MC(A@+J5["^`1MM.(4$(VD=SCR'ASIL[%+G8JQL] M6$!_:3)XUA4J[O&B^A85B,:O1$5"_\F[E:=&W\GF*:$/S4\&1@BLK[@2$+95 ML=R?DBJ"&$PNZH)H5C<"7J2O]%_PC2\Y(3MH%Q#.`Q[*JAK@0L0[B-5R$WQ% MHV`O5\\%?ED'H(&(4*!LVTE(.0],J"MK``HA\S"6WMMAC/WS#+V@##?:T+2U M,$:TR['%MWJY>>#'M"$,T*11%?\^Z@P6EWKA!_(EY#CXX+.?6WDL=MQW=.)) M7:8Y*LM.@K?1)E/;SU5(6_.(2;V-<$PLXK@]IGFS[4EO1Z9)^WS,0Q'EY3K_ MQB>.\CI%!XVA5M334*=D7&S5#MT^*ZJ.]E.]:H+PL@&5UI>'+W.R1D!D1%[G M5KPIFCR<9$"ZKJD=;A9-@'C[5=[G+)CR>Z<1TYE`U6G;F8#85H`@U@Q298:Z MK/.&EF7ZE.O#6HF9*IPES.8.8YVV<@I?2<5!+&J8G_5KT7FWMT4A^*UMJ,&W MP#$BTD3'Y`,^0:2R83*M[Z>AI'/3:7BA'+2NP!H!L0; M2*CXSE!0<06:@(']'^4-(;7:.,Y.0/$$D'3KY\3@PV!E>@%J!O3^(@ED`.!@ M1*2O9`1B)[T*;/<3'J-C\G```L4)N$"(,#+`!B/3Q0)<1R\O*=TB>X[R-_!H M1D#1:@E2A./7:VI*D*5M!X=-=US2S'1I]%MS-'`:%>@>9W4S M/\%9'%7I6?9&.?T)-JEZ>`PTO2OD\##[E*Q(T`[2*JDLN5][O7Z"X_":BW MV]PD97^'TG-\'5_,SG;8\0H75?HOZ(J2.0,YJ+@,Y@\SM;9Q##QNI4&YU2;^G8H=T7'N1CLOOP=PA'9 M1RMX#]ZPM!R!<&E_QS53A+1^$PQ-655@1+U!ES9XW MKY*)SK/6F^[)`XJ7.<[P$WP>*2/;O#W&(YN?M155MC0WOY8@1H+;J.)>,06_ ML00%_6_SL[Y(.4N3#U@'L:]TEI95D3XV!ZCK]W5`D\O(6'HN+MG\@*"HLB4F M^+4$L6-TE<;4,\N?CI\*)+IU+J-C=\[Y=/-#B*K2EA`15!-$@';S;MU(&0@E M"I1MDPDIYX<4=<4ML2*L:/RJZ2$9_\3[\WW-(QG]( MQG](QC^+9/R[#;W*W*TZXI1)M:PH)K;<^\34O4(R?\O1? M](W`5_8X[L,RJOZ*ZR9#5A17YXL%HD]R4@7NHFH81&#'I&TA4R:>NJ.:\;&C MQNGV9&'-M&^;UAC$(,T1_HXXTG%S%^`.E<2O('I?$#M<1<\E<:^/GY^S-*:. M]'T5575%?KI*5VG5A`,.N^V$-8BA;%?#3''NL%E==`([<8)P,^^(7GF<9NNW M`FX6'$W/7^.L3NCFTHJ^PDI?OR53*WT,]P&?OT8KTEB4_`Y5=4%:`V?9!2Z^ M1<4P/\RNJF-+EFR".-;@`%+-!5";QL.WKIIZ+J;30`XJ.-*=H;AHWK;OS?6W18H+ M,B*EF-+>XC87A1I$C%B*\:3)D+J07=%I'2"O2X?-T&4$:.JF!8F M!$Q;J_]I/C<[-LH3T"E@,`*ZHG@\CFM)?'+8A- MN+%P8*BZC(QK M97?H!>4UND?%2QJCR[M[T,Z*U)O^+:$.V/IZFJH"0 M/#?-E$:)[=ZXO$2`+:"LN+*^WKJ!CM&PAJK=SJ!01WMJP.4=Q-3)%_#\]3E= MOWIS-@Z#T2TF!27AK;>%Y3>8]#3*XH^;Y]S)0^;O3VI.H>>LHCQ$=XH=O!"I0@EH.*#W- MN#+[8!T%N[V:PWA]AB5@.$VF`LK\9G&'GNA5V6A[479S'7)H5%5Z9EHY?<`& MUE16U_; MT0CU3<3Z+7&+R+?H28P%Q;+P/"`K.Q?$Z#6"V5PAJR*(R,!NAN";1>.KI65, M-^YO"[1*Z]4`2\KT+%&.G#YYD*Y<"Q1E@N7,R8*F\TQ@C9!Y'^H"_OUSQ:8Q\E#/)"[`CH0+\CSJMWK8DXB,"'08R6`D8S!!?JLUA"S1!/0QQOC=LB_0E MHEL_35ZS:TQUC3+.7*5`N\&1D#9DR*@KJ8P.(4L&!-\;N$S(JS1Z3#,"5T4P M2.A'@.#2SP$4:LIJ`X/+EH'#[R[L;?36C%H7N-C*W/'&FL4<31Q`-Y&)WF@X M+YDSV.2QUF<0+IZLFT,18";U,,3YW=MM+/X:%4645S=%<]QY_DI6>6F) M&J=M\[%LOPXQ9\."O9E@Q")OQ M8]F\`S%`F1HQ2['_QUYYI<3?V5,G9D"$E M#]?(FJJJ#@52KLS0?K=^P2&++>#N44S126;(TRC+4'+R9C+[Z',3340ZW`(& MG=.&LIF>="IED`UID[F)]]VD[Q+O#(&D\![0@#1<)&FH:+:O,^#((NZ,-YXY M\U-$OJ9%6;6HNU^2'\HV]>]PE%&A96.(F#9#@=\MVJZ;W#K)*4V(]=PN[F\6 MQ*\BR_CG*+O,K]%K]?`-92_H"\ZKY=`K<<(+6,P8\`H7>BX;R6`I9%`E`ZK? M+60M)6@_>_B&;?`Y8&$"RPV+/4$CW"13@'!3$\.>YX?1M&4GM0^7^G9,C/&W M9K)/"`2:93(,KNMB*/2[:ZTM_06NA_D[K'B88G#-8X\@"#3*5`A<5\4`&,[6 MM9KPZ8OU*-CE80S`AL<^`7#<*),!L*F*`=!OS+2&\,>+"A7V&`39Z,-PP&8O MD"AJ&O=@'-3&\&B\J0_OH70%NLS;!POD]S9TBP$`$A>;!V`T5#<`B)@[`T1( M6^90"A)Y3@5$C3B\(9T7ARTB2=%*OI M)#+O-GTIA],TJ8`V!VG=*P^X@I^Z5B,>'F!RB,.UI(Z6BB:5L`RBYT+QQ7=I M^4_`RU(A'=T:@$A#]KHTE%3POL3<`@,`?3B#1G!R9VH5TA$`(%)_?IF2>;&6 MJGT8\-GW\0"Q#<)G%OOZ'D*7:]63H3M+-XK1`25H=YPG= M*;S"4>X[X6I7K(LH;J[>C7;1V+I2A98M+L6T_A;0@%R7U-Z;;-O#O`0:)02Z MCTKX\MN5;(A-U.[Y\*)JFN6W"OL@IF](TC8^]@07!?Y&AIO3Z)E\J=X4H",K M*L`0O^@%DTA/7LQJ_'-C4N?'J[ON:8QFV6H`$D M.%]9/J;AU]`-*U9'RW8C5@$FG-W3IU<,IPG%!U@T)P7P&1;/:6@A%:`@5RF= M8'3W$?!J-8#+@E^-1NM^(.PZ<>P\`F$':_9Q@`:?@!V^`01>@S'D5L<*:LDP ML0G'@#@%L6O?%PP\;!>1@.;U'VPA,-S(K-+0BC&SL46#"J0PM.DHE,"K5:&` M"7VS"L,CU`T;3##$'7K!V0O=QNJ?W4!!$4JT;;-(:#TY;\*.BO4TY!M^&QPA MX1=$Y[Y"545SCJU%!`TO(F%>&D@2J)D5]%&Q+LS&MEO#*^5[NM5,R-!]_2CL MI'+"5D,18:!V4]9-Q7HB9K;'C;`-6>B1T'YBHE8_'E&@=E/22<5F/$:V1WRP MO;[2%\%7*>GDR64>%\WJ*B4K*Z]TQGR#7)S=W\`)'I\SV%J]*&4^SLZ"S8C-]>9#HK(?4N$YS$?0"$:Y1=E'G24FK M!.TL)FH5Y1$%:4DEC>2FX[$)HD??%F2LX]J4\Y6=$@^_!FE%L0YR\XW*!Q$O M>Q*5?+/!'UN-AQ^#-)I0`[G-AL6#"%.]B_(G:&4R^IUM\VY_#W\MPE-">1'2 M81!$!VOD@;?JQU^Z%MM)OQ(N-,:VP"*INR;:%-V8)*C]="6CC!QN'V:!U@TR MNPA7"CS+!+,V^$)$7=4KT#K@MU;)P3=/TQ'4/;!8\)%UUE34/H-B0?2=]LH8 M;!_H&[-/_UM@]A$(+K)/O]BX_^SR0G7WXO\+*IL0T?(X3]I;W]O7&WU?J]X* M6EY$:?%[E-7HBG.M6HEVE/,!I`T@Q\7W\7JRBL6LWE`65*#QDK+74;21;"L_ MS7^:X;(NT!U]5JP87U)4+]`VF4J!T"&BK;063E2X!^$2]0.*Y6F,E>G!$.ZP M$A;]97)&ZR^HDRJ(\1O=+A"K@ MJIIQ^;:U#,J'#AS;)M$"D$%EMC>AM8!TF5_4%7'KU6`SI!:#9$L]4TAPU'4! M@"UKVYO)D^4>+B]SNCV&RN-JH]HUJHX?RR:-(G=&TN8@R%0LY1`ZLNR;Q7"^ MTJ@NB,O75V1>I:>5*=+9^=$LM;F2JU@J='29J:^%*.4JPKB]O=7G5]*Z-_GV M_]SQBD>#`HF2QBOM M(5>&`M];PUV<#J4D4Z!P2!#0@R,#2#\?:*BI;#%.@,P94/SN#7=7\]U\X!NY M'_`)G>JRJ"S318J2LYK.>?05^4^?UR_(C]'DEFG;_JZ8AH[+21I/"[RN)&`( M=WRWKR/_93[(87^'LB;W;+E,GTOI0+5\Z)BS;1+#L5&Y,H8DOSO6 MVZ&\URLN<\2V-G)4`L.A=KFV537*A0XPTR;0`I9&)0Q0OE-Z`EL65`,RN.*G MG!XE7^8WU1(5IWCU7*`E#?^DQ#%>H6M7=F>H3)_RAA9**3M]1>R*^(05[32IK3*N=]:T6CUA2JE8WYE16EW( MB]GK%Y!W@$KSAY2G$T[Y/>903A$/[S%#:#J\QVR$A\-[S$Y`$%PWB)YF5=(/-#K_)S&,8Q"AP@0M$9K/SUWA)`[^9!G"^ M)A5:YI.+:0/'@(ZF.E"0\)TF63$].2$UO:"B2HF[MCJFEG(.XA[A.9$E25#2V<1(<^(2IU'6V7H%@6)2M&U'O:*!0\BB M'73PI%=-8#<+3]ZNZ=M(4"XK,='(I^P3?5?+74'[^%CH]L4)PG?MA.-%*]E2 M9DPR`EN7)(2E+(@`K*04/-1T&?:MVV44A*-J:%O!\M2#=<7+4AWS*BY$50P< MS-*3>,??HB)A8Q'L=HB)MJL/D,B[*P'T3ZRH$VS@+<-V?0$R"J('.)'_#8Q$2M^CRB[\!C4VJ?W7EL/'&"6'^.A0-G M=AD9%W3^O3<)&D"\2#TXF"EL[:"\.$M[C[P>[Q:'/#ISDPN].GVC!^/9,389\`HT2&\=>H80G+T+:Q;&)QF)P;-T,)/ ML%$-U'&$&^WX'4OD!..!#R[E?C\\6'1XL,CQU!WL@T5P:%PG@>5_USFB M!'"LDXR.!3;QZ<)Z!4=5(<&+.`(6T[PIVJGP&K\T5:D8C$\[-AI$&ZSAI(JI M&0]B,WEO(Q]_DAEN3#,V6)D?^NOP`?>HV+7BN4)RAA\O>:=XFBK*(+I/('HL*'IF4W M,_$7%-&GJ9I8I#-416E6OO.>.G+M1)(F["TK&D&3FWSSC!8A((YGP?[;O'I\ M-/)2I>UN\;/]=5DU$_CXEVS;PP4(HVP&U=Q,N( M3`'W48;*R[*LZ;JGO$=5MC*7?3YW>K8!`>.PW> M)0U$_SK_HTY?B-A4R.HT*HHWHEK3+H.^K56F$R2M4&;?^HY)4TV*=46!@M@( MO\)17MY&;[3_`4_3#E"I2,U>")91[QL2]9IG4@Q*10EB"YX=$YVAQZ%S`WW: MX*K[:?]`Q%5\8L1TZPWBID!7I(V^`IR,:`#`=&CV&3F\IM@9A#H"!!'"1V7: MWJ]C4_'Q"M?Y^.TC.>GF7K>(=-\`IM$PD^),+$<01WI]$2^B&"E`;4P&PJQ+ MMM\0XS;(#N'5E:&%EM_7W!PNI:$)=2KV[C>,]G0:G]@`<]GFZ3L/?A_"FV+W M:@>;N3O8JSUT/P-#S*4+=N1GARZ!/")HKQO=-YZR$_;YN^^!C/^A^^F98"Y] MCPG/.M[^''>B(L7)91X7A!4Z0^N_)YP-A?5-,#5RZCMT5#L3S:7C\I1A'3F4 ME(B-L!N]KU'%B3+0*#%*=B@HL6_=0;^9)M[#4!"'0=+O$>16U,VCU5JP5"HU M@J:DU/["4Z>Y=@11B4@,II[/*K?:`@>J&[6'QU-ZI=B!E6JI?8.I67-->ZBE M*A*#J=\ST\Y#;4S:FP70U;C#J5JQT7@J*[9O2#5LL!V-J#*9&%;]GLFN]=88 M3=4+L"OW"@7V#9G:C30I)E6D86CT>V3K0O7>A5B'5TSZ%VW=72]I^4[9!:(L M"_0"A&I#!W490B`TZT;-\73UZ6?:T5#RR[NJH`=I]`><5^BU.E^'2?_RKD1/ M]!\A]+F3M\[.RT6!_JA1'K\!=_$U2@S[B:A$&'?SG0$7FS24:YQO;N`KB1+L MM9Z-G.#E:XT2@KWF40E_=_-U<,/9!A;K#\*,7QEO>W94R?X":'2I/20(03?Y MW6-(>*_?'8J"N>4/R5IN1EOXB5J-(@(]4$,2P]%E)<+5%`E[U'Q MDL9$@9L%('1)\S*5\"=P'IR"=6LLMZP]NF82:.))6[$'>5@2"F"W$@0QDLX$ M]2,?:9:X!_W)W0)?[&SN!OKA>**X0.E3?OX:+^E;`2SM'NR"JM`RET),Z\GI MG&3\Q'HMTT6;2WD:]T(L1Q##[65>H0*5U5U4H?MOT3,(-3'1)M<=3+1GX%)J MBRE1Q1-@FGS.-+$"`>X+*JJ4>,W7N$+-`]/P^U6*U)T<&D+J/8..7NM,B2&I M)$'DRS@GLB0)2CI'[8!6\!M#!D79TT-:1?<,HA;M-B5>]<2R3;ENU"?&`W3-%\LVFCXQ\SY"FV3Z3^FE246PS=*C/K.]PI-$VT^)(+$A8^31.MO&AFDES[2(>22A-$"M.\,1Y++9R;(FTK"@V@%\VB(`E%6SQ M0@44FX43=R*HF1LVP*\QB&W8G0%/*;S)/_0D@4Y38$\UZLDE^L(Y>&("KB]> M-QI]%D<^\2F'R((H`XISDH]&6$=M6:`3M[H>>J!JPAJI.A+^J(P4^!5[(>4^ M(`56VSE2?AP@Q>^8>&*_-FL0*:5K7CTYQ=/ONV>;.YZK_9S%Y^8R(YK_@.T5W#N*K; M/9L[1'MDB*\\"<3I$6 M=6I%O(U//)MANLU;5I?K)Y^3!WQ&?A:UAFI9J%GD93V-4EKVQG8MTAV>5.JE MHY)F?4&L[WHRMTK=D1D*?BW"D[M;$"DH)\K]S60QZ*D[JK4AYNQDSJ)?RIP3?T&F]U&;^N-0]QW MGX<[N1(RMFW+)9N)\17U-($`GW403PI!P]%Q'!=UE!TG_ZC+B@JO,/)SRPBF M`J#,3/!BT@*N)@N@GC!>Q;F/ERBI,W2S$&SN@:DI#4JVC:I5@5)@3M^A\(;FE`>]:YIS&-[^HY^P MK%.\6J7-4K-LPA5S&KB(\G@7D5E7]-4Z[P%7-\0ECZC6C3C)>BM_M(QCA_I* MQ.QL7T+L[_"Z0!%U_:/LO*R(NW];8"+JZ,$>&1D[P.:2>>KBBD;"RAIVN[F8 M>7-PS64:A!_=R'W^^IP6S?.2-`;KT\#P(A+V?!A($KS!%333,S;,<)HINB_- M`RI6PM&I2P".2&N"X&TFU4K/8A"[($**^H*5=V1.)L`B"T;Z5*'0TAQ:T.@C MVIG97ZRK#11&G(.(-.J<,9&))$8H*2](`SZ@/,JKXRS#WZ(\'FZZZQ4:G_0) M"P4/&"/M]9"C6D40T4I\F-_7CQG]C?X49>70#]`O*!URQ@6#AY-Q*[@:C,;5 M3)-DZZ*NZ'4A(O.J7C52,)A_)>NZ@L#Z-'I.B0AK"=?Y3TXIT#-Z4C!0@/.H M\K25L)O5$U42/%9WTKIZN)Y*I"#"JGJB]S1E2I[5B-,3C,INLHUIE0T>MS9M MH0='S9J"B.@:]`%-G!F6AJ?R/<":77M83>K*>/,;.*8H]2F]QC>*(#,KK(>V M3>%]`1O<&I-@;5-5&)%EBE)?Y@_?\-]05(AWY#7*ZR&N6WY?0,=MDTEPUZVM M%W4V`^B16I$=^$8X+JPP.&*@"\$. M@_U!(*]5)@)@ISJ&OZ!.'022IR]V8^"(@3;^M@SV"'^<5ID*?]OJ&/[\GF\H M2OZP1`6*%M4H&LFXO![ZNN7W!7S<-ID$>]W:&/2".A?A"6X&.#.8[0^X=@&I M+9#\WJA6VE.$=TM,BNKL`<]GI\2B)2;8`1[MDLS@G(&[1V)86@=GL]H?L6N/ M"=`&[8WX/7)0%9NW,V)<7A-T<]H5L6V3:8`'[(CX/7U0%)RW'V):7`]X<]H+ ML6R126`WW@?Y[/<<0E5NSBZ(:7%-U,UH!\2R1:9!W6CWX[/?(P@EN;E['X:E M=3`WJWT/N_:8`''`GL=GO\<-2F*;P,P$7/L"J>F!M(6/W],"N;"7.4$[:K(\ M9W6"DLN+\AUN"4*D+^;5Q-N%M>H M&GS7QJTJ0V7TRAGN`88U6\TUDN75,SP[?P[=5C33G65-OL[@ND][TF9MN&OP M#G>S/SM_GMU6PFN\?A5B`AB/63M#DRRI,,%3`\Y)0,$"+* MF4!`65D3HXN8!Y%]ZB[*GZ#UY>AWEO%U^_NLUHH\?4Q6A!U>03Q7VL@#9_(= M?^G:<2<]59S]?F06+)*ZEXZ7%=V8Q)6'M#NCC+/6>S`+F*E>8A=Q1GJ.95RL M3YS8IMUL!JT#?FN5''SSE>`:Z!Y8+/C(.FLJ:I]!L2#ZSI?HE6\?Z!NS3_]; M8/81""ZR3[_8N/_L,IGX_3(JT".=$D_QBJ:N6^?$]9S@^WSUG.$WA.Y1\4+= M+2KDR5!(FK,Q;OY%4S?'^"E/_X626U2D>/T8SA4G(_A$W%O+.^?N+^?X6DB4 MP#JTJ0X'C:M7B.4C5RSDJ?]/!1ALV%S=P<6Q;$TV=$69@IA9M@_O/>#C)&E: M)]XN3#!Q_YM(A>YN[CRB4=:C MS#U]VH1*P2*E"VMA-2!K*3.`5RL4XCP9N1#L6B,!>*$X23QI$0#$!0 MHA5CT'_4B@I"^$"2QJD(V`L`$51DBC-(C#8NPP`%M`?K`A7"?5H;7`2SETL' MMYO%?91QSKJYWS>!**/OGM9%:MT;RU52L'$WU&3$+(@>?X\RPO/I5Y2C(LJ. M\^0X61&M:!KM*GU![;8";'.CLLS/URL;.E9LFD(+1YH5!3%V])[M/"5^U1,' M4')"Z$'4`6'H4%%64@L7(JY!O,K&\:>+@I[#K.,PMR3M_93C;U&1\`X,W#%D M0Y(#AO-KWN:/WPEZ"&[6ZYCAZU53L+9MCTU=C>W@+:UFSSK(I%8(:%"7"AZ$(ZJTSWN-\QG=`6LWKVHA_NR@[N.^*$D@<1%#^9 M?NM)GXP[[4^4;KBJ\5/YU'V64_FA(]M:;$:]FZ-.$$]H&S?=190631J3X[*L M5\^T%'WB]@NJECC!&7YZX[S:N<,:;?UBG1KWHD?OWC8!>6YRE)8W/J0ONZ^8[JCW`O>Z[>(>M`H2!/$\O=(*]"%Z/2%S MWR(E*\PHH^M+JA93Y6;15=!DB\6$O\XNBA[_O>@!4[>[I[T0/8G98;+Q:SCP M:7(39Y/&]!X>K8XLV`:_?"4MPUO5F!7NQCQI%-X+*%NUF'N4/BWI7N4+62H]H>;C652A MS4Z'J_7#5'+9+C+)>4S;TS#3B1=H@OS?'(KUEW>['&14A M)A]4Q$(<1A!7%IS3<"%6BXT-,XT(EVJ_.36]PUEV@0M::&=C@JCRR<<"N/+# M&&!KL3GU?5@=UN?]AOSL0&NI;^1U4#"1;G>CAIYTAV%E8,91KQQLFAP''KYWG-.IH M:\J&GIG&ADD;A'AQ"Y32ER?+<,8=$Z$F'W3TA#J,.%-9>$[#C9Z:;*SQ&\:V M`Y=O?<]T]ZNE?KV[6Q*Q>@^#@H6=YM3O1YJPKNTW7G!7I]N>PD0\18$<^K6- ME>;4K8>*L)PDQB&*@??J_FK)T[:#IUV%0Z^VL=*<>O50$=:K]S7FLUV4>.C8 MW)IWM7@_=&]GMII3#P=T89U\IM&5K6(W=55649ZD^=,$01%*E3BZU\FKY/ON MI3H6"*A#2L1F?6^FT8MC[09[>^Q&TVV1QDVHQ&+J?JDI@/L^JRS`H3^[L%S0 M?5U9)38.S#2BL=5\FV)BPJPH.G4YZMV2N@X=6=,>X?59B?2L>QK']<$7<(^? MG@KT%%6HG\2!TV,4J=G3CS+JO4"M7INXQYVT?H:T2;/H2.MQ[ZX= M\N58V"&\@5P@.>N*`<0O/N`M+ M3-0=)Q*=]<<`8GPL-.2O]NX0Q1=]P@CGC3=01]D#*E:?'7=4"PD<]6`C"0Y= MVXGMPNOS1CJQP2"`J"`WPYVBZA/.VKH2N)_.U24X#`9.;!?>8&"D$WM;9:;! M1'K[P'Z.0OR;(OU8!TZ\#BB4J*O,'&55:=V7[-JQW99\_?1 MN2>SE8<.[E(7ULD#CR.2J3Q*L[W+?FY4N:NNKEGYH;?;6BS`#J^I#NOS@<L-JW?5[[6K/_1\>ZL%V/>U%6*]/_"H)?F8QUY8]C3G&U7O;M;7 MK/[0^^VM%F#OUU:(]?Z9)CN3;E!.N4NG6:O;%Z/DM7X?77P2&X6W2Z>L!^O0 M>Q.KYC:YAHR_^ZWT0[(,C78/K^,!$K,N%D`,FH5B_5W!7PM<#I_+FK`&1]T, MK.'0T93:/KRN!LK,.IOG`#/ZEM)E6=8H.:L+,A:L96S4*54>1S1GP+J*`8/] MZ`FV+3@JD[=]>),&*'/;V?Y] MWK%'P&:.\QT,;@W.=BN`&@Z=3:GMP^MLH,RLLP4>%Z2^P3+)C@.7O_MMP<.. M@T:[A]C)1A*S+A9X5(Y-'-)TZ;GM:I]DI^*0<'L7-@NO:YL^FOKOQJ$Y<,X" M8STVHAV3U>^J3;O@.#>(2AVVO5))I::]:/`@UQTE".^.*+/ MO/^.,\(F2ZNW.S)V3-D)Q35.T25Y-1XZJ)%M`N^N/!U8YYUIC(I(U;/T)4U0 MGNRJZT+U3=EQ^_4=NJV!76;2:?L:L"X;0!3*HUS11QU%G5[X5J[(]EZW0D7[ MTSMW88F`;FDKB,[ZXTQ#5B`-[]+RGQ<%HBEI4('*:NHI5%3?%%,H7-_^=-(= MVB7P*136@'59SX$O\1(E=89N%E*5N;'I#W0K>]@U7?-E7=`=WRF[6I1EDW:P MB5IW@H[D3E+689H(F^K3SS0#+$I^>5<5=">5_H!)!WNMSK.&W2_O2O1$_^&Q M=ZW%)[4"%U5 MWN2![5?*WK@+VV7BJK75)D]NLRB_CE;HK)GAG=U]DU=A?;]-5,6DOA`#^_ND MI]`:\S`\K6ZD*;=E%_X].>PND(GJ/_0$\RK^#N9IG&M?0(NHSBJ/G6'4G#OO M#G_O)#KTVB'.5\\9?D.H$W#\!0&12U*ZMB4%=*&N.FU&4ZS>,EINKX%,%*H" M68(8?N_(PK1(Z992(R&(-"%-VY8W7]5 M01A,"R-M2/M]($[80AZ0-Y2'78OQBT"J([`$'_W.D+7]??^6WCRE)UMV=RH, M8SRB\L"CS_A+%Q$[&5F$Z]*Q[;!(ZJY)-T4W)@G+_5`QRFAQX,,LT!))9A?A MJH9GF6`6(E^(J*MZ!5H'_-8J.?CF:4*&N@<6"SZRSIJ*VF=0+(B^\R5ZY=L' M^L;LT_\6F'T$@HOLTR\V[C]_^3!0[XK\=_T%^-!3'+U6*$^V]X][JB]1E%4T M^+K\(<:K#XW6YU%!75[@L;U'1S)-GJ(K2K'SG[4@BK](DS>HJ?4'W**X+ MHBLJSU_CK":J71"3T(F^KIIY_F;!5&#B7PV/H]AIAF.V["#$&5M_9T!V*ARO M<)V/7AETR=--4S.>GD81Y_C#T[1R;SO3D8`10%,7U-;N8W<4V!;!,Y M[63V,Z"&=>#=)Q?Z.)@=Q7H$,6?"`G)/PE7)A7TGD%B-'6"4VQ74HCBFDY`/ M[N#B.QPC=+2E%@Q&P1B*,$`JCJ[P"]-@MCN;)1! M+9GA4T=U3>6(ZI\?"CD',7!]7^?7.J@P/8M6P87:N;+Q2`'GS?B-_/'7J&BR M>-RA+*(7K/!I5"Y/`""U]=0$@8\YND/@-ZQSX36=4*32^Y\.B M.Q7)69"GE-P=T*_K%2HH-2=#$/=[*ROPW1."E1L9R[7J@E;&EX(6X&?K]L#F M.D,Y7J6YP&`"BE8YD&(&1I-KIFLVD&,0ZY?1PBPJT_@X3UHM.+;7+,49;KBE M9H`1LQ;0Q8UR+4%$3H+2JB!'!2?S1<44&`C;/5'S2M2G;6.`NP_E0*.`4=FV%37+S@`]-JVABRG-NEJD^+7"^5K:XZHJTL>ZHN=V#W@<5]X).Q_`SQW#U@HN&,X`J,[;31>]+@1H M(>TW^1&G&[8ZCWJCVO`I*RT>0/FE9X!,NQ9Q-(CR:VLQYS=[SS6J2/_!*W0U M?MT-_,9V7OK?9H`&D3;:.RY]7JTE/3_'D^SJ"S%@8W:'$;1 MBQH<=AJBJ(,8^_;0Q951C6RO[^.,H@/W*JN1/CJ,\A_",%YM;ZPQS_PCGBX`'\=QO:J;2*2;./5^ M];4YYM7PW)#S=1,&,_@Z0[2(-;0%Q(A[$`%69I,MO>1[ M?'-Z>9.?H2)]B>AEF]*59R9C;N6H\9G/$+"3MJ\?-XXO7!#!6PZ5DFJ-OTVJ30UVG1[I/T8IAD] MS'9?$=6H#.=_U&E%8W"><4Y]>""D28EVD^=#2.LUY,D(3EA/?P/<;8*>)/4$ M$?HQ$`V,W1#2L)M1,(V_."(U(V,U[7KGOB+&S94HF.&\S3T*#O%K<"A8QL[B MPN@7,YL'DP"J,W`1]^I7(AH=IZC[=8;*]"EO1K3B?^HH2Q=O:?Y$4XQ<9/C; M;RAYXJ2&<[YH%]\*6O M(,`O?D_,*_R#6<69JL')Z^J"F27\?3_4Y6:\M@"__#$P*Q%MP,]?^>WTP;'V MD>D3E!.N58+ M7*P:2TR,#$S,3(S,5]L86(N>&UL550)``,!92-3`64C4W5X M"P`!!"4.```$.0$``.W]6W/DN+4NBKZ?B/T?<+QGG-D=H;(MM3WG;)^UK!;E1P79.+[ MQABX$/@?_]?+)D'/."_B+/V?OSO^_1]_AW"ZS%9Q^O@_?[(4>7M%Y7"R3K-CE&-UER:XD%@IT/'IQ(=__CCG]$'=/+'XQ_0_5.V*;(4W>)=27RCT^42)[OB M]^@T21`3+U"."YP_X]7O/WR@WI,X_>TO]/\>H@(CTNJT^,M+$?_/WSV5Y?8O M?_C#UZ]??__UA]]G^>,?3O[XQ^,__/]^N;I;/N%-]"%.BS)*E_AWB,C_I6`? M7F7+J&1?N:/^\I`GC8$?_M#Z$DK0?WUHQ#[0CSX^79PF^Q6M$__OK[:50^\<_ M4(D_I+B\BAYP0EPR]?)UB__G[XIXLTUP\]E3CM=\.TF>MV;HK_,C_76._X/^ M.O_GWO(?7)KW2+%XGY51`M-.9F_\?L^<_K'#\!YKXZ!\?Z!\? M_GA<)XK_DWSTOT\WI'7D?^6G)'ILS+%O\C]_QWU6QB7]`H-G?^BWENKWVDM2 M:K;+EWC@8=2"_YT\)$:_5*^CJZ:)C&X2XI86%SC]\.O=[U"\$LDNVH\0_>Q_ M_&'?YO'W/,W[71/ERZ9!Y$_%EZ@E_K#,2+[=9QM1+V2*'Z_^+9B] MOZ">&"HS)-#]PS2@.]OE.?5+RK@H^3N.>(""`J,2^(E5V9Z?_L?6B+-!J4RRU.!/CS;+FC3&M3 M-0?M4IGZ.PMD''#.M0@%!0)M>;]EFC]S']1<\0;1$EL3 MP?DB)71;%#N<#D&G)UM]>(>L`>%5*WAAX;M27GRURS9I61X\_HI M3L@8D\L/@4R/%R,99SX,+,+R@&]3H/[]AFJ'H:`=E&W99J_,@_=`_$^ MJKFV)D5S74_=XFV6EW'Z2`;NY8X/:KEH#]LB46>(\PW#(EWJ0PYXB6J#^Z:H M;V50)10"_A4]G)GU!(\-?*T^*626)^4&(^49J<8>L_R52PFN1(\)`PEG`O3L MP>*>9UH.][%&@W+V!#6/0L`VOZLRK=^6A^2>]S#;>^Z,V(XU6+R.#>#M2_?QR[,T;>%,2I0\2B[3%7[Y7YA?'@AD^J7R4,:]1NY;!"Z.N<85 M53%'IRV'JV>(/43D:0A0%O5;IODSE73;!]V_P\>VAD(?Z%(%=]1+S`-30.U)P0>5@98<3!`QR2-4R:*.44GJ9>+%HOV3UB7PRG&)12`T6C$92`$M&`YO0BT9\\ZIE M(Y[6?N&HNS#*GH>Q="3JPTS[!^W.$HN2&U3XIL\V^*\'(Y&56+U=Q:+ M6>)3U4P(O&KZX.%72W5!GZ)LC1(<%7B%MO5#]%V!WZ>Q3EAG^_PZBJ.'N(D+DDJ^P5O'D9[W55B>^@+Q-S!SS5L"O]R_,;M MB`,R1PH6B%47]5/4>8R^5`+S5U7ROLW,^F'$"Z[&@!D2JQZADI%2S(Z,(7\GF/YQFJY.-W2O^[_8Y\W$Z0U! M1TF>7?QS%V\W7!J!FMVS#LBL.TE!&J+-:=FA$R-J0S9-$0G@7"VN<%&@:&\2 MK3HV9P\AL'#._$)I%*!`/`SB&6"K`V(C9`4*VJBIB%A5N"T)N_:.4&L11>D* M=6T>H<8J^8O:/6(BK>EO!#9"WV$Q>.;*OOD>U^43SL^R#?DV3S@MXF=\F2ZS M#;[*BN(S+J_7]]&+N%`QT1[7(WK:<(%.QQ_PB,'"M6;0TK;8"TT9U4++KAI* MB$8PH<8(4?R(8MK-PKBA8T@0'O3;,#V\C=+U5G38G#/4#1*TOLD>V*_/+MGJ M%5T>+DE7?<2/<9K25>&/44*/P'R/J%>GRPE@/TY^$^#^Q!SWHQ,BG5%_`H_Z M$SGJ+ZJW*=XQY$]"@/Q)V/6>:,7,3$^_QH-;4]/S-'%=9[+@9F"K3W16R_44 M4*6!OJ/H^SZ<)19#%)G176/U3L^$(<,EZWNS4)M$FY^B.*5=_XG\\.>XB!]3 M]@7R_]Y%2;Q^)7G@+"J>/B79UY_QZE&\3@YFNUBQF\6"W+-MXW?&62VSW=[6EH=#H)#V M>SOAS7[HH[53W,:@PT@HG#WF.JV^BE-\6>+-Z$4C2W6SX-%1GR9JM`YG"!=# MWP!QHF]2=^A$-=$7JHN8\F&$CS'4S.,&M_NM`D9KR2)2#%H1>HBXI]N@[<)# M3]4L--2JTX0%YFR&D-#U"Q`.]N;,0@'3.XPHT$>4>008];05^YD5"^9WO(?` M^OL\2HN$+>2?KOZQ*TJZ]3DM7Z5FT MC(\+=ALQBJL!+-W^\X!3O(Y+>J)#]IC& M_\*KN6./'\!GDZ!L&-]`'?4CHH?O$$`,+>ZS6TSA$;-S,SJC_XPN.=[DV7.\ MPJN/K[^2+W&97F_IO?)Q^GBZ+.-G]A*@:%W/HXM1-(5T`192X1KE)ZZ"MT\O MN`*[771G$PAA\\8VVW/9!-Z,_6M)[-,3!ID#]/"*LL8XBEKK[6;-AUT1I]4+ M??_(FK@WUOJW*$"K`]1+)H[M$=+[)[<0<9Y3TTT#3B/^/\(5.<0C--D[63 M@*\F+)B%#\P$PIMMDKUBS%ZQ:HPA_$+_GGOO_524$H5US["5A'@/GH7AWMNW M/(`(`O4>VRN5.@X_1;]/$* M^;<=?F9]6UWC^VG,@EA4F`96#0I)+:L31'N-=O@X:P>T9:X!7-?3@KX`B)DD M':H7]!XJ,IIG0W1V:`=]]R&/EW1'4?5P1Q@T]VOUP!`W#*V&^#(/H!H.3..D M=IO#X>>D19=!FR:BIED)5>_LNV>G`50+(Y0KPM+J&X$-`'A(#)ZUH$F8<;SB M-^^BFBT8UBM&2DTYHJGD&LVTW("N*IAXE$8B?4.+5A85G7"Q#"=U]'M4-O`X'U$[AWE=KS_%:90NZ;N165&.7@G2$&U(*15UI:+$."@!U7ZD MM%.I+[H2M.1>X37.7]L$GC2YQ/70)]182Q)Z'6VD$2R+I'1:*@G M)A+?0R!4.L5!.<7QX(]68F?ZS!+9X*2K MAQ*M:LF06"8#@9!HBGZ2<8VC*J:;T,]\C$O+>!4GNS)^QG=XNZ5_3PW+?7IRC0_^V@8:6;PW M4QJ3/'M?=)^CO4`8%XI.P)-L#`$4$0;>Q5*P\=B[1N;&S2#1S5JD1(AY%`PQ\NSG*A M!QI4K[B'FH"V.K!P^3G:X/-L$\6CO1.:XM+PUA7W$K;V#OR'HY$O\S`S,"$* M'T>("J(OE6B0`8$#!"71^9VE0^"]IIJ80R^!$4X[;I!1\VY\@1BD39C*I+$Y M;UE2M2*@FJ37((\%27JHJ$\JEIVH3>ZWHRMX3CO-F@U1,MT1U@M=WQ!P3+[X/,5S9,@2N>!D# M%+1RJ9%22_- MNG60M:*^!UET$H),IA<<1C(@\!M8!4]X`@=J:/+T%LW%TU54F?MU>VG7C0`L M^:5YSV5:WWKV@&W6[PM>^$V!*0..T<4936CJS"J`A9X'8O` M==[`LE$7MU7?47T,[]S[GHR[5UH,ZO3O_*4AO96)O;5+MU&1\?LNQ[=T@B>/ MTT=N;-)1Z`4LN0((OF4NX-.OAC47=Q%G*V8"J$FO!*Q)SAC'?,"R@I3[D MT):H+NJGB#U&S?,@-DPJ^S4SZX,A!_@:?3;(K`;%"^Y^%[6@A!M`>US$IGWS M0WM?BT)9R)$@MK)H]+&")ZKM*V(=%5>"V++RL3Z>]'1_.BDOBR@Z-#/Z]0>,X"OTZ""S&1(7+LA?Y6MS#?)E M4>SHA;KTO_1:*S:$(2.:^#'%*S5E+(R)F65D#)Z`!NX]\]2\)89T-G6P:*_/ M7F:;#2%\=714S!2#H[T-*.71P1(:RB!B8%<1:XQ;&%)(NA*\Q:(C*@XG'5'X M8''%V\;O(10,_1@2O:\N2-Y7H;RVH=7?]@I'!2X^ M[*V,(F`^G+?EPP--0-`%9MF![#8'LQ+7T#`_B8%N[5 MM=65VA&J%%&MB1I51'3I.\-$&S'U]XAZP>;1:6$_YP94K>;:Y#6;;#8-_\'W MV9MX=:9[=U_^IJ9T0C6:L?HA\-B:O8Z9RIBHTV6EZ7,16`8RSSMO':(N:<4* MH\&GD,OT4_R,'49)(W6S85)'?9H:LW4XUT!IV`"`0K-OD@Z5_NL`F,S#CGG5 MR.U/JZJQM611-@Y:,0.4IQXOC9Q#X]A\Q$35#VC(!(Y^MT$3&/S#SGGM]J/Z M>*[+M'EBG/_4IK1SH.MT24 M/*.OT\6U8NC!10.61H%&#QZF,4=LU2S^J%HW,WLF3,OJAO@DCGZZIA='5I;0 M9>>,Q.;Q-WIQ\1,FO\+.]=6,+O'I,L`=ZQLN!';T)UI&:3W.MA@X;`'$:DK? M)AWE_D?HL4($((O%$6Z?VJV.M*9LUD<&[9@#T9,O#8Z\@\/98GF0ZA_0:-<# M"QP7">%H<`!9\!-AHB9I_OO/@V#^ M&#L6\UR\_K2;YFHLV4QS]5LQ`Y0GG^4=.H?&L<4L+U$_H+P'CG['65XH^`>? M\P1GG5KIFF0[L)-2C;Q![DNW<>P<%_K'L-8Q@+^1!NW2%<[1LHX;[&$1S)&M M=@`S#0KJ`U^-S!A'@T".BU6W]:::P&=OEU^O/^-R\-PX/.@:U(X9:H/>`XFJ M"3-LS=-LDEO1O@H,AU0\+O68DBQ-V0\J!BV M87I(3SN_-O8-C&?#V;7[=XUYEXDU,-`'G^[X5[/8J)HD.JB+74R(?S/7;RE@&%CJAPG]/4`5-0:07!4C80Q+[5Z MBTM%H2:'?@HO,S*N>#I-5_0_].B@YRAADSDXC[/59;K,:=0XQ]5_1^PS5VV9 M:*+JS$I]9QX61XR=RREK:&Y!)U/C^@GZ;E4_^Y[NOEC2TP&]O;BY; MX"IS[^\AQ_6M]/ENZGUB>`/6E>:.(;%]7)^?21',_NAH':%*#UVVT&]49SZ_ M;FIT"ZO):>`];S7):^MI>1;E^6N>#[S`5ICZ#LUY MS;.SY_,A9"01*)1DE?29#DD'ZFIV0B5;QU;.`:!)C'$F0> M(4P^S=:H:OM;!ZI1.H%`JOOIXMJN3LRA>E=&>0D"UA,HL)Y(P?J`'^,TI:_` MOQO(GDP-V9/@:IZ;+(F7K_?XI?Q(?/^F-Y#GZ\A'\$,=/V.;OAN&[.C#F.OG'S1Q`''!I`/1(':`MJMCA[&)1:Z.]Y%_FCQD@J,S\ M(&,<:%PL#V.0>RMGCTX_XQ49T#S^@NF]%H*0PY49Q)&!#%!PZ%GUP7B>`QT: MC_6JC$^?H?HA^E(]#B"MBWN1PSOAC\XG4T^ZD+7NYR1M>S*$GPZN-K+5?4@J/]$S#6&BJY6G,EG9M_4'J"-$5* M9``/B_I35-T&A"Y3HD,47M%=EJRJ-W,3.K-1#0+.,I(C\C)^2##ZG)5$@3(# MSSU$!<)PY@5(@Y#C9K@7G"#:&%88NWC!^3(N\$T>+W'[T"AV:9J0!2RE"1]1 M2N'4>VC2\V\MJ$8)]UA8W=LWU'K]F^B?+K_*ZD;]2P;20W.&>3,ISLIJG126E* M#0"^*WQ`5ZUZ[E2\UK&R..OGQU%;T1?94E"SU_4& M^,BL.W#,5H7RD*):OD*@)7]92?1\3#FHY:2A14]TTE]&XNHT5&&?A[)Z).PL M/OZ5JT9#40&VPU@MVK>'^ZZ#X/$8QT!O,`P,>AK1<%QH8KG[)D(GZJ-_^_T? M_WB\#_U'Z/CDCT=__"/[7Q7W29FW*Y^RG+[F>81^^//1\1__\^B'/_[`JK\? M?CCZ\>1/1W_ZCS\UPMFN+$KRB%0GP=!#O-%6TFU"$`4Z%B"9]P4 M3,?]P'A4'71WA"Z+8H?GWGUMV?^2RMT$`(%4W]7ZYVG+8'&<%$F.0^98$@[K M0]N>R@&!&TW\<[4'U?0H=K*JNOHTG%):V.E\DLAZ1TB7H9*`.7S;X7#H>I_8 M5"3BB(I8U!.%IE''N%<>C?T8$6FHSF=2I[`(F$J\KI=Q2=!%"C)UM*1L&EF? MDTY;G!91&6?I:;JZV&R3[!7CCSC%Z[B\(6`I).L>QJI[NAFHNM-/VYF?\8&I M>P5+SU929RE=3+U>7Z;+;(/OHY>+ M%]KZ)@I52ZP[4CI?;W'.OE,A(3J`M0[YG:P!!`0'_]!!PKTIJL#AZF&Q-T*/ MGHB9&51&+PA7AH**+1!`S;R@91R#'`P/XY)S&X.(5>=XC?,TI>:EKUX MD^(2K6I3+.HDM8W7(...*0`%L<8"$>+XHFE,%%.,VC)K',GQ$PEZ\3.NPN!G M7%ZO2:LY\4(AV8D+0DD`_@ML0_-<[D;%9YGVHB?0U`;?D6(X@*EK92=GQKTQ MYIA`:<@EJ6V_2#*:RE(?BZQVY@"HX]\M[FD+6`YX![B23#RY`PO@`#ZY`Z-C M]]2'=ZF=.2#K9!BK+FM,75%,';&K"TFU0:2/T&E9YO'#KHSH"]/D][Z)Z!4+ M;PEWHI/U0'`WZREZG*9EI>RE(RUQ23W0%_=`N*X#^!/S]!R:$F]D8G&Z7.XV MN^KFB>NSR_#(Q.UV!:-$7:-F55=31:VQEPE0!KH`IN/,%6+'T@#/SKT(;(7+ M!P(-"@H7",Z[8D5^U;2L9K%NX^*W&YS3#Z)'?#P*[VK1-K3+1)T))S8..]A3 M^I'33*&^V']`BZ4EIEZYRO"J?YJ_9-6"0 MF7?7D&-BK3Z_5-;GI%:1)?&*-4UQ]+"&Z)Y:$E%W:@F-`U-+Y4=!+;GZXB8G MH]QXFV`VZ]F3GYT]ZI[.S'MDQ!ZAUH`]"NNSLJ?,=TO:LLOT)L\>"78+[O5W M:LD.=X22`-01V(9FCMR-BC@R[?:&RFV>_0,ORX+>CT7^7A*I^7FCZN3,N#?& MK!$H#4DCM3TG9]CBP2Y*KA^2^)'1^GQ'ZLX[3'[;U=]Q-'Z+4U]ESR(-%7^L:/3490D:%G/*S"!ZC"X-$L_+"-"^83M#,BJK;3I8RT38,`Q1K:FL6[P-O$\%NBB'ER"$$YC0&E4P^[%$E"#3-QY5.V`PS,7PFN>O^ M*TZ>\2]$YHFS>&NHJ$P28T5OG!VZFC!A"%S;49AKC"://X7*4"$ZM'@JZS== ML@YMZ%&6[WE2@$Z06D1NX="I3C-4"U5JJ-)[/U@VSCQP8`XS"]T_Q;G9]H>1 MAC+O=#2\\;GU,6&F&?JT(W'?"LTM_Q$J'\==KT5$;M_H$K!5UF/>P-)L@ M<8S\`8!-G2J8>-`#$@A(&B<%%TS.G`::&UK/\4,IN+U`(K,/]3P9=[*-K?H( MYT(O"DX)]!:"VV]#N>!`UI^9P<\_8L=8?,`'D3U?0(&,PV(/5BBI8FV+$/KP MS0!$'#\M$3)OC"Q*>D-R_APO<7&.MSE>QBR6GZ:KTTU&VOLO]L]1W#34:V.I MMIXS;30]F<9>QD=\I80R8$0R]@B'X>`_ANQ;"YT,(G[Y#"`OSCF\,AY.?I$E(FFF` M>>BA3N>8UR<5/_:C[_#+,MFQ%_?)Q])$0`7^[8?_.#K^KQ^.V!]__/%/1TR* M_N/D3_]UA,@OM,7+DEA+7H_H\4');H57B'RI[.OL+R-SD2"DFFY*$'/&0W#W M&,'-P[0@%A]>-VN%37D_!Q``HP07@@D,P?-^&.P^AP'MWJ*O8#CRH('>@S%!5U+5CP/-[@POYO2@']4,[/K`"'>/& MUHV!THUT],G!(T`>]0P@,&OLR_$J+C]%2W8R[>E+/"H`A0)-].,(N$)Z9!+T MO7Z1=2FD^4J+ZG/4/$!?Z*.Y(2WNLDSW1QY@>B3;`[7`4B"@/L\V43R:7).( M<('=B(!"NS+J#]P]^_KP[JB-`5X]#`KB@^X3@GS\<\M@7DF+@=ZU-A_4=SD] MXY/=:4Z/MR:>DM$I^D/LF^@T9-#3<66'CA=0NA@XE/)'V\Z"REJ&C?CBUJ?7@F!`[K>RAU\ MXS@!>_&,M4U.1#G`ZV:JAG_*-]>JC%Z,'^J!9$W]6B M8&<:#H-%'.S3K75S<,KDEIT!VDJZ4$$%TH#44U@WT/QIG"E0S29A47] M-`PFJ3J9PR2-GN`32:#((Y+4QXP\JL[J;K9'"Q;MY%(M;P12SGSAVH7EB(;NXIT%X)106J MU=!>+Q36F<`EL^[//ALUE+O,U/8U#4;!AAP&_@#@>4SQ*\KM=_C?*8'H9T2[[`QZ@8[0FP46V3B8FJ,V/UG8%/ M0EDXE]/8T-R"_8F*;8ZC%%;6$JFP;R//82(J;LCI2H-QM[4+.$8).I]]MYM.[PI)(>P&&3EZ2F*2 M<&P'0I;..0J?=W2RXGI]\<]=7+YV(IV40R8&N-32,P#*.!V7_HAHX%V?G]I& MQX.ICNH1JI1IYJO4NQDO)'(;P4[(>5,@R$*!CBUQA-!O22"!XU.TQ*>;;)<. MMS.HQ+A!H"L&2O6]87^$'OG0I^U`=7'Z^)CC1SJ+45^V&R64B\O.\3\I3;LA M49'3Q4+"\;M#1JN]AI@\0ZN!4.0LRO/7.'W4H`E?E)\O!Z*PF;%GW/-,.=>9 M0"/H'7G=L;6X3.,R)N.>#H/SP*86=;!B1N!Q-QH3N#)A2."NWRG!ZJOV M4WL%0RJW*A2D(*;U7A"L5SUZ@'`X=>5E2B(L+DJZ3>)BO:X.^KO!A#QI&3W* M%V4U=?GK5"I=V)4KN3>/:UE:C@U6MS3LC:+%M1T>H541[S9`HKXLK\0J9 M?G=+U\SD9B2K:#K^`PD`OZ;U>:!X=1X72^4$H$2>2W2N/"BY.1[\$5KL3)_$ M(AMCXG8D42,:$E-E8!"R4]%?,D9R5,4L%/J9`GU&9:/A($?BTAF$O%KQ/:%0 MJR2$@&&8)2`[UFAE4?^)%)7%WUC16^4W=#5-V2?P:E?S<8TM>O4=6F=Y=3E/ M2!S5PHI602?K1=UJ;FA#KY3C>PZ0Q?R,ILS\-,[NN[.BX MM[#G('N5:;5_%2%4%O:[78MZH[[1Y1M3U"-9QT<@S/HE*GK.'J@QQC'N/@ISXKB M,_EAJV-_1F'70*>-P%HZSI32\*(=EW^LR)6RC98K>636]RMGFZZ=Q6=H,&WXPF@(R:1[YT_3VM*KJEDZ-96M#7!\HG^MI`^N&?NRB)US$A<)M7EMUKG+;$?QC$U8(- MA[>ZW5GU< M%6JJPR5@+8<^*&[H6S,IZYO!]AC\3I4AX+Q,=,!OOB@0EWG&+<=X]UD9)3H#/8E/';X*U1>L!6%P4-J_ M'+ZI^H'/+9X6CT=BZYYA!#X4DSER`8]ZX/6V<*486KD"*X2!5'W>MN!N$D%< MUE,:1&B5$A#)Y&X\K)@8N-7AGH:A,,Z1-P0#AW;Z7<7GGUR?QT0=CY/A$#SL MZ[F$`6$W%=32J!(/\?:0*;"J2!8^P!I$`HE3.LB@EPQ7DX6BG"&2&Z:)L1P4 M(X>6?0R]14ZT6,?5[?"L>LYN>PZKX!)W+H]*LGX0D&>HPN4+W^[L#'&_I1'` MDFBX/.$]C0Z^?3#5STV-KM9[4V(E=NY<$65ZJSTWY&AYG M9Z,9#U`/F5UK/#XJ^]]8KR"3WR: M.(8$:W<2E.F@*%TAIG4`DZ%3H5LQ,>H;WB%,DK9;-#HK@)]Q*=^PJ*W<1UXW5/D\RCT4XFL2&V];W9(MMN4&SW,H5!7TUXR+8M*3M/L5F)JR_= MHB3Q.#M);_$S3G=83DJ^T("$0R$@TO7-^B`9UX,.J3B*^]285P_#H(V@`SDT M$?_Z!7;?KFS4>\.ANN..Z,4HHO#6[-FF$ MM6`GZ$]9LM!)$.#BH^7G/BN+##R7`_W>G;`HKZS21CI`15S),_ MFL_J84?W-0PR-*E'(<7=4Y33.RK[[VG0A6I5N`5T(0K6("Z@^0O0**^#$+CV M&44.*+<+]OS#`[N+>1N]LDM]`@LXD-"7A2M@J"EB'8`W::0$^S;AA-GK\@GG MJD#9$Q*%NEH(.E@QLU[#3=>#4<#8*R[8GW4MRN8ID_U8/##J]SM31M[13Z^@ M7_4CR`C4L1@.!<:LOL4%SI]Q01A]NESFNRA1#MV,C.A7"UPC_NL!CMN),[ZX M!8XY761XT?R+T3>OI0+CKAG*S!*SHL^-4R_'GF%R%;8HG-BAO\Z@O[C@+XG,%H:K@Q8+0=HK@$$-_'?;9D&1S3(X845_F<^]TY,R1#< MJ\7<#E,@W@SJ*HS[F=BL#?N;UNPXL`&!:$J3_F#9&K6G$Z#V>(+#QHON'*8&4THA1Z->*MP,IB/YJ(`AU- M2+`@HZ:\LQ24'"M+J2CR-0T`_0UDQ?X`L"<:YH8_O@5%I.[H%P22@8R-.UN8 M%2O3(DGI@?7@:]1#VW[#OL";^;G?A[9R+>QLY9G>^FO80R7U\=WBU6Q@1'D^ M3K[GQP%,TA,,F=1;`I31T?"FB`HO'!M>)V)XDXCW2T0L[@^QYA/`G2'#ZT*N M#O"J$)LK&.PO"#&Y=T%Q+IJN+?^[B[4:7>4IM*1$E MVEYX*?0W626E:H$Y>>46%\UC5FWAYEF(#%9#24EHK?[5X;?0D)KNBC9,CVO/ M]9S2-S"DI75?HTG^HKH,]!?O&?1&=:,OU(=77_Z49:NO<9*0EEZF)4%G_)#@ M:L9B^&^M-&AA3W[7G8D]/_>,Z;=@LN1IWB:+2\H,?2SVG];S&B&&&1M\JF\P MLX.(UN5F^J8U+CXS;6<(A/)]J9]Y:[QS29K9.S0[_48S'>"$SK/PJ@*M5*^5 MOSW%$,M,JWU3$=>;.>_W6S`.9_Y(GX^FN4Q-'(]99X)48I\?E$'_5##*Z M>)&CIR948">^\^]_3QOP7/\>/VO30 M?>1,L+TQV))O9%=.EH'XHOO)W*#G=$6F_@F'"-Y+]8$ZU`X"CN3O!-YL(D8"%C+Y#"#`>]]%XA%IA!LS3=P-,80GC!YGS%C!Y M_$Q:\HPOTZ+,=^Q`U,OT9[QZQ,5I^2F*<_I2$OZ,2^&DM;6%-I]86'`FL[%/ M+]G&MA5ROMM97=`G[$T^7-`S:_9V4,=00'/F]L#+P)`P#!'&QOH1P[(M\[`! M,--9^_=`!)8'N="/4U0I'Z&H1'NZ5,<\?2.&-'G.P8PP4BO;Q?,YH_D^2D[9 MPH4PB4ID1^F2*PL6"CC68><7U([TR"W2[[*8R1":UE*H$@N%I[).YS)2T3>B)92`WR&:OB<#IT>!@):/H&@V<\1K?B;&!3XA+4RW?C`=1A)J#.[ M?)JNZ/1RG#Z>+LDC%M_.XV*99,4NQ_?XI?Q(FO2;SG*HH2G9NJBV*1]+0IK. MIUHI-6N.\4J1B?E^,?J,B[):,:(;)VHC:&\EE"#B`%'50I$%5#06C#2M*E>. MC%HW,Y/\KK(:-L0GB<3KKGP6H;T=](5:0LQ4,"DZ#':9K,?.0*\#2_LFFZ#, M+-DG?;^;HO1\^YZ7-&L&<)0:ODILD.D#'#G8(]0M*EGNGM(SZAB2@GFK>31< MTMPVHI`73X!YVSXB\.`G4,B=&4XG*+:2=.81`MU.H@*#?%;`?%N)0%4Q$1#H M]I)S7"SS>$O;=KW^:Y23YB;X-BKQQZB0+!GJJ8UXJ%(#HZ/& MJ45'AFY??JZE4$[$T`.5"X6@FF#A\E2_(T5TE5O@LU;':P#D;2<7K]>#O0E" MXJI51J25J8`15NS$X[J1TJD>6Q5F%F&<26B``"X3]7I(Q$*Q-I^!*F\3`<_# M;)3:(03JE+O#?LKIO8?LP=M&IG)&"!::8>SXJQQ0`H\%,4I_2&Z^MT_]EGR2!< M(3\BAE`>C","#W[H(G>FQQR9C1Z)J"#ZCHI^C[(4=1]]IF,B=OYY*,Q2`8-+ M,HV^$_%-H,JGGM1/("SLMDU*/YX@EW=]05#"=4W[8QK'BS[%1LIC;O5(%1*1 MN%TL9)"H,V34Z>J(.3.V'`!9AD06+[4*!,=KK"-!N,75@6E/JZI\+YK+J3SE M'EFH1)AD$78Q?^54TAG")=.!CF"ME&LY`+)\CC;X/-L0+@MI,A89$:0K`D:- MO5$_I!C9UZ/#0*U'!/H,?:F>!C.FX?0?%_W\WUN$^[TT'_%#:P%@_>?X\0GG MS9KG95IB@L62KGW>DFX7YPE-O1$KE'I@5%%X\L,?/:=ZI-*QM:B$]ML!XEJL MVA>04T'T'<'CTRY=Y7A5/A7?A\)!70AQB6G0NR*V*DSP*:SE-P!>LY.EHV5Y M3UPJGB@88/E@+U[DI.(X*H3'"Y3]+?7*K)^T7$KK$6 MGU`BZYYAY6OU1>S-!5W'?'B]360IEU?Q-#PXB/ES"4;KV_?Z';`N-7+_0,+YI7*[I/`UL%LL*:ZIT* MHY[7>)U":4_Y)H5FB\**(+3!^VM#+M/KDM2H]%ZA'#_AM&#"RVR#+]9K3-\/ MP3?TC&[.;0D>;,OBC;UM'V'(MC7>HY-CPXR#EI._Q7>40M^CA,Y_YI0\UZI;'M1#DGHT7*YV^PJ[>NSRR/TR+9!$1UZQV5E+,#0Z,P6 M5<2$`*E&(+5UHXRO;NT/,NRV-P%^(K@XW>.6P/8R+3/GT.MD7R/\6MKW&(*M M6C15&'9IG&THMO>YN+*(PZT[1$/=,!93*^TT(WZA=V/B`XO/;I32C-'.*-:/ MTU:N=&.UP_<((%Y?95]MUC?TU#BKXG(UP#5RF2-?*^8:/G77SY6F%DSF(%$'0N"471HV@\I!5[T M:,A5-CNG*!3."7NBL75//!(ZTJ220+_#IJ+[8A?Z0N40$PQFDE?6[WP>R;M'2*6QFH!-(OOS M$:H]5N=Z3>H-S&-\::R&=LADD\43[,H)BWJR[.W2; M_]!MONC031!CIH6!P-A4T8SK'K3>AV@)2"03.Q!6`^$39<[S".7WY^&N6_T:JC$I\?@;+>SHSZY41Z[@:`SY)K'H$ M$F1=+'5BBZ+C#HQ8[OS'@B(M))^3,6?Y=1'D:IX_%#GJ:K\SC9 MD0PAJ/,,M>J?2UO+D4B:?L`#M)E?&=-,+"T:8;0ED"NH>#`UERE.,J=.[+-2 MTT"7I$8^IP,I6/`W]`F$T.,.1(EX-8]QA)@&JS=JG7>&6D$R\0O;D%*-:'E! M*2=()W!+`D++'B;[5;Y,2#B8H&]95Q\MU)(O+'I)IP"UND+.(.ZLG<*N3P!Y M"^=&L]<*94[(#FBN&0Y"FE'8'$,A15KY!B1-:4'4A=Z*I+`/.:^JY\J$1-R= M20<2AC6V(AGTC9Q.DDU)6CZ"818KM70&QSI#83]C"I^,Z3HP'BU4[*B&`71/ M[(I>[IMWAK$S;XV5]Z.JZ#<9WD)"A9S,T.EP)-JGJBLL)<@6V557E8`+* M#'U9<*=O@CO)5$NR[#&`+(,TI)E,$S3K! MQ%Z7JW^9L=#+XG>S-RT05'FWKL#"AM8Z=': MV/M\3-\\X-4*K_9O-WV*TRA=QE'2>.'I#>P$J/],;>9R3]-LE>,:ZW"7?N2CO; MY3D>77JO+=_26RGOS&F%!U@BZSF3LU?'QN)TNS*SQI!1VN[H)]C*K/PQE;J+J6QV!9+PBX.%3ALHIOUR=VX*:, M55ZL@7/<33P="+TY!(DFC)TA-.N4L4[&N(]>/E:#F5L<)31;T.,;+UYPOHP+ M?+WN?"NK&M?&ODF5:V9_BCK7I$635[H6C7.N=8U]+HA&,\1&>:U3G3&;5?$' MU\JK0`(0.`-,BU=;T%F4KR:NC`M8\^\1=GC]G*7/N*"O!'V-\E7!KI7N/J=% M^>>L_#LN]^6Z39AU\6,2;NW\3!%V;5HV>?AU:*1S&+;VO6"B:)=VKEY8=L\; M66;TN-W]V>%IXZG:E5+/4O14HIR=S%NM=3R2O\N#B.5.-#.-Z:Z(MHCM-BZ- M8[S]]WI[L;Z:FOF4Y?5'5.YXJ@0@=>X[*PBJ.Y1,[8*1*,D@<391UN.R9) M19)?8+[\],]=7+[2EFHOJ$6J? M!7*)JKP3,X/??,!3GGB/3F)[\Z&^*.,-WR4&TX8J3J M2AT#9_`+4N;.I6PS-;?XB5T6U3T,/XQU!QOP9.Z=.J"L@94>DXV]3XQAN(4Q M"\>0`*;+9[4*K5@[./X%1U1TPQ++N\2T:,5M(E#/NB[WLL1%L9_IIC/<_/+T MF@Q_R!_IX_X>G6$>@[#5)#8W6ZY1PL6[=NK[L8H:*7YDFQ)EP0.@/=)@XFQ_ M49E@-RDV&U*K5;+NM.NV.F*X-^,ZSF]:P)]8?JAQ"$PJ/.B%23*!#'- MU04W\L&T>_[X^/&U_?/G&.<$%T^O5_B9P$M:IV@HC4L5J1)EQ?HIVTL;?XO+IUS1[*'#^ M3*/(9;K=E07=TT8&04G,AD2WO6##XM0-()OA"VA%R\G;U0N^5?YO2KH58O>0-_4;0G+ERE.X[7Z/H$)IT3:6N^O>1$42\,8J'F+8T(GOL"3P M9QIIN&86^WHRC-W&1D!0Q`)91ZGI/=16,9;O+2@2MHLGW-?`##0D%!QI>&#@ MP(=O`O+=F?*/9Z4WVA.L%@;Q=ID)-A2LE'2>FI0#914GN;Z"HJ3KL&J"N;0) MILI"&FNTC0ITN#%LW]3S6%7@:O_Y-@<=8_![GBZ:=C;(]V1/*('680'U2G!^ MMQ?;@!LTKL#.[@9M36@;-88-\[U9H^^/-\M/-VAT[`IF_4?;.)CU@`[M]L,/ MX%T=7%C"[^RXXAW7[:']\P?:_9NTRE5>B>@P#')%H:(:Q[B7("7VHQ5S1.JB M/5_!7-FGU>$\7BLZ1D!3CA:7=4+K\Y.HVXWC+2/:@?2\>WC)$Z(]D`.-L?U%9S"1=`83FV8P$95H36/. M,XLY]+Q=M!]+/%1CB=`*""<<.XP. M>:/XH]X0GK*0G4O_E"4KG!?_7I^F)]O1]XU^:G"%RK\@W@CM#'#N\4OYD?C\ M36,L/I*5#,8[LAY&XZUUGQEQFB<)1:>Q;2^S-4(W6D02:"_J=>K0-KM)>I9'&'D7"-@R5N)R161[?J(` MK$^S`]HOTV5.3.%S7/W7XQ8:J3\/^VD$_@+:7,-M8:@[;62-G6K;C;@-BY^B M."W^@+Z[RHAD\3V*TV6R6Y%199RBBRA/B:%0RD[O7/*T/4<)5W][=;BN?6W< MD7S/MQ#XF1E_<;YG'CZLU^;#B>+,C&G0KB[LN4BE9RM[:N1$P7KOLA[]?W?3#SN8]Y/^!WAS%NTK0;6?H)KYUL$2&&C69`*PW=EE)=3 MLUA[#@749Y?'#_@Q3FE1]8W-0)`[;#J[WTGHHU4G`0ZD>HV;FL0GXK>LOA+3 MG`,TBM$)&H,UNGJUKS+Y+08XP?2P8\!)"..CSI3=B?8,\HGV#/*)QQGDDVEF MD$^<9I!/QC/()P'/(`][5C&#S.D"]0SRB=X,\DE8,\C%.:G:G@FIGW%1%W9W M3QB75]0W8?K'U[W`69:R=?U[TKJ/KS_C%2G^'L]Q$3^F3%9Z<*LW1T.:>G`$ MQ7+PIGD)$KY:J15C_#COE#L%ZG@X0LU@ACE!C9-**?4'O!/T]M$.(3;4FC@$`*$Q^\2A:*):$\PG'6[H;"- M!;M+73LA],65R:`1]T;`R@%P$:7CRXYV'1/U)?9G49Z_TJGETTVV2\M0&3?H M=RVVC?M&EVB5IA[)NEY"Y!?IU[R,_\7&2A)*=.B4 M@8HZ#%S!'1&EX60BB@_]61+Z:G!.$Y/\P$317K8YLRF@8Y=,$*+':6X/:C/X MBGOVD;:W$-DI""GWQ+U[)N]9L4[EM97)=W@)@2AT^-$SYBR%*YQ,%$MUV M6$83/?.=>;$S-JA%.L)JNC-A?]0FYHT7@;,R2NP6@3ON+'G;&%C< MTU8$2\AN%^N1;]`1VD0C>IJD:CUX1],$2[E=5VY0.E;-5!TA(OGVD&:\@&L. MM4`7;7^)_I'E9TE4%)^C#>:?#6RGK0[G?&U_C.3YFZAND[BV9*S0HI+!3!,Q M541U0SDGV!)F>D17];TV\7F&-".!N`TA1H:/K_OV\O?`FFJJ(\)8TU\T&/J: M*!((W%I&`:XUU6K3PVLO!@2R`=<837K$EW6S-NF'1C0)S_<=(MEY\T_K$N<@ M&TRXEJR6I@:6)EV>ZOF>;XF*UPRX9:JQ=;I4]2,[@;A\PCF.J$"PL4(;?-:K M5T(4N*Q@]8S:KV)QVG8@L>8S?BGOO^+D&?^2I>630:UA8,PJXHR-31ITAN[G MBSN"EL"%'JX#&GW^=$CA1@@^ZX@C@X!+T!G:M8\[_!8>2.AA\9(0UGT+;<>( M_19:9F3Z+;3$W,Q;:/0_#RF4C$#EMH5VT,7.6VB)/<W;7G] M[G7>E/ M2&U!.AWGU5$/41+*N4>RSLOT?^P!53C2/28(KQX#[.S79[C=/DZQEOQ9@$GVN8!AKA9-WED^=-R!M$DJ@F M`8#2K-4(IV7<`X)4BXLL4K]=X24],37'!>9O& M6*_^S0ST'"FE[0F28J9.990SLU5=H(>R'"7L!CUZ&_N2Z*$U441/5+-`.5YF MCVG\K^I:/;IX1GA39$F\8J_6%27Y#[O@F=X*L\PVVQP_X;2@&X+BE/P;H^^H M]>^)H6*7E/2@+\JQRCP1Z;5L7M:;`S1SQ$X_*FB;Z$8)0[_S18TL6WV-DX25 MVF=L'F*84V4B32S@BKC2GF,4E.%B^U(RB]06S9.C>N!2/YR9/;+>R_1_[0$G M.-(]^`NMS8[TR\TVBG,:&Z_&]:-<:(#VH1`0WOMFM1'_8X7X%#_2#"`;P4L= MZ4"?H[C8?\;25AB@%W0C!_;B'YT/_+X\#_H\B]X0`KMR(/=CAY#C?7Q$\1XK M5V\"*X)1MPM8W*]Q$]L&NXQ-[L(.*"?=1'KYUI`BN&#,!2ES7O;5M(J,A8>; M<(;_OB&#D^6K(-\:ZP]2L8$^$*NT/8)/P-NV0(>.9C87HY?.=\5/?BE_J_]_BE1!])^/UM MYA6&^8BAJ(RF8\:/PKMT7+=/%?%(U*EPHS'C\5?UZUZD6E,Z)D.O M>K#5]BEFZWT'U9N*T92H-T,8,9W'Q3+)Z(7/M$I@18(@/4@D!QF#*PF$6XYM MT[SRC/.'3&]L(_:F@VR1=IN$PD"WK&,Y@%?T`)\"'"4>*X2V_:('?.`@\>,` MG.Y@8"^"O@17W\,@2I$CW2`50AU>S:'A5>I_GRPRM9HAABOCE#W:.&`YXUUX".<2M;L6=GDLL2$>+Y9Z7=V3M]F25+O M(Q>PER,QX&E/`HB1'9L^N#3B.T)9\Z:>HF/EJ9*UNYJTI*+I#L'K`T>(N%`BM>T83_,*8Q)$+D(Z[ M8;010I44N@EH1A`*6*IU*4=DA3#*Y2R/-8],]V+P]=1[,(9Z_A:G^YY\5"BZ M3BV7HCFV`INNU,>%WJ*QN,NTUXK[)C37B'E^YR,K+>-N\FP=C][+&3]I"-=] MXDJIO2U0THS,2FDQD*ZOH-]$^6,\\\U0O%[(E#_?`,![H1Y$A[JS@9"^FD+2 MUSDNXL?J1"7."?URH?H;BX0<4#UQ^C%4X!!'9G8TA^Z6PZ_5X+^H*K]DAI0D]I/3B99GL5N1+"':# M0IBJ?UDW4XY4='$._JX$0&-DK'8VO]A+?6!B*-[O*H^HG>[+ M+/V0XF*U&W7<6STD6HB$^27/2>WD_6_/?=1JDJ>]:4^W\[/??"*:Q-ST4@LVY!_Z2 MG4!$-X]](EU'C_V,TQUIW_46YU5]?X/SCU$1+^^>HGQ(<$OMIC8VU78-0V;^ M(,>K=JZEH<;"XH+]&^$HI^\+%&>JLL2:*\V'\Z=S"QQ%@& MTO&#B&%FJ!O(U M%V?7G^^NKR[/3^\OSM'=/?G/+Q>?[^_0]2=T?7-Q>WI_2030ET9IYEDG52^/ MB";M$AZA1@ICX@AL!IPW/^)UEN-*[CYZP<4O<9J1`=`KNRT%%R5;#^]:H<B0@[-M`XYX)[UL[7@)Z]YWJPMAK/E&5EE$B']I.WW:W0@&W- MXK)W*.8#,]Z`&V:1T$U@BS&@KXNQ]6$((]>6Z&Q@<4 MAHZ_Q:&@XI!HCO1=!"*`&=AI&PPW83M]NP,*0B?[('3%@A`[%WSO%NW]-O&I MLH8J6K.(WR5W1)!E?DP\\DW-";?[(DH>:;-G\+ M=#-0YST&NOEGPMMYABOJB;_]5D.2/_75EX2=_NK:AM^[H?1E,!;;.\1%=QBH/8]:N#(/&TFJBKI5-K727)]-K8ME^8@KV6 MI^''`:/[X4`K@AJ9-X@H:;7M"JDY7\AK\]3^2!SIVH94LA?D!9(@[.':AE_G MD+E1LW5"'E0>!+6O(.WC$&&5/\`C#51H31F)[?KZ<[DBY1LLZ[JYSE=B0 M*2,Q*)H,#'OA"-^'%D%XJAUVH/9Y(!O.E?W*(XBD#P3L&&APJ<&U.C\OJB'1 M([UOFU:7;!PM(H=,=L@0OBP437C6O7!%XDB+,$+]+FLZ0N@+J_&97"CB\?1-MJ+U]:?8C-;UZ&E0;]X" MYUUI(YN+^I.WN#.-"SK3O6DB'%CL3NN:,MZ?-F[''"P`GC.P\`Y.@6/]F?XC M.KV%&L8P"^^5!M:+@M`\"&)*HZV0A5/6(B'A\`QPHGIHUN_0S&AFFJLH&)8% M,]4G[$OID$QGRG@H+Q^.!7!D!&?Z1'20OXZH>%H/[BA_F7$/9Q]JN#.&EK1\<J>M^3$TCE*^MO%&%FZ^L6$)L_]O?GF>^CAX0_9RN1DZR) MU'(>UD.89=]K(5TGINL@>UWA&@@3"8(TLMY5+'V,.D*][,%45$L>';OS4^3B MA:9@_!&G>'SLK$)J2(^A%!0Y^G9]CDZYGK3XP=%LV%$2=N#J,?KNH1((8N%` MW+$\9HA[0<"+O@*7%3R;_E!C]GJ2WDN20D>6J#GFP>8M@$4UUK1""]1[*5SC MP.^0"'U8(N6DEWXOF@#S\0T%&.FK"+:8F7^+/VD6'=ZFRSB)6=E\]D3Z'U^F MYWB-\QROZ/0V.[SGKU&RJ[:NDL'Q5WHUKRA#.QL<)G,'@U"4M&Z"E^K9M35: M-'=SLJ@4$!FK/3<2*&I$`HD([DCE!0\0K`C"C+5M;D1R;.G\L:L?4GD+U(+O MJMKH#F98/C"Q,NRGS+!HBJ=98,"F6=0SMLX6Y_&:\`93KCW@\BO&:><%^7;4 M13[8LLTJNX)N92G*J-P1EKRB-5X1=TE7AWC'*$I7"!/+RS)^QM5'P;TU`,<6 M=3'FB%.M\LW"AT;%9]WRH`@/OX@*UJSIV$Z&QAET\XUQO)*=7EXS:)NI]1FM#A M!&,RE6^+$9CU1D]"2QIC)44KYF<^ M+FZB>'C;L>#ID+?-4RA:5O:\L*YG6HM4'8W%650\H2WY)UI55\J2'J1O5-`] M'NLL#^Z`JW'/\?@R_KD%=*@$N6COVI@?S'WNW9#^R?^.H[S36KT,)M.4)R^^ MII^\Q?,U0U0Z.6XUM^V^8/0;^2?LS+ M*$[+&!>JA3VI\#"0"(2A8@77O)=P(/.DQ7BQ@47[B,V`WV1%S*9(PYOOEG<] MCZ_*#A)0DJO'99W$P_S$P@4)"CA^ENU7Y\F,YY.Z,G"S2GNKGN:61@XT9Y@& M>IUME"3XYNW#0'C![4+^Q!+_%Q=.+^W%!9-,0WOS8[Z?!@5+0J?EIVJU_JY9 MOM_K1Z7FQC@WV_*:U]:VGRK8KC43U,5.#;.HE!W\+>XD.T4""22@^%;7S^ZP MTJJH[=QHU-@N[9\_4-YD2;Q\59XM(1`;AJ^1&%0D&ACV$E3X/K3B`T\UQ`,D M1-W(8ZGD)Q<0;J#!Y0[7ZOPTZ%.:O85ZFJ[H2ZB)\?*42EN>\\7:?K*ZR-\$ M>5OAVB(S2RVRW-N_[N@();@H>)LVZ[?J`N&M(<#425>GU[72JLB01N*4MV'. MF)#CJ,#GN/KO97JZ7-*M?])AM+;*GOT:*NZ45SK1YOF/%<]3_$BZ;:78_ZWK M5L%Q/3.+1H(>J5G]]3U]8R6JQ3MC]2.4XOE)K0^6S+XS1_15:@\XJ^EM(HQ" M;EC6=@@!S^K]VQJ?C3##9R./;L.92_(*3?$^8"_8G'GOKJ"--]&K40H9R"OS M1ROOC9BU!^`*44,%7F;")\>JS>Q0PAHBJNWZAV#6@&=O@-L:I=O M,.`,JWSKMO$JCA[B)*:+_49YA*.GE4QZ>EX9V_'DYU0L(]_V!![:6O2X6_-Y ME&"2O5;(3.;!2)O.@AXVH73'A#ZO1WZGQ/%$Z8?C%0S"NHGHZOUAV"HO08`X MK`S5G(Q\BQ-6WQLD*;6J,$_)5,$I+G;F=S)"Z=>,Y@IS^_GL:EXBW^$5*J(D MRBE8Z4DB]>I4<`S7P)&4Y'K]JZ*YV(J1O>-9+;V@-"M1L7OX!Z[>@XHV M65[&_V*[N>9FM:JS,\-^&7)0H-*GEM3NC(QI^K&:7/^,RXN79;*C@?FG^N5= MX0N7YJHMKTQ4G:FF[PR6?<9^Y80T--?E:+W2$LX+FQ;0R=R[=$A%K2VH/,D-)Z:OD"T%:34(#:D&H#!D*!NQ#0E9&!$U+F[5UM#0$,_-_DJ M?7A9'-;U:D)%R?6^@\09%@FU[V,UZBHY!967LVKZF@9^@&NZVOX`D'?,J]D" MO1O8)R2%B[8^,#GO0FV)Z019_7KP.`/PGNZC??^I.[6Z]H!+*8YI!6%&&HOF MPU!.D.+W3J;UDXZ0W14P^O MSMDIS)])`#X^^25+RR=:K`OB'HS10;AT-0I$/;=F^"FQX1JFPW``1^.XD*WI MF!DEU2%X6;J/$NQ:G>)KM$718X[KM0_*7;J+9K?9L6T=Z/KLDA=;T->X?*)W M4C]A8I_48,8@81M8B^HS:_ITAX8!?SM'9191A]K@E;V3XB_YY_4BUXUBHJ MDQ!I&T(=Q+V18_QH4),`W<6Q-^9C\*9]"\=`7.,*CDHC#%**[][@_[Q\?HQO MW1AJSPY52K@[4@_]@CW#10'J8H^15^J MY_//U1K4-`\SI?FCR=K"C M44J8@F?V5)]&R2U^QND.W^'\.5[BR]L[<2!52WHJ2U?TJ%32QHV:W;&\HJ2_ MNOQX?PAJ^VH$\^T$>( M/CM"]"GZ0I_/SQAQ#V;ZO_B(#R/I`?P%UH)!^WFVB>)4@?>^D`#QC1`PYBNS M/E'?\V""^XZB`/F51'_2F!/WCWUZ._TI>QH"NQ?DX0%]CO'C9QM6UY^0+K0V+\[I>[J7FVV>/5>3+#_E63&J;Y2"7R;PZ<`R;W2G(4 M*J2'\Q:BH&>&<-:X%K(O-P)M*-<^5HVY7E_AHL!8_0J2MGP/S5)Y$(!+/'C8 M&:GK4\T&E8V:("&P0J?31T31[!<>=R2J8SHI_4R!,K"M>=K>G`%VW(;@;(TJ MR3!?+_*'0<%B-#P(YURBOL)EB?/K]5F.5W$I*.#%(FTTYXDX4VML%+9.$=J7 MTT>@MJB>,,94#]'=[@%]BNA55?20M4"J=$EO9OJ__I`48^D^#T36YD/^_ES& M^EC6(>Z%`@WJ.0*NF!^9-$5\F951(JU11"ZDH.ZIM_`.OI9T7:;[8P\` M/I+MP5M@R0L:X*H)H7ES*-!Z8?_@J#E'^G!A(,K^%CB8-;_O6_0IBO._1LFN M4X;<8DK=.'T4ASX=K7$\E&O!T4+FQSARJMY1-?.KR2&EI3ZOJ#AB\L%02PLA M?+[I=I^0@S(#`F*J?4X'3Q^A7,_\;\SD@^&E M'!%\0BI[34A$KJ:`@1(O$P#01YZ0.G-%7S\S,.!=O&&HJ8,^"-8""?/-%6N" M14REH'#Z!&YQ4V@:=`)1Y<5L&-U?`&U&EYWX_9=@R"/J6.FH6F-M5*@C'V2' MLF:JH+":,%IJFI61#S))'7FBEHY/EW0UV'=P>?KQ\NKR_O+B#IU^/D=W]]=G M_^OGZZOSB]N[?T<7__WKY?W?P]F58(H<@[1FQ%:I!9,L%PR3ES@MR.!J_Y8M M?VE,)==R52CG3$Z!90^S7W)/<@[*=!+%&%!M]U,_#>U$>#D#"88^,]BJ MRMBOG(.&YA;U4_30/$;+^OGH4/>ZEOI4]G4>U#D5KQ2IJ\AH3+X M"V=J'[Z):_$ZFJ:5Q450[Z49`$!!2?VWUM3**@(&]DX;IX67*1F'&?%.H"'A MW4C#`^\&/GSSCN_.E'<\*XO]AX'R3@0`!>\D/:3FW4!9Q3NNKZ!X=[K)=FEY MO;_54H-Y0AT)]S@Z'M@W\N*;?R*'I@SDVUE4'W[=60E].O(>J!=:]TWW8:.3&G6UU_0?W8VR.\WQ[,' M3'#VZ1F=?E<0C=L]:H*U:BIB#>P'12AZ'W!F"?R)EO,BK\FG)3:FZQ?XK6&*/5_GEX!%4"1\%7G0Y5TU=D1<5FN?>@ MR'U/;_;68')/3D+;6LX#1YEEWX3L.C%EWUY7G!693(`)L=^]"G*->D+-)*:B MHDW';E`$BS*/EV7\C-$R>\9I-/^+45;` M4_!<#PYJ\HOMJ"*"J@4SGA\9I<5-]$HC%FXT." MA]+#(X+YUH+`N@3C$FR#8MI#83(RK@OD-U%R<+I0`&\]6(O@#%0F]`T"U@1C MPR8P.!Z>>GY8W2K,V'K]&DHN;DL%2:`:R7`B5D<&$+"M55_Y>.A`%\!]O07K M[!>>'ZG3(:#>\!S.GE637&O MTE&9 MSA#12/YF&`FE'/@E*GRWQ%F^C5_8ZS/7Z)H_39;R-DLOT[SC*[[]FDJAI M:H(35/5-`#)+UZG7X91A(W2I:61V07#RYW`8:HPG`8%M^E=,;UUK(O:;M68F MF'O)+Z8-\('Q478Z0GMU>E!78X!N1FA-H#A%U`@B5MXW/S3RWY0$.:CL^8DP MU35]=FW8YL_*QM21A7J=/X-V6@$:7EJ[-(?^YX'%B!ZH7(+$L(\=@P0UYQ0E M]NV9"^WS)=)N"[Q`W3&54C/OG2=0V12,*(>53^-GV>2UL0WK?,IL3!YAB-<` M\NF^%;!!IK%+\^E_'5JZB7?G46[/B/6R:V5D\A4IZG;^@6ZW&;`+4ZUAFHC_ MXV`B!P]93@M,PWYV76&B]MS6F/8MF@WT,R[$=IO@!_&NB['4SC>^@"W)PA$F ME`S[\;5NM_#F`2UA3L;D"0,&B;%Y7_N@A9YT*2\PL/@E3ME)MU&:TG/-MRU] M6U+3(6?>XWC_A?)H]1P1YA5!ONA+/-;?,BFP% M@?3/Y+=2@GTLQ,%[5P@0\GNS7L=5(S>ZZ!\H=HK$L-#.Z4,!X/F_N!CS>WD1 M[(<6O<'#RPAD[,(.&YP1Q,7+,MFQ%TR;P+&O70\?.AK%OBEV0BG6E4.,S_BE MO/^*DV?\2Y:63Z/C2B%LV4R.C6U-.5TP]#[O5)F@-6#S!US[=.+L3^%PVQY\ MMO,!,@PXS`H,S5I/#O#;-S=+YIE;$[7$*T7L9]JH-5290Y6];T03P"A4ILV; MX(OBC+2$U&,X7;Z>1YOH$1=WV>[QJ>2?/J`IWR9JI;QSF%%X@)TYT',F#Q8Z M-MIC_M>HS#$]:W15":*"27;.9+E[(NB+4G1*;);YKBC1Z;)DLW=Q^H]=6AWK MF.,DQNNY8X,N>#++_AU27*':I[&6G]F86M^7Q;WED_NL_BT&SQS9UK,&R2R> M81F+QO+MW6UA7*+([Y-,XZ?L@[@GU@4L1W\^<%:+"7QP\IXUX.P_`IQ% MQ=--GCW'*[SZ^/IK@5>7Z:C\17I[`WLZ&1MPIYFA2V#Z MV7E7T-+&Z((JH762?2T090Q:-PHH:C7^,CN';1&60?7YB/.&M@:QP*HEH<6( MR_09%Z5#C-`P((\14@-^8H3$Y00Q0NW=(D:HC(YB1-PH!!\C=!"FCA&:?:X5 M(R2V-&*$LB4'$".L8X-U3)@P%ABO[V5EE,C6]XQ=PP2`MI9'RSWY=T2:KCKP M^'\H]'>C/03=[6@.LBAGY@YL!<[<+1R(CRL4LQ36J*"'5_3=KQ68OT>M(CI] MAV@6K(]-`>DH&Y2TFK84">OJ0&_-!?XG*"DE;MW2(8J(R.2MJL M40B^I-5!F#H::/:Y5E"0V-((#LJ6A!8C..-TZRDQZZFP":?`IBIIQ:YAYKVX M)>UWNZ8,V':*`]XD6)#!0`8IJ[DOB#DON[DNGP6NP)WO`E?B%@[2Z@*W50R] MP/6"9K,"%Q3.AU'@6A>VU@7MA(7L5,E+[!JF>N4FKV[*XA6P09)>:4=9DNLPVFFS''66G\ M;)]XNL_<^;BW!CS_,3*LX-1`GK$F9I^A[Q+RZ?>SI@;-ZHDX_?0"^+XY=F-X^CD',_GYCTL\9U;5P'1CU]\@9Z^L2U MIT_@>_H'(T:KWJ_DFC?JYQ\X_?P!I;L-3!O//6G MK]&$(QT-UW"C]@$:3K3=2<.%II5%)4A?]"R8*-U?]94*H^6N*$EFS`M$"@'$ M@()7,\<%`X!DUCTXX+5:N<=;75^S\_(6TR/#HH<$W^%'%E@$=!0+#EC($P0B MW]BT#\X)O>A03:#<85C>2J"B%@F#3Y(>YM!(WA=\]HQU>*0169Z/*UFZPD7\ MF-+8QW]K3RS1L(,GX4J+L4U3/NC,,0B]2/D@T%JIJ1ZV540">0=/DD79]I],N#%6+A'")$M/[B!6]41V[>`#)V+ MU,#)FX"):,[2"B=SKJ*0*B>]CU[HB<\#$'*>U%^V]\01XAU;X(>=C6W+4#V4 M7M`/4!F]H%?RT;Q@Y?5%IOP1^]CL"'4Q.=*%[5"P6,6Q:]";QW5WDH_8>?.' MU)V"6*/7GS/'EFK1^`I'!2X^[R\@Z.[RBCU MMJ-*\0A5JLU)-ZA1/D)$'=V_>Q*(,]G$+#B`K"A8([34-LN(8&M_AOX@)PGM M7`.$B?[Z71T1-G5$2*CJ_M:4ZES&_69<]CB;3,'RX$V!LPBQ(]`],$BH[+^2KG<2,`HL;0**V=__,@V,_#D7D` M$/2L50SHV+((`Z.6S`+MJ2MFCGMX5)O7S'&*J`4V9S/SZMN<='`KG$'Y<`"E M,WW#[AF[I<:A`>/4N#-@`DB/:,T-?[7H<2"$8ZL8@&O9VU# M06/++A3T6S(+M&=(C4/W\*BV2XWTL/Z#2HWP='!.C7!\""@UWI(67KQL<5K@ MN]T#FU:@'T5)<2Q/B1J*_%0H582-$Q)7'F>0U%X-HH+*V.*>OCN&BOI9_3I( M4"S708J8W9I]*"6UQ(:$S$K/H7!8''78W=Q.]>W8@FF!V[4P51FP]SEGB3MJ M!4@U,+!*B]S_"(KO1F"R2>O\WK5,ZWMC5GE]V)9Y$#Y]I3OV[P'<5K4N,W%0 MQ:X76KB6NZ"\"+/@_8P5BZ9\6659RV2]5;+$^C3%Z]Z17;W:Z"_H9PA7'P9% M24'_:A6C@V[0K3_I*]M:)6=K/Q3BB+A^QKWUWD[9K+9LE:=)NF?CN]RGK2C[ M#0#(MUV#`5RG;(D9\US)Z4FK+'DVOG'=I@63PW?J`[SA46\5'I4M0NDP>H^V8`],S['$8>`>'L]W^AJ_98>UN@*:! M\\X&*!Z$,9%#&[PZ+0I<:E2E,F%NBAL+@W)_:-[?S@:!)WU.T\X6LE'61C(%#/3'=^!X"H98P%MA5EG;UY%09U]]:DY9?@`3;W13//TLA M)#:J86*>+)TK18N\.&55.$`^0=:OJ+#$;1@4WG&S1GE/4GDKT M.(,XS<2ATWRA>D8_%(().UAK0M!F'E!O^F_NBHP>"WB6;39Q2=G+!F)T$U>U MAZO:PC4DC8%*0Q\M%5PF-4%`9M]#`Z9I:/0+GK&54W<9MCI]P6L3/>+_; MZC,NK]?WT8L@-^BH#'*#7`6(HC(G\"-T?:YI#Q(BM=SR_'^`JT@LTX2#I?X2B,*R6S/7)?IL48BUJN_?/&% M8]BXSE+>,2-WI,Y?>.)E$11&OXR7;0WVZ^L>N8&/W3^1G/;T^N[Q..]?UF0V- M[8UK#*)MC'LI]':1$MV==*5^Q?R>!+6LPKNCO1 M"*(N3CP&4_MF3154G5MH&UP='2]J?;2L#:!RKX.B5BG<:`O`"\VH"X-"_>AK M[T\W"KM^HR"CL6%JL0C%CA[@B]E)@K!EF[0C\(]5!$[Q([VS^-YEVVU$_M6](IUX3'8KO*K6I\FAA^<+!8 MJPPW.LP^[UA-A.X7G'AEETBF6SB-92#"WM`J^/!1X$`9>+AZ=>2(V+,`*"[L MMR%)93\SAV5#\1%/^/;F!?I5'#W$25S&N#B/BV62%;M<>-6NMD*7`@H%"#Y( M78"30\>;DBEJ(S5MKK+T\<,]SC>HHQ+.A;CZD!BR2[O3.%23ZHYXI^$IA&PC M.&!:*##.,V`'18],>LHP!B<]\Y5JDC01-[`<(SO)5OH3"[,+[T!:@:5Y(7V9 MEJ0KXX<$JS;%R"6[(!=)0J"=;QL<]E(W2OQ+M&LB!+2K0=&O0RZH.X!#"K[2 MB!TRVT%.#I-AD*P&T]?2F,3M:7FQ[TV#EEU3(SHJN]W2G#"SM^; M>`7#93O7OG^3?Z]QA*@.HDJHU7HO$);-<7O%\.SST9S<^&N:XRB)_X57/T5Q M2C-E;SK]-(\+\L7.=SGY_QOR>;8RW$/@[D!1?;HX\%2HVC=IBIK6N74VY:^C M4_:JX?*)>&5OJ*^C.$?/4;+#=,TO3DM,>JI$.3TXN_@:;8OV[<*ZFBZC%US0 M?__;C_]Y0T@$/HADD9]#@-= MO5+>WI=.U>_Z3=Y`J/89I7T&Z+!BL\TY`GKOM\&V;IJPS'UC(>7$8!0]YAB' M<(B@%\Q[B:43A5%O$=3WMBSK%GG?D.74LDF9>VQ13'6KJ&]DMH3>H;)Y]F'K M.5[C/,4YQ2]++\W*_*MD[=O61K>V,; M-`!6ROM7LL],>RLG5T>VKRS839V2Q"J6$G`$-#F.[?IDAV&"$V@NSOH9BE;= M!T`257*2=X6<'J($([(9##'V.T'O\4OYD7C^37N[\TA#N=^YH^%MPW/KP]^)H&B+#S-WK^`##8+L)W M=]WO9=$7*HV8>`B;+;U!4C8'`H[)V> M%`3EQG;!"R>A"R6Q!)H+4A]_8&/]Y5.4/Q(J;?-X$^5Q\HH(M(NX8-M<2#E5 MD.?XPP.[8FS9&9R2?Q1!+$=(.G_(+GE/<0@U5AB12&3S4.;YZC="\4H^A`Y1&%+ M9XM>-R0-X=NHQ-SWDP1/ZU]T]-0Q2`SL@>]@^WQ6D^HW2 MWQ"3050HD)>/1)V6:?W2?;8,!+O0Y]J`1P#8\$E@V[#[R;#HC72X8&!CUN-S M#EAN2$M2P8N5W&=-V.H_K M;/K'+4K+6^M6P!/@>,"`:NHK2Y]Q7M+7T%&:D?+IB?*B.LFV.L[T'=-!5([- MP(=YB[JVQ3=YML1X5=##TBX)=JJ)OWE3C79 M+C.RN(N2>LMM\R`8YJI0P&>J1C\)B2G0%1!1ZFD2X,$-J;7=N6-NF%&^:V39 MP9K?HX[XVX6B.DF`83'`)'"/2;HJ3Y,D^TIGP?42@4!)G@Q&2GYX.7`#/^%I MXM:"HCQ#B^I#%&^V>?9-1)!,E.$$#4[)?VG1="!O@9)N1XG`Z?OQ"%P M"8-,50*I<7OZ?K!JEDU`P!I(5KG%6T*(IZC`U^NS;+/)TKMRO/]17V&<380* M<&05N/`[M)`[U62JS,AB_Y"=>K!DSU%!!8*AI`H.?#IJ=)B0B0)=`0NEGB9! MH(]4H7#G#KYABMB+4B16PNCN;2-1G13`H!A(,NBFK/JT3#H2TER<,=&6#SK$ MVGX*/)&_Z>:F%"VPJ/ND%D,X[LX6.>H"3Z<[M0H]D2&-BD_>ANEA['O`HO(- MC$*;:L-\JA[C,."'HS88WGE`?0HZ[7E]E4:< ML1<=5@ZU%LTF3Y20ST/8C"_K.PYQ!#\VGQL=81[^1[;\``(\>G/L6V"A&X7) ML(`^0V>'C@=%L#0#1`A![SX[7?YS%^?XXZZ(4UP4]05;]'C3^LE*$`U-5`=A M4D\5B"XZSCP&5@/W.BS3-K=H!%!$/RYBMG.D/3:S>C>B5JA.RL3D'^5K9[$Z M$*H:`8W#85,`\+FM8X5'>GWO$^,=/&^8.(:$>C?3D`ZH'Z&]5GMW)#L3NU%] M7^!69"[?Z`XAU[%IMLYKD;)U#(X8;_6B)P8Y8]PQ['NE8NQ*>XIXJ-KR,`QN M"7M2--TK^-4E<[P=#>',[LBJ1Z#X65#@.+'%R'CQH"/P-F"CLS9@@9L00F@; M[F_R;(OS\O4FH6O7Z>J"?+JE(JK!@E)1-%20*$(73D)74PP35,Z-*B>YL<7I M?F1`RZ-M+=V.!IAH&*0T`)"L2M+J6D6))+0A+9`4GB?%L+_27^D6#KZ"LK_1 M.4),JQK:7KP_,.L6_![0/&NFJH[<.RT_17'^5WKF=?O'_C0A_LNPYII-KC+1 M="6ZOB_0MP:-W4J);FB-G6=.11"3">5-70O`9,X].:"SOI$>GTU]SWCR1KVB MQ/;#W$3Y=!#6DLI%2>TZ'GI+SX0TZ;D"Y:^)1?M"#MJ%% M*UOM23Q"VZBY@^"[.$6K+$FBO*#']51G>)*&CWS]@0M]C M(+QE+9.2M"?!960M`4H_9M,?U[KF]8FUUQJR"/W;[__XQ^,]E8[0GX_^^,<_ MTO]5+"I0M"N?LIQ>`G&$TBS%*-N514EJX/FG5R3]+>33J(-DY*F*`R%3.K8" MH04C:G':=IF4(2)A+EG&PJ"\&9KW1R&!)WTV<0V,T].(/BQ-59\&E9N$,!!R M2-99,CH-]<3,XGL(BF37^S"HP3*.M(1F/6D//.O8]TVTL2M3I@TM"*G624QA MHOZ$<+5L[FW#DC[+C/XJ4=0'XL/L"ZR-R/8][OW.RO3;"._QM%\=MHM M00RUG:ECY`^65#:NY70SM[@X:^\+[59FRR>\_*U@BVA9`.^%66(J`^GH(:6- M#/7);M&&(,+`95'LZ"D%U^N_1?3L[O&[,EK"')+SA`$Y/3;OB\)"3[J,%1A8 M]%YC0T5]MMC76B8<8DJZ7>>(:3?6$[%,Y,$[PHRV6FC,SD!84G/DH0J3=G`)X, M2Y!JD;`61:WL6X7@R500/)FW^N"_6_%K@=>[Y"I>C[=2:FOL*Q"UACL)53Z` M!P*:[A0TU+*RJ/Z-$O+![&S3[OS,NG=&A%,I#RBGYRL\SGW&Y>E#4>;1DC/T MUE91L:ZGXHMV'2>3\&[LSXIX0S.+&^YKJG\)E(4\-.C04-!;FCSL:&L1<>0M M/";^E&<%9[510UC%OEK8%^^8>5/&E5D9)8I1C]J=%>'V!@14.T*/5"10PO6[ M7H=JHP[2)!G3TZ)7QX-WE`%>!:SCR@UBQWN,U2]L]]_7/D(_O4VHB0?38%B; M>>F1W[J;+(F7K_?XI?R8<.Z2,%131?:1FB_V#1P91WN-.2X3QU:DY)GJ9X!0 MCE$P18D.,R4]J$G1@04MLG*]3@A2_\E"X!0*H>H$4BFA+_5_J39BZK/OJ9\& MQ::9!@C&068?,LPQ&,4;C-Z]CMJG&SOLG=D.U>7CAA2'FCJZW:TY/+<;ENL. MQ_VF@MH!^$*(%?7E(Y<4'6BK"`^OS5PB9?1 M0,`5Y.+9/?%\GFVB.-6M`,8:JD*@J^&+7GL?DTSBC]Q946U@144X*HZ^5`JA M5ND<=.@PD-]]FCS<*VO1<>@K/%)^?*5M/'V)M2?VQQHJ4G8U?)%R[V,24H[< M69%R8$6/E%0\5$IRL*%#27[G:5)RKZQ%R:&O\"AY%:?XLL0;;4:.%%2$["CX MXF/K8A(Z#KU9L;%O1$Y&](5*(R8>*AG'L-#A(K?C-*G8ZFHQ<>!I-B+^]R[* MR<@Z>:U?_(V2RW2=Y9N(;DH3K9.8*=6_GZZ2(RGUW'C8?V[D6,91`T.+5A:U MPJ@CC;[;I=%N%9=X-?/)1H:0R5PZM$]8/?TN:4T\3H96L*42,Y%<'B]-- ME5;RUE9S,D.T-U2=7HJ675,H9K8(9?X2R#G;0%#.?`!J%($<[`ZBE',+9V<= M9`(%:(I?RE6)N&>$GAE,#^/IV$',$.I90I6I;VQ3`RE="X$HB4^`EAW`^(H?A$CZ%H_?H4Q50.#7X#XI=K1Z&87(GP%L0_2 MMO&\&7H`4XZ1"V8=P,%Y"%%+=[7!U;QSQ`IA90,"LP#12K%^XF`5(E*%L$IC MV?1[.M?L\SS\)DW#38!Y'V8TJ*6:X/D*/",T!6%GGB$B_1TG&L7CVXP7E)!HCD@_OLXB7:Q"D3 MO\7E+D^+VRQ)/F7YUR@?'OT^E;M]O>/9G7NH]=I`'S72%`U61&C_3:CO]ROH M!7^[C@-41B_HH7:!OE`U5.O-'YRGH58V#WQ'\=RKYT&DG^!;'D`D@2SG)FGL MW&&D*@$[;FCQUW6$B"IJ7!VAUAEJ5NGW[B@B&X=,K7;Y+0A-B?RW'87FK42W M]=VNTBN\5&)MY2<27"3J"Z:2W1#NXE+ MV;>963\,R,2G^Q%ZGO'Z*' M4XP^9)KH.Z);?!_,AB\=.&06O3:DET2MSS&E?=^X@ST"4LN=$_R..?BKH/96 M,2:,X5`@SDW>%,<"HD',[F/!=RT#B=:D&G2O!3 M'7BO"FRK@6X5\)E>25XPY[Z:U@]20LS8]S>&RKID1Q\W\3XUM MP'D7"\^@L&Y*_4:G'F=6NTRHRA'[?]1HTIZBNN\-Y+(!PB0HGWTZJ&GL617E M9)EL(,)+6*T()'=KH^!%'=^^-@^[:ARVY37;PDL?PWX4$8CSNTMH4DL+V="S M%@;F+S?;*,[I1"VA*MNC=;HDA4!KK<">.1"F_,#S4%NI$^#>>%;WJ$B\O%_?0FM]@I"Q@QMAL$%\@^5$ZD("ROU-!4,_59[*(P@"1].+M?`1JL717OZM`U2GU@)%:##54]U( MC02AD0^\\,ZT8MKB/,Y6=V64EZ81WS+`M^>[YCM,YPP5LXA'Z`$_QBE[!R!; MHZJ]X3%,EU!F`5[%%F_AVSA:5_URD1K7#;91N@[*!CC"Y,,W@B"#"*P#(:`] M71S+8!?[RAS80.=$D,\/&Q>R75D6N)A]#]9X77$_TR*X?L983[X+A:?G9Y5^ M[,G;[(>&4XNU>8$MN]6#8*Z:,<>3>G5>WM5:"_-C$QJ+\B*_89"<3A)Q#Z^3 MR(BF)8&.F^-8]3HEJ7U`G$B/.QT9Q&ENLDZ4346JSE_CB$NG(8,X,:V[22`K M2OD>E*X`=P=*)0"Z_X2:]'!ZAL"%_@:45FEQNEK%]%7@D*8#^UTEW&0R_'%E M6TRHK'B#R=Z2E][W,U_7,V_>]:.9./;D<%&@,Y;3A$%H\V2RDY"TI"6S9[#G M$$GM>TOY0E>F(]K1^3WJJ!H*JPZKF;%R8+4]:^35 M\`IU42TA41%5%UP5Z(S#<>)O_ZO4GU%.$IGA)*GFU>>*BU0<,?F0F*A"B"R= M*7I0D=\XVM*,)_06"#NKN0WQNX-20F&]"[;Q:R]PD_ M?(P*]IK'9HO3HCIKZC*E1P&13^.T#S;N%%1`[R/*@:'8NJ[U9B)71[6-'?J< M`:%Y3Z,.GAM[X(U'(6\62%H#%#LDS3M@H2>#X=5%E-/%95&DE@FU49HOY,P2 MGEG8FDCB0*B>8::A\%00MJ5F M6M-5$!"#IP!,DK$+GX01>C,AC\#(GDBX%@R+/Y+>EW!)WC]R7HUU91P3>9J1 M;\\XW>';ZMQ*6J,*E[!5@BV_Q(+.O!*9AN63PHN<1U+E1?T<=00"6E56=G%F MVAE#\HAT^J216PZ(+(+KL86<$5VG+:+.2!Z<09)+X.&)Q'=FQB>>#1ZM0N.2 MUDWJ!KVC8I;T6G4M/W/R+$N>Z=@LQZNX_!31,Y;+5\%@2$-VSR^9K#NWQ-8] MS%^IO2F(I=!??(K7Y1,ZW>"4SEA58[8@*902ET_^913>-""96&Y!+ M9=\WT``GJS0\.:&,35G5,@W$&JDWBS#AY!44Q.:ICST_I,N;UEFV=N7C!^3(NZ)5,EVF9QVD1+_\:)3M\/*"#?T=U M]_ATY!@*_#4-LA#TWDI9"/+L?-%Y/F^PK.>\T7S M$:+W8AQH@-:G!42`-@(@4(!6^@0)T)K?+&CF@XWM_#=S/MH?-UMP'L9;<#H^ MT,,KZLK5?A!S=(2H*\1\H8XS>B5<'5+NOX44'\A^>S'EC8S'_X;CQR?ZRMXS MSJ-'?(LWU35V9UG*EF=V40):#KJW`'X$K]^"<(;VNFT.I[)T_@X3S0@8M>I- M3A48,]+/'((-Q+U-+N@VQM.L@]EO<9AA:OXRV+W]`<8HF,+Y>E\IMZTX0DT[ M4-T0U+8$=9IRR$7UFXB.T&7X08?'0R[=FIR821@:G*$.&QFLF@,9&:R_BT.,TP% M4[@[M#_`&`57 M*?D6CS$9?YP6!2Z+3[MRE^/339:7\;_8;T)7#=("W],QBNB-`A^FFU(;U+1K M<@)L#'QQ#-\X:4:!=K>X*,IXPTX:6#,U%'7T$*X49P[E/H">^0?8(/8">ND% M5?#6!\97N"K10\.F)"NMZVJ3])SPRN@'9A7MS:+*[A&J+*.N:53;1E^8=13, M;5V'1G%1?74@')^U(HH27-1OG=WA_#E>XN(S'KYBK)!JZA21E&L(X]LUK1XT MKM:4>Y)&%XEF\P[DS&_DJSHQ,_K%!U3C*_18([/I#R%P^4KNPQ(<-(O0IZA^ M?(0:@2-$1-X"8D31V0DR(8PBK]?=+68DYI^FJZLX>J"O?,7TW**(7NRXNDYO M,;W5G(R'/T9%7&@-(T%M#\:10+:!"E.0UG@;24*V3JTQ>Q;7+Q4I[%^(N"@JQ.[D@VAK]?-<5TW.&>+$^QK"6LH2..C M(@K&.%C$A6@.Z*OE/EJF%W'!'/8B;M' MWF#B+2A'N`$7&IFB@`OAAQ]QX;Y!`!'W.!N[UPIJVP<7=;K.)\E<:@-)&"154*Y@QG1&0N&'%M'M%84/' M#C\LZ+=@Y'%RTDVO&9-&42T=2KQQQBHW M!D&@1126;&WS0Y5;2X.@EX<,[MH<_]P:9'K1QNDCQ,SM=T4?0`D0'B65I4(X MG`RMI.ANA^Y^`SHM6VVCWI\Y8EQ>N!N7E!HNQCW$1?OF3%*".#?/-&0Z.ERT M;X1$]1LACWF4EA]648D[J[W%OG2IEHW*)XR^#E6CO2M"9[P*+Y(",$4156'P MJ0ZP]GY4P=;U&P1'>J^%D7O3IF6\I&`:O$$VJ)A:\]T3U`ZB?`J=]`9E5:BL M#Z/UI>\#+A-"H):R`)B36V&D]E^BLMY$<;V^RM)' M^G;X.7[0S>=FZJ,DKJL.%H7T'/K9?67D6R_:&)A<_!*G\6:W05&:TJ,HMCE) MR_&6_E55J-7\0X[;?Y+80V8SA#C-MC=1B6[*R^EURRQ88UF`+$W-0HF-J;``HNY$9K0H%.4A!L$T:]HC5DT;R7932K!2LKHT+!T`I8 M?#+RZ[$\L&F'7F`RM[RXBQ_3>!TOH[1DJ7\_\9'B$JUJ@RS;-R_/!K.YRPZ. MW-!CC0U1T#$RR(\W%FV:CRL>TKA5&SP199"\&WV6M`5OG8:;M^?DC3);ST&< M,'+TKVE>77?_+];T>N:RN,V2Y%.6TP5,S31M:VB4J\[5E4_0B MD97QQ=D3/9NT(&-QM.L88&GZH3812K2Q1B,WX+C@0A1R3&WRHXY=RV8EC(>D M;=L,?VP9I.ZN"9:^&R.(6D&UF8"S]_Q\4N;P^0@51B:7'(?(FBS,W+J*XX.L ME(IP)]HH7/E9O=/TJGD2C8XQ@U--0SO*0!M&_'-A##I8>.:+PH;@0!!S6S/^M](+UW.U<_!3%]=LA5QF)104]1NPL*I[HU2+/."]9(B"M(D]H8W`E MVY$HZ#+._AN$DB5""!C-0!U&L;"<^=)W;8CU+0NX,'_ MMYAMN0G@6]`.<:+DOW=13DK6Y+5M^67*OH_!N,?"QFB<8F0#+-L9>/4SJ6+> M`+U<8FJW%_K_V2BC=1NCX[UZ*)'8!G;72V/)BL(VR?ITB)
`*I]F&P)S^FPC0P_Z7U8/*+L+-L;7?)63L_SW:DJJ4G1\92ABRPRQ_ M^Z4M@(0;+TT,"O94&+8!9L5H$'LZ M*T11M4)4[![^@9?L5I_N59:AA!%SO%DM'1F%#VUC=HM)ON:PC/SZN-?#U+\' M!AC="1GP=,L^B%H.5^GW6TMX@RMCJU[-IL7HO^[O3Z[/+[4**1&XSY ME]BX8DEX:XV-8<$U-?9MG)]S'H8$3FWQ3+C!4*%CIUX$[EEJ7I;^[HI-QX4[ M<@B)>F1.GNVU2KC;9$2%;B]-$(G?D8.2G^: M^U#D9OJ[1!I95`D'NAU;`R'\/15:/2C<\2#4%FQ(4'@+@)T7FVV2O>+F#G3^ M0?JG25+O>KA>W[8OD-S@/,Z(7*&BLP0,W%1V"_ M_7-@:N.HMBZYZV/O@BKNG:#*"V)N0@M^/OC$7[[T`U_AXB:<.\'2)_3W"2&` M#Y9SZV7!M;X;0YS3[,E3N[?9DR*WV@][H M-N`C5*NS"=[*`F(FCNB8+]FM:)EW_S6K/D2_X/(I6P47[(S1J;430PLNNKLP MA,;T=F`HVA)"D($)G.KM8G[\^*H6?6PY@VV9SR,YO;1TTO*Q/TM=RS?7&=?U MXK)CD?RC".<4$%]D\5D*&NUU@W7IM23T=?XG?.M\'`[JIY6SA8+AL:)^AI,A M3K$?>DA1'UQZH#$EC*G\G[)L]35.$G4A)Y0M9Z#.VIL%>I:J4P5R?TP<1EKU$OB\BL-,(GMZ;O M`+A^DV=;G)>O-P1R)6GIQ3]W\9:^R2XGNI[:B.4J-3"*RQWYX;>63SUR:YCJ M,;N1/T),@W&[U0F-UYK8X9):OU]%C)9;X--9QVL`7)9&'>5(RTC;+'][&)%I M^9LACUL-VO0M=@9RT7*9[S"]EFZ8U?,ZJR^?HOPQG#OIS`!FGM--AG]:ABQR M>W"O.POFC/*F$;I124(7[TJ M133=C;HVZ1:#KF!M%YUVCOX.II2!8@$WV`$"4!0&'5WP`R1(NP,(G?L#P#HG M?5VF[5E?W:.^ZC.]/D5Q_M76#6\K=CF`[Y6M.#\U/;4U)9)&`.`EZ%.:0(H'$E6O@A((Q5)>[7 MH>>WTW<.!5]K?X*J94%E;U^OI+*Q[S<>F[=HZK+*NH4.8=G2YZ*Z5Y@=-T#O M#%@GV5?T5%TDP'9QID66Q"LVV_80)>P$Z^()X\#++0=6Z(=;-R`:Q5MS5P81 MU_9[A$CSJ0HO^]9-SG%2?/$+KB-$#89_FL&A,=RNI`J0XK.65?B1MO(6;^EY ME>GCZ0/Y,M&R'%9'"K&FR!&*N08Q@6'0R7&Y#VE`D:DNZJ?H/"Z625;L^$OJ8!(%Q%J>\/`'O'>_"UHAT8 MDG(OF$+/*R1%Q9@73,Y;,"7$YN-/.,5YE)RFJ]/5)DYCFK-H,7CQ0AT; MR/6[?"Z4AY\2K7*A51*R: MI\RI._?LAFIKG6AGW>EJQ1:(HZ3^@ITAMVCN<`I?38#PZ\LUKOAL'6@XFJ"A MTBCFW?_B;K?91/DK79$M2CH,S;;L]H-P9F8GH4TV`SH'$=:GVUY@]O_]#B^> MTS?0RM?.$A8[T/O^*4JO*SY\SM)G7)1X=9LER:2*>P;5,T-D41!'Z#ZR:$F"S<*0F0/9V`#I1.K=H#D%X=?X."B M$=S MQ/L6"N<.A:+IQW<4"V>=`+7]MO5WNMZ511FE]/3KO^'X\8E\N]-G,M!XQ!2P9T:]2B$?Y02Z-& M'#'YMY&>W*D*D:)`P`^4I:S;`I*I''^)PTM6RM3\$S%!7RRKCHR=;)*([];[ M]-#0;;!#L7Y##VA*B-OP>49@G*8LV&=D./5=G%;G\Q=S7PD[-<4F&?.(X3O5 M8*??@FF&.;QO?4`1Y@"F>?B-#B6\3#JU4[FG.QJK!GP+8Y-RY'W%L8.M@KLNX600_7:VLX M.7JD@A_H00QHW9Z&15N:[U*\FZ_%^1T7V4%VA+4BM[_$Y&`OKQ9(8< M:T3%>7*PLHES)&G-W^TM!62CX4HP,R+:7^U@`O)Q?U;E6U@]U+`Z\]CF<./J M>'1TT('UY-#F@;2_U<'$U),Y9Y*.4%MA-VNS3`319G9.F?P6UP\CKI]\B^O6 M/URXLU["<]1UOF]OF=MT7@O>L^[,%:1GWQD;KJV3;D$";[93S@5NS6$/5#SP MSB1E^0&T84Z":X11UH'^[H>;5CYE^1K')7V-;H[<8ND>*L$8NY\[RQ@V.*A4 M8]=VK_G&IDF+6NFMIAU;2D+F'@>8`R<@PY:`9B&K7R'<5.3^NDGUSM/T;S[W M_4[WTG/C-]C9R$%+3=/-EF'ZKHSR_'F*9"Y M39\G27&:LJ@^>P^EL(!CDR0.,7ZG2AO]%DR3-7C?^H!"S`&\@LIO="C19=)7 M4.M`]N9?00TKC$T^G@\CCH7W"JI6J:I56'J*T9.]MFA=8G7O[:DB$=YLD^P5 M8[3LAJ[Z1H,0`XQ^.#"M0=1,\YC?)\C&]KE3D>D.'R9&,5X/)^'%3XT\P?Z/ MYH(X?:Q2P;%6U'4S[7PO!<_T;-=0C!L3Q)F&XG;YN61"X&[!'J#GZDF]3!5B M`'&$-,B=$7(H05T1,?8"D.$3>NFVTUEUKI@9UFL MOD\0*<+K5YMYT=*XQ>,#<[DO9;Z-3?Y\J9)0R=>!#7_#0\O MJW/?)?HISXH"*C.K/0`=#<_U,//9[YPV!9'EE,WS>7J[R.L;.BA7`_2`AZPK M4`9[BCK'&>0QZ<+O`""H>M;9#H-VCIX04[P+(ZP#FA`">"WL3L MC]W+>/._!1/V";>&S92_.7-P[XY/&0X"F]0)>R8GM.F;P'`>E@!=;YW&0\RHA[$&Y!OY4Q:\R]T"'%TKE=:60U,E6I/V39-JS7^Q-Q-`#^"E69NO=!C1<](7;CN->^\CI+<3 MNR>?TSK\X'V0[[+I_@HSG(4C]#S5F.<@3L09M?6@#L41M7[6-#L\&J<_$F&C MCX/==^K`NBGSU+QGY(P:,6G".9B3MG'.E&:Y=\C2/=2]0\;NY[YWR+#!0=T[9-=VK_<.V31I MP90.=5+?%R$A;QUR`#GPK4.&+0&]=;/JQ(2)L\K&$-WCJ,6@'<.(Q_@7"33MZWS5Z2#!D MOH'U"G1XA+;7F0^4T&QG$"]36S79Y\$3)BU9=(3?]&MQEK0#/+["`M.P1UIH M-@#RF`NC[WQX&:1=.3\MBMVF';/A)?F>Y_%SO"*$NHU*L-QAZL\U:^C[FRM? MZ+8PB$QAV%@O.<*H#8OF"5K5CPJ6%9YVZ2K'J_+I8%>0C9D$D0ALP`J4`G1= M@P1_L^]Y>&'?\(J%^ZR,DNE?Q-!IQ,1W<@T;$>RF`%FS@T@E$-\@A(MU.`U; ML,_0(]V>^&%%8]*:;KE]9GLFR>BDVKJ$JK>_#C3]P)!WAEMRQ%28Y\JN_FK+$AZ+V8BJ_4>5O+4_TE\0!4?W$]S!RN.6T*L/X2M])GS!9Y?5-O#&F@ M'S#,*N`&&V4YSB"CK/"[A$GI8"HP2?MF8#-P!=;Q\E8JL'E#@Z<*;)[8<)`5 MF.&T7S@';EFV:^*EGT,^=LOPFQSB`E'8YV[9M'51*;VM76S>@L$,2TE!GKYE MV,0Y%ISLSN`Z@`P\WC/X>;=YP#GP#(C0/OP>Z\;^[)/5@Q8%D:$4C9MHAW3' MIVHO])N8`1&CW\]6YS'@O&UJKEQYVK[<_1X'&UI/5ZN8_A$EYW&Q3+*"CMQ. M'TCBB98E<)C5\@44&6A$)\`8KHU:V'@N=0L9VS6^7^AQ(YBY;JV6SAHT@.>_ M]_Y0Q^&W8.,?ZF\UVASDG'E5%%^OV=/B]#F*$UHK?\IR-BL!55%JNG$M)I5N MYLH'BH8%,9K7:Z.7'*#C>E$/#O?O#Y#_X?R9Q/AUEJ/UCBYB(5R=-,A>/2C> MP)A?ES@0D=P`I$`Q7.$1)'QK?:O#"]RB8S[8RPR79`@5IT6\!%W'M'`).R&K MO/V3C"3JVY&_599W#S9OT^65980;H]56NUR.I>P?0.[6HSH M!C\#K`UG+Y/"4N\>YHDUONWAI0K9R]Q_S1)B)B$UTU2G7/`]^CSG8N@QQ),N M^FT,(DT8-W?RTRXXK=B?=_'"X/-`9+&3I8!A&U8T"+NA7\HB7X%?!52/89_GVEO0%W_/MQ'R3]/5+[A\RE99DCV^0N\?,??H M(^R+/(84^/EM##;T2YL[6?"7M*+=6(*B>F,)]Q"BHCMK%*4K]'6H%NW=D0A# M'AS\PK`%*7UE$37J/>81OG-OF43V70\OE]2S96SE1'2RN+\7J=R\`ZU%&'N? M>5G"L+W![6:T:[_/%0N;%FDFIFY>:E]U>ELO0#F2&'"%PX$9L(L=A@V!7/>P M^@T.+Z(%L\_2LNV!A3/@O9A5"_;'$!RA-EHV^\.K_2"T(8BV!+&F?(N`,S+I M/8?`@]SJ67_=ZUU9E&3,&Z>/$UZ68^@5J%;7]CIS1M-LIVEM7FU_N2NCO/19 MH9NUWF]NTYICP$3#86((?-,9H-@,PM1M_Y<(*0 M43E=L>DB]7KPGF'C`PE"QX,H]/9O[SJ,^..IR`T[`(V+VH`CT$DH`WK#-@<2 M>$Y@!_"](#8:NS?>$7/_+7Y-R([W%+].@AN45]_A-%U=$CRF9?R,;PCYBYLL MB9>O6@-L+0O2P;+"@I>(+_4YT0*33AO,@['::AU7/X[B:HAQ3P]>RABFW=\Z MX4AJ3!U:--HR#^8]+T%H^?<`>,E20%,@L!TVK3YB!E#=GU_J_][CEQ)])!'Z MMR#WUTQ%%*.!AV^FO)%9;B]'$`KMP\]#FEG= M-RO$.=1^ZR;GM,]YT M#=-LY$3AFW=64.?QFXFX_L_\T4*=MP#L[W0?Q?=Z"_'X-DN23UE.'_H+QAPG M\)&XYR2<,-QI5J`Q>-S"B0+PT'%50Q?H"WV`ZB=!SNN#L^?4X1U];M@CU'5`!]J3X//=JZ(-\DUCHBS3#26G@SBK/6WV:^*!L_IO$Z M7D:DHYVFTV4O])UC8X:VNNA1G'F>&.&F,RE/PM@E2^Q1*"`>=QD/R-P?60#F5I8+ MZ(&E^4%]O;XKR=#H*4M6."\NV+5THG.6372&T)?K0+%!YL4+030<:G%&:6=Q M=OWY[OKJ\OST_N(77]"9S^??O[IX@Y=?B:?7Y_]KY^OK\XO M;N_^'5W\]Z^7]W\/YTA@(_SP>*C;O0)JRM2Y;%7["X'`9U'Q]"G)OH[NS1WS M5B@ZIBM'%(ZE(^.>R"GRH\E)OKJ`BG>,BZ=W/Z-/5]=_NPN1=N+NY[--VDU" MDHVT!-P26)^?4A71Z1Q/EM+5K-.76%CSR62'I.++0K&*9]T+K22.M'@EU-^7 MBD>H$D)[*<(G(A<*EZ3=SB.3JG<$;.*I<>DDMN\;7T9+,NI3$G3<.<'L^'>+ M]P(NT?H*&+IF74W99Y++=)EMZ$P7;6&.GW!:Q,^X_E19%)EHC^LD/6VXTDG' MGZ=JRL"U9H&E;5%:)N1F-GR MM\NBV.'5.;OVO#K(G+W?PIX-KK@>O1]BJ]]2UEC?F;^&'GULQ[-L@YS@-C87 M[?F*V1H55*RY0F9N@MOB*@/JZB'U#4WUXX!5.^8`.MQ6/EOOX!BG&_P8L"M% M5&FVMX4PY:.J@YN7[]M31U?OE07"0>K4-)AW,"MN\.F2C+ZK5#Z>AC13TTB% M?36/@:'K:.+$QW%M&PM&IA94D!1@G307IX@P[Q^[E&V^05_C\@E%>[UPB<^% MD";?1=VKS_*N!5URC[U.B.!),AK/*11X]?)75^M]8-1_A=FN/'N*#7KZ](E-]L2("OHGY4%!D9AM,3YEG$ M_QP]/\=%D('_6$&08ZT`?BS`^7$($P_=-Q7IFX>"/=M*R2[019(0N.?;!J>! MU(V2%1+MQ><\VCM@:4>96AVM=9P0V)+8^"A;,DL6/<] MDM9P#P]SX-NH&]N="ZG?+V/,1NA>*3-[.NUM5[\NG_C#'+%4-S'RI"`BPMBN MZ=!&8R>AS(^2W@+-!?LS`*))^F_()OF/S6',6&%$"Y%-?^"`S0EB'Y;(:.9. MZZ?_7N]@)@'[K0!&%F.M$1-6M!1N$%,)"F,FX&8PD6E?BV?V+[5)E0/'^:LA';;;<*F M>J.D>0?^,EUG^2:2O:1DIM743+I:KFS1\P.Z?\'(I915!I8676&TBHMEDA6[ MG.T%6A)=M";**-YKSSTR,81-YM2G`V+J&>BQU<3G?`S^&FWY&XA&#QH>=AZX M4JTU!/6("W:)^EF6/I-P&])VC'''9*J?=`#F5J:' MUX'F;)"\SZ.T6),?G9ZBBO/G>!FGCYV7`2]3PIP=.YR?GK]?\!]QKP?Q8;K^ M;6%-.Q(+LC&0U/30+AFYP=TMF!A-D*T@ZD@&=W` MMSS::)I9W.(M^2F>HJ**)=V]]G-'#@-T9/:]-V2Z6KO/8%UO$X$2;+G)Q"$$ M%(])1JM%J[F'_IM11/X(40U4J;QM<`HF;GVA<\X5K%X;JTU@LCS1E^"EA48" MDG"53=CR4V1>FTP=K3UU6.0.9[^OK.]$O!C_V!(6U)>-BD#?M14&Q+DS'!() M'L2!YCPX-KU!7'L61*0UR`Z!S(#(.DZ$;]6<"$=8B.]`9DF&:499Z2OK>@\% MDX?7/81.S"HB7@P_0E%)RO&B/$(G1R=__M/1CW_^H8[I=&MZ60L'!'_AQ?3R MKE"5./*"QE-Q[;F4MBN<967RX>)`N]95`V'..O;7=!47U1JGCW3" M)LMQ_)C>[1Z*>!5'>3PJ;\T5ZQ_*1-&1(/JN(`L(8Z\R.AD:6_3D4:/`YELK M%=35F9=^%A#*7#NWSU9]&UT6FWJ>D=PY7F:/:?POO+J/7C[B%*_CLCC'2QJ' M<'&+BUU";\?\1/KC)H^SO'JIB<@VYT6.:0]GL@T($":=0X5[(V"#"%A[Y.$% MR,VB54'5FXJ[;4;*O>@%;1LYE..$G8!"J+2EIM`KCO+98Q`@GC-_>!K&+7?K M_8@&U=K08MW]4U3^+=LEJ\O--EJ6%^LU7I;Q,R8BMP2,>M%-TX@\GBF-^(E@ M"K<3Q"R]%EA$*1W#BZXNBTTEVW]%AN4C%>KZ_B M35Q&!M45A`=Y<'+SX"=RN;1I@K`&T#R+F.?L==%:(/58;0'1@(,2:H..%*/6 M"BHJ,_33CJ$@XR((2=1!$PJ56A'5Q9E&N'7_+J'%8KUXJA<3?<4UT]BD^1:9 MW)M%J*G"1?TBT1&IFQ[CE$YUT&"P#>"(&57GJKELS$<-3H',[$ML6[R`J'CS M3.',$CG''>C@=/6V0".8_'=#C?N[BA+C1B\L6E1#.B\K2E7[`S7R/WP)@ M!&\SN@%F_%[C[/FWFA:Z3*MYHV;^2"\KRW7EN5JDZX=0?&\3C#FDCBVH)[%' M^+C$>OC>IP!>]U<5&4\2:J)C1R3%]`H0.:;76J9H&VNYR> MYL_>0LUV)>L]*A`]YIB]B!I"U/-#DU%L](9+7@0%=3:.LQZ^2YC4,NH9QHUMM'>^!&JS-,H43E`48$J%_2SQDGGTO!O@0$`M&\A,LR[ MF4_S*]4S,W=/&)?5U[(MR,263`LOGJ6I@NS8]WR%E+`M('%38+T^3&Y#ZJ'- M;K,OB')^658?WQC#PQH0H7[L$G)@X>N(:!G#G06 ME&=92M.QPN*7*(WJRS3:)S,3C-\YF0*.L!V;A(2NT+H,O@*EQ2U>XQS32R;9/KHPSLB1]%FF^ROWT3R6[2): M9"D(5)^^Q,,0+'K,073U&!#/U*`O-'=LZV*Y51DAF3X)",>]?A*@>/C;BC%, M)44(WEN9#;]_P_'C4XE7IV3X1C+DYQU])_MZ79T]<$U&>F5$"J+T47`&J:UZ M_7N9JSORP]2A*7\T;M*P;(*,9E8F%XT6BBJU]@"EZD5M>FPC'?@_1\G\S8'C'_]3H-4IQRL4=*_>@(&[NDRU()Y"T MM,=\>LY@[X`/-97?&,VJR7T53:\IPF MUO83%T3^)LAK"M<604%J<=$4LJ&S70D@-=]U>E6+\")#&I27MV%Z-$^2YU0- M``8U)]>M:I0?;K;SC'^SC.>)`)99[VOTRG+9\4F=R>@G__N,.%C'>5'^+_"MS-WR M:&QJ9?%+],*V&$6/CSD[J1*E[40,M?.)VD&UH69JAG`W2E]107"48'1\\F&3 MI>53_4)A]\W4%%TORXR:.SY"%#/SJ+, MT?=F2*FNLF6>*(H=VYC??9&G?,+H,GW&1<:^X]!GM!V[L$2F+[;78FP*44?0V1A1HK+[*TL=[G&_.\4-YF2Z3'1UO M_)I&FRPOZ?NUYW&QY+SC8*I6_Q#Z:BZDT?4"'M<-'0L)962'4BM_96\55%MT M29!/B($/]%T"M"(FCL@8H#:"=GLK[-+52H-453G>Q+M-5W2YR^DUQVQ'0TJX MT_R3>2E^CZJ6X>((/>Q*(E&BA!YQQ`XI/:+_)NS>1J\TIQ"1+%UU_DF:16SM MT&GD<8EE7O!E6*\6=1C`*Z_"#:SV'XM&,CO[BG@R,XS0N:8E" M[S/X#=-SV9?LM7_%_F3DY)7FA/HPFR>Z;;3QT]>L"B;:AE%G`8C)X4FOL!E)8+WY@&&IAK>G)",QV>#\%8 MCPH<(BX"U=2"S:>;D!6K7EZQ]`0]Z% M-TKSX,E`UZ.0/WH&%E0,D7]A^KY_G!*`1*BKA"JM_00J^AJ73_O)V'G)I0^3 MS*8G^^Q2JK;TTG3B'9$PH5S;E1L6CVLPDFI""L`WB3A!0`>&'&Q(KT/8:;JZ M2$FS7R_3=99OF&_!VV,F*DU@UU)Q8I*&!T`R&7@3\TG;R*(19;.3E3#J2`?S MJHL1-#+;KANP2T-]3S!]7W`<^YQ51U-4AT^T-Z.<%M?K*_J*?]D]H>)\?+61 MM7[]0UGHNU#1V!UXV67;`B%5[0PN3O<+X+6!9I%D?V%15#0C[X190@^5*510 M6VA%/IQYD&T/OPP"$7VV&YMJJ6_9B,F9`).AK%W# MHTH9U=J(J;.2Z5VB7I#D)H:]XT*&E4^S%0W1=GM1[$_W<) M;<$ZR,30!ET9N29Y.V_69:[BZ"%.XC+&Q2^8[G<;4$-/N/YQ5,(N])3;!J_& MM-P)F:>AO;C%6_)]V:F7G9TBG67KX$E6L,DR5GOUBJ[? M$TRV5I*]2T1?1L$O6P*SZBK+^QA2B\]/PZ`)T45$V(H M8F>V]E#ZI9*<>2H`'%N"R@@,7(XUC]H!8(&CY\P!8B<-Q-B^(BJ&KMX^Q`05 M"AC$0&N/(K+]"PJGCXEV=>?\>J19)I;>ET[37Q/\;803>/:ZC=S MNN;Z3A.\INX`9WMM78NG?NTL+CIZM'*AFHBJHEH7]93#F1:VAEH&TON#"6-3 M6_O98\M63(Y[HU0C.?W.K06P\#_Y!G]+$,P*?]"<)QCQ7Z:?=G0WO]ZZR5!: MODJRE_8P(]88GVH%9.#/=+JKIRY9W?)`D9 M/B^S#>ZNA;!QM'0MY`A]?8J73RC'2=1N5,3URR++UZ8%!1FDQ^MX/\`7M8<\ M(%AE/^;<:CEF2.S&@V92E@7:#\9LM."4(X?)%W MI)`V8S4>?43&O8(0/,2*W=C#;QAR&ZE`RU((3*ECL0NH0&/S+5XF45'$ZWA9 M;?=?_6-7G2M&SSJ]7I]FRUBP5&JC6O\@9JHN'#+Q!$' M7@M#=QA3M6`6@ZRPE+GV<9^>)F9:MEKXGA+.@+MK;%R#8?J$@^FH@^ELQ]97 M3J_/+M\GI@7+FI-@&G[S\%FV(17K$TX+E@=I*7J5%<5'O,YR+&G>9TR:=Q^] M#*@#:K.[%=G=IO/F.MZA6J(S+XH190+HDX M1\WH:?E$&L@*VVA)?ID=78!=H8QM$UQV&T@/FJ%#JOH@_VJIEFV8)D1*BVJC M`'JDE\16(D=HE^8X2M@999W/Z:'@G:7C([2E#LB'S7;7UTY#V;NQ8COT4L22 MGH'3G"8;PMYK,*9FOHC"V0GI:KZ_81*FL4$$%\#MXU#-\1]6VLWH/6.HLH:H M.539&V7H7JE.8Q,IU8G1;[34@=A!\!)B2SU$.Z!WWD.UR3\[VWW\_01-LZ(H M]Y,TF[:%PC_U8,FIA=[9\&VUH15+H&.IMA`$5-F@1!*;W+I@9DJX`Z&N@+TT%4"3&MF1>_ M)T&KZ#8;GW`%W7WU,_F_^D:YXK9:$+S/Z#O$U2'V94R\?Z973W#WREIJUS^6 ML;8+30V=@6<6._]"ZMJ86S0*O:5?.I]#[_A,]W>-L!?X.X80LS0OG6VAEKGW M?Y_;AH9:BELU8&+$P^0G2\>06#_N@/UV#W8^L`/9`CP#P@7I:T*(PQZ:C]-L M0W(HD1<>KB24:(]/XDBX'10S,@AY!)+0N.24%X'.HO,DF#V,LA[+-'_BX4$K M(^G.42HB2QX@`#B_)?%@BH.3-X<#X8$[QCB`/32'%(RY)%8)GS<'XXR?.QWZ M,30'>,R'R+3X8`^^QJ+]/!A1YWR+[9OU^ M\H;Z7738MEF_`U\CFF^SG-UPM(Z7^&X;+3%WM*\6;*\.%0NZ7;`HL@L^7%>Z MDERM*-5"9JS2T)3=LETF<=$DR[3KJM6Q'CNT[4T0)49=?_PTD:13N>Z M1KE9?XB%N@Q4Y<,2J^P"4!Y$`QDP@T%'>.&G(W85CNR1-!)%T$_ MXVCUSUV4T[:P@'06)0DZP_0$P+>&*$&:=T84[&;1O8?+].R)=$F"<_X5&6K) M9I.G3-)I/XG8,/SF3*4O\480A6HW_==/WW/VUP%69H:`P:X/L=)^1X?*L$?< M`NTE5#NQ12S=`UCADXFP\YT;X(81M`$Q)-J5YPXBT'GNZ^KFFBPM[G9;>I;. M:;JZSZ,X)=&A:H?@IB-3O2:HZ^LY4477#7S`-_0L)I.1H4XRV"NBHM)D4;NL M=>OP7KRW]&`,V,P%2P/6ZYK8QP`SIY-Q!2C)F+J$80E-0'KD""4?30-:4:[R MBUK77>$FOB#W?YOZA<'N20^[=QWL-BIU;?'.L"O:HNT7N["#Y^;VP"L<%9A> M+<4OMC@"_:JJ)P#`K8X]7W72V(6*+D.-!;NZK-YNMK^(,:%"8=0S/2['W91-TJ2:FJ=/Q4@?-XLX8Z?.RUE#,W!+]@*/(A7+K@* MW?E9NCRQK"3>V;A;C(Y,IT,'BQY#T?U:!]\(.-"`UEE%ILT@1E=5.\@*I/"W M[''1RJE9E[NND_)L0BZ/BNR;=7Q[YD]WW?,JJT_W.6PV:M5-]61]'^-DAV^7G_&Y>#Y6775_"AS`MMM,RZ8 M73\W!%FO*)E5M"S0=NRI#ZZIR!6XA5Z>*VN<<1%@7'S^A?]%[%, MK<=IL`F31,P6'U8<;PR>(3JRQEK'=0H':':+/IK$SCHB3MCL=KZ-^Z:8.^@R.M< M00.V!;3R!F[7-!0^H6!J\C$V#C5^ZIN>- M9ON6!#B*&37.8U`;^!J.9=+V\?!*MV]#FLG",H>1<)&9SP3HV+SW`AB>ATT/ M*:2$,L(9MVJR8.)AG+-W\(W3YE`\0%+//NSI-\=LY)-1UU-1V_/@9^AL45.9 MG_7;XTO?V`!I0M9Z&R9-P%K0P5*O/:R)C=-?TQ7.3Y.DU_S3=$4: MK-??BE$(CN+PZZ3N0E].7"*DGS;!54!^VR<,F#[=JD+GCGI`;`=!?]Q$1S1D M0$8^;OP,=U86P9R>X9E0V73P[<=?/P[;2.SU^\#%Y+J!MWA3[<0^RU+F:!LQQ=74,C5H4AB5^C)>5+K7R%&\[ M0E_C\@G]1&+>;COS=(T%0C,G[/3CB[Z--F:8NIV.'C`E@+E/(&(XIRO%',I9>T0NA<%I4MS[1$]`?VI!ZJ MG]*+?#Y%<(^3A"U$N]1MOQ$TQ,\LND;#+@]J.A%W]M*/7Y M;8(,#X!IWVL;IX\1M.#XQFIO>'L3K/94776;L6V=^"7:;!,B^.\WQW__ M\R_'/YS_^\Q+`X;(&T<675R((H5,GT-]M;MIX`Y=D.OX`P#ZH&2N%^@K&!]5 M,*[PO64J;QR;RN(4&)Q@Y:/*D9=Z4,`<0A:\)P^/N;X M,2KQ95KF<5K$RZK6$DRSZTDWL^TJ::=Y5+EQP+EW/4?B"54=_44KA5JQ>EHC ME$&/;M]G%ATTF&R5:^[G7+4\P''E%M.#DY8E7MV5V?*WTW0U^.37-"Y%!#$9ME5H]"'3#(:7EL#*W+N[SUHS0RV) MK?S#FFH=UR3-_3!"@$'-T8>'2%XHD2BM4F^31+ M/_QS%R7Q.B:"*[S&>3ZSK+T&>=E M_)#@SUDIN%E,+=B>$B06='N57V37PPD^"E>2]^REF@OZG+Y!T@B@`J=Q1NM8 M(HA6.XQ(%_W7W&_)*WLZ,^J3X0OL(IW.Z^ARL_Y@!'5JB\J')8".:P1U)!`3 M">9L:2#H"(\L<<2.\W$B,N.@QR*J'%DBZ.2]($AX?(8C@F"/MHC7Y=,IR44K MO#K+\2HNF\LIN#E85[PY;D(I[G1PA,(Z>%;6="@^TD%'?W&+G[/DF;[H6*[A^9JCU>VB!'U/Z+U=H)+=AL$/12'69[Y M?`9=+&46_3TX,D&AN3_\0,N%;]`"G5NBZFFXD]0^2NU%M_(A03K+ M5W'*9DJV!*LQ/53TE0W'$/E[5QUR0`PWPP?"D+R\>E0%7JFT M9$VC)PT]J=@Q/LGJQMB?T?SB4)UQY4.!2^)UA9[H4X3I58#D7W%*`$**9@+D M%+/[4JO#WV@134MNMB!9WS'`GZJDKXZ5U7B7F"(V=U1C1]\8VV8%7>TD'V^) M9%K&S2%=[=)G^125Z"M&7[-=LD(/F.C_+ M=O62C:11B)B-4!EOB.DGG++V%&S_*AD&D/;AER7&J_J"N'T080]#"1MR*LCF M705X5<^]=A2E$[`C!YX9YV\AB./(A6OB)2$F&%QJ`L.8P1*1)<@\+!8-/'A> M,>)X.V("5;G$Q]0E00&18.U)DLH@JXZL1W_NV6YR^/TD6X](2)_Y%9) M&I+=5V9$DL[OQ_`-@U=&:E_R]U\DJL-[E>ACU%.JUY=(0;")\CBABT;+'7WO MF+XYG\2/[/#1YI?$@]O!U^9&1`X;\GPE?JOQ,@,>X0OX+M<VP&W>TFI12D4J](81 MS@$A)'O3R@U#CI6$PCI@%:'AR19)I'K@!#T&IS>')$%!`(`D[X7`L78A<*Q= M"!S[*@2.)RP$CNT+@:XJ)<$QS>,=$M2S'?2MI2A]_:"H`>C,0I._F]F+:FZ# M9GSR3:,T_A?[:E&"&C>8F$J2["O;V'+YT^?3?R_0"B]C5J,3[)$'*[3*OJ:( MOFR[K`\=#K`\&*).QD@./-2$/-8@Y+'/\N!XBO+@V*$\.-8H#XX##NJ6$#(H M#PPQY*$\.)ZL/#AV*`^.A^7!\6&5!Y9(,B@/#)'DO3PXT2X/3K3+@Q-?Y<') MA.7!B7UYT%7ES!.NDZ=K4F M?AL_/I4%]7>/7\J/Q,IO`R3J"3?'\BJ$G4Z`E-H&+PJTW(F/?%1K+^Z?V"X* M,MQ'J[A8)M5>A\YE?(0B]'GY2@;WQ=X@RIE%]@[XW"?HZH$C,^["P6&04KW] M(9`:YOTB$.AD7"T_#MBC)^%V\%1)U3&9"B(F.?.*E;8[:5EIV>GW?FMW"^8>]#;VNM9I?NS$6JJ/LR]6_>1^Y` ML,4JUP`P"F!BG,"P2?\?-_>%[/OWX+I7$)D,^M>QUN-8!)S-$5@WZ652O-V+ MZ#SSM=@6_2VHT`SZ&_:8$$RR6I1\VJ6KXC82O#$N%VJ.!!$(.9VIP+4)?_R' MS(WX%`6Q%IM/65?/T9H*H#QB[WU7[Z*P]U6*LOJ0OC3"UEU6>)L5<4G?$H_3 M@C1P5UV61JJ,^!DGKX@4'"MZ94Q"7V0IT!-.5E2;FJP;0^?W MHB(N9DZ?"B!FVK`9'.S`E=\?YR`QYP?=0.>$2.U;X)J>"5+CB3U%]'$@4^?. MT!`=^F&+#=!!P:^$C?2&]A*O+M-EM2DK2DZ72WK&1)9*CW:RTJU_!$-=%S88 MN0)/`3;>A0PR-[8X1?07HB5.?:,=>YDP0@]9GF=?,=V6EZ*GZ)DF#Q+AR^9M MQP@5KRFI#]@\?77X$XH>%U MM$O*WZ/[3OX[0IN(KC+5)UNQE%0/W:+M-B'?BKX'5%EMV\6.8"<_+ON"7^,D MH6]:QBNZ.D%R7B6=D>:/+>"7N*BV'E3?H#U#BVY2;*\:;+]_M?I1_)Y=:!RE M,[M*X))YGSKMV(21S978_$AN9 M:0.TA?-)HQA,JK=R"Q>_2&'0T4$=)=1JA79RV,28%I07$X$:M!BY:PXGO-L] M2"L/M6`S8R\1=)JN%]J%7Z-7N1)/U\LU26F01/DC1DD6M65!O9^?Y$^2O>C) M`B3%TZQ#^K^"28ZWY%&545?XH21I[+1SJB2S14:CFQW)>DE,#$2(/6B/D"2F MR&$[M+`+A>JOYY(R`7H?)O@P5SJ1@ASB18-XC3D4D3145V4_L;J?C)\ MV^)E=<54?9(C"ZMD:-%[QF(J&_$4RR>\VB6X/@MX31!6.Q-0F0;D_:39;$RU?1JRFF:NT[J[IJ M;B]OZ7GQ\#:KD6/)>UT&=A;GN%CF\;:[\A)OMG1')_E7SDPEK\T9_'00MLJV M=-HZ:NVCHG&`LK1[@,:_%VA-:HMT&;,#,,A0B^U"FOT=5D/P90[`&+Y/IF>A M\W*9BL[0*CPQ5R/"(6]U_4ISK/T/"JCN]>"),#B,EURISG4@LT9Z!)! MIV-RA7;!*QVE*_'IN'+-Q2FI./)--2U<[-BFD`*M8O(UZ?&X](3R:H_)-L\> M\VB#-E$:/5;;?^@,QD`RRV?FF`8H,J/N&QR,*]39GXFK,.L/<4`G?RM]6&*- MGO?-!!"50+7($=W.\?M`QJ!@Z!$=\>T*']>#O:7&(<_T5CJR!-&)!$1O!#NB M,[E=L0.:I3]'S\]Q46U=Y*]"2"3J+\:5<($WQR!X)A;[$"):I++XU&9>DEV? M8WHW*WWKL\2/\1+1PJL@7YX=[F^9E1CM[/=YK13T$>O M.&_#$^\X!UK9U77EAG"ZUEO+H4J072**6M%`0KXGS(D6@F%!Y[HTK.,#A+:J>K55R=F\]6L@OVC_/JA$7VBO\` MK\9Z]4]BH.?")&TWX/6*J6Q[V]=CUIU]%A;1%&SAZ.^P+TZ MM:+:L9LP]%1O2K"M:)@60^PUQ0(_LB-JV#N2SU&R8P<&L%5F]I[_.HKS^O.' MJ#Z6F9EOWD6LKH.L79`VS5S>F&,X@#4P89NX0A#BF+ M&ODCM-=`'15T7I_#RY3>!60%U9)GS#I63T:^`*LH8[\PR#UI9VZ:^/HNH"FH ML3Q#TT_-Q3]*4O1X6$&!'!@YM.8AH.L>"\E7:,-S,$<_"OMGA&?U`8]#T3$Z M/1[C2,<:T2.^7I._UUF^H=-/'VGA=DN/Q=CAXC+]>9>N2*%8/A4#\-BJ[P^" M-%1W/$+.R!OXH,"R`;)3Z,SML2'"MM5LMI[FM7QS/7S.A!J3'U@E/_LI=G98 MRP#Z?W0,GI&E[CEY%DV8&O1@)V=:>0:%>W7V9@?K'5#7P],6^=^1`.FM[H*MZ.U.UWV;K\&N7X-%W]'.4K^B=_+Z"N?+,E4"WOM,]& M91Y^@Z"F1_&V&RT#BYMZL+)"12W8G(15'R:9KNH7&G+R`VVSZH2.96T?#_WQAYM;&4VW3_8Y:-2W6_V MT7/B'<9`NPYU7;D!F.Y!;+"X!S#!VE,M&L@*AR?,B;8EPH+.=9.BC@_(O8JZ M_MR@=]*!WET7>C^_"^B)=C7"0@_V383=ANT9><:B&NAS5M[ADGR?U=]Q^7%7 MWN)E]IC2\XR']0F`J:9T<3+E1$P'S_`%CWMCQ'QVM;W86QB/Q@=#=G;J:IJ5 MZ!73<\YP2NH>9KDZ39O=F;XKRFQ#ST6C9Z3MM9ATWKINU@.[=Z:2BBK+B>DH MGWLW$@@%,F`H#H*1@]5]G')NVIP1:C#JZAZQ3`9KBC50GNCGO&ZE,D1,@J6!?)<+E97TH^F5:^[^E MAZ/'Z>-]=E>_Z')3O2&SNDQO:$E3K>T.E[4@3#4O)SF9FS4E&H#?&`%KAC8;T'31< M[GD8IQWBF1#J&Y_&L`F04(X5M:M[P(H:HBG>:'7RC5;@M!+4U$'0"K2FUEG` MOZNN5;K//L5IE-`"/Z6G%[-2T''KF*EI@VUE^J9][[[1;T=\?( ME\,V-C:AS1YU;@2CYR4FK,+?.YW_%F9XAIAL#[)!IOG.(5TO1KN*S)H>$L6G MVWQGVJK)R&VR:4]!XD8>DCO??PM"AP65R\T"/Z M23FF>(/#6*_^H0WT7`*7MANXJ&3L4AAR#"TM]O*H4D#?M2KMZQ??!_-RB3ET M,J=>[5-LL-L5L+" MS+8!H*@G9=K/?SO]._H&?6,,S`A]T!+O9_)_32/*Z"6B%>:2N%\R]P6I558X MCY_9?JD!D6Q4ZY_-3-6%Z":>P$LZ"^="?AO;ZB9_2)E9:.IN[GA+;,/6:C5H=T4=1Q91FH\J8+-^X(D!(,&2!/7DMSY88KXI/Y/<>#%"' M.^74DLW&-YFDTR87L6'X;6E*7^*-*`I5MFF,5EXDPZV3["LBI5BVC-G)Q>PM M:<;,*B?2&WA)/;:JLAP]C[ND]^KF45S0W$?(NHRV!!T)>HXCNE/VF9ZXG$?$ M1$YWGZ5HNWL@@$+;)*KNX(`HW1=V6V_.V2W<#]PP!PO$?UE^D_<@%T MUQ)XG.48%P)W),LB:>>D=Q(."RK3W%=.WYPC2**AMKZ)G,1,>L7-SJHT, M$L/81ZCZ#/UP0/THB$I:'>FXB#8T![AOB6=:NSOI[B/R+[;SEG"6$!\83T/1RXB6]G)BDEQ->>CDYH'Y4IQ=Q1\*EEQ-_ MZ>7$)+V<.*67]B:Q:'];PP%!09U@Q%"`/9LP2]E^UX]Q0H0?B\OTXF6)B^)Z M?1'E:?ORQ4V6Q,O7>_Q2?B36?QM`S,U(>Y2RG1&W(T)M?,*?0>C2#,EIHM96 M%^=QL4RR8IHET=<0)DT;K+*>3$]7FZH?:`$9F!X&9Y::F.O-;U3)P` MK3ROZ4)9]1:6O+I4"]8_CTS0A1]0=XTY2NO[!2V@7U"N/@J5C/GY``.NJ+ MYCVE:D5\2[X^3IN39`=G5JTQW4Y(C%87JC>3+_5!5W3:!:^:6]Q%9V;74S($ M=2NZ5^GAE2E46YOZ=[6WVYWBM'F#C6AM<,0*"+H+N'LD#RD=AA]5FX2+UA<] MKCM:/L7XN;K'JVK]+DI0&>6/\]<;ND#/S-'8CP8*Q38D:#GPS">80D33D0N3 M2$G2#BL=>`L``00E#@``!#D!``#MO5EWXSBR+OI^U[K_(6_MYQJR:O=0O;KO64H/ M53[':7G;SN[;3[UH"9+811%NDG+:]>LOP$D<,`0&"@#MA^YTB8$`(O`A,`4B M_OJ_7O;)AV>4Y3%.__;-Q^]^^.8#2E=X':?;OWUSR+^-\E4_H!1E48'6'QY?/YS'^2K!^2%#'^YQLWB[:[X\/'GG__PX=L//_[P\:?OL/9]OL??_CAX_?_W^?K^]4.[:-OXS0OHG2%OOE`Z/^2 MES]>XU54E")WBK\\9DG#X*?OV[JX%/2_OFW(OJ4_??OQQV]_^OC=2[[^IFXB M_0RHI"%_&='7,A'M_?Q]^;4E)8QB`>M6;**]#Q\J_64X07=H\X'^^^7NBEOZ MY^\IQ?L3^MLW>;Q_2E#SVRY#&S:?),M:-E0[/U/M?/PC MUON'#JFPU_KZ(LA-`95R9N0#3MUJAJ3L4)<7N:_2:?[?"^XKY M_QR(N"A+7B_CE)C*.$JNT@W.]N74\"6-#NN85'*.BBA.A/L=*@%^1OIIBVAU5_NG*,YHY119!E+HUJ0KV;+8H>P:IUMB MG_?7=D"?%,!NPS MNDJ?26\VB/P5K;>T3U?DDZF*U>O0MAEU/YZCQ^(Z3M%RVALRA9_?!1IV%\7O9:9Z==)BTB>_AM_)B@ M19XCHT'/9:7;ME\P7G^-D\2@32,6VBN1PWX?9:_+S7V\3>--O(K2@BS(\*&< M#&]Q$AM.LHH53+LC>8A(+TZX(6GXVUE3Z[>6SNWJE_^1"M3_>9J5F1UK:??>B&[R5=Z^NU6KL+&*LD`TPPN%E8A^@UB,+&U M!C%I%)N3Z0I$OT5##M.N/YI_IUN`'&N8=@4RW=K#YBFHG>-/>^>>-@X\#?13 MX-5O.YRL47977K'>)E&JI2(V(SNK1?-UHMT5HJVUH>U5H;WUH.E*4'\-.,E) MJN4CU).M4$^P-K5_6FKSF-3RFMG::OD$Z^1)5\AVUL:FJV(KZV'#E;"]-;"- MU:_YNM=DQ6MBUU:HN_:\)V*MHVRM:<&XS*9=BT^W!C>9U=*<,%E3&TX4453V M9[DYB_+=98*_:LYM4J96VTLX[PC.47Z5=A:*^<5_#G'Q:DT`22W6>X"LES*T M(TNFTMY2BU(N[LAZ*B7364&@H#4:S>H[D90G$,R^+,LGZJE*?5(GZR1N%=/) M,DWS[;3X4Y10?]/['2*3FU6EBSA;;[G5QAJL'3'9T]*I,5U?D.FE>.TOC`1!MJ[X<9:U-O0E>]:I*J(\VSF2" MT5_^):IE\4@V2=&J7<$FU&GP;]^H%"&?J9BP(M]K2%7IKW1_S-'JNRU^_GZ- MXN^IH/2/4N)O?_A8.Y?_%_GI7U4+[M`VIA6GQ4VT1P,1122U2&R2O@A=0"RR MOCA1MFHXDC][:!B[I-<4WS^50_C;U2Y.6B!M,KQ7[!0,DK#;^K]\@%3PH<`? MV(QQ1A89?_OF!_I,@O#=H"RKG5`%4I*LHMT?4YFKP%&9&2U M"OEDP2`%**D>6/C,:[S\Z#M>*O'^@9+D_Z3X:WJ/HARG:'V5YP>4,0V+A+9G M8+BTP\X.1`-9*^7<4)V[4P`<6AZP!G1!`88L8PF M0!EQK@'RWV$`I+:8=^@)9_6Q8'%@XT1,VE_(<$@#0PU(8J-E#:>"&D-_"`-# M)?+/R#2[Q1E[\!CP+>&Q1_#@`6]Z\75H7%Y'YXO#P5] M*4V?O+,-#*!`W\P("P2&(07IC4R.L)H:87_R'6&-S,>5_B7Y93AO2:@&ATTC MJF``!)-3#S5WA,XM5E M@J/A)2?W>V_#TOL>#"IDLIEL1WI<&S28'J[^]?N12J_)#Y-=O?.]$LS`N8GR MQU+.0_[M-HJ>*H2BI,B;7X90K7_^5\=]JWT$TS0#2IJ10S'$("T&4I"4G^1I"`B$$!BCJX]-/1Q7[S0EUN( M#1@A3:U&#HV_$($(!<0&AY5K-PQ]4)2/J7KB#A#!)Z@UQR+P%PM2<8!`8/%Q M[4.ACX+.&Z>CU1L`04A3*X]#XR\<($(!$<%AY=IO0A\4YW5CB4B5T-QE!H"R M.4D24?H+$[B`0+`(&;IVD["TKQ/MYT3[.)^!8&'F8$\:&LX/Q2B@N#.-257% MV;^S5,;5U9%'N'NWVPP_H:QXI1$ORJ-$LD-]HD=-9/QSSD%4BK0K=$@19THH M@S?0!Y=7^Z<,/U?OR7[).B\%:]'EA+7`(D)G0T.IX[""M/U1`ZF&CB41^W`' MU%GT%!,S&/]>Q22AZ4#N\:;X2GJ%A2@H>7O.)B,/!EV*DNMA3%Y)N,N-L;W4U;9'N^R++$-!N(3 M:5)O,-AKC,91&#.'E'_6F:A,8:.OL,$/"+0*$ENVRF4%LSUZTS@RDIW$P5B& MN[OKW.?=X'0ENPH=TXQO0[LT'H($(HT,%1P>X>[.AC$6";HO7E;)@3XC&T9- M;.]%X47::U)($0\QHR&K#$(PEN%NSSBHX6C+Z][7[.%1+P9X%]Z/VMJ[T61> M97K9?\SVPJ[@3"ZEO5@L*;F!8XD?=5]G$-9'3<[A%K,3=)LL!G,GI/0>1JL0J>`+P#G>/3@9+=@!` M2DIW-$(\.L\A!)50T13Q>(:[GV_\+._0,TH/G!E+3#3P7!T2>8X4D&PJ,.$Q M=+)#9P=S_D0VFS1]TE5Z\;)">;[<(]=W.30=S4.=CH9M2004S;J>1>$Y9N12J>"$R2U!+@<@4FG`A(N1]>Q`FV>$4C/!J1G`MXCPRHH!'C0B.SGQ;&D\I$84Z>@ M8TIH56Q-S^+8LC/S<"]YQ42,6=R+:UXM'$$D-<`0A[W^^4-!ZG&^".R\W.MH M@PLG*/GX?22'/"B(*4JO#S9Y1>&>80S70F+_%(B>181!X0LLL3ZR1%6$ZY4` MOK,#W])Y>2]WVW1*V3I6]"4!Q3'88N&`)-;N,O`3JAP M9CPNSN?VKHOUNG34B)+;*%Y?I?4+QN&-DIBJ MN4_B47F.$)AT*D#A<@QW%7:'BBA.T9H>:M-C[MX;ATV\BH_YVOPV#"_N=AQZ^^1>3AH8?.].Y#3?+3W\\/Z'VXSK$UA;X_4!:\T#:M`-<'DBW2LF7F^43RLHJW"4/KN[= MVT9QSAPE5+U$9PPJ=X>J44(3CY5OK>]1]ARO4#Z.,2NA:HY3>53.!K6L5S!4 MM/ZPY;`MC2./G?[`].2B^`SGQ$PU,HV6M:R/[4*V_]%G.`@%`:-@R"7PQVOW MJ(S1\`M*B35.:!CN]3Y.8RIO$3^C.JWIT&8H%6I,"+"0SQ#2$AQN8(#<:0@-1AF,M_YQGR=S6AE;\VK_%,49U<`9V3)N1W.; MF*@;OY5!Y#.`0(*!(W;$'D!!0-.^H610^`T(N$A@/3%93N"V?-OH_(O(7['4PY^LQ MIG__J\\X$(L"QL"(C7XT'M?FX(CB2Z+$,YP2:!\(NH_G5I_0!F>HD^7]&RV0556?2W6D]QD5.TR^/!.2\C",>>!TTII[AU@GJMGOX>"J"Q2&V@F; M6`_C/P=KQFL=U';I$]EB;T;O4 M+3+>*XHUGVF55521Z_E/&PG83#_]4:S:"CJ\%6L/=W[E M"%I/"C*O8LW28ACS2\\)R$`=309E?OVS7@<83D[@]8%Z/8W:-3PG/%DW,,(& M<0(]`2B/CQ'XE#X##2ZB@G>7@&4#'PVGB+&OEW]NN'X$B)BW3V[?>[#KBB/V M@E(NQ_3/%);S>Z3KB:_IU2FLP*ZWKR]F@!./SHAP] M!E;Z_;;"_&6.4C\IW6(H5L*_W0C7P5\4,U9>T]7@43')A4X,P*J M,,,G4'#?@@!;V"8'L=RR<(^^1(J[Q!G9P*=5-K'5ZT,6I3E18K7D*O\KJ="W M_O>A\D-1'&UV*@%8-9-*YC#JK"K:^L@S;5VXX9HTPH-K1,'V/!"X99R?$K4C M#&J<6_H6$59UF:^W!C7>`("K#=X@>DU'8#.;'H63U1_O,3#.P80[5!`-JTG M08T_(^I%,A!31,(,7]R0N)\8A!TS"EO,%(UCS5F'>-2,L'! M_3Z.]1D.+&1"*6*"P2[X8:$2"Y*'MV M4BT'3P,;#KATE:`Z@\&K"3>$TD#X<[PG1G@`.B%-\XR43>,_F"#"*0*'PS+< MV.><8Q"L=IS`T6+)LPIE+N05[GZT%>R:K&^NR)_<0YD1P?`DID/@,C0+G8S1 M.:K^91UKWN$DN<39UR@;ODK7+'U\'Z!6VJ,$B:-.#RFGMFZWJ2?:5JQ)DGU; MPUP\E=<09,AEA6LOX+=SXV^`+]T;?PV@06[\`SP?ZVVNRBQBBQ41GS2?OK*I M@HN)=JZ2(JRM++=(B`C44(8Q%&%U:ARS_5QA,D5;NO-Y\"+D/97Q*L\/:-V] M*2ZE+K\MG\KWD!MP[,^0/F M')K3L'V;#5H5-.)C$\(*E2X99"IBO3ZUS+6][[#$-<31,8U*C<>,M69I'*;V MIXH01E(I_.-0^#M$-)O'19,DJ#([=VB%MVG)I;1`&D/,1G4*8\^LNKD.2HN= M<)+1:M9>_:-H3R;$VPRO$%J7T8WI6B!*5VBY^4>49=$X\#:,N/7X$1.'.`"4 M%&`,7UEM^D?+\J92>M+-]=4P6)/*O($!\]U-0;1][TY<%&[O/C7CV_F^F(DZI07 M&!J!^:L+C(N4O2-S<6\\OM?$IC>!G-ODMJ8ZZ8%:#3/(F,V_HA]W@N*]?(=! MN.$PU=ZP8*YF)>^F9%G;^SSG]-R)OA.-\MUE@K]Z$8RL;8S\41.7=/R6B4'J M,J88;0[9G#W'I/L^O7[)T?HJ;;.[+59%_%SEJV>K0)_!,3J9,H/W$&R:%LR@ MMY2BL*G78S40F^M+\=Y1'3UG2U=Q@GKB/6"S<3=E%:QC8VM5O*>C=GF)-2EL M;.2RGJ*!RHFPPXW]..-$V%-#5R.+]E1@E:3@#M!-K#O,EIO+.(V(JM(M]3<: MH1-`VF!42#I?I,(U="*\"AL4[GO-OESGZ+$XC_,5/J3%;8;V\6$OA*Z`GHE? M)OT;`;%<5RZ0S&Q5N(]*0>Y?(-CK59DS2IH`?Q;ZL4!DUM):%[S;)T-$`XE9X-8]LS7C- M=GC8U/%I!H]ABS7\K/SRU1W?S"Y6Y0HM)TI&\3,C%IM*$>YK45:1V0X+#8V= M!OVPAFEX9_D.\BJ.1!G3OBC/AX:SA4H1+LA91=X0R*4:)>XXK3DU/,4C2&0AJOO]81<`!_Y7+=[`:P] ML!"EBLHO'-C*"PS@*BH0.$S!NK`)3U&E&NM7/V'9CL%/ASQ.49ZC*CLOU5L3 M*5%F5P%%>9956#1PT&KH9Q+K*JS>./*E+T`>C-;R((*A*9BQE9466UY^Z<`1 MK:>E"6TROP4:GLM^X1JN)^W=@?:N(%@@:^O&!H95*M=W<)[#.0-\)VOEG$%8 MW>Q.*MLG2[KG#``&8HLB9.!90,5KG&X?4+:GSV.&:P=P`6%@Q7X!WPPKI+.Y M\14%N@`95$'E_#"+_4K#/2:\0T_UHD>(0AE9FT211Q8HXH!RV\`9OZK9'`.0 M=361\I"M=E%.QE`GK2U_PR0I,-XC<0L$"D%E75@Q>H!*@]_4P]]],+0U0*P5 M7LHOBYB\`L6Y30W:&`*&[0D^%T9WW0/)ZP*F9ZQ3?\?C@W-46N0R12L1_4!_EV^G]1F,#X3`#$+%K:FN+!\8@1NA\3#5 MWT5D1P&EOP``XWJE&4885#I4=!MIR;:9!K7`]E/3<*[4X9>V5J[4A=6%&R03 M+JWV5;KV%?JLL'DB3)H8:1*FH][`TT(0:,-4JTC\5=FTFV1)5^06'#^0'J-0I6O>% M6E'O46F@"354JE6D'Z[2"X/)%G9!)HPL>R5S`RN%M5(9(1A'90)%H5AV&_`; MU:!_6%SE^2/-R(K9HF^4:_%-X4^2:=(N`C4.G,69)D\9%?WP])24JHB21A57 MZ09G^ZK/.:G?U$HU<=.AI1Q&;RH0`4I!T\H/1&9]:F,P=3^Y&T"*G8*%0@T& M#(QW%>^HRS-<;]LV/#?*F7!@?CU&Y>I_#0L4(M$,<#%@.XM4J,*I2L],JDU5 MX#K"O:%JQ+K!Z8K\>7R#T%HW8J&T_=%H6FF;L[RMS,D$R79YZ33L1SX$4#+E5AR8G(MSB)5_1:S%D2 MPE%3>"FAI81-VD$!H;N5F$CY#Z13/R7CEW=JA1K3#"SD+ERNO".QINR#B+?< MBDH3#*S`;M+D4X]^FC:F*R`QD^DZRM;N!OP-^MK1=X93\F?E'I[3$]GREC1O M,R>4-#&QSF0/S`]:8(UCZX)A@:.]-1JW$TNXOO+,AVJQ]MTXM)A#+S9[/8ZU M%37T9S-N4_7R'-J6L`W3+QBOO\9)HF.'V*.DX./SM;*S1-.2Y" M>2,<0#D0CTGI;!QS^P2KR-8?AT.>=%`)>84]CJX(IW1+W\C4B;,<7JWU&G*# MBHN757)8$R,F&9HZ18]7MM_4N(*N*S'G[8P-,V*HB^U;,H'W4V)FU*VR;>!G%6>D;_1E%5+`J M-X:K4=NVYJAIWAT!A+0&BYC4F8EB-8MG@T"T`G%]L"*@'L-JLO;M@*@&.M`E MG,,>R>6+^69/T4U2ZS2S;*6UMF)QF`G"W;5,J^$R24O;H&9G1:.V'YO<1#'DWDX(OI@.*2]@^'R]0<[CW,9 M2Y'/,>P!NEBM#OM#:8N6J]CE4\RV&?38B)K*#.V(M2SONJEK'34A94KYA^B% M_T[3A,OQ$:<>%Y=G&L,6TJP5@E,,$/GQW$)"[O(]IU&'8V5EC)YYZM1?GU=( MZM4W+..G^2??%M$@`SN<$`GNXNVNR&^32&M7)(@<,63/BR<'H>W&EN#36@Y] M,:R(^Q8;1"P2P8>Q"NL'K"CN,!*#H(XV^(6`=]B3^<7^*<&O"-69*IU>0K0[ MG?("J8@KARW(%81JRZ*7?H"6=E&!W.O"\A:^9++IF[@"V#)LDO M)Q1*<,3VZX)"VG=81^;!6H%31[E,@/`.>T#_SR'*R#XA>:U#4$5))[+GES0Z MK&.RJW$VR(7-DZXB-$O7.%$N[RBX4^T^TIRT9EUVKCB"$X2TW5V(2#T/]J8@ITJ(-S';<"/7 M<]+WB*&D4D:<7BDT<&E(KH0R&']W@7\MN9JO$)'M,4&`J'-BPDZ<.1ZAYY`" MRZB"(Q'3*2($GQ`\MQE^0EGQ2H]CJ%?6RH8S1)$:1G+#[/(Y#Z#E2P#*J8$/$5#]3I1<&J8W\E:Z' M`;^&_UV)/L"4=OEAM$EX><\1:*H1%6!JU&60P])SO#:?5''*+B?'Y[!TM)X-AC[/H1)\(LVC;G57Z<7+"N7Y>%=THGG=H5:B?YM(+X]A&_1-#548VC*P8&MR`\JD`BL\RW&1S M]2`@NVV\36/Y&2R8OCW6D-)[#B15B=4..:2\+>79\<#U7PPL(#7G&4!HH%*3 M5@524L[-R6N`)_W'5TE=/Z?E4^WM1.PST5+\C$H_)^8.P(!#XZ6BP\%S-)IK M106A6K4UJ`WUPN`8)E%R/B^C`N4#L+`_ULH;?O0<%$)95(`P9-1TOL99O=-4A&6B\'%CM MT/J0D-YN5<5S1I53-M.[B-++S$!PV?J#B)7N0\@KY,=?PX-(_3'UGAWH=,/Z M,B:;8G1-IO3127+9@?+AKLQA9`84.`273BXW;5MKE-6/#X$SMC:GT1.*Y`XGR27.OD;9&@AS748CD*LS"@?BADK2!+AZK38]^%UF/W6\ MVYEE#M0CKCY'-(T$70@Q;U-JFJHB4$L;TZ^5?5*+#UV M]38'JV.;\)Z)=8K=)Z/]OT1Q2J,Y7J7W!&-E7*CR++T*WG"+LC)Z0[H"[4NM M\F?L6"WQ#SV1Z]0J'X0+-\ON.D%C9W,>5#X(['@=W>#B'.7Q-BTS4^6UACO: M:G64LY5$NN7X,\Y+?^!K*@E\(^Y!FT8CWVF;YF,M_.G:B2R,4P%G]3*]0ZM#1K.$?HKR&.Q39H_WV-O,!F_OD]1/J9,EM;?<$G=[ M&[:K]S5Z1LE/G6B.K6468EVU6)M?$%K,>X1J:D`-?/!*]%>G3L\K%9.I.YXJ MWU.JBV947E_2;''R.5.I]&A6!)8.*U>ZF7+ZED8I/;IRQ8'>EE2)7EU?CX:? MEKB)HW*(DN5C$F_+[KDD4UJ4_!-%67WG]MK`2KBRL,)K$"='DY>'J8YM:F=P M=3I*@VQ85\B/P=@)DEW?F;ZG29YN\=+DP;E'V7.\0NP(!(LDJ0^'Z@K,^=5<4-R MNL^N])/GAWWU&_`\SR;ST4BUPWQ6PW,"?4\W)NTT=C:WBVR;U%5'O>=\51Y\ M>@P%`TZ5X4P'F9%>3S&P5!LXFW<)-[CTXD3K*K>[VL!1*3P:)+#"LQH0&OJ: M#ORPQH3\0J$)0TC/]9M0A(YWV,/(B)R]LXR,$X'2K_WNH''TLG*U2-?G<7(H M$/2YDQ:7\5Y5C8LSHR/M=VQ+-WV[PJMWL#=4JR_0(_O%:G78'TI[NES%CNU% MMS'4-9$:_0SMB-UOWU%2ZW:#BN6&OAWF9N9F/M#S=.Q0@50B'C5VF MQTQU5IB&/(@F4:RUL62K=2''@X(E$W>\Q'A/*:ZVE!`GJ(8M(#1XC)8-2CQ" MS#]N0UU]U;RB<6\.>P?44;Z@CY?R:_2?^SB MU>Z"M+)X73ZAC!&*7:%$+3BHA.=!V]6E5HGD#N(>;N+RHWWCYITM;1MW*H,5 M&\U>LF+^)4;^]/I`ZEZ\Q,-1IU!"E@ZY6\(_#="VG>-]%*=0#8Q+R#30+6$S ML>+^Z4`F[WN\*;[2\\UT_6N4K>F?GQ$=WR,742!]ZP8JI7=F1%4Z!ZN+WK>E M@,HJQT]I)8$?I5P>LC0N0Q[3!^`O]*^<"34Y8?/>44`8"KC`PFJA2L0]<.^7 MTG=ZAQ/Z6BG#S]6S7B:>`)1=YWX>92B(@HNK!2DA>WTG$.>KOJ/=;?X\IP\! M<:F"THV`"2[E>Z&IZ]Y:)U"]7?K"G?[?1>E6]:>Z1P9T<`T*ACN, M/DKO3`_49;FW"]VZTEW(F:*]X-&E[>0DAE,"M)0\?76%ZKP"K9 M!WX\>HY(HU=5"ID!C%B?VG#LW4^!P$0@CPXL^NPLGVAZOBY2GL\G.,;H5!6N M\F%^&IH^`RK.&O`JG"Q;V9?3PU2INEFX=5-PAYU_F^N8`BVHG&W;"RL'EDYC M_R?CS=X!!K@:%0C*VP.J%&DN[D%%/%0"=R.H4D2J!"^V@DK=BK4T,(C+"JBP M]&D`532%LXSW9DUC*)I8/%AUX1ZUJB\GL,%TV^\)<-V#>-G2.L.=FZ[2-=H< MY7O(HC6ZB?8CGV\I7;OJX]*%!3FHP`8($U01[OB&;=)T-Q4JNS2%.@*/LW.' MGE%Z0'6,O+*3>?&[983MPU<^H;TMZ2W*5K0WMW0G?4QF5(9*JEN07Z6_'M(U MZ8YB-[HHT2S>'._2EO! MJ7SI]@'7T83SVPP_QVNZ6[O-8IQ5$8-'KU@ML&J>MQJQ\ARW%O6D@ENS:FW& M$_1V$P5>S:OLFD1,+3G]GSK<0+/?,P@HP+9&DILSR5[6HWNPIBEW.$DN<4;C M/G-D85`,Q.E1.)>((P:G[0Z'O$C!F-OP_LAF\*!#^EA6?Q/V5%K6^R+*"NN3 M>CL0UNO2X$3)8O6?0UQE3CTO,S95AITWOJ#EA@-/7LYW.*B*KH07`//`';H: M2?O)^3@P8Q,-,#4D\AU`0J&4T#+DI+%U^+F"1HJV-'2;+^`HP4_:#K%$`M*A M\6&2^@X7@(!J)H;)3W^=^8RR1^R/7:FB#^ZH$PO/JK!(!E#ID_@.$8%`2M#H M\ZDA\=_AW;!*5J+_^C'8M>BHZ7JKT3_HKD8O4O8(CWTMH<6>*8C20\7Q;0E6+S:7R M2KIJ(<`._`6F%T@\H+=X)!T]/\?C+8NK1#?(BI]>"=IX1C1YCY-#:4:8"`#3-X%"Y?1AH$-5<`VL M`*IP=TK!N7W=Q1E.SZ,BNG_-J4/G5;IB!PB4$C8WIP+",)`"%E4#(B+>4]QP M.M;Q((Z!ZNPI5W`=ZP#`>`X1$!37FAR-P]_%P.KC=4#@;V48(EUSWLA`2/D+ MP@ZIRHO\*L\/:+W,Z+_4%K7!RVFZMOJK?+`: M,.4/:RVFP6#!A%GX^%?1 MEF7<2ZH.-WIO<_;\2\:_$^]]&UQ@U-^\!Y=(%C6L##A9CI'KS"\"K3L)U11< M)0#EF-X3PG+!P$E5!WI0`]1B^>HTW#TX;WZ/L![CA8D9$U08&Y9"$B""BT,9CX]4SQX/>4B??B%4K))G>[V&9( ME'9/1M/3A8@OJ-C&`!-4I'^,Y@7"RN<4(S6P,`:@K-4MI`P19W#1C9$F MK$K_983K$T.=W;PXR"9@FPONC&$3)`$WV57/P:?-4@!4R0'-1'%0Q[6&ZVSS MGIGO/3.?>0*W]\Q\[YGYWC/SL94RV\Q\_N5F"-"I[STW@U@)+.-\[E@4X3PMDZW@P+?8X*^+?67G6]!G(TU[NJ39I$NRY?_M M_2;#YTQ)`::[U/*EG"Y9DJCZMY,OJ;N(66Z&X@T]D4#$C3^2A#@X'"I);X8] M656S7&Q>'HI#AKJB7[P\H31''-]L&ZSD"U4`*Q^5R6CP#7HI'KZBY!E]QNDX MU8L=9H!=*829CTLT.*@D.U=E;8(7==(FRG:WD*:%.]FI2?Y/%&4/7['1,!GP MT!H=+8\W-BC8NG,Y%MH6S7+^Y0E,JH=OS4%<](=!Q>4M#@2&_IP/A:I-X;I` MJXM\B0_#ZW@S)MI#H6+R!D<"0WNN!T+5I'##(VA(3&C-QT&'B?XX*)F\Q7$P MUI[S<5`V*=S0]FH2+S8%RJP,!B8GK1$QX/3&AH5(CR['QJ!=L_2&M]6M!O>I MICW7O6?]H\U[U@`.MRT>IIH=?9LU)-R]R%6Z1INC[`]9M$;TE<;PF%9*UX8? MX=(%!TZHS&;($]02[M+^&#QK?(]T%#BA`H^4,T2>!58-.(U8A8=?>YHSA+A1 M0VR^&#U]3"KR)WJ(7I`'X:CJIIS'^2K!.9W3>-&GI)2MM1=0N@N"@_=/.*6/ MCBG",Z63W7>3)J-5M7,NJ^0OC4SJ8P"WV.5;71G[/T6U#%=9+4 M'.[M="W:/5$46J3K:U(3%):P,GUPRLK,`Z)*FID`J++ZP[U);D8BSE"\3:'V M4T(]L)]PGM^;`\T?96B1BB\NC0?^9M;#3B5HM"W=^/*\;:[[P MM<"I"7MFPLFY)NM5%*?Q'*7!"@WT(RODS%[8@`+65$[?+ABTI`PE!VR!_OCW M(NQ7(V9O7:4&8)6B`QC#BLX%S!J*F@32L'8$'J^U';_5RDS1)H,*#6VRI-!< M8*RDG&ELLJ0%X;[IL[C-FI:N#M\F`V"C2O_K(Q%Z.J8%@NPG,"> M>.+#(K_VPK;O@X87J]PFE!MPTZK#W85W16_L(A&^]GTCB[0X>HR3N(@1Y!Y/ MD0/C[@[,P?G*KFWA#2J6&YI6L1I,28*_1NF*=PFL6WRPVH,7MY?@XE?R?TW] M1?02T?I74;Y;X?29K+E)]604Q,^D(2,'6IVBM<1J19VO_V#\E^!7U/JN/`PWF\/&AQ'RNXT9?PR<9 M3TK-"]?36U\39>;Y3U&.UEV",YQ+UXP6JS`>KJE6:;/HBQ[W>#L:Y2MI4LZ>4G>F!&5G,=0`.MF`H2+Z@[WD>I83)IY M1XK1+A$7CA713)#'D'@*D%756'[3Z1)/K!#I8B(>GER'0[>*)WE`="MXZH=$ MM_H,U26HQEJ0(8Q?@@/G8;=9ICLBXK7VR1*"X*-B_\FA>T^3>X0/FO:+T=!7W1+2XX;>91"&^K1P:.6=50Z:U2R>_WC195[%C^QU'I+=F3D@$E$ MRGM^UR,-"$X`677QQ&:M[1TWL\99>`_)AS9H4'LSG"=! MV>G096$EPA_L+L]N.S+>H*)^%"\[S146XIWO<@K-`)%PI4QSXLBI>19^)=WM M*[W5N\'I2@92>1GQ8<2PS`P@"E;)A#9T5+'Q^LGUTDGCD95J-QH^K`)7%^ZB MJ=S=49DSM$-I'C^C2C]?T@Q%2?P[6O\2Q2EU7UJFY^VCBGR1Q7F<;L\/&?G_ M6_([IDH:&)5)>-=]:IFW[X-@2E4J#0_+#9DBUM,I1P_7OZ^7#;89#S#J!N$R M:O>OLA>'8H>SN'A=O,3C*.$BHN&;[`&11Z*=XST!M%2X/AE7O(;,78*1*A#$ M&3ZD1?;Z&>T?1T>I(I(F)0B3Q+T1Y74'!DG%,80#IF6*`":S<%T3KE)B3M,H MN4//*#V@>Y0]QRMT=7?/!`B0NAT$$FJO8:,F*QQ!4K[A+BE[P9+^-YGQ\W6\ MHAIA@@E(72M82NTUF-1DA8-)RC?<\#Z2900&S\4R;5*VO9`F(W:6S?L)E0A= M>#*UR5BV]74IX$AQH`"PZ6U\NQ M,^XVK"`L=`RUM92[;_E[LEF-I8N7I[B*7'1.9C@PKMC%I"@;%@L?2WJ$53E=Q M$E>]+\D+98VQ.$JC%F/W:N^WC"/;HLDE0[=Q!]*DUV/Y\:PW">^A\NWP=F]3 M[*$33ZMYCL$R;G]O\V6GW>&N,SF*N*'AXM:'5>D_72OCF*:03@J,%*C&G,1# M#L;I;0PP#:TZ&$ZP5H9[JLL1FQT9'SI@9*7%@X1?^FT,#*#V'`P&?LO"#9I& M/1Q6>)M2'P68A*BD<,N^3;&!H`K3D8 M`^Q6Z<>G\Q3LY239_I1N64X$.D7%<.<4?1MXA^C-`>`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`HKV1(A!X4RB+F0>2&6,L+8BDDXWC4F\$8H9 MT%9,Q!',>3#;3MXSVB9F?$DA32T8A\;9]"3I#0R3JC\)L7E6$>^9O/37DZ8; M7_9!]AE1UR;.\F*0[8[=ZR#BIOLEQ#[C0$5.,"`D3,/=P`FM-P::0;$:FSBB M/%;A;M-$LSE#=U+O4P8_EN)"]SH]9D$X"GL7Y[\Q%A<0TG;A)"+U0%AZ0$$7 MJ-PE!X1T)"R+U-WR(\IWEPG^2M.MDCT;9R(2T+3S#Y/&X4`']`R&R38<\GS. MU2+=59X?Z(MY&JCVHU!")B53R@&E)V-BW$-81431L+CN7IT) M63I9NW&\H2+JA7*'MO3$M13K+M[NBGRQS1"B31^B`4K?8$).[S4R%,6%XT/. M.%P7^K[A.:[)*PHWRMMCCK(A_K[VHRBNS.%]1 M7ZG;#.WCPWX`0C!]K7$`O<]@4Q47##``XW"#IO7E[APF5W_F=!5`)1"38F?3@@DXNK"2XF M8WTG%D].2JH67\8IW>2>X;RHLK./$"6A:Y'$I?,;03#Q%)##96@Y\I47*_TR M1O9:8YG/*RA=XX\+^HTO30586-V/:]`/Z.47`B^C%:H>00CQ-B9CHJM+%@Z6 MN,)I(J?+K\;)SZ'CA+DJO,WBE>3`'%`.OEIORH4#+;CX-E?K307-$6J07A(< M*6\.]`YXN;GXSR$N7H\DXILI%08R/`H8!`E,J$+,$2JHJ8%JD,?]S35P&8G[ M!E,%10EG5@70CKQ'&2>Y9$>;[<_"/* MLB@MEEGIDW+Q@K)5G*-2R/9C7G\=VDP3%HW[KQ8+GU%J02E@N.K5U2`WP.PA MW5>@GUX;CQC`JU(^,>-]*8O8"Y'K9L4T%-M3/6LN-Z2CR?SX1)--WJ"7XN$K M2I[19YP6.]8#3F->#(5I\'+Z#`J`"FQ76^-W4_PV-`^!#.IV]W[Q])BG(6L> MOF(3J`]8Z""\93$W8+-U,RF>VRH#?U:@+C2I?7@7:L9$&\H5DUF"F:&?Z>%< M51IX0#5EL2_Q8?@HT(B'+IPK'G-$,T,[DX.YJG.*('%>8SE^-K;-71[:6"YY MS!++8^U,C^6RSL!3GRE(O=B0%IO#F@@Y,L":NQL"9V8=,GX#37*4S1/"YK8QKL^\] MK<\O)_14_^:C?IK#==V%DO>BCXG(?4:'HK#P[2J MY[:S*$G0^M.KSAV4.C?1=90*-Z_1:E559I=4*M4V6`_?KYB(]MH&XA=?[S-) MV??Y`U*?(:@@I.Z=_8!G<^(6ZE6(]:=\$N\0O];&-A[SV?(&$:V`?_0AVU4; MNK(VH?<[\D/^.7J)]Z,W["#:88A0-JW/X%`1$SZAB9DVD#BM;ZX*)"YQMDP1 M/2*H\K>!L,$K)`3)N%!X:)$(;@B;,?<&/[:\<'V*20<)H`8,1\=A93DNCJ-S M(-;ICTBYLH.>[O$.DX^E,&6GSJW0C9=+0;#L;),]GN]=O%C$8,HFU3IPMIGC%)O`4)0"(8-MB,/,K_?/^5`)>0H?O#H]`VR`EKQ8@(O>UPL'2P M;A>Q:RS/];:&G[TM,N% M,D!Z?,C`\F[4D:*&^P7I>H>OJF:OP&(Q\YV"9,&KL$\8S#Z MO;D!.?[NMLWLNYSQEVZ[V>;OA"W_'*?4&8C9=N:WNO6#;\X&&DN_6-ST_KCJ M,*`C:5`PW,UV[>7%[EC6MZ9C^]^\ZUA!T\4=VR\8;G;LL1W$(C/#4$HSY?8* MS7RNY"I-LAT6X.QCN#RP7/=]2L%51#NC,L2KYYU/N$LP_0R^BQZ(E^*5P#F9$4%X.,7 M#1.%0%58@"._IG`W5"PY+UZ>XDS)!')*"%`X*A$F^,2"6\##\D"%.J`$+G$9Y%C4X.9O*+J,X^WN4'&B?-NW//T5) ME*[0_0ZAXIK63=#UZ?5(<(;3LMT/I'6?7FL!R<(MWJ8E+2ORP?05-<[>$U;D M09+0([CNXOPWA@,;A%0`V2.I!\)VNX7Y`@9".A*61>I,V.Y1T?W7Z(GI224F MJ@7D$3F,?@3H'`R4;A@%B<^:SLT\EOH3\S/*'K'[K<=6`(N4=^"N<"R+%FFPGCGJH,Q'3U"'MBI<),YVB=1^H%?4>@`::4$.C M6D7A[OE!RUVLM%+D*7I<03^//(MQN/[.)]BP8:7=2K];IFM>OU-9S0K7>?0H MUZ?7&WJ>RGH")28:;:?Z1!Z(=A/M9;O%,%F=`8&2L4SU4>6]1*>R2K<<#NGST[$6#WN?+NO]_/C)U^@"^O M).87@^P83V%=EOV)KLOJ?=4"7;4(9D@WZY5^@\)]3C`6EK%2$1/5_<`C\D@T MYFI%1L85S_FJI6D+6B_RNGF=:WS6M*50HEVH`4HX,T/2OL,Z,O`=_&'Z#TW4K*!-7`HI:ITP*KW$CEPF.$R8O_4E#A`NG6ARNH("V5:;(9A7% M9_>^DA*OI$`S^"E74KP&A?M:CNF8\@M!YS7.\U87=R@IIJ76;9%HJ<:GZZ_56'3N\F!$^>XRP5_KMG&O";DTGCOUFU1=N-[B[BU&V\:YO:2`-#O<1 M\GO4.B/GF(O-!JTJO/SO0XHH`=M?04;7."?PZ7R+:`8521C=3,#$H\#1G5;> MX.>R?9">YM..>YM%ZW&/2T6#]CJ+D4?YC3HM)1__(.OQ,+"TP5CNRKU;6F1F#]3$V4T;?/`FK+-W^U:H*=PZ!&!.L-@Y!JFYF9@GC<HU)TR!2O<+\"8Q2'Z#'YE'&:_P598ULW0!U MI><"%X.P8B,,RHJ%A$$E%6AC4%9+N%XE1QE_C;<['1`"RXU0*"T7$@S5E*"- M0VDU3L[-V1?6_2U/ZTZXR)>;:]+@O.@>4S`"Y&N7;U_O*I?W'W&F2E%$GD9U M[I+&*,'P*KT\T%@8,-`-J<40.U('"RB.P';@^*%I] MW*!1N@'1LUD8!]&;61D'#S36-FRY&1R3<54D+S+2B:B(!^-2O=.QED(`CR?% M]?=7(*)Z`_>RE`C9>(`-\W>J%H,!M5-LIF#E*>84@.W4/86?IX\3O?ETH[UK M4:A0/_N7)W&'.GZB"G^*9YR#X\`@9I\Y#PI#@(Q'3X&1Y MR+>!3Y"WMMU1,13M1K"_D]`S;1&3/B1,P80VLDQ,]@W"`KRV[1YY=R,JM<(^ MX$]T)D^B/(\W,5J?'^B4?H->BH\_?L9IL1'V*J+?5 MAF9H:-PFFV]`V`?8'=FOTD$4L6[\HEQZSJA8?NS5""WOP034V7/2[B==C['TKPDIGZN[?GT+?5S&>6$GX2WZ"17G[XNJ83-#RF/#GH/>ZN>NO-JQ0UB$M1 MSMAL*)>K^T2AG/\`U56"(C`5JFD`:%M;Z,BW;A*VVM/+^Z_WC9H2@IZ.X__XXL8JK*6Y5\1A%55ZG1C7<. M`2%M$A(*2=UE7&R:5;V](FCN104J>V6]3-N+1$)P@].L^<_RO4)OY`PU8XOO M4(WF?-WK_--K!_>7&?K/`:6K5T98#8420SV)2KC7`*MMS&`;"B6&&A"5\$H# M>8M:=MY3A2("'8R+N%_E`3H5:RF`LVKCU]>;J(7US"#\`\":<-0N'GHM`46/"/2*^C%.R4H^CY+CX9\W48JK&+O.H MG$GWD$5I3GJ#8N`>9<_QBO3O[K%VF/4=D0W?Q MLMK1)V_-GH^7_5Q.>TR"+J)U9@LG0016TTW?$-IL49V"7=22<*U@URF!FY5= M3,1P)O$B6_M4J`1I8UHX\IK@42X3>II-ALDSRHJ8+"AN<('*5+[L5$I`ZDZN M/B'U[#"GII]IP2=M2[@15RZ(`.LU6G>>YC!4P<[+HU&T2=>C5'1VV#;0W+1` M5VN8DQ@O;-M[&6^*W6)?GMV?D5;$Q66T*M^2L9>@0/)VLR,CGQU$%34T\5I4 MVA@GH5[@RP#P"@`\^<\6>&"MG'[*'X!-PREAFF`:Q[;F-+AO:[LEJ!,1CY#' M)IXQ^@#:.14"V4UQ$NF7!T#R-<[R8C!B.`"$$+<`%!//$(`*VID:@.*FA.O$ M(SOBQI,>^0XN,-AMH1U@MPWO%T_]BR?0-<>4ETV\!H0;'[AS?];^^6N,,M+% MN]=K](P2L6<(H-#8.418R+TJNC?PXZ:"/46D947^$ORR[O5SE3X=BKSLLA_% M3B-\RJ'L+$KWUDNI-[&*X'(?$6Z%O6MO5D7A7O2PQ&+GE`=0"B#F/I^\58A! M\LU;@9C;?/1V3L_S(MY'!2(KKT9`AIJY4-#Q4&JC&$*9J-0>> M:O0&%46U2#W#"7VCET4)$ZIRPB;RJH`P/!B"Q38$G:B><,/HUR\[.R'EH)91 MHV3=$4HEPP.DOF(,$:I4L>6K&#=>Q9"=*,^?&[A3X[H8"^KF^G;SZWP_]N'Y M&\-/&T[C)C;4=6D)=@Y'=HGW9(.NGX#+N]-FRD%N;8J)!]_`4H!M=\:Y10%#T6SN M[S6$D8&4W8#9A.QO([HK64E0J7$D6W&I]]CCGAE/6"];CT(NK%8G'GGXH[05 M\SVQAB(T-96AC4UX?>'&4YM@KE>94":;[R6-"#SCR30[<6QWRVG_'.>Z&]C, ML*GZ\XDGP?=8)Y/_B(O=EQ0_YBA[KK)CTOM?&IPUI1[\95<,%$*5=WO(5KLH M1_E]E*#\*L\/-,94?H\*TI%5U"K)"86+-@A\<$[0ACGT>\EFNB[ML;??6S5[ M]T;8"?@Y]R$6NTI^C36YM+P;&#,I]4W_$UE?X/5]$67%',W_":S["8SWNTF8 MM,OF9Q8ZDH;K'&=1'U3U4QJ#/G_[EJ#A_VX&INJL^=F`1LP9W/Q;Z(5RF7.5 MKC+""IVCZM\)5P?"^B98*G#J>S<8I^K,^1D0GMCA^I0&=M#PKQ_?CQI"L`_L MSIJ?0>@?-F@XZ%:'#1?I>OZW#0Z/CT]U2W%:$R7Z8$TE2F4ZP58`9>8WZ'24-?$@`38IW+W9-8[2_#9ZI:.=X>8R M]$:"43=>2#+J^4%834$3@U?:&/T=@!>>2].$`.PT03].G^O9F0IR#`O4 M+#H6>WQ(QV[3FIWA=;*?9EF\.7(!"E.;24C_+T["*6F.KV\). MJ[HL=BBCRSJR)]AWA'>=6;5J5Z<]W"R_]=0'+U`C!5+`X7Q?`>@,[Y]0FM>= M7;]K.$NB/(\W,:)@I%!$C(6`9OEVA:!AY;*Z9OH&1UUW-_LIUAAL- M4"RL!EHU`#HK3)X(A@/D^9#HJ8D2M[X\%$26VR1*;Z-7T:L4A1*#&'_"$NZN MQ.IL<(J9X M#>L%`!]V<::&OU$)*?PZ)<)''T]\R^#K5!-X6%>^C)?XD!4[)?"-BTC1URT2 M/ORX"K",OVX]@5_/"X2D>=S4\#2JMR4FB/8?=T!G'U(4BN8DVY1ML'9GGKREU[07Z-LK7&N"6(C/^R4L'$[ MP$G7[^."MA-R]JE2I#M\I45\7.?"NA]K:06\^A4VHAW(TLJG"YBU41/Y=]RYDLE,O50%(HYVPZN%_MT/J0H.6&UYDX+_J>0;56-$K6>E$J MZ4PSO;;1`YF$H1EMWC%O%#"?VNI_^[ MJD[>UP_XG/P,V[V)RXIW<+RR?I@S68\/AZ&B3@0VCU/S:%S*:PP^I'Q/WEHA M=SA)+G%&#X!$&.53LU#)HO9*:H"H`/E\&5R"SAF.*[9P@N$SYCT:.2W/603> M'AD/Z4PFG;=\ED.2<*6F"Z*0@X,:[>*DNP8+^S96'>&&QRQO M]J5+4`E5U]_%W\4H`$PP.?5`Q.4=;AC**M-!Z]Y0NSP,L",FZJ8,9Q`%@QR0 ME'K`X;$.U[_V%XS77^,DZ7O&#'`C)JHURB,*!C<@*?5PPV,=>(C'HSC+S151 M2KJ-'Y,ZULY5ND:;.(T+E,3/:'WQLDH.:Z*E1A4#B-E@57>1&:M@X&I18WJ@ M-FN`OI^A)[Z@-FX<89=A]BX@N?6%F^6:HP2!,R0V\144#!51Y;0GE"H---S8 MT06X/^SM$O>/*Y=.QXBC?'1__#S?,Z@5KT50*.AP@D+["!FH8#A%! M?71(J-03KN?=%QJ8EC9__26E`9YB*E&4-+FCCE)^BA+ZNNM^AU#!#"-N@5/= M44:<_`>P/44I(MJHXL#=+,"RG^WH&_'EII)[D9-MU2$IEIN_1UE,=U'T03E. MZR/S89X\-\++)Y1%%$UEV];5Z;/X>;"\R.A=L*B(.W?$ M#)-F%:_T50D]U:7Y%9_H./GT^D#J9CP/5BC1."E"2OBG`=HVYC-BA1(R#71+ MV-PS9T^88(V`;A.3==U3M$+,-X1RPG:WS"=T-@>I]`-6$+8_[0!JJ28;/G?O MSE2B)#DC$A#F;%CPOK>Y<4??@P&!1#2]OA\S]>U=<3WYX#2_/SP1H%)I'K+J MI*-"+!L*RN4:WS%XN5"@HZL*+4@I5.8N6"4':D<#>%5NB=8)RMC@DE,VD=>ZF@.>/PJ]/ MJ/9N/>&>SM_1\R-62*;A[\TKBN/O;MO,CE`R_M)M-]M\G[#E]8T/L^W,;_W[ M->?3#TN_6-ST@>?1D4'G!LQ\U^)Z&'V.7O@=R_K6=&S_FW<=*VBZN&/[!0/V MTQO902PR,PREM-%KNH7>SCS-FTCT9N,.MX!?3+%$O.9$H8$1]_?`7&)W[WPR M%%$'TBBYR$F?HV95-73JDY`U3GU<,GY=;LB_"`LKW0'G8)F#:P M(@B@LZ5RJ78UBV'H669Z(N5W1!T$RRC-T0T:9<^`T#(A,Z(-#CUB:E%+ZL'PIV"3#7OJP?+GT\\ZIC+I7LUSH=*MV7-)9/. MC2EW-CEA!T_L1`+=0H+"0DW35O">TT;D5->NEP,=*/J_:)9F^\!Y[`,#;"E[ MV:576$U'[A=0NE`8.P^:>,,HMH+A43BA1XPGJ9R!`G.]8K3+JT':"\^8Z5$- M](Z9#MAV/&2"PS;/2\:`@S*^??"4.0G"8=XRDV+ M,Z>`.,Q[9DJ$6_&@"0[@'"\:?0;*`/?`D^8D``=YTTP*-6$!G.M5HUU> M#=Y>>-9,CVZ@=\UTX+;C81,6MO40K8?C6:/7$6:G\;B9U4FWV?'HJ9#19%?JG#ZZ5S3=T&LDQ^LH= M6R48RT#3W-[OB)(?J30T+Q!*\Y*OZ\0NQU0ZRTVW7=WTPL>6-Z:'P87YK@AGVO[G#C+;FCQ*D:QHF^R;:L]/83%E%@Z1)JG#6*1?[IP2_(G1? MX-5ORR].(.D7DO7I&) ML92-':!=1-.$:F?3S!:?$)VU*\+B+0/OA,BP^C*, M>+_:<#V,WQ/;O">V>4]L\Y[8YCVQS7MB&W>SN&KV&PLS^"Q2Y$CUP%/#Z%(- M>O0(9@@]:`0P#$^]Y?_]G>RYXG1[B[(8KX>AR:=@;:IR)FM_-^EP*$*V@_KZ M5MS!2YL-VCLJ-=?)NHK]/)S=ZF.JG:K-W,$"*30:!N)"LP.X@HZFA:ZX(8'' M^]56ULV!+@'K-4R^>([BTOWG$F>_D++#B_JIJS&=,Z35S&YX3=H/7LTETJ9; M/C9V<6&,LF>:FYVIHANL.WAIB6;3"G5`H58N?HG2C?V0EO?EU&$9?(U18[*IL]*MEJ8$N.A&FT%=D=UY:\H.(&WH^13&_Q3F/F`#SY*' M)AVESFY_QPEAD\3%ZQU!Y92])*YQBC[CU3@3XVW37&MWV)0FVH915A$L7.>: M2=1S'C_':Y2N3V486/5-:1;Z];T;!5N=%;))Z(L5N-O+HUPYCRK*>4#9GNFE M,6E%71,P444S'_NGZ)Y3#OJ)Y`D\$:E5G=_%^6^7&4)-CIZIUP"B^J98`[#K MF[D=.&%GA;@&8(ME^?HO6%!-=U2H<*03UH&@6+`IO+M"0)==YR'MRR"O_(A4 MI-"/K^C%ID1'/8OUNKQAC9)?4(JR*#G&T[%^P*Q2E[$[.:BN\/JKO@E9'HJ\ MB-)UG&[O<))3][7T19$>S6G7GE_$N&B2442=8%WYQ0O*5G$^\HC79]`, M10T&Q48UI0@Z4QS:SA?4P;]$@H8YHIB<;+D'F-Z9.? M./WKQ_@]#G[I.,9RY_:_/SB/_[ M:-;NC5#&,D..@),'G>2.T^Y3&_P$<%8(X-7;\UYU6T6 MKQ#5UF;JJV#%!MA?(8(;,/?N=M/';CHVQ+G`?.S8G2`4>G6R10=0`Y:G$;'D M;^.BFQN5%O*XVLCNV*_9.)&41LWO]N?$O1N$#;(I?<`7\Z9J:C3AQ/YH56[+ M!"E6_FZ%3M_'LS!$B@H(-[JFL:88%\>GM$::U=NR1\K5OULD%_T\"YNDK()P M`X9:L-^CJ^_3KI&TJK>W2E*L_MTJN>CG65@E916\P="D(1Q43^FE\FY\W!U5 MG\[;Q>/#ZG?_F-+3X(161[%6^[XT[S9G`INCUZMSL#A@R=^]>$[IQ:/G7A&N MAP]8WAG?CDBT=>R5"8-SJ-1E:6Z3U!5>A$V0)**Y"ZC,3FRSV&ZS M\C'M%1D+<9K'JRKF(GN3`J2N>TY*'>S&KK.XZIP9,RC6 M[)[B"-7<-T62!EH^;ADV+/`W579F]KY2)EP,#7DE<2H1_Z?PAOYMQE>(;3.+PF$(/%7P?1UGP+H M9S)@5#4S!=H!;:BA^N=`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`=_-IV?F MTP`N;]A\:AQXO=],>H"*\*XNU:1[CY]6P`O"Z;NWB)1X&Y`)0 MUCH24OHFZ3FFN2=@LO9IQ=(VM,[DI?`B)B=*4/X9,=R)N=]KN1C?G4T:L/[` M.*KSETEAJ\*=V>]4#<2K=DRU%/\0+EJA9H48,!"SLS+5)#! MF@KKVQC+K2NSG@!;%>[ASV+][T->4-/Y@(\9/&ZC>'V5GD5/<1G(GYK8A^CE M8K-!JZ*,F\Y4QPT:I<";AGLS7FQSG^7`FK0+IA^!MIL?<"*JJ1=WTZX(3K0@ MM"Y$N("9XCYGNN/[Z>YVK+;9$AS^^OT(#01SOU7?F)]Z2$$O!4K7QWPI/:SL M4)04-#M!_AVQC%7E%U%&LSCGUSC/B5"E#LY1$<5)_HVS_4W=IJ8]G"P),K)F MQ\$E\^%F;="X\S@Y$!A_>B40W./T+(ERV;V9*H?QK1B<@[OE:'FC2FIAW'(Q MOS5+P?XW?_U5N=?(1PG2]6T2I3?1'C$OP*:L`NI-JE6%NTZA7CI=26C+V-U)]Q-.4%)A:O MR;@;?FA%Y?E/OX)P;3I':N[M#)"7=SV*.,4G/V:]SO=5L9WYWU MR@TJJN-#NB\>RL'ZULC0_^9L^/)UC<4"]`?GB`T=>H/B@5^-@P<4EB-X<.HM MX5SJ4T>UB?HQ3OXU0PL`44M6*8%,X&]^`!3A5OLG;USI>'(B^B=$UZ MCDSU\6H@JU;96@N*9=V=#POZ$YNI8'"8.ZZ(#@K%"@+WYB"V-"M7F%%2+70J M.1<%V0@\'@JZX'G`XZ5G9V4Z]H2VQ/#H+FW,T%5K'O7%()-GX*[A0[G+.7N1 MKFOY@5=[DE*YD=A1WD1;QFHH8/Z-[M#ID<1&C_.)EE1S6:$T]=NEMW*&H M_>^&VA%[1MED/G*:LL/HKK!08E%^J, M[YUU2FR.B;T)7I&V2-VOS)1T;*^NPQ$SY.YOH@T;7(Q]BOYOW]$ M69D)H'8_?\!G4;X[HY'>LB(F)OX&%YRG\)JE:_4JEPX"8&8Z48><=;]B0B-__EB0)=]MNJ);1:96=#2+O$,P>VU`5 MOMCC0SIZ>6^3IQU5-SQ#G?*8)^A3Z-GJ)-@[A[?4VO=IT?JTJ'K&[\D<^`:O M"28X;M:Y0;#3C$!?LR]6J\/^4&[DEZO8]3OV;FMH,@"J^`SM4)J3OCFZT-^@ M8KEYB%XXOC"&7)HY6I>+N]4/K,6L.R"=HFIZ%M.[\7_K-85Y]"&D:WQ%P(#3Z*RP=3-:D&YS+)2<\!G M"D?Y'[(HS9,*#VUP+QG"`87&&!86"@*E<+'5<2CD'>YB'C8+8M@T,MA]B5B7 MOE1LEN%NE[466%AM*3(X[5"HL;JU%]84^)NQ.[2BGF#Q)JY#DQW(LAV@(L;J MT`:K-HR(":O@E,E04)]"GV:#P!+K7+WK%]]0-@="G8'P=N$OV_` M5X&\U3>\)US;:"QH-&;H&2]=G*Q7E!8IMMSUY[KB_M>/[VMN#2VY6W7_M^ZJ M^R)=6U]B"":)ZB`!KV*.#Y1.4<%.&\CYVL;G&WSUYO@2 MU$]8)I_X_%%41Q5K;\!;8T?ZD[&^7-$ MO41S6^MW&7.CY3R?>7!HGU2[9H/%=M/"/?.UJ`FKFV10#?9'F@=+.`^&&VB; MXG#,&6VV!Y,<+J+$]76HR:K=8,UHOF!7J[SNK#\$>FFM>Z]I>"]F=I>I7KGE MX`_^=1#W"0F\K^2OF#3;HM!E=N.CG3PA9YV4]!-*T28N/F,XZD8\6Z?H. M%7$5NOR8B96S:=UR%AJ))88^)8@NIHF]*%"JNPFN#*K3I079JXW&/MGWYG9N/ND5WZ`EG19QN M.;9"1M8\3^.2N3U,DZC=!5'R56ZP=F^9/\EC0[KF"R/75M]82NE"T?-TC5` ME$N[>\0=)2B_0\\H/1"SECW'J_($9S@UBJF:F9%'Y6S+` MI&3*/)!9<_F$JEFR]F"LZ!ZB%Y1_CE.ZFD,<-NZZQGA8GK3I@;LOAI[1V`#A\'S'&AAD9T/6\"3T M9.D@'U-D&U7FZ2GCA2G;>69IL*T>E`X1C68J.H'-'%2O[TKH_W*'B-K-9JD# M9E9Y%3CWR\\6T`(UG0;2_09,<>-^TO@*1/K#JCAD-"84$6F+QG$]^"2M:RR+ M)$0(`H0U1AF[CAI(?PS/.B[RG"Q=]D]1G-$5+AM%8J+F%0"'*$0D@00VQA*O MEAI-?YKL4+K^0O_O,7_!U!+`P04````"`#-@FY$I[[R'2H1``"=O@`` M$0`<`&AW87DM,C`Q,S$R,S$N>'-D550)``,!92-3`64C4W5X"P`!!"4.```$ M.0$``.U=W7/CMA%_[TS_!]8OO5(NJ1YRL`D)"$A M004`;2M_?1<@*?$3("7='3WEDV5@=[&[/WPO0'S_XXOG6D^8<>+3JY/NZ?F) MA:GM.X0NKTX"WD'<)N3DQQ_^_K?O_]'IO,<4,R2P8SUNK!O";=?G`#5Z@P!57)W\&R"4+ M@IT3"SQ`^;L7OA7T_/Q\^GQYZK,E"#GOGOWWPWBFBHYI92'F8D-:\*'8K/%. M^@+Q1R4[SE$LG?-N9\?D$OI'2IV71^;&"EV>R>Q'Q/%6]QQ]I#[XO'>FD M((AH1!/*!:(V3M([8LN0)'Y[%F;&I(0^89XAY=@^7?I/9V%>@:4T\(JU<00[ MD^XY`PK,B+UE\&D%'I]V,GP.)L6J0492+ZAKEB5K&Z+4%TC6:I44):[7A"[\ M*`72I&_?Q7A,\<)2WGXGM;@ZX<1;N]*5*FW%\`)4@)K2B2O);VN&3T&_F(3Y M+M:`([//UK)AT%"S\:[@6`1B=DY*KC:`$'^-F2!0^W:5Z>QH9MG(K6L6L-B! MVVBK'+RH:Q6P$$J:;)2+'NL:!2S8_;3V2#ESL,"2/SY.1V6]K=+GQK<#V<'W MJ3.D@HC-")HH\U1=.K&(^`^V'<^C_S\]AV(HE)'\BZEBA."LA M[_NSK)"L_(!C9T)_4+^SK3GBCDATG)D&4YTQ72>+^:+4&(9#T!G`M,!WB2.G M#=?(E8/+;(6QX"$TY=E:7``5AX!LST8_#ZW1/?P_M-Z,)[-9B^UAV-;H!BI)V+-/ MT`!LZ"0NZW42FH+:7F./F@758H7H$O,1G0G?_F/ENPYF?/AG`.L;37W2\VD1 M_[IRWZ$`O^O?OQ_.`&I(GPS^!:Q9X'F*;R6)&EI0LH-^BHF_;?D`%HJ(.8 M$R%6GFT`Z2(/4B@K":#FW_,_C\,N_SF+5U<-K!([". M+LFCB_N<;[?T&LGO\4QC>,M(NQG MY`;X`T;2G\IW(6;%609\OLOC(^582I"5E-0BD49B(E:8Q7W6F*!'XB8:4&FN M`8]>'@\E*M&]):2UF&07#%RPP!8!DYT4=:;8E4OPP4H>;I+]U\A;0^V6]7FW MK-$QW"W@= M@0&S@E5[0II")R6OQ28SF8-Q(H8A^FWP>,$2/&1L79O9PH(>`LOC/(X,,&#* M$P=P2O(,KB]8B2M!G6LIR4J*:L%(@S%$C$(GP%5@!S/EMA"*PAP#$`4K]%B, M]48*^LH"42$X+1)I)/JV'7B!&D0G-@DQR*09O%^P7D\(L":#4>OS3%>TBT1- MU6GR!Q?%/5%AE@&!@D5\0HX5"K*DI!:)3#_DK5U_@_$UIE!PO`#,I1K\7[`V MCT58L8S6\YDV@)=R3KAS6AP]RJ<;O%^P\HZ$)!);_V?\_U.`&"RIWDM@K(KM/9+8P M0IL]8U,]%FLX5_/M89%>ZTW\JZTA)>'%.7ITXQJ02=,A'),:\/M.%Y"TWH0% MM=@8(I-)C$KR=%CEXI%&T*H$-5OTS-'--'#99#UFNYBF$2Y#3+1%JD)P-`E5 M0;H.JW1(U(C6-^==?5"UQ>O0Z&H2S+I,.J1KQ52-%>'0H&U;3^I$;Y-U0D>@ MP[\D9FM$NGKXM\7T.#'')-K[L>KJP5Z11E,M.5I(LZU#VOA9:J1/IFC'>$5H MA+`TWM9B4BOPEL1(2Z'=A2@)MQE1K!&Z:W&M$<-+HJK)UV%:&KDS@EHG#-BB M6BD>F,2S,$>'9"8*:,3/'$AL43MH-S^)9BT.'"P$$%;.PZ*%=Q@ M@8A;*U00LWR62$'OT$A!I&U;/4H"!:D*D$T\0JB@IP\5M/!4BQ6D8"K+/&:T MH%+)8L`PS.[[U)'>&_N(EB)I MH#\JP+F6F9;P+TLJ(R>EH3IJ#S>\Z4MB`?*=*;PGY/WL\= MZ^T=,=;;5J/:%UE35:8"G:YZ:"^P&JM!W1NQ+=SZV'YZ^I]*.CBZW]-%]UM8 MZH3WT\$$+ MI3!_"URU^ZKIUEB2J6V)V7NJ1OBJ7'9M`:Q^[34]4I9F:T?)_'57(XS5;LVV M0!YVXB8%;CT6'>#'.W/3._C,S?]!!?G^+/.V6IB0?H%-OK]&O+7/A$5SC_\E M7]5;(K1./347/APX]FTE+/T,7"'C&78%CU,Z.U&G+]R)'ZO2JJ-[84ZK3I9' M_CA8@8+7]ZKHD&"+?A^LB3HTQ#:U54GRQ?\HC:.HA]RD\[5:Q9?21B)O7K M&%@D'R:MX@/%(O_KQ'S2$Y?2$P=H\?49DZ\=5E1`4\9 MHBFOZ/?.#=4P*4V7OQ*(@71Y0OSH13`I#0,W`IJN3!7+5<\F*>`T5PG?FJJ2P M>Q!QUF/XON'5B:V.E92;K,*2X;E,=?YY,\%\!372&^L#;B/,`.Q<)$]/)G[NZ[M2N65\3 M:E\66W/YBJQY8+Z-L<-OF>]!G7N2[PE#T?>^2'8V6JK&V.K@1YVI-QB<(0-D M*J[R<0V+:[3F>++HK]?0BJ06\O&E0$#2F'@D7##SA!OVEO!:7'0'5M[@!89E MF"/0"Y(=KHWXRE:8RQ&-.PF1S2R1AT=`C#G_@RS)P+S&!A0GHB# MG1%]`.'L0161]-%A8AK3WYK:TR",)4*_6%81H)N882%<[/R*Q74@9%584O)7 M_,'+<+9XD)C7TOG(DQ`PMK*9OQ#/B&%Y;AHQ1_[\@+U'S%+S9R-M:JKL^!XB MM/&]S0$]2J-[#J?&W6`,NR8BHPR\S2F+S/, ME_I<5B."[E0$<@`-;>:[2B^>:YT5:)O6.N_1TQ/ALEM!=),SJ#"W:28,5H1! M[4("S38<2H$NPC%M]YND:U62#E3R@B:9LCL&2J22RB&27NI,3JBIAGT4=[=]8@0! MY`AE^\P!QE(;:_(US>Q;[&"&W%N8)O$I$OE)91E!TPP)IP[$?D`;F9J>**9S M/LE=--:ET/S4_IS51-M>&NUN5JTDOHT\AM6 M8?I4D#D+N!BC9QX04=0&2DD:9DM\-"Q`[NYZ?H%!!KJ&6?6!4.(%WA3+R0$H MD]0>!M')HTN6N0,Y=9B^6)2S=,JH1M#(!'5U/QY)/\KS,GT7;%@3@=SP6C^, M/O<^'O`)/#EX?6Z$Q@7_PKJ\8*&4RVO:^BC=]&4<)GD6NR"S M>?.F2$OH^F?!6MX"D-]99.$P,5DLY.FA'#(U>!J'F%)O)B\YC.A@A:CC8I8W M4$?5-),&/@,,D#Q,N]6ZX)Q/.5'3#%+W>.1]D(*QNB"O8#1U\SF?J6]K=J<3:MZ8_R$W*;1=QKAY@4(M=Y_<@^K8I3#TFBSEZR5X] M.D128PYP5;J)56+I-5[X#!_/,[_TGU?O)ZYBY'M1`U[3^,J$NJ/E69TXRO\%F_#N@V(1,EJ9IYL`0&YZ5 M]>3IO83BX:(R.9TR439E(6F\A!1'=/E(72"Z=?WGZ-O;X74(6*RLR+IH^VA5H4_LN M,G[W)3>T=P=1'ABLQ1\8]DC@[>ZFI&,3!M*HR7Z>"RI&T^*^1;Z8`9/8\/[B M1\CS8?'W%W;D-\ED,6"Z87)7A2QJJ/OL6?K4$_OL?4$L!`AX#%`````@` MS8)N1.$XCA+VB@$`V3X:`!$`&````````0```*2!`````&AW87DM,C`Q,S$R M,S$N>&UL550%``,!92-3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`S8)N M1/,>F':9%@``?UP!`!4`&````````0```*2!08L!`&AW87DM,C`Q,S$R,S%? M8V%L+GAM;%54!0`#`64C4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`,V" M;D1V`L``00E#@``!#D!``!02P$"'@,4````"`#- M@FY$;SMJW4KB``!.>@T`%0`8```````!````I(&KXP$`:'=A>2TR,#$S,3(S M,5]L86(N>&UL550%``,!92-3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` MS8)N1`1>CA9';P``.>\'`!4`&````````0```*2!1,8"`&AW87DM,C`Q,S$R M,S%?<')E+GAM;%54!0`#`64C4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`,V";D2GOO(=*A$``)V^```1`!@```````$```"D@=HU`P!H=V%Y+3(P,3,Q M,C,Q+GAS9%54!0`#`64C4W5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H" (``!/1P,````` ` end XML 56 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information (USD $)
 12 Months Ended
Dec. 31, 2013
Mar. 07, 2014
Jun. 30, 2013
Document and Entity Information [Abstract]      
Entity Registrant Name Healthways, Inc.    
Entity Central Index Key 0000704415    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Accelerated Filer    
Entity Common Stock, Shares Outstanding   35,208,572  
Document Fiscal Year Focus 2013    
Document Fiscal Period Focus FY    
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2013    
Entity Public Float     $ 534,700,000
XML 57 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Other Long-Term Liabilities
 12 Months Ended
Dec. 31, 2013
Other Long-Term Liabilities [Abstract]  
Other Long-Term Liabilities
9.Other Long-Term Liabilities

Other long-term liabilities consist primarily of the Cash Conversion Derivative (see Notes 6 and 7), deferred rent (see Note 12), a deferred compensation plan, and accrued performance cash (if pre-established performance metrics are met).

We have a non-qualified deferred compensation plan under which certain employees may defer a portion of their salaries and receive a Company matching contribution plus a discretionary contribution based on the Company's performance against targets.  Company contributions vest equally over four years.  We do not fund the plan and carry it as an unsecured obligation.  Participants in the plan elect payout dates for their account balances, which can be no earlier than four years from the period of the deferral.

As of December 31, 2013 and 2012, other long-term liabilities included vested amounts under the non-qualified deferred compensation plan of $6.8 and $6.6 million, respectively, net of the current portions of $1.0 and $4.1 million, respectively.  For the next five years ending December 31, 2018 we must make estimated plan payments of $1.0 million, $0.3 million, $0.4 million, $0.3 million, and $0.2 million, respectively.

In addition, under our stock incentive plan, we issue performance-based cash awards to certain employees based on pre-established performance metrics. Based on achievement of the performance metrics, the awards vest on the third anniversary of the grant date and are paid shortly thereafter.

As of December 31, 2013 and 2012, no accrued performance cash amounts were included in other long-term liabilities.
 
XML 58 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]      
Revenues $ 663,285 $ 677,170 $ 688,765
Cost of services (exclusive of depreciation and amortization of $36,183, $36,094, and $36,248, respectively, included below) 547,387 533,880 510,724
Selling, general and administrative expenses 61,205 60,888 64,843
Depreciation and amortization 52,791 51,734 49,988
Impairment loss 0 0 183,288
Restructuring and related charges 0 1,773 9,036
Operating income (loss) 1,902 28,895 (129,114)
Interest expense 16,079 14,149 13,193
Income (loss) before income taxes (14,177) 14,746 (142,307)
Income tax expense (benefit) (5,636) 6,722 15,386
Net income (loss) (8,541) 8,024 (157,693)
Earnings (loss) per share:      
Basic (in dollars per share) $ (0.25) $ 0.24 $ (4.68)
Diluted (in dollars per share) $ (0.25) [1] $ 0.24 [1] $ (4.68) [1]
Weighted average common shares and equivalents      
Basic (in shares) 34,489 33,597 33,677
Diluted (in shares) 34,489 [1] 33,836 [1] 33,677 [1]
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $ (8,019) $ 8,884 $ (156,049)
[1] The assumed exercise of stock-based compensation awards for the years ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive.
XML 59 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill
 12 Months Ended
Dec. 31, 2013
Goodwill [Abstract]  
Goodwill
3.Goodwill

The change in carrying amount of goodwill during the years ended December 31, 2011, 2012, and 2013 is shown below:

(In thousands)
 
 
Balance, December 31, 2010
 
$
496,265
 
Navvis purchase
  
21,527
 
Impairment loss
  
(182,400
)
Balance, December 31, 2011
  
335,392
 
Ascentia purchase
  
3,303
 
Balance, December 31, 2012
  
338,695
 
Other adjustments
  
105
 
Balance, December 31, 2013
 
$
338,800
 

In August 2011, we acquired Navvis & Company ("Navvis"), a firm that provides strategic counsel and change management services to healthcare systems, for $23.7 million in cash.  In addition, we issued 432,902 unregistered shares of our common stock which were valued in the aggregate at $3.3 million.

We performed a quantitative goodwill impairment review during the fourth quarter of 2011, and as a result of changes in our long-term projections related to the wind-down of our contract with CIGNA, we recorded a $182.4 million goodwill impairment loss.

In April 2012, we acquired Ascentia Health Care Solutions ("Ascentia"), a firm that supports and promotes population health management, patient centered programs, payer strategies and physician practice enhancement programs, for $5.5 million in cash.  In addition, we issued 14,409 unregistered shares of our common stock which were valued in the aggregate at $0.1 million.

As of January 1, 2013, the gross amount of goodwill totaled $521.1 million, and we had accumulated impairment losses of $182.4 million.
 
XML 60 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Recent Accounting Standards
 12 Months Ended
Dec. 31, 2013
Recent Accounting Standards [Abstract]  
Recent Accounting Standards
2.
Recent Accounting Standards

In July 2012, the FASB issued Accounting Standards Update ("ASU") No. 2012-02, "Intangibles—Goodwill and Other (Topic 350)—Testing Indefinite-Lived Intangible Assets for Impairment."  ASU No. 2012-02 permits an entity to perform a qualitative assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value.  If the entity concludes that this is the case, it must perform the currently prescribed quantitative impairment test by comparing the fair value of the indefinite-lived intangible asset with its carrying value.  Otherwise, the quantitative impairment test is not required. ASU No. 2012-02 is effective for fiscal years beginning after September 15, 2012, with earlier adoption permitted.  We adopted this standard for the fiscal year beginning January 1, 2013.  The adoption of this standard did not have a material impact on our consolidated results of operations, financial position, cash flows, or notes to the consolidated financial statements.
 
In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220)—Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income," which requires companies to provide information about the amounts reclassified out of accumulated other comprehensive income ("AOCI") by component. In addition, entities are required to present, either on the face of the statement where net income is presented or in the accompanying notes, significant amounts reclassified out of AOCI by the respective line items of net income, but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period. For amounts that are not required to be reclassified in their entirety to net income, entities are required to cross-reference to other disclosures that provide additional detail on those amounts. ASU No. 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012.  We adopted this standard for the interim period beginning January 1, 2013. The adoption of this standard did not have a material impact on our consolidated results of operations, financial position, cash flows, or notes to the consolidated financial statements.
 
XML 61 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings (Loss) Per Share
 12 Months Ended
Dec. 31, 2013
Earnings (Loss) Per Share [Abstract]  
Earnings (Loss) Per Share
14.Earnings (Loss) Per Share
 
The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the years ended December 31, 2013, 2012, and 2011:

 
(In thousands except per share data)
 
Year Ended December 31,
 
Numerator:
 
2013
  
2012
  
2011
 
Net income (loss)
 
$
(8,541
)
 
$
8,024
  
$
(157,693
)
 
            
Denominator:
            
Shares used for basic earnings (loss) per share
  
34,489
   
33,597
   
33,677
 
Effect of dilutive stock options and restricted stock units outstanding:
            
Non-qualified stock options (1)
  
—
   
37
   
—
 
Restricted stock units (1)
  
—
   
202
   
—
 
Shares used for diluted earnings (loss) per share (1)
  
34,489
   
33,836
   
33,677
 
 
            
Earnings per share:
            
Basic
 
$
(0.25
)
 
$
0.24
  
$
(4.68
)
Diluted (1)
 
$
(0.25
)
 
$
0.24
  
$
(4.68
)
 
            
Dilutive securities outstanding not included in the computation of earnings per share because their effect is anti-dilutive:
            
Non-qualified stock options
  
3,234
   
4,926
   
4,845
 
Restricted stock units
  
334
   
193
   
469
 
Warrants related to Cash Convertible Notes
  
7,707
   
—
   
—
 
CareFirst Convertible Note
  
892
   
—
   
—
 
 
(1) The assumed exercise of stock-based compensation awards for the years ended December 31, 2013 and December 31, 2011 was not considered because the impact would be anti-dilutive.
XML 62 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restructuring and Related Charges and Impairment Loss
 12 Months Ended
Dec. 31, 2013
Restructuring and Related Charges and Impairment Loss [Abstract]  
Restructuring and Related Charges and Impairment Loss
10.Restructuring and Related Charges and Impairment Loss

In December 2012, we began a restructuring of the Company (the "2012 Restructuring"), which was largely completed by the end of 2012, primarily focused on capacity realignment. The majority of these charges were presented as a separate line item in the consolidated statement of operations. We do not expect to incur significant additional costs or adjustments related to this restructuring.

In November 2011, we began a restructuring of the Company (the "2011 Restructuring"), which was largely completed by the end of 2011, primarily focused on aligning our capacity requirements and organizational structure following CIGNA's decision to wind-down its contract beginning in 2012.  The majority of these charges were presented as a separate line item in the consolidated statement of operations.  We do not expect to incur significant additional costs or adjustments related to this restructuring.
 
In November 2010, we began a restructuring of the Company (the "2010 Restructuring"), which was largely completed by the end of 2010, primarily focused on aligning resources with current and emerging markets and consolidating operating capacity.  The majority of these charges were presented as a separate line item in the consolidated statement of operations.  We do not expect to incur significant additional costs or adjustments related to this restructuring.
 
The change in accrued restructuring and related charges related to the 2012 Restructuring, 2011 Restructuring, and 2010 Restructuring activities described above during the year ended December 31, 2013 were as follows:

(In thousands)
 
2012
Restructuring
  
2011
Restructuring(1)
   
2010
Restructuring(2)
   
Total
 
Accrued restructuring and related charges at December 31, 2010
 
$
—
  
$
—
   
$
7,607
   
$
7,607
 
Additions
  
—
   
8,430
    
—
    
8,430
 
Payments
  
—
   
(4
)
   
(5,124
)
   
(5,128
)
Adjustments
  
—
   
—
    
(900
)
(3) 
  
(900
)
Accrued restructuring and related charges at December 31, 2011
 
$
—
  
$
8,426
   
$
1,583
    
10,009
 
Additions
  
1,773
   
—
    
—
    
1,773
 
Payments
  
—
   
(7,368
)
   
(822
)
   
(8,190
)
Adjustments
  
—
   
(504
)
(4) 
  
(132
)
(3) 
  
(636
)
Accrued restructuring and related charges at December 31, 2012
 
$
1,773
  
$
554
   
$
629
    
2,956
 
Additions
  
—
   
—
    
—
    
—
 
Payments
  
(1,700
)
  
(366
)
   
(629
)
   
(2,695
)
Adjustments
  
(73
)
  
(29
)
    
— 
   
(102
)
Accrued restructuring and related charges at December 31, 2013
 
$
—
  
$
159
   
$
—
    
159
 

(1) Excludes non-cash charges of approximately $0.6 million, which primarily consisted of share-based compensation costs.

(2) Excludes non-cash charges of approximately $1.8 million, which primarily consisted of share-based compensation costs.

(3) Adjustments resulted primarily from a favorable adjustment to lease termination costs due to a sublease of certain unused office space.

(4)  Adjustments resulted primarily from actual employee tax and benefit amounts differing from previous estimates.
 
In December 2011, we recorded an impairment loss of $183.3 million which consisted of a goodwill impairment loss of $182.4 million (see Note 3) and an intangible asset write-off of $0.9 million.
XML 63 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt
 12 Months Ended
Dec. 31, 2013
Long-Term Debt [Abstract]  
Long-Term Debt
6.Long-Term Debt

1.50% Cash Convertible Senior Notes Due 2018

On July 16, 2013, the Company completed a private placement of $150.0 million aggregate principal amount of cash convertible senior notes due 2018 (the "Cash Convertible Notes"),  which bear interest at a rate of 1.50 % per year, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2014. The Cash Convertible Notes will mature on July 1, 2018, unless earlier repurchased or converted into cash in accordance with their terms prior to such date. The Cash Convertible Notes are convertible into cash based on the conversion rate set forth below and are not convertible into our common stock or any other securities under any circumstances. The initial cash conversion rate is 51.38 shares of our common stock per $1,000 principal amount of Cash Convertible Notes (equivalent to an initial conversion price of approximately $19.46 per share of common stock). The Cash Convertible Notes are our senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Cash Convertible Notes. As a result of this transaction, we recognized deferred loan costs of approximately $3.9 million, which are being amortized over the term of the Cash Convertible Notes using the effective interest method.

The cash conversion feature of the Cash Convertible Notes (the "Cash Conversion Derivative") requires bifurcation from the Cash Convertible Notes in accordance with ASC Topic 815, Derivatives and Hedging, and is recorded in other long-term liabilities as a derivative liability and carried at fair value. The fair value of the Cash Conversion Derivative at the time of issuance of the Cash Convertible Notes was $36.8 million, which was recorded as a debt discount for purposes of accounting for the debt component of the Cash Convertible Notes. The debt discount is being amortized over the term of the Cash Convertible Notes using the effective interest method. For the twelve months ended December 31, 2013, we recorded $3.1  million of interest expense related to the amortization of the debt discount based upon an effective interest rate of 5.7%. The net carrying amount of the Cash Convertible Notes at  December 31, 2013 was $116.4 million, net of the unamortized discount of $33.6 million.

In connection with the issuance of the Cash Convertible Notes, we entered into privately negotiated convertible note hedge transactions (the "Cash Convertible Notes Hedges"), which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elected to convert the Cash Convertible Notes at a time when our stock price exceeded the conversion price. The initial cost of the Cash Convertible Notes Hedges was $36.8 million. The Cash Convertible Notes Hedges are recorded in other assets as a derivative asset under FASB ASC Topic 815 and are carried at fair value.  See Note 8 for additional information regarding the Cash Convertible Notes Hedges and the Cash Conversion Derivative and their fair values as of December 31, 2013.

In July 2013, we also sold separate privately negotiated warrants (the "Warrants") initially relating, in the aggregate, to approximately 7.7 million shares of our common stock underlying the Cash Convertible Notes Hedges. The Warrants have an initial strike price of approximately $25.95 per share, which effectively increases the conversion price of the Cash Convertible Notes to a 60% premium to our stock price on July 1, 2013. The Warrants will be net share settled by issuing a number of shares of our common stock per Warrant corresponding to the excess of the market price per share of our common stock (as measured on each warrant exercise date under the terms of the Warrants) over the applicable strike price of the Warrants. The Warrants meet the definition of derivatives under the guidance in ASC Topic 815; however, because these instruments have been determined to be indexed to our own stock and meet the criteria for equity classification under ASC Topic 815-40, the Warrants have been accounted for as an adjustment to our additional paid-in-capital.

If the market value per share of our common stock exceeds the strike price of the warrants, the warrants will have a dilutive effect on net income per share, and the "treasury stock" method will be used in calculating the dilutive effect on earnings per share.
 
CareFirst Convertible Note

On October 1, 2013, we entered into an Investment Agreement (the "Investment Agreement") with CareFirst Holdings, LLC ("CareFirst"), which is in addition to certain existing commercial agreements between us and CareFirst relating to, among other things, disease management and care coordination services (the "Commercial Agreements"). Pursuant to the Investment Agreement, we issued to CareFirst a convertible subordinated promissory note in the aggregate original principal amount of $20 million (the "CareFirst Convertible Note") for a purchase price of $20 million. The CareFirst Convertible Note bears interest at a rate of 4.75% per year, payable quarterly in arrears on March 31, June 30, September 30 and December 31 of each calendar year, beginning on December 31, 2013. The CareFirst Convertible Note may be prepaid only under limited circumstances and upon the terms and conditions specified therein. If the CareFirst Convertible Note has not been fully converted or redeemed in accordance with its terms, it will mature on October 1, 2019.  The CareFirst Convertible Note is subordinate in right of payment to the prior payment in full of (a) all indebtedness of the Company under the Fifth Amended Credit Agreement, and (b) any other senior debt of the Company, which currently includes only the Cash Convertible Notes.
 
The CareFirst Convertible Note is convertible into shares of our common stock at the conversion rate determined by dividing (a) the sum of the portion of the principal to be converted and accrued and unpaid interest with respect to such principal by (b) the conversion price equal to $22.41 per share of our common stock.  The conversion price is subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications and similar events.
 
CareFirst has an opportunity to earn warrants to purchase shares of our common stock ("CareFirst Warrants") based on achievement of certain quarterly thresholds (the "Revenue Thresholds") for revenue derived from both the Commercial Agreements and from new business to us from third parties as a result of an introduction or referral to us by CareFirst (collectively, the "Quarterly Revenue").  If the Quarterly Revenue is greater than or equal to the applicable Revenue Threshold for any quarter ending on or prior to September 30, 2017, then we will issue to CareFirst a certain number of warrants exercisable for the number of shares of our common stock ("CareFirst Warrant Shares") determined in accordance with the terms of the Investment Agreement unless (i) CareFirst elects to receive a cash payment in accordance with the terms of the Investment Agreement or (ii) there is a change of control. The aggregate number of CareFirst Warrant Shares in any single 12-month period beginning on October 1, 2013 cannot exceed 400,000, and the aggregate number of CareFirst Warrant Shares issuable pursuant to the Investment Agreement cannot exceed 1,600,000. If issued, the CareFirst Warrants will have a dilutive effect on net income per share, and the "treasury stock" method will be used in calculating the dilutive effect on earnings per share. 
 
Also on October 1, 2013, in connection with the execution of the Investment Agreement, we entered into a Registration Rights Agreement with CareFirst, pursuant to which we agreed to use commercially reasonable efforts to cause any registration statement covering an underwritten offering of our common stock for our own account or for the account of any holder of our common stock (other than a registration statement on Form S-4 or Form S-8 or any successor thereto) to include those registrable common shares that any holder of such registrable common shares has requested to be registered. 

The term of the Investment Agreement expires on the earlier of (a) December 31, 2017 and (b) the first date on which no Commercial Agreement is in effect. 

Credit Facility

On June 8, 2012, we entered into the Fifth Amended Credit Agreement.  The Fifth Amended Credit Agreement provides us with a $200.0 million revolving credit facility that expires on June 8, 2017 and includes a swingline sub facility of $20.0 million and a $75.0 million sub facility for letters of credit.  The Fifth Amended Credit Agreement also provides a $200.0 million term loan facility that matures on June 8, 2017, $110.0 million of which remained outstanding at December 31, 2013, and an uncommitted incremental accordion facility of $200.0 million.

Borrowings under the Fifth Amended Credit Agreement generally bear interest at variable rates based on a margin or spread in excess of either (1) the one-month, two-month, three-month or six-month rate (or with the approval of affected lenders, nine-month or twelve-month rate) for Eurodollar deposits ("LIBOR") or (2) the greatest of (a) the SunTrust Bank prime lending rate, (b) the federal funds rate plus 0.50%, and (c) one-month LIBOR plus 1.00% (the "Base Rate"), as selected by the Company.  The LIBOR margin varies between 1.75% and 3.00%, and the Base Rate margin varies between 0.75% and 2.00%, depending on our leverage ratio.  The Fifth Amended Credit Agreement also provides for an annual fee ranging between 0.30% and 0.50% of the unused commitments under the revolving credit facility.  Extensions of credit under the Fifth Amended Credit Agreement are secured by guarantees from all of the Company's active domestic subsidiaries and by security interests in substantially all of the Company's and such subsidiaries' assets.
 
On February 5, 2013, we entered into an amendment to the Fifth Amended Credit Agreement, which included, among other things, a temporary increase in the LIBOR and Base Rate margins of 0.25%.  The increased margins were effective through December 31, 2013 and applied only when our total funded debt to EBITDA ratio was greater than or equal to 3.50 to 1.00.  On July 1, 2013, we entered into an additional amendment to the Fifth Amended Credit Agreement, which provided for, among other things, the amendment of certain negative covenants to permit the issuance of and payments related to the Cash Convertible Notes described above as well as increases in the maximum required levels of total funded debt to EBITDA beginning with the quarter ended June 30, 2013.  As of December 31, 2013, availability under the revolving credit facility totaled $38.7 million as calculated under the most restrictive covenant.

              We are required to repay outstanding revolving loans under the revolving credit facility on June 8, 2017. We are required to repay term loans in quarterly principal installments aggregating (1) 1.250% of the original aggregate principal amount of the term loans during each of the eight quarters beginning with the quarter ended September 30, 2012, (2) 1.875% of the original aggregate principal amount of the term loans during each of the next four quarters beginning with the quarter ending September 30, 2014, and (3) 2.500% of the original aggregate principal amount of the term loans during each of the remaining quarters prior to maturity on June 8, 2017, at which time the entire unpaid principal balance of the term loans is due and payable.

             The following table summarizes the minimum annual principal payments and repayments of the revolving advances under the Fifth Amended Credit Agreement, the Cash Convertible Notes, and the CareFirst Convertible Note for each of the next five years and thereafter:

(In thousands)
 
 
Year ending December 31,
 
 
2014
 
$
12,500
 
2015
  
17,500
 
2016
  
20,000
 
2017
  
63,625
 
2018
  
150,000
 
2019 and thereafter
  
20,000
 
Total
 
$
283,625
 

The Fifth Amended Credit Agreement contains financial covenants that require us to maintain specified ratios or levels of (1) total funded debt to EBITDA and (2) fixed charge coverage.  As of December 31, 2013, we were in compliance with all of the financial covenant requirements of the Fifth Amended Credit Agreement.

The Fifth Amended Credit Agreement contains various other affirmative and negative covenants that are typical for financings of this type.  Among other things, the Fifth Amended Credit Agreement limits repurchases of the Company's common stock and the amount of dividends that the Company can pay to holders of its common stock.
 
XML 64 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets
 12 Months Ended
Dec. 31, 2013
Intangible Assets [Abstract]  
Intangible Assets
4.Intangible Assets

Intangible assets subject to amortization at December 31, 2013 consisted of the following:

(In thousands)
 
Gross Carrying
Amount
  
Accumulated
Amortization
  
Net
 
 
 
  
  
 
Customer contracts
 
$
59,574
  
$
51,512
  
$
8,062
 
Acquired technology
  
29,431
   
25,589
   
3,842
 
Patents
  
24,547
   
15,081
   
9,466
 
Distributor and provider networks
  
8,709
   
7,190
   
1,519
 
Perpetual license to survey-based data
  
30,000
   
3,986
   
26,014
 
Other
  
5,077
   
3,867
   
1,210
 
Total
 
$
157,338
  
$
107,225
  
$
50,113
 

Intangible assets subject to amortization at December 31, 2012 consisted of the following:

(In thousands)
 
Gross Carrying
Amount
  
Accumulated
Amortization
  
Net
 
 
 
  
  
 
Customer contracts
 
$
59,305
  
$
44,571
  
$
14,734
 
Acquired technology
  
29,287
   
24,299
   
4,988
 
Patents
  
24,337
   
12,723
   
11,614
 
Distributor and provider networks
  
8,709
   
6,669
   
2,040
 
Perpetual license to survey-based data
  
29,000
   
2,708
   
26,292
 
Other
  
5,097
   
3,586
   
1,511
 
Total
 
$
155,735
  
$
94,556
  
$
61,179
 

Intangible assets subject to amortization are being amortized over estimated useful lives ranging from two to 25 years.  Total amortization expense for the years ended December 31, 2013, 2012, and 2011, was $12.7 million, $12.6 million, and $13.4 million, respectively.  The following table summarizes the estimated amortization expense for each of the next five years and thereafter:

(In thousands)
 
 
Year ending December 31,
 
 
2014
 
$
11,170
 
2015
  
6,783
 
2016
  
5,003
 
2017
  
3,343
 
2018
  
3,307
 
2019 and thereafter
  
20,507
 
Total
 
$
50,113
 

Intangible assets not subject to amortization at December 31, 2013 and 2012 consist of a trade name of $29.0 million.
 
XML 65 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
 12 Months Ended
Dec. 31, 2013
Income Taxes [Abstract]  
Income Taxes
5.            Income Taxes

Income tax expense is comprised of the following:

(In thousands)
 
Year Ended December 31,
 
 
 
2013
  
2012
  
2011
 
Current taxes
 
  
  
 
Federal
 
$
(1,311
)
 
$
(1,271
)
 
$
9,388
 
State
  
741
   
774
   
2,109
 
Foreign
  
1,693
   
1,754
   
1,707
 
Deferred taxes
            
Federal
  
(5,842
)
  
4,803
   
2,169
 
State
  
(1,018
)
  
413
   
438
 
Foreign
  
101
   
249
   
(425
)
Total
 
$
(5,636
)
 
$
6,722
  
$
15,386
 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.  The following table sets forth the significant components of our net deferred tax liability as of December 31, 2013 and 2012:
 
(In thousands)
 
December 31, 2013
  
December 31, 2012
 
 
 
  
 
Deferred tax asset:
 
  
 
Accruals and reserves
 
$
14,159
  
$
10,910
 
Deferred compensation
  
3,933
   
6,597
 
Share-based payments
  
10,703
   
12,213
 
Net operating loss carryforwards
  
8,303
   
7,914
 
Cash conversion derivative
  
3,553
   
—
 
Other assets and liabilities
  
1,486
   
1,533
 
 
  
42,137
   
39,167
 
Valuation allowance
  
(3,630
)
  
(3,242
)
 
 
$
38,507
  
$
35,925
 
Deferred tax liability:
        
Property and equipment
 
$
(44,740
)
 
$
(47,317
)
Intangible assets
  
(13,418
)
  
(15,700
)
Cash convertible notes hedges
  
(3,553
)
  
—
 
Other assets and liabilities
  
(449
)
  
(122
)
 
  
(62,160
)
  
(63,139
)
Net deferred tax liability
 
$
(23,653
)
 
$
(27,214
)
 
        
Net current deferred tax asset
 
$
9,667
  
$
8,839
 
Net long-term deferred tax liability
  
(33,320
)
  
(36,053
)
 
 
$
(23,653
)
 
$
(27,214
)

Based on the Company's historical and expected future taxable earnings, we believe it is more likely than not that the Company will realize the benefit of the existing deferred tax assets, net of the valuation allowance, at December 31, 2013.

For 2013, 2012 and 2011, the tax benefit of share-based compensation, excluding the tax benefit related to the deferred tax asset for share-based payments, was recorded as additional paid-in capital.  We recorded a tax effect of $1.0 million, $0.5 million, and $1.1 million in 2013, 2012, and 2011, respectively, related to our interest rate swap agreements (see Note 7) to stockholders' equity as a component of accumulated other comprehensive income (loss).

At December 31, 2013, we had international net operating loss carryforwards totaling approximately $13.9 million with an indefinite carryforward period, approximately $11.0 million of federal loss carryforwards originating from acquired entities, and approximately $17.7 million of state loss carryforwards.  We have provided a valuation allowance on certain deferred tax assets associated with our international net operating loss carryforwards.  The federal loss carryforwards are subject to an annual limitation under Internal Revenue Code Section 382, and expire in 2021 if not utilized.  The state loss carryforwards are expected to be fully utilized during future periods.

Undistributed earnings of the Company's foreign subsidiaries amounted to approximately $10.7 million as of December 31, 2013. Those earnings are considered to be indefinitely reinvested and, accordingly, no U.S. federal or state income taxes have been recorded thereon. Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to both U.S. income taxes (subject to an adjustment for foreign tax credits) and potential withholding taxes payable to the various foreign countries. Determination of the amount of unrecognized deferred U.S. income tax liability is not practical because of the complexities associated with its hypothetical calculation; however, unrecognized foreign tax credits would be available to reduce a portion of the U.S. tax liability.
 
The difference between income tax expense computed using the statutory federal income tax rate and the effective rate is as follows:
 
 
Year Ended December 31,
 
(In thousands)
 
2013
  
2012
  
2011
 
 
 
  
  
 
Statutory federal income tax
 
$
(4,962
)
 
$
5,161
  
$
(49,808
)
Non-deductible goodwill impairment expense
  
—
   
—
   
61,785
 
State income taxes, less federal income tax benefit
  
(669
)
  
453
   
1,520
 
Permanent items
  
634
   
389
   
434
 
Change in valuation allowance
  
388
   
285
   
972
 
Prior year tax adjustments
  
140
   
263
   
150
 
Uncertain tax position reversal
  
(1,137
)
  
—
   
—
 
Other
  
(30
)
  
171
   
333
 
Income tax expense (benefit)
 
$
(5,636
)
 
$
6,722
  
$
15,386
 

Uncertain Tax Positions

During 2013, we recorded a $1.1 million reduction to an unrecognized tax benefit due to the expiration of the applicable statutes of limitations for the 2009 tax year. As of December 31, 2013 and 2012, we had $0.3 and $1.3 million, respectively, of unrecognized tax benefits that, if recognized, would affect our effective tax rate. Our policy is to include interest and penalties related to unrecognized tax benefits in income tax expense.  During 2012, and 2011, we included an immaterial amount of net interest related to uncertain tax positions as a component of income tax expense.

The aggregate changes in the balance of unrecognized tax benefits, exclusive of interest, were as follows:

(In thousands)
 
 
Unrecognized tax benefits at December 31, 2011
 
$
1,392
 
Decreases based upon tax positions related to prior years
  
(44
)
Unrecognized tax benefits at December 31, 2012
 
$
1,348
 
Decreases based upon a lapse of the applicable statute of limitations
  
(1,060
)
Unrecognized tax benefits at December 31, 2013
 
$
288
 

We file income tax returns in the U.S. Federal jurisdiction and in various state and foreign jurisdictions.  Tax years remaining subject to examination in these jurisdictions include 2010 to present.
XML 66 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Investments and Hedging Activities
 12 Months Ended
Dec. 31, 2013
Derivative Investments and Hedging Activities [Abstract]  
Derivative Investments and Hedging Activities
7.Derivative Instruments and Hedging Activities

We use derivative instruments to manage risks related to interest rate swap agreements, foreign currencies, and the Cash Convertible Notes. We account for derivatives in accordance with FASB ASC Topic 815 which establishes accounting and reporting standards requiring that derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value shall be recognized currently in earnings unless specific hedge accounting criteria are met. As permitted under our master netting arrangements, the fair value amounts of our interest rate swaps and foreign currency options and/ or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets.

Derivative Instruments Designated as Hedging Instruments

Cash Flow Hedges
 
Derivative instruments that are designated and qualify as cash flow hedges are recorded at estimated fair value in the consolidated balance sheets, with the effective portion of the gains and losses being reported in accumulated other comprehensive income or loss ("accumulated OCI").  Cash flow hedges for all periods presented consist solely of interest rate swap agreements, which effectively modify our exposure to interest rate risk by converting a portion of our floating rate debt to fixed obligations, thus reducing the impact of interest rate changes on future interest expense. Under these agreements, we receive a variable rate of interest based on LIBOR (as defined in Note 6), and we pay a fixed rate of interest with interest rates ranging from 0.690% to 1.480% plus a spread (see Note 6).  We maintain interest rate swap agreements with current notional amounts of $145.0 million and termination dates ranging from November 2015 to December 2016.  Of this amount, $95.0 million was effective at December 31, 2013, and $50.0 million will become effective in December 2015, as older interest rate swap agreements expire. Gains and losses on these interest rate swap agreements are reclassified to interest expense in the same period during which the hedged transaction affects earnings or the period in which all or a portion of the hedge becomes ineffective.  As of December 31, 2013, we expect to reclassify $0.4 million of net losses on interest rate swap agreements from accumulated OCI to interest expense within the next 12 months due to the scheduled payment of interest associated with our debt.

The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the twelve months ended December 31, 2013 and 2012:

(In thousands)
For the Twelve Months Ended
 
Derivatives in Cash Flow Hedging Relationships
December 31, 2013
 
December 31, 2012
 
(Gain) loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect
 
$
(332
)
 
$
2,029
 
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect
 
$
(1,916
)
 
$
(3,302
)

Gains and losses representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.  During the twelve months ended December 31, 2013 and 2012, there were no gains or losses on cash flow hedges recognized in our consolidated statements of comprehensive income (loss) resulting from hedge ineffectiveness.

Derivative Instruments Not Designated as Hedging Instruments

Our Cash Conversion Derivative, Cash Convertible Notes Hedges, and foreign currency options and/or forward contracts do not qualify for hedge accounting treatment under U.S. GAAP and are measured at fair value with gains and losses recognized immediately in the consolidated statements of comprehensive income (loss). These derivative instruments not designated as hedging instruments did not have a material impact on our consolidated statements of comprehensive income (loss) during the twelve months ended December 31, 2013 and 2012.

The Cash Conversion Derivative is accounted for as a derivative liability and carried at fair value. In order to offset the risk associated with the Cash Conversion Derivative, we entered into Cash Convertible Notes Hedges which are cash-settled and are intended to reduce our exposure to potential cash payments that we would be required to make if holders elected to convert the Cash Convertible Notes at a time when our stock price exceeded the conversion price. The Cash Convertible Notes Hedges are accounted for as a derivative asset and carried at fair value.

The gains and losses resulting from changes in the fair values of the Cash Conversion Derivative and the Cash Convertible Notes Hedges are reported in the consolidated statements of comprehensive income (loss) as follows:
 
 
Twelve Months Ended
 
 
(In thousands)
December 31, 2013
 
December 31, 2012
 
Statements of Comprehensive Income (Loss) Classification
Cash Convertible Notes Hedges:
 
 
    
Net unrealized loss
 
$
(8,984
)
 
$
—
 
Selling, general and administrative expense
Cash Conversion Derivative:
        
     
Net unrealized gain
 
$
8,984
  
$
—
 
Selling, general and administrative expense

We also enter into foreign currency options and/or forward contracts in order to minimize our earnings exposure to fluctuations in foreign currency exchange rates.  Our foreign currency exchange contracts require current period mark-to-market accounting, with any change in fair value being recorded each period in the consolidated statements of comprehensive income (loss) in selling, general and administrative expenses. At December 31, 2013, we had forward contracts with notional amounts of $16.3 million to exchange foreign currencies, primarily the Australian dollar and Euro, that were entered into in order to hedge forecasted foreign net income (loss) and intercompany debt. We routinely monitor our foreign currency exposures to maximize the overall effectiveness of our foreign currency hedge positions.  We do not execute transactions or hold derivative financial instruments for trading or other purposes.

The estimated gross fair values of derivative instruments at December 31, 2013 and December 31, 2012, excluding the impact of netting derivative assets and liabilities when a legally enforceable master netting agreement exists, were as follows:

 
 
December 31, 2013
  
December 31, 2012
 
(In thousands)
 
Foreign currency exchange contracts
  
Interest rate swap agreements
  
Cash Convertible Notes Hedges and Cash Conversion Derivative
  
Foreign currency exchange contracts
  
Interest rate swap agreements
 
Assets:
 
  
  
  
  
 
Derivatives not designated as hedging instruments:
 
  
  
  
  
 
Other current assets
 
$
178
  
$
—
  
$
—
  
$
73
  
$
—
 
Other assets
  
—
   
—
   
27,766
   
—
   
—
 
Total assets
 
$
178
  
$
—
  
$
27,766
  
$
73
  
$
—
 
 
                    
Liabilities:
                    
Derivatives not designated as hedging instruments:
                    
Accrued liabilities
 
$
67
  
$
—
  
$
—
  
$
255
  
$
—
 
Other long-term liabilities
  
—
   
—
   
27,766
   
—
   
—
 
 
                    
Derivatives designated as hedging instruments:
                    
Accrued liabilities
  
—
   
—
   
—
   
—
   
1,742
 
Other long-term liabilities
  
—
   
505
   
—
   
—
   
1,221
 
Total liabilities
 
$
67
  
$
505
  
$
27,766
  
$
255
  
$
2,963
 
XML 67 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Investments and Hedging Activities (Tables)
 12 Months Ended
Dec. 31, 2013
Derivative Investments and Hedging Activities [Abstract]  
Effect of cash flow hedges on consolidated balance sheets
The following table shows the effect of our cash flow hedges on the consolidated balance sheets during the twelve months ended December 31, 2013 and 2012:

(In thousands)
For the Twelve Months Ended
 
Derivatives in Cash Flow Hedging Relationships
December 31, 2013
 
December 31, 2012
 
(Gain) loss related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect
 
$
(332
)
 
$
2,029
 
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect
 
$
(1,916
)
 
$
(3,302
)
Gains and Losses on Cash Convertible Notes Hedges and Cash Conversion Derivative
The gains and losses resulting from changes in the fair values of the Cash Conversion Derivative and the Cash Convertible Notes Hedges are reported in the consolidated statements of comprehensive income (loss) as follows:
 
Twelve Months Ended
 
 
(In thousands)
December 31, 2013
 
December 31, 2012
 
Statements of Comprehensive Income (Loss) Classification
Cash Convertible Notes Hedges:
 
 
    
Net unrealized loss
 
$
(8,984
)
 
$
—
 
Selling, general and administrative expense
Cash Conversion Derivative:
        
     
Net unrealized gain
 
$
8,984
  
$
—
 
Selling, general and administrative expense

 
Fair values of derivative instruments
The estimated gross fair values of derivative instruments at December 31, 2013 and December 31, 2012, excluding the impact of netting derivative assets and liabilities when a legally enforceable master netting agreement exists, were as follows:

 
 
December 31, 2013
  
December 31, 2012
 
(In thousands)
 
Foreign currency exchange contracts
  
Interest rate swap agreements
  
Cash Convertible Notes Hedges and Cash Conversion Derivative
  
Foreign currency exchange contracts
  
Interest rate swap agreements
 
Assets:
 
  
  
  
  
 
Derivatives not designated as hedging instruments:
 
  
  
  
  
 
Other current assets
 
$
178
  
$
—
  
$
—
  
$
73
  
$
—
 
Other assets
  
—
   
—
   
27,766
   
—
   
—
 
Total assets
 
$
178
  
$
—
  
$
27,766
  
$
73
  
$
—
 
 
                    
Liabilities:
                    
Derivatives not designated as hedging instruments:
                    
Accrued liabilities
 
$
67
  
$
—
  
$
—
  
$
255
  
$
—
 
Other long-term liabilities
  
—
   
—
   
27,766
   
—
   
—
 
 
                    
Derivatives designated as hedging instruments:
                    
Accrued liabilities
  
—
   
—
   
—
   
—
   
1,742
 
Other long-term liabilities
  
—
   
505
   
—
   
—
   
1,221
 
Total liabilities
 
$
67
  
$
505
  
$
27,766
  
$
255
  
$
2,963
 
XML 68 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restructuring and Related Charges and Impairment Loss (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Restructuring Cost and Reserve [Line Items]      
Cumulative net cash and non-cash charges   $ 1,800,000  
Restructuring Reserve [Roll Forward]      
Accrued restructuring and related charges, beginning of period 2,956,000 10,009,000 7,607,000
Additions 0 1,773,000 8,430,000
Payments (2,695,000) (8,190,000) (5,128,000)
Adjustments (102,000) (636,000) (900,000)
Accrued restructuring and related charges, end of period 159,000 2,956,000 10,009,000
Non-cash charges primarily consisting of share-based compensation costs   600,000  
Impairment loss 0 0 183,288,000
Goodwill impairment Loss     182,400,000
Intangible asset write-off     900,000
2011 Restructuring Plan [Member]
      
Restructuring Reserve [Roll Forward]      
Accrued restructuring and related charges, beginning of period 554,000 [1] 8,426,000 [1] 0 [1]
Additions 0 [1] 0 [1] 8,430,000 [1]
Payments (366,000) [1] (7,368,000) [1] (4,000) [1]
Adjustments (29,000) [1] (504,000) [1],[2] 0 [1]
Accrued restructuring and related charges, end of period 159,000 [1] 554,000 [1] 8,426,000 [1]
2010 Restructuring Plan [Member]
      
Restructuring Reserve [Roll Forward]      
Accrued restructuring and related charges, beginning of period 629,000 [3] 1,583,000 [3] 7,607,000 [3]
Additions 0 [3] 0 [3] 0 [3]
Payments (629,000) [3] (822,000) [3] (5,124,000) [3]
Adjustments 0 [3] (132,000) [3],[4] (900,000) [3],[4]
Accrued restructuring and related charges, end of period 0 [3] 629,000 [3] 1,583,000 [3]
Non-cash charges primarily consisting of share-based compensation costs   1,800,000  
2012 Restructuring Plan [Member]
      
Restructuring Reserve [Roll Forward]      
Accrued restructuring and related charges, beginning of period 1,773,000 0 0
Additions 0 1,773,000 0
Payments (1,700,000) 0 0
Adjustments (73,000) 0 0
Accrued restructuring and related charges, end of period $ 0 $ 1,773,000 $ 0
[1] Excludes non-cash charges of approximately $0.6 million, which primarily consisted of share-based compensation costs
[2] Adjustments resulted primarily from actual employee tax and benefit amounts differing from previous estimates.
[3] Excludes non-cash charges of approximately $1.8 million, which primarily consisted of share-based compensation costs.
[4] Adjustments resulted primarily from a favorable adjustment to lease termination costs due to a sublease of certain unused office space.
XML 69 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Leases
 12 Months Ended
Dec. 31, 2013
Leases [Abstract]  
Leases
12.Leases

We maintain operating lease agreements principally for our corporate office space, our well-being improvement call centers, and our operations support and training offices.  We lease approximately 264,000 square feet of office space in Franklin, Tennessee, which contains our corporate headquarters and one of our well-being improvement call centers.  This lease commenced in March 2008 and expires in February 2023.  We also lease approximately 92,000 square feet of office space in Chandler, Arizona which contains additional corporate colleagues and one of our well-being improvement call centers.  In addition, we lease office space for our seven other well-being improvement call center locations for an aggregate of approximately 160,000 square feet of space with lease terms expiring on various dates from 2014 to 2020.  Our operations support and training offices contain approximately 66,000 square feet in aggregate and have lease terms expiring from 2014 to 2020.

Our corporate office lease agreement contains escalation clauses and provides for two renewal options of five years each at then prevailing market rates.  The base rent for the initial 15-year term ranges from $4.2 million to $6.3 million per year over the term of the lease.  The landlord provided a tenant improvement allowance equal to approximately $10.3 million.  We record leasehold improvement incentives as deferred rent and amortize them as reductions to rent expense over the lease term.

Most of our operating leases include escalation clauses, some of which are fixed amounts, and some of which reflect changes in price indices.  We recognize rent expense on a straight-line basis over the lease term.  Certain operating leases contain renewal options to extend the lease for additional periods.  For the years ended December 31, 2013, 2012, and 2011, rent expense under lease agreements was approximately $12.9 million, $12.9 million, and $12.7 million, respectively.  Our capital lease obligations, which primarily include computer equipment leases, are included in long-term debt and the current portion of long-term debt.
 
The following table summarizes our future minimum lease payments under all capital leases and non-cancelable operating leases for each of the next five years and thereafter:

 
(In thousands)
 
Capital
  
Operating
 
Year ending December 31,
 
Leases
  
Leases
 
2014
 
$
1,199
  
$
13,198
 
2015
  
66
   
11,781
 
2016
  
—
   
10,764
 
2017
  
—
   
10,198
 
2018
  
—
   
10,707
 
2019 and thereafter
  
—
   
33,262
 
Total minimum lease payments
 
$
1,265
  
$
89,910
 
Less amount representing interest
  
(34
)
    
Present value of minimum lease payments
  
1,231
     
Less current portion
  
(1,166
)
    
 
 
$
65
     
XML 70 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Benefits
 12 Months Ended
Dec. 31, 2013
Employee Benefits [Abstract]  
Employee Benefits
17.Employee Benefits

We have a 401(k) Retirement Savings Plan (the "401(k) Plan") available to substantially all of our employees.  Employees can contribute up to a certain percentage of their base compensation as defined in the 401(k) Plan.  The Company matching contributions are subject to vesting requirements.  Company contributions under the 401(k) Plan totaled $3.1 million, $2.9 million, and $3.5 million for the years ended December 31, 2013, 2012, and 2011, respectively.
XML 71 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Details) (USD $)
 12 Months Ended 12 Months Ended
Dec. 31, 2013
Jul. 16, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2013
Cash Convertible Notes Hedge [Member]
Dec. 31, 2013
Fifth Amended Credit Facility [Member]
Dec. 31, 2013
Cash Convertible Notes [Member]
Dec. 31, 2013
Cash Conversion Derivative [Member]
Dec. 31, 2013
CareFirst Convertible Note [Member]
Dec. 31, 2013
Recurring [Member]
Foreign Exchange Contract [Member]
Level 2 [Member]
Dec. 31, 2012
Recurring [Member]
Foreign Exchange Contract [Member]
Level 2 [Member]
Dec. 31, 2013
Recurring [Member]
Foreign Exchange Contract [Member]
Level 3 [Member]
Dec. 31, 2012
Recurring [Member]
Foreign Exchange Contract [Member]
Level 3 [Member]
Dec. 31, 2013
Recurring [Member]
Foreign Exchange Contract [Member]
Gross Fair Value [Member]
Dec. 31, 2012
Recurring [Member]
Foreign Exchange Contract [Member]
Gross Fair Value [Member]
Dec. 31, 2013
Recurring [Member]
Foreign Exchange Contract [Member]
Netting [Member]
Dec. 31, 2012
Recurring [Member]
Foreign Exchange Contract [Member]
Netting [Member]
Dec. 31, 2013
Recurring [Member]
Foreign Exchange Contract [Member]
Net Fair Value [Member]
Dec. 31, 2012
Recurring [Member]
Foreign Exchange Contract [Member]
Net Fair Value [Member]
Dec. 31, 2013
Recurring [Member]
Interest Rate Swap [Member]
Level 2 [Member]
Dec. 31, 2012
Recurring [Member]
Interest Rate Swap [Member]
Level 2 [Member]
Dec. 31, 2013
Recurring [Member]
Interest Rate Swap [Member]
Level 3 [Member]
Dec. 31, 2012
Recurring [Member]
Interest Rate Swap [Member]
Level 3 [Member]
Dec. 31, 2013
Recurring [Member]
Interest Rate Swap [Member]
Gross Fair Value [Member]
Dec. 31, 2012
Recurring [Member]
Interest Rate Swap [Member]
Gross Fair Value [Member]
Dec. 31, 2013
Recurring [Member]
Interest Rate Swap [Member]
Netting [Member]
Dec. 31, 2012
Recurring [Member]
Interest Rate Swap [Member]
Netting [Member]
Dec. 31, 2013
Recurring [Member]
Interest Rate Swap [Member]
Net Fair Value [Member]
Dec. 31, 2012
Recurring [Member]
Interest Rate Swap [Member]
Net Fair Value [Member]
Dec. 31, 2013
Recurring [Member]
Cash Convertible Notes Hedge [Member]
Level 2 [Member]
Dec. 31, 2013
Recurring [Member]
Cash Convertible Notes Hedge [Member]
Level 3 [Member]
Dec. 31, 2013
Recurring [Member]
Cash Convertible Notes Hedge [Member]
Gross Fair Value [Member]
Dec. 31, 2013
Recurring [Member]
Cash Convertible Notes Hedge [Member]
Netting [Member]
Dec. 31, 2013
Recurring [Member]
Cash Convertible Notes Hedge [Member]
Net Fair Value [Member]
Dec. 31, 2013
Recurring [Member]
Cash Conversion Derivative [Member]
Level 2 [Member]
Dec. 31, 2013
Recurring [Member]
Cash Conversion Derivative [Member]
Level 3 [Member]
Dec. 31, 2013
Recurring [Member]
Cash Conversion Derivative [Member]
Gross Fair Value [Member]
Dec. 31, 2013
Recurring [Member]
Cash Conversion Derivative [Member]
Netting [Member]
Dec. 31, 2013
Recurring [Member]
Cash Conversion Derivative [Member]
Net Fair Value [Member]
Assets [Abstract]                                                                                
Assets, Fair Value                     $ 178,000 $ 73,000 $ 0 $ 0 $ 178,000 $ 73,000 $ (57,000) $ (73,000) $ 121,000 $ 0                     $ 0 $ 27,766,000 $ 27,766,000 $ 0 $ 27,766,000          
Liabilities [Abstract]                                                                                
Liabilities, Fair Value                     67,000 255,000 0 0 67,000 255,000 (57,000) (73,000) 10,000 182,000 505,000 2,963,000 0 0 505,000 2,963,000 0 0 505,000 2,963,000           0 27,766,000 27,766,000 0 27,766,000
Derivative Liability, Fair Value, Gross Liability 27,766,000                                                                              
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                                                                                
Balance at beginning of period           0     0                                                              
Purchases into Level 3           36,750,000                                                                    
Issuances into Level 3                 (36,750,000)                                                              
Gains/ (Losses) included in Earnings           (8,984,000)     8,984,000                                                              
Balance at end of period           27,766,000     (27,766,000)                                                              
Cash and cash equivalents 2,584,000   1,759,000 864,000 1,064,000                                                                      
Debt Instrument, Fair Value             113,100,000 148,100,000   20,000,000                                                            
Debt Instrument, Carrying Amount             113,600,000 116,400,000   20,000,000                                                            
Aggregate Principal of convertible notes   $ 150,000,000                                                                            
XML 72 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Financial Information (unaudited) (Tables)
 12 Months Ended
Dec. 31, 2013
Quarterly Financial Information (unaudited) [Abstract]  
Schedule of quarterly financial information

(In thousands, except per share data)
 
  
  
  
 
 
 
  
  
  
 
Year Ended
December 31, 2013
 
First
  
Second
  
Third
  
Fourth
 
 
  
(1)
 
  
(1)
 
  
(2)
 
  
(1)  (2)
 
Revenues
 
$
165,165
  
$
162,270
  
$
166,615
  
$
169,235
 
Gross margin
 
$
15,083
  
$
19,916
  
$
26,391
  
$
18,326
 
Income (loss) before income taxes
 
$
(6,044
)
 
$
(1,650
)
 
$
1,108
  
$
(7,591
)
Net income (loss)
 
$
(3,949
)
 
$
(1,101
)
 
$
1,799
  
$
(5,290
)
 
                
Basic earnings (loss) per share (3)
 
$
(0.12
)
 
$
(0.03
)
 
$
0.05
  
$
(0.15
)
Diluted earnings (loss) per share (3)
 
$
(0.12
)
 
$
(0.03
)
 
$
0.05
  
$
(0.15
)

Year Ended
December 31, 2012
 
First
  
Second
  
Third
  
Fourth
 
 
  
(1)
 
 
  
   
(4)
 
Revenues
 
$
165,218
  
$
170,214
  
$
166,559
  
$
175,180
 
Gross margin
 
$
16,300
  
$
32,061
  
$
30,619
  
$
28,217
 
Income (loss) before income taxes
 
$
(4,116
)
 
$
8,732
  
$
8,542
  
$
1,587
 
Net income (loss)
 
$
(2,665
)
 
$
5,057
  
$
5,028
  
$
604
 
 
                
Basic earnings (loss) per share (3)
 
$
(0.08
)
 
$
0.15
  
$
0.15
  
$
0.02
 
Diluted earnings (loss) per share (3)
 
$
(0.08
)
 
$
0.15
  
$
0.15
  
$
0.02
 

(1) The assumed exercise of stock-based compensation awards for this period was not considered in the calculation of diluted earnings (loss) per share because the impact would have been anti-dilutive.

(2) Includes charges related to non-cash interest associated with amortization of a debt discount of $1.5 million and $1.6 million for the third and fourth quarter, respectively.

(3) We calculated earnings per share for each of the quarters based on the weighted average number of shares and dilutive securities outstanding for each period.  Accordingly, the sum of the quarters may not necessarily be equal to the full year income per share.

(4) Includes charges related to one-time termination benefits associated with capacity realignment of $1.8 million.
XML 73 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]      
Cost of services, depreciation and amortization $ 36,183 $ 36,094 $ 36,248
XML 74 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
1.Summary of Significant Accounting Policies

Healthways, Inc. and its wholly-owned subsidiaries provide specialized, comprehensive solutions to help people improve physical, emotional and social well-being, thereby reducing both direct healthcare costs and associated costs from the loss of health-related employee productivity.  In North America, our customers include health plans, employers, integrated healthcare systems, hospitals, physicians, and government entities in all 50 states and the District of Columbia. We also provide health improvement programs and services in Brazil, Australia, and France.

As used throughout these notes to the consolidated financial statements, unless the context otherwise indicates, the terms "we," "us," "our," or the "Company" refer collectively to Healthways, Inc. and its wholly-owned subsidiaries.
 
a.  Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned by the Company.  We have eliminated all intercompany profits, transactions and balances.

b.  Cash and Cash Equivalents - Cash and cash equivalents primarily include cash, tax-exempt debt instruments, commercial paper, and other short-term investments with original maturities of less than three months.

c.  Accounts Receivable, net - Billed receivables primarily represent fees that are contractually due in the ordinary course of providing our services, net of contractual adjustments and allowances for doubtful accounts.  Unbilled receivables primarily represent fees for services based on the estimated utilization of fitness facilities, which are generally billed in the following month, and certain performance-based fees that are billed when performance metrics are met and reconciled with the customer.  Historically, we have experienced minimal instances of customer non-payment and therefore consider our accounts receivable to be collectible, but we provide reserves, when appropriate, for doubtful accounts and for billing adjustments (such as data reconciliation differences) on a specific identification basis.

d.  Property and Equipment - Property and equipment is carried at cost and includes expenditures that increase value or extend useful lives.  We recognize depreciation using the straight-line method over useful lives of three to seven years for computer software and hardware and four to seven years for furniture and other office equipment.  Leasehold improvements are depreciated over the shorter of the estimated life of the asset or the life of the lease, which ranges from two to fifteen years.  Depreciation expense for the years ended December 31, 2013, 2012, and 2011 was $40.1 million, $39.1 million, and $36.6 million, respectively, including amortization of assets recorded under capital leases.

Net computer software at December 31, 2013 and 2012 was $99.1 million and $103.7 million, respectively.  Depreciation expense related to computer software for the years ended December 31, 2013, 2012, and 2011 was $26.5 million, $24.9 million, and $21.4 million, respectively.

e.  Other Assets - Other assets consist primarily of cash convertible notes hedges, long-term investments, long-term customer incentives, and deferred loan costs net of accumulated amortization.

f.  Intangible Assets - Intangible assets subject to amortization include customer contracts, acquired technology, patents, distributor and provider networks, a perpetual license, and other intangible assets which we amortize on a straight-line basis over estimated useful lives ranging from two to 25 years.  We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable.

Intangible assets not subject to amortization at December 31, 2013 and 2012 consist of a trade name of $29.0 million.  We review intangible assets not subject to amortization on an annual basis or more frequently whenever events or circumstances indicate that the assets might be impaired.  See Note 4 for further information on intangible assets.

g.  Goodwill - We recognize goodwill for the excess of the purchase price over the fair value of tangible and identifiable intangible net assets of businesses that we acquire.

We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable.  We allocate goodwill to reporting units based on the reporting unit expected to benefit from the combination.
 
We estimate the fair value of each reporting unit using a combination of a discounted cash flow model and a market-based approach, and we reconcile the aggregate fair value of our reporting units to our consolidated market capitalization.

h. Contract Billings in Excess of Earned Revenue - Contract billings in excess of earned revenue primarily represent performance-based fees subject to refund that we have not recognized as revenues because either (1) data from the customer is insufficient or incomplete to measure performance; or (2) interim performance measures indicate that we are not currently meeting performance targets.

i. Income Taxes - We file a consolidated federal income tax return that includes all of our domestic wholly owned subsidiaries.  Generally accepted accounting principles in the United States ("U.S. GAAP") generally require that we record deferred income taxes for the tax effect of differences between the book and tax bases of our assets and liabilities.  We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

j. Revenue Recognition - Our fees are generally billed on a per member per month ("PMPM") basis or upon member participation.  For PMPM fees, we generally determine our contract fees by multiplying the contractually negotiated PMPM rate by the number of members covered by our services during the month.  We typically set PMPM rates during contract negotiations with customers based on the value we expect our programs to create and a sharing of that value between the customer and the Company.  In addition, some of our services, such as the Healthways SilverSneakers® fitness solution, include fees that are based upon member participation.

Our contracts with health plans and integrated healthcare systems generally range from three to five years with a number of comprehensive strategic agreements extending to ten years in length.  Contracts with self-insured employers typically have two to four-year terms. Some of our contracts allow the customer to terminate early.

Some of our contracts place a portion of our fees at risk based on achieving certain performance metrics, cost savings, and/or clinical outcomes improvements ("performance-based").  Approximately 4% of revenues recorded during the year ended December 31, 2013 were performance-based of which 3% were subject to final reconciliation as of December 31, 2013.

We recognize revenue as follows: (1) we recognize the fixed portion of PMPM fees and fees for service as revenue during the period we perform our services; and (2) we recognize performance-based revenue based on the most recent assessment of our performance, which represents the amount that the customer would legally be obligated to pay if the contract were terminated as of the latest balance sheet date.

We generally bill our customers each month for the entire amount of the fees contractually due for the prior month's enrollment, which typically includes the amount, if any, that is performance-based and may be subject to refund should we not meet performance targets.  Fees for participation are typically billed in the month after the services are provided.  Deferred revenues arise from contracts that permit upfront billing and collection of fees covering the entire contractual service period, generally 12 months.  A limited number of our contracts provide for certain performance-based fees that cannot be billed until after they are reconciled with the customer.

We generally assess our level of performance for our contracts based on medical claims and other data that the customer is contractually required to supply, interim assessments of achievement against performance targets, or metrics available from our operating platforms.  A minimum of four to nine months' data is typically required for us to measure performance.  In assessing our performance, we may include estimates such as medical claims incurred but not reported.  In addition, we may also provide contractual allowances for billing adjustments (such as data reconciliation differences) as appropriate.

If data is insufficient or incomplete to measure performance, or interim performance measures indicate that we are not meeting performance targets, we do not recognize performance-based fees subject to refund as revenues but instead record them in a current liability account entitled "contract billings in excess of earned revenue."  Only in the event we do not meet performance levels by the end of the measurement period, typically one year, are we contractually obligated to refund some or all of the performance-based fees.  We would only reverse revenues that we had already recognized if performance to date in the measurement period, previously above targeted levels, subsequently dropped below targeted levels.  Historically, any such adjustments have been immaterial to our financial condition and results of operations.
 
During the settlement process under a contract, which generally occurs six to eight months after the end of a contract year, we settle any performance-based fees and reconcile healthcare claims and clinical data.  As of December 31, 2013, cumulative performance-based revenues that have not yet been settled with our customers but that have been recognized in the current and prior years totaled approximately $24.2 million, all of which were based on actual data.  Data reconciliation differences, for which we provide contractual allowances until we reach agreement with respect to identified issues, can arise between the customer and us due to customer data deficiencies, omissions, and/or data discrepancies.

Performance-related adjustments (including any amounts recorded as revenue that were ultimately refunded), changes in estimates, or data reconciliation differences may cause us to recognize or reverse revenue in a current fiscal year that pertains to services provided during a prior fiscal year.  During 2013, 2012 and 2011, we recognized a net increase in revenue of $8.2 million, $9.2 million, and $2.9 million, respectively, that related to services provided prior to each respective year.

k.  Earnings (Loss) Per Share – We calculate basic earnings (loss) per share using weighted average common shares outstanding during the period.  We calculate diluted earnings (loss) per share using weighted average common shares outstanding during the period plus the effect of all dilutive potential common shares outstanding during the period unless the impact would be anti-dilutive.  See Note 14 for a reconciliation of basic and diluted earnings (loss) per share.

l.  Share-Based Compensation – We recognize all share-based payments to employees, including grants of employee stock options, in the consolidated statements of operations over the required vesting period based on estimated fair values at the date of grant.  See Note 13 for further information on share-based compensation.
 
m. Derivative Instruments and Hedging Activities – We use derivative instruments to manage risks related to interest rate swap agreements, foreign currencies, and the cash convertible senior notes (as discussed in Note 6). We account for derivatives in accordance with Financial Accounting Standards Board Standards Board ("FASB")  Accounting Standards Codification ("ASC") Topic 815, which establishes accounting and reporting standards requiring that certain derivative instruments be recorded on the balance sheet as either an asset or liability measured at fair value. Additionally, changes in the derivative's fair value will be recognized currently in earnings unless specific hedge accounting criteria are met. As permitted under our master netting arrangements, the fair value amounts of our interest rate swaps and foreign currency options and/or forward contracts are presented on a net basis by counterparty in the consolidated balance sheets. See Note 7 for further information on derivative instruments and hedging activities.
 
n. Management Estimates – In preparing our consolidated financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect: (1) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements; and (2) the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
XML 75 R58.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Disclosures (Details)
 12 Months Ended
Dec. 31, 2013
Segment
Dec. 31, 2012
Dec. 31, 2011
Segment Disclosures [Abstract]      
Number of reportable segments 1    
Percentage of revenues from one customer (in hundredths) 10.50% 11.50% 17.00%
XML 76 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Disclosures
 12 Months Ended
Dec. 31, 2013
Segment Disclosures [Abstract]  
Segment Disclosures
18.Segment Disclosures

We have aggregated our operating segments into one reportable segment, well-being improvement services.  Our integrated well-being improvement services include disease management, health coaching, and wellness and prevention programs. Further, we report revenues from our external customers on a consolidated basis since well-being improvement is the only service that we provide.

During 2013 and 2012, we derived approximately 10.5% and 11.5%, respectively, of our revenues from one customer and during 2011, we derived approximately 17% of our revenues from a separate customer, with no other customer comprising 10% or more of our revenues.
XML 77 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 270 391 1 true 79 0 false 6 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://healthways.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 010000 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://healthways.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://healthways.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://healthways.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 020100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Sheet http://healthways.com/role/ConsolidatedStatementsOfOperationsParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) false false R6.htm 030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://healthways.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) false false R7.htm 030100 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) Sheet http://healthways.com/role/ConsolidatedStatementsOfComprehensiveIncomeLossParenthetical CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) false false R8.htm 040000 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://healthways.com/role/ConsolidatedStatementOfChangesInStockholdersEquity CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY false false R9.htm 050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://healthways.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R10.htm 060100 - Disclosure - Summary of Significant Accounting Policies Sheet http://healthways.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R11.htm 060200 - Disclosure - Recent Accounting Standards Sheet http://healthways.com/role/RecentAccountingStandards Recent Accounting Standards false false R12.htm 060300 - Disclosure - Goodwill Sheet http://healthways.com/role/Goodwill Goodwill false false R13.htm 060400 - Disclosure - Intangible Assets Sheet http://healthways.com/role/IntangibleAssets Intangible Assets false false R14.htm 060500 - Disclosure - Income Taxes Sheet http://healthways.com/role/IncomeTaxes Income Taxes false false R15.htm 060600 - Disclosure - Long-Term Debt Sheet http://healthways.com/role/LongtermDebt Long-Term Debt false false R16.htm 060700 - Disclosure - Derivative Investments and Hedging Activities Sheet http://healthways.com/role/DerivativeInvestmentsAndHedgingActivities Derivative Investments and Hedging Activities false false R17.htm 060800 - Disclosure - Fair Value Measurements Sheet http://healthways.com/role/FairValueMeasurements Fair Value Measurements false false R18.htm 060900 - Disclosure - Other Long-Term Liabilities Sheet http://healthways.com/role/OtherLongtermLiabilities Other Long-Term Liabilities false false R19.htm 061000 - Disclosure - Restructuring and Related Charges and Impairment Loss Sheet http://healthways.com/role/RestructuringAndRelatedChargesAndImpairmentLoss Restructuring and Related Charges and Impairment Loss false false R20.htm 061100 - Disclosure - Commitments and Contingencies Sheet http://healthways.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R21.htm 061200 - Disclosure - Leases Sheet http://healthways.com/role/Leases Leases false false R22.htm 061300 - Disclosure - Share-Based Compensation Sheet http://healthways.com/role/SharebasedCompensation Share-Based Compensation false false R23.htm 061400 - Disclosure - Earnings (Loss) Per Share Sheet http://healthways.com/role/EarningsLossPerShare Earnings (Loss) Per Share false false R24.htm 061500 - Disclosure - Accumulated OCI Sheet http://healthways.com/role/AccumulatedOci Accumulated OCI false false R25.htm 061600 - Disclosure - Stockholder Rights Plan Sheet http://healthways.com/role/StockholderRightsPlan Stockholder Rights Plan false false R26.htm 061700 - Disclosure - Employee Benefits Sheet http://healthways.com/role/EmployeeBenefits Employee Benefits false false R27.htm 061800 - Disclosure - Segment Disclosures Sheet http://healthways.com/role/SegmentDisclosures Segment Disclosures false false R28.htm 061900 - Disclosure - Quarterly Financial Information (unaudited) Sheet http://healthways.com/role/QuarterlyFinancialInformationUnaudited Quarterly Financial Information (unaudited) false false R29.htm 070100 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://healthways.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R30.htm 080300 - Disclosure - Goodwill (Tables) Sheet http://healthways.com/role/GoodwillTables Goodwill (Tables) false false R31.htm 080400 - Disclosure - Intangible Assets (Tables) Sheet http://healthways.com/role/IntangibleAssetsTables Intangible Assets (Tables) false false R32.htm 080500 - Disclosure - Income Taxes (Tables) Sheet http://healthways.com/role/IncomeTaxesTables Income Taxes (Tables) false false R33.htm 080601 - Disclosure - Long-Term Debt (Tables) Sheet http://healthways.com/role/LongtermDebtTables Long-Term Debt (Tables) false false R34.htm 080700 - Disclosure - Derivative Investments and Hedging Activities (Tables) Sheet http://healthways.com/role/DerivativeInvestmentsAndHedgingActivitiesTables Derivative Investments and Hedging Activities (Tables) false false R35.htm 080800 - Disclosure - Fair Value Measurements (Tables) Sheet http://healthways.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) false false R36.htm 081000 - Disclosure - Restructuring and Related Charges and Impairment Loss (Tables) Sheet http://healthways.com/role/RestructuringAndRelatedChargesAndImpairmentLossTables Restructuring and Related Charges and Impairment Loss (Tables) false false R37.htm 081200 - Disclosure - Leases (Tables) Sheet http://healthways.com/role/LeasesTables Leases (Tables) false false R38.htm 081300 - Disclosure - Share-Based Compensation (Tables) Sheet http://healthways.com/role/SharebasedCompensationTables Share-Based Compensation (Tables) false false R39.htm 081400 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://healthways.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) false false R40.htm 081500 - Disclosure - Accumulated OCI (Tables) Sheet http://healthways.com/role/AccumulatedOciTables Accumulated OCI (Tables) false false R41.htm 081900 - Disclosure - Quarterly Financial Information (unaudited) (Tables) Sheet http://healthways.com/role/QuarterlyFinancialInformationUnauditedTables Quarterly Financial Information (unaudited) (Tables) false false R42.htm 090100 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://healthways.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R43.htm 090300 - Disclosure - Goodwill (Details) Sheet http://healthways.com/role/GoodwillDetails Goodwill (Details) false false R44.htm 090400 - Disclosure - Intangible Assets (Details) Sheet http://healthways.com/role/IntangibleAssetsDetails Intangible Assets (Details) false false R45.htm 090500 - Disclosure - Income Taxes (Details) Sheet http://healthways.com/role/IncomeTaxesDetails Income Taxes (Details) false false R46.htm 090600 - Disclosure - Long-Term Debt (Details) Sheet http://healthways.com/role/LongtermDebtDetails Long-Term Debt (Details) false false R47.htm 090602 - Disclosure - Long-Term Debt, Line of Credit and Term Loan (Details) Sheet http://healthways.com/role/LongtermDebtLineOfCreditAndTermLoanDetails Long-Term Debt, Line of Credit and Term Loan (Details) false false R48.htm 090700 - Disclosure - Derivative Investments and Hedging Activities (Details) Sheet http://healthways.com/role/DerivativeInvestmentsAndHedgingActivitiesDetails Derivative Investments and Hedging Activities (Details) false false R49.htm 090800 - Disclosure - Fair Value Measurements (Details) Sheet http://healthways.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) false false R50.htm 090900 - Disclosure - Other Long-Term Liabilities (Details) Sheet http://healthways.com/role/OtherLongtermLiabilitiesDetails Other Long-Term Liabilities (Details) false false R51.htm 091000 - Disclosure - Restructuring and Related Charges and Impairment Loss (Details) Sheet http://healthways.com/role/RestructuringAndRelatedChargesAndImpairmentLossDetails Restructuring and Related Charges and Impairment Loss (Details) false false R52.htm 091100 - Disclosure - Commitments and Contingencies (Details) Sheet http://healthways.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R53.htm 091200 - Disclosure - Leases (Details) Sheet http://healthways.com/role/LeasesDetails Leases (Details) false false R54.htm 091300 - Disclosure - Share-Based Compensation (Details) Sheet http://healthways.com/role/SharebasedCompensationDetails Share-Based Compensation (Details) false false R55.htm 091400 - Disclosure - Earnings (Loss) Per Share (Details) Sheet http://healthways.com/role/EarningsLossPerShareDetails Earnings (Loss) Per Share (Details) false false R56.htm 091500 - Disclosure - Accumulated OCI (Details) Sheet http://healthways.com/role/AccumulatedOciDetails Accumulated OCI (Details) false false R57.htm 091700 - Disclosure - Employee Benefits (Details) Sheet http://healthways.com/role/EmployeeBenefitsDetails Employee Benefits (Details) false false R58.htm 091800 - Disclosure - Segment Disclosures (Details) Sheet http://healthways.com/role/SegmentDisclosuresDetails Segment Disclosures (Details) false false R59.htm 091900 - Disclosure - Quarterly Financial Information (unaudited) (Details) Sheet http://healthways.com/role/QuarterlyFinancialInformationUnauditedDetails Quarterly Financial Information (unaudited) (Details) false false All Reports Book All Reports Element us-gaap_ConcentrationRiskPercentage1 had a mix of decimals attribute values: 2 3. Element us-gaap_DebtInstrumentCarryingAmount had a mix of decimals attribute values: -6 -5. Element us-gaap_DebtInstrumentInterestRateStatedPercentage had a mix of decimals attribute values: 3 4. Element us-gaap_DebtInstrumentUnamortizedDiscount had a mix of decimals attribute values: -5 -4 0. Element us-gaap_LongTermDebtFairValue had a mix of decimals attribute values: -6 -5. Element us-gaap_PaymentsForDerivativeInstrumentFinancingActivities had a mix of decimals attribute values: -4 -3. Element us-gaap_PropertyPlantAndEquipmentNet had a mix of decimals attribute values: -5 -3. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate had a mix of decimals attribute values: 2 3. 'Monetary' elements on report '090100 - Disclosure - Summary of Significant Accounting Policies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090300 - Disclosure - Goodwill (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090400 - Disclosure - Intangible Assets (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090500 - Disclosure - Income Taxes (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090600 - Disclosure - Long-Term Debt (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090800 - Disclosure - Fair Value Measurements (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '091000 - Disclosure - Restructuring and Related Charges and Impairment Loss (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '091200 - Disclosure - Leases (Details)' had a mix of different decimal attribute values. 'Shares' elements on report '091300 - Disclosure - Share-Based Compensation (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '091300 - Disclosure - Share-Based Compensation (Details)' had a mix of different decimal attribute values. Process Flow-Through: 010000 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: 020100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Process Flow-Through: 030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: 030100 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) Process Flow-Through: 050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS hway-20131231.xml hway-20131231.xsd hway-20131231_cal.xml hway-20131231_def.xml hway-20131231_lab.xml hway-20131231_pre.xml true true XML 78 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2013
Share-Based Compensation [Abstract]  
Allocated share-based compensation costs
Following are certain amounts recognized in the consolidated statements of operations for share-based compensation arrangements for the years ended December 31, 2013, 2012, and 2011.  We did not capitalize any share-based compensation costs during these periods.

 
 
Year Ended
 
 
 
December 31,
  
December 31,
 
December 31,
 
(In millions)
 
2013
  
2012
 
2011
 
Total share-based compensation
 
$
7.1
  
$
6.4
  
$
9.2
 
Share-based compensation included in cost of services
  
2.9
   
3.0
   
4.1
 
Share-based compensation included in selling, general and administrative expenses
  
4.2
   
3.4
   
4.5
 
Share-based compensation included in restructuring and related charges
  
—
   
—
   
0.6
 
Total income tax benefit recognized
  
2.8
   
2.5
   
3.6
 
Weighted average grant-date fair values of options and the weighted average assumptions used
The following table sets forth the weighted average grant-date fair values of options and the weighted average assumptions we used to develop the fair value estimates under each of the option valuation models for the years ended December 31, 2013, 2012 and 2011:

 
 
Year Ended December 31,
 
 
 
2013
  
2012
  
2011
 
Weighted average grant-date fair value of options per share
 
$
7.29
  
$
4.01
  
$
5.94
 
 
            
Assumptions:
            
Expected volatility
  
53.8
%
  
54.4
%
  
53.0
%
Expected dividends
  
—
   
—
   
—
 
Expected term (in years)
  
5.1
   
5.1
   
5.6
 
Risk-free rate
  
1.9
%
  
2.0
%
  
2.4
%
Summary of option activity
A summary of option activity as of December 31, 2013 and the changes during the year then ended is presented below:

Options
 
Shares (thousands)
  
Weighted
Average Exercise
Price Per Share
  
Weighted Average
Remaining Contractual Term
  
Aggregate  Intrinsic Value (thousands)
 
Outstanding at January 1, 2013
  
4,689
  
$
15.65
  
  
 
Granted
  
1,085
   
13.26
  
  
 
Exercised
  
(1,077
)
  
14.25
  
  
 
Forfeited
  
(163
)
  
11.34
  
  
 
Expired
  
(209
)
  
25.50
  
  
 
Outstanding at December 31, 2013
  
4,325
  
$
15.09
   
6.4
  
$
13,182
 
Exercisable at December 31, 2013
  
2,032
  
$
19.21
   
4.3
  
$
3,992
 
Summary of nonvested shares
The following table sets forth a summary of our nonvested shares as of December 31, 2013 as well as activity during the year then ended.  The total grant-date fair value of shares vested during the years ended December 31, 2013, 2012 and 2011 was $3.1 million, $3.6 million, and $7.4 million, respectively.

Nonvested Shares
 
Shares (thousands)
  
Weighted Average Grant Date Fair Value Per Share
 
Nonvested at January 1, 2013
  
1,013
  
$
9.93
 
Granted
  
186
   
13.12
 
Vested
  
(293
)
  
10.43
 
Forfeited
  
(65
)
  
10.15
 
Nonvested at December 31, 2013
  
841
  
$
10.44
 
XML 79 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2013
Commitments and Contingencies [Abstract]  
Commitments and Contingencies
11.Commitments and Contingencies

Contract Disputes

We currently are involved in a contractual dispute with Blue Cross Blue Shield of Minnesota regarding fees paid to us as part of a former contractual relationship.  On January 25, 2010, Blue Cross Blue Shield of Minnesota issued notice of arbitration with the American Arbitration Association in Minneapolis in accordance with the terms of the contract alleging violations of certain contract provisions and seeking recoupment of an unspecified amount of payments made to us under the contract. We believe we performed our services in compliance with the terms of our agreement and that the assertions made in the arbitration notice are without merit.  On August 3, 2011, we asserted numerous counterclaims against Blue Cross Blue Shield of Minnesota. The arbitration hearing concluded on October 23, 2013.  During and after the conclusion of the arbitration hearing in October, the parties entered into settlement negotiations to resolve all claims in dispute. The parties have jointly requested that the arbitrator not issue any award or decision while the parties are engaged in settlement discussions. We cannot predict whether these discussions will result in a settlement. 
 
We are involved in a contractual dispute with Plastipak Packaging, Inc. ("Plastipak"). On September 10, 2012, Plastipak filed suit in the Circuit Court for Wayne County, Michigan seeking damages relating to an alleged breach of a services agreement with us.  The case is currently in the discovery phase of litigation.  We deny Plastipak's claims and intend to vigorously defend the action. 
 
Performance Award Lawsuit

On September 4, 2012, Milton Pfeiffer ("Plaintiff"), claiming to be a stockholder of the Company, filed a putative derivative action against the Company and the Board of Directors (the "Board") in Delaware Chancery Court (the "Court") alleging that the Compensation Committee of the Board and the Board breached their fiduciary duties and violated the Company's 2007 Stock Incentive Plan (the "Plan") by granting Ben R. Leedle, Jr., Chief Executive Officer and President of the Company, discretionary performance awards under the Plan in the form of options to purchase an aggregate of 500,000 shares of the Company's common stock, which consisted of a performance award in November 2011 granting Mr. Leedle the right to purchase 365,000 shares and a performance award in February 2012 granting Mr. Leedle the right to purchase 135,000 shares (the "Performance Awards").  Plaintiff alleges that the Performance Awards exceeded what is authorized by the Plan and that the Company's 2012 proxy statement, in which the Performance Awards are disclosed, is false and misleading.  Plaintiff also alleges that Mr. Leedle breached his fiduciary duties and was unjustly enriched by receiving the Performance Awards.  Plaintiff is seeking, among other things, the rescission or disgorgement of all alleged "excess" awards granted to Mr. Leedle under the Performance Awards, to recover any incidental damages to the Company, and an award of attorneys' fees and expenses.  On November 2, 2012, the Company and the Board filed a Motion to Dismiss because Plaintiff failed to make a demand upon the Board as required by Delaware law.  On November 8, 2013, the Court denied the Company's Motion to Dismiss. On February 21, 2014, the Company filed its answer and intends to vigorously defend the allegations.

Outlook

We are also subject to other contractual disputes, claims and legal proceedings that arise from time to time in the ordinary course of our business.  While we are unable to estimate a range of potential losses, we do not believe that any of such legal proceedings pending against us as of the date of this report will have a material adverse effect on our liquidity or financial condition.  As these matters are subject to inherent uncertainties, our view of these matters may change in the future.

Contractual Commitments

We entered into a 25-year strategic relationship agreement with Gallup in January 2008 and a 5-year global joint venture agreement with Gallup in October 2012.  We have minimum remaining contractual cash obligations of $42.0 million related to these agreements.
 
In May 2011, we entered into a ten-year applications and technology services outsourcing agreement with HP Enterprise Services, LLC that contains minimum fee requirements.  Total payments over the remaining term, including an estimate for future contractual cost of living adjustments, must equal or exceed a minimum level of approximately $142.2 million; however, based on initial required service and equipment level assumptions, we estimate that the remaining payments will be approximately $297.6 million.  The agreement allows us to terminate all or a portion of the services after the first two years provided we pay certain termination fees, which could be material to the Company.